data_2b1o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b1o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.102 0.477 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.39 139.7 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -15.94 34.32 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.464 -1.397 . . . . 0.0 113.42 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -108.48 2.09 22.03 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.09 2.156 . . . . 0.0 113.349 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -144.89 175.45 10.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.854 2.062 . . . . 0.0 110.24 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.25 158.33 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.141 -0.974 . . . . 0.0 111.124 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -149.44 143.92 26.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.356 0.662 . . . . 0.0 112.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -134.79 131.36 37.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.418 1.887 . . . . 0.0 109.362 -165.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.32 137.39 51.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.604 1.562 . . . . 0.0 110.286 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.94 45.23 0.7 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.809 1.644 . . . . 0.0 112.901 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.15 132.92 2.12 Favored Glycine 0 CA--C 1.519 0.306 0 O-C-N 120.282 -1.511 . . . . 0.0 111.527 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 148.14 7.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 110.722 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.48 25.97 13.67 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m 63.98 72.33 0.46 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.567 2.347 . . . . 0.0 114.803 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -137.18 -179.4 5.69 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.311 1.445 . . . . 0.0 112.382 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -72.76 2.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.436 1.493 . . . . 0.0 115.466 169.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.36 165.23 28.51 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.69 1.996 . . . . 0.0 108.933 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -127.02 154.16 44.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.531 1.132 . . . . 0.0 112.609 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 146.23 20.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.853 1.661 . . . . 0.0 109.897 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.27 141.71 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.356 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.44 129.37 31.03 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.766 1.226 . . . . 0.0 110.592 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.89 158.97 34.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.37 0.605 . . . . 0.0 111.518 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.0 147.3 47.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.574 -0.704 . . . . 0.0 111.622 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.6 45.55 75.99 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.653 0.644 . . . . 0.0 113.493 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.74 159.46 39.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.907 0.883 . . . . 0.0 112.117 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.3 m -136.52 132.93 35.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.937 1.295 . . . . 0.0 108.449 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.58 159.69 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.767 1.227 . . . . 0.0 110.883 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -130.2 118.94 22.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 108.303 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 m0 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 122.181 0.991 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.47 -38.34 71.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.455 1.102 . . . . 0.0 110.673 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -39.44 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.035 2.534 . . . . 0.0 111.717 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.8 42.25 0.39 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 112.654 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -148.03 155.34 41.38 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 122.542 1.163 . . . . 0.0 111.511 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -152.91 -45.45 0.1 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.229 163.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -120.45 129.43 53.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.448 1.022 . . . . 0.0 109.58 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 p -140.78 158.33 44.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.167 0.984 . . . . 0.0 112.391 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.95 134.48 47.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.966 1.306 . . . . 0.0 108.269 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.76 105.23 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.304 1.442 . . . . 0.0 108.573 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.19 152.81 6.39 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.217 1.389 . . . . 0.0 114.96 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -64.31 -2.83 2.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -135.63 29.7 3.21 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.329 1.451 . . . . 0.0 112.238 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.5 155.13 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.816 2.446 . . . . 0.0 109.996 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -125.54 152.76 44.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.514 1.526 . . . . 0.0 109.569 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 m -116.46 149.55 39.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.267 1.032 . . . . 0.0 110.423 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.35 120.99 19.45 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.74 1.616 . . . . 0.0 107.521 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.9 pt -116.79 137.71 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 123.561 0.744 . . . . 0.0 109.973 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 116.14 12.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -43.03 -69.52 0.13 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.755 2.022 . . . . 0.0 115.051 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.81 35.96 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.906 0.882 . . . . 0.0 109.495 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.283 0.6 OUTLIER 42.21 57.71 3.21 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.092 1.757 . . . . 0.0 112.546 178.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.22 131.36 48.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.466 1.506 . . . . 0.0 113.279 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -93.21 38.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.388 1.475 . . . . 0.0 111.719 -167.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.33 50.9 m-20 55.05 46.42 24.19 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 123.691 1.71 . . . . 0.0 112.166 -168.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.69 171.88 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.585 2.354 . . . . 0.0 110.86 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.25 7.34 0.87 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.103 2.536 . . . . 0.0 114.972 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -137.98 112.03 8.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 124.978 1.311 . . . . 0.0 110.769 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.81 125.44 13.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.59 -120.83 0.08 OUTLIER Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.744 1.164 . . . . 0.0 111.423 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.152 0.981 . . . . 0.0 111.052 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -154.07 139.53 17.74 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.402 1.081 . . . . 0.0 112.583 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.68 141.83 27.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.823 0.82 . . . . 0.0 110.199 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.6 79.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -46.52 102.66 0.03 OUTLIER 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.947 2.099 . . . . 0.0 110.773 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.28 126.53 23.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.414 . . . . 0.0 111.558 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -55.5 109.53 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.216 1.406 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.52 55.8 1.99 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.966 0.793 . . . . 0.0 114.481 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.44 163.53 36.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.981 0.891 . . . . 0.0 113.138 174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.0 m -123.61 133.74 53.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.713 1.605 . . . . 0.0 108.985 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -119.72 102.85 8.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.079 1.751 . . . . 0.0 109.015 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -71.79 -24.33 61.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -151.69 137.73 18.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.89 1.676 . . . . 0.0 110.203 171.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.14 14.33 7.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.436 1.495 . . . . 0.0 112.537 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -53.89 -19.49 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.249 1.82 . . . . 0.0 115.256 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -48.61 -29.65 4.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 162.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.0 mt -133.0 58.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 128.963 2.905 . . . . 0.0 108.003 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -52.47 -29.98 27.6 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.149 -0.97 . . . . 0.0 112.248 163.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.42 103.55 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.662 1.125 . . . . 0.0 112.892 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 43.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -52.25 -18.54 1.58 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 120.007 -1.683 . . . . 0.0 115.4 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -113.55 141.67 46.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.018 2.127 . . . . 0.0 111.581 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -128.89 134.65 48.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.949 2.099 . . . . 0.0 109.365 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -125.72 129.29 49.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.171 1.788 . . . . 0.0 109.288 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.27 116.1 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.419 1.487 . . . . 0.0 108.203 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.6 mt -127.77 140.81 39.16 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.771 0.828 . . . . 0.0 110.808 -167.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.72 164.61 35.12 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.885 2.39 . . . . 0.0 112.812 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.1 -24.77 58.96 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 113.912 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.12 68.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.129 1.372 . . . . 0.0 114.389 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -123.23 116.28 23.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.232 1.413 . . . . 0.0 110.722 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.14 -44.23 65.99 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.197 -0.94 . . . . 0.0 112.161 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 162.6 40.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.514 1.926 . . . . 0.0 109.155 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.57 157.06 45.58 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.478 -0.764 . . . . 0.0 110.393 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.77 132.6 68.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.805 0.842 . . . . 0.0 109.95 -169.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.28 128.19 34.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -126.62 145.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.17 1.388 . . . . 0.0 108.27 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -149.79 157.99 43.74 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.19 134.37 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.113 1.765 . . . . 0.0 106.973 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.43 135.64 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.035 0.921 . . . . 0.0 110.745 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -79.09 122.1 25.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.982 0.913 . . . . 0.0 112.343 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -110.93 -3.12 15.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.464 1.506 . . . . 0.0 112.696 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.4 t -138.46 -48.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 126.115 1.766 . . . . 0.0 112.699 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -74.51 80.22 1.95 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.328 0.967 . . . . 0.0 112.189 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -68.53 53.34 0.08 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.471 2.308 . . . . 0.0 114.069 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.9 m -137.53 -45.01 0.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.674 1.99 . . . . 0.0 111.642 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 56.94 158.51 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.013 2.125 . . . . 0.0 115.609 -172.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.75 -38.08 0.38 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.856 2.646 . . . . 0.0 115.039 -176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.4 p -67.75 -6.6 21.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.577 2.751 . . . . 0.0 114.795 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -115.6 113.61 23.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.232 2.613 . . . . 0.0 108.686 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -120.67 121.17 37.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.128 1.371 . . . . 0.0 110.079 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 ttp -107.62 139.22 42.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.967 0.507 . . . . 0.0 111.563 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -126.4 122.62 35.86 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.467 1.507 . . . . 0.0 108.531 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -122.66 137.93 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.224 1.01 . . . . 0.0 109.051 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -140.33 100.19 7.02 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.506 1.122 . . . . 0.0 110.282 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.16 162.12 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.319 2.012 . . . . 0.0 111.458 168.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -26.08 93.61 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.288 2.635 . . . . 0.0 115.852 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 47.24 42.82 14.06 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.792 1.637 . . . . 0.0 114.664 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.54 163.89 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.874 2.07 . . . . 0.0 110.955 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.25 94.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.177 1.791 . . . . 0.0 111.658 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.66 36.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 111.199 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.6 p -123.53 131.69 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.122 0.569 . . . . 0.0 109.972 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.08 133.65 55.24 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.327 1.451 . . . . 0.0 109.165 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -139.45 146.48 40.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.464 1.105 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -104.5 127.99 52.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.211 1.404 . . . . 0.0 109.033 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -49.2 103.81 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.841 1.656 . . . . 0.0 111.893 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 135.29 -26.71 3.2 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.997 0.808 . . . . 0.0 113.732 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.39 159.14 18.86 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.156 0.978 . . . . 0.0 111.113 162.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -64.29 171.47 3.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 0.0 112.054 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -50.29 130.58 23.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.202 -0.936 . . . . 0.0 111.152 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.84 153.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 109.313 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -108.84 129.57 55.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.61 89.86 13.76 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.35 1.46 . . . . 0.0 108.671 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.75 149.24 60.23 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.079 1.853 . . . . 0.0 112.048 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.4 mt -127.52 128.27 24.0 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.495 1.918 . . . . 0.0 106.81 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.25 -175.26 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.527 2.818 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 110.86 0.38 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.315 1.046 . . . . 0.0 111.484 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 tp -121.17 75.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.169 1.388 . . . . 0.0 109.743 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 m -107.45 131.63 21.57 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.317 1.047 . . . . 0.0 110.557 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.51 152.28 94.07 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.577 0.885 . . . . 0.0 112.081 -4.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.72 -40.29 74.33 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.653 2.236 . . . . 0.0 113.061 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.25 -4.22 10.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.575 1.55 . . . . 0.0 114.88 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 p -62.14 157.77 18.39 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.457 1.026 . . . . 0.0 111.11 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -105.3 110.61 23.04 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.696 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.7 tt -77.96 122.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.211 1.005 . . . . 0.0 109.049 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.46 138.87 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.431 0.692 . . . . 0.0 110.784 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -147.47 158.82 44.14 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.045 0.926 . . . . 0.0 112.439 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.94 133.86 54.37 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.521 1.129 . . . . 0.0 109.459 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.9 124.3 42.91 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.868 1.667 . . . . 0.0 107.606 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.2 t -139.54 134.6 32.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.891 0.853 . . . . 0.0 109.753 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.91 130.27 52.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.845 0.831 . . . . 0.0 109.135 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -143.63 130.04 19.98 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.619 1.568 . . . . 0.0 109.327 -168.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -64.34 135.17 55.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 109.481 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.2 p -88.76 10.18 21.84 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.37 1.068 . . . . 0.0 113.004 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -141.13 145.65 36.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.711 2.404 . . . . 0.0 109.635 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.2 t -63.76 135.0 96.09 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 121.829 -0.544 . . . . 0.0 111.859 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.57 125.47 10.26 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.666 0.917 . . . . 0.0 112.454 -6.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.84 25.11 11.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.368 1.867 . . . . 0.0 113.644 -170.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.16 159.85 9.08 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.079 -1.013 . . . . 0.0 111.939 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -58.16 107.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.744 0.817 . . . . 0.0 110.857 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 81.1 t -60.02 -55.01 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.877 1.271 . . . . 0.0 109.334 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.69 147.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.408 1.083 . . . . 0.0 110.299 164.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -136.63 120.68 17.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.894 1.678 . . . . 0.0 107.833 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.79 -173.07 31.06 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 122.1 0.833 . . . . 0.0 112.869 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.0 m -118.02 161.91 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.638 1.209 . . . . 0.0 111.224 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.25 164.6 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.731 2.412 . . . . 0.0 106.656 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -132.21 131.89 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.11 152.51 23.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -144.71 146.5 32.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.229 1.812 . . . . 0.0 109.842 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -119.46 151.95 37.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.963 1.305 . . . . 0.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 55.8 m -137.46 112.15 9.18 Favored Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 110.427 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.33 -15.43 20.03 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.487 2.791 . . . . 0.0 112.061 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.6 m -43.79 -42.31 5.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.421 2.689 . . . . 0.0 112.36 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.8 p -145.32 27.65 1.25 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.235 1.414 . . . . 0.0 113.069 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 45.29 41.65 8.59 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 120.258 -1.526 . . . . 0.0 113.997 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -87.74 137.74 32.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.3 1.44 . . . . 0.0 109.05 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.15 140.9 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -135.15 139.14 44.38 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.809 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.7 135.25 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 110.397 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.3 123.44 69.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 126.211 1.805 . . . . 0.0 106.751 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -139.46 124.98 19.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.895 1.678 . . . . 0.0 107.207 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -128.65 152.97 47.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 109.331 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -17.98 54.41 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.95 -18.74 62.62 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.649 1.58 . . . . 0.0 114.72 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.8 p -132.51 -50.86 0.92 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 112.89 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.42 142.17 40.13 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.319 1.448 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.86 164.91 34.24 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.468 2.112 . . . . 0.0 111.623 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -93.87 8.06 42.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.821 1.248 . . . . 0.0 112.854 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.303 1.441 . . . . 0.0 113.197 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -114.83 149.69 36.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.111 1.764 . . . . 0.0 107.267 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.2 p -133.21 161.77 33.55 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.771 0.828 . . . . 0.0 108.966 165.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 207' ' ' PHE . 8.0 p -129.28 125.79 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.818 0.847 . . . . 0.0 109.004 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 10.0 t -104.7 144.19 32.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.9 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -82.89 80.18 9.03 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.569 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.23 -36.56 75.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.698 1.199 . . . . 0.0 112.538 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -150.55 173.44 14.09 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.133 1.773 . . . . 0.0 111.691 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.05 128.78 28.64 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.126 -1.609 . . . . 0.0 108.983 165.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.0 m 60.34 24.4 13.89 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 119.78 14.28 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.685 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -127.81 124.56 37.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 110.953 -167.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.42 100.19 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.643 0.777 . . . . 0.0 109.774 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 197' ' ' VAL . 96.0 m-85 -76.01 125.18 28.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.866 1.267 . . . . 0.0 110.248 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -121.93 126.88 49.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.913 1.285 . . . . 0.0 111.377 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 211' ' ' SER . 1.3 tm? -92.96 109.66 21.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.233 1.013 . . . . 0.0 110.92 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -110.62 10.74 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.466 1.506 . . . . 0.0 113.914 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.518 ' H ' HD12 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -168.04 109.91 0.59 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.696 1.998 . . . . 0.0 111.544 -178.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.86 -23.61 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 119.56 -1.963 . . . . 0.0 114.409 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 126.619 1.968 . . . . 0.0 111.865 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.77 150.28 41.82 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.592 -0.692 . . . . 0.0 110.33 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -22.35 27.59 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.185 -0.947 . . . . 0.0 113.414 172.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.93 15.96 17.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.558 1.943 . . . . 0.0 113.332 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -140.63 169.3 17.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.876 1.27 . . . . 0.0 110.279 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.3 t -131.46 148.4 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.898 0.879 . . . . 0.0 109.17 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 151.42 49.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.78 0.832 . . . . 0.0 110.842 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -145.15 127.09 15.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.651 -164.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.0 140.28 42.02 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 123.766 1.746 . . . . 0.0 111.198 -169.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.86 44.79 0.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 111.384 -168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.76 159.14 26.62 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.293 1.901 . . . . 0.0 110.44 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.81 139.18 58.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 111.337 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 t30 51.21 36.83 16.86 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.86 1.264 . . . . 0.0 114.056 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.8 m 61.85 64.46 1.01 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.218 1.807 . . . . 0.0 114.57 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 p -122.38 -44.91 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -69.86 1.36 Allowed Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.973 1.26 . . . . 0.0 113.624 -169.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -133.13 169.88 16.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.452 1.501 . . . . 0.0 109.772 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -136.42 149.67 48.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.891 1.277 . . . . 0.0 112.559 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 161.76 41.82 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.316 1.846 . . . . 0.0 110.912 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -134.01 141.07 47.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.17 1.388 . . . . 0.0 110.148 -175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.61 140.6 46.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.51 . . . . 0.0 109.986 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.93 147.22 23.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.903 0.881 . . . . 0.0 110.721 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -66.62 131.86 46.9 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.444 -0.785 . . . . 0.0 110.718 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.17 54.7 3.29 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.838 -0.423 . . . . 0.0 113.402 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.12 157.84 45.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.929 . . . . 0.0 112.088 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -132.93 127.44 34.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.664 1.186 . . . . 0.0 108.033 172.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.52 142.36 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.39 1.076 . . . . 0.0 109.747 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -135.64 119.23 17.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.521 1.128 . . . . 0.0 109.052 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--N 1.322 -0.589 0 C-N-CA 126.05 1.74 . . . . 0.0 107.98 -173.211 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.4 m0 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -53.76 9.57 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.379 1.471 . . . . 0.0 110.399 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.68 -12.43 61.39 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -30.7 14.82 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.623 -1.298 . . . . 0.0 112.66 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.2 157.44 3.51 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 122.924 1.345 . . . . 0.0 114.303 173.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 -38.49 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.345 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -132.84 149.21 52.29 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.092 0.949 . . . . 0.0 112.682 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.5 p -151.84 143.92 23.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.72 0.772 . . . . 0.0 110.825 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.14 118.93 34.74 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -109.36 110.98 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.17 1.388 . . . . 0.0 108.841 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.83 166.91 4.53 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 122.901 1.278 . . . . 0.0 114.125 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.97 -27.51 64.78 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.873 -1.369 . . . . 0.0 114.647 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -121.47 36.26 4.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.243 1.817 . . . . 0.0 110.786 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.88 135.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.182 2.193 . . . . 0.0 109.956 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 150.58 28.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 109.315 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.36 152.23 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.819 0.819 . . . . 0.0 110.897 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -138.76 122.51 17.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.534 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.98 128.03 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.927 0.891 . . . . 0.0 110.284 -173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.82 113.42 10.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.676 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.34 -38.65 69.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.103 1.361 . . . . 0.0 113.628 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.64 174.3 15.18 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.982 1.313 . . . . 0.0 109.47 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -63.33 -66.57 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.832 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.264 0.6 OUTLIER 50.72 169.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.961 2.504 . . . . 0.0 117.225 -174.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.414 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 pt -152.06 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 126.623 1.969 . . . . 0.0 112.064 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 67.72 36.84 3.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.885 2.074 . . . . 0.0 111.589 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 60' ' ' ILE . 3.9 p -67.95 165.55 31.18 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.712 2.005 . . . . 0.0 110.373 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.86 19.59 0.28 Allowed 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.137 2.558 . . . . 0.0 114.142 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -149.23 60.18 4.5 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.0 112.306 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.99 140.13 49.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.028 1.818 . . . . 0.0 111.992 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.87 -115.45 1.36 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.282 1.42 . . . . 0.0 112.055 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 148.73 41.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.067 1.347 . . . . 0.0 112.265 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.03 137.69 23.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.252 1.821 . . . . 0.0 109.044 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -155.59 167.96 28.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.6 1.16 . . . . 0.0 110.754 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -127.53 108.25 10.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.401 1.48 . . . . 0.0 109.773 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.99 98.62 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.053 1.341 . . . . 0.0 109.607 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 142.94 25.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.421 1.489 . . . . 0.0 113.09 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 147.25 16.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.464 1.506 . . . . 0.0 113.458 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.64 45.18 96.83 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.709 0.671 . . . . 0.0 114.294 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.16 163.97 38.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.307 1.043 . . . . 0.0 112.385 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -137.06 142.61 42.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.33 1.052 . . . . 0.0 109.094 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -131.22 129.45 41.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.243 1.017 . . . . 0.0 108.289 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -129.37 -16.87 3.85 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.36 59.22 1.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.146 1.779 . . . . 0.0 110.391 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.94 10.04 11.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.123 2.569 . . . . 0.0 112.258 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -16.79 4.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.977 1.311 . . . . 0.0 112.952 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.6 m -46.32 -30.24 1.99 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.328 1.851 . . . . 0.0 114.639 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.06 -29.95 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 20.91 58.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 129.737 3.215 . . . . 0.0 114.022 -168.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.56 82.29 0.08 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -163.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 tt -126.2 45.68 2.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.284 1.433 . . . . 0.0 112.159 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -67.21 -34.77 78.2 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 119.876 -1.765 . . . . 0.0 113.236 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -117.42 128.42 55.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.628 1.171 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -122.32 123.67 41.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 109.556 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 125.92 54.69 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.31 121.84 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.874 1.27 . . . . 0.0 107.859 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -125.42 150.82 68.82 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.403 1.081 . . . . 0.0 109.893 -172.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.82 168.9 21.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.598 2.199 . . . . 0.0 111.448 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.46 40.07 1.08 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.691 2.091 . . . . 0.0 114.985 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.83 -43.24 0.15 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.483 1.913 . . . . 0.0 111.504 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.6 129.95 34.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.249 1.019 . . . . 0.0 109.48 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -86.85 -36.38 18.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.439 0.696 . . . . 0.0 112.224 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -148.22 156.43 42.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.215 2.206 . . . . 0.0 108.102 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.44 131.47 34.12 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -102.99 133.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 C-N-CA 124.605 1.162 . . . . 0.0 110.754 -175.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.47 135.96 36.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.13 150.98 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.897 -0.502 . . . . 0.0 110.418 167.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -139.18 149.0 43.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.225 1.01 . . . . 0.0 111.229 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.5 mt -109.46 128.75 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.196 1.798 . . . . 0.0 108.308 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.23 111.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.492 1.517 . . . . 0.0 109.232 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -65.98 141.7 58.1 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.737 -0.602 . . . . 0.0 110.574 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.3 23.95 3.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.182 1.393 . . . . 0.0 111.628 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.07 -56.12 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.326 1.85 . . . . 0.0 112.155 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -129.31 108.75 10.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.961 1.304 . . . . 0.0 110.028 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.4 t -71.75 89.69 1.04 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 0.0 111.029 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -149.41 -39.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.8 1.24 . . . . 0.0 111.865 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 54.5 172.99 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.232 1.813 . . . . 0.0 114.432 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.68 -42.29 0.56 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.716 1.627 . . . . 0.0 115.816 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -64.49 -28.6 69.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.572 1.549 . . . . 0.0 113.901 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -88.31 115.18 25.62 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.513 1.125 . . . . 0.0 109.644 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.69 123.22 49.38 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.317 1.447 . . . . 0.0 108.898 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -113.52 130.83 56.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.824 0.849 . . . . 0.0 110.116 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.5 m -123.46 132.58 53.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.506 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.73 127.77 71.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -123.87 88.68 52.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.786 1.634 . . . . 0.0 108.417 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.47 163.98 35.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 111.944 172.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -36.36 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.626 2.37 . . . . 0.0 114.055 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 38.95 46.57 1.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.658 1.583 . . . . 0.0 114.699 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.45 156.34 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.499 1.92 . . . . 0.0 109.589 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -45.14 93.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.609 1.963 . . . . 0.0 113.03 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 155.44 24.13 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.328 1.051 . . . . 0.0 110.663 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.52 146.57 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.382 0.61 . . . . 0.0 110.222 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -122.72 134.27 54.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.781 1.232 . . . . 0.0 108.417 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.5 t -134.7 149.76 50.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 145.13 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -48.26 127.53 12.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.247 1.019 . . . . 0.0 109.617 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.34 48.9 4.62 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.78 167.32 21.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.408 1.483 . . . . 0.0 110.968 169.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -59.49 154.69 16.66 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.585 -0.697 . . . . 0.0 111.056 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -47.87 126.05 9.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 111.253 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 123.6 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.326 0.584 . . . . 0.0 110.017 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -75.79 129.86 37.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 110.365 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.9 tp -119.3 106.4 42.86 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.116 1.766 . . . . 0.0 108.104 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 142.73 39.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.669 2.246 . . . . 0.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.3 mm -134.18 127.08 18.86 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.292 1.037 . . . . 0.0 109.183 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.02 176.62 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.783 2.989 . . . . 0.0 112.777 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -80.24 144.64 32.73 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.522 -0.736 . . . . 0.0 111.434 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.44 48.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.857 1.663 . . . . 0.0 111.447 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -47.62 136.55 9.96 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 125.032 1.333 . . . . 0.0 113.785 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.1 143.72 77.14 Favored 'Cis proline' 0 CA--C 1.543 0.966 0 CA-C-N 119.963 1.023 . . . . 0.0 111.747 -1.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.03 -16.49 45.08 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.479 2.119 . . . . 0.0 113.96 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -3.09 5.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.546 1.139 . . . . 0.0 113.978 168.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 m -66.85 124.16 22.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.969 -1.082 . . . . 0.0 111.267 163.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -64.22 133.0 51.98 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.556 0.743 . . . . 0.0 111.644 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.2 tt -100.38 132.59 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.478 1.511 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.1 p -77.35 142.15 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.798 -0.564 . . . . 0.0 110.677 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.4 m -144.15 159.19 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.315 1.446 . . . . 0.0 110.409 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -123.09 141.15 52.28 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.673 0.789 . . . . 0.0 110.068 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.24 126.93 46.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.91 1.684 . . . . 0.0 108.992 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.28 112.94 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.58 126.66 71.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -131.17 139.55 49.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.066 1.747 . . . . 0.0 108.868 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.52 124.26 23.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -71.31 -15.68 62.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.794 1.237 . . . . 0.0 113.137 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.04 173.36 6.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.718 2.007 . . . . 0.0 111.366 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.6 p -52.75 147.83 14.56 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.814 1.246 . . . . 0.0 113.648 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 7.17 16.26 Favored 'Cis proline' 0 CA--C 1.546 1.092 0 N-CA-C 114.398 0.884 . . . . 0.0 114.398 0.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.04 32.76 10.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.656 1.583 . . . . 0.0 113.648 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 150.19 20.65 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.736 1.214 . . . . 0.0 111.395 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -57.73 108.64 0.59 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.821 0.848 . . . . 0.0 109.548 167.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.8 t -65.48 -56.82 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.079 0.952 . . . . 0.0 109.581 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.72 155.05 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.652 0.781 . . . . 0.0 111.984 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -142.72 77.89 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.268 1.827 . . . . 0.0 110.767 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -115.09 -178.03 18.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.17 1.367 . . . . 0.0 112.954 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.3 m -127.05 148.5 50.12 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 110.188 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.31 160.55 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.055 1.742 . . . . 0.0 109.494 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.73 137.61 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.34 145.6 43.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -140.93 158.0 44.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.859 1.264 . . . . 0.0 109.586 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -127.11 116.45 20.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.011 0.925 . . . . 0.0 110.98 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.5 m -83.33 118.47 71.69 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.92 -1.113 . . . . 0.0 109.282 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.35 -19.6 43.49 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.526 2.151 . . . . 0.0 112.547 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.3 m -45.33 -51.7 10.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.918 2.087 . . . . 0.0 112.469 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 20.8 p -143.26 34.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 0.0 112.407 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.83 42.43 94.59 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.211 -1.555 . . . . 0.0 114.1 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.97 173.91 10.18 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.105 1.362 . . . . 0.0 112.717 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.414 HG13 ' CG1' ' A' ' 100' ' ' VAL . 17.3 m -128.62 142.01 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 111.177 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 72.7 m -137.83 108.86 6.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.65 1.18 . . . . 0.0 108.188 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.81 141.25 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.826 0.822 . . . . 0.0 111.21 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -120.8 134.76 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.813 2.045 . . . . 0.0 107.337 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -152.58 132.92 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.27 1.428 . . . . 0.0 107.816 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -114.77 152.99 31.15 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.756 1.223 . . . . 0.0 109.664 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.66 -15.58 61.51 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.55 -31.64 13.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.544 1.537 . . . . 0.0 114.38 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.6 p -87.5 -42.28 12.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 0.0 111.326 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -87.3 148.61 45.08 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.729 2.011 . . . . 0.0 110.759 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.95 178.2 7.93 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.443 2.095 . . . . 0.0 111.608 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.91 44.03 2.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.051 1.74 . . . . 0.0 110.87 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -144.98 -27.61 0.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.94 1.296 . . . . 0.0 113.529 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.6 ttm -137.71 139.89 40.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.22 2.208 . . . . 0.0 107.673 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.8 p -134.79 155.8 49.97 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.76 140.8 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.233 1.013 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 8.8 t -140.16 163.02 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.041 1.337 . . . . 0.0 110.49 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 118.71 26.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.218 1.407 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.8 8.29 5.28 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 112.717 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.94 16.92 2.84 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.819 1.248 . . . . 0.0 113.333 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.47 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.047 2.539 . . . . 0.0 114.368 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.7 m 80.89 21.29 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.43 1.092 . . . . 0.0 111.676 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -136.74 128.63 29.22 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.788 1.635 . . . . 0.0 111.37 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -118.99 133.6 55.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.805 1.642 . . . . 0.0 111.335 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.65 106.25 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.642 0.777 . . . . 0.0 109.268 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -84.84 126.35 33.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.074 1.35 . . . . 0.0 110.951 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -117.91 121.32 40.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.364 1.466 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.86 98.82 11.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.816 1.246 . . . . 0.0 109.601 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -80.42 -30.1 37.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 113.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -144.96 134.88 23.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 109.353 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.1 -50.83 72.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.258 0.935 . . . . 0.0 111.783 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 125.156 1.382 . . . . 0.0 111.416 -169.514 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.16 143.29 57.96 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.807 -0.558 . . . . 0.0 109.536 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.43 -19.1 5.02 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -116.28 17.83 15.48 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.246 2.219 . . . . 0.0 113.647 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -135.34 171.63 14.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.689 1.596 . . . . 0.0 111.051 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 150.47 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.594 1.158 . . . . 0.0 108.806 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 149.77 34.47 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 112.938 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.93 130.83 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.333 1.453 . . . . 0.0 109.495 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.98 125.91 42.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.589 1.155 . . . . 0.0 110.199 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.98 55.04 3.31 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.236 1.017 . . . . 0.0 112.046 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.95 148.27 7.58 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.979 1.276 . . . . 0.0 111.039 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -59.53 133.21 55.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.431 1.092 . . . . 0.0 111.279 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 71.52 41.97 0.7 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.202 1.801 . . . . 0.0 114.021 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m 53.08 61.91 2.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.519 1.528 . . . . 0.0 113.592 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.0 p -130.56 178.48 6.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.131 1.372 . . . . 0.0 112.188 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.34 -85.26 1.04 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.343 1.449 . . . . 0.0 113.752 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.22 170.52 14.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.364 1.466 . . . . 0.0 110.777 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -139.53 148.54 42.75 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 111.304 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.75 147.56 26.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.582 1.553 . . . . 0.0 110.487 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -125.06 132.59 53.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.462 1.105 . . . . 0.0 110.399 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -129.76 133.44 47.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.908 1.337 . . . . 0.0 111.454 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.62 138.57 43.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.946 1.298 . . . . 0.0 111.473 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 148.43 51.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.278 1.031 . . . . 0.0 111.42 168.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.32 41.29 68.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.43 1.014 . . . . 0.0 112.553 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -144.14 160.76 40.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.076 1.35 . . . . 0.0 112.248 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 m -121.56 131.7 54.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.288 1.435 . . . . 0.0 108.25 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.54 141.13 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.918 0.887 . . . . 0.0 108.727 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -126.77 151.37 48.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.436 1.095 . . . . 0.0 110.982 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 125.661 1.584 . . . . 0.0 109.72 178.478 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -63.98 -24.74 67.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -70.19 0.11 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.713 168.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.303 0.3 OUTLIER 27.75 48.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 128.164 2.586 . . . . 0.0 115.761 -175.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.02 133.78 46.06 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.986 2.114 . . . . 0.0 109.337 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mmt -153.78 -45.24 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.487 1.915 . . . . 0.0 111.324 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 t -136.07 130.24 33.13 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.415 1.086 . . . . 0.0 109.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 89.6 m -140.96 145.4 35.97 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.54 121.72 36.36 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.325 1.05 . . . . 0.0 108.606 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.4 t -105.49 143.08 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.454 1.902 . . . . 0.0 106.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.92 -97.09 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.324 1.916 . . . . 0.0 117.301 -172.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -161.57 -42.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.634 1.173 . . . . 0.0 111.504 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.88 33.88 4.95 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.261 1.425 . . . . 0.0 110.617 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -146.69 157.12 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.524 2.33 . . . . 0.0 109.798 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -136.75 154.52 50.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.428 1.891 . . . . 0.0 110.132 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.7 t -123.55 143.26 50.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.683 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -134.04 139.09 45.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 109.405 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.1 119.75 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.009 1.324 . . . . 0.0 107.989 -167.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.72 135.51 50.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.962 0.905 . . . . 0.0 109.817 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.02 -60.7 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.246 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.5 -178.73 7.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.553 0.741 . . . . 0.0 111.957 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -65.95 129.97 41.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.923 0.889 . . . . 0.0 113.074 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -178.14 6.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.175 1.79 . . . . 0.0 110.088 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.74 44.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.227 1.411 . . . . 0.0 113.104 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 57.68 48.53 13.89 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.16 1.457 . . . . 0.0 111.855 -171.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -64.31 167.36 8.51 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.804 1.642 . . . . 0.0 110.791 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.9 11.08 0.93 Allowed 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.954 2.436 . . . . 0.0 113.967 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -147.28 57.85 3.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.768 1.627 . . . . 0.0 111.973 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.86 154.06 73.95 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.408 1.405 . . . . 0.0 110.659 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.45 -105.52 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -142.85 150.91 40.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.773 1.629 . . . . 0.0 110.217 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -151.39 140.03 20.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.222 1.409 . . . . 0.0 109.254 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.33 156.73 26.75 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 110.341 172.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.13 97.95 5.66 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.851 0.861 . . . . 0.0 109.799 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.14 124.36 14.24 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.525 1.13 . . . . 0.0 109.677 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.92 163.37 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.563 1.145 . . . . 0.0 113.024 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 165.51 1.19 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.866 171.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -21.22 108.4 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.883 2.183 . . . . 0.0 118.296 -171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 p -167.1 177.35 6.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.375 1.07 . . . . 0.0 112.906 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 m -107.89 97.69 7.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.499 1.919 . . . . 0.0 109.45 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.877 0.871 . . . . 0.0 109.836 171.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -128.83 12.52 6.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.03 1.332 . . . . 0.0 112.493 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -153.21 38.26 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.699 -1.25 . . . . 0.0 113.106 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.9 -1.91 57.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.701 1.2 . . . . 0.0 114.036 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -12.62 1.95 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.042 1.737 . . . . 0.0 114.394 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -46.57 -32.0 3.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.022 1.329 . . . . 0.0 113.883 165.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.3 tp -70.34 -35.5 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.258 7.3 m-20 30.73 46.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.336 2.655 . . . . 0.0 115.411 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.04 107.95 0.24 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.94 0.781 . . . . 0.0 112.649 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.3 85.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.113 0.958 . . . . 0.0 113.111 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -75.59 -6.57 51.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.744 -1.223 . . . . 0.0 113.171 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -129.95 137.6 50.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.738 2.415 . . . . 0.0 111.048 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.86 128.48 38.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.114 1.366 . . . . 0.0 109.183 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.96 119.41 25.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.952 0.901 . . . . 0.0 108.825 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.39 118.17 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.92 150.28 71.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.102 0.961 . . . . 0.0 110.205 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.5 -173.49 0.99 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.674 2.249 . . . . 0.0 112.64 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.67 -26.64 24.34 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.146 1.355 . . . . 0.0 113.498 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -43.44 87.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.014 0.907 . . . . 0.0 112.287 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.55 126.07 37.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.868 1.267 . . . . 0.0 109.062 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.89 -47.39 11.11 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.307 -0.87 . . . . 0.0 110.853 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -143.06 160.0 41.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.561 1.944 . . . . 0.0 108.794 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.21 152.17 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.548 0.739 . . . . 0.0 109.817 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.4 139.7 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.781 0.832 . . . . 0.0 111.003 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.41 139.18 38.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.79 143.47 40.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 125.737 1.615 . . . . 0.0 109.725 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -148.39 133.05 17.82 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.83 1.252 . . . . 0.0 109.688 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.04 137.01 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.332 1.053 . . . . 0.0 108.432 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -140.49 95.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.92 2.088 . . . . 0.0 108.823 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -71.92 122.7 21.27 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.891 -1.131 . . . . 0.0 111.256 173.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 12.72 31.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.574 1.55 . . . . 0.0 112.891 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -127.21 -66.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.606 1.562 . . . . 0.0 110.865 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.47 128.12 37.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.757 0.823 . . . . 0.0 110.524 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -102.4 53.91 0.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.339 1.066 . . . . 0.0 110.947 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -140.32 63.54 1.47 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 123.579 1.657 . . . . 0.0 110.61 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.67 143.84 19.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 113.537 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.34 9.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.394 1.473 . . . . 0.0 114.397 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -87.19 -35.57 18.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.478 1.139 . . . . 0.0 113.707 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.41 126.47 29.71 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.071 0.948 . . . . 0.0 109.891 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -128.75 125.68 38.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.4 1.48 . . . . 0.0 108.957 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.2 ttp -114.27 134.96 54.57 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.294 1.437 . . . . 0.0 109.38 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -122.42 135.33 54.66 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.443 1.497 . . . . 0.0 108.058 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.5 pt -131.17 137.19 56.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.943 0.897 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 m -137.84 94.64 11.4 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 0.0 109.504 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.14 165.43 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.957 2.438 . . . . 0.0 111.455 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -26.17 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.907 3.283 . . . . 0.0 115.689 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 42.22 45.78 3.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.407 1.483 . . . . 0.0 114.324 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.2 t -111.19 159.82 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.055 2.142 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.55 94.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.997 2.519 . . . . 0.0 112.937 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 143.63 56.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 110.728 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.01 145.28 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.926 0.89 . . . . 0.0 110.293 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -130.29 138.01 50.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.46 1.504 . . . . 0.0 109.245 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.12 160.78 40.33 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.84 1.256 . . . . 0.0 110.423 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -120.32 154.45 34.99 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.963 0.905 . . . . 0.0 109.79 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.62 143.96 39.33 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.167 -0.333 . . . . 0.0 110.935 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.94 47.96 43.63 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.702 0.667 . . . . 0.0 114.61 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.36 162.16 24.41 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.453 1.501 . . . . 0.0 110.996 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 153.02 6.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.006 0.922 . . . . 0.0 111.941 169.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.26 118.49 3.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.307 1.043 . . . . 0.0 111.754 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.3 t -92.78 141.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 108.881 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -104.28 135.98 44.73 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.956 0.798 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tp -115.95 101.7 53.99 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.782 2.033 . . . . 0.0 108.155 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.58 147.55 40.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.562 2.175 . . . . 0.0 112.336 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -137.41 132.85 17.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.009 1.324 . . . . 0.0 109.33 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.52 174.73 11.71 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.377 3.385 . . . . 0.0 112.646 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -64.27 147.11 53.19 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.59 -0.694 . . . . 0.0 112.337 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 pp -153.97 158.84 41.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.83 2.052 . . . . 0.0 110.186 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -147.97 139.95 14.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 111.998 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.83 155.75 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 CA-C-N 119.662 0.915 . . . . 0.0 112.377 -9.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.25 -39.64 37.09 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.901 1.734 . . . . 0.0 111.761 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -72.08 8.28 1.34 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.122 1.769 . . . . 0.0 113.631 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -78.0 -178.05 5.33 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.42 -1.425 . . . . 0.0 111.554 166.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 160.39 21.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.279 1.432 . . . . 0.0 112.368 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 16.0 tt -122.56 133.11 69.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.722 1.609 . . . . 0.0 109.827 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.06 131.9 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.936 0.894 . . . . 0.0 110.666 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.2 m -146.39 166.45 26.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.136 0.97 . . . . 0.0 111.335 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -134.01 147.36 50.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.853 0.861 . . . . 0.0 111.023 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.6 tt -130.1 130.44 44.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.055 1.742 . . . . 0.0 109.164 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.51 117.33 9.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.745 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.32 132.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.847 1.259 . . . . 0.0 108.753 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.24 144.92 27.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 110.195 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -77.79 126.12 30.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -68.1 -28.65 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.246 1.018 . . . . 0.0 113.346 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.53 174.08 6.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.695 1.598 . . . . 0.0 111.923 172.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 p -52.18 147.5 13.21 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.36 1.464 . . . . 0.0 113.517 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.2 12.13 19.74 Favored 'Cis proline' 0 CA--C 1.545 1.047 0 N-CA-C 114.714 1.006 . . . . 0.0 114.714 3.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.76 24.46 9.9 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.343 1.457 . . . . 0.0 113.082 170.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -88.81 135.53 33.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.897 -1.127 . . . . 0.0 111.276 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -57.64 111.1 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.732 0.813 . . . . 0.0 109.996 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.71 -57.99 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.351 1.06 . . . . 0.0 109.028 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.4 153.55 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.733 0.777 . . . . 0.0 111.978 169.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -145.75 105.92 4.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.043 1.737 . . . . 0.0 108.72 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.12 157.33 28.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 121.837 0.687 . . . . 0.0 113.003 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.2 m -74.15 150.44 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.173 0.987 . . . . 0.0 111.196 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.35 161.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.951 2.1 . . . . 0.0 108.526 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.86 132.22 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.485 0.659 . . . . 0.0 109.656 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.03 152.83 23.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -145.19 151.44 38.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.732 2.013 . . . . 0.0 108.121 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -115.39 132.95 56.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.423 1.089 . . . . 0.0 108.931 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.8 t -93.38 103.49 9.79 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.09 -17.43 45.69 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.734 2.289 . . . . 0.0 112.828 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.4 m -53.08 -42.9 66.31 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.994 2.118 . . . . 0.0 112.958 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 48.2 p -144.16 18.33 1.75 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.35 1.46 . . . . 0.0 112.483 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.46 73.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.761 1.648 . . . . 0.0 114.622 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.417 ' CG ' ' H ' ' A' ' 182' ' ' VAL . 4.0 tt0 -73.33 -170.27 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.079 1.419 . . . . 0.0 111.585 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.429 HG12 ' CZ ' ' A' ' 205' ' ' PHE . 1.4 p -135.41 155.18 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 128.041 2.537 . . . . 0.0 107.749 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.0 m -140.31 150.76 44.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.208 1.803 . . . . 0.0 107.996 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 205' ' ' PHE . 6.8 p -121.5 140.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 22.9 mt -123.6 129.95 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.51 140.39 33.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 108.896 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.82 34.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.509 1.123 . . . . 0.0 109.707 -168.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -28.58 67.0 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.46 -30.52 47.45 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.311 1.844 . . . . 0.0 115.039 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 p -101.21 -53.54 3.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.531 1.132 . . . . 0.0 111.632 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.65 148.74 49.68 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.537 1.935 . . . . 0.0 110.913 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.1 -175.05 2.45 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.692 2.928 . . . . 0.0 111.577 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.25 30.17 6.68 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.01 1.724 . . . . 0.0 111.967 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -132.15 -38.86 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.862 1.665 . . . . 0.0 113.187 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 30.0 ttm -112.77 145.45 40.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.434 1.893 . . . . 0.0 106.804 167.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -140.43 150.05 43.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.949 0.899 . . . . 0.0 110.579 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.16 142.44 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.521 -0.737 . . . . 0.0 111.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 12.2 t -139.95 156.13 46.81 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.611 1.164 . . . . 0.0 111.232 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.64 81.79 0.84 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 111.349 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -60.59 -31.21 70.37 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.854 -1.154 . . . . 0.0 112.627 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.46 173.91 11.39 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.639 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.37 118.76 7.91 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.76 174.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.251 30.0 m 63.08 28.85 16.24 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 112.593 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 t -137.38 125.08 22.35 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.096 -1.003 . . . . 0.0 112.389 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.447 ' CZ ' ' HB ' ' A' ' 184' ' ' VAL . 12.3 m-85 -109.08 134.75 51.28 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 112.317 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.87 107.32 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.76 1.224 . . . . 0.0 109.72 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.91 108.43 17.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.855 1.262 . . . . 0.0 109.916 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -92.77 136.3 33.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.302 1.441 . . . . 0.0 110.185 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.56 119.96 40.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.631 0.773 . . . . 0.0 110.258 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -107.87 -6.21 16.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.899 1.68 . . . . 0.0 113.701 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -121.64 -169.91 1.95 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.767 2.027 . . . . 0.0 111.628 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -154.05 26.59 0.48 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 126.078 1.751 . . . . 0.0 113.75 -177.386 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.461 ' CG2' ' H ' ' A' ' 4' ' ' ASP 0.291 8.4 p . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.461 ' H ' ' CG2' ' A' ' 3' ' ' VAL . 4.0 t70 -75.15 147.97 40.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 119.834 -1.791 . . . . 0.0 109.916 169.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.12 -18.52 10.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.09 14.96 17.16 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.313 2.245 . . . . 0.0 113.87 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -138.74 177.79 7.63 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.107 1.321 . . . . 0.0 111.175 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.21 156.55 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.015 1.326 . . . . 0.0 111.318 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.32 145.44 33.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.661 1.185 . . . . 0.0 110.927 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 137.09 36.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.427 1.491 . . . . 0.0 108.421 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -132.34 124.57 29.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.515 1.126 . . . . 0.0 110.521 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -80.21 60.09 3.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.133 1.373 . . . . 0.0 111.441 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.9 131.11 1.44 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 141.23 15.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.362 1.065 . . . . 0.0 111.116 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.39 42.45 14.68 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.22 59.62 2.64 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.63 1.972 . . . . 0.0 113.302 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.8 m -133.9 -179.35 5.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.334 1.454 . . . . 0.0 111.206 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 17' ' ' THR . . . 69.22 -105.63 1.55 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.586 1.565 . . . . 0.0 113.379 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -113.53 164.54 13.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.156 0.982 . . . . 0.0 111.634 174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -130.38 145.29 51.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.551 1.14 . . . . 0.0 111.938 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 160.24 43.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.897 1.679 . . . . 0.0 110.673 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -127.99 154.99 44.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.24 1.016 . . . . 0.0 110.722 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.44 136.96 45.51 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.661 1.184 . . . . 0.0 110.935 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -92.1 147.82 22.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.53 1.132 . . . . 0.0 110.278 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.06 139.44 58.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.174 0.59 . . . . 0.0 111.64 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.69 28.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.98 0.8 . . . . 0.0 112.764 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.34 122.24 22.36 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.328 1.051 . . . . 0.0 110.763 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 m -107.37 130.28 54.81 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.978 1.311 . . . . 0.0 108.595 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.72 132.66 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.348 1.459 . . . . 0.0 109.776 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -122.79 140.05 53.33 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.801 1.241 . . . . 0.0 109.707 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 C-N-CA 124.878 1.271 . . . . 0.0 108.952 -173.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.3 m0 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 121.155 0.502 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -39.12 64.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.142 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.82 -62.66 1.55 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.174 0.989 . . . . 0.0 109.211 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.21 31.86 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.198 1.799 . . . . 0.0 113.582 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.66 128.0 40.05 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.111 2.164 . . . . 0.0 107.813 -172.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 mtp -138.45 -50.16 0.55 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 111.823 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.4 p -133.54 122.98 24.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.543 0.687 . . . . 0.0 110.697 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.6 m -144.81 154.53 42.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.67 149.73 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.236 1.017 . . . . 0.0 111.166 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.8 136.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.64 1.576 . . . . 0.0 109.019 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -87.28 0.03 OUTLIER Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.675 1.131 . . . . 0.0 114.959 -167.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.0 p -173.01 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -127.12 33.16 4.95 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.317 1.447 . . . . 0.0 111.186 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.61 146.09 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.518 1.927 . . . . 0.0 108.753 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -114.29 143.75 44.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.638 1.175 . . . . 0.0 108.553 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.67 131.97 54.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 109.439 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.37 123.77 47.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.987 1.315 . . . . 0.0 108.244 -170.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.05 119.86 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 122.122 0.963 . . . . 0.0 111.822 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -132.38 118.19 19.06 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 109.976 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.52 -54.92 15.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.53 1.132 . . . . 0.0 111.356 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -130.3 122.29 27.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -164.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.02 31.54 0.44 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.9 1.28 . . . . 0.0 112.431 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.46 165.07 5.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.144 2.578 . . . . 0.0 114.335 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 mm -112.76 39.43 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.29 52.2 m-20 57.15 50.31 12.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.617 1.967 . . . . 0.0 112.837 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 p -73.67 176.34 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.865 2.466 . . . . 0.0 110.893 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.16 3.95 4.18 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.9 2.4 . . . . 0.0 113.796 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -136.32 64.32 52.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.93 1.692 . . . . 0.0 110.502 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.89 138.33 57.18 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.302 1.335 . . . . 0.0 109.326 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.62 -121.91 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.873 0.749 . . . . 0.0 111.663 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -134.33 140.16 46.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.508 1.123 . . . . 0.0 111.052 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.72 139.76 24.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.702 1.201 . . . . 0.0 109.868 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -157.25 165.77 34.98 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.559 1.171 . . . . 0.0 111.263 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -132.7 104.46 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.307 1.443 . . . . 0.0 107.5 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -64.75 116.05 5.89 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.71 160.94 0.39 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.832 2.053 . . . . 0.0 114.227 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -47.28 -34.17 6.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.16 135.24 3.63 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 164.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.54 167.86 0.65 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.789 2.036 . . . . 0.0 110.824 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -123.31 105.48 9.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.802 1.241 . . . . 0.0 110.098 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -83.82 100.88 11.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -70.49 -20.69 62.84 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.6 73.85 0.98 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.96 2.43 12.63 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.69 -1.257 . . . . 0.0 114.023 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -53.0 -10.78 0.19 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.96 2.104 . . . . 0.0 115.298 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.2 m -48.95 -32.08 8.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.057 1.299 . . . . 0.0 113.994 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -87.56 -32.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.84 30.02 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.545 2.738 . . . . 0.0 115.95 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.84 109.75 0.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -160.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 178.31 55.09 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.416 2.286 . . . . 0.0 110.027 -170.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -57.99 -22.17 48.22 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 134.45 53.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.856 1.263 . . . . 0.0 110.648 173.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 135.59 35.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.555 1.542 . . . . 0.0 109.815 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -141.88 142.63 33.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.717 0.77 . . . . 0.0 112.088 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.87 123.08 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.605 . . . . 0.0 109.238 -170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -141.03 157.64 66.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.978 0.911 . . . . 0.0 111.236 -168.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.57 160.7 43.71 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.895 2.397 . . . . 0.0 113.315 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.88 -17.08 69.07 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 121.24 -0.913 . . . . 0.0 115.022 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.09 70.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.84 163.71 27.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.947 1.299 . . . . 0.0 111.477 173.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -35.62 0.99 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.152 1.381 . . . . 0.0 111.54 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -154.39 160.99 41.97 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.298 1.839 . . . . 0.0 109.666 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.42 160.98 39.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.522 0.729 . . . . 0.0 110.197 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.0 145.45 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.315 1.046 . . . . 0.0 110.516 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.11 127.78 45.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.05 1.34 . . . . 0.0 108.287 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -128.58 135.38 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.818 -0.551 . . . . 0.0 110.295 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -123.81 143.35 50.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.443 1.497 . . . . 0.0 109.539 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.3 mt -111.85 131.08 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.64 103.3 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 122.564 1.173 . . . . 0.0 110.962 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.1 134.33 49.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.409 1.884 . . . . 0.0 110.751 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 -21.95 8.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.429 1.092 . . . . 0.0 113.571 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.59 -55.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 119.085 0.857 . . . . 0.0 111.026 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.04 93.4 4.48 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 109.026 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -73.42 48.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.593 1.557 . . . . 0.0 112.553 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -143.16 51.7 1.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.229 2.612 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.58 129.03 31.34 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.717 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.8 -31.83 3.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.119 1.819 . . . . 0.0 112.25 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 m -79.53 -18.0 52.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 114.066 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.66 137.35 38.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.16 1.384 . . . . 0.0 108.622 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.9 121.15 34.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.849 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 4.8 ttp -113.4 132.95 55.43 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.458 1.103 . . . . 0.0 110.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.7 m -122.1 132.42 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.383 1.473 . . . . 0.0 108.343 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.2 122.72 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.0 m -120.54 86.46 39.69 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 125.797 1.639 . . . . 0.0 109.16 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.39 157.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.609 2.872 . . . . 0.0 112.693 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -39.53 86.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.659 2.784 . . . . 0.0 114.576 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 38.87 42.53 0.65 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.02 159.4 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.755 2.022 . . . . 0.0 109.434 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.61 92.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.201 2.2 . . . . 0.0 113.047 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 149.5 49.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.61 0.764 . . . . 0.0 110.917 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.06 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.225 1.01 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.51 136.36 50.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.1 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 17.9 p -137.57 137.63 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.045 1.338 . . . . 0.0 108.606 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.54 142.13 33.14 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 166.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.59 151.37 6.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 111.043 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.01 42.85 10.38 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 120.846 -1.159 . . . . 0.0 113.155 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.01 161.64 29.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.167 1.787 . . . . 0.0 108.927 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 151.58 14.91 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.462 -0.774 . . . . 0.0 110.619 166.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -38.43 115.2 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.649 1.58 . . . . 0.0 111.784 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.02 130.64 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -81.28 123.62 28.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.417 0.687 . . . . 0.0 109.46 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.53 96.06 49.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.067 1.747 . . . . 0.0 108.534 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 146.81 41.55 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.212 1.941 . . . . 0.0 111.287 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.38 132.08 24.14 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.926 2.091 . . . . 0.0 107.633 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.93 175.83 9.87 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.144 2.562 . . . . 0.0 113.195 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -57.72 155.96 9.31 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.376 0.671 . . . . 0.0 112.534 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 pp -170.86 156.96 5.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.613 1.965 . . . . 0.0 109.86 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.8 t -137.24 138.41 25.17 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.966 0.906 . . . . 0.0 111.565 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 157.28 72.12 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 119.527 0.867 . . . . 0.0 111.97 -7.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.02 -36.39 48.97 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.577 1.518 . . . . 0.0 112.09 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -74.18 7.52 2.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.3 p -65.71 174.97 2.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.904 -1.123 . . . . 0.0 112.804 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.42 132.4 56.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.843 1.257 . . . . 0.0 110.952 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.27 116.18 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.788 1.635 . . . . 0.0 108.4 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.5 133.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 122.97 0.508 . . . . 0.0 109.949 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.1 p -131.32 160.46 34.92 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.794 1.237 . . . . 0.0 110.397 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -114.4 137.18 52.15 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.212 0.605 . . . . 0.0 109.543 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.81 138.65 49.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.955 1.702 . . . . 0.0 107.931 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.46 111.54 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.573 1.549 . . . . 0.0 108.186 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.52 130.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.963 1.305 . . . . 0.0 109.461 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -144.24 141.65 29.99 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.265 1.826 . . . . 0.0 109.349 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 137.98 52.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.493 0.317 . . . . 0.0 111.339 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -77.19 -5.26 48.53 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.613 1.165 . . . . 0.0 113.843 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 179.75 5.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.766 2.426 . . . . 0.0 110.686 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.15 150.13 22.44 Favored Pre-proline 0 N--CA 1.481 1.081 0 O-C-N 121.017 -1.052 . . . . 0.0 113.193 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.13 7.22 22.77 Favored 'Cis proline' 0 CA--C 1.545 1.029 0 CA-C-N 119.847 0.981 . . . . 0.0 114.513 -0.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.36 35.18 24.64 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 113.626 171.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -102.05 156.33 17.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 111.302 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -64.86 86.88 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.9 -1.125 . . . . 0.0 111.696 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.5 -54.38 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.763 2.025 . . . . 0.0 110.848 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 96.4 t -146.71 127.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.161 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -144.94 136.37 25.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 109.927 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.86 178.77 41.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.674 0.654 . . . . 0.0 112.255 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.2 m -109.77 149.62 29.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.005 0.907 . . . . 0.0 111.798 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.95 147.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.149 2.18 . . . . 0.0 108.215 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.36 132.54 54.34 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.405 -0.809 . . . . 0.0 109.491 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -107.73 141.23 39.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.557 1.143 . . . . 0.0 109.517 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -136.18 143.39 44.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.714 1.605 . . . . 0.0 109.573 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -115.09 115.31 26.58 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.826 0.851 . . . . 0.0 110.413 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.9 m -76.49 107.8 5.27 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.422 1.089 . . . . 0.0 109.525 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.75 -14.37 32.91 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.629 2.219 . . . . 0.0 112.908 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.2 m -53.35 -44.8 68.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 113.348 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.3 p -142.32 22.92 2.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.097 1.359 . . . . 0.0 113.016 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 53.1 39.03 57.12 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.974 1.75 . . . . 0.0 114.571 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -80.02 166.25 21.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.518 0.727 . . . . 0.0 110.815 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.76 148.83 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.4 m -129.58 145.31 51.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.055 2.142 . . . . 0.0 108.527 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.26 128.28 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.176 1.39 . . . . 0.0 109.746 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.56 120.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.733 1.613 . . . . 0.0 106.921 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.18 140.56 37.85 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.774 1.63 . . . . 0.0 107.846 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -136.67 130.54 32.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.76 -16.54 17.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.7 -14.98 63.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.536 2.335 . . . . 0.0 114.411 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.7 t -142.27 -36.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.75 1.62 . . . . 0.0 113.254 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -82.29 138.3 45.29 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.564 1.546 . . . . 0.0 110.054 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.43 178.87 6.48 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.719 2.946 . . . . 0.0 112.467 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -116.65 29.39 7.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.936 1.694 . . . . 0.0 111.842 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -114.01 -36.11 4.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.867 1.267 . . . . 0.0 112.204 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.6 ttt -121.36 142.9 49.54 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.761 2.024 . . . . 0.0 108.096 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 p -137.64 131.51 31.63 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.897 0.856 . . . . 0.0 110.909 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.77 137.17 40.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.905 0.882 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.7 t -127.89 160.06 33.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 111.268 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.79 84.29 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 111.1 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.33 -39.97 94.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.27 1.028 . . . . 0.0 112.257 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -146.0 -174.81 4.53 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.249 2.219 . . . . 0.0 111.613 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.465 HD21 HG23 ' A' ' 203' ' ' THR . 4.7 t30 -43.34 -53.27 5.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.041 2.136 . . . . 0.0 113.352 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.465 HG23 HD21 ' A' ' 202' ' ' ASN . 73.5 p -133.59 29.71 3.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.449 1.1 . . . . 0.0 112.199 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -129.83 130.09 44.85 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.581 1.152 . . . . 0.0 109.719 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -129.41 151.09 50.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.175 1.39 . . . . 0.0 110.092 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.3 tt -132.09 109.88 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.859 0.837 . . . . 0.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -83.26 101.45 11.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.08 2.152 . . . . 0.0 110.168 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -83.8 126.08 32.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.655 1.582 . . . . 0.0 109.828 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 tp -126.78 109.09 11.65 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.358 0.981 . . . . 0.0 110.925 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.39 19.81 7.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.913 1.685 . . . . 0.0 113.206 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.0 m -150.92 111.36 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.85 1.66 . . . . 0.0 111.588 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.1 -40.48 93.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.927 1.291 . . . . 0.0 113.142 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 127.337 2.255 . . . . 0.0 113.181 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 121.195 0.521 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.6 139.38 56.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.071 0.548 . . . . 0.0 109.672 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -12.33 21.68 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.545 -1.347 . . . . 0.0 113.274 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.29 9.74 17.03 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.468 1.907 . . . . 0.0 113.353 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.61 176.66 9.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.717 1.607 . . . . 0.0 110.176 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 128.28 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.251 1.021 . . . . 0.0 109.256 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 150.4 20.39 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.819 -0.55 . . . . 0.0 110.142 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.24 127.95 16.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.988 1.315 . . . . 0.0 109.275 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -129.48 135.0 48.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.257 1.423 . . . . 0.0 110.223 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -78.34 44.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.828 2.051 . . . . 0.0 112.547 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.73 150.54 8.89 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 120.805 -1.184 . . . . 0.0 112.173 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.71 146.21 37.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.992 0.917 . . . . 0.0 111.917 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 51.42 40.92 27.74 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.9 m 59.15 64.33 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.639 1.575 . . . . 0.0 113.421 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.0 p -130.88 177.37 7.48 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.821 1.248 . . . . 0.0 111.981 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.74 -87.49 0.74 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.219 1.39 . . . . 0.0 113.59 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -135.98 165.64 25.2 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.584 1.553 . . . . 0.0 110.699 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.8 p -127.81 145.68 50.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.513 1.125 . . . . 0.0 112.032 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.31 162.48 40.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.275 1.83 . . . . 0.0 110.703 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -136.91 141.08 42.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.118 1.367 . . . . 0.0 109.193 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -120.68 138.51 53.91 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.093 1.757 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -76.79 143.07 40.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.065 1.746 . . . . 0.0 111.49 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -64.68 145.75 55.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.14 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.95 49.7 15.9 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.111 0.386 . . . . 0.0 112.64 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.45 159.37 43.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.59 1.156 . . . . 0.0 111.221 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -140.48 118.89 12.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.022 1.329 . . . . 0.0 109.432 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 m -127.12 147.38 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.125 0.97 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -136.36 134.93 38.37 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.579 1.152 . . . . 0.0 109.441 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 124.8 1.24 . . . . 0.0 108.967 -173.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.7 m0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.25 -43.68 20.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.438 1.495 . . . . 0.0 111.349 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -77.37 52.3 0.93 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.442 1.497 . . . . 0.0 112.351 166.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.72 4.44 49.61 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.288 -1.508 . . . . 0.0 114.858 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 13.0 m-85 -78.16 137.22 38.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.117 0.967 . . . . 0.0 111.754 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.48 -62.09 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.511 1.924 . . . . 0.0 111.463 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -122.39 124.57 43.98 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.906 0.882 . . . . 0.0 109.582 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.45 156.06 44.54 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.252 1.025 . . . . 0.0 110.584 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.53 127.69 49.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.274 1.03 . . . . 0.0 108.418 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.6 t -106.53 107.79 23.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.46 1.504 . . . . 0.0 109.352 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.21 162.2 3.82 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 122.568 1.094 . . . . 0.0 113.703 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -13.88 61.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.3 34.23 4.22 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.396 1.478 . . . . 0.0 111.735 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -149.85 157.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.174 2.59 . . . . 0.0 110.296 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.5 149.22 46.62 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 110.285 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.5 m -116.09 133.97 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.521 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -122.4 117.02 25.03 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.469 1.107 . . . . 0.0 109.116 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.1 mt -111.37 114.35 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.351 1.461 . . . . 0.0 108.984 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.29 124.81 39.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.526 1.13 . . . . 0.0 108.025 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.7 -58.38 7.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.668 0.747 . . . . 0.0 111.615 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.89 179.92 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.971 0.909 . . . . 0.0 109.812 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -67.2 71.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.826 0.85 . . . . 0.0 111.174 164.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.19 -37.29 74.46 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.666 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.1 pt 42.28 30.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 71.45 22.58 4.15 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.707 2.003 . . . . 0.0 113.429 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 t -61.86 144.21 93.71 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.314 1.845 . . . . 0.0 111.221 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 34.99 0.33 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 124.531 3.488 . . . . 0.0 113.852 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -156.35 50.58 0.47 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.931 2.092 . . . . 0.0 111.939 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.71 135.49 38.75 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.46 1.44 . . . . 0.0 109.656 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.96 -92.62 0.49 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -142.82 159.85 41.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.637 1.575 . . . . 0.0 111.149 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -148.76 140.84 23.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.798 1.639 . . . . 0.0 109.514 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -153.5 147.59 25.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.144 0.974 . . . . 0.0 111.22 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -118.66 102.95 9.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.404 1.482 . . . . 0.0 109.047 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.39 96.47 1.89 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.352 1.061 . . . . 0.0 109.418 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.42 145.19 8.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.808 1.643 . . . . 0.0 113.234 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.51 147.26 18.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.55 1.54 . . . . 0.0 112.635 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.45 51.33 59.74 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.67 0.652 . . . . 0.0 114.104 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -149.94 170.73 18.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.531 1.132 . . . . 0.0 112.402 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.3 m -139.89 142.96 36.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.674 1.19 . . . . 0.0 109.876 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -132.89 106.87 7.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.527 1.131 . . . . 0.0 109.659 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.79 -28.82 22.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.062 1.345 . . . . 0.0 112.52 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.31 62.0 1.1 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.569 1.947 . . . . 0.0 110.75 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.55 14.04 0.86 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.73 -9.92 0.25 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.87 1.668 . . . . 0.0 115.203 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -45.5 -26.1 0.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.258 1.423 . . . . 0.0 114.606 158.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.273 2.7 tt -109.06 45.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.198 1.399 . . . . 0.0 112.724 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -49.55 -22.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.719 1.208 . . . . 0.0 113.729 165.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.24 84.57 1.55 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.975 0.797 . . . . 0.0 112.537 159.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.33 141.92 51.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.141 1.376 . . . . 0.0 110.37 164.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -145.38 -32.82 0.37 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.395 1.478 . . . . 0.0 113.418 164.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -112.83 125.88 54.83 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.85 1.26 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 41' ' ' PHE . 4.1 t80 -123.85 134.49 53.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.649 0.78 . . . . 0.0 110.109 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -126.35 126.96 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.563 1.145 . . . . 0.0 108.357 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -104.41 120.63 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.7 mt -110.67 150.65 42.05 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.204 1.002 . . . . 0.0 109.953 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.51 168.56 19.65 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.353 2.035 . . . . 0.0 112.569 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.88 32.09 1.48 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.525 1.536 . . . . 0.0 114.9 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.78 -48.19 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.707 1.603 . . . . 0.0 111.703 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -82.99 136.75 34.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.046 0.938 . . . . 0.0 109.201 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -78.08 -32.67 50.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.531 -0.731 . . . . 0.0 111.69 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -155.48 167.92 28.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.73 2.012 . . . . 0.0 109.786 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.03 164.15 28.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.569 0.699 . . . . 0.0 111.166 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.51 141.21 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 109.025 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.7 129.62 34.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.58 148.27 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.727 0.811 . . . . 0.0 109.664 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -148.98 158.35 44.12 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.042 0.937 . . . . 0.0 110.193 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mt -111.91 130.63 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 110.78 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.744 0.817 . . . . 0.0 109.462 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.28 127.27 32.77 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.215 -0.928 . . . . 0.0 111.576 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -112.63 17.18 19.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.693 1.597 . . . . 0.0 111.757 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.6 -57.44 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.489 1.915 . . . . 0.0 110.654 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -153.95 138.76 17.09 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.139 1.376 . . . . 0.0 111.378 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 p -49.7 -58.38 5.42 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.749 1.62 . . . . 0.0 115.209 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.3 m 31.22 63.22 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.011 2.524 . . . . 0.0 113.5 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.34 -98.16 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -59.38 -18.03 41.71 Favored Glycine 0 CA--C 1.541 1.662 0 O-C-N 119.699 -1.876 . . . . 0.0 113.575 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.5 m -60.81 -20.82 62.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.4 1.88 . . . . 0.0 115.027 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.81 128.42 40.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 109.785 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.63 127.56 40.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.956 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.2 ttp -126.95 152.73 46.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.017 1.727 . . . . 0.0 110.358 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.4 m -137.55 131.01 31.09 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.59 133.07 68.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 p -133.12 86.49 42.1 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 109.68 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.16 112.29 2.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.051 1.834 . . . . 0.0 108.621 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.5 t80 40.19 54.67 2.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.567 1.947 . . . . 0.0 112.99 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.38 31.75 0.92 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.6 1.56 . . . . 0.0 114.956 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.32 133.21 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.059 2.143 . . . . 0.0 108.597 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 t70 38.23 71.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.45 1.9 . . . . 0.0 113.348 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 138.97 41.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.59 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.84 140.1 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.591 0.756 . . . . 0.0 110.168 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.39 140.11 40.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.224 1.01 . . . . 0.0 110.022 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.6 p -140.85 143.03 34.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 109.22 -174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -131.49 143.99 50.81 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.715 1.206 . . . . 0.0 109.307 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.31 90.85 0.1 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.106 0.955 . . . . 0.0 111.897 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.02 -22.02 0.99 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.162 -0.961 . . . . 0.0 113.216 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -60.75 150.99 30.71 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.492 1.146 . . . . 0.0 112.308 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.2 66.66 9.35 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.378 -0.826 . . . . 0.0 111.08 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 62.47 166.58 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.143 1.777 . . . . 0.0 112.569 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.37 138.42 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.548 1.539 . . . . 0.0 109.599 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.34 122.25 28.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.348 0.659 . . . . 0.0 110.223 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.55 110.76 56.35 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.274 1.43 . . . . 0.0 109.482 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.72 136.68 15.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.673 2.249 . . . . 0.0 110.675 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.0 mm -129.01 124.53 22.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 177.1 6.77 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.261 2.641 . . . . 0.0 112.075 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -65.08 141.55 58.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.786 . . . . 0.0 111.983 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.751 2.021 . . . . 0.0 109.483 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.8 m -126.24 135.32 26.99 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.741 1.216 . . . . 0.0 109.995 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.15 154.3 84.95 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.477 0.849 . . . . 0.0 112.488 -3.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.82 -27.19 67.51 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.931 1.754 . . . . 0.0 112.401 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -9.89 22.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.5 m -62.57 166.41 5.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.741 1.258 . . . . 0.0 113.315 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.69 153.24 26.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.686 1.194 . . . . 0.0 111.897 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.5 tt -119.42 131.29 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 128.224 2.61 . . . . 0.0 107.957 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.2 m -73.77 134.11 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.689 0.795 . . . . 0.0 109.788 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -135.74 131.27 35.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.288 0.635 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -96.59 147.42 23.89 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.728 -0.608 . . . . 0.0 109.974 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.99 132.46 40.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.36 1.464 . . . . 0.0 108.645 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -141.41 118.27 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.518 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.95 133.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.469 1.507 . . . . 0.0 109.943 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.84 149.77 39.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.03 1.732 . . . . 0.0 109.182 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 146.44 47.79 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 64.4 p -73.74 -4.01 31.92 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.062 -1.024 . . . . 0.0 113.45 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.94 155.14 43.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.401 2.281 . . . . 0.0 111.683 -177.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 151.5 28.13 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.615 1.166 . . . . 0.0 113.395 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.56 -2.15 17.2 Favored 'Cis proline' 0 C--N 1.354 0.849 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 3.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . 0.26 0.2 OUTLIER 39.41 37.76 0.31 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 115.411 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -82.47 46.65 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.128 0.971 . . . . 0.0 113.486 -164.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 40.73 74.43 0.1 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.78 2.032 . . . . 0.0 112.834 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -37.11 -51.88 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.25 1.82 . . . . 0.0 111.802 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.9 t -138.58 128.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -136.1 109.64 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.422 1.089 . . . . 0.0 108.254 171.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.76 -165.75 33.25 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.712 0.672 . . . . 0.0 112.275 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.8 m -136.78 163.95 29.42 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.094 -0.65 . . . . 0.0 110.816 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.12 150.73 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.228 1.411 . . . . 0.0 109.438 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.0 135.96 34.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.577 -0.702 . . . . 0.0 109.869 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -113.22 132.12 55.63 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.828 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -123.64 156.97 34.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.581 1.552 . . . . 0.0 109.073 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.261 0.937 . . . . 0.0 109.669 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.2 m -97.97 102.16 12.87 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 123.724 0.81 . . . . 0.0 109.074 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.37 -15.71 42.51 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.26 1.973 . . . . 0.0 113.288 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.6 m -47.8 -40.62 21.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.416 1.886 . . . . 0.0 112.767 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 33.4 p -144.81 20.46 1.64 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.867 1.267 . . . . 0.0 112.729 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.39 37.02 59.03 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.964 1.745 . . . . 0.0 115.276 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -80.88 179.17 7.96 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.652 0.739 . . . . 0.0 112.657 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 t -130.63 144.15 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.388 2.675 . . . . 0.0 107.713 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.3 m -134.79 123.16 23.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.297 2.239 . . . . 0.0 108.167 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.79 116.9 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.949 0.881 . . . . 0.0 111.312 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.56 118.1 35.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.897 1.279 . . . . 0.0 108.526 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 142.56 51.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.31 1.844 . . . . 0.0 109.04 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -167.48 160.01 12.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.602 1.561 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.48 -20.07 4.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.042 1.737 . . . . 0.0 114.029 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.25 -29.09 57.37 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.141 1.776 . . . . 0.0 114.819 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.4 p -149.61 -43.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.397 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -96.44 137.37 21.56 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.842 1.257 . . . . 0.0 110.323 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.05 -171.52 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.84 -20.4 13.07 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.721 2.009 . . . . 0.0 114.474 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -67.65 -12.32 60.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.106 1.762 . . . . 0.0 113.159 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.4 ttm -131.36 145.77 51.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.645 1.578 . . . . 0.0 108.507 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.3 p -136.81 155.88 49.23 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.988 1.315 . . . . 0.0 109.042 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.36 125.9 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.939 -0.476 . . . . 0.0 109.82 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.4 m -117.11 130.32 56.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.462 1.105 . . . . 0.0 109.318 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -76.39 70.58 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.841 1.656 . . . . 0.0 111.093 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.22 -42.16 76.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.807 1.243 . . . . 0.0 113.553 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -147.93 177.9 8.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.885 2.074 . . . . 0.0 109.543 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -68.47 129.84 41.1 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.51 -1.369 . . . . 0.0 108.534 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 19.4 p 55.99 29.89 15.16 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.279 1.432 . . . . 0.0 114.316 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.8 m -135.28 123.87 23.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.556 1.142 . . . . 0.0 111.869 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -124.84 134.89 52.56 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.978 1.311 . . . . 0.0 110.406 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 14.1 mt -120.69 116.1 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -77.14 93.99 4.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.59 1.956 . . . . 0.0 109.971 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.76 121.54 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.451 1.101 . . . . 0.0 109.916 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.26 102.96 13.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.921 0.888 . . . . 0.0 109.795 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -83.7 -29.05 27.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.886 1.274 . . . . 0.0 113.343 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 58.4 m -159.54 133.25 7.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.153 2.181 . . . . 0.0 110.839 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.6 15.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 126.481 1.913 . . . . 0.0 113.944 -163.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.64 146.22 40.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.443 0.697 . . . . 0.0 110.331 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.01 -17.44 17.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -112.97 12.19 19.25 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.115 2.566 . . . . 0.0 113.57 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -138.75 174.03 10.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.024 1.33 . . . . 0.0 110.256 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -140.0 148.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.088 0.955 . . . . 0.0 108.434 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -132.05 143.57 50.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.45 1.1 . . . . 0.0 110.873 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.31 137.31 49.89 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.461 1.504 . . . . 0.0 108.55 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.78 150.24 46.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.139 1.776 . . . . 0.0 109.38 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -115.1 92.52 3.96 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.051 1.34 . . . . 0.0 109.831 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.76 -62.06 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.948 161.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 161.51 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 130.382 3.473 . . . . 0.0 108.663 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 36.84 58.33 1.12 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 114.786 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m 52.26 63.85 2.08 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.069 1.748 . . . . 0.0 115.426 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.5 m -123.21 -41.48 2.31 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.73 -120.6 3.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.676 1.125 . . . . 0.0 112.752 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.93 165.95 22.26 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.558 1.179 . . . . 0.0 111.423 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.0 p -136.66 157.96 45.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.3 1.44 . . . . 0.0 111.903 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.08 131.25 15.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.296 1.838 . . . . 0.0 108.291 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -132.67 120.84 22.26 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.06 1.344 . . . . 0.0 108.8 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -147.19 138.55 23.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.987 1.375 . . . . 0.0 111.266 -169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -70.41 153.52 42.89 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.189 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -63.18 161.9 12.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.554 0.742 . . . . 0.0 112.074 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.42 45.74 76.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.496 0.569 . . . . 0.0 112.847 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -138.63 158.24 44.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.624 1.97 . . . . 0.0 111.247 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -134.68 117.83 16.48 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.347 1.059 . . . . 0.0 108.551 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 139.02 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 109.617 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -144.62 101.21 3.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.402 1.081 . . . . 0.0 108.514 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.468 0.466 0 C-N-CA 123.735 0.814 . . . . 0.0 111.067 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -52.24 -28.81 20.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.625 1.102 . . . . 0.0 112.857 166.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 -0.95 4.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.142 0.977 . . . . 0.0 113.619 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.18 -39.73 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.416 1.487 . . . . 0.0 112.721 165.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -60.23 124.3 19.86 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 123.082 1.42 . . . . 0.0 111.782 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 tpt -149.56 -35.56 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.436 1.494 . . . . 0.0 113.349 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 p -141.03 125.06 17.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.124 0.874 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.11 159.2 42.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.423 1.106 . . . . 0.0 112.32 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.56 121.5 17.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.32 112.3 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 126.479 1.911 . . . . 0.0 108.108 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -32.61 -83.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.752 2.596 . . . . 0.0 116.742 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.633 1.973 . . . . 0.0 112.694 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -121.09 37.91 4.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 110.472 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -151.01 143.81 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 128.566 2.747 . . . . 0.0 109.028 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -119.5 148.83 42.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.951 1.7 . . . . 0.0 109.167 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.09 140.91 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.258 0.551 . . . . 0.0 109.833 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -131.92 131.07 42.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.435 1.094 . . . . 0.0 108.781 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.75 126.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 129.33 41.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.93 1.292 . . . . 0.0 109.458 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -54.76 -62.31 1.74 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 113.301 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.83 173.85 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.345 1.458 . . . . 0.0 109.785 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.98 139.85 39.06 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.5 -173.87 1.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 110.988 -170.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.06 39.19 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.834 1.654 . . . . 0.0 112.004 -173.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.326 43.0 m-20 56.38 48.43 17.02 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.102 1.761 . . . . 0.0 111.053 -167.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.36 153.52 19.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 112.626 -2.079 . . . . 0.0 109.968 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.53 26.43 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.677 3.584 . . . . 0.0 115.203 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 58.66 2.92 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.704 2.002 . . . . 0.0 110.636 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.51 145.62 59.17 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.579 1.52 . . . . 0.0 110.385 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 -129.58 0.51 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.084 1.326 . . . . 0.0 113.151 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.36 158.2 31.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 111.038 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -147.91 153.29 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.848 1.659 . . . . 0.0 109.765 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.4 163.1 35.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.882 0.873 . . . . 0.0 110.784 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -123.55 105.12 9.49 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.274 1.43 . . . . 0.0 110.494 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -74.18 102.08 4.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 109.611 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.95 148.84 24.57 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.766 1.627 . . . . 0.0 113.744 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.39 140.94 38.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.742 1.617 . . . . 0.0 113.108 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 55.61 29.17 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 125.007 1.289 . . . . 0.0 114.366 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -148.62 164.01 35.55 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -134.35 129.9 36.13 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.868 1.667 . . . . 0.0 108.513 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.2 130.84 50.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.626 1.571 . . . . 0.0 107.492 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -139.85 -8.36 1.22 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -140.92 68.02 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.415 1.886 . . . . 0.0 110.819 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.43 20.7 12.41 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.255 2.222 . . . . 0.0 112.237 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.24 -11.97 1.39 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.625 1.57 . . . . 0.0 114.077 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -19.75 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.401 -1.437 . . . . 0.0 114.138 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.98 34.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 126.821 2.048 . . . . 0.0 111.745 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -49.67 -28.98 6.61 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.367 -1.458 . . . . 0.0 113.418 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.54 71.71 1.04 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.046 1.308 . . . . 0.0 113.653 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.51 147.57 46.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.27 1.428 . . . . 0.0 109.481 164.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -147.91 -14.81 0.36 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 159.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -133.4 127.37 33.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.367 1.467 . . . . 0.0 109.564 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.09 124.24 36.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.814 1.246 . . . . 0.0 109.263 -166.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -117.09 115.86 26.2 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.449 1.499 . . . . 0.0 108.425 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 t -115.94 117.01 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.4 mt -128.44 151.83 77.28 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.978 0.911 . . . . 0.0 109.797 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.16 -178.85 3.48 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.072 2.515 . . . . 0.0 111.617 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.61 -23.02 71.2 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.167 -0.958 . . . . 0.0 113.855 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.25 74.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.117 0.967 . . . . 0.0 112.417 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.67 149.21 21.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.89 1.276 . . . . 0.0 109.484 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.81 -31.88 4.4 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.577 -1.327 . . . . 0.0 113.181 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.73 148.43 31.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.667 1.587 . . . . 0.0 108.19 167.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -119.19 154.94 32.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.766 0.793 . . . . 0.0 110.077 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.06 150.01 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.392 1.477 . . . . 0.0 109.433 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.62 126.99 51.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.51 136.05 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.7 -0.625 . . . . 0.0 110.206 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -140.71 134.09 29.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.931 0.492 . . . . 0.0 111.387 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.8 mt -85.38 146.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.495 1.518 . . . . 0.0 109.481 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.3 t -135.9 102.56 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.135 1.774 . . . . 0.0 109.118 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -58.16 119.94 7.73 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.054 0.942 . . . . 0.0 111.662 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -112.65 -35.6 5.46 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.016 0.926 . . . . 0.0 111.646 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -91.12 -36.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.373 1.069 . . . . 0.0 113.76 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' THR . 63.4 m-20 -91.58 91.66 8.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.595 1.158 . . . . 0.0 109.924 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 65.3 p -64.33 17.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' ASN . 94.5 m -133.94 80.95 1.89 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.394 2.678 . . . . 0.0 109.074 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.58 130.69 47.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.072 0.949 . . . . 0.0 111.811 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.87 -38.44 2.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.283 1.42 . . . . 0.0 113.537 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.4 m -71.47 -27.58 63.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.613 1.165 . . . . 0.0 112.946 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.85 126.97 32.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.631 1.172 . . . . 0.0 109.847 171.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -129.23 141.71 51.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.765 1.626 . . . . 0.0 109.43 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -135.85 138.77 42.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.962 0.905 . . . . 0.0 110.146 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -123.61 138.49 54.54 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.411 1.484 . . . . 0.0 107.793 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.8 145.63 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.619 0.767 . . . . 0.0 110.682 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 t -144.73 94.91 5.4 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 111.294 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.27 165.84 23.24 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.828 2.352 . . . . 0.0 112.164 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -29.67 94.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 128.092 2.557 . . . . 0.0 114.17 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 47.72 37.93 7.73 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.68 1.592 . . . . 0.0 114.867 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.0 t -93.65 155.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.946 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.64 98.85 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.335 . . . . 0.0 111.195 170.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.85 151.33 18.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.743 -0.598 . . . . 0.0 112.084 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.35 131.22 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.102 0.561 . . . . 0.0 110.219 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.23 33.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.326 0.65 . . . . 0.0 109.477 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.66 142.18 51.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.808 1.243 . . . . 0.0 108.371 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -127.5 137.66 52.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 108.2 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.48 108.99 0.54 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.468 0.707 . . . . 0.0 111.326 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.95 -25.69 4.91 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 113.791 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.75 146.27 55.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.892 1.346 . . . . 0.0 110.871 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.61 167.88 14.18 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.637 -0.664 . . . . 0.0 111.376 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -47.0 105.05 0.06 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.848 1.259 . . . . 0.0 112.78 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.01 126.29 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.506 1.122 . . . . 0.0 109.126 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.12 124.17 22.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.961 0.41 . . . . 0.0 109.949 176.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.81 96.43 49.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.557 1.943 . . . . 0.0 107.112 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -74.37 143.49 31.41 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.473 2.115 . . . . 0.0 112.733 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.7 mm -122.06 133.78 24.47 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.794 1.637 . . . . 0.0 108.565 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.47 170.44 12.29 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 112.752 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -49.82 138.68 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.669 . . . . 0.0 112.716 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.17 122.71 9.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.649 0.779 . . . . 0.0 110.532 -174.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.4 t -134.6 131.66 20.38 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 110.9 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.85 152.98 83.67 Favored 'Cis proline' 0 CA--C 1.548 1.204 0 CA-C-N 119.345 0.802 . . . . 0.0 112.148 -6.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.36 -37.48 81.64 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.709 2.273 . . . . 0.0 112.089 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -7.15 8.65 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.053 1.741 . . . . 0.0 114.414 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.3 t -74.6 -179.42 4.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.136 -0.978 . . . . 0.0 112.347 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -130.5 154.52 47.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.975 1.31 . . . . 0.0 112.826 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.49 130.6 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.541 1.936 . . . . 0.0 109.854 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.23 141.29 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.96 0.904 . . . . 0.0 111.017 172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 t -148.29 158.7 44.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.211 1.404 . . . . 0.0 110.764 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.55 136.45 53.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.31 1.044 . . . . 0.0 109.216 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.34 126.31 46.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.186 1.794 . . . . 0.0 108.367 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 p -133.46 131.15 39.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.78 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.29 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.607 1.563 . . . . 0.0 107.02 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -143.71 151.59 40.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.729 1.612 . . . . 0.0 109.336 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -85.53 142.67 29.0 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.816 -0.552 . . . . 0.0 111.524 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.9 p -85.85 7.57 23.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.912 1.685 . . . . 0.0 112.926 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.94 16.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.31 1.844 . . . . 0.0 110.733 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -51.41 139.47 27.15 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.923 1.289 . . . . 0.0 113.442 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.94 11.74 19.29 Favored 'Cis proline' 0 CA--C 1.549 1.229 0 N-CA-C 114.904 1.078 . . . . 0.0 114.904 4.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.67 15.33 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.664 1.986 . . . . 0.0 114.149 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.76 164.64 19.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.19 1.396 . . . . 0.0 112.469 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -68.98 154.59 41.8 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.812 0.815 . . . . 0.0 112.121 171.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.3 -38.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.786 1.634 . . . . 0.0 110.339 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.3 t -146.06 140.92 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -144.35 105.79 4.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.432 1.493 . . . . 0.0 108.579 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.11 -179.98 38.65 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.466 -0.771 . . . . 0.0 114.487 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.5 p -113.21 136.1 53.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.703 1.201 . . . . 0.0 112.004 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.35 150.04 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.974 2.11 . . . . 0.0 107.722 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -124.52 135.47 53.21 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.1 149.54 30.69 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.458 -0.776 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -138.26 153.68 49.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.837 2.055 . . . . 0.0 108.654 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -115.7 164.65 14.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.197 0.999 . . . . 0.0 109.719 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -136.46 105.29 9.24 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.342 1.057 . . . . 0.0 109.582 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -67.8 -14.96 43.13 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.53 2.82 . . . . 0.0 113.262 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.0 m -45.5 -46.54 13.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.49 2.316 . . . . 0.0 113.171 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 65.1 p -145.21 11.03 1.32 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.734 1.214 . . . . 0.0 113.14 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 69.29 42.71 73.99 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.199 -1.563 . . . . 0.0 112.768 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -83.52 156.67 22.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.897 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.36 155.12 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.739 0.815 . . . . 0.0 110.274 165.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.6 m -143.63 114.95 7.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.696 1.199 . . . . 0.0 108.571 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.32 146.81 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.142 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.58 132.62 66.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.565 1.946 . . . . 0.0 107.56 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 138.66 32.65 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.198 1.399 . . . . 0.0 108.661 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -127.82 144.36 51.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.151 1.38 . . . . 0.0 108.539 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.49 -18.81 20.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.78 -33.6 16.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.46 1.504 . . . . 0.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.2 p -98.83 -53.05 3.39 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.77 1.228 . . . . 0.0 110.888 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -85.79 148.29 48.2 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.419 1.488 . . . . 0.0 109.997 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.08 175.17 11.24 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.386 2.058 . . . . 0.0 111.672 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 8.71 44.58 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.945 1.298 . . . . 0.0 113.147 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.97 -37.52 10.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.355 1.462 . . . . 0.0 111.707 -164.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 146.45 40.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 128.76 2.824 . . . . 0.0 106.953 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.3 p -139.91 153.17 46.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.565 0.746 . . . . 0.0 110.896 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.93 137.6 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.501 0.72 . . . . 0.0 110.27 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 33.4 m -120.72 140.76 51.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.806 1.642 . . . . 0.0 109.39 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -68.59 91.2 0.41 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.985 1.314 . . . . 0.0 110.635 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -75.27 -48.97 20.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 122.215 -0.303 . . . . 0.0 110.934 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.97 -178.59 5.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.631 1.572 . . . . 0.0 112.121 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -58.78 -34.54 71.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.138 1.375 . . . . 0.0 114.607 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.6 p -138.0 25.16 2.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.985 1.714 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 t -125.26 136.22 53.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.083 0.953 . . . . 0.0 111.255 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.5 133.3 52.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.178 1.391 . . . . 0.0 110.637 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.7 tt -115.97 112.35 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.154 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.94 125.62 39.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.842 2.457 . . . . 0.0 108.231 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -125.27 129.96 51.09 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.14 1.376 . . . . 0.0 111.319 -172.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.6 tt -121.87 114.9 21.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.889 0.876 . . . . 0.0 111.608 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -123.14 7.4 9.17 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.888 1.675 . . . . 0.0 113.938 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.67 -8.69 13.78 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 40.96 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 129.363 3.065 . . . . 0.0 118.67 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 -172.772 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.1 142.73 57.68 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.251 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -19.39 51.04 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.28 9.12 23.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.639 1.976 . . . . 0.0 113.255 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -136.83 -178.31 5.13 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 120.485 1.493 . . . . 0.0 110.81 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.69 148.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.675 1.19 . . . . 0.0 110.653 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 142.52 49.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.471 1.108 . . . . 0.0 109.404 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -135.55 127.9 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.149 1.38 . . . . 0.0 108.51 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -133.54 130.78 38.93 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.506 1.122 . . . . 0.0 110.601 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.44 56.88 4.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.792 1.237 . . . . 0.0 111.274 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.43 140.24 3.62 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.922 0.772 . . . . 0.0 111.183 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -58.23 139.16 55.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.459 0.703 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 70.55 37.62 1.44 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 125.376 1.47 . . . . 0.0 113.808 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.9 m 54.14 64.12 1.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.331 1.852 . . . . 0.0 113.673 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.9 p -132.45 179.24 6.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.969 1.307 . . . . 0.0 112.755 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.97 -81.27 1.17 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.877 1.703 . . . . 0.0 114.71 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -138.53 166.73 23.55 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.053 1.741 . . . . 0.0 110.019 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -130.94 152.78 49.88 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.759 1.224 . . . . 0.0 112.758 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -160.68 162.76 32.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.373 1.469 . . . . 0.0 111.304 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -134.67 140.93 46.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.925 1.29 . . . . 0.0 110.812 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -124.87 141.19 52.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.851 1.661 . . . . 0.0 110.119 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -88.84 143.72 26.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.515 0.726 . . . . 0.0 111.444 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.26 150.68 38.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.06 1.344 . . . . 0.0 111.7 170.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.51 58.17 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.113 1.339 . . . . 0.0 113.438 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -137.77 159.09 42.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.942 1.697 . . . . 0.0 111.356 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.4 m -117.93 128.97 55.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.993 1.317 . . . . 0.0 108.86 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.89 114.85 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.747 1.219 . . . . 0.0 109.432 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.47 145.83 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.746 1.218 . . . . 0.0 111.074 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CE2' ' HE3' ' A' ' 40' ' ' LYS . 63.1 m-85 . . . . . 0 C--N 1.327 -0.39 0 C-N-CA 125.243 1.417 . . . . 0.0 110.09 168.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.5 m0 . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -62.15 -42.26 99.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.492 1.517 . . . . 0.0 111.813 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.46 34.93 0.14 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.029 1.731 . . . . 0.0 113.047 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -78.27 -20.28 51.93 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 118.902 -2.374 . . . . 0.0 114.596 177.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.87 145.52 35.05 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.814 0.816 . . . . 0.0 111.706 176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 ttt -155.7 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.1 p -134.56 132.56 39.26 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.613 1.097 . . . . 0.0 110.697 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.2 m -143.45 152.47 41.56 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 108.041 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.44 145.67 47.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.511 1.148 . . . . 0.0 112.273 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.73 120.18 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.354 2.661 . . . . 0.0 108.843 -170.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.66 -86.2 0.01 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -168.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 t -164.13 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.99 0.916 . . . . 0.0 111.792 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.76 32.67 5.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.846 1.258 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.55 164.07 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 110.276 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -144.43 154.12 42.63 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.742 2.017 . . . . 0.0 110.067 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.96 134.56 52.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.85 0.86 . . . . 0.0 110.806 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.19 118.33 31.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.89 1.276 . . . . 0.0 109.492 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.0 mm -110.1 106.49 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.294 1.038 . . . . 0.0 108.998 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.94 117.79 24.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.005 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.09 -45.46 81.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 122.205 1.003 . . . . 0.0 112.479 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 167.77 29.25 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.091 1.756 . . . . 0.0 109.923 -169.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -108.91 48.93 0.84 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.439 0.696 . . . . 0.0 110.537 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.75 160.68 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.505 1.922 . . . . 0.0 114.686 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.68 52.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.433 -1.417 . . . . 0.0 110.684 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 71.68 36.35 1.26 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.704 2.402 . . . . 0.0 111.58 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 p -67.46 155.96 89.72 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.789 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.79 32.35 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.33 3.353 . . . . 0.0 113.38 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -151.16 99.64 3.05 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 109.995 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 118.06 5.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.688 1.592 . . . . 0.0 108.965 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.89 -120.87 0.1 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.49 144.05 44.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 112.52 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -161.82 132.45 5.03 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 110.226 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -143.22 163.1 33.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.599 1.159 . . . . 0.0 110.665 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.02 107.68 9.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.364 1.466 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -84.05 95.55 8.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.815 0.846 . . . . 0.0 108.941 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.24 150.53 3.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 113.044 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -66.61 145.95 55.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.829 0.452 . . . . 0.0 112.177 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.5 64.58 3.94 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.452 1.025 . . . . 0.0 115.413 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -153.02 177.2 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.147 0.979 . . . . 0.0 112.868 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.8 m -130.7 142.43 50.42 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.182 1.393 . . . . 0.0 110.241 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.82 134.55 44.81 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.962 1.305 . . . . 0.0 109.884 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.2 -33.02 1.15 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 123.579 0.752 . . . . 0.0 112.489 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -118.06 40.34 3.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.053 1.406 . . . . 0.0 110.965 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -16.35 62.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.385 1.074 . . . . 0.0 113.213 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -61.58 -11.47 11.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.269 1.427 . . . . 0.0 113.184 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.5 t -47.35 -36.74 9.96 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.82 -1.175 . . . . 0.0 113.127 167.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 tt -81.0 -35.17 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.84 42.22 11.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.998 2.119 . . . . 0.0 113.811 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.05 67.31 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.297 0.951 . . . . 0.0 113.022 -161.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.1 tp -131.61 115.35 15.97 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.722 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.4 m -120.9 -20.6 6.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.481 1.113 . . . . 0.0 112.891 167.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -127.52 122.37 33.15 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.078 0.951 . . . . 0.0 110.189 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.35 137.11 44.91 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.232 1.013 . . . . 0.0 109.084 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.06 136.11 55.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.95 118.55 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -131.41 146.94 64.14 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.967 0.907 . . . . 0.0 109.359 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.71 165.77 24.47 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.114 2.543 . . . . 0.0 112.308 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.73 -14.3 36.04 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 124.358 0.98 . . . . 0.0 114.828 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.06 -28.07 63.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.134 1.374 . . . . 0.0 113.946 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -123.49 102.93 8.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.693 1.597 . . . . 0.0 109.535 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.9 -27.89 26.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.43 -1.419 . . . . 0.0 113.513 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.24 145.18 24.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.489 2.315 . . . . 0.0 106.856 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.43 165.71 24.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.782 0.801 . . . . 0.0 111.054 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 151.13 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.858 1.263 . . . . 0.0 109.261 -173.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.86 125.33 44.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.63 138.2 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.978 0.894 . . . . 0.0 110.729 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.09 118.07 15.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.547 1.539 . . . . 0.0 108.54 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 149.01 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 122.894 0.478 . . . . 0.0 109.822 165.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.96 129.49 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.29 121.72 34.07 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.017 -0.427 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -26.13 6.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.764 1.626 . . . . 0.0 113.142 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.12 -35.68 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.897 0.879 . . . . 0.0 113.266 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -108.91 -179.59 3.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.085 1.354 . . . . 0.0 109.735 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.8 t -120.93 -39.54 2.71 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.504 1.122 . . . . 0.0 111.826 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.7 m -60.19 -39.73 87.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.103 0.961 . . . . 0.0 112.204 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.16 -179.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.246 1.818 . . . . 0.0 114.789 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.98 -25.68 0.8 Allowed Glycine 0 N--CA 1.478 1.476 0 O-C-N 120.071 -1.643 . . . . 0.0 115.55 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 m -53.36 -35.5 60.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.13 1.372 . . . . 0.0 111.906 163.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -90.45 131.37 36.25 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.238 1.815 . . . . 0.0 110.466 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.52 130.35 42.22 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.871 1.269 . . . . 0.0 111.229 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -92.86 135.58 34.01 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.916 1.686 . . . . 0.0 110.092 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -133.91 97.4 3.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.912 1.685 . . . . 0.0 108.304 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.2 mm -94.22 132.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -131.61 92.96 29.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.99 171.99 12.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.475 . . . . 0.0 112.328 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -35.37 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.0 2.52 . . . . 0.0 114.969 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 41.53 59.23 2.48 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.888 1.675 . . . . 0.0 114.486 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.93 157.95 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.171 1.788 . . . . 0.0 111.593 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -40.54 115.35 0.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.859 1.663 . . . . 0.0 111.85 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 136.16 51.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.95 151.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.668 0.787 . . . . 0.0 109.339 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.3 132.89 41.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.204 1.001 . . . . 0.0 110.383 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.3 t -133.52 119.25 19.28 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.644 1.178 . . . . 0.0 108.936 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -114.81 121.87 44.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.578 1.551 . . . . 0.0 108.301 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t0 55.54 -175.86 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.862 0.839 . . . . 0.0 113.054 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.65 30.64 1.24 Allowed Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.173 1.368 . . . . 0.0 113.587 161.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -56.56 175.55 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.998 1.399 . . . . 0.0 111.389 166.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -44.84 122.15 3.09 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.892 -1.13 . . . . 0.0 111.731 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -53.25 159.48 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.142 0.977 . . . . 0.0 112.416 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.41 135.24 54.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.766 0.793 . . . . 0.0 110.279 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -75.55 142.7 42.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.18 91.15 48.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 125.465 1.506 . . . . 0.0 109.345 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.05 144.18 46.55 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.196 1.931 . . . . 0.0 111.464 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 46.3 mm -128.17 135.4 27.47 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.718 1.607 . . . . 0.0 108.522 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.21 177.39 8.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.033 3.156 . . . . 0.0 112.306 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.08 141.81 57.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.395 0.678 . . . . 0.0 111.791 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.46 147.33 7.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.981 1.712 . . . . 0.0 110.314 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 98.8 m -147.48 135.33 10.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.087 0.955 . . . . 0.0 109.71 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.08 153.23 87.89 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.422 0.829 . . . . 0.0 112.722 -5.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.18 -36.58 68.31 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.182 1.921 . . . . 0.0 112.158 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.25 -16.48 60.37 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.81 128.68 36.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 110.857 170.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 162.37 25.49 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 112.723 171.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.9 151.75 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.871 1.668 . . . . 0.0 109.098 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.53 118.41 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.565 0.746 . . . . 0.0 110.821 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.4 m -130.42 150.52 51.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.4 1.08 . . . . 0.0 111.609 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.25 123.21 48.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.93 0.892 . . . . 0.0 108.602 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.09 113.85 26.27 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.04 1.336 . . . . 0.0 107.758 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.63 145.31 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.36 130.7 51.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -145.07 153.88 41.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.968 1.307 . . . . 0.0 109.331 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 143.24 54.71 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.941 168.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.4 p -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.245 1.418 . . . . 0.0 113.946 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -141.6 161.06 38.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.751 2.021 . . . . 0.0 110.89 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -66.37 139.36 96.21 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 127.43 12.13 Favored 'Cis proline' 0 C--N 1.353 0.8 0 CA-C-N 120.331 1.154 . . . . 0.0 111.443 -6.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -74.22 49.91 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.713 1.605 . . . . 0.0 111.13 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.86 131.81 52.03 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.286 -1.509 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.06 90.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.174 0.589 . . . . 0.0 109.839 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.2 t -42.47 -52.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.782 2.033 . . . . 0.0 111.087 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.8 p -159.47 152.51 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.917 -0.489 . . . . 0.0 111.838 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.87 102.87 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.845 1.658 . . . . 0.0 108.385 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.01 -174.36 13.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.928 1.728 . . . . 0.0 111.863 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.4 m -132.88 150.34 52.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.458 1.103 . . . . 0.0 110.906 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.46 163.5 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 126.314 1.846 . . . . 0.0 108.507 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -129.49 136.38 49.81 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.927 0.491 . . . . 0.0 109.867 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.28 137.05 52.45 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.659 1.184 . . . . 0.0 107.983 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 160.13 38.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.269 1.428 . . . . 0.0 110.154 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 114.38 18.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.996 0.816 . . . . 0.0 110.253 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 m -76.46 118.2 69.8 Favored Pre-proline 0 N--CA 1.476 0.843 0 O-C-N 120.359 -1.463 . . . . 0.0 109.95 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.36 -19.36 55.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.59 2.193 . . . . 0.0 113.957 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.2 m -52.7 -50.27 63.68 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.902 2.081 . . . . 0.0 114.3 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.3 p -136.11 18.26 3.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.578 1.551 . . . . 0.0 111.803 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.76 41.14 97.75 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.095 0.855 . . . . 0.0 114.135 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -72.67 164.04 27.13 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.716 -1.461 . . . . 0.0 111.982 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 135.83 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.8 m -131.77 135.08 46.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.401 1.08 . . . . 0.0 108.298 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.27 135.75 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.9 0.857 . . . . 0.0 110.743 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.33 134.84 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.601 1.961 . . . . 0.0 106.721 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 133.76 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.789 1.235 . . . . 0.0 108.061 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.27 150.32 39.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.153 1.381 . . . . 0.0 108.882 -166.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -57.41 -23.42 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.74 -31.66 20.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.832 1.253 . . . . 0.0 113.6 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.2 p -96.34 -49.92 4.99 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.378 1.071 . . . . 0.0 110.199 -170.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.91 148.3 97.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 110.016 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.87 -95.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.118 1.879 . . . . 0.0 111.003 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 164.39 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 128.103 2.561 . . . . 0.0 112.942 -171.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -61.21 -43.76 98.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.643 1.177 . . . . 0.0 112.515 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.7 149.31 25.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.856 1.662 . . . . 0.0 109.57 170.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -134.94 133.82 39.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.29 1.036 . . . . 0.0 110.286 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.02 130.82 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.634 0.774 . . . . 0.0 109.665 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.2 m -128.86 131.13 47.64 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.187 1.395 . . . . 0.0 108.9 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.06 94.21 1.48 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 0.0 110.342 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.59 -46.88 35.72 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.06 0.544 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -145.45 -172.6 3.92 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.475 1.91 . . . . 0.0 111.221 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -51.38 -49.41 61.59 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.708 -1.245 . . . . 0.0 113.242 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.6 p -128.24 32.51 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 110.823 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.1 t -137.37 127.96 26.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.241 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -125.07 137.09 54.21 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.011 1.324 . . . . 0.0 109.707 -174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.31 128.16 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.977 0.894 . . . . 0.0 109.007 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -115.69 94.51 4.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.433 1.893 . . . . 0.0 107.377 -165.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -85.79 121.4 28.39 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.775 -0.578 . . . . 0.0 110.186 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.78 101.5 11.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 111.836 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.79 10.13 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.597 1.159 . . . . 0.0 112.675 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.68 157.07 34.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.423 1.489 . . . . 0.0 112.834 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.63 -4.56 59.06 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 126.121 1.769 . . . . 0.0 112.184 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.25 142.73 58.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -18.86 10.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.726 1.148 . . . . 0.0 113.623 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -113.35 15.72 19.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.95 2.1 . . . . 0.0 112.753 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -139.5 166.49 24.42 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.188 -1.57 . . . . 0.0 109.725 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.15 159.78 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.383 0.611 . . . . 0.0 110.037 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.87 161.31 39.63 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.842 0.857 . . . . 0.0 111.301 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -128.11 145.85 50.88 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.337 1.455 . . . . 0.0 109.311 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.44 114.07 14.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.77 2.028 . . . . 0.0 110.618 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.38 77.01 6.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 109.189 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.59 -87.97 0.07 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.832 -0.982 . . . . 0.0 112.844 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.15 124.15 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 129.738 3.215 . . . . 0.0 109.512 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 63.78 44.05 5.18 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.541 1.136 . . . . 0.0 114.028 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m 68.02 58.09 0.48 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.383 2.273 . . . . 0.0 113.961 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -141.73 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.896 1.678 . . . . 0.0 112.002 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.28 -121.09 12.72 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.366 0.984 . . . . 0.0 111.686 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.97 166.26 15.23 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.119 0.959 . . . . 0.0 111.361 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -132.12 154.18 49.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.056 1.342 . . . . 0.0 111.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.81 141.61 22.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.509 1.524 . . . . 0.0 109.513 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -117.44 135.32 53.98 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.076 0.95 . . . . 0.0 110.042 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -131.84 139.1 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.353 1.461 . . . . 0.0 109.946 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.8 150.45 24.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.609 -0.682 . . . . 0.0 111.284 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.28 162.63 29.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.941 0.896 . . . . 0.0 111.43 170.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.54 33.31 40.51 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.636 0.636 . . . . 0.0 113.906 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -134.06 148.11 51.0 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.267 1.427 . . . . 0.0 110.625 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -105.96 132.8 51.62 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.426 1.49 . . . . 0.0 108.31 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.8 126.02 69.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.247 1.019 . . . . 0.0 109.247 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 150.16 28.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.81 1.644 . . . . 0.0 110.379 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.577 1.551 . . . . 0.0 110.201 171.695 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.35 0.595 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -65.05 -41.84 94.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 0.0 113.773 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.76 -94.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 108.119 158.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 29.3 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 127.238 2.215 . . . . 0.0 116.178 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.14 147.15 50.26 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 128.728 2.811 . . . . 0.0 110.058 176.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.8 tpt -151.56 -53.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.339 1.055 . . . . 0.0 111.947 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -137.11 131.15 32.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 125.322 1.449 . . . . 0.0 109.433 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.63 155.57 44.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.65 1.18 . . . . 0.0 109.583 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.9 117.2 18.93 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.137 0.975 . . . . 0.0 108.61 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.84 117.26 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.997 1.719 . . . . 0.0 108.547 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -41.02 -95.77 0.01 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 127.472 2.463 . . . . 0.0 117.519 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 t -162.19 -40.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.476 1.111 . . . . 0.0 111.908 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.61 35.84 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.656 1.582 . . . . 0.0 110.355 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.76 135.91 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.435 1.494 . . . . 0.0 109.245 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.98 153.73 25.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 109.5 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.63 142.39 47.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.199 1.0 . . . . 0.0 109.392 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.74 127.98 39.86 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.561 1.544 . . . . 0.0 107.412 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 pt -121.6 125.57 73.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.453 0.644 . . . . 0.0 109.707 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -140.05 100.03 3.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.933 1.349 . . . . 0.0 111.201 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.53 104.85 2.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.44 1.496 . . . . 0.0 111.303 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.46 154.11 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.327 1.537 . . . . 0.0 114.25 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -92.06 139.67 30.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.781 -1.199 . . . . 0.0 112.24 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.34 179.73 8.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.626 1.171 . . . . 0.0 111.597 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.83 44.0 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 126.022 1.729 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 59.86 47.5 10.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.97 1.708 . . . . 0.0 112.332 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -79.36 179.78 1.69 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.719 2.008 . . . . 0.0 111.007 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -70.45 12.08 0.42 Allowed 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.871 2.38 . . . . 0.0 114.397 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -145.18 65.99 12.22 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.597 1.559 . . . . 0.0 110.997 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.61 132.86 32.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.246 1.298 . . . . 0.0 109.359 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.41 164.35 11.28 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.215 171.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -57.55 109.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.385 0.674 . . . . 0.0 110.663 163.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -111.67 139.01 47.47 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.928 1.691 . . . . 0.0 109.259 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -160.77 158.75 29.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.06 0.933 . . . . 0.0 111.361 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.47 95.83 5.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.456 1.502 . . . . 0.0 109.613 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.07 108.15 1.75 Allowed 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.37 -0.831 . . . . 0.0 109.476 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.73 143.1 10.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.982 1.713 . . . . 0.0 113.209 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.39 138.11 57.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.872 0.869 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.41 73.32 0.49 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.436 1.493 . . . . 0.0 116.097 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.98 177.43 8.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.6 m -122.22 135.42 54.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.382 1.073 . . . . 0.0 109.402 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -115.26 134.82 54.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.467 1.507 . . . . 0.0 107.671 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -144.64 5.89 1.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.61 33.26 0.41 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.142 1.377 . . . . 0.0 111.595 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.59 -4.23 57.35 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.083 -1.011 . . . . 0.0 113.72 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.39 -13.13 26.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.13 0.972 . . . . 0.0 113.617 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.0 m -50.73 -32.79 20.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.901 1.681 . . . . 0.0 114.072 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -30.83 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.418 0.687 . . . . 0.0 112.254 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.6 t30 35.89 43.42 0.19 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.579 2.752 . . . . 0.0 115.456 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.42 95.12 0.12 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.884 1.23 . . . . 0.0 111.685 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.25 155.71 46.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.833 2.053 . . . . 0.0 109.287 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 m -157.1 -32.68 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.388 1.075 . . . . 0.0 112.458 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -119.28 138.65 52.87 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.05 1.34 . . . . 0.0 109.822 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -130.44 129.68 43.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.13 1.372 . . . . 0.0 107.981 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -129.52 117.7 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.88 131.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.81 148.78 38.02 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.401 1.08 . . . . 0.0 109.675 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' CG ' ' CD2' ' A' ' 96' ' ' PHE . 77.8 Cg_endo -77.67 15.76 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.527 3.485 . . . . 0.0 112.907 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.18 -35.66 0.42 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.846 2.641 . . . . 0.0 116.042 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -34.21 73.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.987 1.715 . . . . 0.0 112.588 168.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.431 ' CD2' ' CG ' ' A' ' 93' ' ' PRO . 11.0 m-85 -92.54 138.2 31.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 110.325 174.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -79.35 -35.06 41.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.022 0.929 . . . . 0.0 111.74 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -158.58 170.75 21.49 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 109.756 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.65 165.15 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.042 0.937 . . . . 0.0 110.673 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.88 149.24 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.436 1.095 . . . . 0.0 109.928 -171.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -99.98 122.45 42.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.04 137.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.441 0.697 . . . . 0.0 110.456 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -138.53 155.36 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.174 1.39 . . . . 0.0 110.091 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 mt -124.06 135.67 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.46 121.74 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -85.04 118.72 24.78 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -102.91 -8.95 20.28 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.3 t -108.72 -57.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.952 0.901 . . . . 0.0 112.216 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.78 -33.49 76.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.024 0.53 . . . . 0.0 110.505 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.97 17.97 3.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.712 2.005 . . . . 0.0 114.381 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -103.02 -47.14 4.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 111.521 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 57.07 153.48 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.226 2.21 . . . . 0.0 116.072 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.37 58.93 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.834 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.7 p -90.43 -61.8 1.6 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.05 1.34 . . . . 0.0 112.203 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -47.23 108.39 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.254 2.222 . . . . 0.0 111.326 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.64 124.34 47.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.326 1.05 . . . . 0.0 109.209 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -114.19 141.15 47.9 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.591 1.156 . . . . 0.0 109.255 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.9 m -132.03 137.38 47.8 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.344 1.458 . . . . 0.0 107.855 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.2 pt -133.72 145.15 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 123.618 0.767 . . . . 0.0 111.123 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.0 m -135.61 95.68 14.08 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 108.916 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 75.49 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.291 3.328 . . . . 0.0 111.583 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.9 t80 60.18 81.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.967 2.107 . . . . 0.0 112.041 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 42.93 46.28 4.6 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.911 1.684 . . . . 0.0 115.084 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.92 168.6 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.322 2.249 . . . . 0.0 109.848 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -36.44 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.991 2.517 . . . . 0.0 113.7 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 145.31 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.241 1.016 . . . . 0.0 110.396 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 139.18 50.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 109.395 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.3 133.56 55.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.295 -1.32 . . . . 0.0 108.78 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 22.4 p -135.19 150.45 50.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.339 1.066 . . . . 0.0 110.431 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -102.61 144.08 31.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.753 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.59 27.43 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.128 2.171 . . . . 0.0 115.922 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.51 2.39 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.422 1.963 . . . . 0.0 114.089 -173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.54 174.92 10.08 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.671 1.988 . . . . 0.0 110.11 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -56.57 158.99 4.05 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.887 -1.133 . . . . 0.0 112.468 163.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -51.96 153.66 2.51 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.72 0.808 . . . . 0.0 112.04 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.16 139.09 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.435 0.636 . . . . 0.0 110.747 172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.21 108.19 11.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.787 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.2 tp -88.22 112.29 48.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.194 1.398 . . . . 0.0 109.258 170.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 56.8 Cg_endo -78.5 152.36 26.32 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.823 1.682 . . . . 0.0 112.728 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 30.4 mm -133.8 131.77 21.25 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.428 1.491 . . . . 0.0 109.873 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.94 170.96 19.05 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.281 2.654 . . . . 0.0 112.366 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.67 149.21 42.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.75 154.25 24.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.484 1.914 . . . . 0.0 109.877 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -134.78 135.93 24.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.392 1.077 . . . . 0.0 110.975 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 150.49 77.51 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.639 0.907 . . . . 0.0 111.421 -5.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.17 -32.15 74.51 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.76 1.64 . . . . 0.0 111.704 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.35 -5.91 4.08 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.706 2.002 . . . . 0.0 114.908 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 p -69.63 -178.87 1.56 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.873 -1.142 . . . . 0.0 112.276 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.87 150.49 40.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.034 0.934 . . . . 0.0 111.91 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.9 tt -107.02 138.69 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.379 1.472 . . . . 0.0 109.583 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.47 138.23 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.008 0.923 . . . . 0.0 109.617 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -141.6 131.31 24.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.999 -1.063 . . . . 0.0 110.601 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -82.9 141.52 32.14 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.545 -0.722 . . . . 0.0 109.84 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.24 111.17 13.64 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.616 1.166 . . . . 0.0 110.0 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.9 p -128.02 115.23 18.17 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.872 1.269 . . . . 0.0 110.34 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.59 121.34 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.301 1.44 . . . . 0.0 107.527 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -127.93 136.79 51.82 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.214 1.406 . . . . 0.0 108.911 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.26 130.48 35.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.234 0.54 . . . . 0.0 110.428 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -75.94 -30.81 58.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.232 1.013 . . . . 0.0 112.206 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.51 -179.29 4.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.839 2.055 . . . . 0.0 112.266 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.49 148.71 32.43 Favored Pre-proline 0 N--CA 1.481 1.105 0 O-C-N 121.214 -0.929 . . . . 0.0 112.651 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.3 17.15 11.71 Favored 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 119.956 1.02 . . . . 0.0 114.65 -1.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 63.61 18.69 11.27 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.204 1.802 . . . . 0.0 113.986 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -94.35 178.99 5.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.188 1.795 . . . . 0.0 112.289 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -79.37 144.31 34.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.65 -1.281 . . . . 0.0 112.328 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.48 -43.51 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.412 1.885 . . . . 0.0 110.994 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.6 t -140.39 123.55 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -135.97 97.39 3.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.43 10.35 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.667 1.127 . . . . 0.0 111.848 -168.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 m -139.13 169.63 17.44 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.291 1.036 . . . . 0.0 110.66 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.0 156.98 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 127.282 2.233 . . . . 0.0 108.461 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -120.96 139.76 52.81 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -120.23 130.79 54.68 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.286 -0.883 . . . . 0.0 109.7 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -120.56 153.37 36.84 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.294 1.437 . . . . 0.0 110.249 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -128.63 124.37 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.209 1.403 . . . . 0.0 110.132 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.8 m -95.55 113.75 62.47 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 109.823 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.16 -11.68 32.76 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.064 2.509 . . . . 0.0 112.827 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m -43.34 -48.22 6.87 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.878 2.471 . . . . 0.0 112.985 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 80.7 p -144.84 17.87 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.206 1.402 . . . . 0.0 112.395 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.0 88.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.681 -1.262 . . . . 0.0 113.542 -171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -73.77 152.07 40.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.811 0.805 . . . . 0.0 110.778 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.82 134.32 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.952 1.301 . . . . 0.0 108.351 167.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 17.8 m -134.83 109.34 8.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.034 1.734 . . . . 0.0 107.729 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 2.0 p -76.82 147.03 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.544 -0.722 . . . . 0.0 109.409 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.66 125.46 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.902 1.681 . . . . 0.0 106.893 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 135.92 44.31 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.642 1.177 . . . . 0.0 109.785 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -146.89 158.12 43.83 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.957 1.703 . . . . 0.0 109.914 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.53 -19.47 10.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.112 1.765 . . . . 0.0 113.944 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -58.09 -23.59 55.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -149.47 -46.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.029 1.332 . . . . 0.0 113.297 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -85.69 133.05 42.55 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.975 1.31 . . . . 0.0 109.392 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.01 -172.17 1.06 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 122.565 2.177 . . . . 0.0 112.676 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -107.08 -22.41 12.66 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.562 1.145 . . . . 0.0 113.526 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -55.12 -40.26 70.31 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.776 1.23 . . . . 0.0 112.566 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -105.46 144.47 32.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.939 1.695 . . . . 0.0 109.397 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.3 p -139.89 157.26 45.99 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.762 1.225 . . . . 0.0 109.536 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.3 127.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.851 0.461 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 51.5 m -119.06 131.4 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.617 1.567 . . . . 0.0 109.763 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -65.76 122.12 16.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.857 1.263 . . . . 0.0 111.066 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.36 -28.82 8.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.029 0.932 . . . . 0.0 112.057 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.73 -175.27 4.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.357 1.863 . . . . 0.0 110.914 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.58 -31.48 64.27 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.08 1.352 . . . . 0.0 113.764 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 61.3 p -143.4 33.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.422 . . . . 0.0 111.813 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 48.9 m -129.71 134.4 47.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.866 0.867 . . . . 0.0 111.943 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.437 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 23.8 m-85 -130.88 138.96 50.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.877 1.671 . . . . 0.0 110.801 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 34.5 mt -125.19 122.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -98.03 112.28 24.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.689 1.996 . . . . 0.0 108.348 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -103.28 124.18 48.17 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.27 116.58 32.19 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 110.945 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -120.2 20.81 11.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.541 1.937 . . . . 0.0 112.172 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.76 -168.91 3.22 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.332 1.453 . . . . 0.0 111.614 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.76 26.47 1.39 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.824 -1.173 . . . . 0.0 113.778 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 127.746 2.419 . . . . 0.0 115.01 -166.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.238 0.542 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.15 138.82 57.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.919 0.888 . . . . 0.0 110.318 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.35 -13.06 4.46 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -117.19 9.38 13.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.438 2.295 . . . . 0.0 112.635 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -144.56 175.15 10.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.33 1.852 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.97 154.97 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.194 0.998 . . . . 0.0 109.452 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 149.39 42.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.88 1.272 . . . . 0.0 110.391 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.79 26.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.068 1.347 . . . . 0.0 108.942 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.33 131.83 38.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.114 1.366 . . . . 0.0 110.7 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -79.52 51.95 1.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.605 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.26 134.95 2.27 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 120.21 -1.556 . . . . 0.0 112.869 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 145.72 14.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.656 0.782 . . . . 0.0 111.102 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.48 26.22 13.99 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.3 t 67.25 71.8 0.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.824 1.649 . . . . 0.0 111.578 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -137.83 -178.14 5.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.524 1.529 . . . . 0.0 112.181 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.88 -82.89 0.5 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 126.066 1.793 . . . . 0.0 115.173 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -138.57 163.85 30.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.747 1.619 . . . . 0.0 110.345 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.2 p -135.75 145.32 46.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.217 1.007 . . . . 0.0 112.882 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -156.61 169.76 23.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.54 1.536 . . . . 0.0 111.821 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.21 153.91 48.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.307 1.443 . . . . 0.0 110.689 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.99 131.13 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.392 1.477 . . . . 0.0 109.731 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.62 128.43 33.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.864 . . . . 0.0 109.924 175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -54.55 139.9 36.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.75 0.82 . . . . 0.0 110.979 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.72 42.79 16.31 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.48 0.562 . . . . 0.0 112.527 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -133.32 154.62 50.55 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.514 1.525 . . . . 0.0 111.291 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m -140.09 122.51 16.07 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.132 1.373 . . . . 0.0 108.393 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.97 153.81 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.024 0.916 . . . . 0.0 110.549 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.7 mtm-85 -133.74 118.84 18.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.9 1.68 . . . . 0.0 107.873 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.7 m0 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.57 -19.48 65.27 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.859 1.664 . . . . 0.0 114.084 173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.03 -68.86 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.122 165.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 28.22 37.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.15 2.58 . . . . 0.0 116.194 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -136.15 127.68 28.71 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.593 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -158.17 -39.72 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 111.387 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -142.2 126.14 17.22 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.246 1.018 . . . . 0.0 110.052 164.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.8 m -133.6 155.05 50.36 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.002 0.906 . . . . 0.0 109.398 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.04 127.13 33.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.86 108.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.753 1.621 . . . . 0.0 108.95 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.38 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.472 1.037 0 C-N-CA 128.383 2.897 . . . . 0.0 117.589 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -166.86 -42.8 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.146 0.978 . . . . 0.0 112.561 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -106.94 37.63 2.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.395 1.478 . . . . 0.0 110.481 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.61 158.59 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.358 1.863 . . . . 0.0 110.688 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -139.05 150.97 46.37 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.546 1.938 . . . . 0.0 109.909 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.62 126.53 54.3 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.176 0.59 . . . . 0.0 109.82 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -116.32 120.35 38.61 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.624 1.169 . . . . 0.0 108.145 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -113.63 115.22 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 110.411 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -124.16 123.66 40.77 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.598 1.159 . . . . 0.0 108.796 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.21 -45.06 84.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 112.782 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 172.01 16.35 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.652 1.981 . . . . 0.0 107.66 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -60.13 -66.33 0.54 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.385 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.255 1.8 pp20? 48.72 167.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.59 54.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.349 -1.469 . . . . 0.0 112.554 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.263 44.0 m-20 53.33 45.97 27.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.349 1.859 . . . . 0.0 112.485 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -73.61 166.38 44.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.03 22.52 0.31 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.536 2.824 . . . . 0.0 113.835 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -152.23 58.63 2.66 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 126.467 1.907 . . . . 0.0 111.277 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.9 134.39 34.41 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.551 1.5 . . . . 0.0 109.552 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -101.81 0.1 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.814 0.721 . . . . 0.0 111.8 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 154.77 44.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.893 1.277 . . . . 0.0 111.881 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.61 139.26 16.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.852 1.661 . . . . 0.0 110.59 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -158.61 159.07 35.03 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.167 0.984 . . . . 0.0 111.768 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.88 90.4 3.19 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.514 1.525 . . . . 0.0 108.923 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.71 105.33 0.79 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 148.57 11.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.428 1.891 . . . . 0.0 113.8 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.57 151.78 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.47 1.108 . . . . 0.0 112.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.33 52.78 45.22 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 124.655 1.121 . . . . 0.0 114.997 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.78 175.45 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.815 0.846 . . . . 0.0 112.874 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.1 m -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.16 1.384 . . . . 0.0 109.698 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.33 121.71 19.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.84 1.256 . . . . 0.0 109.314 -175.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -117.9 15.79 14.31 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.066 1.746 . . . . 0.0 112.671 -172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -140.23 38.66 1.92 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.328 1.451 . . . . 0.0 112.741 -171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.86 -17.36 64.86 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.797 -1.189 . . . . 0.0 111.971 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -56.49 -19.19 14.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.81 1.644 . . . . 0.0 114.624 168.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.2 t -54.14 -27.27 32.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.247 -0.908 . . . . 0.0 112.285 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.0 mt -134.07 73.87 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 127.046 2.138 . . . . 0.0 108.848 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -60.94 -23.08 65.02 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.809 -1.182 . . . . 0.0 112.657 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.38 80.33 0.15 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.8 1.666 . . . . 0.0 113.232 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 153.03 42.8 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.9 1.68 . . . . 0.0 111.661 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -158.53 -22.12 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.471 1.509 . . . . 0.0 114.201 161.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.06 129.45 55.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.474 1.51 . . . . 0.0 108.75 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.65 121.07 31.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.93 132.38 54.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -126.37 130.17 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 pp -144.82 148.81 40.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.406 0.682 . . . . 0.0 110.152 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.52 155.06 70.33 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.898 1.732 . . . . 0.0 112.391 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.95 -24.3 64.64 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.059 0.838 . . . . 0.0 114.528 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.43 -22.88 67.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.52 1.128 . . . . 0.0 113.679 169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -111.0 130.08 55.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.933 1.693 . . . . 0.0 108.741 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -85.75 -40.16 16.37 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.505 -1.372 . . . . 0.0 112.194 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -152.23 159.28 43.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.77 2.028 . . . . 0.0 109.041 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.02 146.41 50.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.609 0.763 . . . . 0.0 110.766 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.91 135.19 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.747 1.219 . . . . 0.0 110.166 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -77.23 134.66 38.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.276 0.63 . . . . 0.0 109.885 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.55 140.4 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 109.938 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.33 157.15 45.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.06 1.744 . . . . 0.0 110.609 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 92.6 mt -118.76 139.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.959 2.104 . . . . 0.0 109.535 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.33 106.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.755 1.622 . . . . 0.0 109.601 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.69 111.83 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.415 0.686 . . . . 0.0 110.727 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.8 15.35 11.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.421 1.088 . . . . 0.0 111.466 168.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -96.28 -61.83 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.869 1.667 . . . . 0.0 111.063 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -151.63 99.08 2.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.386 1.875 . . . . 0.0 108.799 -172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.5 m -53.16 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.88 1.672 . . . . 0.0 113.052 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.1 m -146.69 -53.89 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.743 1.617 . . . . 0.0 110.779 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.2 159.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.175 2.19 . . . . 0.0 114.96 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.42 -36.1 0.44 Allowed Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.531 -1.355 . . . . 0.0 115.293 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.6 m -64.63 1.7 0.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.175 2.19 . . . . 0.0 115.033 170.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.401 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 17.9 t80 -134.99 122.18 21.5 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.258 2.223 . . . . 0.0 109.76 -173.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 130.34 40.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.958 1.303 . . . . 0.0 110.387 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.6 ttm -115.57 141.57 47.88 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.694 1.598 . . . . 0.0 110.632 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.6 m -128.27 116.41 19.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.573 1.149 . . . . 0.0 108.171 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mt -96.64 122.83 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.4 m -116.04 87.54 19.38 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.981 1.712 . . . . 0.0 109.24 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.0 163.53 37.32 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.58 2.853 . . . . 0.0 112.465 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -45.16 96.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.577 1.951 . . . . 0.0 113.259 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 37.29 47.47 0.69 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.267 1.827 . . . . 0.0 114.881 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.34 155.18 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.966 1.707 . . . . 0.0 109.535 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.75 92.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.356 1.462 . . . . 0.0 112.288 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.51 160.47 4.18 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.475 1.51 . . . . 0.0 111.523 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.49 145.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 111.391 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.85 138.86 33.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.457 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 39.8 t -135.78 124.61 24.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.339 1.455 . . . . 0.0 107.855 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -118.52 141.19 48.82 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 109.03 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.92 105.23 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.431 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.15 63.0 0.32 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.318 0.961 . . . . 0.0 113.658 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -141.59 155.89 45.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.456 1.903 . . . . 0.0 111.657 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.38 55.11 2.71 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.609 -1.307 . . . . 0.0 111.662 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 59.61 169.78 0.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.539 1.936 . . . . 0.0 112.826 -167.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.14 126.17 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.845 -1.159 . . . . 0.0 109.741 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 127.17 31.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.841 0.456 . . . . 0.0 110.047 171.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.18 95.83 47.98 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.059 1.743 . . . . 0.0 107.685 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.98 148.13 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.903 2.402 . . . . 0.0 112.669 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 87.2 mt -136.03 131.72 18.98 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.309 1.443 . . . . 0.0 109.1 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.47 169.85 21.34 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.922 3.748 . . . . 0.0 112.112 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -68.6 149.04 49.63 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.517 -0.739 . . . . 0.0 111.677 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.61 163.63 39.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.097 2.159 . . . . 0.0 109.573 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.3 m -131.25 131.4 23.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.942 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.97 153.63 80.41 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 119.343 0.801 . . . . 0.0 111.877 -3.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.85 -17.28 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.734 1.623 . . . . 0.0 112.886 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.49 13.53 21.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 114.415 169.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.87 152.11 46.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.744 -1.223 . . . . 0.0 112.437 174.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.79 113.63 19.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.315 0.646 . . . . 0.0 111.018 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.6 tt -85.71 120.25 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.62 0.768 . . . . 0.0 109.828 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.49 139.42 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.542 0.687 . . . . 0.0 110.703 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.1 t -143.8 150.42 38.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.44 1.096 . . . . 0.0 109.798 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -111.32 145.17 39.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.704 0.802 . . . . 0.0 109.62 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 tt -133.85 120.73 20.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.665 0.745 . . . . 0.0 109.311 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.04 124.45 26.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.309 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.401 HG21 ' CZ ' ' A' ' 115' ' ' TYR . 2.2 p -145.34 135.16 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.57 1.148 . . . . 0.0 109.698 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 162.14 35.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.226 1.41 . . . . 0.0 111.523 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -66.5 128.52 36.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.126 170.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.9 p -73.57 -6.46 46.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.892 0.877 . . . . 0.0 113.326 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -122.54 141.0 52.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.279 2.232 . . . . 0.0 108.869 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -65.59 140.84 97.66 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.696 -0.668 . . . . 0.0 111.643 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 131.67 20.94 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.415 1.184 . . . . 0.0 111.492 -4.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -73.68 41.68 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 112.499 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.91 126.7 14.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -68.63 82.15 0.28 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.391 1.077 . . . . 0.0 110.046 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 m -45.91 -37.84 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.976 1.71 . . . . 0.0 113.017 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.88 136.9 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.488 1.115 . . . . 0.0 109.697 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -142.03 115.2 8.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.787 1.235 . . . . 0.0 108.137 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.35 -162.21 24.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.02 0.819 . . . . 0.0 113.298 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.92 153.66 51.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.625 1.17 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.92 143.58 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.168 1.787 . . . . 0.0 109.245 -175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -115.05 115.11 26.28 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.182 -0.949 . . . . 0.0 109.328 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 152.82 26.16 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.462 -0.774 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.77 154.65 45.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 108.709 167.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -127.91 127.48 43.44 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.869 1.268 . . . . 0.0 108.727 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.3 m -86.17 106.68 10.64 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.59 -17.68 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.43 2.753 . . . . 0.0 112.514 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.3 m -55.91 -38.83 70.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.199 1.8 . . . . 0.0 113.079 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.8 p -147.75 24.59 1.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.013 1.325 . . . . 0.0 112.705 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 50.71 31.12 22.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.406 1.955 . . . . 0.0 115.851 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.59 164.5 25.76 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.182 0.991 . . . . 0.0 111.152 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.62 135.5 55.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.074 1.35 . . . . 0.0 109.008 165.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.9 m -133.49 107.17 7.87 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.83 151.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.4 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.91 135.44 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 125.874 1.67 . . . . 0.0 107.709 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.98 140.2 36.23 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.833 1.653 . . . . 0.0 107.425 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -125.29 146.14 49.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.303 1.441 . . . . 0.0 108.353 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.95 -14.42 47.07 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -17.44 61.05 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 171.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.0 p -130.38 -32.3 1.77 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.608 1.563 . . . . 0.0 113.231 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.95 146.89 76.41 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.996 1.318 . . . . 0.0 110.782 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.28 -7.72 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.586 2.857 . . . . 0.0 113.99 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.4 tttm 64.56 -24.2 0.08 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.341 2.656 . . . . 0.0 115.993 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -67.74 -18.17 64.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.43 1.092 . . . . 0.0 113.685 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.7 ttm -103.3 151.44 22.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.563 1.945 . . . . 0.0 109.418 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.0 p -131.76 159.67 37.8 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.455 1.502 . . . . 0.0 110.144 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.61 130.75 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.157 0.983 . . . . 0.0 109.683 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.2 m -134.31 126.78 30.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.471 1.109 . . . . 0.0 108.697 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.42 141.4 28.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.565 1.146 . . . . 0.0 110.481 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -117.47 -36.18 3.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.564 0.746 . . . . 0.0 111.704 171.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -129.38 178.78 6.2 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.527 1.131 . . . . 0.0 111.849 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.78 -40.41 63.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.226 1.01 . . . . 0.0 112.144 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -137.01 33.8 2.61 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 111.205 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.7 t -129.18 116.99 20.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.882 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -100.17 136.29 40.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.365 2.266 . . . . 0.0 109.73 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.04 112.77 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.608 1.163 . . . . 0.0 109.54 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.02 120.19 22.5 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.109 1.363 . . . . 0.0 109.872 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -106.41 133.79 50.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 45.6 tp -127.47 111.54 13.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.812 -0.555 . . . . 0.0 110.966 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.58 -26.19 15.33 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.92 132.57 53.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 111.053 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.6 -48.91 79.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 127.264 2.225 . . . . 0.0 112.507 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.075 0.464 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.57 144.34 43.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.623 0.369 . . . . 0.0 110.686 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.86 -17.12 34.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.037 -1.039 . . . . 0.0 113.179 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -108.91 13.47 24.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.442 1.897 . . . . 0.0 113.275 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -137.55 170.96 15.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.58 151.58 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.51 152.11 50.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.112 0.965 . . . . 0.0 110.812 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.74 133.99 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 108.256 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -121.73 127.73 51.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.818 1.647 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.42 61.4 6.17 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.761 1.225 . . . . 0.0 110.884 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.42 142.99 3.86 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.235 0.922 . . . . 0.0 112.019 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -59.2 132.17 53.22 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.948 0.874 . . . . 0.0 109.669 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 t30 77.09 41.88 0.15 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.743 1.617 . . . . 0.0 113.199 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.343 31.1 p 49.87 58.2 5.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.921 2.488 . . . . 0.0 115.485 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 p -127.81 179.47 5.53 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.164 1.785 . . . . 0.0 113.18 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.23 -74.74 1.84 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.463 1.982 . . . . 0.0 113.957 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -139.13 170.16 16.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.655 1.582 . . . . 0.0 109.781 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -137.32 143.91 42.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.535 1.134 . . . . 0.0 111.166 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -143.4 155.46 44.41 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.552 1.541 . . . . 0.0 110.465 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -125.67 134.8 51.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.761 1.224 . . . . 0.0 109.204 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -127.52 131.33 50.09 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.483 1.135 . . . . 0.0 110.521 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -91.91 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.716 1.207 . . . . 0.0 109.349 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 145.07 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.819 -0.55 . . . . 0.0 112.409 172.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.7 73.08 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.172 0.415 . . . . 0.0 113.837 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -127.9 126.01 40.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.297 1.439 . . . . 0.0 109.936 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m -109.19 126.56 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.25 146.1 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 110.037 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -125.95 144.37 50.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.037 1.335 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 125.43 1.492 . . . . 0.0 109.628 173.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.2 m0 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.19 -45.4 33.45 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 111.34 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.66 35.73 0.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.265 1.426 . . . . 0.0 113.15 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -16.12 62.67 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 119.651 -1.906 . . . . 0.0 114.247 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.7 134.76 56.49 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 mtp -150.01 -58.76 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 112.07 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -136.27 115.54 12.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.948 1.299 . . . . 0.0 109.905 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.08 146.95 37.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.709 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.87 128.15 43.27 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.112 1.365 . . . . 0.0 109.081 -168.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.55 119.75 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.268 1.427 . . . . 0.0 110.185 -173.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.74 0.01 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.516 1.532 . . . . 0.0 116.66 -164.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.33 -21.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 27.34 7.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.798 1.639 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.77 141.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.912 2.085 . . . . 0.0 109.416 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -116.23 153.06 32.55 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.12 128.33 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.232 0.539 . . . . 0.0 109.626 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.24 126.15 54.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.073 0.949 . . . . 0.0 108.448 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.26 104.18 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 122.194 0.997 . . . . 0.0 109.516 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.82 123.05 49.34 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.611 1.164 . . . . 0.0 108.769 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.84 -57.87 10.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.161 0.982 . . . . 0.0 111.491 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 158.42 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.657 1.183 . . . . 0.0 109.383 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.42 124.38 33.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.8 172.97 16.71 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.588 1.555 . . . . 0.0 111.999 -169.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.0 pt -123.68 34.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.503 -1.373 . . . . 0.0 114.211 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.299 67.4 m-20 61.94 51.04 3.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.979 2.112 . . . . 0.0 111.689 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -65.74 166.41 15.28 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.655 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.37 20.38 0.36 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 123.456 2.771 . . . . 0.0 114.285 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -148.03 63.7 7.67 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.656 1.582 . . . . 0.0 111.957 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.64 140.42 62.25 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.751 1.634 . . . . 0.0 110.535 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.02 -92.81 1.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -145.62 153.92 41.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.174 1.39 . . . . 0.0 110.787 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -153.33 137.55 16.53 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.056 1.342 . . . . 0.0 108.715 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -155.83 164.67 38.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.377 1.084 . . . . 0.0 111.198 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -133.84 104.84 6.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.391 1.076 . . . . 0.0 108.355 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -68.23 115.31 7.54 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.813 0.845 . . . . 0.0 109.598 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.17 152.92 1.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.155 1.782 . . . . 0.0 112.882 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.83 -21.93 32.75 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.87 88.16 0.12 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.135 1.35 . . . . 0.0 112.282 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -161.05 171.75 18.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.674 1.19 . . . . 0.0 112.446 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.0 m -124.3 140.11 53.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.35 1.06 . . . . 0.0 109.187 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -131.09 119.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -107.58 -20.87 13.1 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.865 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -121.43 49.69 1.49 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.85 -16.72 59.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.103 -0.998 . . . . 0.0 112.626 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.19 -17.28 2.67 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.972 1.309 . . . . 0.0 114.36 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -55.15 -29.56 58.02 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.473 -1.392 . . . . 0.0 113.656 165.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 tp -78.58 -39.33 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.899 0.772 . . . . 0.0 112.195 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 33.58 43.78 0.06 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.256 1.822 . . . . 0.0 114.293 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.86 61.96 0.14 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.753 -155.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.2 tp -139.9 124.85 18.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.268 1.027 . . . . 0.0 110.4 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -132.05 -15.67 2.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -129.99 110.1 11.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.383 1.473 . . . . 0.0 109.443 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 120.66 43.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -168.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -116.62 112.39 21.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 109.59 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.26 131.19 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.586 1.554 . . . . 0.0 109.182 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.2 mt -132.06 136.2 27.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.415 0.686 . . . . 0.0 110.376 -161.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.2 14.91 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.561 2.841 . . . . 0.0 114.535 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.14 -35.54 0.64 Allowed Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.997 2.237 . . . . 0.0 115.023 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.33 65.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.847 1.659 . . . . 0.0 112.526 167.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.18 153.08 1.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.876 1.271 . . . . 0.0 110.757 159.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -132.28 -33.89 1.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.327 0.651 . . . . 0.0 111.842 167.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.63 166.94 29.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.068 1.747 . . . . 0.0 109.673 171.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.4 166.26 23.58 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.142 0.973 . . . . 0.0 111.193 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.51 121.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.698 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.84 120.74 19.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -115.46 144.77 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.976 1.31 . . . . 0.0 109.414 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.35 152.11 40.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.761 1.624 . . . . 0.0 108.912 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.8 mt -123.13 124.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.512 0.725 . . . . 0.0 109.62 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -124.65 116.64 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.475 1.51 . . . . 0.0 109.631 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -83.31 120.36 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.161 1.784 . . . . 0.0 110.68 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.64 27.03 4.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.102 1.761 . . . . 0.0 111.405 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.85 -56.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.95 1.7 . . . . 0.0 111.37 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -119.74 128.48 53.8 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.217 1.407 . . . . 0.0 109.743 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.6 56.6 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.967 1.307 . . . . 0.0 111.702 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.9 m -132.76 -66.32 0.68 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.004 1.322 . . . . 0.0 111.349 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.67 170.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -172.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.59 -12.61 60.72 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.468 -1.395 . . . . 0.0 115.178 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 p -110.3 -25.94 9.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.573 1.549 . . . . 0.0 113.894 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.98 135.02 46.27 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 165.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -131.88 138.77 48.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.147 0.975 . . . . 0.0 109.817 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.8 ttp -121.8 137.29 54.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.683 2.393 . . . . 0.0 108.165 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.0 m -136.45 135.52 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.12 123.66 54.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -120.8 90.55 46.59 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.016 1.327 . . . . 0.0 110.416 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.22 82.07 1.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.064 3.176 . . . . 0.0 113.126 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 55.32 57.83 5.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.293 1.437 . . . . 0.0 112.129 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.83 50.09 16.43 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.377 1.471 . . . . 0.0 113.239 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.92 169.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 127.692 2.397 . . . . 0.0 109.243 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.15 79.56 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.936 2.894 . . . . 0.0 114.579 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 159.75 30.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.212 1.405 . . . . 0.0 110.504 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.39 151.18 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.438 1.095 . . . . 0.0 109.652 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.29 131.02 54.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.047 0.939 . . . . 0.0 109.593 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -137.62 150.64 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -144.92 137.99 26.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.468 1.107 . . . . 0.0 110.537 -170.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.76 100.75 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.084 2.154 . . . . 0.0 111.564 -173.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.14 43.74 0.59 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.327 0.489 . . . . 0.0 114.123 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -136.32 164.52 27.91 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.678 1.591 . . . . 0.0 111.784 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.49 165.64 18.59 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.126 -0.984 . . . . 0.0 111.565 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -54.38 132.0 43.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.222 -0.924 . . . . 0.0 111.404 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 t -100.18 116.07 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.768 1.227 . . . . 0.0 110.446 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.47 100.43 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.87 1.268 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mt -83.02 112.71 40.4 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.289 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.41 134.48 15.57 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.486 2.124 . . . . 0.0 110.342 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 mm -122.89 124.29 26.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.487 1.515 . . . . 0.0 108.644 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.65 174.2 13.05 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.593 2.862 . . . . 0.0 112.564 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.11 137.84 58.22 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.585 -0.697 . . . . 0.0 111.756 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.2 pp -151.79 38.19 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.162 1.385 . . . . 0.0 112.723 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 t -40.25 138.29 1.17 Allowed Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 127.381 2.272 . . . . 0.0 114.766 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.55 158.62 90.16 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 CA-C-N 119.836 0.977 . . . . 0.0 113.137 0.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.59 -33.82 66.02 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.067 1.844 . . . . 0.0 112.877 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.28 0.79 9.01 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.106 1.362 . . . . 0.0 114.618 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 p -66.94 175.62 2.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.293 1.044 . . . . 0.0 113.268 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.61 103.76 7.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.544 1.538 . . . . 0.0 110.508 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 tt -78.61 132.08 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.845 1.258 . . . . 0.0 110.181 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.17 143.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 110.363 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.4 t -137.35 153.43 50.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.56 1.144 . . . . 0.0 109.135 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -112.17 119.82 39.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 tt -101.18 126.2 47.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.977 1.311 . . . . 0.0 109.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.46 125.14 37.86 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.635 1.574 . . . . 0.0 108.817 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.33 119.19 47.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.809 1.243 . . . . 0.0 109.033 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -147.91 149.08 31.58 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.644 1.178 . . . . 0.0 109.802 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -70.87 134.08 47.0 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.217 -0.302 . . . . 0.0 110.948 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.1 p -72.71 -19.23 61.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.486 1.515 . . . . 0.0 113.733 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 169.62 10.95 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.321 1.848 . . . . 0.0 111.298 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 p -53.18 146.09 22.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.252 1.021 . . . . 0.0 113.583 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.0 6.39 18.37 Favored 'Cis proline' 0 CA--C 1.545 1.056 0 N-CA-C 114.933 1.09 . . . . 0.0 114.933 4.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.93 24.47 14.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.837 1.255 . . . . 0.0 112.377 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.17 142.19 43.55 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.623 -1.298 . . . . 0.0 111.015 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -57.9 146.17 33.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.11 0.564 . . . . 0.0 111.379 168.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.38 -40.67 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.348 1.059 . . . . 0.0 111.604 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.6 t -146.67 137.92 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.584 0.754 . . . . 0.0 109.402 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -149.6 139.13 21.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.56 1.144 . . . . 0.0 110.445 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.66 -172.37 44.15 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.71 0.671 . . . . 0.0 114.238 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.7 m -115.81 132.25 56.7 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.718 0.807 . . . . 0.0 111.598 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.61 116.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.976 2.11 . . . . 0.0 108.139 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.4 138.68 31.35 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.89 -1.131 . . . . 0.0 109.143 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -112.77 146.53 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.134 0.968 . . . . 0.0 109.629 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -141.26 152.2 44.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.916 1.686 . . . . 0.0 108.209 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -121.13 150.25 41.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.788 1.235 . . . . 0.0 109.43 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 m -111.23 105.38 56.96 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 123.804 0.842 . . . . 0.0 109.458 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.44 48.69 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.855 1 C-N-CA 126.271 4.648 . . . . 0.0 113.596 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.4 t -123.04 -45.43 2.13 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.408 1.483 . . . . 0.0 110.923 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.9 p -151.09 34.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.227 1.811 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.8 71.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.978 1.275 . . . . 0.0 114.878 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.48 171.3 15.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.761 1.28 . . . . 0.0 110.948 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.69 152.43 36.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.453 1.101 . . . . 0.0 109.794 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 m -138.32 140.93 39.73 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.43 1.892 . . . . 0.0 107.468 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 1.1 p -110.29 141.54 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 24.9 mt -133.02 120.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 142.31 38.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.635 1.174 . . . . 0.0 109.037 175.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 140.4 52.75 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.057 1.343 . . . . 0.0 108.309 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.48 -20.09 11.64 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.66 -16.36 64.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.282 1.433 . . . . 0.0 114.607 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 32.7 p -141.07 -42.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.697 1.599 . . . . 0.0 113.59 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -88.19 146.82 38.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.983 1.313 . . . . 0.0 110.591 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.03 168.99 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.224 2.616 . . . . 0.0 112.656 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -94.77 10.87 33.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.482 1.513 . . . . 0.0 112.514 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -93.64 -44.51 8.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 111.986 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -100.48 144.87 28.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.366 1.466 . . . . 0.0 109.108 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -139.97 158.46 44.03 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.07 1.348 . . . . 0.0 108.978 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 72.1 t -121.01 135.56 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.3 m -127.91 126.1 40.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.16 0.984 . . . . 0.0 109.092 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -68.06 137.0 54.67 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.417 0.687 . . . . 0.0 110.401 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.69 -26.79 2.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.318 1.047 . . . . 0.0 112.945 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -161.4 172.52 16.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.139 1.776 . . . . 0.0 111.039 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.09 136.21 57.15 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.915 -1.116 . . . . 0.0 109.942 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 2.3 p 56.31 6.51 0.26 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 31.8 m -113.67 133.4 55.34 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.989 1.316 . . . . 0.0 111.412 -169.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.404 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 4.4 m-85 -142.49 137.61 30.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.734 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 60.9 mt -122.67 118.95 56.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.31 126.85 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.205 1.402 . . . . 0.0 108.707 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -119.26 132.32 55.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.753 1.221 . . . . 0.0 109.388 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.5 tt -113.7 125.44 54.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 109.526 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -128.62 3.71 5.53 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.583 1.153 . . . . 0.0 113.864 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 m -150.5 115.63 5.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.547 1.939 . . . . 0.0 110.675 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -52.88 -35.41 57.8 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 119.618 1.099 . . . . 0.0 113.682 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.949 1.7 . . . . 0.0 113.453 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.612 0.72 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.17 138.26 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.392 166.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.39 139.7 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -15.94 34.32 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.464 -1.397 . . . . 0.0 113.42 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -108.48 2.09 22.03 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.09 2.156 . . . . 0.0 113.349 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -144.89 175.45 10.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.854 2.062 . . . . 0.0 110.24 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.25 158.33 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.141 -0.974 . . . . 0.0 111.124 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -149.44 143.92 26.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.356 0.662 . . . . 0.0 112.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -134.79 131.36 37.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.418 1.887 . . . . 0.0 109.362 -165.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.32 137.39 51.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.604 1.562 . . . . 0.0 110.286 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.94 45.23 0.7 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.809 1.644 . . . . 0.0 112.901 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.15 132.92 2.12 Favored Glycine 0 CA--C 1.519 0.306 0 O-C-N 120.282 -1.511 . . . . 0.0 111.527 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 148.14 7.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 110.722 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.48 25.97 13.67 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m 63.98 72.33 0.46 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.567 2.347 . . . . 0.0 114.803 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -137.18 -179.4 5.69 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.311 1.445 . . . . 0.0 112.382 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -72.76 2.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.436 1.493 . . . . 0.0 115.466 169.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.36 165.23 28.51 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.69 1.996 . . . . 0.0 108.933 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -127.02 154.16 44.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.531 1.132 . . . . 0.0 112.609 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 146.23 20.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.853 1.661 . . . . 0.0 109.897 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.27 141.71 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.356 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.44 129.37 31.03 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.766 1.226 . . . . 0.0 110.592 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.89 158.97 34.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.37 0.605 . . . . 0.0 111.518 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.0 147.3 47.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.574 -0.704 . . . . 0.0 111.622 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.6 45.55 75.99 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.653 0.644 . . . . 0.0 113.493 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.74 159.46 39.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.907 0.883 . . . . 0.0 112.117 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.3 m -136.52 132.93 35.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.937 1.295 . . . . 0.0 108.449 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.58 159.69 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.767 1.227 . . . . 0.0 110.883 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -130.2 118.94 22.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 108.303 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.57 92.03 3.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.05 153.41 25.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.714 1.206 . . . . 0.0 112.013 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -144.44 54.75 1.27 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.021 1.728 . . . . 0.0 109.789 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 40.53 39.55 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.212 0.911 . . . . 0.0 114.688 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.328 0.2 OUTLIER 63.39 86.31 0.12 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -174.92 -79.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.097 2.559 . . . . 0.0 111.388 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -101.78 30.82 4.14 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.327 1.851 . . . . 0.0 112.212 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.47 -38.34 71.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.455 1.102 . . . . 0.0 110.673 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -39.44 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.035 2.534 . . . . 0.0 111.717 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.8 42.25 0.39 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 112.654 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -148.03 155.34 41.38 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 122.542 1.163 . . . . 0.0 111.511 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -152.91 -45.45 0.1 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.229 163.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -120.45 129.43 53.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.448 1.022 . . . . 0.0 109.58 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 p -140.78 158.33 44.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.167 0.984 . . . . 0.0 112.391 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.95 134.48 47.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.966 1.306 . . . . 0.0 108.269 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.76 105.23 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.304 1.442 . . . . 0.0 108.573 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.19 152.81 6.39 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.217 1.389 . . . . 0.0 114.96 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -64.31 -2.83 2.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -135.63 29.7 3.21 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.329 1.451 . . . . 0.0 112.238 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.5 155.13 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.816 2.446 . . . . 0.0 109.996 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -125.54 152.76 44.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.514 1.526 . . . . 0.0 109.569 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 m -116.46 149.55 39.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.267 1.032 . . . . 0.0 110.423 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.35 120.99 19.45 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.74 1.616 . . . . 0.0 107.521 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.9 pt -116.79 137.71 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 123.561 0.744 . . . . 0.0 109.973 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.53 116.14 12.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -43.03 -69.52 0.13 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.755 2.022 . . . . 0.0 115.051 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.81 35.96 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.906 0.882 . . . . 0.0 109.495 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.283 0.6 OUTLIER 42.21 57.71 3.21 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.092 1.757 . . . . 0.0 112.546 178.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -63.22 131.36 48.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.466 1.506 . . . . 0.0 113.279 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -93.21 38.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.388 1.475 . . . . 0.0 111.719 -167.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.33 50.9 m-20 55.05 46.42 24.19 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 123.691 1.71 . . . . 0.0 112.166 -168.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.69 171.88 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.585 2.354 . . . . 0.0 110.86 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.25 7.34 0.87 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.103 2.536 . . . . 0.0 114.972 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -137.98 112.03 8.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 124.978 1.311 . . . . 0.0 110.769 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.81 125.44 13.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.59 -120.83 0.08 OUTLIER Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.744 1.164 . . . . 0.0 111.423 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.152 0.981 . . . . 0.0 111.052 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -154.07 139.53 17.74 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.402 1.081 . . . . 0.0 112.583 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.68 141.83 27.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.823 0.82 . . . . 0.0 110.199 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -113.6 79.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -46.52 102.66 0.03 OUTLIER 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.947 2.099 . . . . 0.0 110.773 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.28 126.53 23.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.414 . . . . 0.0 111.558 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -55.5 109.53 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.216 1.406 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.52 55.8 1.99 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.966 0.793 . . . . 0.0 114.481 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.44 163.53 36.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.981 0.891 . . . . 0.0 113.138 174.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.0 m -123.61 133.74 53.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.713 1.605 . . . . 0.0 108.985 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -119.72 102.85 8.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.079 1.751 . . . . 0.0 109.015 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -71.79 -24.33 61.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -151.69 137.73 18.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.89 1.676 . . . . 0.0 110.203 171.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.14 14.33 7.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.436 1.495 . . . . 0.0 112.537 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -53.89 -19.49 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.249 1.82 . . . . 0.0 115.256 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -48.61 -29.65 4.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 162.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.0 mt -133.0 58.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 128.963 2.905 . . . . 0.0 108.003 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -52.47 -29.98 27.6 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.149 -0.97 . . . . 0.0 112.248 163.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.42 103.55 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.662 1.125 . . . . 0.0 112.892 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.73 43.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -52.25 -18.54 1.58 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 120.007 -1.683 . . . . 0.0 115.4 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -113.55 141.67 46.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.018 2.127 . . . . 0.0 111.581 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -128.89 134.65 48.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.949 2.099 . . . . 0.0 109.365 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -125.72 129.29 49.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.171 1.788 . . . . 0.0 109.288 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.27 116.1 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.419 1.487 . . . . 0.0 108.203 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.6 mt -127.77 140.81 39.16 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.771 0.828 . . . . 0.0 110.808 -167.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.72 164.61 35.12 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.885 2.39 . . . . 0.0 112.812 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.1 -24.77 58.96 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 113.912 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.12 68.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.129 1.372 . . . . 0.0 114.389 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -123.23 116.28 23.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.232 1.413 . . . . 0.0 110.722 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.14 -44.23 65.99 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.197 -0.94 . . . . 0.0 112.161 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 162.6 40.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.514 1.926 . . . . 0.0 109.155 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.57 157.06 45.58 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.478 -0.764 . . . . 0.0 110.393 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.77 132.6 68.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.805 0.842 . . . . 0.0 109.95 -169.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.28 128.19 34.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -126.62 145.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.17 1.388 . . . . 0.0 108.27 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -149.79 157.99 43.74 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.19 134.37 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.113 1.765 . . . . 0.0 106.973 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.43 135.64 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.035 0.921 . . . . 0.0 110.745 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -79.09 122.1 25.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.982 0.913 . . . . 0.0 112.343 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -110.93 -3.12 15.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.464 1.506 . . . . 0.0 112.696 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.4 t -138.46 -48.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 126.115 1.766 . . . . 0.0 112.699 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -74.51 80.22 1.95 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.328 0.967 . . . . 0.0 112.189 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -68.53 53.34 0.08 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.471 2.308 . . . . 0.0 114.069 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.9 m -137.53 -45.01 0.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.674 1.99 . . . . 0.0 111.642 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 56.94 158.51 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.013 2.125 . . . . 0.0 115.609 -172.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.75 -38.08 0.38 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.856 2.646 . . . . 0.0 115.039 -176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.4 p -67.75 -6.6 21.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.577 2.751 . . . . 0.0 114.795 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -115.6 113.61 23.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.232 2.613 . . . . 0.0 108.686 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -120.67 121.17 37.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.128 1.371 . . . . 0.0 110.079 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 ttp -107.62 139.22 42.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.967 0.507 . . . . 0.0 111.563 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -126.4 122.62 35.86 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.467 1.507 . . . . 0.0 108.531 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -122.66 137.93 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.224 1.01 . . . . 0.0 109.051 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -140.33 100.19 7.02 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.506 1.122 . . . . 0.0 110.282 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.16 162.12 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.319 2.012 . . . . 0.0 111.458 168.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -26.08 93.61 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.288 2.635 . . . . 0.0 115.852 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 47.24 42.82 14.06 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.792 1.637 . . . . 0.0 114.664 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.54 163.89 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.874 2.07 . . . . 0.0 110.955 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.25 94.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.177 1.791 . . . . 0.0 111.658 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.66 36.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 111.199 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.6 p -123.53 131.69 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.122 0.569 . . . . 0.0 109.972 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.08 133.65 55.24 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.327 1.451 . . . . 0.0 109.165 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -139.45 146.48 40.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.464 1.105 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -104.5 127.99 52.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.211 1.404 . . . . 0.0 109.033 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -49.2 103.81 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.841 1.656 . . . . 0.0 111.893 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 135.29 -26.71 3.2 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.997 0.808 . . . . 0.0 113.732 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.39 159.14 18.86 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.156 0.978 . . . . 0.0 111.113 162.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -64.29 171.47 3.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 0.0 112.054 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -50.29 130.58 23.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.202 -0.936 . . . . 0.0 111.152 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.84 153.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 109.313 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -108.84 129.57 55.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.61 89.86 13.76 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.35 1.46 . . . . 0.0 108.671 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.75 149.24 60.23 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.079 1.853 . . . . 0.0 112.048 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.4 mt -127.52 128.27 24.0 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.495 1.918 . . . . 0.0 106.81 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.25 -175.26 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.527 2.818 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 110.86 0.38 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.315 1.046 . . . . 0.0 111.484 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.3 tp -121.17 75.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.169 1.388 . . . . 0.0 109.743 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 m -107.45 131.63 21.57 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.317 1.047 . . . . 0.0 110.557 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.51 152.28 94.07 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.577 0.885 . . . . 0.0 112.081 -4.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.72 -40.29 74.33 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.653 2.236 . . . . 0.0 113.061 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.25 -4.22 10.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.575 1.55 . . . . 0.0 114.88 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 p -62.14 157.77 18.39 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.457 1.026 . . . . 0.0 111.11 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -105.3 110.61 23.04 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.696 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.7 tt -77.96 122.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.211 1.005 . . . . 0.0 109.049 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.46 138.87 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.431 0.692 . . . . 0.0 110.784 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -147.47 158.82 44.14 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.045 0.926 . . . . 0.0 112.439 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.94 133.86 54.37 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.521 1.129 . . . . 0.0 109.459 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.9 124.3 42.91 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.868 1.667 . . . . 0.0 107.606 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.2 t -139.54 134.6 32.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.891 0.853 . . . . 0.0 109.753 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.91 130.27 52.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.845 0.831 . . . . 0.0 109.135 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -143.63 130.04 19.98 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.619 1.568 . . . . 0.0 109.327 -168.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -64.34 135.17 55.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 109.481 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.2 p -88.76 10.18 21.84 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.37 1.068 . . . . 0.0 113.004 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -141.13 145.65 36.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.711 2.404 . . . . 0.0 109.635 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.2 t -63.76 135.0 96.09 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 121.829 -0.544 . . . . 0.0 111.859 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.57 125.47 10.26 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.666 0.917 . . . . 0.0 112.454 -6.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.84 25.11 11.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.368 1.867 . . . . 0.0 113.644 -170.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.16 159.85 9.08 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.079 -1.013 . . . . 0.0 111.939 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -58.16 107.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.744 0.817 . . . . 0.0 110.857 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 81.1 t -60.02 -55.01 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.877 1.271 . . . . 0.0 109.334 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.69 147.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.408 1.083 . . . . 0.0 110.299 164.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -136.63 120.68 17.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.894 1.678 . . . . 0.0 107.833 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.79 -173.07 31.06 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 122.1 0.833 . . . . 0.0 112.869 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.0 m -118.02 161.91 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.638 1.209 . . . . 0.0 111.224 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.25 164.6 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.731 2.412 . . . . 0.0 106.656 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -132.21 131.89 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.11 152.51 23.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -144.71 146.5 32.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.229 1.812 . . . . 0.0 109.842 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -119.46 151.95 37.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.963 1.305 . . . . 0.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 55.8 m -137.46 112.15 9.18 Favored Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 110.427 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.33 -15.43 20.03 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.487 2.791 . . . . 0.0 112.061 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.6 m -43.79 -42.31 5.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.421 2.689 . . . . 0.0 112.36 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.8 p -145.32 27.65 1.25 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.235 1.414 . . . . 0.0 113.069 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 45.29 41.65 8.59 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 120.258 -1.526 . . . . 0.0 113.997 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -87.74 137.74 32.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.3 1.44 . . . . 0.0 109.05 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.15 140.9 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -135.15 139.14 44.38 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.809 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.7 135.25 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 110.397 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.3 123.44 69.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 126.211 1.805 . . . . 0.0 106.751 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -139.46 124.98 19.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.895 1.678 . . . . 0.0 107.207 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -128.65 152.97 47.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 109.331 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -17.98 54.41 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.95 -18.74 62.62 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.649 1.58 . . . . 0.0 114.72 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.8 p -132.51 -50.86 0.92 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 112.89 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.42 142.17 40.13 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.319 1.448 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.86 164.91 34.24 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.468 2.112 . . . . 0.0 111.623 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -93.87 8.06 42.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.821 1.248 . . . . 0.0 112.854 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.303 1.441 . . . . 0.0 113.197 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -114.83 149.69 36.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.111 1.764 . . . . 0.0 107.267 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.2 p -133.21 161.77 33.55 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.771 0.828 . . . . 0.0 108.966 165.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 207' ' ' PHE . 8.0 p -129.28 125.79 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.818 0.847 . . . . 0.0 109.004 176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 10.0 t -104.7 144.19 32.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.9 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -82.89 80.18 9.03 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.569 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.23 -36.56 75.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.698 1.199 . . . . 0.0 112.538 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -150.55 173.44 14.09 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.133 1.773 . . . . 0.0 111.691 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.05 128.78 28.64 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.126 -1.609 . . . . 0.0 108.983 165.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.0 m 60.34 24.4 13.89 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 119.78 14.28 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.685 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -127.81 124.56 37.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 110.953 -167.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.42 100.19 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.643 0.777 . . . . 0.0 109.774 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 197' ' ' VAL . 96.0 m-85 -76.01 125.18 28.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.866 1.267 . . . . 0.0 110.248 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -121.93 126.88 49.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.913 1.285 . . . . 0.0 111.377 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 211' ' ' SER . 1.3 tm? -92.96 109.66 21.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.233 1.013 . . . . 0.0 110.92 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -110.62 10.74 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.466 1.506 . . . . 0.0 113.914 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.518 ' H ' HD12 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -168.04 109.91 0.59 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.696 1.998 . . . . 0.0 111.544 -178.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.86 -23.61 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 119.56 -1.963 . . . . 0.0 114.409 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 126.619 1.968 . . . . 0.0 111.865 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.54 124.73 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.443 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.77 150.28 41.82 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.592 -0.692 . . . . 0.0 110.33 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -22.35 27.59 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.185 -0.947 . . . . 0.0 113.414 172.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.93 15.96 17.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.558 1.943 . . . . 0.0 113.332 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -140.63 169.3 17.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.876 1.27 . . . . 0.0 110.279 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.3 t -131.46 148.4 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.898 0.879 . . . . 0.0 109.17 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 151.42 49.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.78 0.832 . . . . 0.0 110.842 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -145.15 127.09 15.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.651 -164.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.0 140.28 42.02 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 123.766 1.746 . . . . 0.0 111.198 -169.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.86 44.79 0.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 111.384 -168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.76 159.14 26.62 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.293 1.901 . . . . 0.0 110.44 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.81 139.18 58.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 111.337 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 t30 51.21 36.83 16.86 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.86 1.264 . . . . 0.0 114.056 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.8 m 61.85 64.46 1.01 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.218 1.807 . . . . 0.0 114.57 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 p -122.38 -44.91 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -69.86 1.36 Allowed Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.973 1.26 . . . . 0.0 113.624 -169.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -133.13 169.88 16.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.452 1.501 . . . . 0.0 109.772 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -136.42 149.67 48.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.891 1.277 . . . . 0.0 112.559 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 161.76 41.82 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.316 1.846 . . . . 0.0 110.912 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -134.01 141.07 47.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.17 1.388 . . . . 0.0 110.148 -175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.61 140.6 46.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.51 . . . . 0.0 109.986 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.93 147.22 23.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.903 0.881 . . . . 0.0 110.721 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -66.62 131.86 46.9 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.444 -0.785 . . . . 0.0 110.718 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.17 54.7 3.29 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.838 -0.423 . . . . 0.0 113.402 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.12 157.84 45.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.929 . . . . 0.0 112.088 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -132.93 127.44 34.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.664 1.186 . . . . 0.0 108.033 172.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.52 142.36 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.39 1.076 . . . . 0.0 109.747 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -135.64 119.23 17.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.521 1.128 . . . . 0.0 109.052 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.63 131.62 31.8 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.05 1.74 . . . . 0.0 107.98 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -154.76 145.75 22.64 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 110.893 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.09 26.39 0.17 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.863 0.865 . . . . 0.0 113.209 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.26 54.23 2.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.854 0.74 . . . . 0.0 114.109 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 47.57 64.56 1.56 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.423 1.889 . . . . 0.0 115.466 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -36.4 0.09 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -176.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.86 -28.82 9.87 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.898 1.226 . . . . 0.0 113.463 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -53.76 9.57 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.379 1.471 . . . . 0.0 110.399 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.68 -12.43 61.39 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -30.7 14.82 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.623 -1.298 . . . . 0.0 112.66 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.2 157.44 3.51 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 122.924 1.345 . . . . 0.0 114.303 173.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 -38.49 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.345 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -132.84 149.21 52.29 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.092 0.949 . . . . 0.0 112.682 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.5 p -151.84 143.92 23.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.72 0.772 . . . . 0.0 110.825 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.14 118.93 34.74 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -109.36 110.98 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.17 1.388 . . . . 0.0 108.841 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.83 166.91 4.53 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 122.901 1.278 . . . . 0.0 114.125 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.97 -27.51 64.78 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.873 -1.369 . . . . 0.0 114.647 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -121.47 36.26 4.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.243 1.817 . . . . 0.0 110.786 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.88 135.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.182 2.193 . . . . 0.0 109.956 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 150.58 28.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 109.315 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.36 152.23 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.819 0.819 . . . . 0.0 110.897 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -138.76 122.51 17.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.534 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.98 128.03 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.927 0.891 . . . . 0.0 110.284 -173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.82 113.42 10.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.676 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.34 -38.65 69.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.103 1.361 . . . . 0.0 113.628 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.64 174.3 15.18 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.982 1.313 . . . . 0.0 109.47 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -63.33 -66.57 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.832 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.264 0.6 OUTLIER 50.72 169.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.961 2.504 . . . . 0.0 117.225 -174.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.414 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 pt -152.06 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 126.623 1.969 . . . . 0.0 112.064 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 67.72 36.84 3.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.885 2.074 . . . . 0.0 111.589 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 60' ' ' ILE . 3.9 p -67.95 165.55 31.18 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.712 2.005 . . . . 0.0 110.373 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.86 19.59 0.28 Allowed 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.137 2.558 . . . . 0.0 114.142 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -149.23 60.18 4.5 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.0 112.306 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.99 140.13 49.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.028 1.818 . . . . 0.0 111.992 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.87 -115.45 1.36 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.282 1.42 . . . . 0.0 112.055 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 148.73 41.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.067 1.347 . . . . 0.0 112.265 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.03 137.69 23.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.252 1.821 . . . . 0.0 109.044 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -155.59 167.96 28.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.6 1.16 . . . . 0.0 110.754 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -127.53 108.25 10.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.401 1.48 . . . . 0.0 109.773 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.99 98.62 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.053 1.341 . . . . 0.0 109.607 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 142.94 25.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.421 1.489 . . . . 0.0 113.09 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 147.25 16.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.464 1.506 . . . . 0.0 113.458 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.64 45.18 96.83 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.709 0.671 . . . . 0.0 114.294 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.16 163.97 38.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.307 1.043 . . . . 0.0 112.385 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -137.06 142.61 42.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.33 1.052 . . . . 0.0 109.094 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -131.22 129.45 41.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.243 1.017 . . . . 0.0 108.289 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -129.37 -16.87 3.85 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.36 59.22 1.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.146 1.779 . . . . 0.0 110.391 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.94 10.04 11.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.123 2.569 . . . . 0.0 112.258 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -16.79 4.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.977 1.311 . . . . 0.0 112.952 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.6 m -46.32 -30.24 1.99 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.328 1.851 . . . . 0.0 114.639 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.06 -29.95 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 20.91 58.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 129.737 3.215 . . . . 0.0 114.022 -168.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.56 82.29 0.08 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -163.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 tt -126.2 45.68 2.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.284 1.433 . . . . 0.0 112.159 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -67.21 -34.77 78.2 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 119.876 -1.765 . . . . 0.0 113.236 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -117.42 128.42 55.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.628 1.171 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -122.32 123.67 41.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 109.556 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 125.92 54.69 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.31 121.84 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.874 1.27 . . . . 0.0 107.859 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -125.42 150.82 68.82 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.403 1.081 . . . . 0.0 109.893 -172.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.82 168.9 21.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.598 2.199 . . . . 0.0 111.448 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.46 40.07 1.08 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.691 2.091 . . . . 0.0 114.985 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.83 -43.24 0.15 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.483 1.913 . . . . 0.0 111.504 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.6 129.95 34.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.249 1.019 . . . . 0.0 109.48 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -86.85 -36.38 18.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.439 0.696 . . . . 0.0 112.224 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -148.22 156.43 42.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.215 2.206 . . . . 0.0 108.102 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.44 131.47 34.12 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.414 ' CG1' HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -102.99 133.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 C-N-CA 124.605 1.162 . . . . 0.0 110.754 -175.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.47 135.96 36.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.13 150.98 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.897 -0.502 . . . . 0.0 110.418 167.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -139.18 149.0 43.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.225 1.01 . . . . 0.0 111.229 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.5 mt -109.46 128.75 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.196 1.798 . . . . 0.0 108.308 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.23 111.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.492 1.517 . . . . 0.0 109.232 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -65.98 141.7 58.1 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.737 -0.602 . . . . 0.0 110.574 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.3 23.95 3.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.182 1.393 . . . . 0.0 111.628 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.07 -56.12 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.326 1.85 . . . . 0.0 112.155 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -129.31 108.75 10.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.961 1.304 . . . . 0.0 110.028 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.4 t -71.75 89.69 1.04 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 0.0 111.029 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -149.41 -39.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.8 1.24 . . . . 0.0 111.865 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 54.5 172.99 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.232 1.813 . . . . 0.0 114.432 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.68 -42.29 0.56 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.716 1.627 . . . . 0.0 115.816 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -64.49 -28.6 69.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.572 1.549 . . . . 0.0 113.901 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -88.31 115.18 25.62 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.513 1.125 . . . . 0.0 109.644 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.69 123.22 49.38 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.317 1.447 . . . . 0.0 108.898 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -113.52 130.83 56.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.824 0.849 . . . . 0.0 110.116 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.5 m -123.46 132.58 53.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.506 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.73 127.77 71.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -123.87 88.68 52.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.786 1.634 . . . . 0.0 108.417 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.47 163.98 35.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 111.944 172.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -36.36 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.626 2.37 . . . . 0.0 114.055 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 38.95 46.57 1.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.658 1.583 . . . . 0.0 114.699 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.45 156.34 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.499 1.92 . . . . 0.0 109.589 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -45.14 93.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.609 1.963 . . . . 0.0 113.03 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 155.44 24.13 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.328 1.051 . . . . 0.0 110.663 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.52 146.57 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.382 0.61 . . . . 0.0 110.222 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -122.72 134.27 54.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.781 1.232 . . . . 0.0 108.417 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.5 t -134.7 149.76 50.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 145.13 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -48.26 127.53 12.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.247 1.019 . . . . 0.0 109.617 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.34 48.9 4.62 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.78 167.32 21.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.408 1.483 . . . . 0.0 110.968 169.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -59.49 154.69 16.66 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.585 -0.697 . . . . 0.0 111.056 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -47.87 126.05 9.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 111.253 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 123.6 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.326 0.584 . . . . 0.0 110.017 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -75.79 129.86 37.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 110.365 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.9 tp -119.3 106.4 42.86 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.116 1.766 . . . . 0.0 108.104 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 142.73 39.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.669 2.246 . . . . 0.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.3 mm -134.18 127.08 18.86 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.292 1.037 . . . . 0.0 109.183 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.02 176.62 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.783 2.989 . . . . 0.0 112.777 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -80.24 144.64 32.73 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.522 -0.736 . . . . 0.0 111.434 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.44 48.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.857 1.663 . . . . 0.0 111.447 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -47.62 136.55 9.96 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 125.032 1.333 . . . . 0.0 113.785 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.1 143.72 77.14 Favored 'Cis proline' 0 CA--C 1.543 0.966 0 CA-C-N 119.963 1.023 . . . . 0.0 111.747 -1.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.03 -16.49 45.08 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.479 2.119 . . . . 0.0 113.96 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -3.09 5.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.546 1.139 . . . . 0.0 113.978 168.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 m -66.85 124.16 22.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.969 -1.082 . . . . 0.0 111.267 163.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -64.22 133.0 51.98 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.556 0.743 . . . . 0.0 111.644 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.2 tt -100.38 132.59 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.478 1.511 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.1 p -77.35 142.15 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.798 -0.564 . . . . 0.0 110.677 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.4 m -144.15 159.19 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.315 1.446 . . . . 0.0 110.409 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -123.09 141.15 52.28 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.673 0.789 . . . . 0.0 110.068 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.24 126.93 46.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.91 1.684 . . . . 0.0 108.992 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.28 112.94 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.58 126.66 71.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -131.17 139.55 49.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.066 1.747 . . . . 0.0 108.868 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.52 124.26 23.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -71.31 -15.68 62.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.794 1.237 . . . . 0.0 113.137 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.04 173.36 6.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.718 2.007 . . . . 0.0 111.366 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.6 p -52.75 147.83 14.56 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.814 1.246 . . . . 0.0 113.648 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 7.17 16.26 Favored 'Cis proline' 0 CA--C 1.546 1.092 0 N-CA-C 114.398 0.884 . . . . 0.0 114.398 0.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.04 32.76 10.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.656 1.583 . . . . 0.0 113.648 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 150.19 20.65 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.736 1.214 . . . . 0.0 111.395 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -57.73 108.64 0.59 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.821 0.848 . . . . 0.0 109.548 167.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.8 t -65.48 -56.82 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.079 0.952 . . . . 0.0 109.581 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.72 155.05 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.652 0.781 . . . . 0.0 111.984 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -142.72 77.89 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.268 1.827 . . . . 0.0 110.767 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -115.09 -178.03 18.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.17 1.367 . . . . 0.0 112.954 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.3 m -127.05 148.5 50.12 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 110.188 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.31 160.55 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.055 1.742 . . . . 0.0 109.494 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.73 137.61 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.34 145.6 43.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -140.93 158.0 44.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.859 1.264 . . . . 0.0 109.586 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -127.11 116.45 20.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.011 0.925 . . . . 0.0 110.98 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.5 m -83.33 118.47 71.69 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.92 -1.113 . . . . 0.0 109.282 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.35 -19.6 43.49 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.526 2.151 . . . . 0.0 112.547 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.3 m -45.33 -51.7 10.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.918 2.087 . . . . 0.0 112.469 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 20.8 p -143.26 34.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 0.0 112.407 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.83 42.43 94.59 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.211 -1.555 . . . . 0.0 114.1 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.97 173.91 10.18 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.105 1.362 . . . . 0.0 112.717 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.414 HG13 ' CG1' ' A' ' 100' ' ' VAL . 17.3 m -128.62 142.01 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 111.177 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 72.7 m -137.83 108.86 6.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.65 1.18 . . . . 0.0 108.188 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.81 141.25 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.826 0.822 . . . . 0.0 111.21 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -120.8 134.76 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.813 2.045 . . . . 0.0 107.337 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -152.58 132.92 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.27 1.428 . . . . 0.0 107.816 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -114.77 152.99 31.15 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.756 1.223 . . . . 0.0 109.664 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.66 -15.58 61.51 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.55 -31.64 13.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.544 1.537 . . . . 0.0 114.38 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.6 p -87.5 -42.28 12.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 0.0 111.326 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -87.3 148.61 45.08 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.729 2.011 . . . . 0.0 110.759 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.95 178.2 7.93 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.443 2.095 . . . . 0.0 111.608 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.91 44.03 2.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.051 1.74 . . . . 0.0 110.87 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -144.98 -27.61 0.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.94 1.296 . . . . 0.0 113.529 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.6 ttm -137.71 139.89 40.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.22 2.208 . . . . 0.0 107.673 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.8 p -134.79 155.8 49.97 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.76 140.8 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.233 1.013 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 8.8 t -140.16 163.02 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.041 1.337 . . . . 0.0 110.49 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 118.71 26.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.218 1.407 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.8 8.29 5.28 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 112.717 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.94 16.92 2.84 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.819 1.248 . . . . 0.0 113.333 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.47 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.047 2.539 . . . . 0.0 114.368 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.7 m 80.89 21.29 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.43 1.092 . . . . 0.0 111.676 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -136.74 128.63 29.22 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.788 1.635 . . . . 0.0 111.37 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -118.99 133.6 55.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.805 1.642 . . . . 0.0 111.335 -174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.65 106.25 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.642 0.777 . . . . 0.0 109.268 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -84.84 126.35 33.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.074 1.35 . . . . 0.0 110.951 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -117.91 121.32 40.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.364 1.466 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.86 98.82 11.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.816 1.246 . . . . 0.0 109.601 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -80.42 -30.1 37.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 113.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -144.96 134.88 23.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 109.353 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.1 -50.83 72.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.258 0.935 . . . . 0.0 111.783 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 125.156 1.382 . . . . 0.0 111.416 -169.514 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p -71.26 126.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.554 -1.341 . . . . 0.0 109.413 164.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.16 143.29 57.96 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.807 -0.558 . . . . 0.0 109.536 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.43 -19.1 5.02 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -116.28 17.83 15.48 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.246 2.219 . . . . 0.0 113.647 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -135.34 171.63 14.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.689 1.596 . . . . 0.0 111.051 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 150.47 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.594 1.158 . . . . 0.0 108.806 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 149.77 34.47 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 112.938 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.93 130.83 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.333 1.453 . . . . 0.0 109.495 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.98 125.91 42.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.589 1.155 . . . . 0.0 110.199 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.98 55.04 3.31 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.236 1.017 . . . . 0.0 112.046 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.95 148.27 7.58 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.979 1.276 . . . . 0.0 111.039 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -59.53 133.21 55.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.431 1.092 . . . . 0.0 111.279 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 71.52 41.97 0.7 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.202 1.801 . . . . 0.0 114.021 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m 53.08 61.91 2.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.519 1.528 . . . . 0.0 113.592 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.0 p -130.56 178.48 6.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.131 1.372 . . . . 0.0 112.188 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.34 -85.26 1.04 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.343 1.449 . . . . 0.0 113.752 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.22 170.52 14.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.364 1.466 . . . . 0.0 110.777 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -139.53 148.54 42.75 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 111.304 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.75 147.56 26.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.582 1.553 . . . . 0.0 110.487 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -125.06 132.59 53.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.462 1.105 . . . . 0.0 110.399 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -129.76 133.44 47.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.908 1.337 . . . . 0.0 111.454 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.62 138.57 43.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.946 1.298 . . . . 0.0 111.473 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 148.43 51.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.278 1.031 . . . . 0.0 111.42 168.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.32 41.29 68.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.43 1.014 . . . . 0.0 112.553 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -144.14 160.76 40.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.076 1.35 . . . . 0.0 112.248 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 m -121.56 131.7 54.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.288 1.435 . . . . 0.0 108.25 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.54 141.13 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.918 0.887 . . . . 0.0 108.727 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -126.77 151.37 48.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.436 1.095 . . . . 0.0 110.982 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -124.97 171.26 10.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.661 1.584 . . . . 0.0 109.72 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.9 107.86 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.495 1.518 . . . . 0.0 112.464 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.96 -16.29 50.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.21 1.004 . . . . 0.0 113.693 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.36 -9.45 49.54 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 126.134 1.825 . . . . 0.0 115.453 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.253 0.1 OUTLIER 67.46 88.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 169.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -140.95 -54.32 0.49 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.673 -171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.66 18.86 0.71 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.214 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -63.98 -24.74 67.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -70.19 0.11 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.713 168.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.303 0.3 OUTLIER 27.75 48.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 128.164 2.586 . . . . 0.0 115.761 -175.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.02 133.78 46.06 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.986 2.114 . . . . 0.0 109.337 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mmt -153.78 -45.24 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.487 1.915 . . . . 0.0 111.324 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 t -136.07 130.24 33.13 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.415 1.086 . . . . 0.0 109.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 89.6 m -140.96 145.4 35.97 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.54 121.72 36.36 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.325 1.05 . . . . 0.0 108.606 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.4 t -105.49 143.08 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.454 1.902 . . . . 0.0 106.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.92 -97.09 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.324 1.916 . . . . 0.0 117.301 -172.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 t -161.57 -42.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.634 1.173 . . . . 0.0 111.504 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.88 33.88 4.95 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.261 1.425 . . . . 0.0 110.617 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -146.69 157.12 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.524 2.33 . . . . 0.0 109.798 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -136.75 154.52 50.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.428 1.891 . . . . 0.0 110.132 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.7 t -123.55 143.26 50.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.683 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -134.04 139.09 45.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 109.405 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.1 119.75 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.009 1.324 . . . . 0.0 107.989 -167.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.72 135.51 50.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.962 0.905 . . . . 0.0 109.817 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.02 -60.7 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.246 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.5 -178.73 7.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.553 0.741 . . . . 0.0 111.957 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -65.95 129.97 41.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.923 0.889 . . . . 0.0 113.074 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -178.14 6.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.175 1.79 . . . . 0.0 110.088 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.74 44.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.227 1.411 . . . . 0.0 113.104 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 57.68 48.53 13.89 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.16 1.457 . . . . 0.0 111.855 -171.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -64.31 167.36 8.51 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.804 1.642 . . . . 0.0 110.791 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.9 11.08 0.93 Allowed 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.954 2.436 . . . . 0.0 113.967 172.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -147.28 57.85 3.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.768 1.627 . . . . 0.0 111.973 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.86 154.06 73.95 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.408 1.405 . . . . 0.0 110.659 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.45 -105.52 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -142.85 150.91 40.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.773 1.629 . . . . 0.0 110.217 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -151.39 140.03 20.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.222 1.409 . . . . 0.0 109.254 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.33 156.73 26.75 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 110.341 172.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.13 97.95 5.66 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.851 0.861 . . . . 0.0 109.799 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.14 124.36 14.24 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.525 1.13 . . . . 0.0 109.677 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.92 163.37 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.563 1.145 . . . . 0.0 113.024 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 165.51 1.19 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.866 171.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -21.22 108.4 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.883 2.183 . . . . 0.0 118.296 -171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 p -167.1 177.35 6.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.375 1.07 . . . . 0.0 112.906 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 m -107.89 97.69 7.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.499 1.919 . . . . 0.0 109.45 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.877 0.871 . . . . 0.0 109.836 171.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -128.83 12.52 6.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.03 1.332 . . . . 0.0 112.493 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -153.21 38.26 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.699 -1.25 . . . . 0.0 113.106 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.9 -1.91 57.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.701 1.2 . . . . 0.0 114.036 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -12.62 1.95 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.042 1.737 . . . . 0.0 114.394 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -46.57 -32.0 3.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.022 1.329 . . . . 0.0 113.883 165.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.3 tp -70.34 -35.5 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.258 7.3 m-20 30.73 46.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.336 2.655 . . . . 0.0 115.411 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.04 107.95 0.24 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.94 0.781 . . . . 0.0 112.649 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.3 85.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.113 0.958 . . . . 0.0 113.111 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -75.59 -6.57 51.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.744 -1.223 . . . . 0.0 113.171 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -129.95 137.6 50.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.738 2.415 . . . . 0.0 111.048 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.86 128.48 38.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.114 1.366 . . . . 0.0 109.183 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.96 119.41 25.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.952 0.901 . . . . 0.0 108.825 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.39 118.17 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.92 150.28 71.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.102 0.961 . . . . 0.0 110.205 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.5 -173.49 0.99 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.674 2.249 . . . . 0.0 112.64 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.67 -26.64 24.34 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.146 1.355 . . . . 0.0 113.498 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -43.44 87.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.014 0.907 . . . . 0.0 112.287 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.55 126.07 37.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.868 1.267 . . . . 0.0 109.062 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.89 -47.39 11.11 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.307 -0.87 . . . . 0.0 110.853 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -143.06 160.0 41.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.561 1.944 . . . . 0.0 108.794 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.21 152.17 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.548 0.739 . . . . 0.0 109.817 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.4 139.7 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.781 0.832 . . . . 0.0 111.003 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.41 139.18 38.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.79 143.47 40.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 125.737 1.615 . . . . 0.0 109.725 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -148.39 133.05 17.82 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.83 1.252 . . . . 0.0 109.688 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.04 137.01 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.332 1.053 . . . . 0.0 108.432 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -140.49 95.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.92 2.088 . . . . 0.0 108.823 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -71.92 122.7 21.27 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.891 -1.131 . . . . 0.0 111.256 173.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 12.72 31.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.574 1.55 . . . . 0.0 112.891 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -127.21 -66.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.606 1.562 . . . . 0.0 110.865 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.47 128.12 37.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.757 0.823 . . . . 0.0 110.524 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -102.4 53.91 0.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.339 1.066 . . . . 0.0 110.947 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -140.32 63.54 1.47 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 123.579 1.657 . . . . 0.0 110.61 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.67 143.84 19.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 113.537 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.34 9.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.394 1.473 . . . . 0.0 114.397 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -87.19 -35.57 18.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.478 1.139 . . . . 0.0 113.707 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.41 126.47 29.71 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.071 0.948 . . . . 0.0 109.891 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -128.75 125.68 38.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.4 1.48 . . . . 0.0 108.957 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.2 ttp -114.27 134.96 54.57 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.294 1.437 . . . . 0.0 109.38 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -122.42 135.33 54.66 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.443 1.497 . . . . 0.0 108.058 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.5 pt -131.17 137.19 56.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.943 0.897 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 m -137.84 94.64 11.4 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 0.0 109.504 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.14 165.43 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.957 2.438 . . . . 0.0 111.455 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -26.17 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.907 3.283 . . . . 0.0 115.689 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 42.22 45.78 3.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.407 1.483 . . . . 0.0 114.324 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.2 t -111.19 159.82 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.055 2.142 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.55 94.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.997 2.519 . . . . 0.0 112.937 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 143.63 56.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 110.728 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.01 145.28 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.926 0.89 . . . . 0.0 110.293 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -130.29 138.01 50.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.46 1.504 . . . . 0.0 109.245 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.12 160.78 40.33 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.84 1.256 . . . . 0.0 110.423 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -120.32 154.45 34.99 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.963 0.905 . . . . 0.0 109.79 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.62 143.96 39.33 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.167 -0.333 . . . . 0.0 110.935 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.94 47.96 43.63 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.702 0.667 . . . . 0.0 114.61 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.36 162.16 24.41 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.453 1.501 . . . . 0.0 110.996 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 153.02 6.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.006 0.922 . . . . 0.0 111.941 169.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.26 118.49 3.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.307 1.043 . . . . 0.0 111.754 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.3 t -92.78 141.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 108.881 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -104.28 135.98 44.73 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.956 0.798 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tp -115.95 101.7 53.99 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.782 2.033 . . . . 0.0 108.155 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.58 147.55 40.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.562 2.175 . . . . 0.0 112.336 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -137.41 132.85 17.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.009 1.324 . . . . 0.0 109.33 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.52 174.73 11.71 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.377 3.385 . . . . 0.0 112.646 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -64.27 147.11 53.19 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.59 -0.694 . . . . 0.0 112.337 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 pp -153.97 158.84 41.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.83 2.052 . . . . 0.0 110.186 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -147.97 139.95 14.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 111.998 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.83 155.75 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 CA-C-N 119.662 0.915 . . . . 0.0 112.377 -9.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.25 -39.64 37.09 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.901 1.734 . . . . 0.0 111.761 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -72.08 8.28 1.34 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.122 1.769 . . . . 0.0 113.631 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -78.0 -178.05 5.33 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.42 -1.425 . . . . 0.0 111.554 166.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 160.39 21.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.279 1.432 . . . . 0.0 112.368 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 16.0 tt -122.56 133.11 69.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.722 1.609 . . . . 0.0 109.827 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.06 131.9 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.936 0.894 . . . . 0.0 110.666 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.2 m -146.39 166.45 26.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.136 0.97 . . . . 0.0 111.335 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -134.01 147.36 50.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.853 0.861 . . . . 0.0 111.023 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.6 tt -130.1 130.44 44.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.055 1.742 . . . . 0.0 109.164 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.51 117.33 9.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.745 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.32 132.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.847 1.259 . . . . 0.0 108.753 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.24 144.92 27.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 110.195 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -77.79 126.12 30.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -68.1 -28.65 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.246 1.018 . . . . 0.0 113.346 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.53 174.08 6.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.695 1.598 . . . . 0.0 111.923 172.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 p -52.18 147.5 13.21 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.36 1.464 . . . . 0.0 113.517 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.2 12.13 19.74 Favored 'Cis proline' 0 CA--C 1.545 1.047 0 N-CA-C 114.714 1.006 . . . . 0.0 114.714 3.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.76 24.46 9.9 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.343 1.457 . . . . 0.0 113.082 170.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -88.81 135.53 33.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.897 -1.127 . . . . 0.0 111.276 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -57.64 111.1 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.732 0.813 . . . . 0.0 109.996 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.71 -57.99 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.351 1.06 . . . . 0.0 109.028 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 33.5 m -147.4 153.55 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.733 0.777 . . . . 0.0 111.978 169.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -145.75 105.92 4.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.043 1.737 . . . . 0.0 108.72 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.12 157.33 28.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 121.837 0.687 . . . . 0.0 113.003 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.2 m -74.15 150.44 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.173 0.987 . . . . 0.0 111.196 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.35 161.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.951 2.1 . . . . 0.0 108.526 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.86 132.22 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.485 0.659 . . . . 0.0 109.656 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.03 152.83 23.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -145.19 151.44 38.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.732 2.013 . . . . 0.0 108.121 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -115.39 132.95 56.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.423 1.089 . . . . 0.0 108.931 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.8 t -93.38 103.49 9.79 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.09 -17.43 45.69 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.734 2.289 . . . . 0.0 112.828 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.4 m -53.08 -42.9 66.31 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.994 2.118 . . . . 0.0 112.958 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 48.2 p -144.16 18.33 1.75 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.35 1.46 . . . . 0.0 112.483 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.46 73.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.761 1.648 . . . . 0.0 114.622 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.417 ' CG ' ' H ' ' A' ' 182' ' ' VAL . 4.0 tt0 -73.33 -170.27 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.079 1.419 . . . . 0.0 111.585 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.429 HG12 ' CZ ' ' A' ' 205' ' ' PHE . 1.4 p -135.41 155.18 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 128.041 2.537 . . . . 0.0 107.749 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.0 m -140.31 150.76 44.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.208 1.803 . . . . 0.0 107.996 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.447 ' HB ' ' CZ ' ' A' ' 205' ' ' PHE . 6.8 p -121.5 140.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 22.9 mt -123.6 129.95 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.51 140.39 33.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 108.896 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.82 34.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.509 1.123 . . . . 0.0 109.707 -168.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -28.58 67.0 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.46 -30.52 47.45 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.311 1.844 . . . . 0.0 115.039 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 p -101.21 -53.54 3.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.531 1.132 . . . . 0.0 111.632 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -85.65 148.74 49.68 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.537 1.935 . . . . 0.0 110.913 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.1 -175.05 2.45 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.692 2.928 . . . . 0.0 111.577 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.25 30.17 6.68 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.01 1.724 . . . . 0.0 111.967 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -132.15 -38.86 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.862 1.665 . . . . 0.0 113.187 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 30.0 ttm -112.77 145.45 40.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.434 1.893 . . . . 0.0 106.804 167.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -140.43 150.05 43.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.949 0.899 . . . . 0.0 110.579 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.16 142.44 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.521 -0.737 . . . . 0.0 111.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 12.2 t -139.95 156.13 46.81 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.611 1.164 . . . . 0.0 111.232 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.64 81.79 0.84 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 111.349 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -60.59 -31.21 70.37 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.854 -1.154 . . . . 0.0 112.627 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.46 173.91 11.39 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.639 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.37 118.76 7.91 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.76 174.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.251 30.0 m 63.08 28.85 16.24 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 112.593 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 t -137.38 125.08 22.35 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.096 -1.003 . . . . 0.0 112.389 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.447 ' CZ ' ' HB ' ' A' ' 184' ' ' VAL . 12.3 m-85 -109.08 134.75 51.28 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 112.317 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.87 107.32 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.76 1.224 . . . . 0.0 109.72 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.91 108.43 17.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.855 1.262 . . . . 0.0 109.916 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -92.77 136.3 33.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.302 1.441 . . . . 0.0 110.185 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.56 119.96 40.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.631 0.773 . . . . 0.0 110.258 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -107.87 -6.21 16.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.899 1.68 . . . . 0.0 113.701 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -121.64 -169.91 1.95 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.767 2.027 . . . . 0.0 111.628 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -154.05 26.59 0.48 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 126.078 1.751 . . . . 0.0 113.75 -177.386 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 119.858 -0.115 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.461 ' CG2' ' H ' ' A' ' 4' ' ' ASP 0.291 8.4 p 47.65 -176.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 127.158 2.183 . . . . 0.0 113.881 -171.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' H ' ' CG2' ' A' ' 3' ' ' VAL . 4.0 t70 -75.15 147.97 40.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 119.834 -1.791 . . . . 0.0 109.916 169.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.12 -18.52 10.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.09 14.96 17.16 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.313 2.245 . . . . 0.0 113.87 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -138.74 177.79 7.63 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.107 1.321 . . . . 0.0 111.175 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.21 156.55 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.015 1.326 . . . . 0.0 111.318 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.32 145.44 33.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.661 1.185 . . . . 0.0 110.927 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 137.09 36.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.427 1.491 . . . . 0.0 108.421 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -132.34 124.57 29.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.515 1.126 . . . . 0.0 110.521 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -80.21 60.09 3.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.133 1.373 . . . . 0.0 111.441 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.9 131.11 1.44 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 141.23 15.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.362 1.065 . . . . 0.0 111.116 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.39 42.45 14.68 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.22 59.62 2.64 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.63 1.972 . . . . 0.0 113.302 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.8 m -133.9 -179.35 5.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.334 1.454 . . . . 0.0 111.206 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' H ' HG22 ' A' ' 17' ' ' THR . . . 69.22 -105.63 1.55 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.586 1.565 . . . . 0.0 113.379 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -113.53 164.54 13.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.156 0.982 . . . . 0.0 111.634 174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -130.38 145.29 51.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.551 1.14 . . . . 0.0 111.938 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 160.24 43.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.897 1.679 . . . . 0.0 110.673 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -127.99 154.99 44.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.24 1.016 . . . . 0.0 110.722 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.44 136.96 45.51 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.661 1.184 . . . . 0.0 110.935 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -92.1 147.82 22.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.53 1.132 . . . . 0.0 110.278 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.06 139.44 58.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.174 0.59 . . . . 0.0 111.64 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.69 28.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.98 0.8 . . . . 0.0 112.764 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.34 122.24 22.36 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.328 1.051 . . . . 0.0 110.763 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 m -107.37 130.28 54.81 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.978 1.311 . . . . 0.0 108.595 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.72 132.66 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.348 1.459 . . . . 0.0 109.776 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -122.79 140.05 53.33 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.801 1.241 . . . . 0.0 109.707 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 133.75 31.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.878 1.271 . . . . 0.0 108.952 -173.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -163.54 56.86 0.18 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.9 -1.125 . . . . 0.0 111.826 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -71.24 54.41 0.2 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.83 1.652 . . . . 0.0 113.67 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.82 47.65 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 125.377 1.465 . . . . 0.0 114.535 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.284 1.3 t70 49.83 74.11 0.22 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.249 2.219 . . . . 0.0 116.386 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -160.48 -42.32 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -124.72 18.11 8.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 111.69 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -39.12 64.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.142 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.82 -62.66 1.55 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.174 0.989 . . . . 0.0 109.211 176.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.21 31.86 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.198 1.799 . . . . 0.0 113.582 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.66 128.0 40.05 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.111 2.164 . . . . 0.0 107.813 -172.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 mtp -138.45 -50.16 0.55 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 111.823 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.4 p -133.54 122.98 24.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.543 0.687 . . . . 0.0 110.697 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.6 m -144.81 154.53 42.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.67 149.73 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.236 1.017 . . . . 0.0 111.166 -173.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.8 136.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.64 1.576 . . . . 0.0 109.019 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -87.28 0.03 OUTLIER Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.675 1.131 . . . . 0.0 114.959 -167.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.0 p -173.01 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -127.12 33.16 4.95 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.317 1.447 . . . . 0.0 111.186 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.61 146.09 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.518 1.927 . . . . 0.0 108.753 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -114.29 143.75 44.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.638 1.175 . . . . 0.0 108.553 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.67 131.97 54.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 109.439 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.37 123.77 47.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.987 1.315 . . . . 0.0 108.244 -170.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.05 119.86 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 122.122 0.963 . . . . 0.0 111.822 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -132.38 118.19 19.06 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 109.976 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.52 -54.92 15.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.53 1.132 . . . . 0.0 111.356 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -130.3 122.29 27.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -164.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.02 31.54 0.44 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.9 1.28 . . . . 0.0 112.431 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.46 165.07 5.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.144 2.578 . . . . 0.0 114.335 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 mm -112.76 39.43 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.29 52.2 m-20 57.15 50.31 12.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.617 1.967 . . . . 0.0 112.837 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.9 p -73.67 176.34 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.865 2.466 . . . . 0.0 110.893 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.16 3.95 4.18 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.9 2.4 . . . . 0.0 113.796 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -136.32 64.32 52.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.93 1.692 . . . . 0.0 110.502 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.89 138.33 57.18 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.302 1.335 . . . . 0.0 109.326 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.62 -121.91 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.873 0.749 . . . . 0.0 111.663 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -134.33 140.16 46.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.508 1.123 . . . . 0.0 111.052 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.72 139.76 24.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.702 1.201 . . . . 0.0 109.868 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -157.25 165.77 34.98 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.559 1.171 . . . . 0.0 111.263 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -132.7 104.46 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.307 1.443 . . . . 0.0 107.5 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -64.75 116.05 5.89 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.71 160.94 0.39 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.832 2.053 . . . . 0.0 114.227 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -47.28 -34.17 6.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.16 135.24 3.63 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 164.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.54 167.86 0.65 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.789 2.036 . . . . 0.0 110.824 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -123.31 105.48 9.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.802 1.241 . . . . 0.0 110.098 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -83.82 100.88 11.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -70.49 -20.69 62.84 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.6 73.85 0.98 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.96 2.43 12.63 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.69 -1.257 . . . . 0.0 114.023 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -53.0 -10.78 0.19 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.96 2.104 . . . . 0.0 115.298 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.2 m -48.95 -32.08 8.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.057 1.299 . . . . 0.0 113.994 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -87.56 -32.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.84 30.02 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.545 2.738 . . . . 0.0 115.95 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.84 109.75 0.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -160.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 178.31 55.09 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.416 2.286 . . . . 0.0 110.027 -170.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -57.99 -22.17 48.22 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 134.45 53.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.856 1.263 . . . . 0.0 110.648 173.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.07 135.59 35.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.555 1.542 . . . . 0.0 109.815 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -141.88 142.63 33.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.717 0.77 . . . . 0.0 112.088 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.87 123.08 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.605 . . . . 0.0 109.238 -170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -141.03 157.64 66.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.978 0.911 . . . . 0.0 111.236 -168.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.57 160.7 43.71 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.895 2.397 . . . . 0.0 113.315 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.88 -17.08 69.07 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 121.24 -0.913 . . . . 0.0 115.022 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.09 70.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -72.84 163.71 27.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.947 1.299 . . . . 0.0 111.477 173.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -35.62 0.99 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.152 1.381 . . . . 0.0 111.54 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -154.39 160.99 41.97 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.298 1.839 . . . . 0.0 109.666 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.42 160.98 39.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.522 0.729 . . . . 0.0 110.197 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.0 145.45 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.315 1.046 . . . . 0.0 110.516 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.11 127.78 45.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.05 1.34 . . . . 0.0 108.287 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -128.58 135.38 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.818 -0.551 . . . . 0.0 110.295 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -123.81 143.35 50.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.443 1.497 . . . . 0.0 109.539 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.3 mt -111.85 131.08 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.64 103.3 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 122.564 1.173 . . . . 0.0 110.962 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.1 134.33 49.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.409 1.884 . . . . 0.0 110.751 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 -21.95 8.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.429 1.092 . . . . 0.0 113.571 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.59 -55.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 119.085 0.857 . . . . 0.0 111.026 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.04 93.4 4.48 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 109.026 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -73.42 48.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.593 1.557 . . . . 0.0 112.553 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -143.16 51.7 1.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.229 2.612 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.58 129.03 31.34 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.717 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.8 -31.83 3.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.119 1.819 . . . . 0.0 112.25 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 m -79.53 -18.0 52.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 114.066 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.66 137.35 38.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.16 1.384 . . . . 0.0 108.622 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.9 121.15 34.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.849 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 4.8 ttp -113.4 132.95 55.43 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.458 1.103 . . . . 0.0 110.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.7 m -122.1 132.42 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.383 1.473 . . . . 0.0 108.343 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.2 122.72 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.0 m -120.54 86.46 39.69 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 125.797 1.639 . . . . 0.0 109.16 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.39 157.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.609 2.872 . . . . 0.0 112.693 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -39.53 86.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.659 2.784 . . . . 0.0 114.576 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 38.87 42.53 0.65 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.02 159.4 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.755 2.022 . . . . 0.0 109.434 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.61 92.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.201 2.2 . . . . 0.0 113.047 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 149.5 49.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.61 0.764 . . . . 0.0 110.917 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.06 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.225 1.01 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.51 136.36 50.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.1 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 17.9 p -137.57 137.63 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.045 1.338 . . . . 0.0 108.606 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.54 142.13 33.14 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 166.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.59 151.37 6.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 111.043 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.01 42.85 10.38 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 120.846 -1.159 . . . . 0.0 113.155 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.01 161.64 29.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.167 1.787 . . . . 0.0 108.927 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 151.58 14.91 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.462 -0.774 . . . . 0.0 110.619 166.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -38.43 115.2 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.649 1.58 . . . . 0.0 111.784 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.02 130.64 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -81.28 123.62 28.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.417 0.687 . . . . 0.0 109.46 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.53 96.06 49.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.067 1.747 . . . . 0.0 108.534 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 146.81 41.55 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.212 1.941 . . . . 0.0 111.287 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.38 132.08 24.14 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.926 2.091 . . . . 0.0 107.633 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.93 175.83 9.87 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.144 2.562 . . . . 0.0 113.195 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -57.72 155.96 9.31 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.376 0.671 . . . . 0.0 112.534 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 pp -170.86 156.96 5.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.613 1.965 . . . . 0.0 109.86 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.8 t -137.24 138.41 25.17 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.966 0.906 . . . . 0.0 111.565 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 157.28 72.12 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 119.527 0.867 . . . . 0.0 111.97 -7.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.02 -36.39 48.97 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.577 1.518 . . . . 0.0 112.09 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -74.18 7.52 2.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.3 p -65.71 174.97 2.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.904 -1.123 . . . . 0.0 112.804 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.42 132.4 56.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.843 1.257 . . . . 0.0 110.952 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.27 116.18 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.788 1.635 . . . . 0.0 108.4 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.5 133.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 122.97 0.508 . . . . 0.0 109.949 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.1 p -131.32 160.46 34.92 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.794 1.237 . . . . 0.0 110.397 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -114.4 137.18 52.15 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.212 0.605 . . . . 0.0 109.543 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.81 138.65 49.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.955 1.702 . . . . 0.0 107.931 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.46 111.54 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.573 1.549 . . . . 0.0 108.186 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.7 p -120.52 130.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.963 1.305 . . . . 0.0 109.461 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -144.24 141.65 29.99 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.265 1.826 . . . . 0.0 109.349 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 137.98 52.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.493 0.317 . . . . 0.0 111.339 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -77.19 -5.26 48.53 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.613 1.165 . . . . 0.0 113.843 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 179.75 5.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.766 2.426 . . . . 0.0 110.686 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.15 150.13 22.44 Favored Pre-proline 0 N--CA 1.481 1.081 0 O-C-N 121.017 -1.052 . . . . 0.0 113.193 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.13 7.22 22.77 Favored 'Cis proline' 0 CA--C 1.545 1.029 0 CA-C-N 119.847 0.981 . . . . 0.0 114.513 -0.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.36 35.18 24.64 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 113.626 171.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -102.05 156.33 17.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 111.302 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -64.86 86.88 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.9 -1.125 . . . . 0.0 111.696 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.5 -54.38 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.763 2.025 . . . . 0.0 110.848 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 96.4 t -146.71 127.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.161 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -144.94 136.37 25.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 109.927 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.86 178.77 41.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.674 0.654 . . . . 0.0 112.255 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.2 m -109.77 149.62 29.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.005 0.907 . . . . 0.0 111.798 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.95 147.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.149 2.18 . . . . 0.0 108.215 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.36 132.54 54.34 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.405 -0.809 . . . . 0.0 109.491 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -107.73 141.23 39.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.557 1.143 . . . . 0.0 109.517 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -136.18 143.39 44.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.714 1.605 . . . . 0.0 109.573 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -115.09 115.31 26.58 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.826 0.851 . . . . 0.0 110.413 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.9 m -76.49 107.8 5.27 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.422 1.089 . . . . 0.0 109.525 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.75 -14.37 32.91 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.629 2.219 . . . . 0.0 112.908 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.2 m -53.35 -44.8 68.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 113.348 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.3 p -142.32 22.92 2.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.097 1.359 . . . . 0.0 113.016 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 53.1 39.03 57.12 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.974 1.75 . . . . 0.0 114.571 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -80.02 166.25 21.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.518 0.727 . . . . 0.0 110.815 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.76 148.83 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.4 m -129.58 145.31 51.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.055 2.142 . . . . 0.0 108.527 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.26 128.28 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.176 1.39 . . . . 0.0 109.746 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.56 120.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.733 1.613 . . . . 0.0 106.921 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.18 140.56 37.85 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.774 1.63 . . . . 0.0 107.846 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -136.67 130.54 32.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.76 -16.54 17.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.7 -14.98 63.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.536 2.335 . . . . 0.0 114.411 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.7 t -142.27 -36.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.75 1.62 . . . . 0.0 113.254 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -82.29 138.3 45.29 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.564 1.546 . . . . 0.0 110.054 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.43 178.87 6.48 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.719 2.946 . . . . 0.0 112.467 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -116.65 29.39 7.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.936 1.694 . . . . 0.0 111.842 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -114.01 -36.11 4.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.867 1.267 . . . . 0.0 112.204 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.6 ttt -121.36 142.9 49.54 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.761 2.024 . . . . 0.0 108.096 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 p -137.64 131.51 31.63 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.897 0.856 . . . . 0.0 110.909 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.77 137.17 40.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.905 0.882 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.7 t -127.89 160.06 33.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 111.268 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.79 84.29 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 111.1 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.33 -39.97 94.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.27 1.028 . . . . 0.0 112.257 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -146.0 -174.81 4.53 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.249 2.219 . . . . 0.0 111.613 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.465 HD21 HG23 ' A' ' 203' ' ' THR . 4.7 t30 -43.34 -53.27 5.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.041 2.136 . . . . 0.0 113.352 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.465 HG23 HD21 ' A' ' 202' ' ' ASN . 73.5 p -133.59 29.71 3.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.449 1.1 . . . . 0.0 112.199 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -129.83 130.09 44.85 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.581 1.152 . . . . 0.0 109.719 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -129.41 151.09 50.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.175 1.39 . . . . 0.0 110.092 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.3 tt -132.09 109.88 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.859 0.837 . . . . 0.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -83.26 101.45 11.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.08 2.152 . . . . 0.0 110.168 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -83.8 126.08 32.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.655 1.582 . . . . 0.0 109.828 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 tp -126.78 109.09 11.65 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.358 0.981 . . . . 0.0 110.925 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.39 19.81 7.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.913 1.685 . . . . 0.0 113.206 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.0 m -150.92 111.36 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.85 1.66 . . . . 0.0 111.588 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.1 -40.48 93.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.927 1.291 . . . . 0.0 113.142 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 127.337 2.255 . . . . 0.0 113.181 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 121.836 0.827 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.9 141.03 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.676 0.79 . . . . 0.0 111.484 169.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.6 139.38 56.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.071 0.548 . . . . 0.0 109.672 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -12.33 21.68 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.545 -1.347 . . . . 0.0 113.274 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.29 9.74 17.03 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.468 1.907 . . . . 0.0 113.353 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.61 176.66 9.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.717 1.607 . . . . 0.0 110.176 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.12 128.28 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.251 1.021 . . . . 0.0 109.256 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 150.4 20.39 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.819 -0.55 . . . . 0.0 110.142 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.24 127.95 16.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.988 1.315 . . . . 0.0 109.275 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -129.48 135.0 48.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.257 1.423 . . . . 0.0 110.223 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -78.34 44.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.828 2.051 . . . . 0.0 112.547 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.73 150.54 8.89 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 120.805 -1.184 . . . . 0.0 112.173 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.71 146.21 37.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.992 0.917 . . . . 0.0 111.917 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 51.42 40.92 27.74 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.9 m 59.15 64.33 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.639 1.575 . . . . 0.0 113.421 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.0 p -130.88 177.37 7.48 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.821 1.248 . . . . 0.0 111.981 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.74 -87.49 0.74 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.219 1.39 . . . . 0.0 113.59 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -135.98 165.64 25.2 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.584 1.553 . . . . 0.0 110.699 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.8 p -127.81 145.68 50.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.513 1.125 . . . . 0.0 112.032 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.31 162.48 40.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.275 1.83 . . . . 0.0 110.703 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -136.91 141.08 42.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.118 1.367 . . . . 0.0 109.193 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -120.68 138.51 53.91 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.093 1.757 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -76.79 143.07 40.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.065 1.746 . . . . 0.0 111.49 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -64.68 145.75 55.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.14 168.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.95 49.7 15.9 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.111 0.386 . . . . 0.0 112.64 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.45 159.37 43.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.59 1.156 . . . . 0.0 111.221 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -140.48 118.89 12.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.022 1.329 . . . . 0.0 109.432 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 m -127.12 147.38 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.125 0.97 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -136.36 134.93 38.37 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.579 1.152 . . . . 0.0 109.441 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.15 134.6 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.8 1.24 . . . . 0.0 108.967 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -146.84 138.65 24.48 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.341 1.057 . . . . 0.0 110.314 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -172.5 60.13 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.642 1.577 . . . . 0.0 112.27 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.49 39.42 59.93 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.86 74.43 0.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -42.88 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -98.33 -18.08 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.303 1.411 . . . . 0.0 114.803 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.25 -43.68 20.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.438 1.495 . . . . 0.0 111.349 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -77.37 52.3 0.93 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.442 1.497 . . . . 0.0 112.351 166.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.72 4.44 49.61 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.288 -1.508 . . . . 0.0 114.858 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 13.0 m-85 -78.16 137.22 38.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.117 0.967 . . . . 0.0 111.754 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.48 -62.09 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.511 1.924 . . . . 0.0 111.463 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -122.39 124.57 43.98 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.906 0.882 . . . . 0.0 109.582 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.45 156.06 44.54 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.252 1.025 . . . . 0.0 110.584 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.53 127.69 49.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.274 1.03 . . . . 0.0 108.418 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.6 t -106.53 107.79 23.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.46 1.504 . . . . 0.0 109.352 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.21 162.2 3.82 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 122.568 1.094 . . . . 0.0 113.703 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -13.88 61.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.3 34.23 4.22 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.396 1.478 . . . . 0.0 111.735 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.9 m -149.85 157.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.174 2.59 . . . . 0.0 110.296 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.5 149.22 46.62 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 110.285 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.5 m -116.09 133.97 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.521 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -122.4 117.02 25.03 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.469 1.107 . . . . 0.0 109.116 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.1 mt -111.37 114.35 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.351 1.461 . . . . 0.0 108.984 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.29 124.81 39.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.526 1.13 . . . . 0.0 108.025 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.7 -58.38 7.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.668 0.747 . . . . 0.0 111.615 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.89 179.92 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.971 0.909 . . . . 0.0 109.812 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -67.2 71.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.826 0.85 . . . . 0.0 111.174 164.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.19 -37.29 74.46 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.666 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.1 pt 42.28 30.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 71.45 22.58 4.15 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.707 2.003 . . . . 0.0 113.429 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 t -61.86 144.21 93.71 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.314 1.845 . . . . 0.0 111.221 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 34.99 0.33 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 124.531 3.488 . . . . 0.0 113.852 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -156.35 50.58 0.47 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.931 2.092 . . . . 0.0 111.939 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.71 135.49 38.75 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.46 1.44 . . . . 0.0 109.656 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.96 -92.62 0.49 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -142.82 159.85 41.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.637 1.575 . . . . 0.0 111.149 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -148.76 140.84 23.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.798 1.639 . . . . 0.0 109.514 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -153.5 147.59 25.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.144 0.974 . . . . 0.0 111.22 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -118.66 102.95 9.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.404 1.482 . . . . 0.0 109.047 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.39 96.47 1.89 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.352 1.061 . . . . 0.0 109.418 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.42 145.19 8.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.808 1.643 . . . . 0.0 113.234 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.51 147.26 18.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.55 1.54 . . . . 0.0 112.635 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.45 51.33 59.74 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.67 0.652 . . . . 0.0 114.104 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -149.94 170.73 18.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.531 1.132 . . . . 0.0 112.402 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.3 m -139.89 142.96 36.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.674 1.19 . . . . 0.0 109.876 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -132.89 106.87 7.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.527 1.131 . . . . 0.0 109.659 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.79 -28.82 22.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.062 1.345 . . . . 0.0 112.52 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.31 62.0 1.1 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.569 1.947 . . . . 0.0 110.75 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.55 14.04 0.86 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.73 -9.92 0.25 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.87 1.668 . . . . 0.0 115.203 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -45.5 -26.1 0.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.258 1.423 . . . . 0.0 114.606 158.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.273 2.7 tt -109.06 45.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.198 1.399 . . . . 0.0 112.724 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -49.55 -22.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.719 1.208 . . . . 0.0 113.729 165.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.24 84.57 1.55 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.975 0.797 . . . . 0.0 112.537 159.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.6 tp -125.33 141.92 51.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.141 1.376 . . . . 0.0 110.37 164.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -145.38 -32.82 0.37 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.395 1.478 . . . . 0.0 113.418 164.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -112.83 125.88 54.83 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.85 1.26 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 41' ' ' PHE . 4.1 t80 -123.85 134.49 53.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.649 0.78 . . . . 0.0 110.109 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -126.35 126.96 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.563 1.145 . . . . 0.0 108.357 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -104.41 120.63 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.7 mt -110.67 150.65 42.05 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.204 1.002 . . . . 0.0 109.953 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.51 168.56 19.65 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.353 2.035 . . . . 0.0 112.569 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.88 32.09 1.48 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.525 1.536 . . . . 0.0 114.9 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.78 -48.19 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.707 1.603 . . . . 0.0 111.703 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -82.99 136.75 34.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.046 0.938 . . . . 0.0 109.201 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -78.08 -32.67 50.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.531 -0.731 . . . . 0.0 111.69 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -155.48 167.92 28.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.73 2.012 . . . . 0.0 109.786 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.03 164.15 28.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.569 0.699 . . . . 0.0 111.166 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.51 141.21 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 109.025 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.7 129.62 34.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.58 148.27 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.727 0.811 . . . . 0.0 109.664 170.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -148.98 158.35 44.12 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.042 0.937 . . . . 0.0 110.193 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mt -111.91 130.63 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 110.78 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.744 0.817 . . . . 0.0 109.462 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.28 127.27 32.77 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.215 -0.928 . . . . 0.0 111.576 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -112.63 17.18 19.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.693 1.597 . . . . 0.0 111.757 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 64.6 t -126.6 -57.44 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.489 1.915 . . . . 0.0 110.654 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -153.95 138.76 17.09 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.139 1.376 . . . . 0.0 111.378 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 p -49.7 -58.38 5.42 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.749 1.62 . . . . 0.0 115.209 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.3 m 31.22 63.22 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.011 2.524 . . . . 0.0 113.5 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.34 -98.16 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -59.38 -18.03 41.71 Favored Glycine 0 CA--C 1.541 1.662 0 O-C-N 119.699 -1.876 . . . . 0.0 113.575 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.5 m -60.81 -20.82 62.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.4 1.88 . . . . 0.0 115.027 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.81 128.42 40.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 109.785 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.63 127.56 40.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.956 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.2 ttp -126.95 152.73 46.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.017 1.727 . . . . 0.0 110.358 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.4 m -137.55 131.01 31.09 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.59 133.07 68.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 p -133.12 86.49 42.1 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 109.68 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.16 112.29 2.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.051 1.834 . . . . 0.0 108.621 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.5 t80 40.19 54.67 2.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.567 1.947 . . . . 0.0 112.99 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.38 31.75 0.92 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.6 1.56 . . . . 0.0 114.956 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.32 133.21 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.059 2.143 . . . . 0.0 108.597 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 t70 38.23 71.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.45 1.9 . . . . 0.0 113.348 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 138.97 41.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.59 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.84 140.1 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.591 0.756 . . . . 0.0 110.168 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.39 140.11 40.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.224 1.01 . . . . 0.0 110.022 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.6 p -140.85 143.03 34.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 109.22 -174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -131.49 143.99 50.81 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.715 1.206 . . . . 0.0 109.307 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.31 90.85 0.1 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.106 0.955 . . . . 0.0 111.897 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.02 -22.02 0.99 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.162 -0.961 . . . . 0.0 113.216 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -60.75 150.99 30.71 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.492 1.146 . . . . 0.0 112.308 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.2 66.66 9.35 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.378 -0.826 . . . . 0.0 111.08 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 62.47 166.58 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.143 1.777 . . . . 0.0 112.569 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.37 138.42 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.548 1.539 . . . . 0.0 109.599 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.34 122.25 28.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.348 0.659 . . . . 0.0 110.223 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.55 110.76 56.35 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.274 1.43 . . . . 0.0 109.482 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.72 136.68 15.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.673 2.249 . . . . 0.0 110.675 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.0 mm -129.01 124.53 22.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 177.1 6.77 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.261 2.641 . . . . 0.0 112.075 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -65.08 141.55 58.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.786 . . . . 0.0 111.983 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.751 2.021 . . . . 0.0 109.483 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.8 m -126.24 135.32 26.99 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.741 1.216 . . . . 0.0 109.995 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.15 154.3 84.95 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.477 0.849 . . . . 0.0 112.488 -3.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.82 -27.19 67.51 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.931 1.754 . . . . 0.0 112.401 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -9.89 22.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.5 m -62.57 166.41 5.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.741 1.258 . . . . 0.0 113.315 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.69 153.24 26.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.686 1.194 . . . . 0.0 111.897 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.5 tt -119.42 131.29 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 128.224 2.61 . . . . 0.0 107.957 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.2 m -73.77 134.11 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.689 0.795 . . . . 0.0 109.788 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -135.74 131.27 35.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.288 0.635 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -96.59 147.42 23.89 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.728 -0.608 . . . . 0.0 109.974 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.99 132.46 40.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.36 1.464 . . . . 0.0 108.645 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -141.41 118.27 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.518 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.95 133.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.469 1.507 . . . . 0.0 109.943 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.84 149.77 39.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.03 1.732 . . . . 0.0 109.182 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 146.44 47.79 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 64.4 p -73.74 -4.01 31.92 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.062 -1.024 . . . . 0.0 113.45 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.94 155.14 43.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.401 2.281 . . . . 0.0 111.683 -177.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 151.5 28.13 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.615 1.166 . . . . 0.0 113.395 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.56 -2.15 17.2 Favored 'Cis proline' 0 C--N 1.354 0.849 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 3.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . 0.26 0.2 OUTLIER 39.41 37.76 0.31 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 115.411 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -82.47 46.65 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.128 0.971 . . . . 0.0 113.486 -164.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 40.73 74.43 0.1 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.78 2.032 . . . . 0.0 112.834 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -37.11 -51.88 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.25 1.82 . . . . 0.0 111.802 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.9 t -138.58 128.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -136.1 109.64 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.422 1.089 . . . . 0.0 108.254 171.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.76 -165.75 33.25 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.712 0.672 . . . . 0.0 112.275 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.8 m -136.78 163.95 29.42 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.094 -0.65 . . . . 0.0 110.816 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.12 150.73 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.228 1.411 . . . . 0.0 109.438 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.0 135.96 34.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.577 -0.702 . . . . 0.0 109.869 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -113.22 132.12 55.63 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.828 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -123.64 156.97 34.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.581 1.552 . . . . 0.0 109.073 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.261 0.937 . . . . 0.0 109.669 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.2 m -97.97 102.16 12.87 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 123.724 0.81 . . . . 0.0 109.074 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.37 -15.71 42.51 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.26 1.973 . . . . 0.0 113.288 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.6 m -47.8 -40.62 21.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.416 1.886 . . . . 0.0 112.767 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 33.4 p -144.81 20.46 1.64 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.867 1.267 . . . . 0.0 112.729 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.39 37.02 59.03 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.964 1.745 . . . . 0.0 115.276 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -80.88 179.17 7.96 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.652 0.739 . . . . 0.0 112.657 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.6 t -130.63 144.15 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.388 2.675 . . . . 0.0 107.713 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.3 m -134.79 123.16 23.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.297 2.239 . . . . 0.0 108.167 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.79 116.9 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.949 0.881 . . . . 0.0 111.312 -178.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.56 118.1 35.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.897 1.279 . . . . 0.0 108.526 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 142.56 51.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.31 1.844 . . . . 0.0 109.04 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -167.48 160.01 12.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.602 1.561 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.48 -20.07 4.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.042 1.737 . . . . 0.0 114.029 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.25 -29.09 57.37 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.141 1.776 . . . . 0.0 114.819 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.4 p -149.61 -43.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.397 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -96.44 137.37 21.56 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.842 1.257 . . . . 0.0 110.323 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.05 -171.52 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.84 -20.4 13.07 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.721 2.009 . . . . 0.0 114.474 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -67.65 -12.32 60.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.106 1.762 . . . . 0.0 113.159 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.4 ttm -131.36 145.77 51.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.645 1.578 . . . . 0.0 108.507 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.3 p -136.81 155.88 49.23 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.988 1.315 . . . . 0.0 109.042 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.36 125.9 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.939 -0.476 . . . . 0.0 109.82 -177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.4 m -117.11 130.32 56.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.462 1.105 . . . . 0.0 109.318 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -76.39 70.58 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.841 1.656 . . . . 0.0 111.093 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.22 -42.16 76.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.807 1.243 . . . . 0.0 113.553 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -147.93 177.9 8.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.885 2.074 . . . . 0.0 109.543 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -68.47 129.84 41.1 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.51 -1.369 . . . . 0.0 108.534 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 19.4 p 55.99 29.89 15.16 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.279 1.432 . . . . 0.0 114.316 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.8 m -135.28 123.87 23.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.556 1.142 . . . . 0.0 111.869 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -124.84 134.89 52.56 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.978 1.311 . . . . 0.0 110.406 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 14.1 mt -120.69 116.1 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -77.14 93.99 4.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.59 1.956 . . . . 0.0 109.971 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.76 121.54 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.451 1.101 . . . . 0.0 109.916 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.26 102.96 13.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.921 0.888 . . . . 0.0 109.795 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -83.7 -29.05 27.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.886 1.274 . . . . 0.0 113.343 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 58.4 m -159.54 133.25 7.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.153 2.181 . . . . 0.0 110.839 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.6 15.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 126.481 1.913 . . . . 0.0 113.944 -163.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.525 0.679 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.67 137.42 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.101 0.96 . . . . 0.0 110.73 168.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.64 146.22 40.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.443 0.697 . . . . 0.0 110.331 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.01 -17.44 17.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -112.97 12.19 19.25 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.115 2.566 . . . . 0.0 113.57 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -138.75 174.03 10.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.024 1.33 . . . . 0.0 110.256 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -140.0 148.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.088 0.955 . . . . 0.0 108.434 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -132.05 143.57 50.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.45 1.1 . . . . 0.0 110.873 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.31 137.31 49.89 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.461 1.504 . . . . 0.0 108.55 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.78 150.24 46.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.139 1.776 . . . . 0.0 109.38 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -115.1 92.52 3.96 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.051 1.34 . . . . 0.0 109.831 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.76 -62.06 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.948 161.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 161.51 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 130.382 3.473 . . . . 0.0 108.663 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 36.84 58.33 1.12 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 114.786 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m 52.26 63.85 2.08 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.069 1.748 . . . . 0.0 115.426 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.5 m -123.21 -41.48 2.31 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.73 -120.6 3.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.676 1.125 . . . . 0.0 112.752 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.93 165.95 22.26 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.558 1.179 . . . . 0.0 111.423 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.0 p -136.66 157.96 45.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.3 1.44 . . . . 0.0 111.903 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.08 131.25 15.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.296 1.838 . . . . 0.0 108.291 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -132.67 120.84 22.26 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.06 1.344 . . . . 0.0 108.8 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -147.19 138.55 23.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.987 1.375 . . . . 0.0 111.266 -169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -70.41 153.52 42.89 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.189 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -63.18 161.9 12.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.554 0.742 . . . . 0.0 112.074 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.42 45.74 76.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.496 0.569 . . . . 0.0 112.847 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -138.63 158.24 44.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.624 1.97 . . . . 0.0 111.247 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -134.68 117.83 16.48 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.347 1.059 . . . . 0.0 108.551 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 139.02 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 109.617 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -144.62 101.21 3.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.402 1.081 . . . . 0.0 108.514 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.1 124.34 30.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.735 0.814 . . . . 0.0 111.067 -171.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -152.54 165.93 33.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.364 1.466 . . . . 0.0 112.334 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -153.1 110.09 3.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.19 1.396 . . . . 0.0 108.889 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 51.86 34.73 38.09 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 125.338 1.447 . . . . 0.0 115.612 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.286 0.7 OUTLIER 48.42 40.81 15.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.673 1.989 . . . . 0.0 115.506 -170.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -135.15 -49.43 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -66.58 -20.76 66.08 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 122.408 2.367 . . . . 0.0 115.427 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -52.24 -28.81 20.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.625 1.102 . . . . 0.0 112.857 166.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 -0.95 4.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.142 0.977 . . . . 0.0 113.619 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.18 -39.73 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.416 1.487 . . . . 0.0 112.721 165.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -60.23 124.3 19.86 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 123.082 1.42 . . . . 0.0 111.782 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 tpt -149.56 -35.56 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.436 1.494 . . . . 0.0 113.349 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 p -141.03 125.06 17.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.124 0.874 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.11 159.2 42.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.423 1.106 . . . . 0.0 112.32 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.56 121.5 17.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.32 112.3 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 126.479 1.911 . . . . 0.0 108.108 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -32.61 -83.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.752 2.596 . . . . 0.0 116.742 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.633 1.973 . . . . 0.0 112.694 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -121.09 37.91 4.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 110.472 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -151.01 143.81 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 128.566 2.747 . . . . 0.0 109.028 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -119.5 148.83 42.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.951 1.7 . . . . 0.0 109.167 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.09 140.91 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.258 0.551 . . . . 0.0 109.833 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -131.92 131.07 42.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.435 1.094 . . . . 0.0 108.781 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.75 126.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 129.33 41.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.93 1.292 . . . . 0.0 109.458 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -54.76 -62.31 1.74 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 113.301 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.83 173.85 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.345 1.458 . . . . 0.0 109.785 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.98 139.85 39.06 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.5 -173.87 1.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 110.988 -170.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.06 39.19 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.834 1.654 . . . . 0.0 112.004 -173.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.326 43.0 m-20 56.38 48.43 17.02 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.102 1.761 . . . . 0.0 111.053 -167.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.36 153.52 19.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 112.626 -2.079 . . . . 0.0 109.968 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.53 26.43 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.677 3.584 . . . . 0.0 115.203 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 58.66 2.92 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.704 2.002 . . . . 0.0 110.636 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.51 145.62 59.17 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.579 1.52 . . . . 0.0 110.385 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 -129.58 0.51 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.084 1.326 . . . . 0.0 113.151 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.36 158.2 31.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 111.038 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -147.91 153.29 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.848 1.659 . . . . 0.0 109.765 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.4 163.1 35.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.882 0.873 . . . . 0.0 110.784 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -123.55 105.12 9.49 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.274 1.43 . . . . 0.0 110.494 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -74.18 102.08 4.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 109.611 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.95 148.84 24.57 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.766 1.627 . . . . 0.0 113.744 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.39 140.94 38.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.742 1.617 . . . . 0.0 113.108 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 55.61 29.17 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 125.007 1.289 . . . . 0.0 114.366 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -148.62 164.01 35.55 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -134.35 129.9 36.13 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.868 1.667 . . . . 0.0 108.513 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.2 130.84 50.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.626 1.571 . . . . 0.0 107.492 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -139.85 -8.36 1.22 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -140.92 68.02 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.415 1.886 . . . . 0.0 110.819 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.43 20.7 12.41 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.255 2.222 . . . . 0.0 112.237 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.24 -11.97 1.39 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.625 1.57 . . . . 0.0 114.077 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -19.75 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.401 -1.437 . . . . 0.0 114.138 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.98 34.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 126.821 2.048 . . . . 0.0 111.745 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -49.67 -28.98 6.61 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.367 -1.458 . . . . 0.0 113.418 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.54 71.71 1.04 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.046 1.308 . . . . 0.0 113.653 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.51 147.57 46.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.27 1.428 . . . . 0.0 109.481 164.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -147.91 -14.81 0.36 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 159.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -133.4 127.37 33.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.367 1.467 . . . . 0.0 109.564 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.09 124.24 36.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.814 1.246 . . . . 0.0 109.263 -166.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -117.09 115.86 26.2 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.449 1.499 . . . . 0.0 108.425 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 t -115.94 117.01 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.4 mt -128.44 151.83 77.28 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.978 0.911 . . . . 0.0 109.797 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.16 -178.85 3.48 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.072 2.515 . . . . 0.0 111.617 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.61 -23.02 71.2 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.167 -0.958 . . . . 0.0 113.855 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.25 74.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.117 0.967 . . . . 0.0 112.417 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -91.67 149.21 21.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.89 1.276 . . . . 0.0 109.484 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.81 -31.88 4.4 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.577 -1.327 . . . . 0.0 113.181 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.73 148.43 31.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.667 1.587 . . . . 0.0 108.19 167.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -119.19 154.94 32.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.766 0.793 . . . . 0.0 110.077 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.06 150.01 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.392 1.477 . . . . 0.0 109.433 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.62 126.99 51.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.51 136.05 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.7 -0.625 . . . . 0.0 110.206 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -140.71 134.09 29.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.931 0.492 . . . . 0.0 111.387 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.8 mt -85.38 146.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.495 1.518 . . . . 0.0 109.481 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.3 t -135.9 102.56 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.135 1.774 . . . . 0.0 109.118 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -58.16 119.94 7.73 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.054 0.942 . . . . 0.0 111.662 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -112.65 -35.6 5.46 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.016 0.926 . . . . 0.0 111.646 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -91.12 -36.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.373 1.069 . . . . 0.0 113.76 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' THR . 63.4 m-20 -91.58 91.66 8.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.595 1.158 . . . . 0.0 109.924 178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 65.3 p -64.33 17.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' ASN . 94.5 m -133.94 80.95 1.89 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.394 2.678 . . . . 0.0 109.074 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.58 130.69 47.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.072 0.949 . . . . 0.0 111.811 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.87 -38.44 2.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.283 1.42 . . . . 0.0 113.537 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.4 m -71.47 -27.58 63.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.613 1.165 . . . . 0.0 112.946 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -75.85 126.97 32.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.631 1.172 . . . . 0.0 109.847 171.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -129.23 141.71 51.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.765 1.626 . . . . 0.0 109.43 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -135.85 138.77 42.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.962 0.905 . . . . 0.0 110.146 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -123.61 138.49 54.54 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.411 1.484 . . . . 0.0 107.793 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.8 145.63 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.619 0.767 . . . . 0.0 110.682 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 t -144.73 94.91 5.4 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 111.294 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.27 165.84 23.24 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.828 2.352 . . . . 0.0 112.164 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -29.67 94.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 128.092 2.557 . . . . 0.0 114.17 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 47.72 37.93 7.73 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.68 1.592 . . . . 0.0 114.867 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.0 t -93.65 155.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.946 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.64 98.85 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.335 . . . . 0.0 111.195 170.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.85 151.33 18.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.743 -0.598 . . . . 0.0 112.084 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.35 131.22 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.102 0.561 . . . . 0.0 110.219 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.23 33.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.326 0.65 . . . . 0.0 109.477 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.66 142.18 51.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.808 1.243 . . . . 0.0 108.371 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -127.5 137.66 52.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 108.2 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.48 108.99 0.54 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.468 0.707 . . . . 0.0 111.326 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.95 -25.69 4.91 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 113.791 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.75 146.27 55.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.892 1.346 . . . . 0.0 110.871 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.61 167.88 14.18 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.637 -0.664 . . . . 0.0 111.376 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -47.0 105.05 0.06 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.848 1.259 . . . . 0.0 112.78 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.01 126.29 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.506 1.122 . . . . 0.0 109.126 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.12 124.17 22.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.961 0.41 . . . . 0.0 109.949 176.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.81 96.43 49.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.557 1.943 . . . . 0.0 107.112 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -74.37 143.49 31.41 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.473 2.115 . . . . 0.0 112.733 175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.7 mm -122.06 133.78 24.47 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.794 1.637 . . . . 0.0 108.565 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.47 170.44 12.29 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 112.752 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -49.82 138.68 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.669 . . . . 0.0 112.716 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.17 122.71 9.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.649 0.779 . . . . 0.0 110.532 -174.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.4 t -134.6 131.66 20.38 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 110.9 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.85 152.98 83.67 Favored 'Cis proline' 0 CA--C 1.548 1.204 0 CA-C-N 119.345 0.802 . . . . 0.0 112.148 -6.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.36 -37.48 81.64 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.709 2.273 . . . . 0.0 112.089 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -7.15 8.65 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.053 1.741 . . . . 0.0 114.414 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.3 t -74.6 -179.42 4.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.136 -0.978 . . . . 0.0 112.347 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -130.5 154.52 47.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.975 1.31 . . . . 0.0 112.826 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.49 130.6 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.541 1.936 . . . . 0.0 109.854 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.23 141.29 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.96 0.904 . . . . 0.0 111.017 172.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 t -148.29 158.7 44.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.211 1.404 . . . . 0.0 110.764 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.55 136.45 53.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.31 1.044 . . . . 0.0 109.216 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.34 126.31 46.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.186 1.794 . . . . 0.0 108.367 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 p -133.46 131.15 39.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.78 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.29 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.607 1.563 . . . . 0.0 107.02 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -143.71 151.59 40.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.729 1.612 . . . . 0.0 109.336 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -85.53 142.67 29.0 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.816 -0.552 . . . . 0.0 111.524 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.9 p -85.85 7.57 23.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.912 1.685 . . . . 0.0 112.926 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.94 16.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.31 1.844 . . . . 0.0 110.733 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -51.41 139.47 27.15 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.923 1.289 . . . . 0.0 113.442 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.94 11.74 19.29 Favored 'Cis proline' 0 CA--C 1.549 1.229 0 N-CA-C 114.904 1.078 . . . . 0.0 114.904 4.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.67 15.33 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.664 1.986 . . . . 0.0 114.149 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.76 164.64 19.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.19 1.396 . . . . 0.0 112.469 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -68.98 154.59 41.8 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.812 0.815 . . . . 0.0 112.121 171.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.3 -38.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.786 1.634 . . . . 0.0 110.339 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.3 t -146.06 140.92 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -144.35 105.79 4.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.432 1.493 . . . . 0.0 108.579 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.11 -179.98 38.65 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.466 -0.771 . . . . 0.0 114.487 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.5 p -113.21 136.1 53.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.703 1.201 . . . . 0.0 112.004 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.35 150.04 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.974 2.11 . . . . 0.0 107.722 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -124.52 135.47 53.21 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.1 149.54 30.69 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.458 -0.776 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -138.26 153.68 49.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.837 2.055 . . . . 0.0 108.654 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -115.7 164.65 14.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.197 0.999 . . . . 0.0 109.719 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -136.46 105.29 9.24 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.342 1.057 . . . . 0.0 109.582 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -67.8 -14.96 43.13 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.53 2.82 . . . . 0.0 113.262 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.0 m -45.5 -46.54 13.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.49 2.316 . . . . 0.0 113.171 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 65.1 p -145.21 11.03 1.32 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.734 1.214 . . . . 0.0 113.14 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 69.29 42.71 73.99 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.199 -1.563 . . . . 0.0 112.768 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -83.52 156.67 22.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.897 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -112.36 155.12 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.739 0.815 . . . . 0.0 110.274 165.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.6 m -143.63 114.95 7.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.696 1.199 . . . . 0.0 108.571 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.32 146.81 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.142 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.58 132.62 66.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.565 1.946 . . . . 0.0 107.56 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 138.66 32.65 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.198 1.399 . . . . 0.0 108.661 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -127.82 144.36 51.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.151 1.38 . . . . 0.0 108.539 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.49 -18.81 20.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.78 -33.6 16.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.46 1.504 . . . . 0.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.2 p -98.83 -53.05 3.39 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.77 1.228 . . . . 0.0 110.888 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -85.79 148.29 48.2 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.419 1.488 . . . . 0.0 109.997 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.08 175.17 11.24 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.386 2.058 . . . . 0.0 111.672 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 8.71 44.58 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.945 1.298 . . . . 0.0 113.147 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.97 -37.52 10.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.355 1.462 . . . . 0.0 111.707 -164.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 146.45 40.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 128.76 2.824 . . . . 0.0 106.953 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.3 p -139.91 153.17 46.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.565 0.746 . . . . 0.0 110.896 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.93 137.6 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.501 0.72 . . . . 0.0 110.27 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 33.4 m -120.72 140.76 51.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.806 1.642 . . . . 0.0 109.39 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -68.59 91.2 0.41 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.985 1.314 . . . . 0.0 110.635 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -75.27 -48.97 20.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 122.215 -0.303 . . . . 0.0 110.934 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.97 -178.59 5.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.631 1.572 . . . . 0.0 112.121 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -58.78 -34.54 71.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.138 1.375 . . . . 0.0 114.607 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.6 p -138.0 25.16 2.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.985 1.714 . . . . 0.0 112.158 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 t -125.26 136.22 53.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.083 0.953 . . . . 0.0 111.255 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.5 133.3 52.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.178 1.391 . . . . 0.0 110.637 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.7 tt -115.97 112.35 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.154 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.94 125.62 39.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.842 2.457 . . . . 0.0 108.231 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -125.27 129.96 51.09 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.14 1.376 . . . . 0.0 111.319 -172.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.6 tt -121.87 114.9 21.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.889 0.876 . . . . 0.0 111.608 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -123.14 7.4 9.17 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.888 1.675 . . . . 0.0 113.938 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.67 -8.69 13.78 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 40.96 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 129.363 3.065 . . . . 0.0 118.67 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 -172.772 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.372 0.606 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -56.93 152.21 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.172 0.589 . . . . 0.0 111.565 167.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.1 142.73 57.68 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.251 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -19.39 51.04 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.28 9.12 23.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.639 1.976 . . . . 0.0 113.255 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -136.83 -178.31 5.13 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 120.485 1.493 . . . . 0.0 110.81 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.69 148.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.675 1.19 . . . . 0.0 110.653 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 142.52 49.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.471 1.108 . . . . 0.0 109.404 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -135.55 127.9 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.149 1.38 . . . . 0.0 108.51 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -133.54 130.78 38.93 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.506 1.122 . . . . 0.0 110.601 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.44 56.88 4.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.792 1.237 . . . . 0.0 111.274 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.43 140.24 3.62 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.922 0.772 . . . . 0.0 111.183 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -58.23 139.16 55.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.459 0.703 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 70.55 37.62 1.44 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 125.376 1.47 . . . . 0.0 113.808 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.9 m 54.14 64.12 1.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.331 1.852 . . . . 0.0 113.673 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.9 p -132.45 179.24 6.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.969 1.307 . . . . 0.0 112.755 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.97 -81.27 1.17 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.877 1.703 . . . . 0.0 114.71 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -138.53 166.73 23.55 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.053 1.741 . . . . 0.0 110.019 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -130.94 152.78 49.88 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.759 1.224 . . . . 0.0 112.758 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -160.68 162.76 32.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.373 1.469 . . . . 0.0 111.304 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -134.67 140.93 46.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.925 1.29 . . . . 0.0 110.812 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -124.87 141.19 52.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.851 1.661 . . . . 0.0 110.119 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -88.84 143.72 26.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.515 0.726 . . . . 0.0 111.444 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.26 150.68 38.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.06 1.344 . . . . 0.0 111.7 170.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.51 58.17 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.113 1.339 . . . . 0.0 113.438 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -137.77 159.09 42.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.942 1.697 . . . . 0.0 111.356 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.4 m -117.93 128.97 55.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.993 1.317 . . . . 0.0 108.86 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.89 114.85 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.747 1.219 . . . . 0.0 109.432 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.47 145.83 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.746 1.218 . . . . 0.0 111.074 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.4 ' CE2' ' HE3' ' A' ' 40' ' ' LYS . 63.1 m-85 -131.89 176.25 8.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.243 1.417 . . . . 0.0 110.09 168.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.69 167.18 2.18 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.696 1.199 . . . . 0.0 111.48 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -118.07 25.46 10.32 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.827 -1.17 . . . . 0.0 112.484 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.76 11.72 69.49 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 126.099 1.809 . . . . 0.0 115.918 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.81 63.63 1.53 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -160.17 -44.39 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -122.03 -26.54 4.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.379 1.072 . . . . 0.0 112.746 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -62.15 -42.26 99.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.492 1.517 . . . . 0.0 111.813 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.46 34.93 0.14 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.029 1.731 . . . . 0.0 113.047 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -78.27 -20.28 51.93 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 118.902 -2.374 . . . . 0.0 114.596 177.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.87 145.52 35.05 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.814 0.816 . . . . 0.0 111.706 176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 ttt -155.7 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.1 p -134.56 132.56 39.26 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.613 1.097 . . . . 0.0 110.697 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.2 m -143.45 152.47 41.56 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 108.041 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.44 145.67 47.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.511 1.148 . . . . 0.0 112.273 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.73 120.18 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.354 2.661 . . . . 0.0 108.843 -170.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.66 -86.2 0.01 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -168.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 t -164.13 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.99 0.916 . . . . 0.0 111.792 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.76 32.67 5.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.846 1.258 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.55 164.07 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 110.276 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -144.43 154.12 42.63 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.742 2.017 . . . . 0.0 110.067 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -124.96 134.56 52.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.85 0.86 . . . . 0.0 110.806 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.19 118.33 31.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.89 1.276 . . . . 0.0 109.492 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.0 mm -110.1 106.49 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.294 1.038 . . . . 0.0 108.998 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.94 117.79 24.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.005 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.09 -45.46 81.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 122.205 1.003 . . . . 0.0 112.479 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 167.77 29.25 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.091 1.756 . . . . 0.0 109.923 -169.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -108.91 48.93 0.84 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.439 0.696 . . . . 0.0 110.537 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.75 160.68 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.505 1.922 . . . . 0.0 114.686 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.68 52.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.433 -1.417 . . . . 0.0 110.684 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 71.68 36.35 1.26 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.704 2.402 . . . . 0.0 111.58 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 p -67.46 155.96 89.72 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.789 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.79 32.35 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.33 3.353 . . . . 0.0 113.38 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -151.16 99.64 3.05 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 109.995 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 118.06 5.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.688 1.592 . . . . 0.0 108.965 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.89 -120.87 0.1 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.49 144.05 44.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 112.52 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -161.82 132.45 5.03 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 110.226 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -143.22 163.1 33.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.599 1.159 . . . . 0.0 110.665 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.02 107.68 9.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.364 1.466 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -84.05 95.55 8.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.815 0.846 . . . . 0.0 108.941 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.24 150.53 3.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 113.044 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -66.61 145.95 55.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.829 0.452 . . . . 0.0 112.177 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.5 64.58 3.94 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.452 1.025 . . . . 0.0 115.413 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -153.02 177.2 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.147 0.979 . . . . 0.0 112.868 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.8 m -130.7 142.43 50.42 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.182 1.393 . . . . 0.0 110.241 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.82 134.55 44.81 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.962 1.305 . . . . 0.0 109.884 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.2 -33.02 1.15 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 123.579 0.752 . . . . 0.0 112.489 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -118.06 40.34 3.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.053 1.406 . . . . 0.0 110.965 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.35 -16.35 62.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.385 1.074 . . . . 0.0 113.213 172.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -61.58 -11.47 11.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.269 1.427 . . . . 0.0 113.184 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.5 t -47.35 -36.74 9.96 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.82 -1.175 . . . . 0.0 113.127 167.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 tt -81.0 -35.17 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.84 42.22 11.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.998 2.119 . . . . 0.0 113.811 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.05 67.31 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.297 0.951 . . . . 0.0 113.022 -161.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.1 tp -131.61 115.35 15.97 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.722 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.4 m -120.9 -20.6 6.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.481 1.113 . . . . 0.0 112.891 167.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -127.52 122.37 33.15 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.078 0.951 . . . . 0.0 110.189 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.35 137.11 44.91 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.232 1.013 . . . . 0.0 109.084 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.06 136.11 55.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.95 118.55 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -131.41 146.94 64.14 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.967 0.907 . . . . 0.0 109.359 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.71 165.77 24.47 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.114 2.543 . . . . 0.0 112.308 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.73 -14.3 36.04 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 124.358 0.98 . . . . 0.0 114.828 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.06 -28.07 63.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.134 1.374 . . . . 0.0 113.946 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -123.49 102.93 8.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.693 1.597 . . . . 0.0 109.535 -166.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.9 -27.89 26.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.43 -1.419 . . . . 0.0 113.513 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.24 145.18 24.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.489 2.315 . . . . 0.0 106.856 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.43 165.71 24.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.782 0.801 . . . . 0.0 111.054 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 151.13 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.858 1.263 . . . . 0.0 109.261 -173.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.86 125.33 44.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.63 138.2 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.978 0.894 . . . . 0.0 110.729 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.09 118.07 15.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.547 1.539 . . . . 0.0 108.54 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 149.01 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 122.894 0.478 . . . . 0.0 109.822 165.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.96 129.49 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.29 121.72 34.07 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.017 -0.427 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -26.13 6.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.764 1.626 . . . . 0.0 113.142 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.12 -35.68 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.897 0.879 . . . . 0.0 113.266 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -108.91 -179.59 3.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.085 1.354 . . . . 0.0 109.735 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.8 t -120.93 -39.54 2.71 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.504 1.122 . . . . 0.0 111.826 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.7 m -60.19 -39.73 87.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.103 0.961 . . . . 0.0 112.204 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.16 -179.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.246 1.818 . . . . 0.0 114.789 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.98 -25.68 0.8 Allowed Glycine 0 N--CA 1.478 1.476 0 O-C-N 120.071 -1.643 . . . . 0.0 115.55 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 m -53.36 -35.5 60.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.13 1.372 . . . . 0.0 111.906 163.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -90.45 131.37 36.25 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.238 1.815 . . . . 0.0 110.466 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.52 130.35 42.22 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.871 1.269 . . . . 0.0 111.229 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -92.86 135.58 34.01 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.916 1.686 . . . . 0.0 110.092 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -133.91 97.4 3.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.912 1.685 . . . . 0.0 108.304 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.2 mm -94.22 132.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -131.61 92.96 29.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.99 171.99 12.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.475 . . . . 0.0 112.328 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -35.37 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.0 2.52 . . . . 0.0 114.969 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 41.53 59.23 2.48 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.888 1.675 . . . . 0.0 114.486 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.93 157.95 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.171 1.788 . . . . 0.0 111.593 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -40.54 115.35 0.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.859 1.663 . . . . 0.0 111.85 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 136.16 51.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.95 151.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.668 0.787 . . . . 0.0 109.339 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.3 132.89 41.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.204 1.001 . . . . 0.0 110.383 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.3 t -133.52 119.25 19.28 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.644 1.178 . . . . 0.0 108.936 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -114.81 121.87 44.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.578 1.551 . . . . 0.0 108.301 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t0 55.54 -175.86 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.862 0.839 . . . . 0.0 113.054 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.65 30.64 1.24 Allowed Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.173 1.368 . . . . 0.0 113.587 161.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -56.56 175.55 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.998 1.399 . . . . 0.0 111.389 166.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -44.84 122.15 3.09 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.892 -1.13 . . . . 0.0 111.731 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -53.25 159.48 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.142 0.977 . . . . 0.0 112.416 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.41 135.24 54.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.766 0.793 . . . . 0.0 110.279 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -75.55 142.7 42.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.18 91.15 48.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 125.465 1.506 . . . . 0.0 109.345 -178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.05 144.18 46.55 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.196 1.931 . . . . 0.0 111.464 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 46.3 mm -128.17 135.4 27.47 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.718 1.607 . . . . 0.0 108.522 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.21 177.39 8.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.033 3.156 . . . . 0.0 112.306 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.08 141.81 57.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.395 0.678 . . . . 0.0 111.791 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.46 147.33 7.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.981 1.712 . . . . 0.0 110.314 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 98.8 m -147.48 135.33 10.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.087 0.955 . . . . 0.0 109.71 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.08 153.23 87.89 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.422 0.829 . . . . 0.0 112.722 -5.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.18 -36.58 68.31 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.182 1.921 . . . . 0.0 112.158 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.25 -16.48 60.37 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.81 128.68 36.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 110.857 170.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 162.37 25.49 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 112.723 171.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.9 151.75 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.871 1.668 . . . . 0.0 109.098 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.53 118.41 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.565 0.746 . . . . 0.0 110.821 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.4 m -130.42 150.52 51.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.4 1.08 . . . . 0.0 111.609 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.25 123.21 48.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.93 0.892 . . . . 0.0 108.602 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.09 113.85 26.27 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.04 1.336 . . . . 0.0 107.758 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.63 145.31 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 11.2 t -135.36 130.7 51.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -145.07 153.88 41.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.968 1.307 . . . . 0.0 109.331 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 143.24 54.71 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.941 168.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.4 p -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.245 1.418 . . . . 0.0 113.946 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -141.6 161.06 38.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.751 2.021 . . . . 0.0 110.89 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -66.37 139.36 96.21 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 127.43 12.13 Favored 'Cis proline' 0 C--N 1.353 0.8 0 CA-C-N 120.331 1.154 . . . . 0.0 111.443 -6.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -74.22 49.91 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.713 1.605 . . . . 0.0 111.13 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.86 131.81 52.03 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.286 -1.509 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.06 90.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.174 0.589 . . . . 0.0 109.839 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.2 t -42.47 -52.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.782 2.033 . . . . 0.0 111.087 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.8 p -159.47 152.51 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.917 -0.489 . . . . 0.0 111.838 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.87 102.87 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.845 1.658 . . . . 0.0 108.385 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.01 -174.36 13.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.928 1.728 . . . . 0.0 111.863 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.4 m -132.88 150.34 52.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.458 1.103 . . . . 0.0 110.906 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.46 163.5 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 126.314 1.846 . . . . 0.0 108.507 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -129.49 136.38 49.81 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.927 0.491 . . . . 0.0 109.867 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.28 137.05 52.45 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.659 1.184 . . . . 0.0 107.983 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 160.13 38.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.269 1.428 . . . . 0.0 110.154 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 114.38 18.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.996 0.816 . . . . 0.0 110.253 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 m -76.46 118.2 69.8 Favored Pre-proline 0 N--CA 1.476 0.843 0 O-C-N 120.359 -1.463 . . . . 0.0 109.95 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.36 -19.36 55.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.59 2.193 . . . . 0.0 113.957 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.2 m -52.7 -50.27 63.68 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.902 2.081 . . . . 0.0 114.3 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.3 p -136.11 18.26 3.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.578 1.551 . . . . 0.0 111.803 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.76 41.14 97.75 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.095 0.855 . . . . 0.0 114.135 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -72.67 164.04 27.13 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.716 -1.461 . . . . 0.0 111.982 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 135.83 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.8 m -131.77 135.08 46.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.401 1.08 . . . . 0.0 108.298 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.27 135.75 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.9 0.857 . . . . 0.0 110.743 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.33 134.84 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.601 1.961 . . . . 0.0 106.721 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 133.76 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.789 1.235 . . . . 0.0 108.061 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.27 150.32 39.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.153 1.381 . . . . 0.0 108.882 -166.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -57.41 -23.42 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.74 -31.66 20.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.832 1.253 . . . . 0.0 113.6 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.2 p -96.34 -49.92 4.99 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.378 1.071 . . . . 0.0 110.199 -170.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.91 148.3 97.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 110.016 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.87 -95.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.118 1.879 . . . . 0.0 111.003 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 164.39 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 128.103 2.561 . . . . 0.0 112.942 -171.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -61.21 -43.76 98.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.643 1.177 . . . . 0.0 112.515 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.7 149.31 25.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.856 1.662 . . . . 0.0 109.57 170.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -134.94 133.82 39.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.29 1.036 . . . . 0.0 110.286 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.02 130.82 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.634 0.774 . . . . 0.0 109.665 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.2 m -128.86 131.13 47.64 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.187 1.395 . . . . 0.0 108.9 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.06 94.21 1.48 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 0.0 110.342 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.59 -46.88 35.72 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.06 0.544 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -145.45 -172.6 3.92 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.475 1.91 . . . . 0.0 111.221 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -51.38 -49.41 61.59 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.708 -1.245 . . . . 0.0 113.242 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.6 p -128.24 32.51 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 110.823 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.1 t -137.37 127.96 26.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.241 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -125.07 137.09 54.21 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.011 1.324 . . . . 0.0 109.707 -174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.31 128.16 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.977 0.894 . . . . 0.0 109.007 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -115.69 94.51 4.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.433 1.893 . . . . 0.0 107.377 -165.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -85.79 121.4 28.39 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.775 -0.578 . . . . 0.0 110.186 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.78 101.5 11.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 111.836 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.79 10.13 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.597 1.159 . . . . 0.0 112.675 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.68 157.07 34.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.423 1.489 . . . . 0.0 112.834 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.63 -4.56 59.06 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 126.121 1.769 . . . . 0.0 112.184 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.755 0.788 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.6 126.16 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.427 166.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.25 142.73 58.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -18.86 10.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.726 1.148 . . . . 0.0 113.623 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -113.35 15.72 19.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.95 2.1 . . . . 0.0 112.753 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -139.5 166.49 24.42 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.188 -1.57 . . . . 0.0 109.725 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.15 159.78 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.383 0.611 . . . . 0.0 110.037 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.87 161.31 39.63 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.842 0.857 . . . . 0.0 111.301 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -128.11 145.85 50.88 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.337 1.455 . . . . 0.0 109.311 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.44 114.07 14.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.77 2.028 . . . . 0.0 110.618 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.38 77.01 6.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 109.189 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.59 -87.97 0.07 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.832 -0.982 . . . . 0.0 112.844 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.15 124.15 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 129.738 3.215 . . . . 0.0 109.512 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 63.78 44.05 5.18 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.541 1.136 . . . . 0.0 114.028 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m 68.02 58.09 0.48 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.383 2.273 . . . . 0.0 113.961 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -141.73 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.896 1.678 . . . . 0.0 112.002 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.28 -121.09 12.72 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.366 0.984 . . . . 0.0 111.686 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.97 166.26 15.23 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.119 0.959 . . . . 0.0 111.361 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -132.12 154.18 49.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.056 1.342 . . . . 0.0 111.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.81 141.61 22.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.509 1.524 . . . . 0.0 109.513 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -117.44 135.32 53.98 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.076 0.95 . . . . 0.0 110.042 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -131.84 139.1 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.353 1.461 . . . . 0.0 109.946 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.8 150.45 24.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.609 -0.682 . . . . 0.0 111.284 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.28 162.63 29.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.941 0.896 . . . . 0.0 111.43 170.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.54 33.31 40.51 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.636 0.636 . . . . 0.0 113.906 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -134.06 148.11 51.0 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.267 1.427 . . . . 0.0 110.625 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -105.96 132.8 51.62 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.426 1.49 . . . . 0.0 108.31 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.8 126.02 69.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.247 1.019 . . . . 0.0 109.247 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 150.16 28.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.81 1.644 . . . . 0.0 110.379 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.82 162.25 29.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.577 1.551 . . . . 0.0 110.201 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.26 127.38 8.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.451 1.9 . . . . 0.0 113.899 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.68 -6.25 30.36 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.7 -7.78 23.49 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 125.292 1.425 . . . . 0.0 115.692 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.93 24.01 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.806 1.642 . . . . 0.0 115.17 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -48.2 39.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.538 1.135 . . . . 0.0 112.674 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.32 29.12 0.06 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.263 1.825 . . . . 0.0 111.804 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -65.05 -41.84 94.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 0.0 113.773 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -66.76 -94.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 108.119 158.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 29.3 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 127.238 2.215 . . . . 0.0 116.178 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.14 147.15 50.26 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 128.728 2.811 . . . . 0.0 110.058 176.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.8 tpt -151.56 -53.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.339 1.055 . . . . 0.0 111.947 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -137.11 131.15 32.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 125.322 1.449 . . . . 0.0 109.433 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.63 155.57 44.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.65 1.18 . . . . 0.0 109.583 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.9 117.2 18.93 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.137 0.975 . . . . 0.0 108.61 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.84 117.26 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.997 1.719 . . . . 0.0 108.547 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -41.02 -95.77 0.01 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 127.472 2.463 . . . . 0.0 117.519 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 t -162.19 -40.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.476 1.111 . . . . 0.0 111.908 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.61 35.84 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.656 1.582 . . . . 0.0 110.355 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.76 135.91 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.435 1.494 . . . . 0.0 109.245 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.98 153.73 25.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 109.5 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.63 142.39 47.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.199 1.0 . . . . 0.0 109.392 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.74 127.98 39.86 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.561 1.544 . . . . 0.0 107.412 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 pt -121.6 125.57 73.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.453 0.644 . . . . 0.0 109.707 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -140.05 100.03 3.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.933 1.349 . . . . 0.0 111.201 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.53 104.85 2.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.44 1.496 . . . . 0.0 111.303 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.46 154.11 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.327 1.537 . . . . 0.0 114.25 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -92.06 139.67 30.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.781 -1.199 . . . . 0.0 112.24 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.34 179.73 8.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.626 1.171 . . . . 0.0 111.597 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.83 44.0 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 126.022 1.729 . . . . 0.0 111.328 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 59.86 47.5 10.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.97 1.708 . . . . 0.0 112.332 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 p -79.36 179.78 1.69 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.719 2.008 . . . . 0.0 111.007 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -70.45 12.08 0.42 Allowed 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.871 2.38 . . . . 0.0 114.397 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -145.18 65.99 12.22 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.597 1.559 . . . . 0.0 110.997 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.61 132.86 32.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.246 1.298 . . . . 0.0 109.359 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.41 164.35 11.28 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.215 171.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -57.55 109.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.385 0.674 . . . . 0.0 110.663 163.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -111.67 139.01 47.47 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.928 1.691 . . . . 0.0 109.259 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -160.77 158.75 29.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.06 0.933 . . . . 0.0 111.361 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.47 95.83 5.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.456 1.502 . . . . 0.0 109.613 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.07 108.15 1.75 Allowed 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.37 -0.831 . . . . 0.0 109.476 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.73 143.1 10.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.982 1.713 . . . . 0.0 113.209 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.39 138.11 57.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.872 0.869 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.41 73.32 0.49 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.436 1.493 . . . . 0.0 116.097 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.98 177.43 8.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.6 m -122.22 135.42 54.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.382 1.073 . . . . 0.0 109.402 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -115.26 134.82 54.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.467 1.507 . . . . 0.0 107.671 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -144.64 5.89 1.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.61 33.26 0.41 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.142 1.377 . . . . 0.0 111.595 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.59 -4.23 57.35 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.083 -1.011 . . . . 0.0 113.72 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.39 -13.13 26.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.13 0.972 . . . . 0.0 113.617 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.0 m -50.73 -32.79 20.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.901 1.681 . . . . 0.0 114.072 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -30.83 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.418 0.687 . . . . 0.0 112.254 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.6 t30 35.89 43.42 0.19 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.579 2.752 . . . . 0.0 115.456 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.42 95.12 0.12 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.884 1.23 . . . . 0.0 111.685 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.25 155.71 46.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.833 2.053 . . . . 0.0 109.287 170.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 m -157.1 -32.68 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.388 1.075 . . . . 0.0 112.458 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -119.28 138.65 52.87 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.05 1.34 . . . . 0.0 109.822 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -130.44 129.68 43.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.13 1.372 . . . . 0.0 107.981 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -129.52 117.7 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.88 131.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.81 148.78 38.02 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.401 1.08 . . . . 0.0 109.675 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' CG ' ' CD2' ' A' ' 96' ' ' PHE . 77.8 Cg_endo -77.67 15.76 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.527 3.485 . . . . 0.0 112.907 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.18 -35.66 0.42 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.846 2.641 . . . . 0.0 116.042 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -34.21 73.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.987 1.715 . . . . 0.0 112.588 168.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.431 ' CD2' ' CG ' ' A' ' 93' ' ' PRO . 11.0 m-85 -92.54 138.2 31.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 110.325 174.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -79.35 -35.06 41.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.022 0.929 . . . . 0.0 111.74 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -158.58 170.75 21.49 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 109.756 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.65 165.15 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.042 0.937 . . . . 0.0 110.673 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.88 149.24 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.436 1.095 . . . . 0.0 109.928 -171.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -99.98 122.45 42.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.04 137.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.441 0.697 . . . . 0.0 110.456 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -138.53 155.36 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.174 1.39 . . . . 0.0 110.091 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.7 mt -124.06 135.67 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -176.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.46 121.74 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -85.04 118.72 24.78 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -102.91 -8.95 20.28 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.3 t -108.72 -57.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.952 0.901 . . . . 0.0 112.216 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.78 -33.49 76.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.024 0.53 . . . . 0.0 110.505 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.97 17.97 3.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.712 2.005 . . . . 0.0 114.381 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -103.02 -47.14 4.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 111.521 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 57.07 153.48 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.226 2.21 . . . . 0.0 116.072 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.37 58.93 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.834 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.7 p -90.43 -61.8 1.6 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.05 1.34 . . . . 0.0 112.203 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -47.23 108.39 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.254 2.222 . . . . 0.0 111.326 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.64 124.34 47.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.326 1.05 . . . . 0.0 109.209 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -114.19 141.15 47.9 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.591 1.156 . . . . 0.0 109.255 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.9 m -132.03 137.38 47.8 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.344 1.458 . . . . 0.0 107.855 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.2 pt -133.72 145.15 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 123.618 0.767 . . . . 0.0 111.123 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.0 m -135.61 95.68 14.08 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 108.916 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 75.49 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.291 3.328 . . . . 0.0 111.583 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.9 t80 60.18 81.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.967 2.107 . . . . 0.0 112.041 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 42.93 46.28 4.6 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.911 1.684 . . . . 0.0 115.084 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.92 168.6 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.322 2.249 . . . . 0.0 109.848 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -36.44 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.991 2.517 . . . . 0.0 113.7 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 145.31 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.241 1.016 . . . . 0.0 110.396 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 139.18 50.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 109.395 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.3 133.56 55.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.295 -1.32 . . . . 0.0 108.78 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 22.4 p -135.19 150.45 50.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.339 1.066 . . . . 0.0 110.431 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -102.61 144.08 31.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.753 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.59 27.43 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.128 2.171 . . . . 0.0 115.922 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.51 2.39 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.422 1.963 . . . . 0.0 114.089 -173.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.54 174.92 10.08 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.671 1.988 . . . . 0.0 110.11 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -56.57 158.99 4.05 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.887 -1.133 . . . . 0.0 112.468 163.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -51.96 153.66 2.51 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.72 0.808 . . . . 0.0 112.04 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.16 139.09 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.435 0.636 . . . . 0.0 110.747 172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.21 108.19 11.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.787 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.2 tp -88.22 112.29 48.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.194 1.398 . . . . 0.0 109.258 170.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 56.8 Cg_endo -78.5 152.36 26.32 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.823 1.682 . . . . 0.0 112.728 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 30.4 mm -133.8 131.77 21.25 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.428 1.491 . . . . 0.0 109.873 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.94 170.96 19.05 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.281 2.654 . . . . 0.0 112.366 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.67 149.21 42.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.75 154.25 24.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.484 1.914 . . . . 0.0 109.877 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -134.78 135.93 24.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.392 1.077 . . . . 0.0 110.975 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 150.49 77.51 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.639 0.907 . . . . 0.0 111.421 -5.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.17 -32.15 74.51 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.76 1.64 . . . . 0.0 111.704 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.35 -5.91 4.08 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.706 2.002 . . . . 0.0 114.908 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 p -69.63 -178.87 1.56 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.873 -1.142 . . . . 0.0 112.276 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.87 150.49 40.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.034 0.934 . . . . 0.0 111.91 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.9 tt -107.02 138.69 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.379 1.472 . . . . 0.0 109.583 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.47 138.23 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.008 0.923 . . . . 0.0 109.617 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -141.6 131.31 24.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.999 -1.063 . . . . 0.0 110.601 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -82.9 141.52 32.14 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.545 -0.722 . . . . 0.0 109.84 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.24 111.17 13.64 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.616 1.166 . . . . 0.0 110.0 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.9 p -128.02 115.23 18.17 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.872 1.269 . . . . 0.0 110.34 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.59 121.34 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.301 1.44 . . . . 0.0 107.527 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -127.93 136.79 51.82 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.214 1.406 . . . . 0.0 108.911 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.26 130.48 35.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.234 0.54 . . . . 0.0 110.428 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -75.94 -30.81 58.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.232 1.013 . . . . 0.0 112.206 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.51 -179.29 4.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.839 2.055 . . . . 0.0 112.266 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.49 148.71 32.43 Favored Pre-proline 0 N--CA 1.481 1.105 0 O-C-N 121.214 -0.929 . . . . 0.0 112.651 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.3 17.15 11.71 Favored 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 119.956 1.02 . . . . 0.0 114.65 -1.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 63.61 18.69 11.27 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.204 1.802 . . . . 0.0 113.986 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -94.35 178.99 5.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.188 1.795 . . . . 0.0 112.289 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -79.37 144.31 34.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.65 -1.281 . . . . 0.0 112.328 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.48 -43.51 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.412 1.885 . . . . 0.0 110.994 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.6 t -140.39 123.55 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -135.97 97.39 3.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.43 10.35 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.667 1.127 . . . . 0.0 111.848 -168.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 m -139.13 169.63 17.44 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.291 1.036 . . . . 0.0 110.66 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.0 156.98 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 127.282 2.233 . . . . 0.0 108.461 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -120.96 139.76 52.81 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -120.23 130.79 54.68 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.286 -0.883 . . . . 0.0 109.7 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -120.56 153.37 36.84 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.294 1.437 . . . . 0.0 110.249 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -128.63 124.37 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.209 1.403 . . . . 0.0 110.132 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.8 m -95.55 113.75 62.47 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 109.823 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.16 -11.68 32.76 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.064 2.509 . . . . 0.0 112.827 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m -43.34 -48.22 6.87 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.878 2.471 . . . . 0.0 112.985 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 80.7 p -144.84 17.87 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.206 1.402 . . . . 0.0 112.395 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.0 88.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.681 -1.262 . . . . 0.0 113.542 -171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -73.77 152.07 40.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.811 0.805 . . . . 0.0 110.778 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.82 134.32 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.952 1.301 . . . . 0.0 108.351 167.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 17.8 m -134.83 109.34 8.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.034 1.734 . . . . 0.0 107.729 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 2.0 p -76.82 147.03 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.544 -0.722 . . . . 0.0 109.409 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.66 125.46 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.902 1.681 . . . . 0.0 106.893 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 135.92 44.31 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.642 1.177 . . . . 0.0 109.785 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -146.89 158.12 43.83 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.957 1.703 . . . . 0.0 109.914 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.53 -19.47 10.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.112 1.765 . . . . 0.0 113.944 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -58.09 -23.59 55.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -149.47 -46.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.029 1.332 . . . . 0.0 113.297 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -85.69 133.05 42.55 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.975 1.31 . . . . 0.0 109.392 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.01 -172.17 1.06 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 122.565 2.177 . . . . 0.0 112.676 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -107.08 -22.41 12.66 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.562 1.145 . . . . 0.0 113.526 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -55.12 -40.26 70.31 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.776 1.23 . . . . 0.0 112.566 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -105.46 144.47 32.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.939 1.695 . . . . 0.0 109.397 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.3 p -139.89 157.26 45.99 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.762 1.225 . . . . 0.0 109.536 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.3 127.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.851 0.461 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 51.5 m -119.06 131.4 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.617 1.567 . . . . 0.0 109.763 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -65.76 122.12 16.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.857 1.263 . . . . 0.0 111.066 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.36 -28.82 8.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.029 0.932 . . . . 0.0 112.057 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.73 -175.27 4.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.357 1.863 . . . . 0.0 110.914 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.58 -31.48 64.27 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.08 1.352 . . . . 0.0 113.764 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 61.3 p -143.4 33.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.422 . . . . 0.0 111.813 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 48.9 m -129.71 134.4 47.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.866 0.867 . . . . 0.0 111.943 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.437 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 23.8 m-85 -130.88 138.96 50.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.877 1.671 . . . . 0.0 110.801 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 34.5 mt -125.19 122.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -98.03 112.28 24.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.689 1.996 . . . . 0.0 108.348 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -103.28 124.18 48.17 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.27 116.58 32.19 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 110.945 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -120.2 20.81 11.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.541 1.937 . . . . 0.0 112.172 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.76 -168.91 3.22 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.332 1.453 . . . . 0.0 111.614 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.76 26.47 1.39 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.824 -1.173 . . . . 0.0 113.778 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 127.746 2.419 . . . . 0.0 115.01 -166.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -102.37 128.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.572 1.149 . . . . 0.0 109.654 170.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.15 138.82 57.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.919 0.888 . . . . 0.0 110.318 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.35 -13.06 4.46 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -117.19 9.38 13.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.438 2.295 . . . . 0.0 112.635 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -144.56 175.15 10.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.33 1.852 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.97 154.97 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.194 0.998 . . . . 0.0 109.452 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 149.39 42.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.88 1.272 . . . . 0.0 110.391 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.79 26.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.068 1.347 . . . . 0.0 108.942 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.33 131.83 38.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.114 1.366 . . . . 0.0 110.7 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -79.52 51.95 1.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.605 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.26 134.95 2.27 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 120.21 -1.556 . . . . 0.0 112.869 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 145.72 14.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.656 0.782 . . . . 0.0 111.102 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.48 26.22 13.99 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.3 t 67.25 71.8 0.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.824 1.649 . . . . 0.0 111.578 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -137.83 -178.14 5.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.524 1.529 . . . . 0.0 112.181 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.88 -82.89 0.5 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 126.066 1.793 . . . . 0.0 115.173 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -138.57 163.85 30.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.747 1.619 . . . . 0.0 110.345 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.2 p -135.75 145.32 46.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.217 1.007 . . . . 0.0 112.882 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -156.61 169.76 23.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.54 1.536 . . . . 0.0 111.821 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.21 153.91 48.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.307 1.443 . . . . 0.0 110.689 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.99 131.13 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.392 1.477 . . . . 0.0 109.731 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.62 128.43 33.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.864 . . . . 0.0 109.924 175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -54.55 139.9 36.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.75 0.82 . . . . 0.0 110.979 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.72 42.79 16.31 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.48 0.562 . . . . 0.0 112.527 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -133.32 154.62 50.55 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.514 1.525 . . . . 0.0 111.291 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m -140.09 122.51 16.07 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.132 1.373 . . . . 0.0 108.393 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.97 153.81 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.024 0.916 . . . . 0.0 110.549 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.7 mtm-85 -133.74 118.84 18.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.9 1.68 . . . . 0.0 107.873 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 122.9 15.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -165.01 155.08 13.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.662 1.22 . . . . 0.0 113.338 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -142.01 18.24 2.12 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 128.426 2.691 . . . . 0.0 110.803 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.72 -88.31 0.23 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.317 2.389 . . . . 0.0 110.289 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.05 104.02 0.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.369 1.868 . . . . 0.0 110.396 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.13 -59.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 128.174 2.59 . . . . 0.0 115.28 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -80.56 -23.48 39.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 120.982 1.719 . . . . 0.0 112.568 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.57 -19.48 65.27 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.859 1.664 . . . . 0.0 114.084 173.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.03 -68.86 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.122 165.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 28.22 37.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.15 2.58 . . . . 0.0 116.194 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -136.15 127.68 28.71 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.593 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -158.17 -39.72 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 111.387 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -142.2 126.14 17.22 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.246 1.018 . . . . 0.0 110.052 164.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.8 m -133.6 155.05 50.36 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.002 0.906 . . . . 0.0 109.398 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.04 127.13 33.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.86 108.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.753 1.621 . . . . 0.0 108.95 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.38 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.472 1.037 0 C-N-CA 128.383 2.897 . . . . 0.0 117.589 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -166.86 -42.8 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.146 0.978 . . . . 0.0 112.561 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -106.94 37.63 2.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.395 1.478 . . . . 0.0 110.481 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.61 158.59 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.358 1.863 . . . . 0.0 110.688 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -139.05 150.97 46.37 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.546 1.938 . . . . 0.0 109.909 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.62 126.53 54.3 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.176 0.59 . . . . 0.0 109.82 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -116.32 120.35 38.61 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.624 1.169 . . . . 0.0 108.145 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.3 pp -113.63 115.22 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 110.411 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -124.16 123.66 40.77 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.598 1.159 . . . . 0.0 108.796 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.21 -45.06 84.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 112.782 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 172.01 16.35 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.652 1.981 . . . . 0.0 107.66 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -60.13 -66.33 0.54 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.385 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.255 1.8 pp20? 48.72 167.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.59 54.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.349 -1.469 . . . . 0.0 112.554 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.263 44.0 m-20 53.33 45.97 27.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.349 1.859 . . . . 0.0 112.485 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -73.61 166.38 44.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.03 22.52 0.31 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.536 2.824 . . . . 0.0 113.835 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -152.23 58.63 2.66 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 126.467 1.907 . . . . 0.0 111.277 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.9 134.39 34.41 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.551 1.5 . . . . 0.0 109.552 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -101.81 0.1 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.814 0.721 . . . . 0.0 111.8 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 154.77 44.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.893 1.277 . . . . 0.0 111.881 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.61 139.26 16.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.852 1.661 . . . . 0.0 110.59 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -158.61 159.07 35.03 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.167 0.984 . . . . 0.0 111.768 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.88 90.4 3.19 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.514 1.525 . . . . 0.0 108.923 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.71 105.33 0.79 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 148.57 11.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.428 1.891 . . . . 0.0 113.8 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.57 151.78 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.47 1.108 . . . . 0.0 112.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.33 52.78 45.22 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 124.655 1.121 . . . . 0.0 114.997 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.78 175.45 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.815 0.846 . . . . 0.0 112.874 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.1 m -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.16 1.384 . . . . 0.0 109.698 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.33 121.71 19.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.84 1.256 . . . . 0.0 109.314 -175.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -117.9 15.79 14.31 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.066 1.746 . . . . 0.0 112.671 -172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -140.23 38.66 1.92 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.328 1.451 . . . . 0.0 112.741 -171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.86 -17.36 64.86 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.797 -1.189 . . . . 0.0 111.971 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -56.49 -19.19 14.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.81 1.644 . . . . 0.0 114.624 168.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.2 t -54.14 -27.27 32.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.247 -0.908 . . . . 0.0 112.285 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.0 mt -134.07 73.87 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 127.046 2.138 . . . . 0.0 108.848 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -60.94 -23.08 65.02 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.809 -1.182 . . . . 0.0 112.657 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.38 80.33 0.15 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.8 1.666 . . . . 0.0 113.232 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.59 153.03 42.8 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.9 1.68 . . . . 0.0 111.661 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -158.53 -22.12 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.471 1.509 . . . . 0.0 114.201 161.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.06 129.45 55.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.474 1.51 . . . . 0.0 108.75 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.65 121.07 31.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.93 132.38 54.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -126.37 130.17 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 pp -144.82 148.81 40.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.406 0.682 . . . . 0.0 110.152 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.52 155.06 70.33 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.898 1.732 . . . . 0.0 112.391 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.95 -24.3 64.64 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.059 0.838 . . . . 0.0 114.528 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.43 -22.88 67.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.52 1.128 . . . . 0.0 113.679 169.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -111.0 130.08 55.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.933 1.693 . . . . 0.0 108.741 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -85.75 -40.16 16.37 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.505 -1.372 . . . . 0.0 112.194 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -152.23 159.28 43.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.77 2.028 . . . . 0.0 109.041 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.02 146.41 50.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.609 0.763 . . . . 0.0 110.766 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.91 135.19 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.747 1.219 . . . . 0.0 110.166 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -77.23 134.66 38.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.276 0.63 . . . . 0.0 109.885 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.55 140.4 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 109.938 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.33 157.15 45.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.06 1.744 . . . . 0.0 110.609 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 92.6 mt -118.76 139.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.959 2.104 . . . . 0.0 109.535 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.33 106.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.755 1.622 . . . . 0.0 109.601 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.69 111.83 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.415 0.686 . . . . 0.0 110.727 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.8 15.35 11.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.421 1.088 . . . . 0.0 111.466 168.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -96.28 -61.83 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.869 1.667 . . . . 0.0 111.063 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -151.63 99.08 2.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.386 1.875 . . . . 0.0 108.799 -172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.5 m -53.16 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.88 1.672 . . . . 0.0 113.052 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.1 m -146.69 -53.89 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.743 1.617 . . . . 0.0 110.779 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.2 159.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.175 2.19 . . . . 0.0 114.96 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.42 -36.1 0.44 Allowed Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.531 -1.355 . . . . 0.0 115.293 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.6 m -64.63 1.7 0.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.175 2.19 . . . . 0.0 115.033 170.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.401 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 17.9 t80 -134.99 122.18 21.5 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.258 2.223 . . . . 0.0 109.76 -173.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 130.34 40.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.958 1.303 . . . . 0.0 110.387 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.6 ttm -115.57 141.57 47.88 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.694 1.598 . . . . 0.0 110.632 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.6 m -128.27 116.41 19.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.573 1.149 . . . . 0.0 108.171 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mt -96.64 122.83 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.4 m -116.04 87.54 19.38 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.981 1.712 . . . . 0.0 109.24 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.0 163.53 37.32 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.58 2.853 . . . . 0.0 112.465 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -45.16 96.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.577 1.951 . . . . 0.0 113.259 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 37.29 47.47 0.69 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.267 1.827 . . . . 0.0 114.881 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.34 155.18 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.966 1.707 . . . . 0.0 109.535 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.75 92.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.356 1.462 . . . . 0.0 112.288 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.51 160.47 4.18 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.475 1.51 . . . . 0.0 111.523 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.49 145.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 111.391 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.85 138.86 33.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.457 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 39.8 t -135.78 124.61 24.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.339 1.455 . . . . 0.0 107.855 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -118.52 141.19 48.82 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 109.03 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.92 105.23 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.431 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.15 63.0 0.32 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.318 0.961 . . . . 0.0 113.658 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -141.59 155.89 45.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.456 1.903 . . . . 0.0 111.657 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.38 55.11 2.71 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.609 -1.307 . . . . 0.0 111.662 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 59.61 169.78 0.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.539 1.936 . . . . 0.0 112.826 -167.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.14 126.17 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.845 -1.159 . . . . 0.0 109.741 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 127.17 31.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.841 0.456 . . . . 0.0 110.047 171.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.18 95.83 47.98 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.059 1.743 . . . . 0.0 107.685 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.98 148.13 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.903 2.402 . . . . 0.0 112.669 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 87.2 mt -136.03 131.72 18.98 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.309 1.443 . . . . 0.0 109.1 -174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.47 169.85 21.34 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.922 3.748 . . . . 0.0 112.112 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -68.6 149.04 49.63 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.517 -0.739 . . . . 0.0 111.677 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.61 163.63 39.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.097 2.159 . . . . 0.0 109.573 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.3 m -131.25 131.4 23.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.942 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.97 153.63 80.41 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 119.343 0.801 . . . . 0.0 111.877 -3.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.85 -17.28 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.734 1.623 . . . . 0.0 112.886 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.49 13.53 21.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 114.415 169.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.87 152.11 46.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.744 -1.223 . . . . 0.0 112.437 174.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.79 113.63 19.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.315 0.646 . . . . 0.0 111.018 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.6 tt -85.71 120.25 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.62 0.768 . . . . 0.0 109.828 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.49 139.42 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.542 0.687 . . . . 0.0 110.703 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.1 t -143.8 150.42 38.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.44 1.096 . . . . 0.0 109.798 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -111.32 145.17 39.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.704 0.802 . . . . 0.0 109.62 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 tt -133.85 120.73 20.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.665 0.745 . . . . 0.0 109.311 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.04 124.45 26.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.309 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.401 HG21 ' CZ ' ' A' ' 115' ' ' TYR . 2.2 p -145.34 135.16 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.57 1.148 . . . . 0.0 109.698 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 162.14 35.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.226 1.41 . . . . 0.0 111.523 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -66.5 128.52 36.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.126 170.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.9 p -73.57 -6.46 46.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.892 0.877 . . . . 0.0 113.326 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -122.54 141.0 52.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.279 2.232 . . . . 0.0 108.869 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -65.59 140.84 97.66 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.696 -0.668 . . . . 0.0 111.643 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 131.67 20.94 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.415 1.184 . . . . 0.0 111.492 -4.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -73.68 41.68 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 112.499 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.91 126.7 14.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -68.63 82.15 0.28 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.391 1.077 . . . . 0.0 110.046 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.0 m -45.91 -37.84 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.976 1.71 . . . . 0.0 113.017 177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.88 136.9 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.488 1.115 . . . . 0.0 109.697 165.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -142.03 115.2 8.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.787 1.235 . . . . 0.0 108.137 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.35 -162.21 24.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.02 0.819 . . . . 0.0 113.298 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.92 153.66 51.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.625 1.17 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.92 143.58 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.168 1.787 . . . . 0.0 109.245 -175.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -115.05 115.11 26.28 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.182 -0.949 . . . . 0.0 109.328 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 152.82 26.16 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.462 -0.774 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.77 154.65 45.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 108.709 167.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -127.91 127.48 43.44 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.869 1.268 . . . . 0.0 108.727 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.3 m -86.17 106.68 10.64 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.59 -17.68 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.43 2.753 . . . . 0.0 112.514 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.3 m -55.91 -38.83 70.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.199 1.8 . . . . 0.0 113.079 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.8 p -147.75 24.59 1.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.013 1.325 . . . . 0.0 112.705 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 50.71 31.12 22.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.406 1.955 . . . . 0.0 115.851 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.59 164.5 25.76 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.182 0.991 . . . . 0.0 111.152 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.62 135.5 55.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.074 1.35 . . . . 0.0 109.008 165.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.9 m -133.49 107.17 7.87 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.0 p -83.83 151.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.4 174.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.91 135.44 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 125.874 1.67 . . . . 0.0 107.709 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.98 140.2 36.23 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.833 1.653 . . . . 0.0 107.425 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -125.29 146.14 49.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.303 1.441 . . . . 0.0 108.353 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.95 -14.42 47.07 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -17.44 61.05 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 171.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.0 p -130.38 -32.3 1.77 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.608 1.563 . . . . 0.0 113.231 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.95 146.89 76.41 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.996 1.318 . . . . 0.0 110.782 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.28 -7.72 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.586 2.857 . . . . 0.0 113.99 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.4 tttm 64.56 -24.2 0.08 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.341 2.656 . . . . 0.0 115.993 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -67.74 -18.17 64.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.43 1.092 . . . . 0.0 113.685 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.7 ttm -103.3 151.44 22.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.563 1.945 . . . . 0.0 109.418 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.0 p -131.76 159.67 37.8 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.455 1.502 . . . . 0.0 110.144 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 77.8 t -121.61 130.75 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.157 0.983 . . . . 0.0 109.683 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.2 m -134.31 126.78 30.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.471 1.109 . . . . 0.0 108.697 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.42 141.4 28.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.565 1.146 . . . . 0.0 110.481 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -117.47 -36.18 3.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.564 0.746 . . . . 0.0 111.704 171.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -129.38 178.78 6.2 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.527 1.131 . . . . 0.0 111.849 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.78 -40.41 63.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.226 1.01 . . . . 0.0 112.144 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -137.01 33.8 2.61 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 111.205 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.7 t -129.18 116.99 20.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.882 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -100.17 136.29 40.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.365 2.266 . . . . 0.0 109.73 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.04 112.77 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.608 1.163 . . . . 0.0 109.54 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.02 120.19 22.5 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.109 1.363 . . . . 0.0 109.872 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -106.41 133.79 50.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 45.6 tp -127.47 111.54 13.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.812 -0.555 . . . . 0.0 110.966 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.58 -26.19 15.33 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.92 132.57 53.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 111.053 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.6 -48.91 79.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 127.264 2.225 . . . . 0.0 112.507 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.1 p . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.532 0.682 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.55 148.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.926 -0.484 . . . . 0.0 111.374 177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.57 144.34 43.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.623 0.369 . . . . 0.0 110.686 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.86 -17.12 34.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.037 -1.039 . . . . 0.0 113.179 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -108.91 13.47 24.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.442 1.897 . . . . 0.0 113.275 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -137.55 170.96 15.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.58 151.58 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.0 110.517 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -130.51 152.11 50.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.112 0.965 . . . . 0.0 110.812 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.74 133.99 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 108.256 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -121.73 127.73 51.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.818 1.647 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.42 61.4 6.17 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.761 1.225 . . . . 0.0 110.884 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.42 142.99 3.86 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.235 0.922 . . . . 0.0 112.019 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -59.2 132.17 53.22 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.948 0.874 . . . . 0.0 109.669 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 t30 77.09 41.88 0.15 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.743 1.617 . . . . 0.0 113.199 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.343 31.1 p 49.87 58.2 5.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.921 2.488 . . . . 0.0 115.485 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 p -127.81 179.47 5.53 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.164 1.785 . . . . 0.0 113.18 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.23 -74.74 1.84 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.463 1.982 . . . . 0.0 113.957 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -139.13 170.16 16.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.655 1.582 . . . . 0.0 109.781 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -137.32 143.91 42.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.535 1.134 . . . . 0.0 111.166 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -143.4 155.46 44.41 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.552 1.541 . . . . 0.0 110.465 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -125.67 134.8 51.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.761 1.224 . . . . 0.0 109.204 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -127.52 131.33 50.09 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.483 1.135 . . . . 0.0 110.521 -175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -91.91 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.716 1.207 . . . . 0.0 109.349 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 145.07 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.819 -0.55 . . . . 0.0 112.409 172.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.7 73.08 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.172 0.415 . . . . 0.0 113.837 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -127.9 126.01 40.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.297 1.439 . . . . 0.0 109.936 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m -109.19 126.56 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.25 146.1 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 110.037 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -125.95 144.37 50.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.037 1.335 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -135.38 146.23 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.43 1.492 . . . . 0.0 109.628 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.5 139.97 8.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.553 1.141 . . . . 0.0 110.193 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.11 30.36 0.06 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.135 0.974 . . . . 0.0 113.537 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.42 45.27 4.09 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 113.833 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.251 0.4 OUTLIER 54.12 55.89 7.69 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 174.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.93 -53.15 0.06 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -84.66 -17.35 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.19 -45.4 33.45 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 111.34 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.66 35.73 0.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.265 1.426 . . . . 0.0 113.15 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -16.12 62.67 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 119.651 -1.906 . . . . 0.0 114.247 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.7 134.76 56.49 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 mtp -150.01 -58.76 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 112.07 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -136.27 115.54 12.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.948 1.299 . . . . 0.0 109.905 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.08 146.95 37.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.709 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.87 128.15 43.27 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.112 1.365 . . . . 0.0 109.081 -168.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.55 119.75 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.268 1.427 . . . . 0.0 110.185 -173.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.74 0.01 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.516 1.532 . . . . 0.0 116.66 -164.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.33 -21.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 27.34 7.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.798 1.639 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.77 141.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.912 2.085 . . . . 0.0 109.416 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -116.23 153.06 32.55 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.12 128.33 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.232 0.539 . . . . 0.0 109.626 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.24 126.15 54.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.073 0.949 . . . . 0.0 108.448 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.26 104.18 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 122.194 0.997 . . . . 0.0 109.516 -174.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.82 123.05 49.34 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.611 1.164 . . . . 0.0 108.769 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.84 -57.87 10.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.161 0.982 . . . . 0.0 111.491 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 158.42 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.657 1.183 . . . . 0.0 109.383 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.42 124.38 33.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.8 172.97 16.71 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.588 1.555 . . . . 0.0 111.999 -169.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.0 pt -123.68 34.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.503 -1.373 . . . . 0.0 114.211 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.299 67.4 m-20 61.94 51.04 3.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.979 2.112 . . . . 0.0 111.689 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -65.74 166.41 15.28 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.655 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.37 20.38 0.36 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 123.456 2.771 . . . . 0.0 114.285 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -148.03 63.7 7.67 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.656 1.582 . . . . 0.0 111.957 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.64 140.42 62.25 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.751 1.634 . . . . 0.0 110.535 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.02 -92.81 1.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -145.62 153.92 41.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.174 1.39 . . . . 0.0 110.787 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -153.33 137.55 16.53 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.056 1.342 . . . . 0.0 108.715 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -155.83 164.67 38.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.377 1.084 . . . . 0.0 111.198 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -133.84 104.84 6.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.391 1.076 . . . . 0.0 108.355 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -68.23 115.31 7.54 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.813 0.845 . . . . 0.0 109.598 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.17 152.92 1.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.155 1.782 . . . . 0.0 112.882 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.83 -21.93 32.75 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.87 88.16 0.12 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.135 1.35 . . . . 0.0 112.282 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -161.05 171.75 18.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.674 1.19 . . . . 0.0 112.446 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.0 m -124.3 140.11 53.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.35 1.06 . . . . 0.0 109.187 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -131.09 119.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -107.58 -20.87 13.1 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.865 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -121.43 49.69 1.49 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.85 -16.72 59.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.103 -0.998 . . . . 0.0 112.626 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.19 -17.28 2.67 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.972 1.309 . . . . 0.0 114.36 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -55.15 -29.56 58.02 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.473 -1.392 . . . . 0.0 113.656 165.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 tp -78.58 -39.33 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.899 0.772 . . . . 0.0 112.195 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 33.58 43.78 0.06 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.256 1.822 . . . . 0.0 114.293 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.86 61.96 0.14 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.753 -155.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.2 tp -139.9 124.85 18.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.268 1.027 . . . . 0.0 110.4 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -132.05 -15.67 2.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -129.99 110.1 11.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.383 1.473 . . . . 0.0 109.443 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 120.66 43.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -168.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -116.62 112.39 21.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 109.59 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.5 t -95.26 131.19 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.586 1.554 . . . . 0.0 109.182 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 11.2 mt -132.06 136.2 27.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.415 0.686 . . . . 0.0 110.376 -161.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.2 14.91 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.561 2.841 . . . . 0.0 114.535 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.14 -35.54 0.64 Allowed Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.997 2.237 . . . . 0.0 115.023 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.33 65.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.847 1.659 . . . . 0.0 112.526 167.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.18 153.08 1.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.876 1.271 . . . . 0.0 110.757 159.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -132.28 -33.89 1.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.327 0.651 . . . . 0.0 111.842 167.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.63 166.94 29.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.068 1.747 . . . . 0.0 109.673 171.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.4 166.26 23.58 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.142 0.973 . . . . 0.0 111.193 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.51 121.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.698 176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.84 120.74 19.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -115.46 144.77 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.976 1.31 . . . . 0.0 109.414 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.35 152.11 40.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.761 1.624 . . . . 0.0 108.912 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.8 mt -123.13 124.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.512 0.725 . . . . 0.0 109.62 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -124.65 116.64 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.475 1.51 . . . . 0.0 109.631 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -83.31 120.36 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.161 1.784 . . . . 0.0 110.68 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.64 27.03 4.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.102 1.761 . . . . 0.0 111.405 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.85 -56.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.95 1.7 . . . . 0.0 111.37 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -119.74 128.48 53.8 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.217 1.407 . . . . 0.0 109.743 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.6 56.6 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.967 1.307 . . . . 0.0 111.702 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.9 m -132.76 -66.32 0.68 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.004 1.322 . . . . 0.0 111.349 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.67 170.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -172.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.59 -12.61 60.72 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.468 -1.395 . . . . 0.0 115.178 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 p -110.3 -25.94 9.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.573 1.549 . . . . 0.0 113.894 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.98 135.02 46.27 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 165.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -131.88 138.77 48.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.147 0.975 . . . . 0.0 109.817 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.8 ttp -121.8 137.29 54.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.683 2.393 . . . . 0.0 108.165 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.0 m -136.45 135.52 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.12 123.66 54.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -120.8 90.55 46.59 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.016 1.327 . . . . 0.0 110.416 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.22 82.07 1.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.064 3.176 . . . . 0.0 113.126 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 55.32 57.83 5.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.293 1.437 . . . . 0.0 112.129 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.83 50.09 16.43 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.377 1.471 . . . . 0.0 113.239 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.92 169.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 127.692 2.397 . . . . 0.0 109.243 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.15 79.56 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.936 2.894 . . . . 0.0 114.579 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 159.75 30.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.212 1.405 . . . . 0.0 110.504 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.39 151.18 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.438 1.095 . . . . 0.0 109.652 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.29 131.02 54.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.047 0.939 . . . . 0.0 109.593 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -137.62 150.64 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -144.92 137.99 26.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.468 1.107 . . . . 0.0 110.537 -170.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.76 100.75 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.084 2.154 . . . . 0.0 111.564 -173.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.14 43.74 0.59 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.327 0.489 . . . . 0.0 114.123 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -136.32 164.52 27.91 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.678 1.591 . . . . 0.0 111.784 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.49 165.64 18.59 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.126 -0.984 . . . . 0.0 111.565 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -54.38 132.0 43.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.222 -0.924 . . . . 0.0 111.404 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.9 t -100.18 116.07 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.768 1.227 . . . . 0.0 110.446 -175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.47 100.43 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.87 1.268 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mt -83.02 112.71 40.4 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.289 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.41 134.48 15.57 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.486 2.124 . . . . 0.0 110.342 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 mm -122.89 124.29 26.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.487 1.515 . . . . 0.0 108.644 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.65 174.2 13.05 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.593 2.862 . . . . 0.0 112.564 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.11 137.84 58.22 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.585 -0.697 . . . . 0.0 111.756 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.2 pp -151.79 38.19 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.162 1.385 . . . . 0.0 112.723 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 t -40.25 138.29 1.17 Allowed Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 127.381 2.272 . . . . 0.0 114.766 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.55 158.62 90.16 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 CA-C-N 119.836 0.977 . . . . 0.0 113.137 0.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.59 -33.82 66.02 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.067 1.844 . . . . 0.0 112.877 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.28 0.79 9.01 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.106 1.362 . . . . 0.0 114.618 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 p -66.94 175.62 2.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.293 1.044 . . . . 0.0 113.268 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.61 103.76 7.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.544 1.538 . . . . 0.0 110.508 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 tt -78.61 132.08 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.845 1.258 . . . . 0.0 110.181 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.17 143.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 110.363 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.4 t -137.35 153.43 50.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.56 1.144 . . . . 0.0 109.135 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -112.17 119.82 39.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 tt -101.18 126.2 47.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.977 1.311 . . . . 0.0 109.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.46 125.14 37.86 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.635 1.574 . . . . 0.0 108.817 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.33 119.19 47.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.809 1.243 . . . . 0.0 109.033 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -147.91 149.08 31.58 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.644 1.178 . . . . 0.0 109.802 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -70.87 134.08 47.0 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.217 -0.302 . . . . 0.0 110.948 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.1 p -72.71 -19.23 61.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.486 1.515 . . . . 0.0 113.733 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 169.62 10.95 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.321 1.848 . . . . 0.0 111.298 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 p -53.18 146.09 22.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.252 1.021 . . . . 0.0 113.583 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.0 6.39 18.37 Favored 'Cis proline' 0 CA--C 1.545 1.056 0 N-CA-C 114.933 1.09 . . . . 0.0 114.933 4.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.93 24.47 14.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.837 1.255 . . . . 0.0 112.377 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.17 142.19 43.55 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.623 -1.298 . . . . 0.0 111.015 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -57.9 146.17 33.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.11 0.564 . . . . 0.0 111.379 168.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.38 -40.67 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.348 1.059 . . . . 0.0 111.604 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.6 t -146.67 137.92 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.584 0.754 . . . . 0.0 109.402 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -149.6 139.13 21.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.56 1.144 . . . . 0.0 110.445 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.66 -172.37 44.15 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.71 0.671 . . . . 0.0 114.238 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.7 m -115.81 132.25 56.7 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.718 0.807 . . . . 0.0 111.598 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.61 116.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.976 2.11 . . . . 0.0 108.139 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.4 138.68 31.35 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.89 -1.131 . . . . 0.0 109.143 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -112.77 146.53 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.134 0.968 . . . . 0.0 109.629 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -141.26 152.2 44.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.916 1.686 . . . . 0.0 108.209 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -121.13 150.25 41.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.788 1.235 . . . . 0.0 109.43 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 m -111.23 105.38 56.96 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 123.804 0.842 . . . . 0.0 109.458 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.44 48.69 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.855 1 C-N-CA 126.271 4.648 . . . . 0.0 113.596 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.4 t -123.04 -45.43 2.13 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.408 1.483 . . . . 0.0 110.923 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.9 p -151.09 34.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.227 1.811 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.98 32.8 71.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.978 1.275 . . . . 0.0 114.878 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.48 171.3 15.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.761 1.28 . . . . 0.0 110.948 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.69 152.43 36.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.453 1.101 . . . . 0.0 109.794 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 m -138.32 140.93 39.73 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.43 1.892 . . . . 0.0 107.468 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 1.1 p -110.29 141.54 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 24.9 mt -133.02 120.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.96 142.31 38.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.635 1.174 . . . . 0.0 109.037 175.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 140.4 52.75 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.057 1.343 . . . . 0.0 108.309 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.48 -20.09 11.64 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.66 -16.36 64.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.282 1.433 . . . . 0.0 114.607 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 32.7 p -141.07 -42.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.697 1.599 . . . . 0.0 113.59 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -88.19 146.82 38.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.983 1.313 . . . . 0.0 110.591 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.03 168.99 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.224 2.616 . . . . 0.0 112.656 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -94.77 10.87 33.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.482 1.513 . . . . 0.0 112.514 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -93.64 -44.51 8.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 111.986 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -100.48 144.87 28.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.366 1.466 . . . . 0.0 109.108 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -139.97 158.46 44.03 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.07 1.348 . . . . 0.0 108.978 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 72.1 t -121.01 135.56 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.3 m -127.91 126.1 40.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.16 0.984 . . . . 0.0 109.092 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -68.06 137.0 54.67 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.417 0.687 . . . . 0.0 110.401 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.69 -26.79 2.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.318 1.047 . . . . 0.0 112.945 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -161.4 172.52 16.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.139 1.776 . . . . 0.0 111.039 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -58.09 136.21 57.15 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.915 -1.116 . . . . 0.0 109.942 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 2.3 p 56.31 6.51 0.26 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 31.8 m -113.67 133.4 55.34 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.989 1.316 . . . . 0.0 111.412 -169.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.404 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 4.4 m-85 -142.49 137.61 30.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.734 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 60.9 mt -122.67 118.95 56.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.31 126.85 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.205 1.402 . . . . 0.0 108.707 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -119.26 132.32 55.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.753 1.221 . . . . 0.0 109.388 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.5 tt -113.7 125.44 54.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 109.526 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -128.62 3.71 5.53 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.583 1.153 . . . . 0.0 113.864 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 m -150.5 115.63 5.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.547 1.939 . . . . 0.0 110.675 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -52.88 -35.41 57.8 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 119.618 1.099 . . . . 0.0 113.682 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.949 1.7 . . . . 0.0 113.453 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.102 0.477 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.39 139.7 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -15.94 34.32 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.464 -1.397 . . . . 0.0 113.42 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -108.48 2.09 22.03 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.09 2.156 . . . . 0.0 113.349 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -144.89 175.45 10.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.854 2.062 . . . . 0.0 110.24 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.25 158.33 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.141 -0.974 . . . . 0.0 111.124 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -149.44 143.92 26.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.356 0.662 . . . . 0.0 112.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -134.79 131.36 37.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.418 1.887 . . . . 0.0 109.362 -165.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.32 137.39 51.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.604 1.562 . . . . 0.0 110.286 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.94 45.23 0.7 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.809 1.644 . . . . 0.0 112.901 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.15 132.92 2.12 Favored Glycine 0 CA--C 1.519 0.306 0 O-C-N 120.282 -1.511 . . . . 0.0 111.527 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 148.14 7.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 110.722 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.48 25.97 13.67 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m 63.98 72.33 0.46 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.567 2.347 . . . . 0.0 114.803 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -137.18 -179.4 5.69 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.311 1.445 . . . . 0.0 112.382 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -72.76 2.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.436 1.493 . . . . 0.0 115.466 169.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.36 165.23 28.51 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.69 1.996 . . . . 0.0 108.933 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -127.02 154.16 44.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.531 1.132 . . . . 0.0 112.609 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 146.23 20.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.853 1.661 . . . . 0.0 109.897 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.27 141.71 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.356 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.44 129.37 31.03 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.766 1.226 . . . . 0.0 110.592 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.89 158.97 34.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.37 0.605 . . . . 0.0 111.518 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.0 147.3 47.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.574 -0.704 . . . . 0.0 111.622 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.6 45.55 75.99 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.653 0.644 . . . . 0.0 113.493 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.74 159.46 39.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.907 0.883 . . . . 0.0 112.117 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.3 m -136.52 132.93 35.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.937 1.295 . . . . 0.0 108.449 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.58 159.69 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.767 1.227 . . . . 0.0 110.883 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -130.2 118.94 22.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 108.303 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 m0 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 122.181 0.991 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.47 -38.34 71.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.455 1.102 . . . . 0.0 110.673 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -39.44 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.035 2.534 . . . . 0.0 111.717 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.8 42.25 0.39 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 112.654 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 86' ' ' LEU . 2.8 p90 -148.03 155.34 41.38 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 122.542 1.163 . . . . 0.0 111.511 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -152.91 -45.45 0.1 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.229 163.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -120.45 129.43 53.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.448 1.022 . . . . 0.0 109.58 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 p -140.78 158.33 44.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.167 0.984 . . . . 0.0 112.391 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.95 134.48 47.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.966 1.306 . . . . 0.0 108.269 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.76 105.23 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.304 1.442 . . . . 0.0 108.573 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.19 152.81 6.39 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.217 1.389 . . . . 0.0 114.96 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -64.31 -2.83 2.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -135.63 29.7 3.21 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.329 1.451 . . . . 0.0 112.238 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.5 155.13 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.816 2.446 . . . . 0.0 109.996 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 70' ' ' GLU . 12.6 ttt85 -125.54 152.76 44.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.514 1.526 . . . . 0.0 109.569 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 m -116.46 149.55 39.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.267 1.032 . . . . 0.0 110.423 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.35 120.99 19.45 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.74 1.616 . . . . 0.0 107.521 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.9 pt -116.79 137.71 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 123.561 0.744 . . . . 0.0 109.973 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -137.53 116.14 12.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -43.03 -69.52 0.13 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.755 2.022 . . . . 0.0 115.051 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.81 35.96 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.906 0.882 . . . . 0.0 109.495 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.283 0.6 OUTLIER 42.21 57.71 3.21 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.092 1.757 . . . . 0.0 112.546 178.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 1.5 pp20? -63.22 131.36 48.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.466 1.506 . . . . 0.0 113.279 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -93.21 38.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.388 1.475 . . . . 0.0 111.719 -167.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.33 50.9 m-20 55.05 46.42 24.19 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 123.691 1.71 . . . . 0.0 112.166 -168.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 62' ' ' THR . 0.7 OUTLIER -68.69 171.88 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.585 2.354 . . . . 0.0 110.86 176.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.25 7.34 0.87 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.103 2.536 . . . . 0.0 114.972 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -137.98 112.03 8.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 124.978 1.311 . . . . 0.0 110.769 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.81 125.44 13.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.59 -120.83 0.08 OUTLIER Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.744 1.164 . . . . 0.0 111.423 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.152 0.981 . . . . 0.0 111.052 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -154.07 139.53 17.74 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.402 1.081 . . . . 0.0 112.583 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -146.68 141.83 27.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.823 0.82 . . . . 0.0 110.199 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 51' ' ' ARG . 32.4 tt0 -113.6 79.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -46.52 102.66 0.03 OUTLIER 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.947 2.099 . . . . 0.0 110.773 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.28 126.53 23.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.414 . . . . 0.0 111.558 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -55.5 109.53 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.216 1.406 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.52 55.8 1.99 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.966 0.793 . . . . 0.0 114.481 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.44 163.53 36.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.981 0.891 . . . . 0.0 113.138 174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.0 m -123.61 133.74 53.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.713 1.605 . . . . 0.0 108.985 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -119.72 102.85 8.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.079 1.751 . . . . 0.0 109.015 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -71.79 -24.33 61.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -151.69 137.73 18.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.89 1.676 . . . . 0.0 110.203 171.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.14 14.33 7.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.436 1.495 . . . . 0.0 112.537 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -53.89 -19.49 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.249 1.82 . . . . 0.0 115.256 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -48.61 -29.65 4.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 162.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.0 mt -133.0 58.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 128.963 2.905 . . . . 0.0 108.003 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -52.47 -29.98 27.6 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.149 -0.97 . . . . 0.0 112.248 163.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.42 103.55 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.662 1.125 . . . . 0.0 112.892 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -161.73 43.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -52.25 -18.54 1.58 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 120.007 -1.683 . . . . 0.0 115.4 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -113.55 141.67 46.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.018 2.127 . . . . 0.0 111.581 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -128.89 134.65 48.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.949 2.099 . . . . 0.0 109.365 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -125.72 129.29 49.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.171 1.788 . . . . 0.0 109.288 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.27 116.1 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.419 1.487 . . . . 0.0 108.203 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.6 mt -127.77 140.81 39.16 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.771 0.828 . . . . 0.0 110.808 -167.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.72 164.61 35.12 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.885 2.39 . . . . 0.0 112.812 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.1 -24.77 58.96 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 113.912 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.12 68.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.129 1.372 . . . . 0.0 114.389 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -123.23 116.28 23.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.232 1.413 . . . . 0.0 110.722 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.14 -44.23 65.99 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.197 -0.94 . . . . 0.0 112.161 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 162.6 40.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.514 1.926 . . . . 0.0 109.155 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.57 157.06 45.58 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.478 -0.764 . . . . 0.0 110.393 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -127.77 132.6 68.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.805 0.842 . . . . 0.0 109.95 -169.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.28 128.19 34.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -126.62 145.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.17 1.388 . . . . 0.0 108.27 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -149.79 157.99 43.74 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.19 134.37 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.113 1.765 . . . . 0.0 106.973 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.43 135.64 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.035 0.921 . . . . 0.0 110.745 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -79.09 122.1 25.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.982 0.913 . . . . 0.0 112.343 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -110.93 -3.12 15.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.464 1.506 . . . . 0.0 112.696 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.4 t -138.46 -48.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 126.115 1.766 . . . . 0.0 112.699 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -74.51 80.22 1.95 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.328 0.967 . . . . 0.0 112.189 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -68.53 53.34 0.08 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.471 2.308 . . . . 0.0 114.069 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.9 m -137.53 -45.01 0.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.674 1.99 . . . . 0.0 111.642 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 56.94 158.51 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.013 2.125 . . . . 0.0 115.609 -172.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.75 -38.08 0.38 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.856 2.646 . . . . 0.0 115.039 -176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.4 p -67.75 -6.6 21.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.577 2.751 . . . . 0.0 114.795 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 63.5 t80 -115.6 113.61 23.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.232 2.613 . . . . 0.0 108.686 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -120.67 121.17 37.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.128 1.371 . . . . 0.0 110.079 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 ttp -107.62 139.22 42.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.967 0.507 . . . . 0.0 111.563 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -126.4 122.62 35.86 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.467 1.507 . . . . 0.0 108.531 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -122.66 137.93 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.224 1.01 . . . . 0.0 109.051 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -140.33 100.19 7.02 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.506 1.122 . . . . 0.0 110.282 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.16 162.12 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.319 2.012 . . . . 0.0 111.458 168.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -26.08 93.61 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.288 2.635 . . . . 0.0 115.852 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 47.24 42.82 14.06 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.792 1.637 . . . . 0.0 114.664 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.54 163.89 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.874 2.07 . . . . 0.0 110.955 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.25 94.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.177 1.791 . . . . 0.0 111.658 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.66 36.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 111.199 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.6 p -123.53 131.69 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.122 0.569 . . . . 0.0 109.972 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.08 133.65 55.24 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.327 1.451 . . . . 0.0 109.165 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -139.45 146.48 40.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.464 1.105 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -104.5 127.99 52.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.211 1.404 . . . . 0.0 109.033 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -49.2 103.81 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.841 1.656 . . . . 0.0 111.893 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 135.29 -26.71 3.2 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.997 0.808 . . . . 0.0 113.732 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.39 159.14 18.86 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.156 0.978 . . . . 0.0 111.113 162.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -64.29 171.47 3.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 0.0 112.054 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -50.29 130.58 23.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.202 -0.936 . . . . 0.0 111.152 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.84 153.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 109.313 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -108.84 129.57 55.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.61 89.86 13.76 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.35 1.46 . . . . 0.0 108.671 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.75 149.24 60.23 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.079 1.853 . . . . 0.0 112.048 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.4 mt -127.52 128.27 24.0 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.495 1.918 . . . . 0.0 106.81 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.25 -175.26 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.527 2.818 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 110.86 0.38 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.315 1.046 . . . . 0.0 111.484 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 150' ' ' ILE . 4.3 tp -121.17 75.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.169 1.388 . . . . 0.0 109.743 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 m -107.45 131.63 21.57 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.317 1.047 . . . . 0.0 110.557 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.51 152.28 94.07 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.577 0.885 . . . . 0.0 112.081 -4.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.72 -40.29 74.33 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.653 2.236 . . . . 0.0 113.061 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.25 -4.22 10.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.575 1.55 . . . . 0.0 114.88 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 p -62.14 157.77 18.39 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.457 1.026 . . . . 0.0 111.11 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -105.3 110.61 23.04 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.696 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.419 ' HB ' HD11 ' A' ' 143' ' ' LEU . 8.7 tt -77.96 122.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.211 1.005 . . . . 0.0 109.049 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.46 138.87 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.431 0.692 . . . . 0.0 110.784 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -147.47 158.82 44.14 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.045 0.926 . . . . 0.0 112.439 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.94 133.86 54.37 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.521 1.129 . . . . 0.0 109.459 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.9 124.3 42.91 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.868 1.667 . . . . 0.0 107.606 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.2 t -139.54 134.6 32.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.891 0.853 . . . . 0.0 109.753 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 115' ' ' TYR . 9.2 p -134.91 130.27 52.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.845 0.831 . . . . 0.0 109.135 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -143.63 130.04 19.98 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.619 1.568 . . . . 0.0 109.327 -168.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -64.34 135.17 55.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 109.481 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.2 p -88.76 10.18 21.84 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.37 1.068 . . . . 0.0 113.004 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -141.13 145.65 36.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.711 2.404 . . . . 0.0 109.635 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.2 t -63.76 135.0 96.09 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 121.829 -0.544 . . . . 0.0 111.859 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.57 125.47 10.26 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.666 0.917 . . . . 0.0 112.454 -6.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.84 25.11 11.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.368 1.867 . . . . 0.0 113.644 -170.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.16 159.85 9.08 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.079 -1.013 . . . . 0.0 111.939 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -58.16 107.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.744 0.817 . . . . 0.0 110.857 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.441 ' HB ' HG13 ' A' ' 156' ' ' VAL . 81.1 t -60.02 -55.01 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.877 1.271 . . . . 0.0 109.334 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.69 147.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.408 1.083 . . . . 0.0 110.299 164.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -136.63 120.68 17.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.894 1.678 . . . . 0.0 107.833 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.79 -173.07 31.06 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 122.1 0.833 . . . . 0.0 112.869 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.0 m -118.02 161.91 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.638 1.209 . . . . 0.0 111.224 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.25 164.6 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.731 2.412 . . . . 0.0 106.656 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -132.21 131.89 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.11 152.51 23.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -144.71 146.5 32.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.229 1.812 . . . . 0.0 109.842 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -119.46 151.95 37.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.963 1.305 . . . . 0.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 55.8 m -137.46 112.15 9.18 Favored Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 110.427 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.33 -15.43 20.03 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.487 2.791 . . . . 0.0 112.061 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.6 m -43.79 -42.31 5.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.421 2.689 . . . . 0.0 112.36 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.8 p -145.32 27.65 1.25 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.235 1.414 . . . . 0.0 113.069 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 45.29 41.65 8.59 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 120.258 -1.526 . . . . 0.0 113.997 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -87.74 137.74 32.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.3 1.44 . . . . 0.0 109.05 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.15 140.9 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -135.15 139.14 44.38 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.809 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -112.7 135.25 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.3 123.44 69.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 126.211 1.805 . . . . 0.0 106.751 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -139.46 124.98 19.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.895 1.678 . . . . 0.0 107.207 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -128.65 152.97 47.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 109.331 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -17.98 54.41 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.95 -18.74 62.62 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.649 1.58 . . . . 0.0 114.72 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.8 p -132.51 -50.86 0.92 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 112.89 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.42 142.17 40.13 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.319 1.448 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.86 164.91 34.24 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.468 2.112 . . . . 0.0 111.623 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -93.87 8.06 42.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.821 1.248 . . . . 0.0 112.854 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.303 1.441 . . . . 0.0 113.197 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -114.83 149.69 36.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.111 1.764 . . . . 0.0 107.267 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.2 p -133.21 161.77 33.55 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.771 0.828 . . . . 0.0 108.966 165.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.0 p -129.28 125.79 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.818 0.847 . . . . 0.0 109.004 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 10.0 t -104.7 144.19 32.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.9 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -82.89 80.18 9.03 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.569 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.23 -36.56 75.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.698 1.199 . . . . 0.0 112.538 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -150.55 173.44 14.09 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.133 1.773 . . . . 0.0 111.691 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -53.05 128.78 28.64 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.126 -1.609 . . . . 0.0 108.983 165.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.0 m 60.34 24.4 13.89 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 119.78 14.28 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.685 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 100' ' ' VAL . 20.5 m-85 -127.81 124.56 37.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 110.953 -167.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.42 100.19 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.643 0.777 . . . . 0.0 109.774 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -76.01 125.18 28.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.866 1.267 . . . . 0.0 110.248 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -121.93 126.88 49.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.913 1.285 . . . . 0.0 111.377 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 211' ' ' SER . 1.3 tm? -92.96 109.66 21.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.233 1.013 . . . . 0.0 110.92 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -110.62 10.74 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.466 1.506 . . . . 0.0 113.914 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.578 ' H ' HD13 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -168.04 109.91 0.59 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.696 1.998 . . . . 0.0 111.544 -178.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.86 -23.61 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 119.56 -1.963 . . . . 0.0 114.409 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 126.619 1.968 . . . . 0.0 111.865 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.77 150.28 41.82 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.592 -0.692 . . . . 0.0 110.33 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -22.35 27.59 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.185 -0.947 . . . . 0.0 113.414 172.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.93 15.96 17.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.558 1.943 . . . . 0.0 113.332 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -140.63 169.3 17.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.876 1.27 . . . . 0.0 110.279 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.3 t -131.46 148.4 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.898 0.879 . . . . 0.0 109.17 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 151.42 49.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.78 0.832 . . . . 0.0 110.842 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -145.15 127.09 15.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.651 -164.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.0 140.28 42.02 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 123.766 1.746 . . . . 0.0 111.198 -169.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.86 44.79 0.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 111.384 -168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.76 159.14 26.62 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.293 1.901 . . . . 0.0 110.44 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.81 139.18 58.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 111.337 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 t30 51.21 36.83 16.86 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.86 1.264 . . . . 0.0 114.056 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.8 m 61.85 64.46 1.01 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.218 1.807 . . . . 0.0 114.57 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 p -122.38 -44.91 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -69.86 1.36 Allowed Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.973 1.26 . . . . 0.0 113.624 -169.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -133.13 169.88 16.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.452 1.501 . . . . 0.0 109.772 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -136.42 149.67 48.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.891 1.277 . . . . 0.0 112.559 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 161.76 41.82 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.316 1.846 . . . . 0.0 110.912 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -134.01 141.07 47.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.17 1.388 . . . . 0.0 110.148 -175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.61 140.6 46.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.51 . . . . 0.0 109.986 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.93 147.22 23.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.903 0.881 . . . . 0.0 110.721 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -66.62 131.86 46.9 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.444 -0.785 . . . . 0.0 110.718 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.17 54.7 3.29 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.838 -0.423 . . . . 0.0 113.402 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.12 157.84 45.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.929 . . . . 0.0 112.088 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -132.93 127.44 34.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.664 1.186 . . . . 0.0 108.033 172.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.52 142.36 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.39 1.076 . . . . 0.0 109.747 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -135.64 119.23 17.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.521 1.128 . . . . 0.0 109.052 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--N 1.322 -0.589 0 C-N-CA 126.05 1.74 . . . . 0.0 107.98 -173.211 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.4 m0 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -73.78 -53.76 9.57 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.379 1.471 . . . . 0.0 110.399 168.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.68 -12.43 61.39 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -30.7 14.82 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.623 -1.298 . . . . 0.0 112.66 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.2 157.44 3.51 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 122.924 1.345 . . . . 0.0 114.303 173.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 -38.49 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.345 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -132.84 149.21 52.29 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.092 0.949 . . . . 0.0 112.682 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.5 p -151.84 143.92 23.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.72 0.772 . . . . 0.0 110.825 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.14 118.93 34.74 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -109.36 110.98 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.17 1.388 . . . . 0.0 108.841 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.83 166.91 4.53 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 122.901 1.278 . . . . 0.0 114.125 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.97 -27.51 64.78 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.873 -1.369 . . . . 0.0 114.647 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -121.47 36.26 4.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.243 1.817 . . . . 0.0 110.786 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.88 135.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.182 2.193 . . . . 0.0 109.956 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 150.58 28.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 109.315 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.36 152.23 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.819 0.819 . . . . 0.0 110.897 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -138.76 122.51 17.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.534 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.98 128.03 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.927 0.891 . . . . 0.0 110.284 -173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.82 113.42 10.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.676 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.34 -38.65 69.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.103 1.361 . . . . 0.0 113.628 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.64 174.3 15.18 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.982 1.313 . . . . 0.0 109.47 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -63.33 -66.57 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.832 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.264 0.6 OUTLIER 50.72 169.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.961 2.504 . . . . 0.0 117.225 -174.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.528 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 pt -152.06 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 126.623 1.969 . . . . 0.0 112.064 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 67.72 36.84 3.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.885 2.074 . . . . 0.0 111.589 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 60' ' ' ILE . 3.9 p -67.95 165.55 31.18 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.712 2.005 . . . . 0.0 110.373 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.86 19.59 0.28 Allowed 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.137 2.558 . . . . 0.0 114.142 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -149.23 60.18 4.5 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.0 112.306 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.99 140.13 49.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.028 1.818 . . . . 0.0 111.992 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.87 -115.45 1.36 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.282 1.42 . . . . 0.0 112.055 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 148.73 41.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.067 1.347 . . . . 0.0 112.265 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.03 137.69 23.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.252 1.821 . . . . 0.0 109.044 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -155.59 167.96 28.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.6 1.16 . . . . 0.0 110.754 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -127.53 108.25 10.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.401 1.48 . . . . 0.0 109.773 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.99 98.62 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.053 1.341 . . . . 0.0 109.607 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 142.94 25.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.421 1.489 . . . . 0.0 113.09 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 147.25 16.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.464 1.506 . . . . 0.0 113.458 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.64 45.18 96.83 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.709 0.671 . . . . 0.0 114.294 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.16 163.97 38.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.307 1.043 . . . . 0.0 112.385 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -137.06 142.61 42.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.33 1.052 . . . . 0.0 109.094 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.4 ' HB3' HD12 ' A' ' 80' ' ' LEU . 27.2 m-80 -131.22 129.45 41.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.243 1.017 . . . . 0.0 108.289 -172.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -129.37 -16.87 3.85 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.36 59.22 1.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.146 1.779 . . . . 0.0 110.391 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.647 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.94 10.04 11.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.123 2.569 . . . . 0.0 112.258 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -16.79 4.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.977 1.311 . . . . 0.0 112.952 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.6 m -46.32 -30.24 1.99 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.328 1.851 . . . . 0.0 114.639 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.06 -29.95 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 20.91 58.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 129.737 3.215 . . . . 0.0 114.022 -168.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.56 82.29 0.08 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -163.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 tt -126.2 45.68 2.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.284 1.433 . . . . 0.0 112.159 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -67.21 -34.77 78.2 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 119.876 -1.765 . . . . 0.0 113.236 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -117.42 128.42 55.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.628 1.171 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -122.32 123.67 41.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 109.556 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 125.92 54.69 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.31 121.84 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.874 1.27 . . . . 0.0 107.859 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -125.42 150.82 68.82 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.403 1.081 . . . . 0.0 109.893 -172.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.82 168.9 21.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.598 2.199 . . . . 0.0 111.448 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.46 40.07 1.08 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.691 2.091 . . . . 0.0 114.985 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.83 -43.24 0.15 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.483 1.913 . . . . 0.0 111.504 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.6 129.95 34.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.249 1.019 . . . . 0.0 109.48 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -86.85 -36.38 18.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.439 0.696 . . . . 0.0 112.224 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -148.22 156.43 42.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.215 2.206 . . . . 0.0 108.102 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.44 131.47 34.12 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -102.99 133.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 C-N-CA 124.605 1.162 . . . . 0.0 110.754 -175.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.47 135.96 36.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.13 150.98 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.897 -0.502 . . . . 0.0 110.418 167.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -139.18 149.0 43.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.225 1.01 . . . . 0.0 111.229 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.5 mt -109.46 128.75 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.196 1.798 . . . . 0.0 108.308 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.23 111.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.492 1.517 . . . . 0.0 109.232 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -65.98 141.7 58.1 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.737 -0.602 . . . . 0.0 110.574 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.3 23.95 3.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.182 1.393 . . . . 0.0 111.628 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.07 -56.12 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.326 1.85 . . . . 0.0 112.155 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -129.31 108.75 10.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.961 1.304 . . . . 0.0 110.028 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.4 t -71.75 89.69 1.04 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 0.0 111.029 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -149.41 -39.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.8 1.24 . . . . 0.0 111.865 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 54.5 172.99 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.232 1.813 . . . . 0.0 114.432 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.68 -42.29 0.56 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.716 1.627 . . . . 0.0 115.816 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -64.49 -28.6 69.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.572 1.549 . . . . 0.0 113.901 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -88.31 115.18 25.62 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.513 1.125 . . . . 0.0 109.644 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.69 123.22 49.38 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.317 1.447 . . . . 0.0 108.898 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -113.52 130.83 56.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.824 0.849 . . . . 0.0 110.116 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.5 m -123.46 132.58 53.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.506 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.73 127.77 71.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -123.87 88.68 52.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.786 1.634 . . . . 0.0 108.417 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.47 163.98 35.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 111.944 172.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -36.36 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.626 2.37 . . . . 0.0 114.055 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 38.95 46.57 1.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.658 1.583 . . . . 0.0 114.699 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.45 156.34 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.499 1.92 . . . . 0.0 109.589 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -45.14 93.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.609 1.963 . . . . 0.0 113.03 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 155.44 24.13 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.328 1.051 . . . . 0.0 110.663 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.52 146.57 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.382 0.61 . . . . 0.0 110.222 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -122.72 134.27 54.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.781 1.232 . . . . 0.0 108.417 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.5 t -134.7 149.76 50.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 145.13 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -48.26 127.53 12.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.247 1.019 . . . . 0.0 109.617 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.34 48.9 4.62 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.78 167.32 21.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.408 1.483 . . . . 0.0 110.968 169.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -59.49 154.69 16.66 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.585 -0.697 . . . . 0.0 111.056 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -47.87 126.05 9.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 111.253 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 123.6 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.326 0.584 . . . . 0.0 110.017 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -75.79 129.86 37.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 110.365 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.9 tp -119.3 106.4 42.86 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.116 1.766 . . . . 0.0 108.104 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 142.73 39.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.669 2.246 . . . . 0.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.3 mm -134.18 127.08 18.86 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.292 1.037 . . . . 0.0 109.183 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.02 176.62 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.783 2.989 . . . . 0.0 112.777 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -80.24 144.64 32.73 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.522 -0.736 . . . . 0.0 111.434 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.44 48.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.857 1.663 . . . . 0.0 111.447 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -47.62 136.55 9.96 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 125.032 1.333 . . . . 0.0 113.785 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.1 143.72 77.14 Favored 'Cis proline' 0 CA--C 1.543 0.966 0 CA-C-N 119.963 1.023 . . . . 0.0 111.747 -1.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.03 -16.49 45.08 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.479 2.119 . . . . 0.0 113.96 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -3.09 5.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.546 1.139 . . . . 0.0 113.978 168.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 m -66.85 124.16 22.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.969 -1.082 . . . . 0.0 111.267 163.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -64.22 133.0 51.98 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.556 0.743 . . . . 0.0 111.644 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.2 tt -100.38 132.59 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.478 1.511 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.1 p -77.35 142.15 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.798 -0.564 . . . . 0.0 110.677 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.4 m -144.15 159.19 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.315 1.446 . . . . 0.0 110.409 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -123.09 141.15 52.28 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.673 0.789 . . . . 0.0 110.068 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.24 126.93 46.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.91 1.684 . . . . 0.0 108.992 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.28 112.94 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.58 126.66 71.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -131.17 139.55 49.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.066 1.747 . . . . 0.0 108.868 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.52 124.26 23.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -71.31 -15.68 62.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.794 1.237 . . . . 0.0 113.137 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.04 173.36 6.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.718 2.007 . . . . 0.0 111.366 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.6 p -52.75 147.83 14.56 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.814 1.246 . . . . 0.0 113.648 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 7.17 16.26 Favored 'Cis proline' 0 CA--C 1.546 1.092 0 N-CA-C 114.398 0.884 . . . . 0.0 114.398 0.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.04 32.76 10.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.656 1.583 . . . . 0.0 113.648 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 150.19 20.65 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.736 1.214 . . . . 0.0 111.395 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -57.73 108.64 0.59 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.821 0.848 . . . . 0.0 109.548 167.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.8 t -65.48 -56.82 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.079 0.952 . . . . 0.0 109.581 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.72 155.05 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.652 0.781 . . . . 0.0 111.984 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -142.72 77.89 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.268 1.827 . . . . 0.0 110.767 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -115.09 -178.03 18.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.17 1.367 . . . . 0.0 112.954 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.3 m -127.05 148.5 50.12 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 110.188 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.31 160.55 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.055 1.742 . . . . 0.0 109.494 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.73 137.61 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.34 145.6 43.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -140.93 158.0 44.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.859 1.264 . . . . 0.0 109.586 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -127.11 116.45 20.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.011 0.925 . . . . 0.0 110.98 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.5 m -83.33 118.47 71.69 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.92 -1.113 . . . . 0.0 109.282 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.35 -19.6 43.49 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.526 2.151 . . . . 0.0 112.547 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.3 m -45.33 -51.7 10.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.918 2.087 . . . . 0.0 112.469 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 20.8 p -143.26 34.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 0.0 112.407 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.83 42.43 94.59 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.211 -1.555 . . . . 0.0 114.1 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.97 173.91 10.18 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.105 1.362 . . . . 0.0 112.717 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 100' ' ' VAL . 17.3 m -128.62 142.01 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 111.177 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 72.7 m -137.83 108.86 6.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.65 1.18 . . . . 0.0 108.188 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.53 HG13 ' CZ ' ' A' ' 205' ' ' PHE . 2.6 m -83.81 141.25 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.826 0.822 . . . . 0.0 111.21 173.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -120.8 134.76 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.813 2.045 . . . . 0.0 107.337 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -152.58 132.92 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.27 1.428 . . . . 0.0 107.816 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -114.77 152.99 31.15 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.756 1.223 . . . . 0.0 109.664 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.66 -15.58 61.51 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.55 -31.64 13.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.544 1.537 . . . . 0.0 114.38 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.6 p -87.5 -42.28 12.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 0.0 111.326 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.465 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.2 t80 -87.3 148.61 45.08 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.729 2.011 . . . . 0.0 110.759 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 95.4 Cg_endo -76.95 178.2 7.93 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.443 2.095 . . . . 0.0 111.608 173.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.91 44.03 2.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.051 1.74 . . . . 0.0 110.87 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -144.98 -27.61 0.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.94 1.296 . . . . 0.0 113.529 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.6 ttm -137.71 139.89 40.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.22 2.208 . . . . 0.0 107.673 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.8 p -134.79 155.8 49.97 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.76 140.8 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.233 1.013 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 8.8 t -140.16 163.02 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.041 1.337 . . . . 0.0 110.49 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 118.71 26.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.218 1.407 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.8 8.29 5.28 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 112.717 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.94 16.92 2.84 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.819 1.248 . . . . 0.0 113.333 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.47 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.047 2.539 . . . . 0.0 114.368 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.7 m 80.89 21.29 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.43 1.092 . . . . 0.0 111.676 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -136.74 128.63 29.22 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.788 1.635 . . . . 0.0 111.37 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 49.1 m-85 -118.99 133.6 55.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.805 1.642 . . . . 0.0 111.335 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.65 106.25 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.642 0.777 . . . . 0.0 109.268 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -84.84 126.35 33.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.074 1.35 . . . . 0.0 110.951 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -117.91 121.32 40.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.364 1.466 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.86 98.82 11.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.816 1.246 . . . . 0.0 109.601 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -80.42 -30.1 37.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 113.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -144.96 134.88 23.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 109.353 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.1 -50.83 72.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.258 0.935 . . . . 0.0 111.783 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 125.156 1.382 . . . . 0.0 111.416 -169.514 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.16 143.29 57.96 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.807 -0.558 . . . . 0.0 109.536 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.43 -19.1 5.02 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -116.28 17.83 15.48 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.246 2.219 . . . . 0.0 113.647 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -135.34 171.63 14.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.689 1.596 . . . . 0.0 111.051 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 150.47 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.594 1.158 . . . . 0.0 108.806 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 149.77 34.47 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 112.938 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.93 130.83 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.333 1.453 . . . . 0.0 109.495 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.98 125.91 42.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.589 1.155 . . . . 0.0 110.199 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.98 55.04 3.31 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.236 1.017 . . . . 0.0 112.046 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.95 148.27 7.58 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.979 1.276 . . . . 0.0 111.039 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -59.53 133.21 55.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.431 1.092 . . . . 0.0 111.279 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 71.52 41.97 0.7 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.202 1.801 . . . . 0.0 114.021 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m 53.08 61.91 2.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.519 1.528 . . . . 0.0 113.592 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.0 p -130.56 178.48 6.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.131 1.372 . . . . 0.0 112.188 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.34 -85.26 1.04 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.343 1.449 . . . . 0.0 113.752 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.22 170.52 14.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.364 1.466 . . . . 0.0 110.777 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -139.53 148.54 42.75 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 111.304 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.75 147.56 26.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.582 1.553 . . . . 0.0 110.487 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -125.06 132.59 53.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.462 1.105 . . . . 0.0 110.399 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -129.76 133.44 47.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.908 1.337 . . . . 0.0 111.454 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.62 138.57 43.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.946 1.298 . . . . 0.0 111.473 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 148.43 51.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.278 1.031 . . . . 0.0 111.42 168.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.32 41.29 68.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.43 1.014 . . . . 0.0 112.553 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -144.14 160.76 40.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.076 1.35 . . . . 0.0 112.248 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 m -121.56 131.7 54.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.288 1.435 . . . . 0.0 108.25 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.54 141.13 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.918 0.887 . . . . 0.0 108.727 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -126.77 151.37 48.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.436 1.095 . . . . 0.0 110.982 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 125.661 1.584 . . . . 0.0 109.72 178.478 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -63.98 -24.74 67.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -70.19 0.11 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.713 168.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.303 0.3 OUTLIER 27.75 48.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 128.164 2.586 . . . . 0.0 115.761 -175.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.02 133.78 46.06 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.986 2.114 . . . . 0.0 109.337 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mmt -153.78 -45.24 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.487 1.915 . . . . 0.0 111.324 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 t -136.07 130.24 33.13 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.415 1.086 . . . . 0.0 109.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 89.6 m -140.96 145.4 35.97 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.54 121.72 36.36 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.325 1.05 . . . . 0.0 108.606 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.4 t -105.49 143.08 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.454 1.902 . . . . 0.0 106.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.92 -97.09 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.324 1.916 . . . . 0.0 117.301 -172.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 4.2 t -161.57 -42.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.634 1.173 . . . . 0.0 111.504 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.88 33.88 4.95 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.261 1.425 . . . . 0.0 110.617 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -146.69 157.12 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.524 2.33 . . . . 0.0 109.798 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -136.75 154.52 50.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.428 1.891 . . . . 0.0 110.132 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.7 t -123.55 143.26 50.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.683 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -134.04 139.09 45.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 109.405 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.1 119.75 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.009 1.324 . . . . 0.0 107.989 -167.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.72 135.51 50.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.962 0.905 . . . . 0.0 109.817 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.02 -60.7 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.246 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.5 -178.73 7.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.553 0.741 . . . . 0.0 111.957 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -65.95 129.97 41.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.923 0.889 . . . . 0.0 113.074 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -178.14 6.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.175 1.79 . . . . 0.0 110.088 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.74 44.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.227 1.411 . . . . 0.0 113.104 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 57.68 48.53 13.89 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.16 1.457 . . . . 0.0 111.855 -171.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 8.3 p -64.31 167.36 8.51 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.804 1.642 . . . . 0.0 110.791 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 53.2 Cg_endo -72.9 11.08 0.93 Allowed 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.954 2.436 . . . . 0.0 113.967 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -147.28 57.85 3.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.768 1.627 . . . . 0.0 111.973 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.86 154.06 73.95 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.408 1.405 . . . . 0.0 110.659 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.45 -105.52 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -142.85 150.91 40.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.773 1.629 . . . . 0.0 110.217 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -151.39 140.03 20.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.222 1.409 . . . . 0.0 109.254 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.33 156.73 26.75 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 110.341 172.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.13 97.95 5.66 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.851 0.861 . . . . 0.0 109.799 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.14 124.36 14.24 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.525 1.13 . . . . 0.0 109.677 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.92 163.37 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.563 1.145 . . . . 0.0 113.024 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 165.51 1.19 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.866 171.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 48' ' ' SER . . . -21.22 108.4 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.883 2.183 . . . . 0.0 118.296 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 p -167.1 177.35 6.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.375 1.07 . . . . 0.0 112.906 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 m -107.89 97.69 7.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.499 1.919 . . . . 0.0 109.45 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.877 0.871 . . . . 0.0 109.836 171.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -128.83 12.52 6.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.03 1.332 . . . . 0.0 112.493 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -153.21 38.26 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.699 -1.25 . . . . 0.0 113.106 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.9 -1.91 57.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.701 1.2 . . . . 0.0 114.036 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -12.62 1.95 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.042 1.737 . . . . 0.0 114.394 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -46.57 -32.0 3.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.022 1.329 . . . . 0.0 113.883 165.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.3 tp -70.34 -35.5 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.258 7.3 m-20 30.73 46.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.336 2.655 . . . . 0.0 115.411 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.04 107.95 0.24 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.94 0.781 . . . . 0.0 112.649 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.3 85.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.113 0.958 . . . . 0.0 113.111 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -75.59 -6.57 51.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.744 -1.223 . . . . 0.0 113.171 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -129.95 137.6 50.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.738 2.415 . . . . 0.0 111.048 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.86 128.48 38.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.114 1.366 . . . . 0.0 109.183 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.96 119.41 25.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.952 0.901 . . . . 0.0 108.825 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.39 118.17 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.92 150.28 71.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.102 0.961 . . . . 0.0 110.205 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.5 -173.49 0.99 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.674 2.249 . . . . 0.0 112.64 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.67 -26.64 24.34 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.146 1.355 . . . . 0.0 113.498 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -43.44 87.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.014 0.907 . . . . 0.0 112.287 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.55 126.07 37.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.868 1.267 . . . . 0.0 109.062 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.89 -47.39 11.11 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.307 -0.87 . . . . 0.0 110.853 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -143.06 160.0 41.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.561 1.944 . . . . 0.0 108.794 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.21 152.17 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.548 0.739 . . . . 0.0 109.817 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.4 139.7 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.781 0.832 . . . . 0.0 111.003 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.41 139.18 38.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.79 143.47 40.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 125.737 1.615 . . . . 0.0 109.725 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -148.39 133.05 17.82 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.83 1.252 . . . . 0.0 109.688 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.04 137.01 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.332 1.053 . . . . 0.0 108.432 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -140.49 95.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.92 2.088 . . . . 0.0 108.823 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -71.92 122.7 21.27 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.891 -1.131 . . . . 0.0 111.256 173.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 12.72 31.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.574 1.55 . . . . 0.0 112.891 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -127.21 -66.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.606 1.562 . . . . 0.0 110.865 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.47 128.12 37.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.757 0.823 . . . . 0.0 110.524 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -102.4 53.91 0.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.339 1.066 . . . . 0.0 110.947 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -140.32 63.54 1.47 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 123.579 1.657 . . . . 0.0 110.61 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.67 143.84 19.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 113.537 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.34 9.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.394 1.473 . . . . 0.0 114.397 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -87.19 -35.57 18.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.478 1.139 . . . . 0.0 113.707 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.41 126.47 29.71 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.071 0.948 . . . . 0.0 109.891 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -128.75 125.68 38.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.4 1.48 . . . . 0.0 108.957 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.2 ttp -114.27 134.96 54.57 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.294 1.437 . . . . 0.0 109.38 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -122.42 135.33 54.66 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.443 1.497 . . . . 0.0 108.058 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.5 pt -131.17 137.19 56.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.943 0.897 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 m -137.84 94.64 11.4 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 0.0 109.504 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.14 165.43 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.957 2.438 . . . . 0.0 111.455 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -26.17 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.907 3.283 . . . . 0.0 115.689 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 42.22 45.78 3.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.407 1.483 . . . . 0.0 114.324 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.2 t -111.19 159.82 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.055 2.142 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.55 94.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.997 2.519 . . . . 0.0 112.937 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 143.63 56.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 110.728 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.01 145.28 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.926 0.89 . . . . 0.0 110.293 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -130.29 138.01 50.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.46 1.504 . . . . 0.0 109.245 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.12 160.78 40.33 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.84 1.256 . . . . 0.0 110.423 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -120.32 154.45 34.99 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.963 0.905 . . . . 0.0 109.79 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.62 143.96 39.33 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.167 -0.333 . . . . 0.0 110.935 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.94 47.96 43.63 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.702 0.667 . . . . 0.0 114.61 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.36 162.16 24.41 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.453 1.501 . . . . 0.0 110.996 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 153.02 6.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.006 0.922 . . . . 0.0 111.941 169.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.26 118.49 3.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.307 1.043 . . . . 0.0 111.754 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.3 t -92.78 141.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 108.881 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -104.28 135.98 44.73 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.956 0.798 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tp -115.95 101.7 53.99 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.782 2.033 . . . . 0.0 108.155 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.58 147.55 40.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.562 2.175 . . . . 0.0 112.336 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -137.41 132.85 17.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.009 1.324 . . . . 0.0 109.33 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.52 174.73 11.71 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.377 3.385 . . . . 0.0 112.646 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -64.27 147.11 53.19 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.59 -0.694 . . . . 0.0 112.337 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 pp -153.97 158.84 41.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.83 2.052 . . . . 0.0 110.186 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -147.97 139.95 14.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 111.998 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.83 155.75 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 CA-C-N 119.662 0.915 . . . . 0.0 112.377 -9.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.25 -39.64 37.09 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.901 1.734 . . . . 0.0 111.761 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -72.08 8.28 1.34 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.122 1.769 . . . . 0.0 113.631 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -78.0 -178.05 5.33 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.42 -1.425 . . . . 0.0 111.554 166.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 160.39 21.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.279 1.432 . . . . 0.0 112.368 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 16.0 tt -122.56 133.11 69.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.722 1.609 . . . . 0.0 109.827 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.06 131.9 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.936 0.894 . . . . 0.0 110.666 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.2 m -146.39 166.45 26.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.136 0.97 . . . . 0.0 111.335 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -134.01 147.36 50.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.853 0.861 . . . . 0.0 111.023 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.6 tt -130.1 130.44 44.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.055 1.742 . . . . 0.0 109.164 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.51 117.33 9.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.745 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 167' ' ' VAL . 1.4 p -122.32 132.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.847 1.259 . . . . 0.0 108.753 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.24 144.92 27.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 110.195 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -77.79 126.12 30.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -68.1 -28.65 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.246 1.018 . . . . 0.0 113.346 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.53 174.08 6.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.695 1.598 . . . . 0.0 111.923 172.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 p -52.18 147.5 13.21 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.36 1.464 . . . . 0.0 113.517 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.2 12.13 19.74 Favored 'Cis proline' 0 CA--C 1.545 1.047 0 N-CA-C 114.714 1.006 . . . . 0.0 114.714 3.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.76 24.46 9.9 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.343 1.457 . . . . 0.0 113.082 170.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -88.81 135.53 33.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.897 -1.127 . . . . 0.0 111.276 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -57.64 111.1 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.732 0.813 . . . . 0.0 109.996 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.71 -57.99 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.351 1.06 . . . . 0.0 109.028 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.425 HG22 ' CG1' ' A' ' 156' ' ' VAL . 33.5 m -147.4 153.55 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.733 0.777 . . . . 0.0 111.978 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -145.75 105.92 4.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.043 1.737 . . . . 0.0 108.72 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.12 157.33 28.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 121.837 0.687 . . . . 0.0 113.003 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.2 m -74.15 150.44 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.173 0.987 . . . . 0.0 111.196 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.35 161.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.951 2.1 . . . . 0.0 108.526 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.86 132.22 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.485 0.659 . . . . 0.0 109.656 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.03 152.83 23.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -145.19 151.44 38.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.732 2.013 . . . . 0.0 108.121 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -115.39 132.95 56.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.423 1.089 . . . . 0.0 108.931 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.8 t -93.38 103.49 9.79 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.09 -17.43 45.69 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.734 2.289 . . . . 0.0 112.828 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.4 m -53.08 -42.9 66.31 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.994 2.118 . . . . 0.0 112.958 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 48.2 p -144.16 18.33 1.75 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.35 1.46 . . . . 0.0 112.483 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.46 73.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.761 1.648 . . . . 0.0 114.622 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.678 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 4.0 tt0 -73.33 -170.27 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.079 1.419 . . . . 0.0 111.585 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.678 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 1.4 p -135.41 155.18 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 128.041 2.537 . . . . 0.0 107.749 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.0 m -140.31 150.76 44.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.208 1.803 . . . . 0.0 107.996 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 205' ' ' PHE . 6.8 p -121.5 140.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 22.9 mt -123.6 129.95 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.51 140.39 33.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 108.896 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.82 34.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.509 1.123 . . . . 0.0 109.707 -168.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -28.58 67.0 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.46 -30.52 47.45 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.311 1.844 . . . . 0.0 115.039 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 p -101.21 -53.54 3.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.531 1.132 . . . . 0.0 111.632 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.525 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 17.6 t80 -85.65 148.74 49.68 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.537 1.935 . . . . 0.0 110.913 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 72.5 Cg_endo -77.1 -175.05 2.45 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.692 2.928 . . . . 0.0 111.577 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.25 30.17 6.68 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.01 1.724 . . . . 0.0 111.967 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -132.15 -38.86 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.862 1.665 . . . . 0.0 113.187 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 30.0 ttm -112.77 145.45 40.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.434 1.893 . . . . 0.0 106.804 167.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -140.43 150.05 43.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.949 0.899 . . . . 0.0 110.579 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.16 142.44 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.521 -0.737 . . . . 0.0 111.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 12.2 t -139.95 156.13 46.81 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.611 1.164 . . . . 0.0 111.232 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.64 81.79 0.84 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 111.349 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -60.59 -31.21 70.37 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.854 -1.154 . . . . 0.0 112.627 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.46 173.91 11.39 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.639 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.37 118.76 7.91 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.76 174.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.251 30.0 m 63.08 28.85 16.24 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 112.593 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 t -137.38 125.08 22.35 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.096 -1.003 . . . . 0.0 112.389 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 184' ' ' VAL . 12.3 m-85 -109.08 134.75 51.28 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 112.317 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.87 107.32 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.76 1.224 . . . . 0.0 109.72 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.91 108.43 17.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.855 1.262 . . . . 0.0 109.916 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -92.77 136.3 33.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.302 1.441 . . . . 0.0 110.185 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.56 119.96 40.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.631 0.773 . . . . 0.0 110.258 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -107.87 -6.21 16.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.899 1.68 . . . . 0.0 113.701 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -121.64 -169.91 1.95 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.767 2.027 . . . . 0.0 111.628 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -154.05 26.59 0.48 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 126.078 1.751 . . . . 0.0 113.75 -177.386 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 4' ' ' ASP 0.291 8.4 p . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 3' ' ' VAL . 4.0 t70 -75.15 147.97 40.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 119.834 -1.791 . . . . 0.0 109.916 169.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.12 -18.52 10.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.09 14.96 17.16 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.313 2.245 . . . . 0.0 113.87 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -138.74 177.79 7.63 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.107 1.321 . . . . 0.0 111.175 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.21 156.55 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.015 1.326 . . . . 0.0 111.318 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.442 ' HD2' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.32 145.44 33.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.661 1.185 . . . . 0.0 110.927 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 137.09 36.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.427 1.491 . . . . 0.0 108.421 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -132.34 124.57 29.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.515 1.126 . . . . 0.0 110.521 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -80.21 60.09 3.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.133 1.373 . . . . 0.0 111.441 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.9 131.11 1.44 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 141.23 15.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.362 1.065 . . . . 0.0 111.116 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.39 42.45 14.68 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.22 59.62 2.64 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.63 1.972 . . . . 0.0 113.302 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.8 m -133.9 -179.35 5.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.334 1.454 . . . . 0.0 111.206 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 17' ' ' THR . . . 69.22 -105.63 1.55 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.586 1.565 . . . . 0.0 113.379 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -113.53 164.54 13.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.156 0.982 . . . . 0.0 111.634 174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -130.38 145.29 51.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.551 1.14 . . . . 0.0 111.938 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 160.24 43.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.897 1.679 . . . . 0.0 110.673 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -127.99 154.99 44.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.24 1.016 . . . . 0.0 110.722 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.44 136.96 45.51 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.661 1.184 . . . . 0.0 110.935 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -92.1 147.82 22.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.53 1.132 . . . . 0.0 110.278 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.06 139.44 58.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.174 0.59 . . . . 0.0 111.64 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.69 28.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.98 0.8 . . . . 0.0 112.764 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.34 122.24 22.36 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.328 1.051 . . . . 0.0 110.763 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 m -107.37 130.28 54.81 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.978 1.311 . . . . 0.0 108.595 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' A' ' 89' ' ' PHE . 2.3 m -133.72 132.66 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.348 1.459 . . . . 0.0 109.776 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -122.79 140.05 53.33 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.801 1.241 . . . . 0.0 109.707 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 C-N-CA 124.878 1.271 . . . . 0.0 108.952 -173.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.3 m0 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 121.155 0.502 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -39.12 64.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.142 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -55.82 -62.66 1.55 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.174 0.989 . . . . 0.0 109.211 176.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.21 31.86 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.198 1.799 . . . . 0.0 113.582 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.66 128.0 40.05 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.111 2.164 . . . . 0.0 107.813 -172.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 mtp -138.45 -50.16 0.55 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 111.823 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.4 p -133.54 122.98 24.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.543 0.687 . . . . 0.0 110.697 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.6 m -144.81 154.53 42.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -138.67 149.73 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.236 1.017 . . . . 0.0 111.166 -173.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 8' ' ' VAL . 21.3 t -122.8 136.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.64 1.576 . . . . 0.0 109.019 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -87.28 0.03 OUTLIER Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.675 1.131 . . . . 0.0 114.959 -167.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.0 p -173.01 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -127.12 33.16 4.95 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.317 1.447 . . . . 0.0 111.186 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 46' ' ' VAL . 3.0 m -141.61 146.09 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.518 1.927 . . . . 0.0 108.753 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -114.29 143.75 44.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.638 1.175 . . . . 0.0 108.553 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.67 131.97 54.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 109.439 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -117.37 123.77 47.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.987 1.315 . . . . 0.0 108.244 -170.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.05 119.86 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 122.122 0.963 . . . . 0.0 111.822 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -132.38 118.19 19.06 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 109.976 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.52 -54.92 15.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.53 1.132 . . . . 0.0 111.356 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -130.3 122.29 27.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -164.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.02 31.54 0.44 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.9 1.28 . . . . 0.0 112.431 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.46 165.07 5.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.144 2.578 . . . . 0.0 114.335 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 mm -112.76 39.43 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.29 52.2 m-20 57.15 50.31 12.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.617 1.967 . . . . 0.0 112.837 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.9 p -73.67 176.34 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.865 2.466 . . . . 0.0 110.893 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 65.7 Cg_endo -73.16 3.95 4.18 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.9 2.4 . . . . 0.0 113.796 173.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -136.32 64.32 52.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.93 1.692 . . . . 0.0 110.502 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.89 138.33 57.18 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.302 1.335 . . . . 0.0 109.326 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.62 -121.91 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.873 0.749 . . . . 0.0 111.663 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -134.33 140.16 46.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.508 1.123 . . . . 0.0 111.052 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.72 139.76 24.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.702 1.201 . . . . 0.0 109.868 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -157.25 165.77 34.98 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.559 1.171 . . . . 0.0 111.263 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -132.7 104.46 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.307 1.443 . . . . 0.0 107.5 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 46' ' ' VAL . 6.7 mp -64.75 116.05 5.89 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.71 160.94 0.39 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.832 2.053 . . . . 0.0 114.227 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -47.28 -34.17 6.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.16 135.24 3.63 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 164.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.54 167.86 0.65 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.789 2.036 . . . . 0.0 110.824 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -123.31 105.48 9.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.802 1.241 . . . . 0.0 110.098 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -83.82 100.88 11.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -70.49 -20.69 62.84 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.6 73.85 0.98 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.96 2.43 12.63 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.69 -1.257 . . . . 0.0 114.023 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -53.0 -10.78 0.19 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.96 2.104 . . . . 0.0 115.298 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.2 m -48.95 -32.08 8.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.057 1.299 . . . . 0.0 113.994 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -87.56 -32.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.84 30.02 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.545 2.738 . . . . 0.0 115.95 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.84 109.75 0.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -160.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 178.31 55.09 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.416 2.286 . . . . 0.0 110.027 -170.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -57.99 -22.17 48.22 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 134.45 53.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.856 1.263 . . . . 0.0 110.648 173.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -138.07 135.59 35.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.555 1.542 . . . . 0.0 109.815 -174.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -141.88 142.63 33.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.717 0.77 . . . . 0.0 112.088 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.87 123.08 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.605 . . . . 0.0 109.238 -170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 96' ' ' PHE . 93.1 mt -141.03 157.64 66.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.978 0.911 . . . . 0.0 111.236 -168.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.57 160.7 43.71 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.895 2.397 . . . . 0.0 113.315 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.88 -17.08 69.07 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 121.24 -0.913 . . . . 0.0 115.022 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.09 70.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -72.84 163.71 27.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.947 1.299 . . . . 0.0 111.477 173.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -35.62 0.99 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.152 1.381 . . . . 0.0 111.54 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -154.39 160.99 41.97 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.298 1.839 . . . . 0.0 109.666 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.42 160.98 39.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.522 0.729 . . . . 0.0 110.197 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.0 145.45 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.315 1.046 . . . . 0.0 110.516 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.11 127.78 45.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.05 1.34 . . . . 0.0 108.287 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -128.58 135.38 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.818 -0.551 . . . . 0.0 110.295 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -123.81 143.35 50.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.443 1.497 . . . . 0.0 109.539 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.3 mt -111.85 131.08 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.64 103.3 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 122.564 1.173 . . . . 0.0 110.962 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.1 134.33 49.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.409 1.884 . . . . 0.0 110.751 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 -21.95 8.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.429 1.092 . . . . 0.0 113.571 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.59 -55.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 119.085 0.857 . . . . 0.0 111.026 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.04 93.4 4.48 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 109.026 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -73.42 48.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.593 1.557 . . . . 0.0 112.553 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -143.16 51.7 1.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.229 2.612 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.58 129.03 31.34 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.717 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.8 -31.83 3.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.119 1.819 . . . . 0.0 112.25 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 m -79.53 -18.0 52.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 114.066 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.66 137.35 38.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.16 1.384 . . . . 0.0 108.622 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.9 121.15 34.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.849 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 4.8 ttp -113.4 132.95 55.43 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.458 1.103 . . . . 0.0 110.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.7 m -122.1 132.42 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.383 1.473 . . . . 0.0 108.343 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.2 122.72 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.0 m -120.54 86.46 39.69 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 125.797 1.639 . . . . 0.0 109.16 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.39 157.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.609 2.872 . . . . 0.0 112.693 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -39.53 86.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.659 2.784 . . . . 0.0 114.576 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 38.87 42.53 0.65 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.02 159.4 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.755 2.022 . . . . 0.0 109.434 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.61 92.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.201 2.2 . . . . 0.0 113.047 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 149.5 49.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.61 0.764 . . . . 0.0 110.917 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.06 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.225 1.01 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.51 136.36 50.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.1 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 17.9 p -137.57 137.63 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.045 1.338 . . . . 0.0 108.606 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.54 142.13 33.14 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 166.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.59 151.37 6.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 111.043 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.01 42.85 10.38 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 120.846 -1.159 . . . . 0.0 113.155 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.01 161.64 29.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.167 1.787 . . . . 0.0 108.927 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 151.58 14.91 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.462 -0.774 . . . . 0.0 110.619 166.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -38.43 115.2 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.649 1.58 . . . . 0.0 111.784 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.02 130.64 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -81.28 123.62 28.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.417 0.687 . . . . 0.0 109.46 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.53 96.06 49.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.067 1.747 . . . . 0.0 108.534 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 146.81 41.55 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.212 1.941 . . . . 0.0 111.287 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.38 132.08 24.14 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.926 2.091 . . . . 0.0 107.633 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.93 175.83 9.87 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.144 2.562 . . . . 0.0 113.195 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -57.72 155.96 9.31 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.376 0.671 . . . . 0.0 112.534 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 pp -170.86 156.96 5.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.613 1.965 . . . . 0.0 109.86 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.8 t -137.24 138.41 25.17 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.966 0.906 . . . . 0.0 111.565 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 157.28 72.12 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 119.527 0.867 . . . . 0.0 111.97 -7.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.02 -36.39 48.97 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.577 1.518 . . . . 0.0 112.09 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -74.18 7.52 2.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.3 p -65.71 174.97 2.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.904 -1.123 . . . . 0.0 112.804 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.42 132.4 56.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.843 1.257 . . . . 0.0 110.952 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.27 116.18 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.788 1.635 . . . . 0.0 108.4 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.5 133.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 122.97 0.508 . . . . 0.0 109.949 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.1 p -131.32 160.46 34.92 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.794 1.237 . . . . 0.0 110.397 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -114.4 137.18 52.15 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.212 0.605 . . . . 0.0 109.543 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.81 138.65 49.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.955 1.702 . . . . 0.0 107.931 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.46 111.54 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.573 1.549 . . . . 0.0 108.186 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 4.7 p -120.52 130.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.963 1.305 . . . . 0.0 109.461 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -144.24 141.65 29.99 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.265 1.826 . . . . 0.0 109.349 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 137.98 52.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.493 0.317 . . . . 0.0 111.339 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -77.19 -5.26 48.53 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.613 1.165 . . . . 0.0 113.843 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 179.75 5.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.766 2.426 . . . . 0.0 110.686 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.15 150.13 22.44 Favored Pre-proline 0 N--CA 1.481 1.081 0 O-C-N 121.017 -1.052 . . . . 0.0 113.193 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.13 7.22 22.77 Favored 'Cis proline' 0 CA--C 1.545 1.029 0 CA-C-N 119.847 0.981 . . . . 0.0 114.513 -0.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.36 35.18 24.64 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 113.626 171.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -102.05 156.33 17.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 111.302 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -64.86 86.88 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.9 -1.125 . . . . 0.0 111.696 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.5 -54.38 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.763 2.025 . . . . 0.0 110.848 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 96.4 t -146.71 127.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.161 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -144.94 136.37 25.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 109.927 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.86 178.77 41.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.674 0.654 . . . . 0.0 112.255 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.2 m -109.77 149.62 29.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.005 0.907 . . . . 0.0 111.798 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.95 147.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.149 2.18 . . . . 0.0 108.215 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.36 132.54 54.34 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.405 -0.809 . . . . 0.0 109.491 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -107.73 141.23 39.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.557 1.143 . . . . 0.0 109.517 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -136.18 143.39 44.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.714 1.605 . . . . 0.0 109.573 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -115.09 115.31 26.58 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.826 0.851 . . . . 0.0 110.413 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.9 m -76.49 107.8 5.27 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.422 1.089 . . . . 0.0 109.525 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.75 -14.37 32.91 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.629 2.219 . . . . 0.0 112.908 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.2 m -53.35 -44.8 68.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 113.348 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.3 p -142.32 22.92 2.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.097 1.359 . . . . 0.0 113.016 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 53.1 39.03 57.12 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.974 1.75 . . . . 0.0 114.571 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -80.02 166.25 21.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.518 0.727 . . . . 0.0 110.815 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.76 148.83 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.4 m -129.58 145.31 51.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.055 2.142 . . . . 0.0 108.527 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.26 128.28 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.176 1.39 . . . . 0.0 109.746 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.56 120.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.733 1.613 . . . . 0.0 106.921 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.18 140.56 37.85 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.774 1.63 . . . . 0.0 107.846 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -136.67 130.54 32.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.76 -16.54 17.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.7 -14.98 63.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.536 2.335 . . . . 0.0 114.411 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.7 t -142.27 -36.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.75 1.62 . . . . 0.0 113.254 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -82.29 138.3 45.29 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.564 1.546 . . . . 0.0 110.054 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.43 178.87 6.48 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.719 2.946 . . . . 0.0 112.467 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -116.65 29.39 7.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.936 1.694 . . . . 0.0 111.842 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -114.01 -36.11 4.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.867 1.267 . . . . 0.0 112.204 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.6 ttt -121.36 142.9 49.54 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.761 2.024 . . . . 0.0 108.096 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 p -137.64 131.51 31.63 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.897 0.856 . . . . 0.0 110.909 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.77 137.17 40.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.905 0.882 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.7 t -127.89 160.06 33.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 111.268 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -79.79 84.29 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 111.1 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.33 -39.97 94.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.27 1.028 . . . . 0.0 112.257 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -146.0 -174.81 4.53 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.249 2.219 . . . . 0.0 111.613 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.34 -53.27 5.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.041 2.136 . . . . 0.0 113.352 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 73.5 p -133.59 29.71 3.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.449 1.1 . . . . 0.0 112.199 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -129.83 130.09 44.85 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.581 1.152 . . . . 0.0 109.719 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -129.41 151.09 50.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.175 1.39 . . . . 0.0 110.092 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.3 tt -132.09 109.88 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.859 0.837 . . . . 0.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -83.26 101.45 11.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.08 2.152 . . . . 0.0 110.168 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -83.8 126.08 32.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.655 1.582 . . . . 0.0 109.828 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 tp -126.78 109.09 11.65 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.358 0.981 . . . . 0.0 110.925 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.39 19.81 7.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.913 1.685 . . . . 0.0 113.206 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.0 m -150.92 111.36 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.85 1.66 . . . . 0.0 111.588 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.1 -40.48 93.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.927 1.291 . . . . 0.0 113.142 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 127.337 2.255 . . . . 0.0 113.181 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 121.195 0.521 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.6 139.38 56.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.071 0.548 . . . . 0.0 109.672 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -12.33 21.68 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.545 -1.347 . . . . 0.0 113.274 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.29 9.74 17.03 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.468 1.907 . . . . 0.0 113.353 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.61 176.66 9.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.717 1.607 . . . . 0.0 110.176 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.455 HG11 ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -134.12 128.28 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.251 1.021 . . . . 0.0 109.256 -177.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 150.4 20.39 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.819 -0.55 . . . . 0.0 110.142 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.24 127.95 16.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.988 1.315 . . . . 0.0 109.275 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -129.48 135.0 48.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.257 1.423 . . . . 0.0 110.223 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -78.34 44.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.828 2.051 . . . . 0.0 112.547 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.73 150.54 8.89 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 120.805 -1.184 . . . . 0.0 112.173 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.71 146.21 37.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.992 0.917 . . . . 0.0 111.917 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 51.42 40.92 27.74 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.9 m 59.15 64.33 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.639 1.575 . . . . 0.0 113.421 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.0 p -130.88 177.37 7.48 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.821 1.248 . . . . 0.0 111.981 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.74 -87.49 0.74 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.219 1.39 . . . . 0.0 113.59 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -135.98 165.64 25.2 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.584 1.553 . . . . 0.0 110.699 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.8 p -127.81 145.68 50.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.513 1.125 . . . . 0.0 112.032 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.31 162.48 40.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.275 1.83 . . . . 0.0 110.703 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -136.91 141.08 42.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.118 1.367 . . . . 0.0 109.193 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -120.68 138.51 53.91 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.093 1.757 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -76.79 143.07 40.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.065 1.746 . . . . 0.0 111.49 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG3' HG12 ' A' ' 50' ' ' VAL . 12.0 ttmt -64.68 145.75 55.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.14 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.95 49.7 15.9 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.111 0.386 . . . . 0.0 112.64 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.45 159.37 43.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.59 1.156 . . . . 0.0 111.221 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -140.48 118.89 12.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.022 1.329 . . . . 0.0 109.432 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 m -127.12 147.38 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.125 0.97 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -136.36 134.93 38.37 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.579 1.152 . . . . 0.0 109.441 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 124.8 1.24 . . . . 0.0 108.967 -173.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.7 m0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.25 -43.68 20.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.438 1.495 . . . . 0.0 111.349 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -77.37 52.3 0.93 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.442 1.497 . . . . 0.0 112.351 166.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.72 4.44 49.61 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.288 -1.508 . . . . 0.0 114.858 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 13.0 m-85 -78.16 137.22 38.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.117 0.967 . . . . 0.0 111.754 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.48 -62.09 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.511 1.924 . . . . 0.0 111.463 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -122.39 124.57 43.98 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.906 0.882 . . . . 0.0 109.582 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.45 156.06 44.54 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.252 1.025 . . . . 0.0 110.584 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.53 127.69 49.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.274 1.03 . . . . 0.0 108.418 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.6 t -106.53 107.79 23.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.46 1.504 . . . . 0.0 109.352 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.21 162.2 3.82 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 122.568 1.094 . . . . 0.0 113.703 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -13.88 61.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.3 34.23 4.22 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.396 1.478 . . . . 0.0 111.735 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 25' ' ' LYS . 32.9 m -149.85 157.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.174 2.59 . . . . 0.0 110.296 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.5 149.22 46.62 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 110.285 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' SG ' HG11 ' A' ' 8' ' ' VAL . 3.5 m -116.09 133.97 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.521 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -122.4 117.02 25.03 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.469 1.107 . . . . 0.0 109.116 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.536 HG23 HD13 ' A' ' 86' ' ' LEU . 81.1 mt -111.37 114.35 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.351 1.461 . . . . 0.0 108.984 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.29 124.81 39.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.526 1.13 . . . . 0.0 108.025 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.7 -58.38 7.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.668 0.747 . . . . 0.0 111.615 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.89 179.92 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.971 0.909 . . . . 0.0 109.812 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.2 71.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.826 0.85 . . . . 0.0 111.174 164.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.19 -37.29 74.46 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.666 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.1 pt 42.28 30.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 71.45 22.58 4.15 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.707 2.003 . . . . 0.0 113.429 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 t -61.86 144.21 93.71 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.314 1.845 . . . . 0.0 111.221 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 34.99 0.33 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 124.531 3.488 . . . . 0.0 113.852 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -156.35 50.58 0.47 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.931 2.092 . . . . 0.0 111.939 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.71 135.49 38.75 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.46 1.44 . . . . 0.0 109.656 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.96 -92.62 0.49 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -142.82 159.85 41.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.637 1.575 . . . . 0.0 111.149 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -148.76 140.84 23.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.798 1.639 . . . . 0.0 109.514 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -153.5 147.59 25.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.144 0.974 . . . . 0.0 111.22 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -118.66 102.95 9.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.404 1.482 . . . . 0.0 109.047 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.39 96.47 1.89 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.352 1.061 . . . . 0.0 109.418 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.42 145.19 8.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.808 1.643 . . . . 0.0 113.234 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.51 147.26 18.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.55 1.54 . . . . 0.0 112.635 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.45 51.33 59.74 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.67 0.652 . . . . 0.0 114.104 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -149.94 170.73 18.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.531 1.132 . . . . 0.0 112.402 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.3 m -139.89 142.96 36.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.674 1.19 . . . . 0.0 109.876 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -132.89 106.87 7.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.527 1.131 . . . . 0.0 109.659 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.79 -28.82 22.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.062 1.345 . . . . 0.0 112.52 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.31 62.0 1.1 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.569 1.947 . . . . 0.0 110.75 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.55 14.04 0.86 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.73 -9.92 0.25 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.87 1.668 . . . . 0.0 115.203 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -45.5 -26.1 0.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.258 1.423 . . . . 0.0 114.606 158.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.273 2.7 tt -109.06 45.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.198 1.399 . . . . 0.0 112.724 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -49.55 -22.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.719 1.208 . . . . 0.0 113.729 165.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.24 84.57 1.55 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.975 0.797 . . . . 0.0 112.537 159.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 54' ' ' ILE . 11.6 tp -125.33 141.92 51.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.141 1.376 . . . . 0.0 110.37 164.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -145.38 -32.82 0.37 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.395 1.478 . . . . 0.0 113.418 164.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -112.83 125.88 54.83 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.85 1.26 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 41' ' ' PHE . 4.1 t80 -123.85 134.49 53.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.649 0.78 . . . . 0.0 110.109 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -126.35 126.96 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.563 1.145 . . . . 0.0 108.357 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -104.41 120.63 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.7 mt -110.67 150.65 42.05 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.204 1.002 . . . . 0.0 109.953 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 96' ' ' PHE . 86.3 Cg_endo -79.51 168.56 19.65 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.353 2.035 . . . . 0.0 112.569 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.88 32.09 1.48 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.525 1.536 . . . . 0.0 114.9 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.78 -48.19 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.707 1.603 . . . . 0.0 111.703 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 1.6 m-30 -82.99 136.75 34.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.046 0.938 . . . . 0.0 109.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -78.08 -32.67 50.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.531 -0.731 . . . . 0.0 111.69 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.512 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 14.2 p-90 -155.48 167.92 28.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.73 2.012 . . . . 0.0 109.786 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.03 164.15 28.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.569 0.699 . . . . 0.0 111.166 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.51 141.21 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 109.025 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.7 129.62 34.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.404 HG22 HD23 ' A' ' 138' ' ' LEU . 15.1 m -125.58 148.27 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.727 0.811 . . . . 0.0 109.664 170.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -148.98 158.35 44.12 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.042 0.937 . . . . 0.0 110.193 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mt -111.91 130.63 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 110.78 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.744 0.817 . . . . 0.0 109.462 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.28 127.27 32.77 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.215 -0.928 . . . . 0.0 111.576 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -112.63 17.18 19.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.693 1.597 . . . . 0.0 111.757 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 211' ' ' SER . 64.6 t -126.6 -57.44 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.489 1.915 . . . . 0.0 110.654 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -153.95 138.76 17.09 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.139 1.376 . . . . 0.0 111.378 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 p -49.7 -58.38 5.42 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.749 1.62 . . . . 0.0 115.209 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.3 m 31.22 63.22 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.011 2.524 . . . . 0.0 113.5 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.34 -98.16 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -59.38 -18.03 41.71 Favored Glycine 0 CA--C 1.541 1.662 0 O-C-N 119.699 -1.876 . . . . 0.0 113.575 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.5 m -60.81 -20.82 62.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.4 1.88 . . . . 0.0 115.027 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.81 128.42 40.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 109.785 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.63 127.56 40.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.956 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.2 ttp -126.95 152.73 46.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.017 1.727 . . . . 0.0 110.358 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.4 m -137.55 131.01 31.09 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.59 133.07 68.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 p -133.12 86.49 42.1 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 109.68 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.16 112.29 2.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.051 1.834 . . . . 0.0 108.621 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.5 t80 40.19 54.67 2.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.567 1.947 . . . . 0.0 112.99 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.38 31.75 0.92 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.6 1.56 . . . . 0.0 114.956 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.32 133.21 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.059 2.143 . . . . 0.0 108.597 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 t70 38.23 71.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.45 1.9 . . . . 0.0 113.348 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 138.97 41.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.59 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.84 140.1 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.591 0.756 . . . . 0.0 110.168 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.39 140.11 40.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.224 1.01 . . . . 0.0 110.022 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.432 ' HB3' HG21 ' A' ' 136' ' ' VAL . 7.6 p -140.85 143.03 34.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 109.22 -174.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -131.49 143.99 50.81 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.715 1.206 . . . . 0.0 109.307 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.31 90.85 0.1 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.106 0.955 . . . . 0.0 111.897 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.02 -22.02 0.99 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.162 -0.961 . . . . 0.0 113.216 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -60.75 150.99 30.71 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.492 1.146 . . . . 0.0 112.308 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.2 66.66 9.35 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.378 -0.826 . . . . 0.0 111.08 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 62.47 166.58 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.143 1.777 . . . . 0.0 112.569 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 129' ' ' CYS . 62.6 t -138.37 138.42 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.548 1.539 . . . . 0.0 109.599 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.34 122.25 28.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.348 0.659 . . . . 0.0 110.223 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 102' ' ' VAL . 3.2 mm? -97.55 110.76 56.35 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.274 1.43 . . . . 0.0 109.482 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 96.1 Cg_endo -77.72 136.68 15.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.673 2.249 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.512 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 17.0 mm -129.01 124.53 22.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 177.1 6.77 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.261 2.641 . . . . 0.0 112.075 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -65.08 141.55 58.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.786 . . . . 0.0 111.983 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.751 2.021 . . . . 0.0 109.483 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.8 m -126.24 135.32 26.99 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.741 1.216 . . . . 0.0 109.995 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.15 154.3 84.95 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.477 0.849 . . . . 0.0 112.488 -3.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.82 -27.19 67.51 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.931 1.754 . . . . 0.0 112.401 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -9.89 22.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.5 m -62.57 166.41 5.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.741 1.258 . . . . 0.0 113.315 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.69 153.24 26.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.686 1.194 . . . . 0.0 111.897 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.5 tt -119.42 131.29 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 128.224 2.61 . . . . 0.0 107.957 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.2 m -73.77 134.11 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.689 0.795 . . . . 0.0 109.788 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -135.74 131.27 35.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.288 0.635 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -96.59 147.42 23.89 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.728 -0.608 . . . . 0.0 109.974 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.99 132.46 40.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.36 1.464 . . . . 0.0 108.645 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -141.41 118.27 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.518 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.95 133.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.469 1.507 . . . . 0.0 109.943 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.84 149.77 39.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.03 1.732 . . . . 0.0 109.182 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 146.44 47.79 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 64.4 p -73.74 -4.01 31.92 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.062 -1.024 . . . . 0.0 113.45 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.94 155.14 43.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.401 2.281 . . . . 0.0 111.683 -177.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 151.5 28.13 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.615 1.166 . . . . 0.0 113.395 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.56 -2.15 17.2 Favored 'Cis proline' 0 C--N 1.354 0.849 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 3.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . 0.26 0.2 OUTLIER 39.41 37.76 0.31 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 115.411 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -82.47 46.65 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.128 0.971 . . . . 0.0 113.486 -164.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 40.73 74.43 0.1 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.78 2.032 . . . . 0.0 112.834 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -37.11 -51.88 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.25 1.82 . . . . 0.0 111.802 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.9 t -138.58 128.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -136.1 109.64 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.422 1.089 . . . . 0.0 108.254 171.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.76 -165.75 33.25 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.712 0.672 . . . . 0.0 112.275 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.8 m -136.78 163.95 29.42 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.094 -0.65 . . . . 0.0 110.816 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.12 150.73 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.228 1.411 . . . . 0.0 109.438 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.0 135.96 34.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.577 -0.702 . . . . 0.0 109.869 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -113.22 132.12 55.63 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.828 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -123.64 156.97 34.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.581 1.552 . . . . 0.0 109.073 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 98' ' ' TRP . 44.9 t80 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.261 0.937 . . . . 0.0 109.669 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.2 m -97.97 102.16 12.87 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 123.724 0.81 . . . . 0.0 109.074 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.37 -15.71 42.51 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.26 1.973 . . . . 0.0 113.288 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.6 m -47.8 -40.62 21.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.416 1.886 . . . . 0.0 112.767 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 33.4 p -144.81 20.46 1.64 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.867 1.267 . . . . 0.0 112.729 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.39 37.02 59.03 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.964 1.745 . . . . 0.0 115.276 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.64 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 9.3 tt0 -80.88 179.17 7.96 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.652 0.739 . . . . 0.0 112.657 177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.64 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 t -130.63 144.15 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.388 2.675 . . . . 0.0 107.713 166.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.3 m -134.79 123.16 23.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.297 2.239 . . . . 0.0 108.167 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 197' ' ' VAL . 0.3 OUTLIER -100.79 116.9 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.949 0.881 . . . . 0.0 111.312 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.56 118.1 35.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.897 1.279 . . . . 0.0 108.526 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 142.56 51.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.31 1.844 . . . . 0.0 109.04 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -167.48 160.01 12.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.602 1.561 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.48 -20.07 4.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.042 1.737 . . . . 0.0 114.029 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.25 -29.09 57.37 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.141 1.776 . . . . 0.0 114.819 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.4 p -149.61 -43.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.397 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -96.44 137.37 21.56 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.842 1.257 . . . . 0.0 110.323 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.05 -171.52 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.84 -20.4 13.07 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.721 2.009 . . . . 0.0 114.474 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -67.65 -12.32 60.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.106 1.762 . . . . 0.0 113.159 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.4 ttm -131.36 145.77 51.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.645 1.578 . . . . 0.0 108.507 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.3 p -136.81 155.88 49.23 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.988 1.315 . . . . 0.0 109.042 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' VAL . 2.6 t -116.36 125.9 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.939 -0.476 . . . . 0.0 109.82 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.4 m -117.11 130.32 56.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.462 1.105 . . . . 0.0 109.318 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -76.39 70.58 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.841 1.656 . . . . 0.0 111.093 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.22 -42.16 76.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.807 1.243 . . . . 0.0 113.553 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -147.93 177.9 8.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.885 2.074 . . . . 0.0 109.543 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -68.47 129.84 41.1 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.51 -1.369 . . . . 0.0 108.534 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 19.4 p 55.99 29.89 15.16 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.279 1.432 . . . . 0.0 114.316 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.8 m -135.28 123.87 23.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.556 1.142 . . . . 0.0 111.869 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' HG13 ' A' ' 184' ' ' VAL . 19.9 m-85 -124.84 134.89 52.56 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.978 1.311 . . . . 0.0 110.406 -173.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 14.1 mt -120.69 116.1 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -77.14 93.99 4.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.59 1.956 . . . . 0.0 109.971 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.76 121.54 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.451 1.101 . . . . 0.0 109.916 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.26 102.96 13.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.921 0.888 . . . . 0.0 109.795 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -83.7 -29.05 27.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.886 1.274 . . . . 0.0 113.343 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 108' ' ' VAL . 58.4 m -159.54 133.25 7.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.153 2.181 . . . . 0.0 110.839 173.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.6 15.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 126.481 1.913 . . . . 0.0 113.944 -163.418 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.64 146.22 40.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.443 0.697 . . . . 0.0 110.331 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.01 -17.44 17.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -112.97 12.19 19.25 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.115 2.566 . . . . 0.0 113.57 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -138.75 174.03 10.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.024 1.33 . . . . 0.0 110.256 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -140.0 148.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.088 0.955 . . . . 0.0 108.434 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -132.05 143.57 50.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.45 1.1 . . . . 0.0 110.873 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.31 137.31 49.89 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.461 1.504 . . . . 0.0 108.55 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.78 150.24 46.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.139 1.776 . . . . 0.0 109.38 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -115.1 92.52 3.96 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.051 1.34 . . . . 0.0 109.831 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.76 -62.06 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.948 161.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 161.51 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 130.382 3.473 . . . . 0.0 108.663 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 36.84 58.33 1.12 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 114.786 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m 52.26 63.85 2.08 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.069 1.748 . . . . 0.0 115.426 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.5 m -123.21 -41.48 2.31 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.73 -120.6 3.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.676 1.125 . . . . 0.0 112.752 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.93 165.95 22.26 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.558 1.179 . . . . 0.0 111.423 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.0 p -136.66 157.96 45.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.3 1.44 . . . . 0.0 111.903 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.08 131.25 15.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.296 1.838 . . . . 0.0 108.291 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -132.67 120.84 22.26 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.06 1.344 . . . . 0.0 108.8 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -147.19 138.55 23.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.987 1.375 . . . . 0.0 111.266 -169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -70.41 153.52 42.89 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.189 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -63.18 161.9 12.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.554 0.742 . . . . 0.0 112.074 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.42 45.74 76.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.496 0.569 . . . . 0.0 112.847 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -138.63 158.24 44.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.624 1.97 . . . . 0.0 111.247 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -134.68 117.83 16.48 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.347 1.059 . . . . 0.0 108.551 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 139.02 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 109.617 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -144.62 101.21 3.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.402 1.081 . . . . 0.0 108.514 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.468 0.466 0 C-N-CA 123.735 0.814 . . . . 0.0 111.067 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -52.24 -28.81 20.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.625 1.102 . . . . 0.0 112.857 166.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 -0.95 4.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.142 0.977 . . . . 0.0 113.619 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.18 -39.73 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.416 1.487 . . . . 0.0 112.721 165.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -60.23 124.3 19.86 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 123.082 1.42 . . . . 0.0 111.782 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 tpt -149.56 -35.56 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.436 1.494 . . . . 0.0 113.349 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 p -141.03 125.06 17.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.124 0.874 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.11 159.2 42.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.423 1.106 . . . . 0.0 112.32 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.56 121.5 17.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.32 112.3 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 126.479 1.911 . . . . 0.0 108.108 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -32.61 -83.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.752 2.596 . . . . 0.0 116.742 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.633 1.973 . . . . 0.0 112.694 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -121.09 37.91 4.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 110.472 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -151.01 143.81 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 128.566 2.747 . . . . 0.0 109.028 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -119.5 148.83 42.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.951 1.7 . . . . 0.0 109.167 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.09 140.91 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.258 0.551 . . . . 0.0 109.833 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -131.92 131.07 42.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.435 1.094 . . . . 0.0 108.781 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.75 126.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 129.33 41.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.93 1.292 . . . . 0.0 109.458 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -54.76 -62.31 1.74 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 113.301 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.83 173.85 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.345 1.458 . . . . 0.0 109.785 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.98 139.85 39.06 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.5 -173.87 1.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 110.988 -170.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.06 39.19 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.834 1.654 . . . . 0.0 112.004 -173.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.326 43.0 m-20 56.38 48.43 17.02 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.102 1.761 . . . . 0.0 111.053 -167.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.36 153.52 19.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 112.626 -2.079 . . . . 0.0 109.968 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.53 26.43 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.677 3.584 . . . . 0.0 115.203 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 58.66 2.92 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.704 2.002 . . . . 0.0 110.636 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.51 145.62 59.17 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.579 1.52 . . . . 0.0 110.385 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 -129.58 0.51 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.084 1.326 . . . . 0.0 113.151 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.36 158.2 31.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 111.038 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -147.91 153.29 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.848 1.659 . . . . 0.0 109.765 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.4 163.1 35.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.882 0.873 . . . . 0.0 110.784 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -123.55 105.12 9.49 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.274 1.43 . . . . 0.0 110.494 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -74.18 102.08 4.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 109.611 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.95 148.84 24.57 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.766 1.627 . . . . 0.0 113.744 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.39 140.94 38.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.742 1.617 . . . . 0.0 113.108 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 55.61 29.17 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 125.007 1.289 . . . . 0.0 114.366 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -148.62 164.01 35.55 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -134.35 129.9 36.13 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.868 1.667 . . . . 0.0 108.513 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.2 130.84 50.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.626 1.571 . . . . 0.0 107.492 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -139.85 -8.36 1.22 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -140.92 68.02 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.415 1.886 . . . . 0.0 110.819 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.43 20.7 12.41 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.255 2.222 . . . . 0.0 112.237 -177.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.24 -11.97 1.39 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.625 1.57 . . . . 0.0 114.077 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -19.75 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.401 -1.437 . . . . 0.0 114.138 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.98 34.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 126.821 2.048 . . . . 0.0 111.745 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -49.67 -28.98 6.61 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.367 -1.458 . . . . 0.0 113.418 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.54 71.71 1.04 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.046 1.308 . . . . 0.0 113.653 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.51 147.57 46.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.27 1.428 . . . . 0.0 109.481 164.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -147.91 -14.81 0.36 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 159.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -133.4 127.37 33.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.367 1.467 . . . . 0.0 109.564 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.09 124.24 36.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.814 1.246 . . . . 0.0 109.263 -166.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -117.09 115.86 26.2 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.449 1.499 . . . . 0.0 108.425 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 t -115.94 117.01 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.4 mt -128.44 151.83 77.28 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.978 0.911 . . . . 0.0 109.797 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.16 -178.85 3.48 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.072 2.515 . . . . 0.0 111.617 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.61 -23.02 71.2 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.167 -0.958 . . . . 0.0 113.855 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.25 74.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.117 0.967 . . . . 0.0 112.417 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.437 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 1.4 m-30 -91.67 149.21 21.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.89 1.276 . . . . 0.0 109.484 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.81 -31.88 4.4 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.577 -1.327 . . . . 0.0 113.181 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.73 148.43 31.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.667 1.587 . . . . 0.0 108.19 167.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -119.19 154.94 32.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.766 0.793 . . . . 0.0 110.077 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.06 150.01 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.392 1.477 . . . . 0.0 109.433 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.62 126.99 51.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.51 136.05 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.7 -0.625 . . . . 0.0 110.206 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -140.71 134.09 29.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.931 0.492 . . . . 0.0 111.387 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 115' ' ' TYR . 39.8 mt -85.38 146.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.495 1.518 . . . . 0.0 109.481 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.3 t -135.9 102.56 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.135 1.774 . . . . 0.0 109.118 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -58.16 119.94 7.73 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.054 0.942 . . . . 0.0 111.662 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -112.65 -35.6 5.46 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.016 0.926 . . . . 0.0 111.646 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -91.12 -36.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.373 1.069 . . . . 0.0 113.76 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -91.58 91.66 8.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.595 1.158 . . . . 0.0 109.924 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 65.3 p -64.33 17.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.5 m -133.94 80.95 1.89 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.394 2.678 . . . . 0.0 109.074 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.58 130.69 47.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.072 0.949 . . . . 0.0 111.811 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.87 -38.44 2.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.283 1.42 . . . . 0.0 113.537 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.4 m -71.47 -27.58 63.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.613 1.165 . . . . 0.0 112.946 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE1' HG21 ' A' ' 104' ' ' ILE . 1.7 t80 -75.85 126.97 32.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.631 1.172 . . . . 0.0 109.847 171.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -129.23 141.71 51.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.765 1.626 . . . . 0.0 109.43 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -135.85 138.77 42.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.962 0.905 . . . . 0.0 110.146 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -123.61 138.49 54.54 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.411 1.484 . . . . 0.0 107.793 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.8 145.63 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.619 0.767 . . . . 0.0 110.682 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 t -144.73 94.91 5.4 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 111.294 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.27 165.84 23.24 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.828 2.352 . . . . 0.0 112.164 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -29.67 94.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 128.092 2.557 . . . . 0.0 114.17 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 47.72 37.93 7.73 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.68 1.592 . . . . 0.0 114.867 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.0 t -93.65 155.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.946 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.64 98.85 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.335 . . . . 0.0 111.195 170.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.85 151.33 18.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.743 -0.598 . . . . 0.0 112.084 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.35 131.22 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.102 0.561 . . . . 0.0 110.219 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.23 33.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.326 0.65 . . . . 0.0 109.477 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.66 142.18 51.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.808 1.243 . . . . 0.0 108.371 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -127.5 137.66 52.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 108.2 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.48 108.99 0.54 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.468 0.707 . . . . 0.0 111.326 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.95 -25.69 4.91 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 113.791 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.75 146.27 55.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.892 1.346 . . . . 0.0 110.871 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.61 167.88 14.18 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.637 -0.664 . . . . 0.0 111.376 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -47.0 105.05 0.06 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.848 1.259 . . . . 0.0 112.78 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.01 126.29 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.506 1.122 . . . . 0.0 109.126 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.12 124.17 22.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.961 0.41 . . . . 0.0 109.949 176.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.81 96.43 49.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.557 1.943 . . . . 0.0 107.112 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 40.8 Cg_endo -74.37 143.49 31.41 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.473 2.115 . . . . 0.0 112.733 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.7 mm -122.06 133.78 24.47 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.794 1.637 . . . . 0.0 108.565 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.47 170.44 12.29 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 112.752 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -49.82 138.68 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.669 . . . . 0.0 112.716 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.17 122.71 9.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.649 0.779 . . . . 0.0 110.532 -174.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.4 t -134.6 131.66 20.38 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 110.9 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.85 152.98 83.67 Favored 'Cis proline' 0 CA--C 1.548 1.204 0 CA-C-N 119.345 0.802 . . . . 0.0 112.148 -6.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.36 -37.48 81.64 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.709 2.273 . . . . 0.0 112.089 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -7.15 8.65 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.053 1.741 . . . . 0.0 114.414 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.3 t -74.6 -179.42 4.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.136 -0.978 . . . . 0.0 112.347 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -130.5 154.52 47.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.975 1.31 . . . . 0.0 112.826 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.49 130.6 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.541 1.936 . . . . 0.0 109.854 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.23 141.29 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.96 0.904 . . . . 0.0 111.017 172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 t -148.29 158.7 44.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.211 1.404 . . . . 0.0 110.764 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.55 136.45 53.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.31 1.044 . . . . 0.0 109.216 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.34 126.31 46.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.186 1.794 . . . . 0.0 108.367 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 p -133.46 131.15 39.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.78 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.29 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.607 1.563 . . . . 0.0 107.02 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -143.71 151.59 40.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.729 1.612 . . . . 0.0 109.336 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -85.53 142.67 29.0 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.816 -0.552 . . . . 0.0 111.524 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.9 p -85.85 7.57 23.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.912 1.685 . . . . 0.0 112.926 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.94 16.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.31 1.844 . . . . 0.0 110.733 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -51.41 139.47 27.15 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.923 1.289 . . . . 0.0 113.442 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.94 11.74 19.29 Favored 'Cis proline' 0 CA--C 1.549 1.229 0 N-CA-C 114.904 1.078 . . . . 0.0 114.904 4.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.67 15.33 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.664 1.986 . . . . 0.0 114.149 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.76 164.64 19.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.19 1.396 . . . . 0.0 112.469 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -68.98 154.59 41.8 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.812 0.815 . . . . 0.0 112.121 171.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.3 -38.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.786 1.634 . . . . 0.0 110.339 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.3 t -146.06 140.92 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -144.35 105.79 4.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.432 1.493 . . . . 0.0 108.579 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.11 -179.98 38.65 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.466 -0.771 . . . . 0.0 114.487 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.5 p -113.21 136.1 53.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.703 1.201 . . . . 0.0 112.004 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.35 150.04 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.974 2.11 . . . . 0.0 107.722 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -124.52 135.47 53.21 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.1 149.54 30.69 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.458 -0.776 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -138.26 153.68 49.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.837 2.055 . . . . 0.0 108.654 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -115.7 164.65 14.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.197 0.999 . . . . 0.0 109.719 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -136.46 105.29 9.24 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.342 1.057 . . . . 0.0 109.582 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -67.8 -14.96 43.13 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.53 2.82 . . . . 0.0 113.262 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.0 m -45.5 -46.54 13.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.49 2.316 . . . . 0.0 113.171 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 65.1 p -145.21 11.03 1.32 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.734 1.214 . . . . 0.0 113.14 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 69.29 42.71 73.99 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.199 -1.563 . . . . 0.0 112.768 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -83.52 156.67 22.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.897 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 203' ' ' THR . 0.4 OUTLIER -112.36 155.12 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.739 0.815 . . . . 0.0 110.274 165.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.6 m -143.63 114.95 7.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.696 1.199 . . . . 0.0 108.571 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.32 146.81 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.142 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.58 132.62 66.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.565 1.946 . . . . 0.0 107.56 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 138.66 32.65 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.198 1.399 . . . . 0.0 108.661 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -127.82 144.36 51.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.151 1.38 . . . . 0.0 108.539 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.49 -18.81 20.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.78 -33.6 16.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.46 1.504 . . . . 0.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.2 p -98.83 -53.05 3.39 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.77 1.228 . . . . 0.0 110.888 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -85.79 148.29 48.2 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.419 1.488 . . . . 0.0 109.997 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.08 175.17 11.24 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.386 2.058 . . . . 0.0 111.672 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 8.71 44.58 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.945 1.298 . . . . 0.0 113.147 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.97 -37.52 10.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.355 1.462 . . . . 0.0 111.707 -164.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 146.45 40.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 128.76 2.824 . . . . 0.0 106.953 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.3 p -139.91 153.17 46.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.565 0.746 . . . . 0.0 110.896 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.93 137.6 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.501 0.72 . . . . 0.0 110.27 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 33.4 m -120.72 140.76 51.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.806 1.642 . . . . 0.0 109.39 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -68.59 91.2 0.41 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.985 1.314 . . . . 0.0 110.635 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -75.27 -48.97 20.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 122.215 -0.303 . . . . 0.0 110.934 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.97 -178.59 5.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.631 1.572 . . . . 0.0 112.121 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -58.78 -34.54 71.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.138 1.375 . . . . 0.0 114.607 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 182' ' ' VAL . 50.6 p -138.0 25.16 2.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.985 1.714 . . . . 0.0 112.158 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 t -125.26 136.22 53.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.083 0.953 . . . . 0.0 111.255 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.5 133.3 52.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.178 1.391 . . . . 0.0 110.637 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.7 tt -115.97 112.35 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.154 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.94 125.62 39.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.842 2.457 . . . . 0.0 108.231 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -125.27 129.96 51.09 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.14 1.376 . . . . 0.0 111.319 -172.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.6 tt -121.87 114.9 21.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.889 0.876 . . . . 0.0 111.608 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -123.14 7.4 9.17 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.888 1.675 . . . . 0.0 113.938 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.67 -8.69 13.78 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 40.96 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 129.363 3.065 . . . . 0.0 118.67 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 -172.772 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' A' ' 47' ' ' GLY . 8.7 p . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 0.0 111.565 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.1 142.73 57.68 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.251 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -19.39 51.04 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.28 9.12 23.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.639 1.976 . . . . 0.0 113.255 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -136.83 -178.31 5.13 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 120.485 1.493 . . . . 0.0 110.81 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -135.69 148.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.675 1.19 . . . . 0.0 110.653 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 142.52 49.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.471 1.108 . . . . 0.0 109.404 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -135.55 127.9 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.149 1.38 . . . . 0.0 108.51 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -133.54 130.78 38.93 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.506 1.122 . . . . 0.0 110.601 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.44 56.88 4.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.792 1.237 . . . . 0.0 111.274 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.43 140.24 3.62 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.922 0.772 . . . . 0.0 111.183 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -58.23 139.16 55.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.459 0.703 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 70.55 37.62 1.44 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 125.376 1.47 . . . . 0.0 113.808 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.9 m 54.14 64.12 1.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.331 1.852 . . . . 0.0 113.673 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.9 p -132.45 179.24 6.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.969 1.307 . . . . 0.0 112.755 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.97 -81.27 1.17 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.877 1.703 . . . . 0.0 114.71 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -138.53 166.73 23.55 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.053 1.741 . . . . 0.0 110.019 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -130.94 152.78 49.88 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.759 1.224 . . . . 0.0 112.758 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -160.68 162.76 32.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.373 1.469 . . . . 0.0 111.304 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -134.67 140.93 46.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.925 1.29 . . . . 0.0 110.812 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -124.87 141.19 52.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.851 1.661 . . . . 0.0 110.119 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -88.84 143.72 26.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.515 0.726 . . . . 0.0 111.444 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.26 150.68 38.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.06 1.344 . . . . 0.0 111.7 170.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.51 58.17 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.113 1.339 . . . . 0.0 113.438 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -137.77 159.09 42.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.942 1.697 . . . . 0.0 111.356 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.4 m -117.93 128.97 55.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.993 1.317 . . . . 0.0 108.86 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.89 114.85 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.747 1.219 . . . . 0.0 109.432 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.47 145.83 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.746 1.218 . . . . 0.0 111.074 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CE2' ' HE3' ' A' ' 40' ' ' LYS . 63.1 m-85 . . . . . 0 C--N 1.327 -0.39 0 C-N-CA 125.243 1.417 . . . . 0.0 110.09 168.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.5 m0 . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.15 -42.26 99.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.492 1.517 . . . . 0.0 111.813 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.46 34.93 0.14 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.029 1.731 . . . . 0.0 113.047 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -78.27 -20.28 51.93 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 118.902 -2.374 . . . . 0.0 114.596 177.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CE2' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.87 145.52 35.05 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.814 0.816 . . . . 0.0 111.706 176.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 ttt -155.7 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.1 p -134.56 132.56 39.26 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.613 1.097 . . . . 0.0 110.697 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.2 m -143.45 152.47 41.56 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 108.041 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.44 145.67 47.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.511 1.148 . . . . 0.0 112.273 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 8' ' ' VAL . 95.3 t -106.73 120.18 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.354 2.661 . . . . 0.0 108.843 -170.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 3' ' ' VAL . . . -47.66 -86.2 0.01 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -168.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 t -164.13 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.99 0.916 . . . . 0.0 111.792 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.76 32.67 5.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.846 1.258 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.55 164.07 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 110.276 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -144.43 154.12 42.63 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.742 2.017 . . . . 0.0 110.067 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.415 ' SG ' HG11 ' A' ' 8' ' ' VAL . 1.2 m -124.96 134.56 52.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.85 0.86 . . . . 0.0 110.806 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.19 118.33 31.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.89 1.276 . . . . 0.0 109.492 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.0 mm -110.1 106.49 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.294 1.038 . . . . 0.0 108.998 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.94 117.79 24.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.005 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.09 -45.46 81.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 122.205 1.003 . . . . 0.0 112.479 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 167.77 29.25 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.091 1.756 . . . . 0.0 109.923 -169.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -108.91 48.93 0.84 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.439 0.696 . . . . 0.0 110.537 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.75 160.68 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.505 1.922 . . . . 0.0 114.686 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.68 52.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.433 -1.417 . . . . 0.0 110.684 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 71.68 36.35 1.26 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.704 2.402 . . . . 0.0 111.58 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 p -67.46 155.96 89.72 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.789 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.79 32.35 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.33 3.353 . . . . 0.0 113.38 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -151.16 99.64 3.05 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 109.995 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 118.06 5.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.688 1.592 . . . . 0.0 108.965 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.89 -120.87 0.1 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.49 144.05 44.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 112.52 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -161.82 132.45 5.03 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 110.226 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -143.22 163.1 33.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.599 1.159 . . . . 0.0 110.665 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.02 107.68 9.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.364 1.466 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -84.05 95.55 8.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.815 0.846 . . . . 0.0 108.941 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.24 150.53 3.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 113.044 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -66.61 145.95 55.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.829 0.452 . . . . 0.0 112.177 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.5 64.58 3.94 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.452 1.025 . . . . 0.0 115.413 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -153.02 177.2 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.147 0.979 . . . . 0.0 112.868 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.8 m -130.7 142.43 50.42 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.182 1.393 . . . . 0.0 110.241 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.82 134.55 44.81 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.962 1.305 . . . . 0.0 109.884 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.2 -33.02 1.15 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 123.579 0.752 . . . . 0.0 112.489 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -118.06 40.34 3.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.053 1.406 . . . . 0.0 110.965 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' CE2' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -70.35 -16.35 62.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.385 1.074 . . . . 0.0 113.213 172.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -61.58 -11.47 11.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.269 1.427 . . . . 0.0 113.184 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.5 t -47.35 -36.74 9.96 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.82 -1.175 . . . . 0.0 113.127 167.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 tt -81.0 -35.17 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.84 42.22 11.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.998 2.119 . . . . 0.0 113.811 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.05 67.31 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.297 0.951 . . . . 0.0 113.022 -161.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.1 tp -131.61 115.35 15.97 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.722 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.4 m -120.9 -20.6 6.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.481 1.113 . . . . 0.0 112.891 167.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -127.52 122.37 33.15 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.078 0.951 . . . . 0.0 110.189 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.35 137.11 44.91 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.232 1.013 . . . . 0.0 109.084 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.06 136.11 55.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.95 118.55 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -131.41 146.94 64.14 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.967 0.907 . . . . 0.0 109.359 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.71 165.77 24.47 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.114 2.543 . . . . 0.0 112.308 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.73 -14.3 36.04 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 124.358 0.98 . . . . 0.0 114.828 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.06 -28.07 63.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.134 1.374 . . . . 0.0 113.946 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 7.9 m-30 -123.49 102.93 8.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.693 1.597 . . . . 0.0 109.535 -166.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.9 -27.89 26.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.43 -1.419 . . . . 0.0 113.513 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.24 145.18 24.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.489 2.315 . . . . 0.0 106.856 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.43 165.71 24.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.782 0.801 . . . . 0.0 111.054 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 151.13 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.858 1.263 . . . . 0.0 109.261 -173.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.86 125.33 44.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.63 138.2 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.978 0.894 . . . . 0.0 110.729 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.09 118.07 15.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.547 1.539 . . . . 0.0 108.54 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 149.01 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 122.894 0.478 . . . . 0.0 109.822 165.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.96 129.49 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.29 121.72 34.07 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.017 -0.427 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -26.13 6.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.764 1.626 . . . . 0.0 113.142 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.12 -35.68 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.897 0.879 . . . . 0.0 113.266 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -108.91 -179.59 3.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.085 1.354 . . . . 0.0 109.735 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.8 t -120.93 -39.54 2.71 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.504 1.122 . . . . 0.0 111.826 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.7 m -60.19 -39.73 87.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.103 0.961 . . . . 0.0 112.204 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.16 -179.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.246 1.818 . . . . 0.0 114.789 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.98 -25.68 0.8 Allowed Glycine 0 N--CA 1.478 1.476 0 O-C-N 120.071 -1.643 . . . . 0.0 115.55 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 m -53.36 -35.5 60.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.13 1.372 . . . . 0.0 111.906 163.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -90.45 131.37 36.25 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.238 1.815 . . . . 0.0 110.466 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.52 130.35 42.22 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.871 1.269 . . . . 0.0 111.229 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.444 ' HG2' HG22 ' A' ' 156' ' ' VAL . 1.4 tmm? -92.86 135.58 34.01 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.916 1.686 . . . . 0.0 110.092 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -133.91 97.4 3.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.912 1.685 . . . . 0.0 108.304 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 127' ' ' VAL . 6.2 mm -94.22 132.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -131.61 92.96 29.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.99 171.99 12.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.475 . . . . 0.0 112.328 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -35.37 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.0 2.52 . . . . 0.0 114.969 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 41.53 59.23 2.48 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.888 1.675 . . . . 0.0 114.486 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.93 157.95 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.171 1.788 . . . . 0.0 111.593 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -40.54 115.35 0.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.859 1.663 . . . . 0.0 111.85 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 136.16 51.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.419 HG11 ' HG ' ' A' ' 138' ' ' LEU . 13.1 p -115.95 151.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.668 0.787 . . . . 0.0 109.339 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.3 132.89 41.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.204 1.001 . . . . 0.0 110.383 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.3 t -133.52 119.25 19.28 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.644 1.178 . . . . 0.0 108.936 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -114.81 121.87 44.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.578 1.551 . . . . 0.0 108.301 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t0 55.54 -175.86 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.862 0.839 . . . . 0.0 113.054 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.65 30.64 1.24 Allowed Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.173 1.368 . . . . 0.0 113.587 161.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -56.56 175.55 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.998 1.399 . . . . 0.0 111.389 166.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -44.84 122.15 3.09 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.892 -1.13 . . . . 0.0 111.731 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -53.25 159.48 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.142 0.977 . . . . 0.0 112.416 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.41 135.24 54.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.766 0.793 . . . . 0.0 110.279 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -75.55 142.7 42.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -126.18 91.15 48.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 125.465 1.506 . . . . 0.0 109.345 -178.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 34.5 Cg_endo -71.05 144.18 46.55 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.196 1.931 . . . . 0.0 111.464 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 46.3 mm -128.17 135.4 27.47 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.718 1.607 . . . . 0.0 108.522 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.21 177.39 8.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.033 3.156 . . . . 0.0 112.306 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.08 141.81 57.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.395 0.678 . . . . 0.0 111.791 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.46 147.33 7.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.981 1.712 . . . . 0.0 110.314 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 98.8 m -147.48 135.33 10.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.087 0.955 . . . . 0.0 109.71 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.08 153.23 87.89 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.422 0.829 . . . . 0.0 112.722 -5.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.18 -36.58 68.31 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.182 1.921 . . . . 0.0 112.158 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.25 -16.48 60.37 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.81 128.68 36.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 110.857 170.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 162.37 25.49 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 112.723 171.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.9 151.75 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.871 1.668 . . . . 0.0 109.098 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.53 118.41 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.565 0.746 . . . . 0.0 110.821 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.4 m -130.42 150.52 51.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.4 1.08 . . . . 0.0 111.609 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -115.25 123.21 48.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.93 0.892 . . . . 0.0 108.602 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.09 113.85 26.27 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.04 1.336 . . . . 0.0 107.758 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.63 145.31 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.444 HG22 ' HG2' ' A' ' 117' ' ' MET . 11.2 t -135.36 130.7 51.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -145.07 153.88 41.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.968 1.307 . . . . 0.0 109.331 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 143.24 54.71 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.941 168.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.4 p -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.245 1.418 . . . . 0.0 113.946 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -141.6 161.06 38.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.751 2.021 . . . . 0.0 110.89 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -66.37 139.36 96.21 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 127.43 12.13 Favored 'Cis proline' 0 C--N 1.353 0.8 0 CA-C-N 120.331 1.154 . . . . 0.0 111.443 -6.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -74.22 49.91 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.713 1.605 . . . . 0.0 111.13 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.86 131.81 52.03 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.286 -1.509 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.06 90.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.174 0.589 . . . . 0.0 109.839 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.2 t -42.47 -52.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.782 2.033 . . . . 0.0 111.087 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.8 p -159.47 152.51 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.917 -0.489 . . . . 0.0 111.838 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -133.87 102.87 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.845 1.658 . . . . 0.0 108.385 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.01 -174.36 13.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.928 1.728 . . . . 0.0 111.863 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.4 m -132.88 150.34 52.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.458 1.103 . . . . 0.0 110.906 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.46 163.5 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 126.314 1.846 . . . . 0.0 108.507 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -129.49 136.38 49.81 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.927 0.491 . . . . 0.0 109.867 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.28 137.05 52.45 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.659 1.184 . . . . 0.0 107.983 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 160.13 38.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.269 1.428 . . . . 0.0 110.154 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 114.38 18.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.996 0.816 . . . . 0.0 110.253 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 m -76.46 118.2 69.8 Favored Pre-proline 0 N--CA 1.476 0.843 0 O-C-N 120.359 -1.463 . . . . 0.0 109.95 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.36 -19.36 55.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.59 2.193 . . . . 0.0 113.957 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.2 m -52.7 -50.27 63.68 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.902 2.081 . . . . 0.0 114.3 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.3 p -136.11 18.26 3.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.578 1.551 . . . . 0.0 111.803 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.76 41.14 97.75 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.095 0.855 . . . . 0.0 114.135 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -72.67 164.04 27.13 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.716 -1.461 . . . . 0.0 111.982 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 135.83 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.8 m -131.77 135.08 46.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.401 1.08 . . . . 0.0 108.298 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.443 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -102.27 135.75 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.9 0.857 . . . . 0.0 110.743 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.33 134.84 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.601 1.961 . . . . 0.0 106.721 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 133.76 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.789 1.235 . . . . 0.0 108.061 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.27 150.32 39.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.153 1.381 . . . . 0.0 108.882 -166.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -57.41 -23.42 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.74 -31.66 20.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.832 1.253 . . . . 0.0 113.6 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.2 p -96.34 -49.92 4.99 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.378 1.071 . . . . 0.0 110.199 -170.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.4 t80 -64.91 148.3 97.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 110.016 168.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 74.2 Cg_endo -75.87 -95.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.118 1.879 . . . . 0.0 111.003 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 164.39 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 128.103 2.561 . . . . 0.0 112.942 -171.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -61.21 -43.76 98.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.643 1.177 . . . . 0.0 112.515 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.7 149.31 25.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.856 1.662 . . . . 0.0 109.57 170.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -134.94 133.82 39.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.29 1.036 . . . . 0.0 110.286 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.02 130.82 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.634 0.774 . . . . 0.0 109.665 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.2 m -128.86 131.13 47.64 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.187 1.395 . . . . 0.0 108.9 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.06 94.21 1.48 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 0.0 110.342 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.59 -46.88 35.72 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.06 0.544 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -145.45 -172.6 3.92 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.475 1.91 . . . . 0.0 111.221 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -51.38 -49.41 61.59 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.708 -1.245 . . . . 0.0 113.242 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.6 p -128.24 32.51 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 110.823 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.1 t -137.37 127.96 26.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.241 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 184' ' ' VAL . 18.6 m-85 -125.07 137.09 54.21 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.011 1.324 . . . . 0.0 109.707 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.31 128.16 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.977 0.894 . . . . 0.0 109.007 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -115.69 94.51 4.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.433 1.893 . . . . 0.0 107.377 -165.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -85.79 121.4 28.39 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.775 -0.578 . . . . 0.0 110.186 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.78 101.5 11.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 111.836 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.79 10.13 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.597 1.159 . . . . 0.0 112.675 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.68 157.07 34.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.423 1.489 . . . . 0.0 112.834 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.63 -4.56 59.06 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 126.121 1.769 . . . . 0.0 112.184 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.25 142.73 58.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -18.86 10.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.726 1.148 . . . . 0.0 113.623 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -113.35 15.72 19.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.95 2.1 . . . . 0.0 112.753 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -139.5 166.49 24.42 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.188 -1.57 . . . . 0.0 109.725 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.15 159.78 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.383 0.611 . . . . 0.0 110.037 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.87 161.31 39.63 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.842 0.857 . . . . 0.0 111.301 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -128.11 145.85 50.88 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.337 1.455 . . . . 0.0 109.311 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.44 114.07 14.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.77 2.028 . . . . 0.0 110.618 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.38 77.01 6.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 109.189 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.59 -87.97 0.07 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.832 -0.982 . . . . 0.0 112.844 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.15 124.15 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 129.738 3.215 . . . . 0.0 109.512 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 63.78 44.05 5.18 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.541 1.136 . . . . 0.0 114.028 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m 68.02 58.09 0.48 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.383 2.273 . . . . 0.0 113.961 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -141.73 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.896 1.678 . . . . 0.0 112.002 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.28 -121.09 12.72 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.366 0.984 . . . . 0.0 111.686 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.97 166.26 15.23 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.119 0.959 . . . . 0.0 111.361 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -132.12 154.18 49.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.056 1.342 . . . . 0.0 111.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.81 141.61 22.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.509 1.524 . . . . 0.0 109.513 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -117.44 135.32 53.98 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.076 0.95 . . . . 0.0 110.042 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -131.84 139.1 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.353 1.461 . . . . 0.0 109.946 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.8 150.45 24.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.609 -0.682 . . . . 0.0 111.284 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.28 162.63 29.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.941 0.896 . . . . 0.0 111.43 170.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.54 33.31 40.51 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.636 0.636 . . . . 0.0 113.906 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -134.06 148.11 51.0 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.267 1.427 . . . . 0.0 110.625 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -105.96 132.8 51.62 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.426 1.49 . . . . 0.0 108.31 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.8 126.02 69.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.247 1.019 . . . . 0.0 109.247 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 150.16 28.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.81 1.644 . . . . 0.0 110.379 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.577 1.551 . . . . 0.0 110.201 171.695 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.35 0.595 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -65.05 -41.84 94.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 0.0 113.773 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.458 ' HB2' ' H ' ' A' ' 86' ' ' LEU . 8.5 t0 -66.76 -94.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 108.119 158.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 29.3 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 127.238 2.215 . . . . 0.0 116.178 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.14 147.15 50.26 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 128.728 2.811 . . . . 0.0 110.058 176.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.8 tpt -151.56 -53.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.339 1.055 . . . . 0.0 111.947 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -137.11 131.15 32.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 125.322 1.449 . . . . 0.0 109.433 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.63 155.57 44.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.65 1.18 . . . . 0.0 109.583 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.9 117.2 18.93 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.137 0.975 . . . . 0.0 108.61 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.84 117.26 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.997 1.719 . . . . 0.0 108.547 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -41.02 -95.77 0.01 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 127.472 2.463 . . . . 0.0 117.519 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 t -162.19 -40.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.476 1.111 . . . . 0.0 111.908 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.61 35.84 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.656 1.582 . . . . 0.0 110.355 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.76 135.91 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.435 1.494 . . . . 0.0 109.245 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.98 153.73 25.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 109.5 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.63 142.39 47.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.199 1.0 . . . . 0.0 109.392 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.74 127.98 39.86 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.561 1.544 . . . . 0.0 107.412 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 pt -121.6 125.57 73.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.453 0.644 . . . . 0.0 109.707 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -140.05 100.03 3.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.933 1.349 . . . . 0.0 111.201 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.53 104.85 2.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.44 1.496 . . . . 0.0 111.303 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.46 154.11 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.327 1.537 . . . . 0.0 114.25 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -92.06 139.67 30.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.781 -1.199 . . . . 0.0 112.24 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.34 179.73 8.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.626 1.171 . . . . 0.0 111.597 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -136.83 44.0 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 126.022 1.729 . . . . 0.0 111.328 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 59.86 47.5 10.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.97 1.708 . . . . 0.0 112.332 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.7 p -79.36 179.78 1.69 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.719 2.008 . . . . 0.0 111.007 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 41.3 Cg_endo -70.45 12.08 0.42 Allowed 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.871 2.38 . . . . 0.0 114.397 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -145.18 65.99 12.22 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.597 1.559 . . . . 0.0 110.997 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.61 132.86 32.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.246 1.298 . . . . 0.0 109.359 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.41 164.35 11.28 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.215 171.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -57.55 109.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.385 0.674 . . . . 0.0 110.663 163.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -111.67 139.01 47.47 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.928 1.691 . . . . 0.0 109.259 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -160.77 158.75 29.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.06 0.933 . . . . 0.0 111.361 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.47 95.83 5.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.456 1.502 . . . . 0.0 109.613 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.07 108.15 1.75 Allowed 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.37 -0.831 . . . . 0.0 109.476 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.73 143.1 10.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.982 1.713 . . . . 0.0 113.209 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.39 138.11 57.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.872 0.869 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.41 73.32 0.49 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.436 1.493 . . . . 0.0 116.097 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.98 177.43 8.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.6 m -122.22 135.42 54.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.382 1.073 . . . . 0.0 109.402 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -115.26 134.82 54.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.467 1.507 . . . . 0.0 107.671 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -144.64 5.89 1.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.61 33.26 0.41 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.142 1.377 . . . . 0.0 111.595 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.59 -4.23 57.35 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.083 -1.011 . . . . 0.0 113.72 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.39 -13.13 26.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.13 0.972 . . . . 0.0 113.617 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.0 m -50.73 -32.79 20.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.901 1.681 . . . . 0.0 114.072 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -30.83 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.418 0.687 . . . . 0.0 112.254 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.6 t30 35.89 43.42 0.19 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.579 2.752 . . . . 0.0 115.456 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.42 95.12 0.12 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.884 1.23 . . . . 0.0 111.685 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.458 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 5.3 mp -140.25 155.71 46.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.833 2.053 . . . . 0.0 109.287 170.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 m -157.1 -32.68 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.388 1.075 . . . . 0.0 112.458 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -119.28 138.65 52.87 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.05 1.34 . . . . 0.0 109.822 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -130.44 129.68 43.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.13 1.372 . . . . 0.0 107.981 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -129.52 117.7 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.88 131.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.81 148.78 38.02 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.401 1.08 . . . . 0.0 109.675 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' CG ' ' CD2' ' A' ' 96' ' ' PHE . 77.8 Cg_endo -77.67 15.76 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.527 3.485 . . . . 0.0 112.907 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.18 -35.66 0.42 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.846 2.641 . . . . 0.0 116.042 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -34.21 73.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.987 1.715 . . . . 0.0 112.588 168.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.431 ' CD2' ' CG ' ' A' ' 93' ' ' PRO . 11.0 m-85 -92.54 138.2 31.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 110.325 174.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -79.35 -35.06 41.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.022 0.929 . . . . 0.0 111.74 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -158.58 170.75 21.49 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 109.756 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.65 165.15 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.042 0.937 . . . . 0.0 110.673 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.88 149.24 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.436 1.095 . . . . 0.0 109.928 -171.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -99.98 122.45 42.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.04 137.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.441 0.697 . . . . 0.0 110.456 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -138.53 155.36 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.174 1.39 . . . . 0.0 110.091 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 117' ' ' MET . 3.7 mt -124.06 135.67 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.46 121.74 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -85.04 118.72 24.78 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -102.91 -8.95 20.28 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.3 t -108.72 -57.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.952 0.901 . . . . 0.0 112.216 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.78 -33.49 76.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.024 0.53 . . . . 0.0 110.505 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.97 17.97 3.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.712 2.005 . . . . 0.0 114.381 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -103.02 -47.14 4.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 111.521 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 57.07 153.48 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.226 2.21 . . . . 0.0 116.072 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.37 58.93 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.834 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.7 p -90.43 -61.8 1.6 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.05 1.34 . . . . 0.0 112.203 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -47.23 108.39 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.254 2.222 . . . . 0.0 111.326 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.64 124.34 47.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.326 1.05 . . . . 0.0 109.209 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.483 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.5 tmm? -114.19 141.15 47.9 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.591 1.156 . . . . 0.0 109.255 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.9 m -132.03 137.38 47.8 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.344 1.458 . . . . 0.0 107.855 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 138' ' ' LEU . 14.2 pt -133.72 145.15 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 123.618 0.767 . . . . 0.0 111.123 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.0 m -135.61 95.68 14.08 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 108.916 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 75.49 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.291 3.328 . . . . 0.0 111.583 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 124' ' ' VAL . 58.9 t80 60.18 81.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.967 2.107 . . . . 0.0 112.041 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 42.93 46.28 4.6 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.911 1.684 . . . . 0.0 115.084 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 141' ' ' PRO . 11.9 t -121.92 168.6 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.322 2.249 . . . . 0.0 109.848 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -36.44 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.991 2.517 . . . . 0.0 113.7 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 145.31 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.241 1.016 . . . . 0.0 110.396 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 139.18 50.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 109.395 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.3 133.56 55.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.295 -1.32 . . . . 0.0 108.78 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.453 ' HB3' HG11 ' A' ' 136' ' ' VAL . 22.4 p -135.19 150.45 50.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.339 1.066 . . . . 0.0 110.431 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -102.61 144.08 31.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.753 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.59 27.43 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.128 2.171 . . . . 0.0 115.922 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.51 2.39 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.422 1.963 . . . . 0.0 114.089 -173.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.54 174.92 10.08 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.671 1.988 . . . . 0.0 110.11 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -56.57 158.99 4.05 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.887 -1.133 . . . . 0.0 112.468 163.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -51.96 153.66 2.51 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.72 0.808 . . . . 0.0 112.04 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 129' ' ' CYS . 29.0 m -107.16 139.09 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.435 0.636 . . . . 0.0 110.747 172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.21 108.19 11.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.787 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 119' ' ' ILE . 20.2 tp -88.22 112.29 48.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.194 1.398 . . . . 0.0 109.258 170.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 56.8 Cg_endo -78.5 152.36 26.32 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.823 1.682 . . . . 0.0 112.728 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 30.4 mm -133.8 131.77 21.25 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.428 1.491 . . . . 0.0 109.873 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.476 ' HG3' HG21 ' A' ' 124' ' ' VAL . 85.6 Cg_endo -75.94 170.96 19.05 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.281 2.654 . . . . 0.0 112.366 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.67 149.21 42.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.75 154.25 24.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.484 1.914 . . . . 0.0 109.877 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -134.78 135.93 24.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.392 1.077 . . . . 0.0 110.975 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 150.49 77.51 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.639 0.907 . . . . 0.0 111.421 -5.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.17 -32.15 74.51 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.76 1.64 . . . . 0.0 111.704 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.35 -5.91 4.08 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.706 2.002 . . . . 0.0 114.908 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 p -69.63 -178.87 1.56 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.873 -1.142 . . . . 0.0 112.276 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.87 150.49 40.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.034 0.934 . . . . 0.0 111.91 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.9 tt -107.02 138.69 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.379 1.472 . . . . 0.0 109.583 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.47 138.23 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.008 0.923 . . . . 0.0 109.617 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -141.6 131.31 24.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.999 -1.063 . . . . 0.0 110.601 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -82.9 141.52 32.14 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.545 -0.722 . . . . 0.0 109.84 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.24 111.17 13.64 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.616 1.166 . . . . 0.0 110.0 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.9 p -128.02 115.23 18.17 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.872 1.269 . . . . 0.0 110.34 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.59 121.34 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.301 1.44 . . . . 0.0 107.527 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -127.93 136.79 51.82 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.214 1.406 . . . . 0.0 108.911 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.26 130.48 35.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.234 0.54 . . . . 0.0 110.428 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -75.94 -30.81 58.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.232 1.013 . . . . 0.0 112.206 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 -179.29 4.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.839 2.055 . . . . 0.0 112.266 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.49 148.71 32.43 Favored Pre-proline 0 N--CA 1.481 1.105 0 O-C-N 121.214 -0.929 . . . . 0.0 112.651 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.3 17.15 11.71 Favored 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 119.956 1.02 . . . . 0.0 114.65 -1.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 63.61 18.69 11.27 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.204 1.802 . . . . 0.0 113.986 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -94.35 178.99 5.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.188 1.795 . . . . 0.0 112.289 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -79.37 144.31 34.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.65 -1.281 . . . . 0.0 112.328 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.48 -43.51 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.412 1.885 . . . . 0.0 110.994 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.6 t -140.39 123.55 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -135.97 97.39 3.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.43 10.35 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.667 1.127 . . . . 0.0 111.848 -168.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 m -139.13 169.63 17.44 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.291 1.036 . . . . 0.0 110.66 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.0 156.98 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 127.282 2.233 . . . . 0.0 108.461 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -120.96 139.76 52.81 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -120.23 130.79 54.68 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.286 -0.883 . . . . 0.0 109.7 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -120.56 153.37 36.84 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.294 1.437 . . . . 0.0 110.249 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -128.63 124.37 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.209 1.403 . . . . 0.0 110.132 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.8 m -95.55 113.75 62.47 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 109.823 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.16 -11.68 32.76 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.064 2.509 . . . . 0.0 112.827 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m -43.34 -48.22 6.87 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.878 2.471 . . . . 0.0 112.985 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 80.7 p -144.84 17.87 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.206 1.402 . . . . 0.0 112.395 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.0 88.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.681 -1.262 . . . . 0.0 113.542 -171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -73.77 152.07 40.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.811 0.805 . . . . 0.0 110.778 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.82 134.32 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.952 1.301 . . . . 0.0 108.351 167.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 17.8 m -134.83 109.34 8.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.034 1.734 . . . . 0.0 107.729 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 2.0 p -76.82 147.03 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.544 -0.722 . . . . 0.0 109.409 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.66 125.46 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.902 1.681 . . . . 0.0 106.893 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 135.92 44.31 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.642 1.177 . . . . 0.0 109.785 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -146.89 158.12 43.83 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.957 1.703 . . . . 0.0 109.914 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.53 -19.47 10.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.112 1.765 . . . . 0.0 113.944 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -58.09 -23.59 55.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -149.47 -46.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.029 1.332 . . . . 0.0 113.297 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -85.69 133.05 42.55 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.975 1.31 . . . . 0.0 109.392 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.01 -172.17 1.06 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 122.565 2.177 . . . . 0.0 112.676 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -107.08 -22.41 12.66 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.562 1.145 . . . . 0.0 113.526 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -55.12 -40.26 70.31 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.776 1.23 . . . . 0.0 112.566 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -105.46 144.47 32.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.939 1.695 . . . . 0.0 109.397 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.3 p -139.89 157.26 45.99 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.762 1.225 . . . . 0.0 109.536 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.3 127.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.851 0.461 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 51.5 m -119.06 131.4 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.617 1.567 . . . . 0.0 109.763 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -65.76 122.12 16.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.857 1.263 . . . . 0.0 111.066 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.36 -28.82 8.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.029 0.932 . . . . 0.0 112.057 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.73 -175.27 4.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.357 1.863 . . . . 0.0 110.914 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -56.58 -31.48 64.27 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.08 1.352 . . . . 0.0 113.764 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 61.3 p -143.4 33.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.422 . . . . 0.0 111.813 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 48.9 m -129.71 134.4 47.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.866 0.867 . . . . 0.0 111.943 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.456 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 23.8 m-85 -130.88 138.96 50.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.877 1.671 . . . . 0.0 110.801 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 34.5 mt -125.19 122.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -98.03 112.28 24.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.689 1.996 . . . . 0.0 108.348 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -103.28 124.18 48.17 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.27 116.58 32.19 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 110.945 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -120.2 20.81 11.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.541 1.937 . . . . 0.0 112.172 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.76 -168.91 3.22 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.332 1.453 . . . . 0.0 111.614 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.76 26.47 1.39 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.824 -1.173 . . . . 0.0 113.778 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 127.746 2.419 . . . . 0.0 115.01 -166.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.238 0.542 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.15 138.82 57.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.919 0.888 . . . . 0.0 110.318 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.35 -13.06 4.46 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -117.19 9.38 13.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.438 2.295 . . . . 0.0 112.635 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -144.56 175.15 10.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.33 1.852 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.97 154.97 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.194 0.998 . . . . 0.0 109.452 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 149.39 42.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.88 1.272 . . . . 0.0 110.391 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.79 26.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.068 1.347 . . . . 0.0 108.942 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.33 131.83 38.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.114 1.366 . . . . 0.0 110.7 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -79.52 51.95 1.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.605 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.26 134.95 2.27 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 120.21 -1.556 . . . . 0.0 112.869 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 145.72 14.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.656 0.782 . . . . 0.0 111.102 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.48 26.22 13.99 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.3 t 67.25 71.8 0.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.824 1.649 . . . . 0.0 111.578 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -137.83 -178.14 5.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.524 1.529 . . . . 0.0 112.181 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.88 -82.89 0.5 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 126.066 1.793 . . . . 0.0 115.173 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -138.57 163.85 30.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.747 1.619 . . . . 0.0 110.345 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.2 p -135.75 145.32 46.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.217 1.007 . . . . 0.0 112.882 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -156.61 169.76 23.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.54 1.536 . . . . 0.0 111.821 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.21 153.91 48.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.307 1.443 . . . . 0.0 110.689 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.99 131.13 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.392 1.477 . . . . 0.0 109.731 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.62 128.43 33.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.864 . . . . 0.0 109.924 175.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -54.55 139.9 36.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.75 0.82 . . . . 0.0 110.979 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.72 42.79 16.31 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.48 0.562 . . . . 0.0 112.527 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -133.32 154.62 50.55 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.514 1.525 . . . . 0.0 111.291 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m -140.09 122.51 16.07 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.132 1.373 . . . . 0.0 108.393 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.97 153.81 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.024 0.916 . . . . 0.0 110.549 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.7 mtm-85 -133.74 118.84 18.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.9 1.68 . . . . 0.0 107.873 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.7 m0 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.57 -19.48 65.27 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.859 1.664 . . . . 0.0 114.084 173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.03 -68.86 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.122 165.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 28.22 37.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.15 2.58 . . . . 0.0 116.194 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -136.15 127.68 28.71 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.593 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -158.17 -39.72 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 111.387 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -142.2 126.14 17.22 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.246 1.018 . . . . 0.0 110.052 164.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.8 m -133.6 155.05 50.36 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.002 0.906 . . . . 0.0 109.398 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.04 127.13 33.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.86 108.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.753 1.621 . . . . 0.0 108.95 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.38 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.472 1.037 0 C-N-CA 128.383 2.897 . . . . 0.0 117.589 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -166.86 -42.8 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.146 0.978 . . . . 0.0 112.561 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -106.94 37.63 2.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.395 1.478 . . . . 0.0 110.481 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' PRO . 4.5 m -143.61 158.59 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.358 1.863 . . . . 0.0 110.688 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -139.05 150.97 46.37 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.546 1.938 . . . . 0.0 109.909 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.62 126.53 54.3 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.176 0.59 . . . . 0.0 109.82 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -116.32 120.35 38.61 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.624 1.169 . . . . 0.0 108.145 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 HD11 ' A' ' 86' ' ' LEU . 1.3 pp -113.63 115.22 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 110.411 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -124.16 123.66 40.77 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.598 1.159 . . . . 0.0 108.796 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.21 -45.06 84.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 112.782 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 172.01 16.35 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.652 1.981 . . . . 0.0 107.66 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -60.13 -66.33 0.54 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.385 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.255 1.8 pp20? 48.72 167.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.59 54.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.349 -1.469 . . . . 0.0 112.554 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.263 44.0 m-20 53.33 45.97 27.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.349 1.859 . . . . 0.0 112.485 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -73.61 166.38 44.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.03 22.52 0.31 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.536 2.824 . . . . 0.0 113.835 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -152.23 58.63 2.66 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 126.467 1.907 . . . . 0.0 111.277 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.9 134.39 34.41 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.551 1.5 . . . . 0.0 109.552 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -101.81 0.1 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.814 0.721 . . . . 0.0 111.8 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 154.77 44.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.893 1.277 . . . . 0.0 111.881 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.61 139.26 16.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.852 1.661 . . . . 0.0 110.59 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -158.61 159.07 35.03 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.167 0.984 . . . . 0.0 111.768 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.88 90.4 3.19 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.514 1.525 . . . . 0.0 108.923 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.71 105.33 0.79 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 148.57 11.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.428 1.891 . . . . 0.0 113.8 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.57 151.78 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.47 1.108 . . . . 0.0 112.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.33 52.78 45.22 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 124.655 1.121 . . . . 0.0 114.997 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.78 175.45 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.815 0.846 . . . . 0.0 112.874 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.1 m -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.16 1.384 . . . . 0.0 109.698 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.33 121.71 19.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.84 1.256 . . . . 0.0 109.314 -175.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -117.9 15.79 14.31 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.066 1.746 . . . . 0.0 112.671 -172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -140.23 38.66 1.92 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.328 1.451 . . . . 0.0 112.741 -171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.86 -17.36 64.86 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.797 -1.189 . . . . 0.0 111.971 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -56.49 -19.19 14.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.81 1.644 . . . . 0.0 114.624 168.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.2 t -54.14 -27.27 32.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.247 -0.908 . . . . 0.0 112.285 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.0 mt -134.07 73.87 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 127.046 2.138 . . . . 0.0 108.848 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -60.94 -23.08 65.02 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.809 -1.182 . . . . 0.0 112.657 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.38 80.33 0.15 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.8 1.666 . . . . 0.0 113.232 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 54' ' ' ILE . 1.6 mp -124.59 153.03 42.8 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.9 1.68 . . . . 0.0 111.661 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -158.53 -22.12 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.471 1.509 . . . . 0.0 114.201 161.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.06 129.45 55.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.474 1.51 . . . . 0.0 108.75 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.65 121.07 31.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.93 132.38 54.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -126.37 130.17 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 pp -144.82 148.81 40.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.406 0.682 . . . . 0.0 110.152 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 96' ' ' PHE . 36.7 Cg_endo -68.52 155.06 70.33 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.898 1.732 . . . . 0.0 112.391 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.95 -24.3 64.64 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.059 0.838 . . . . 0.0 114.528 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.43 -22.88 67.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.52 1.128 . . . . 0.0 113.679 169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 93' ' ' PRO . 11.5 m-30 -111.0 130.08 55.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.933 1.693 . . . . 0.0 108.741 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -85.75 -40.16 16.37 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.505 -1.372 . . . . 0.0 112.194 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' HD12 ' A' ' 140' ' ' ILE . 39.1 p-90 -152.23 159.28 43.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.77 2.028 . . . . 0.0 109.041 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.02 146.41 50.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.609 0.763 . . . . 0.0 110.766 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.91 135.19 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.747 1.219 . . . . 0.0 110.166 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -77.23 134.66 38.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.276 0.63 . . . . 0.0 109.885 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.55 140.4 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 109.938 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.33 157.15 45.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.06 1.744 . . . . 0.0 110.609 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 92.6 mt -118.76 139.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.959 2.104 . . . . 0.0 109.535 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.33 106.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.755 1.622 . . . . 0.0 109.601 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.69 111.83 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.415 0.686 . . . . 0.0 110.727 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.8 15.35 11.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.421 1.088 . . . . 0.0 111.466 168.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -96.28 -61.83 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.869 1.667 . . . . 0.0 111.063 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -151.63 99.08 2.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.386 1.875 . . . . 0.0 108.799 -172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.5 m -53.16 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.88 1.672 . . . . 0.0 113.052 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.1 m -146.69 -53.89 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.743 1.617 . . . . 0.0 110.779 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.2 159.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.175 2.19 . . . . 0.0 114.96 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.42 -36.1 0.44 Allowed Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.531 -1.355 . . . . 0.0 115.293 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.6 m -64.63 1.7 0.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.175 2.19 . . . . 0.0 115.033 170.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.446 ' CE2' HG21 ' A' ' 166' ' ' VAL . 17.9 t80 -134.99 122.18 21.5 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.258 2.223 . . . . 0.0 109.76 -173.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -132.18 130.34 40.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.958 1.303 . . . . 0.0 110.387 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 3.6 ttm -115.57 141.57 47.88 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.694 1.598 . . . . 0.0 110.632 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.6 m -128.27 116.41 19.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.573 1.149 . . . . 0.0 108.171 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mt -96.64 122.83 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.4 m -116.04 87.54 19.38 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.981 1.712 . . . . 0.0 109.24 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.0 163.53 37.32 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.58 2.853 . . . . 0.0 112.465 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -45.16 96.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.577 1.951 . . . . 0.0 113.259 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 37.29 47.47 0.69 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.267 1.827 . . . . 0.0 114.881 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.34 155.18 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.966 1.707 . . . . 0.0 109.535 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.75 92.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.356 1.462 . . . . 0.0 112.288 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.51 160.47 4.18 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.475 1.51 . . . . 0.0 111.523 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.49 145.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 111.391 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.85 138.86 33.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.457 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 39.8 t -135.78 124.61 24.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.339 1.455 . . . . 0.0 107.855 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -118.52 141.19 48.82 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 109.03 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.92 105.23 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.431 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.15 63.0 0.32 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.318 0.961 . . . . 0.0 113.658 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -141.59 155.89 45.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.456 1.903 . . . . 0.0 111.657 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.38 55.11 2.71 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.609 -1.307 . . . . 0.0 111.662 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 59.61 169.78 0.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.539 1.936 . . . . 0.0 112.826 -167.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.14 126.17 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.845 -1.159 . . . . 0.0 109.741 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 127.17 31.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.841 0.456 . . . . 0.0 110.047 171.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.18 95.83 47.98 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.059 1.743 . . . . 0.0 107.685 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 55.4 Cg_endo -77.98 148.13 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.903 2.402 . . . . 0.0 112.669 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.411 HD12 ' CZ3' ' A' ' 98' ' ' TRP . 87.2 mt -136.03 131.72 18.98 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.309 1.443 . . . . 0.0 109.1 -174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.47 169.85 21.34 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.922 3.748 . . . . 0.0 112.112 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -68.6 149.04 49.63 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.517 -0.739 . . . . 0.0 111.677 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.61 163.63 39.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.097 2.159 . . . . 0.0 109.573 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.3 m -131.25 131.4 23.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.942 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.97 153.63 80.41 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 119.343 0.801 . . . . 0.0 111.877 -3.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.85 -17.28 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.734 1.623 . . . . 0.0 112.886 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.49 13.53 21.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 114.415 169.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.87 152.11 46.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.744 -1.223 . . . . 0.0 112.437 174.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.79 113.63 19.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.315 0.646 . . . . 0.0 111.018 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.6 tt -85.71 120.25 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.62 0.768 . . . . 0.0 109.828 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.49 139.42 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.542 0.687 . . . . 0.0 110.703 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.1 t -143.8 150.42 38.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.44 1.096 . . . . 0.0 109.798 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -111.32 145.17 39.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.704 0.802 . . . . 0.0 109.62 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 tt -133.85 120.73 20.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.665 0.745 . . . . 0.0 109.311 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.04 124.45 26.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.309 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 116' ' ' GLU . 2.2 p -145.34 135.16 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.57 1.148 . . . . 0.0 109.698 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 162.14 35.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.226 1.41 . . . . 0.0 111.523 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -66.5 128.52 36.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.126 170.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.9 p -73.57 -6.46 46.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.892 0.877 . . . . 0.0 113.326 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -122.54 141.0 52.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.279 2.232 . . . . 0.0 108.869 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -65.59 140.84 97.66 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.696 -0.668 . . . . 0.0 111.643 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 131.67 20.94 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.415 1.184 . . . . 0.0 111.492 -4.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -73.68 41.68 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 112.499 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.91 126.7 14.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -68.63 82.15 0.28 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.391 1.077 . . . . 0.0 110.046 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 156' ' ' VAL . 14.0 m -45.91 -37.84 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.976 1.71 . . . . 0.0 113.017 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 33.7 t -147.88 136.9 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.488 1.115 . . . . 0.0 109.697 165.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -142.03 115.2 8.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.787 1.235 . . . . 0.0 108.137 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.35 -162.21 24.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.02 0.819 . . . . 0.0 113.298 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.92 153.66 51.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.625 1.17 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.92 143.58 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.168 1.787 . . . . 0.0 109.245 -175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -115.05 115.11 26.28 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.182 -0.949 . . . . 0.0 109.328 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 152.82 26.16 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.462 -0.774 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.77 154.65 45.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 108.709 167.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -127.91 127.48 43.44 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.869 1.268 . . . . 0.0 108.727 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.3 m -86.17 106.68 10.64 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.59 -17.68 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.43 2.753 . . . . 0.0 112.514 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.3 m -55.91 -38.83 70.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.199 1.8 . . . . 0.0 113.079 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.8 p -147.75 24.59 1.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.013 1.325 . . . . 0.0 112.705 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 50.71 31.12 22.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.406 1.955 . . . . 0.0 115.851 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.59 164.5 25.76 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.182 0.991 . . . . 0.0 111.152 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.62 135.5 55.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.074 1.35 . . . . 0.0 109.008 165.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.9 m -133.49 107.17 7.87 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.481 HG11 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -83.83 151.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.4 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.91 135.44 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 125.874 1.67 . . . . 0.0 107.709 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.472 ' HD2' HG21 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 140.2 36.23 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.833 1.653 . . . . 0.0 107.425 177.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -125.29 146.14 49.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.303 1.441 . . . . 0.0 108.353 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.95 -14.42 47.07 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -17.44 61.05 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 171.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.0 p -130.38 -32.3 1.77 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.608 1.563 . . . . 0.0 113.231 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.95 146.89 76.41 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.996 1.318 . . . . 0.0 110.782 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.28 -7.72 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.586 2.857 . . . . 0.0 113.99 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.4 tttm 64.56 -24.2 0.08 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.341 2.656 . . . . 0.0 115.993 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -67.74 -18.17 64.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.43 1.092 . . . . 0.0 113.685 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.7 ttm -103.3 151.44 22.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.563 1.945 . . . . 0.0 109.418 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.0 p -131.76 159.67 37.8 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.455 1.502 . . . . 0.0 110.144 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 186' ' ' LYS . 77.8 t -121.61 130.75 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.157 0.983 . . . . 0.0 109.683 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.2 m -134.31 126.78 30.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.471 1.109 . . . . 0.0 108.697 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.42 141.4 28.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.565 1.146 . . . . 0.0 110.481 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -117.47 -36.18 3.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.564 0.746 . . . . 0.0 111.704 171.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -129.38 178.78 6.2 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.527 1.131 . . . . 0.0 111.849 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.78 -40.41 63.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.226 1.01 . . . . 0.0 112.144 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -137.01 33.8 2.61 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 111.205 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.7 t -129.18 116.99 20.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.882 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.481 ' CE2' HG11 ' A' ' 184' ' ' VAL . 2.5 t80 -100.17 136.29 40.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.365 2.266 . . . . 0.0 109.73 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.04 112.77 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.608 1.163 . . . . 0.0 109.54 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.02 120.19 22.5 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.109 1.363 . . . . 0.0 109.872 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -106.41 133.79 50.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 45.6 tp -127.47 111.54 13.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.812 -0.555 . . . . 0.0 110.966 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.58 -26.19 15.33 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.92 132.57 53.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 111.053 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.6 -48.91 79.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 127.264 2.225 . . . . 0.0 112.507 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' CD ' ' A' ' 9' ' ' LYS . 9.9 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.075 0.464 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.57 144.34 43.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.623 0.369 . . . . 0.0 110.686 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.86 -17.12 34.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.037 -1.039 . . . . 0.0 113.179 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -108.91 13.47 24.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.442 1.897 . . . . 0.0 113.275 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -137.55 170.96 15.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 46' ' ' VAL . 3.8 m -142.58 151.58 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.0 110.517 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' CD ' HG23 ' A' ' 3' ' ' VAL . 2.4 mptm? -130.51 152.11 50.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.112 0.965 . . . . 0.0 110.812 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.74 133.99 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 108.256 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -121.73 127.73 51.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.818 1.647 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.42 61.4 6.17 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.761 1.225 . . . . 0.0 110.884 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.42 142.99 3.86 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.235 0.922 . . . . 0.0 112.019 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -59.2 132.17 53.22 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.948 0.874 . . . . 0.0 109.669 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 t30 77.09 41.88 0.15 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.743 1.617 . . . . 0.0 113.199 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.343 31.1 p 49.87 58.2 5.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.921 2.488 . . . . 0.0 115.485 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 p -127.81 179.47 5.53 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.164 1.785 . . . . 0.0 113.18 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.23 -74.74 1.84 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.463 1.982 . . . . 0.0 113.957 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -139.13 170.16 16.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.655 1.582 . . . . 0.0 109.781 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -137.32 143.91 42.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.535 1.134 . . . . 0.0 111.166 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -143.4 155.46 44.41 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.552 1.541 . . . . 0.0 110.465 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -125.67 134.8 51.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.761 1.224 . . . . 0.0 109.204 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' HB2' HG23 ' A' ' 8' ' ' VAL . 17.8 m-85 -127.52 131.33 50.09 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.483 1.135 . . . . 0.0 110.521 -175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -91.91 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.716 1.207 . . . . 0.0 109.349 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 145.07 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.819 -0.55 . . . . 0.0 112.409 172.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.7 73.08 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.172 0.415 . . . . 0.0 113.837 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -127.9 126.01 40.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.297 1.439 . . . . 0.0 109.936 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m -109.19 126.56 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.25 146.1 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 110.037 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -125.95 144.37 50.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.037 1.335 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 125.43 1.492 . . . . 0.0 109.628 173.896 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.2 m0 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.19 -45.4 33.45 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 111.34 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.66 35.73 0.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.265 1.426 . . . . 0.0 113.15 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -16.12 62.67 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 119.651 -1.906 . . . . 0.0 114.247 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.7 134.76 56.49 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 mtp -150.01 -58.76 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 112.07 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -136.27 115.54 12.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.948 1.299 . . . . 0.0 109.905 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.08 146.95 37.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.709 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.87 128.15 43.27 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.112 1.365 . . . . 0.0 109.081 -168.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 8' ' ' VAL . 59.0 t -118.55 119.75 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.268 1.427 . . . . 0.0 110.185 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.74 0.01 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.516 1.532 . . . . 0.0 116.66 -164.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.33 -21.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 27.34 7.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.798 1.639 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.77 141.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.912 2.085 . . . . 0.0 109.416 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -116.23 153.06 32.55 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.12 128.33 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.232 0.539 . . . . 0.0 109.626 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.24 126.15 54.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.073 0.949 . . . . 0.0 108.448 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.6 pp -117.26 104.18 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 122.194 0.997 . . . . 0.0 109.516 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.82 123.05 49.34 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.611 1.164 . . . . 0.0 108.769 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.84 -57.87 10.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.161 0.982 . . . . 0.0 111.491 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 158.42 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.657 1.183 . . . . 0.0 109.383 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.42 124.38 33.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' H ' ' HB2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -159.8 172.97 16.71 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.588 1.555 . . . . 0.0 111.999 -169.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.0 pt -123.68 34.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.503 -1.373 . . . . 0.0 114.211 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.299 67.4 m-20 61.94 51.04 3.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.979 2.112 . . . . 0.0 111.689 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p -65.74 166.41 15.28 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.655 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 56.6 Cg_endo -73.37 20.38 0.36 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 123.456 2.771 . . . . 0.0 114.285 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -148.03 63.7 7.67 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.656 1.582 . . . . 0.0 111.957 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.64 140.42 62.25 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.751 1.634 . . . . 0.0 110.535 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.02 -92.81 1.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -145.62 153.92 41.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.174 1.39 . . . . 0.0 110.787 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -153.33 137.55 16.53 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.056 1.342 . . . . 0.0 108.715 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -155.83 164.67 38.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.377 1.084 . . . . 0.0 111.198 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -133.84 104.84 6.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.391 1.076 . . . . 0.0 108.355 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -68.23 115.31 7.54 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.813 0.845 . . . . 0.0 109.598 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.17 152.92 1.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.155 1.782 . . . . 0.0 112.882 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.83 -21.93 32.75 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.87 88.16 0.12 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.135 1.35 . . . . 0.0 112.282 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -161.05 171.75 18.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.674 1.19 . . . . 0.0 112.446 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.0 m -124.3 140.11 53.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.35 1.06 . . . . 0.0 109.187 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -131.09 119.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -107.58 -20.87 13.1 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.865 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -121.43 49.69 1.49 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.85 -16.72 59.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.103 -0.998 . . . . 0.0 112.626 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.19 -17.28 2.67 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.972 1.309 . . . . 0.0 114.36 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -55.15 -29.56 58.02 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.473 -1.392 . . . . 0.0 113.656 165.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 tp -78.58 -39.33 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.899 0.772 . . . . 0.0 112.195 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 33.58 43.78 0.06 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.256 1.822 . . . . 0.0 114.293 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.86 61.96 0.14 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.753 -155.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 ' HB ' ' A' ' 54' ' ' ILE . 27.2 tp -139.9 124.85 18.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.268 1.027 . . . . 0.0 110.4 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -132.05 -15.67 2.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -129.99 110.1 11.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.383 1.473 . . . . 0.0 109.443 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 120.66 43.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -168.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -116.62 112.39 21.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 109.59 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG13 HG21 ' A' ' 8' ' ' VAL . 38.5 t -95.26 131.19 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.586 1.554 . . . . 0.0 109.182 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.75 HD13 ' CE1' ' A' ' 96' ' ' PHE . 11.2 mt -132.06 136.2 27.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.415 0.686 . . . . 0.0 110.376 -161.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.2 14.91 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.561 2.841 . . . . 0.0 114.535 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.14 -35.54 0.64 Allowed Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.997 2.237 . . . . 0.0 115.023 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.33 65.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.847 1.659 . . . . 0.0 112.526 167.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.75 ' CE1' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -50.18 153.08 1.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.876 1.271 . . . . 0.0 110.757 159.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HG3' ' CZ3' ' A' ' 98' ' ' TRP . 27.6 tp60 -132.28 -33.89 1.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.327 0.651 . . . . 0.0 111.842 167.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -151.63 166.94 29.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.068 1.747 . . . . 0.0 109.673 171.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.4 166.26 23.58 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.142 0.973 . . . . 0.0 111.193 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 HG11 ' A' ' 182' ' ' VAL . 9.2 p -134.51 121.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.698 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.84 120.74 19.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -115.46 144.77 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.976 1.31 . . . . 0.0 109.414 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.35 152.11 40.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.761 1.624 . . . . 0.0 108.912 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.8 mt -123.13 124.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.512 0.725 . . . . 0.0 109.62 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -124.65 116.64 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.475 1.51 . . . . 0.0 109.631 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.31 120.36 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.161 1.784 . . . . 0.0 110.68 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.64 27.03 4.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.102 1.761 . . . . 0.0 111.405 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.85 -56.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.95 1.7 . . . . 0.0 111.37 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -119.74 128.48 53.8 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.217 1.407 . . . . 0.0 109.743 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.6 56.6 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.967 1.307 . . . . 0.0 111.702 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.9 m -132.76 -66.32 0.68 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.004 1.322 . . . . 0.0 111.349 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.67 170.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -172.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.59 -12.61 60.72 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.468 -1.395 . . . . 0.0 115.178 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 p -110.3 -25.94 9.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.573 1.549 . . . . 0.0 113.894 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.98 135.02 46.27 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 165.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -131.88 138.77 48.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.147 0.975 . . . . 0.0 109.817 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.637 ' HG3' HG22 ' A' ' 156' ' ' VAL . 2.8 ttp -121.8 137.29 54.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.683 2.393 . . . . 0.0 108.165 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.0 m -136.45 135.52 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.12 123.66 54.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -120.8 90.55 46.59 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.016 1.327 . . . . 0.0 110.416 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.22 82.07 1.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.064 3.176 . . . . 0.0 113.126 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 55.32 57.83 5.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.293 1.437 . . . . 0.0 112.129 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.83 50.09 16.43 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.377 1.471 . . . . 0.0 113.239 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.92 169.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 127.692 2.397 . . . . 0.0 109.243 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.15 79.56 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.936 2.894 . . . . 0.0 114.579 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 159.75 30.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.212 1.405 . . . . 0.0 110.504 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.39 151.18 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.438 1.095 . . . . 0.0 109.652 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.29 131.02 54.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.047 0.939 . . . . 0.0 109.593 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.536 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -137.62 150.64 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -144.92 137.99 26.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.468 1.107 . . . . 0.0 110.537 -170.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.76 100.75 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.084 2.154 . . . . 0.0 111.564 -173.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.14 43.74 0.59 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.327 0.489 . . . . 0.0 114.123 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -136.32 164.52 27.91 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.678 1.591 . . . . 0.0 111.784 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.49 165.64 18.59 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.126 -0.984 . . . . 0.0 111.565 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -54.38 132.0 43.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.222 -0.924 . . . . 0.0 111.404 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 129' ' ' CYS . 14.9 t -100.18 116.07 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.768 1.227 . . . . 0.0 110.446 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.47 100.43 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.87 1.268 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mt -83.02 112.71 40.4 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.289 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.41 134.48 15.57 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.486 2.124 . . . . 0.0 110.342 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 mm -122.89 124.29 26.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.487 1.515 . . . . 0.0 108.644 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.65 174.2 13.05 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.593 2.862 . . . . 0.0 112.564 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.11 137.84 58.22 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.585 -0.697 . . . . 0.0 111.756 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.2 pp -151.79 38.19 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.162 1.385 . . . . 0.0 112.723 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 t -40.25 138.29 1.17 Allowed Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 127.381 2.272 . . . . 0.0 114.766 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.55 158.62 90.16 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 CA-C-N 119.836 0.977 . . . . 0.0 113.137 0.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.59 -33.82 66.02 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.067 1.844 . . . . 0.0 112.877 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.28 0.79 9.01 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.106 1.362 . . . . 0.0 114.618 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 p -66.94 175.62 2.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.293 1.044 . . . . 0.0 113.268 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.61 103.76 7.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.544 1.538 . . . . 0.0 110.508 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 tt -78.61 132.08 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.845 1.258 . . . . 0.0 110.181 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.17 143.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 110.363 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.4 t -137.35 153.43 50.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.56 1.144 . . . . 0.0 109.135 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -112.17 119.82 39.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 tt -101.18 126.2 47.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.977 1.311 . . . . 0.0 109.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.46 125.14 37.86 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.635 1.574 . . . . 0.0 108.817 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 117' ' ' MET . 2.4 t -129.33 119.19 47.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.809 1.243 . . . . 0.0 109.033 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -147.91 149.08 31.58 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.644 1.178 . . . . 0.0 109.802 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -70.87 134.08 47.0 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.217 -0.302 . . . . 0.0 110.948 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.1 p -72.71 -19.23 61.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.486 1.515 . . . . 0.0 113.733 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 169.62 10.95 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.321 1.848 . . . . 0.0 111.298 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 p -53.18 146.09 22.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.252 1.021 . . . . 0.0 113.583 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.0 6.39 18.37 Favored 'Cis proline' 0 CA--C 1.545 1.056 0 N-CA-C 114.933 1.09 . . . . 0.0 114.933 4.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.93 24.47 14.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.837 1.255 . . . . 0.0 112.377 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.17 142.19 43.55 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.623 -1.298 . . . . 0.0 111.015 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -57.9 146.17 33.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.11 0.564 . . . . 0.0 111.379 168.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.38 -40.67 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.348 1.059 . . . . 0.0 111.604 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.6 t -146.67 137.92 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.584 0.754 . . . . 0.0 109.402 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -149.6 139.13 21.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.56 1.144 . . . . 0.0 110.445 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.66 -172.37 44.15 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.71 0.671 . . . . 0.0 114.238 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.7 m -115.81 132.25 56.7 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.718 0.807 . . . . 0.0 111.598 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.61 116.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.976 2.11 . . . . 0.0 108.139 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.4 138.68 31.35 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.89 -1.131 . . . . 0.0 109.143 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -112.77 146.53 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.134 0.968 . . . . 0.0 109.629 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -141.26 152.2 44.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.916 1.686 . . . . 0.0 108.209 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' ' HA2' ' A' ' 180' ' ' GLY . 31.8 t80 -121.13 150.25 41.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.788 1.235 . . . . 0.0 109.43 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 m -111.23 105.38 56.96 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 123.804 0.842 . . . . 0.0 109.458 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.44 48.69 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.855 1 C-N-CA 126.271 4.648 . . . . 0.0 113.596 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.4 t -123.04 -45.43 2.13 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.408 1.483 . . . . 0.0 110.923 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.9 p -151.09 34.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.227 1.811 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 175' ' ' TYR . . . 58.98 32.8 71.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.978 1.275 . . . . 0.0 114.878 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.48 171.3 15.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.761 1.28 . . . . 0.0 110.948 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.443 HG11 HG23 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -132.69 152.43 36.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.453 1.101 . . . . 0.0 109.794 177.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 m -138.32 140.93 39.73 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.43 1.892 . . . . 0.0 107.468 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.49 HG22 ' HD2' ' A' ' 186' ' ' LYS . 1.1 p -110.29 141.54 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 24.9 mt -133.02 120.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.49 ' HD2' HG22 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -138.96 142.31 38.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.635 1.174 . . . . 0.0 109.037 175.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 140.4 52.75 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.057 1.343 . . . . 0.0 108.309 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.48 -20.09 11.64 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.66 -16.36 64.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.282 1.433 . . . . 0.0 114.607 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 32.7 p -141.07 -42.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.697 1.599 . . . . 0.0 113.59 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.432 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 10.0 t80 -88.19 146.82 38.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.983 1.313 . . . . 0.0 110.591 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 45.9 Cg_endo -76.03 168.99 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.224 2.616 . . . . 0.0 112.656 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -94.77 10.87 33.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.482 1.513 . . . . 0.0 112.514 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -93.64 -44.51 8.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 111.986 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -100.48 144.87 28.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.366 1.466 . . . . 0.0 109.108 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -139.97 158.46 44.03 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.07 1.348 . . . . 0.0 108.978 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 72.1 t -121.01 135.56 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.3 m -127.91 126.1 40.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.16 0.984 . . . . 0.0 109.092 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -68.06 137.0 54.67 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.417 0.687 . . . . 0.0 110.401 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.69 -26.79 2.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.318 1.047 . . . . 0.0 112.945 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -161.4 172.52 16.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.139 1.776 . . . . 0.0 111.039 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' A' ' 59' ' ' GLU . 8.0 t30 -58.09 136.21 57.15 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.915 -1.116 . . . . 0.0 109.942 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.413 ' HA ' ' CG1' ' A' ' 182' ' ' VAL 0.25 2.3 p 56.31 6.51 0.26 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 31.8 m -113.67 133.4 55.34 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.989 1.316 . . . . 0.0 111.412 -169.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 4.4 m-85 -142.49 137.61 30.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.734 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 60.9 mt -122.67 118.95 56.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.31 126.85 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.205 1.402 . . . . 0.0 108.707 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -119.26 132.32 55.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.753 1.221 . . . . 0.0 109.388 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.5 tt -113.7 125.44 54.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 109.526 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -128.62 3.71 5.53 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.583 1.153 . . . . 0.0 113.864 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 m -150.5 115.63 5.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.547 1.939 . . . . 0.0 110.675 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -52.88 -35.41 57.8 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 119.618 1.099 . . . . 0.0 113.682 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.949 1.7 . . . . 0.0 113.453 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.612 0.72 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.17 138.26 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.392 166.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.39 139.7 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -15.94 34.32 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.464 -1.397 . . . . 0.0 113.42 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -108.48 2.09 22.03 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.09 2.156 . . . . 0.0 113.349 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -144.89 175.45 10.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.854 2.062 . . . . 0.0 110.24 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.25 158.33 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.141 -0.974 . . . . 0.0 111.124 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -149.44 143.92 26.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.356 0.662 . . . . 0.0 112.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -134.79 131.36 37.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.418 1.887 . . . . 0.0 109.362 -165.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.32 137.39 51.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.604 1.562 . . . . 0.0 110.286 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.94 45.23 0.7 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.809 1.644 . . . . 0.0 112.901 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.15 132.92 2.12 Favored Glycine 0 CA--C 1.519 0.306 0 O-C-N 120.282 -1.511 . . . . 0.0 111.527 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 148.14 7.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 110.722 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.48 25.97 13.67 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m 63.98 72.33 0.46 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.567 2.347 . . . . 0.0 114.803 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -137.18 -179.4 5.69 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.311 1.445 . . . . 0.0 112.382 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -72.76 2.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.436 1.493 . . . . 0.0 115.466 169.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.36 165.23 28.51 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.69 1.996 . . . . 0.0 108.933 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -127.02 154.16 44.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.531 1.132 . . . . 0.0 112.609 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 146.23 20.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.853 1.661 . . . . 0.0 109.897 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.27 141.71 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.356 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.44 129.37 31.03 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.766 1.226 . . . . 0.0 110.592 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.89 158.97 34.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.37 0.605 . . . . 0.0 111.518 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.0 147.3 47.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.574 -0.704 . . . . 0.0 111.622 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.6 45.55 75.99 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.653 0.644 . . . . 0.0 113.493 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.74 159.46 39.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.907 0.883 . . . . 0.0 112.117 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.3 m -136.52 132.93 35.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.937 1.295 . . . . 0.0 108.449 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.58 159.69 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.767 1.227 . . . . 0.0 110.883 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -130.2 118.94 22.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 108.303 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.57 92.03 3.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.05 153.41 25.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.714 1.206 . . . . 0.0 112.013 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -144.44 54.75 1.27 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.021 1.728 . . . . 0.0 109.789 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 40.53 39.55 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.212 0.911 . . . . 0.0 114.688 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.328 0.2 OUTLIER 63.39 86.31 0.12 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -174.92 -79.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.097 2.559 . . . . 0.0 111.388 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -101.78 30.82 4.14 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.327 1.851 . . . . 0.0 112.212 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.47 -38.34 71.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.455 1.102 . . . . 0.0 110.673 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -39.44 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.035 2.534 . . . . 0.0 111.717 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.8 42.25 0.39 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 112.654 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 86' ' ' LEU . 2.8 p90 -148.03 155.34 41.38 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 122.542 1.163 . . . . 0.0 111.511 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -152.91 -45.45 0.1 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.229 163.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -120.45 129.43 53.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.448 1.022 . . . . 0.0 109.58 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 p -140.78 158.33 44.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.167 0.984 . . . . 0.0 112.391 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.95 134.48 47.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.966 1.306 . . . . 0.0 108.269 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.76 105.23 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.304 1.442 . . . . 0.0 108.573 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.19 152.81 6.39 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.217 1.389 . . . . 0.0 114.96 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -64.31 -2.83 2.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -135.63 29.7 3.21 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.329 1.451 . . . . 0.0 112.238 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.5 155.13 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.816 2.446 . . . . 0.0 109.996 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 70' ' ' GLU . 12.6 ttt85 -125.54 152.76 44.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.514 1.526 . . . . 0.0 109.569 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 m -116.46 149.55 39.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.267 1.032 . . . . 0.0 110.423 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.35 120.99 19.45 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.74 1.616 . . . . 0.0 107.521 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.9 pt -116.79 137.71 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 123.561 0.744 . . . . 0.0 109.973 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -137.53 116.14 12.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -43.03 -69.52 0.13 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.755 2.022 . . . . 0.0 115.051 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.81 35.96 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.906 0.882 . . . . 0.0 109.495 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.283 0.6 OUTLIER 42.21 57.71 3.21 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.092 1.757 . . . . 0.0 112.546 178.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 1.5 pp20? -63.22 131.36 48.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.466 1.506 . . . . 0.0 113.279 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -93.21 38.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.388 1.475 . . . . 0.0 111.719 -167.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.33 50.9 m-20 55.05 46.42 24.19 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 123.691 1.71 . . . . 0.0 112.166 -168.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 62' ' ' THR . 0.7 OUTLIER -68.69 171.88 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.585 2.354 . . . . 0.0 110.86 176.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.25 7.34 0.87 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.103 2.536 . . . . 0.0 114.972 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -137.98 112.03 8.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 124.978 1.311 . . . . 0.0 110.769 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.81 125.44 13.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.59 -120.83 0.08 OUTLIER Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.744 1.164 . . . . 0.0 111.423 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.152 0.981 . . . . 0.0 111.052 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -154.07 139.53 17.74 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.402 1.081 . . . . 0.0 112.583 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -146.68 141.83 27.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.823 0.82 . . . . 0.0 110.199 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 51' ' ' ARG . 32.4 tt0 -113.6 79.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -46.52 102.66 0.03 OUTLIER 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.947 2.099 . . . . 0.0 110.773 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.28 126.53 23.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.414 . . . . 0.0 111.558 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -55.5 109.53 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.216 1.406 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.52 55.8 1.99 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.966 0.793 . . . . 0.0 114.481 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.44 163.53 36.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.981 0.891 . . . . 0.0 113.138 174.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.0 m -123.61 133.74 53.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.713 1.605 . . . . 0.0 108.985 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -119.72 102.85 8.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.079 1.751 . . . . 0.0 109.015 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -71.79 -24.33 61.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -151.69 137.73 18.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.89 1.676 . . . . 0.0 110.203 171.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.14 14.33 7.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.436 1.495 . . . . 0.0 112.537 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -53.89 -19.49 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.249 1.82 . . . . 0.0 115.256 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -48.61 -29.65 4.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 162.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.0 mt -133.0 58.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 128.963 2.905 . . . . 0.0 108.003 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -52.47 -29.98 27.6 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.149 -0.97 . . . . 0.0 112.248 163.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.42 103.55 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.662 1.125 . . . . 0.0 112.892 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -161.73 43.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -52.25 -18.54 1.58 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 120.007 -1.683 . . . . 0.0 115.4 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -113.55 141.67 46.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.018 2.127 . . . . 0.0 111.581 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -128.89 134.65 48.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.949 2.099 . . . . 0.0 109.365 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -125.72 129.29 49.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.171 1.788 . . . . 0.0 109.288 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.27 116.1 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.419 1.487 . . . . 0.0 108.203 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.6 mt -127.77 140.81 39.16 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.771 0.828 . . . . 0.0 110.808 -167.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.72 164.61 35.12 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.885 2.39 . . . . 0.0 112.812 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.1 -24.77 58.96 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 113.912 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.12 68.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.129 1.372 . . . . 0.0 114.389 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -123.23 116.28 23.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.232 1.413 . . . . 0.0 110.722 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.14 -44.23 65.99 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.197 -0.94 . . . . 0.0 112.161 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 162.6 40.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.514 1.926 . . . . 0.0 109.155 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.57 157.06 45.58 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.478 -0.764 . . . . 0.0 110.393 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -127.77 132.6 68.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.805 0.842 . . . . 0.0 109.95 -169.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.28 128.19 34.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -126.62 145.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.17 1.388 . . . . 0.0 108.27 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -149.79 157.99 43.74 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.19 134.37 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.113 1.765 . . . . 0.0 106.973 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.43 135.64 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.035 0.921 . . . . 0.0 110.745 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -79.09 122.1 25.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.982 0.913 . . . . 0.0 112.343 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -110.93 -3.12 15.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.464 1.506 . . . . 0.0 112.696 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.4 t -138.46 -48.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 126.115 1.766 . . . . 0.0 112.699 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -74.51 80.22 1.95 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.328 0.967 . . . . 0.0 112.189 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -68.53 53.34 0.08 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.471 2.308 . . . . 0.0 114.069 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.9 m -137.53 -45.01 0.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.674 1.99 . . . . 0.0 111.642 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 56.94 158.51 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.013 2.125 . . . . 0.0 115.609 -172.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.75 -38.08 0.38 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.856 2.646 . . . . 0.0 115.039 -176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.4 p -67.75 -6.6 21.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.577 2.751 . . . . 0.0 114.795 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 63.5 t80 -115.6 113.61 23.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.232 2.613 . . . . 0.0 108.686 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -120.67 121.17 37.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.128 1.371 . . . . 0.0 110.079 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 ttp -107.62 139.22 42.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.967 0.507 . . . . 0.0 111.563 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -126.4 122.62 35.86 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.467 1.507 . . . . 0.0 108.531 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -122.66 137.93 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.224 1.01 . . . . 0.0 109.051 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -140.33 100.19 7.02 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.506 1.122 . . . . 0.0 110.282 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.16 162.12 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.319 2.012 . . . . 0.0 111.458 168.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -26.08 93.61 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.288 2.635 . . . . 0.0 115.852 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 47.24 42.82 14.06 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.792 1.637 . . . . 0.0 114.664 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.54 163.89 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.874 2.07 . . . . 0.0 110.955 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.25 94.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.177 1.791 . . . . 0.0 111.658 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.66 36.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 111.199 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.6 p -123.53 131.69 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.122 0.569 . . . . 0.0 109.972 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.08 133.65 55.24 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.327 1.451 . . . . 0.0 109.165 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -139.45 146.48 40.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.464 1.105 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -104.5 127.99 52.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.211 1.404 . . . . 0.0 109.033 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -49.2 103.81 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.841 1.656 . . . . 0.0 111.893 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 135.29 -26.71 3.2 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.997 0.808 . . . . 0.0 113.732 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.39 159.14 18.86 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.156 0.978 . . . . 0.0 111.113 162.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -64.29 171.47 3.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 0.0 112.054 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -50.29 130.58 23.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.202 -0.936 . . . . 0.0 111.152 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.84 153.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 109.313 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -108.84 129.57 55.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.61 89.86 13.76 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.35 1.46 . . . . 0.0 108.671 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.75 149.24 60.23 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.079 1.853 . . . . 0.0 112.048 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.4 mt -127.52 128.27 24.0 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.495 1.918 . . . . 0.0 106.81 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.25 -175.26 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.527 2.818 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 110.86 0.38 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.315 1.046 . . . . 0.0 111.484 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 150' ' ' ILE . 4.3 tp -121.17 75.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.169 1.388 . . . . 0.0 109.743 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 m -107.45 131.63 21.57 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.317 1.047 . . . . 0.0 110.557 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.51 152.28 94.07 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.577 0.885 . . . . 0.0 112.081 -4.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.72 -40.29 74.33 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.653 2.236 . . . . 0.0 113.061 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.25 -4.22 10.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.575 1.55 . . . . 0.0 114.88 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 p -62.14 157.77 18.39 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.457 1.026 . . . . 0.0 111.11 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -105.3 110.61 23.04 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.696 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.419 ' HB ' HD11 ' A' ' 143' ' ' LEU . 8.7 tt -77.96 122.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.211 1.005 . . . . 0.0 109.049 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.46 138.87 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.431 0.692 . . . . 0.0 110.784 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -147.47 158.82 44.14 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.045 0.926 . . . . 0.0 112.439 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.94 133.86 54.37 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.521 1.129 . . . . 0.0 109.459 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.9 124.3 42.91 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.868 1.667 . . . . 0.0 107.606 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.2 t -139.54 134.6 32.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.891 0.853 . . . . 0.0 109.753 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 115' ' ' TYR . 9.2 p -134.91 130.27 52.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.845 0.831 . . . . 0.0 109.135 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -143.63 130.04 19.98 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.619 1.568 . . . . 0.0 109.327 -168.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -64.34 135.17 55.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 109.481 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.2 p -88.76 10.18 21.84 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.37 1.068 . . . . 0.0 113.004 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -141.13 145.65 36.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.711 2.404 . . . . 0.0 109.635 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.2 t -63.76 135.0 96.09 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 121.829 -0.544 . . . . 0.0 111.859 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.57 125.47 10.26 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.666 0.917 . . . . 0.0 112.454 -6.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.84 25.11 11.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.368 1.867 . . . . 0.0 113.644 -170.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.16 159.85 9.08 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.079 -1.013 . . . . 0.0 111.939 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -58.16 107.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.744 0.817 . . . . 0.0 110.857 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.441 ' HB ' HG13 ' A' ' 156' ' ' VAL . 81.1 t -60.02 -55.01 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.877 1.271 . . . . 0.0 109.334 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.69 147.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.408 1.083 . . . . 0.0 110.299 164.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -136.63 120.68 17.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.894 1.678 . . . . 0.0 107.833 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.79 -173.07 31.06 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 122.1 0.833 . . . . 0.0 112.869 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.0 m -118.02 161.91 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.638 1.209 . . . . 0.0 111.224 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.25 164.6 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.731 2.412 . . . . 0.0 106.656 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -132.21 131.89 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.11 152.51 23.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -144.71 146.5 32.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.229 1.812 . . . . 0.0 109.842 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -119.46 151.95 37.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.963 1.305 . . . . 0.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 55.8 m -137.46 112.15 9.18 Favored Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 110.427 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.33 -15.43 20.03 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.487 2.791 . . . . 0.0 112.061 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.6 m -43.79 -42.31 5.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.421 2.689 . . . . 0.0 112.36 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.8 p -145.32 27.65 1.25 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.235 1.414 . . . . 0.0 113.069 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 45.29 41.65 8.59 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 120.258 -1.526 . . . . 0.0 113.997 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -87.74 137.74 32.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.3 1.44 . . . . 0.0 109.05 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.15 140.9 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -135.15 139.14 44.38 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.809 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -112.7 135.25 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.3 123.44 69.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 126.211 1.805 . . . . 0.0 106.751 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -139.46 124.98 19.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.895 1.678 . . . . 0.0 107.207 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -128.65 152.97 47.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 109.331 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -17.98 54.41 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.95 -18.74 62.62 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.649 1.58 . . . . 0.0 114.72 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.8 p -132.51 -50.86 0.92 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 112.89 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.42 142.17 40.13 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.319 1.448 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.86 164.91 34.24 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.468 2.112 . . . . 0.0 111.623 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -93.87 8.06 42.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.821 1.248 . . . . 0.0 112.854 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.303 1.441 . . . . 0.0 113.197 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -114.83 149.69 36.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.111 1.764 . . . . 0.0 107.267 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.2 p -133.21 161.77 33.55 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.771 0.828 . . . . 0.0 108.966 165.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.0 p -129.28 125.79 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.818 0.847 . . . . 0.0 109.004 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 10.0 t -104.7 144.19 32.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.9 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -82.89 80.18 9.03 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.569 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.23 -36.56 75.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.698 1.199 . . . . 0.0 112.538 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -150.55 173.44 14.09 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.133 1.773 . . . . 0.0 111.691 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -53.05 128.78 28.64 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.126 -1.609 . . . . 0.0 108.983 165.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.0 m 60.34 24.4 13.89 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 119.78 14.28 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.685 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 100' ' ' VAL . 20.5 m-85 -127.81 124.56 37.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 110.953 -167.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.42 100.19 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.643 0.777 . . . . 0.0 109.774 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -76.01 125.18 28.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.866 1.267 . . . . 0.0 110.248 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -121.93 126.88 49.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.913 1.285 . . . . 0.0 111.377 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 211' ' ' SER . 1.3 tm? -92.96 109.66 21.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.233 1.013 . . . . 0.0 110.92 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -110.62 10.74 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.466 1.506 . . . . 0.0 113.914 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.578 ' H ' HD13 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -168.04 109.91 0.59 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.696 1.998 . . . . 0.0 111.544 -178.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.86 -23.61 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 119.56 -1.963 . . . . 0.0 114.409 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 126.619 1.968 . . . . 0.0 111.865 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.54 124.73 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.443 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.77 150.28 41.82 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.592 -0.692 . . . . 0.0 110.33 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -22.35 27.59 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.185 -0.947 . . . . 0.0 113.414 172.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.93 15.96 17.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.558 1.943 . . . . 0.0 113.332 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -140.63 169.3 17.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.876 1.27 . . . . 0.0 110.279 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.3 t -131.46 148.4 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.898 0.879 . . . . 0.0 109.17 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 151.42 49.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.78 0.832 . . . . 0.0 110.842 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -145.15 127.09 15.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.651 -164.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.0 140.28 42.02 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 123.766 1.746 . . . . 0.0 111.198 -169.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.86 44.79 0.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 111.384 -168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.76 159.14 26.62 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.293 1.901 . . . . 0.0 110.44 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.81 139.18 58.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 111.337 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 t30 51.21 36.83 16.86 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.86 1.264 . . . . 0.0 114.056 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.8 m 61.85 64.46 1.01 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.218 1.807 . . . . 0.0 114.57 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 p -122.38 -44.91 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -69.86 1.36 Allowed Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.973 1.26 . . . . 0.0 113.624 -169.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -133.13 169.88 16.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.452 1.501 . . . . 0.0 109.772 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -136.42 149.67 48.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.891 1.277 . . . . 0.0 112.559 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 161.76 41.82 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.316 1.846 . . . . 0.0 110.912 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -134.01 141.07 47.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.17 1.388 . . . . 0.0 110.148 -175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.61 140.6 46.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.51 . . . . 0.0 109.986 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.93 147.22 23.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.903 0.881 . . . . 0.0 110.721 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -66.62 131.86 46.9 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.444 -0.785 . . . . 0.0 110.718 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.17 54.7 3.29 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.838 -0.423 . . . . 0.0 113.402 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.12 157.84 45.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.929 . . . . 0.0 112.088 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -132.93 127.44 34.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.664 1.186 . . . . 0.0 108.033 172.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.52 142.36 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.39 1.076 . . . . 0.0 109.747 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -135.64 119.23 17.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.521 1.128 . . . . 0.0 109.052 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.63 131.62 31.8 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.05 1.74 . . . . 0.0 107.98 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -154.76 145.75 22.64 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 110.893 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.09 26.39 0.17 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.863 0.865 . . . . 0.0 113.209 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.26 54.23 2.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.854 0.74 . . . . 0.0 114.109 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 47.57 64.56 1.56 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.423 1.889 . . . . 0.0 115.466 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -36.4 0.09 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -176.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.86 -28.82 9.87 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.898 1.226 . . . . 0.0 113.463 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -73.78 -53.76 9.57 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.379 1.471 . . . . 0.0 110.399 168.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.68 -12.43 61.39 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -30.7 14.82 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.623 -1.298 . . . . 0.0 112.66 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.2 157.44 3.51 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 122.924 1.345 . . . . 0.0 114.303 173.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 -38.49 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.345 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -132.84 149.21 52.29 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.092 0.949 . . . . 0.0 112.682 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.5 p -151.84 143.92 23.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.72 0.772 . . . . 0.0 110.825 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.14 118.93 34.74 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -109.36 110.98 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.17 1.388 . . . . 0.0 108.841 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.83 166.91 4.53 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 122.901 1.278 . . . . 0.0 114.125 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.97 -27.51 64.78 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.873 -1.369 . . . . 0.0 114.647 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -121.47 36.26 4.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.243 1.817 . . . . 0.0 110.786 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.88 135.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.182 2.193 . . . . 0.0 109.956 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 150.58 28.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 109.315 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.36 152.23 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.819 0.819 . . . . 0.0 110.897 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -138.76 122.51 17.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.534 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.98 128.03 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.927 0.891 . . . . 0.0 110.284 -173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.82 113.42 10.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.676 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.34 -38.65 69.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.103 1.361 . . . . 0.0 113.628 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.64 174.3 15.18 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.982 1.313 . . . . 0.0 109.47 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -63.33 -66.57 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.832 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.264 0.6 OUTLIER 50.72 169.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.961 2.504 . . . . 0.0 117.225 -174.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.528 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 pt -152.06 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 126.623 1.969 . . . . 0.0 112.064 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 67.72 36.84 3.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.885 2.074 . . . . 0.0 111.589 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 60' ' ' ILE . 3.9 p -67.95 165.55 31.18 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.712 2.005 . . . . 0.0 110.373 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.86 19.59 0.28 Allowed 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.137 2.558 . . . . 0.0 114.142 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -149.23 60.18 4.5 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.0 112.306 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.99 140.13 49.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.028 1.818 . . . . 0.0 111.992 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.87 -115.45 1.36 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.282 1.42 . . . . 0.0 112.055 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 148.73 41.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.067 1.347 . . . . 0.0 112.265 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.03 137.69 23.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.252 1.821 . . . . 0.0 109.044 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -155.59 167.96 28.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.6 1.16 . . . . 0.0 110.754 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -127.53 108.25 10.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.401 1.48 . . . . 0.0 109.773 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.99 98.62 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.053 1.341 . . . . 0.0 109.607 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 142.94 25.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.421 1.489 . . . . 0.0 113.09 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 147.25 16.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.464 1.506 . . . . 0.0 113.458 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.64 45.18 96.83 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.709 0.671 . . . . 0.0 114.294 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.16 163.97 38.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.307 1.043 . . . . 0.0 112.385 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -137.06 142.61 42.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.33 1.052 . . . . 0.0 109.094 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.4 ' HB3' HD12 ' A' ' 80' ' ' LEU . 27.2 m-80 -131.22 129.45 41.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.243 1.017 . . . . 0.0 108.289 -172.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -129.37 -16.87 3.85 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.36 59.22 1.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.146 1.779 . . . . 0.0 110.391 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.647 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.94 10.04 11.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.123 2.569 . . . . 0.0 112.258 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -16.79 4.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.977 1.311 . . . . 0.0 112.952 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.6 m -46.32 -30.24 1.99 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.328 1.851 . . . . 0.0 114.639 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.06 -29.95 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 20.91 58.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 129.737 3.215 . . . . 0.0 114.022 -168.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.56 82.29 0.08 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -163.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 tt -126.2 45.68 2.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.284 1.433 . . . . 0.0 112.159 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -67.21 -34.77 78.2 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 119.876 -1.765 . . . . 0.0 113.236 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -117.42 128.42 55.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.628 1.171 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -122.32 123.67 41.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 109.556 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 125.92 54.69 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.31 121.84 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.874 1.27 . . . . 0.0 107.859 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -125.42 150.82 68.82 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.403 1.081 . . . . 0.0 109.893 -172.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.82 168.9 21.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.598 2.199 . . . . 0.0 111.448 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.46 40.07 1.08 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.691 2.091 . . . . 0.0 114.985 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.83 -43.24 0.15 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.483 1.913 . . . . 0.0 111.504 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.6 129.95 34.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.249 1.019 . . . . 0.0 109.48 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -86.85 -36.38 18.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.439 0.696 . . . . 0.0 112.224 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -148.22 156.43 42.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.215 2.206 . . . . 0.0 108.102 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.44 131.47 34.12 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -102.99 133.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 C-N-CA 124.605 1.162 . . . . 0.0 110.754 -175.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.47 135.96 36.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.13 150.98 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.897 -0.502 . . . . 0.0 110.418 167.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -139.18 149.0 43.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.225 1.01 . . . . 0.0 111.229 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.5 mt -109.46 128.75 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.196 1.798 . . . . 0.0 108.308 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.23 111.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.492 1.517 . . . . 0.0 109.232 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -65.98 141.7 58.1 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.737 -0.602 . . . . 0.0 110.574 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.3 23.95 3.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.182 1.393 . . . . 0.0 111.628 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.07 -56.12 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.326 1.85 . . . . 0.0 112.155 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -129.31 108.75 10.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.961 1.304 . . . . 0.0 110.028 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.4 t -71.75 89.69 1.04 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 0.0 111.029 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -149.41 -39.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.8 1.24 . . . . 0.0 111.865 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 54.5 172.99 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.232 1.813 . . . . 0.0 114.432 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.68 -42.29 0.56 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.716 1.627 . . . . 0.0 115.816 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -64.49 -28.6 69.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.572 1.549 . . . . 0.0 113.901 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -88.31 115.18 25.62 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.513 1.125 . . . . 0.0 109.644 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.69 123.22 49.38 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.317 1.447 . . . . 0.0 108.898 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -113.52 130.83 56.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.824 0.849 . . . . 0.0 110.116 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.5 m -123.46 132.58 53.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.506 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.73 127.77 71.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -123.87 88.68 52.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.786 1.634 . . . . 0.0 108.417 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.47 163.98 35.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 111.944 172.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -36.36 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.626 2.37 . . . . 0.0 114.055 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 38.95 46.57 1.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.658 1.583 . . . . 0.0 114.699 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.45 156.34 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.499 1.92 . . . . 0.0 109.589 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -45.14 93.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.609 1.963 . . . . 0.0 113.03 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 155.44 24.13 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.328 1.051 . . . . 0.0 110.663 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.52 146.57 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.382 0.61 . . . . 0.0 110.222 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -122.72 134.27 54.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.781 1.232 . . . . 0.0 108.417 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.5 t -134.7 149.76 50.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 145.13 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -48.26 127.53 12.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.247 1.019 . . . . 0.0 109.617 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.34 48.9 4.62 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.78 167.32 21.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.408 1.483 . . . . 0.0 110.968 169.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -59.49 154.69 16.66 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.585 -0.697 . . . . 0.0 111.056 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -47.87 126.05 9.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 111.253 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 123.6 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.326 0.584 . . . . 0.0 110.017 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -75.79 129.86 37.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 110.365 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.9 tp -119.3 106.4 42.86 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.116 1.766 . . . . 0.0 108.104 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 142.73 39.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.669 2.246 . . . . 0.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.3 mm -134.18 127.08 18.86 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.292 1.037 . . . . 0.0 109.183 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.02 176.62 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.783 2.989 . . . . 0.0 112.777 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -80.24 144.64 32.73 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.522 -0.736 . . . . 0.0 111.434 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.44 48.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.857 1.663 . . . . 0.0 111.447 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -47.62 136.55 9.96 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 125.032 1.333 . . . . 0.0 113.785 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.1 143.72 77.14 Favored 'Cis proline' 0 CA--C 1.543 0.966 0 CA-C-N 119.963 1.023 . . . . 0.0 111.747 -1.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.03 -16.49 45.08 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.479 2.119 . . . . 0.0 113.96 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -3.09 5.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.546 1.139 . . . . 0.0 113.978 168.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 m -66.85 124.16 22.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.969 -1.082 . . . . 0.0 111.267 163.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -64.22 133.0 51.98 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.556 0.743 . . . . 0.0 111.644 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.2 tt -100.38 132.59 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.478 1.511 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.1 p -77.35 142.15 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.798 -0.564 . . . . 0.0 110.677 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.4 m -144.15 159.19 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.315 1.446 . . . . 0.0 110.409 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -123.09 141.15 52.28 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.673 0.789 . . . . 0.0 110.068 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.24 126.93 46.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.91 1.684 . . . . 0.0 108.992 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.28 112.94 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.58 126.66 71.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -131.17 139.55 49.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.066 1.747 . . . . 0.0 108.868 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.52 124.26 23.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -71.31 -15.68 62.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.794 1.237 . . . . 0.0 113.137 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.04 173.36 6.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.718 2.007 . . . . 0.0 111.366 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.6 p -52.75 147.83 14.56 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.814 1.246 . . . . 0.0 113.648 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 7.17 16.26 Favored 'Cis proline' 0 CA--C 1.546 1.092 0 N-CA-C 114.398 0.884 . . . . 0.0 114.398 0.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.04 32.76 10.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.656 1.583 . . . . 0.0 113.648 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 150.19 20.65 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.736 1.214 . . . . 0.0 111.395 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -57.73 108.64 0.59 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.821 0.848 . . . . 0.0 109.548 167.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.8 t -65.48 -56.82 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.079 0.952 . . . . 0.0 109.581 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.72 155.05 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.652 0.781 . . . . 0.0 111.984 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -142.72 77.89 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.268 1.827 . . . . 0.0 110.767 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -115.09 -178.03 18.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.17 1.367 . . . . 0.0 112.954 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.3 m -127.05 148.5 50.12 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 110.188 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.31 160.55 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.055 1.742 . . . . 0.0 109.494 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.73 137.61 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.34 145.6 43.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -140.93 158.0 44.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.859 1.264 . . . . 0.0 109.586 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -127.11 116.45 20.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.011 0.925 . . . . 0.0 110.98 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.5 m -83.33 118.47 71.69 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.92 -1.113 . . . . 0.0 109.282 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.35 -19.6 43.49 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.526 2.151 . . . . 0.0 112.547 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.3 m -45.33 -51.7 10.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.918 2.087 . . . . 0.0 112.469 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 20.8 p -143.26 34.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 0.0 112.407 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.83 42.43 94.59 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.211 -1.555 . . . . 0.0 114.1 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.97 173.91 10.18 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.105 1.362 . . . . 0.0 112.717 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 100' ' ' VAL . 17.3 m -128.62 142.01 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 111.177 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 72.7 m -137.83 108.86 6.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.65 1.18 . . . . 0.0 108.188 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.53 HG13 ' CZ ' ' A' ' 205' ' ' PHE . 2.6 m -83.81 141.25 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.826 0.822 . . . . 0.0 111.21 173.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -120.8 134.76 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.813 2.045 . . . . 0.0 107.337 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -152.58 132.92 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.27 1.428 . . . . 0.0 107.816 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -114.77 152.99 31.15 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.756 1.223 . . . . 0.0 109.664 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.66 -15.58 61.51 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.55 -31.64 13.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.544 1.537 . . . . 0.0 114.38 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.6 p -87.5 -42.28 12.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 0.0 111.326 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.465 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.2 t80 -87.3 148.61 45.08 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.729 2.011 . . . . 0.0 110.759 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 95.4 Cg_endo -76.95 178.2 7.93 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.443 2.095 . . . . 0.0 111.608 173.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.91 44.03 2.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.051 1.74 . . . . 0.0 110.87 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -144.98 -27.61 0.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.94 1.296 . . . . 0.0 113.529 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.6 ttm -137.71 139.89 40.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.22 2.208 . . . . 0.0 107.673 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.8 p -134.79 155.8 49.97 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.76 140.8 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.233 1.013 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 8.8 t -140.16 163.02 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.041 1.337 . . . . 0.0 110.49 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 118.71 26.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.218 1.407 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.8 8.29 5.28 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 112.717 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.94 16.92 2.84 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.819 1.248 . . . . 0.0 113.333 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.47 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.047 2.539 . . . . 0.0 114.368 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.7 m 80.89 21.29 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.43 1.092 . . . . 0.0 111.676 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -136.74 128.63 29.22 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.788 1.635 . . . . 0.0 111.37 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 49.1 m-85 -118.99 133.6 55.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.805 1.642 . . . . 0.0 111.335 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.65 106.25 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.642 0.777 . . . . 0.0 109.268 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -84.84 126.35 33.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.074 1.35 . . . . 0.0 110.951 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -117.91 121.32 40.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.364 1.466 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.86 98.82 11.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.816 1.246 . . . . 0.0 109.601 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -80.42 -30.1 37.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 113.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -144.96 134.88 23.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 109.353 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.1 -50.83 72.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.258 0.935 . . . . 0.0 111.783 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 125.156 1.382 . . . . 0.0 111.416 -169.514 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p -71.26 126.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.554 -1.341 . . . . 0.0 109.413 164.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.16 143.29 57.96 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.807 -0.558 . . . . 0.0 109.536 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.43 -19.1 5.02 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -116.28 17.83 15.48 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.246 2.219 . . . . 0.0 113.647 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -135.34 171.63 14.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.689 1.596 . . . . 0.0 111.051 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 150.47 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.594 1.158 . . . . 0.0 108.806 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 149.77 34.47 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 112.938 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.93 130.83 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.333 1.453 . . . . 0.0 109.495 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.98 125.91 42.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.589 1.155 . . . . 0.0 110.199 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.98 55.04 3.31 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.236 1.017 . . . . 0.0 112.046 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.95 148.27 7.58 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.979 1.276 . . . . 0.0 111.039 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -59.53 133.21 55.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.431 1.092 . . . . 0.0 111.279 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 71.52 41.97 0.7 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.202 1.801 . . . . 0.0 114.021 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m 53.08 61.91 2.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.519 1.528 . . . . 0.0 113.592 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.0 p -130.56 178.48 6.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.131 1.372 . . . . 0.0 112.188 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.34 -85.26 1.04 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.343 1.449 . . . . 0.0 113.752 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.22 170.52 14.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.364 1.466 . . . . 0.0 110.777 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -139.53 148.54 42.75 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 111.304 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.75 147.56 26.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.582 1.553 . . . . 0.0 110.487 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -125.06 132.59 53.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.462 1.105 . . . . 0.0 110.399 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -129.76 133.44 47.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.908 1.337 . . . . 0.0 111.454 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.62 138.57 43.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.946 1.298 . . . . 0.0 111.473 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 148.43 51.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.278 1.031 . . . . 0.0 111.42 168.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.32 41.29 68.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.43 1.014 . . . . 0.0 112.553 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -144.14 160.76 40.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.076 1.35 . . . . 0.0 112.248 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 m -121.56 131.7 54.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.288 1.435 . . . . 0.0 108.25 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.54 141.13 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.918 0.887 . . . . 0.0 108.727 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -126.77 151.37 48.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.436 1.095 . . . . 0.0 110.982 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -124.97 171.26 10.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.661 1.584 . . . . 0.0 109.72 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.9 107.86 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.495 1.518 . . . . 0.0 112.464 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.96 -16.29 50.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.21 1.004 . . . . 0.0 113.693 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.36 -9.45 49.54 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 126.134 1.825 . . . . 0.0 115.453 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.253 0.1 OUTLIER 67.46 88.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 169.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -140.95 -54.32 0.49 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.673 -171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.66 18.86 0.71 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.214 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -63.98 -24.74 67.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -70.19 0.11 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.713 168.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.303 0.3 OUTLIER 27.75 48.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 128.164 2.586 . . . . 0.0 115.761 -175.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.02 133.78 46.06 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.986 2.114 . . . . 0.0 109.337 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mmt -153.78 -45.24 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.487 1.915 . . . . 0.0 111.324 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 t -136.07 130.24 33.13 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.415 1.086 . . . . 0.0 109.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 89.6 m -140.96 145.4 35.97 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.54 121.72 36.36 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.325 1.05 . . . . 0.0 108.606 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.4 t -105.49 143.08 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.454 1.902 . . . . 0.0 106.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.92 -97.09 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.324 1.916 . . . . 0.0 117.301 -172.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 4.2 t -161.57 -42.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.634 1.173 . . . . 0.0 111.504 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.88 33.88 4.95 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.261 1.425 . . . . 0.0 110.617 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -146.69 157.12 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.524 2.33 . . . . 0.0 109.798 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -136.75 154.52 50.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.428 1.891 . . . . 0.0 110.132 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.7 t -123.55 143.26 50.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.683 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -134.04 139.09 45.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 109.405 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.1 119.75 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.009 1.324 . . . . 0.0 107.989 -167.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.72 135.51 50.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.962 0.905 . . . . 0.0 109.817 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.02 -60.7 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.246 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.5 -178.73 7.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.553 0.741 . . . . 0.0 111.957 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -65.95 129.97 41.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.923 0.889 . . . . 0.0 113.074 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -178.14 6.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.175 1.79 . . . . 0.0 110.088 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.74 44.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.227 1.411 . . . . 0.0 113.104 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 57.68 48.53 13.89 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.16 1.457 . . . . 0.0 111.855 -171.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 8.3 p -64.31 167.36 8.51 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.804 1.642 . . . . 0.0 110.791 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 53.2 Cg_endo -72.9 11.08 0.93 Allowed 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.954 2.436 . . . . 0.0 113.967 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -147.28 57.85 3.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.768 1.627 . . . . 0.0 111.973 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.86 154.06 73.95 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.408 1.405 . . . . 0.0 110.659 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.45 -105.52 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -142.85 150.91 40.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.773 1.629 . . . . 0.0 110.217 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -151.39 140.03 20.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.222 1.409 . . . . 0.0 109.254 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.33 156.73 26.75 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 110.341 172.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.13 97.95 5.66 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.851 0.861 . . . . 0.0 109.799 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.14 124.36 14.24 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.525 1.13 . . . . 0.0 109.677 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.92 163.37 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.563 1.145 . . . . 0.0 113.024 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 165.51 1.19 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.866 171.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 48' ' ' SER . . . -21.22 108.4 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.883 2.183 . . . . 0.0 118.296 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 p -167.1 177.35 6.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.375 1.07 . . . . 0.0 112.906 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 m -107.89 97.69 7.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.499 1.919 . . . . 0.0 109.45 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.877 0.871 . . . . 0.0 109.836 171.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -128.83 12.52 6.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.03 1.332 . . . . 0.0 112.493 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -153.21 38.26 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.699 -1.25 . . . . 0.0 113.106 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.9 -1.91 57.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.701 1.2 . . . . 0.0 114.036 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -12.62 1.95 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.042 1.737 . . . . 0.0 114.394 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -46.57 -32.0 3.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.022 1.329 . . . . 0.0 113.883 165.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.3 tp -70.34 -35.5 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.258 7.3 m-20 30.73 46.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.336 2.655 . . . . 0.0 115.411 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.04 107.95 0.24 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.94 0.781 . . . . 0.0 112.649 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.3 85.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.113 0.958 . . . . 0.0 113.111 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -75.59 -6.57 51.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.744 -1.223 . . . . 0.0 113.171 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -129.95 137.6 50.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.738 2.415 . . . . 0.0 111.048 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.86 128.48 38.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.114 1.366 . . . . 0.0 109.183 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.96 119.41 25.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.952 0.901 . . . . 0.0 108.825 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.39 118.17 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.92 150.28 71.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.102 0.961 . . . . 0.0 110.205 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.5 -173.49 0.99 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.674 2.249 . . . . 0.0 112.64 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.67 -26.64 24.34 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.146 1.355 . . . . 0.0 113.498 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -43.44 87.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.014 0.907 . . . . 0.0 112.287 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.55 126.07 37.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.868 1.267 . . . . 0.0 109.062 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.89 -47.39 11.11 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.307 -0.87 . . . . 0.0 110.853 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -143.06 160.0 41.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.561 1.944 . . . . 0.0 108.794 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.21 152.17 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.548 0.739 . . . . 0.0 109.817 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.4 139.7 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.781 0.832 . . . . 0.0 111.003 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.41 139.18 38.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.79 143.47 40.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 125.737 1.615 . . . . 0.0 109.725 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -148.39 133.05 17.82 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.83 1.252 . . . . 0.0 109.688 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.04 137.01 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.332 1.053 . . . . 0.0 108.432 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -140.49 95.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.92 2.088 . . . . 0.0 108.823 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -71.92 122.7 21.27 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.891 -1.131 . . . . 0.0 111.256 173.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 12.72 31.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.574 1.55 . . . . 0.0 112.891 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -127.21 -66.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.606 1.562 . . . . 0.0 110.865 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.47 128.12 37.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.757 0.823 . . . . 0.0 110.524 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -102.4 53.91 0.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.339 1.066 . . . . 0.0 110.947 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -140.32 63.54 1.47 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 123.579 1.657 . . . . 0.0 110.61 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.67 143.84 19.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 113.537 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.34 9.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.394 1.473 . . . . 0.0 114.397 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -87.19 -35.57 18.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.478 1.139 . . . . 0.0 113.707 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.41 126.47 29.71 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.071 0.948 . . . . 0.0 109.891 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -128.75 125.68 38.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.4 1.48 . . . . 0.0 108.957 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.2 ttp -114.27 134.96 54.57 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.294 1.437 . . . . 0.0 109.38 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -122.42 135.33 54.66 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.443 1.497 . . . . 0.0 108.058 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.5 pt -131.17 137.19 56.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.943 0.897 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 m -137.84 94.64 11.4 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 0.0 109.504 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.14 165.43 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.957 2.438 . . . . 0.0 111.455 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -26.17 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.907 3.283 . . . . 0.0 115.689 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 42.22 45.78 3.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.407 1.483 . . . . 0.0 114.324 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.2 t -111.19 159.82 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.055 2.142 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.55 94.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.997 2.519 . . . . 0.0 112.937 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 143.63 56.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 110.728 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.01 145.28 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.926 0.89 . . . . 0.0 110.293 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -130.29 138.01 50.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.46 1.504 . . . . 0.0 109.245 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.12 160.78 40.33 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.84 1.256 . . . . 0.0 110.423 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -120.32 154.45 34.99 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.963 0.905 . . . . 0.0 109.79 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.62 143.96 39.33 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.167 -0.333 . . . . 0.0 110.935 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.94 47.96 43.63 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.702 0.667 . . . . 0.0 114.61 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.36 162.16 24.41 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.453 1.501 . . . . 0.0 110.996 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 153.02 6.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.006 0.922 . . . . 0.0 111.941 169.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.26 118.49 3.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.307 1.043 . . . . 0.0 111.754 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.3 t -92.78 141.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 108.881 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -104.28 135.98 44.73 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.956 0.798 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tp -115.95 101.7 53.99 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.782 2.033 . . . . 0.0 108.155 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.58 147.55 40.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.562 2.175 . . . . 0.0 112.336 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -137.41 132.85 17.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.009 1.324 . . . . 0.0 109.33 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.52 174.73 11.71 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.377 3.385 . . . . 0.0 112.646 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -64.27 147.11 53.19 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.59 -0.694 . . . . 0.0 112.337 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 pp -153.97 158.84 41.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.83 2.052 . . . . 0.0 110.186 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -147.97 139.95 14.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 111.998 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.83 155.75 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 CA-C-N 119.662 0.915 . . . . 0.0 112.377 -9.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.25 -39.64 37.09 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.901 1.734 . . . . 0.0 111.761 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -72.08 8.28 1.34 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.122 1.769 . . . . 0.0 113.631 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -78.0 -178.05 5.33 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.42 -1.425 . . . . 0.0 111.554 166.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 160.39 21.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.279 1.432 . . . . 0.0 112.368 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 16.0 tt -122.56 133.11 69.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.722 1.609 . . . . 0.0 109.827 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.06 131.9 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.936 0.894 . . . . 0.0 110.666 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.2 m -146.39 166.45 26.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.136 0.97 . . . . 0.0 111.335 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -134.01 147.36 50.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.853 0.861 . . . . 0.0 111.023 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.6 tt -130.1 130.44 44.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.055 1.742 . . . . 0.0 109.164 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.51 117.33 9.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.745 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 167' ' ' VAL . 1.4 p -122.32 132.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.847 1.259 . . . . 0.0 108.753 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.24 144.92 27.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 110.195 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -77.79 126.12 30.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -68.1 -28.65 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.246 1.018 . . . . 0.0 113.346 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.53 174.08 6.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.695 1.598 . . . . 0.0 111.923 172.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 p -52.18 147.5 13.21 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.36 1.464 . . . . 0.0 113.517 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.2 12.13 19.74 Favored 'Cis proline' 0 CA--C 1.545 1.047 0 N-CA-C 114.714 1.006 . . . . 0.0 114.714 3.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.76 24.46 9.9 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.343 1.457 . . . . 0.0 113.082 170.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -88.81 135.53 33.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.897 -1.127 . . . . 0.0 111.276 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -57.64 111.1 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.732 0.813 . . . . 0.0 109.996 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.71 -57.99 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.351 1.06 . . . . 0.0 109.028 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.425 HG22 ' CG1' ' A' ' 156' ' ' VAL . 33.5 m -147.4 153.55 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.733 0.777 . . . . 0.0 111.978 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -145.75 105.92 4.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.043 1.737 . . . . 0.0 108.72 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.12 157.33 28.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 121.837 0.687 . . . . 0.0 113.003 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.2 m -74.15 150.44 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.173 0.987 . . . . 0.0 111.196 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.35 161.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.951 2.1 . . . . 0.0 108.526 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.86 132.22 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.485 0.659 . . . . 0.0 109.656 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.03 152.83 23.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -145.19 151.44 38.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.732 2.013 . . . . 0.0 108.121 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -115.39 132.95 56.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.423 1.089 . . . . 0.0 108.931 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.8 t -93.38 103.49 9.79 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.09 -17.43 45.69 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.734 2.289 . . . . 0.0 112.828 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.4 m -53.08 -42.9 66.31 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.994 2.118 . . . . 0.0 112.958 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 48.2 p -144.16 18.33 1.75 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.35 1.46 . . . . 0.0 112.483 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.46 73.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.761 1.648 . . . . 0.0 114.622 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.678 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 4.0 tt0 -73.33 -170.27 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.079 1.419 . . . . 0.0 111.585 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.678 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 1.4 p -135.41 155.18 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 128.041 2.537 . . . . 0.0 107.749 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.0 m -140.31 150.76 44.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.208 1.803 . . . . 0.0 107.996 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 205' ' ' PHE . 6.8 p -121.5 140.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 22.9 mt -123.6 129.95 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.51 140.39 33.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 108.896 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.82 34.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.509 1.123 . . . . 0.0 109.707 -168.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -28.58 67.0 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.46 -30.52 47.45 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.311 1.844 . . . . 0.0 115.039 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 p -101.21 -53.54 3.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.531 1.132 . . . . 0.0 111.632 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.525 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 17.6 t80 -85.65 148.74 49.68 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.537 1.935 . . . . 0.0 110.913 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 72.5 Cg_endo -77.1 -175.05 2.45 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.692 2.928 . . . . 0.0 111.577 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.25 30.17 6.68 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.01 1.724 . . . . 0.0 111.967 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -132.15 -38.86 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.862 1.665 . . . . 0.0 113.187 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 30.0 ttm -112.77 145.45 40.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.434 1.893 . . . . 0.0 106.804 167.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -140.43 150.05 43.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.949 0.899 . . . . 0.0 110.579 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.16 142.44 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.521 -0.737 . . . . 0.0 111.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 12.2 t -139.95 156.13 46.81 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.611 1.164 . . . . 0.0 111.232 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.64 81.79 0.84 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 111.349 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -60.59 -31.21 70.37 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.854 -1.154 . . . . 0.0 112.627 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.46 173.91 11.39 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.639 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.37 118.76 7.91 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.76 174.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.251 30.0 m 63.08 28.85 16.24 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 112.593 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 t -137.38 125.08 22.35 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.096 -1.003 . . . . 0.0 112.389 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 184' ' ' VAL . 12.3 m-85 -109.08 134.75 51.28 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 112.317 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.87 107.32 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.76 1.224 . . . . 0.0 109.72 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.91 108.43 17.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.855 1.262 . . . . 0.0 109.916 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -92.77 136.3 33.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.302 1.441 . . . . 0.0 110.185 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.56 119.96 40.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.631 0.773 . . . . 0.0 110.258 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -107.87 -6.21 16.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.899 1.68 . . . . 0.0 113.701 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -121.64 -169.91 1.95 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.767 2.027 . . . . 0.0 111.628 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -154.05 26.59 0.48 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 126.078 1.751 . . . . 0.0 113.75 -177.386 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 119.858 -0.115 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 4' ' ' ASP 0.291 8.4 p 47.65 -176.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 127.158 2.183 . . . . 0.0 113.881 -171.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 3' ' ' VAL . 4.0 t70 -75.15 147.97 40.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 119.834 -1.791 . . . . 0.0 109.916 169.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.12 -18.52 10.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.09 14.96 17.16 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.313 2.245 . . . . 0.0 113.87 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -138.74 177.79 7.63 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.107 1.321 . . . . 0.0 111.175 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.21 156.55 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.015 1.326 . . . . 0.0 111.318 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' HD2' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.32 145.44 33.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.661 1.185 . . . . 0.0 110.927 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 137.09 36.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.427 1.491 . . . . 0.0 108.421 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -132.34 124.57 29.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.515 1.126 . . . . 0.0 110.521 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -80.21 60.09 3.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.133 1.373 . . . . 0.0 111.441 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.9 131.11 1.44 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 141.23 15.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.362 1.065 . . . . 0.0 111.116 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.39 42.45 14.68 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.22 59.62 2.64 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.63 1.972 . . . . 0.0 113.302 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.8 m -133.9 -179.35 5.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.334 1.454 . . . . 0.0 111.206 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 17' ' ' THR . . . 69.22 -105.63 1.55 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.586 1.565 . . . . 0.0 113.379 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -113.53 164.54 13.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.156 0.982 . . . . 0.0 111.634 174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -130.38 145.29 51.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.551 1.14 . . . . 0.0 111.938 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 160.24 43.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.897 1.679 . . . . 0.0 110.673 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -127.99 154.99 44.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.24 1.016 . . . . 0.0 110.722 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.44 136.96 45.51 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.661 1.184 . . . . 0.0 110.935 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -92.1 147.82 22.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.53 1.132 . . . . 0.0 110.278 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.06 139.44 58.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.174 0.59 . . . . 0.0 111.64 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.69 28.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.98 0.8 . . . . 0.0 112.764 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.34 122.24 22.36 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.328 1.051 . . . . 0.0 110.763 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 m -107.37 130.28 54.81 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.978 1.311 . . . . 0.0 108.595 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' A' ' 89' ' ' PHE . 2.3 m -133.72 132.66 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.348 1.459 . . . . 0.0 109.776 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -122.79 140.05 53.33 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.801 1.241 . . . . 0.0 109.707 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 133.75 31.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.878 1.271 . . . . 0.0 108.952 -173.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -163.54 56.86 0.18 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.9 -1.125 . . . . 0.0 111.826 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -71.24 54.41 0.2 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.83 1.652 . . . . 0.0 113.67 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.82 47.65 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 125.377 1.465 . . . . 0.0 114.535 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.284 1.3 t70 49.83 74.11 0.22 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.249 2.219 . . . . 0.0 116.386 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -160.48 -42.32 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -124.72 18.11 8.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 111.69 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -39.12 64.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.142 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -55.82 -62.66 1.55 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.174 0.989 . . . . 0.0 109.211 176.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.21 31.86 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.198 1.799 . . . . 0.0 113.582 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.66 128.0 40.05 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.111 2.164 . . . . 0.0 107.813 -172.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 mtp -138.45 -50.16 0.55 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 111.823 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.4 p -133.54 122.98 24.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.543 0.687 . . . . 0.0 110.697 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.6 m -144.81 154.53 42.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -138.67 149.73 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.236 1.017 . . . . 0.0 111.166 -173.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 8' ' ' VAL . 21.3 t -122.8 136.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.64 1.576 . . . . 0.0 109.019 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -87.28 0.03 OUTLIER Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.675 1.131 . . . . 0.0 114.959 -167.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.0 p -173.01 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -127.12 33.16 4.95 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.317 1.447 . . . . 0.0 111.186 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 46' ' ' VAL . 3.0 m -141.61 146.09 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.518 1.927 . . . . 0.0 108.753 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -114.29 143.75 44.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.638 1.175 . . . . 0.0 108.553 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.67 131.97 54.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 109.439 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -117.37 123.77 47.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.987 1.315 . . . . 0.0 108.244 -170.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.05 119.86 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 122.122 0.963 . . . . 0.0 111.822 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -132.38 118.19 19.06 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 109.976 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.52 -54.92 15.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.53 1.132 . . . . 0.0 111.356 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -130.3 122.29 27.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -164.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.02 31.54 0.44 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.9 1.28 . . . . 0.0 112.431 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.46 165.07 5.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.144 2.578 . . . . 0.0 114.335 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 mm -112.76 39.43 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.29 52.2 m-20 57.15 50.31 12.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.617 1.967 . . . . 0.0 112.837 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.9 p -73.67 176.34 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.865 2.466 . . . . 0.0 110.893 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 65.7 Cg_endo -73.16 3.95 4.18 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.9 2.4 . . . . 0.0 113.796 173.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -136.32 64.32 52.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.93 1.692 . . . . 0.0 110.502 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.89 138.33 57.18 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.302 1.335 . . . . 0.0 109.326 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.62 -121.91 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.873 0.749 . . . . 0.0 111.663 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -134.33 140.16 46.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.508 1.123 . . . . 0.0 111.052 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.72 139.76 24.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.702 1.201 . . . . 0.0 109.868 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -157.25 165.77 34.98 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.559 1.171 . . . . 0.0 111.263 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -132.7 104.46 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.307 1.443 . . . . 0.0 107.5 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 46' ' ' VAL . 6.7 mp -64.75 116.05 5.89 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.71 160.94 0.39 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.832 2.053 . . . . 0.0 114.227 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -47.28 -34.17 6.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.16 135.24 3.63 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 164.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.54 167.86 0.65 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.789 2.036 . . . . 0.0 110.824 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -123.31 105.48 9.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.802 1.241 . . . . 0.0 110.098 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -83.82 100.88 11.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -70.49 -20.69 62.84 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.6 73.85 0.98 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.96 2.43 12.63 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.69 -1.257 . . . . 0.0 114.023 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -53.0 -10.78 0.19 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.96 2.104 . . . . 0.0 115.298 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.2 m -48.95 -32.08 8.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.057 1.299 . . . . 0.0 113.994 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -87.56 -32.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.84 30.02 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.545 2.738 . . . . 0.0 115.95 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.84 109.75 0.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -160.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 178.31 55.09 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.416 2.286 . . . . 0.0 110.027 -170.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -57.99 -22.17 48.22 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 134.45 53.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.856 1.263 . . . . 0.0 110.648 173.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -138.07 135.59 35.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.555 1.542 . . . . 0.0 109.815 -174.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -141.88 142.63 33.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.717 0.77 . . . . 0.0 112.088 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.87 123.08 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.605 . . . . 0.0 109.238 -170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 96' ' ' PHE . 93.1 mt -141.03 157.64 66.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.978 0.911 . . . . 0.0 111.236 -168.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.57 160.7 43.71 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.895 2.397 . . . . 0.0 113.315 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.88 -17.08 69.07 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 121.24 -0.913 . . . . 0.0 115.022 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.09 70.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -72.84 163.71 27.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.947 1.299 . . . . 0.0 111.477 173.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -35.62 0.99 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.152 1.381 . . . . 0.0 111.54 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -154.39 160.99 41.97 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.298 1.839 . . . . 0.0 109.666 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.42 160.98 39.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.522 0.729 . . . . 0.0 110.197 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.0 145.45 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.315 1.046 . . . . 0.0 110.516 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.11 127.78 45.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.05 1.34 . . . . 0.0 108.287 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -128.58 135.38 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.818 -0.551 . . . . 0.0 110.295 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -123.81 143.35 50.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.443 1.497 . . . . 0.0 109.539 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.3 mt -111.85 131.08 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.64 103.3 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 122.564 1.173 . . . . 0.0 110.962 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.1 134.33 49.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.409 1.884 . . . . 0.0 110.751 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 -21.95 8.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.429 1.092 . . . . 0.0 113.571 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.59 -55.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 119.085 0.857 . . . . 0.0 111.026 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.04 93.4 4.48 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 109.026 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -73.42 48.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.593 1.557 . . . . 0.0 112.553 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -143.16 51.7 1.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.229 2.612 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.58 129.03 31.34 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.717 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.8 -31.83 3.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.119 1.819 . . . . 0.0 112.25 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 m -79.53 -18.0 52.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 114.066 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.66 137.35 38.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.16 1.384 . . . . 0.0 108.622 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.9 121.15 34.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.849 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 4.8 ttp -113.4 132.95 55.43 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.458 1.103 . . . . 0.0 110.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.7 m -122.1 132.42 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.383 1.473 . . . . 0.0 108.343 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.2 122.72 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.0 m -120.54 86.46 39.69 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 125.797 1.639 . . . . 0.0 109.16 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.39 157.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.609 2.872 . . . . 0.0 112.693 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -39.53 86.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.659 2.784 . . . . 0.0 114.576 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 38.87 42.53 0.65 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.02 159.4 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.755 2.022 . . . . 0.0 109.434 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.61 92.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.201 2.2 . . . . 0.0 113.047 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 149.5 49.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.61 0.764 . . . . 0.0 110.917 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.06 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.225 1.01 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.51 136.36 50.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.1 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 17.9 p -137.57 137.63 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.045 1.338 . . . . 0.0 108.606 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.54 142.13 33.14 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 166.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.59 151.37 6.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 111.043 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.01 42.85 10.38 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 120.846 -1.159 . . . . 0.0 113.155 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.01 161.64 29.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.167 1.787 . . . . 0.0 108.927 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 151.58 14.91 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.462 -0.774 . . . . 0.0 110.619 166.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -38.43 115.2 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.649 1.58 . . . . 0.0 111.784 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.02 130.64 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -81.28 123.62 28.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.417 0.687 . . . . 0.0 109.46 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.53 96.06 49.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.067 1.747 . . . . 0.0 108.534 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 146.81 41.55 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.212 1.941 . . . . 0.0 111.287 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.38 132.08 24.14 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.926 2.091 . . . . 0.0 107.633 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.93 175.83 9.87 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.144 2.562 . . . . 0.0 113.195 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -57.72 155.96 9.31 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.376 0.671 . . . . 0.0 112.534 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 pp -170.86 156.96 5.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.613 1.965 . . . . 0.0 109.86 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.8 t -137.24 138.41 25.17 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.966 0.906 . . . . 0.0 111.565 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 157.28 72.12 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 119.527 0.867 . . . . 0.0 111.97 -7.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.02 -36.39 48.97 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.577 1.518 . . . . 0.0 112.09 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -74.18 7.52 2.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.3 p -65.71 174.97 2.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.904 -1.123 . . . . 0.0 112.804 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.42 132.4 56.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.843 1.257 . . . . 0.0 110.952 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.27 116.18 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.788 1.635 . . . . 0.0 108.4 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.5 133.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 122.97 0.508 . . . . 0.0 109.949 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.1 p -131.32 160.46 34.92 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.794 1.237 . . . . 0.0 110.397 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -114.4 137.18 52.15 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.212 0.605 . . . . 0.0 109.543 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.81 138.65 49.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.955 1.702 . . . . 0.0 107.931 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.46 111.54 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.573 1.549 . . . . 0.0 108.186 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 4.7 p -120.52 130.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.963 1.305 . . . . 0.0 109.461 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -144.24 141.65 29.99 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.265 1.826 . . . . 0.0 109.349 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 137.98 52.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.493 0.317 . . . . 0.0 111.339 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -77.19 -5.26 48.53 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.613 1.165 . . . . 0.0 113.843 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 179.75 5.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.766 2.426 . . . . 0.0 110.686 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.15 150.13 22.44 Favored Pre-proline 0 N--CA 1.481 1.081 0 O-C-N 121.017 -1.052 . . . . 0.0 113.193 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.13 7.22 22.77 Favored 'Cis proline' 0 CA--C 1.545 1.029 0 CA-C-N 119.847 0.981 . . . . 0.0 114.513 -0.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.36 35.18 24.64 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 113.626 171.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -102.05 156.33 17.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 111.302 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -64.86 86.88 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.9 -1.125 . . . . 0.0 111.696 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.5 -54.38 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.763 2.025 . . . . 0.0 110.848 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 96.4 t -146.71 127.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.161 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -144.94 136.37 25.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 109.927 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.86 178.77 41.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.674 0.654 . . . . 0.0 112.255 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.2 m -109.77 149.62 29.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.005 0.907 . . . . 0.0 111.798 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.95 147.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.149 2.18 . . . . 0.0 108.215 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.36 132.54 54.34 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.405 -0.809 . . . . 0.0 109.491 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -107.73 141.23 39.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.557 1.143 . . . . 0.0 109.517 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -136.18 143.39 44.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.714 1.605 . . . . 0.0 109.573 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -115.09 115.31 26.58 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.826 0.851 . . . . 0.0 110.413 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.9 m -76.49 107.8 5.27 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.422 1.089 . . . . 0.0 109.525 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.75 -14.37 32.91 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.629 2.219 . . . . 0.0 112.908 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.2 m -53.35 -44.8 68.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 113.348 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.3 p -142.32 22.92 2.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.097 1.359 . . . . 0.0 113.016 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 53.1 39.03 57.12 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.974 1.75 . . . . 0.0 114.571 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -80.02 166.25 21.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.518 0.727 . . . . 0.0 110.815 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.76 148.83 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.4 m -129.58 145.31 51.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.055 2.142 . . . . 0.0 108.527 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.26 128.28 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.176 1.39 . . . . 0.0 109.746 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.56 120.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.733 1.613 . . . . 0.0 106.921 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.18 140.56 37.85 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.774 1.63 . . . . 0.0 107.846 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -136.67 130.54 32.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.76 -16.54 17.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.7 -14.98 63.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.536 2.335 . . . . 0.0 114.411 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.7 t -142.27 -36.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.75 1.62 . . . . 0.0 113.254 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -82.29 138.3 45.29 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.564 1.546 . . . . 0.0 110.054 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.43 178.87 6.48 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.719 2.946 . . . . 0.0 112.467 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -116.65 29.39 7.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.936 1.694 . . . . 0.0 111.842 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -114.01 -36.11 4.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.867 1.267 . . . . 0.0 112.204 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.6 ttt -121.36 142.9 49.54 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.761 2.024 . . . . 0.0 108.096 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 p -137.64 131.51 31.63 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.897 0.856 . . . . 0.0 110.909 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.77 137.17 40.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.905 0.882 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.7 t -127.89 160.06 33.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 111.268 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -79.79 84.29 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 111.1 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.33 -39.97 94.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.27 1.028 . . . . 0.0 112.257 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -146.0 -174.81 4.53 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.249 2.219 . . . . 0.0 111.613 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -43.34 -53.27 5.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.041 2.136 . . . . 0.0 113.352 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 73.5 p -133.59 29.71 3.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.449 1.1 . . . . 0.0 112.199 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -129.83 130.09 44.85 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.581 1.152 . . . . 0.0 109.719 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -129.41 151.09 50.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.175 1.39 . . . . 0.0 110.092 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.3 tt -132.09 109.88 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.859 0.837 . . . . 0.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -83.26 101.45 11.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.08 2.152 . . . . 0.0 110.168 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -83.8 126.08 32.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.655 1.582 . . . . 0.0 109.828 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 tp -126.78 109.09 11.65 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.358 0.981 . . . . 0.0 110.925 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.39 19.81 7.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.913 1.685 . . . . 0.0 113.206 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.0 m -150.92 111.36 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.85 1.66 . . . . 0.0 111.588 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.1 -40.48 93.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.927 1.291 . . . . 0.0 113.142 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 127.337 2.255 . . . . 0.0 113.181 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 121.836 0.827 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.9 141.03 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.676 0.79 . . . . 0.0 111.484 169.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.6 139.38 56.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.071 0.548 . . . . 0.0 109.672 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -12.33 21.68 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.545 -1.347 . . . . 0.0 113.274 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.29 9.74 17.03 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.468 1.907 . . . . 0.0 113.353 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.61 176.66 9.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.717 1.607 . . . . 0.0 110.176 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.455 HG11 ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -134.12 128.28 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.251 1.021 . . . . 0.0 109.256 -177.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 150.4 20.39 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.819 -0.55 . . . . 0.0 110.142 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.24 127.95 16.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.988 1.315 . . . . 0.0 109.275 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -129.48 135.0 48.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.257 1.423 . . . . 0.0 110.223 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -78.34 44.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.828 2.051 . . . . 0.0 112.547 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.73 150.54 8.89 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 120.805 -1.184 . . . . 0.0 112.173 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.71 146.21 37.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.992 0.917 . . . . 0.0 111.917 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 51.42 40.92 27.74 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.9 m 59.15 64.33 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.639 1.575 . . . . 0.0 113.421 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.0 p -130.88 177.37 7.48 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.821 1.248 . . . . 0.0 111.981 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.74 -87.49 0.74 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.219 1.39 . . . . 0.0 113.59 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -135.98 165.64 25.2 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.584 1.553 . . . . 0.0 110.699 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.8 p -127.81 145.68 50.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.513 1.125 . . . . 0.0 112.032 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.31 162.48 40.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.275 1.83 . . . . 0.0 110.703 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -136.91 141.08 42.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.118 1.367 . . . . 0.0 109.193 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -120.68 138.51 53.91 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.093 1.757 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -76.79 143.07 40.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.065 1.746 . . . . 0.0 111.49 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG3' HG12 ' A' ' 50' ' ' VAL . 12.0 ttmt -64.68 145.75 55.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.14 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.95 49.7 15.9 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.111 0.386 . . . . 0.0 112.64 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.45 159.37 43.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.59 1.156 . . . . 0.0 111.221 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -140.48 118.89 12.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.022 1.329 . . . . 0.0 109.432 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 m -127.12 147.38 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.125 0.97 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -136.36 134.93 38.37 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.579 1.152 . . . . 0.0 109.441 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.15 134.6 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.8 1.24 . . . . 0.0 108.967 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -146.84 138.65 24.48 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.341 1.057 . . . . 0.0 110.314 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -172.5 60.13 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.642 1.577 . . . . 0.0 112.27 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.49 39.42 59.93 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.86 74.43 0.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -42.88 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -98.33 -18.08 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.303 1.411 . . . . 0.0 114.803 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.438 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -80.25 -43.68 20.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.438 1.495 . . . . 0.0 111.349 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -77.37 52.3 0.93 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.442 1.497 . . . . 0.0 112.351 166.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.72 4.44 49.61 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.288 -1.508 . . . . 0.0 114.858 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 13.0 m-85 -78.16 137.22 38.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.117 0.967 . . . . 0.0 111.754 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.48 -62.09 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.511 1.924 . . . . 0.0 111.463 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -122.39 124.57 43.98 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.906 0.882 . . . . 0.0 109.582 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.45 156.06 44.54 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.252 1.025 . . . . 0.0 110.584 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.53 127.69 49.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.274 1.03 . . . . 0.0 108.418 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.6 t -106.53 107.79 23.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.46 1.504 . . . . 0.0 109.352 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.21 162.2 3.82 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 122.568 1.094 . . . . 0.0 113.703 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -13.88 61.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.3 34.23 4.22 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.396 1.478 . . . . 0.0 111.735 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 25' ' ' LYS . 32.9 m -149.85 157.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.174 2.59 . . . . 0.0 110.296 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.5 149.22 46.62 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 110.285 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' SG ' HG11 ' A' ' 8' ' ' VAL . 3.5 m -116.09 133.97 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.521 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -122.4 117.02 25.03 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.469 1.107 . . . . 0.0 109.116 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.536 HG23 HD13 ' A' ' 86' ' ' LEU . 81.1 mt -111.37 114.35 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.351 1.461 . . . . 0.0 108.984 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.29 124.81 39.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.526 1.13 . . . . 0.0 108.025 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.7 -58.38 7.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.668 0.747 . . . . 0.0 111.615 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.89 179.92 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.971 0.909 . . . . 0.0 109.812 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.2 71.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.826 0.85 . . . . 0.0 111.174 164.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.19 -37.29 74.46 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.666 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.1 pt 42.28 30.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 71.45 22.58 4.15 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.707 2.003 . . . . 0.0 113.429 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 t -61.86 144.21 93.71 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.314 1.845 . . . . 0.0 111.221 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 34.99 0.33 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 124.531 3.488 . . . . 0.0 113.852 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -156.35 50.58 0.47 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.931 2.092 . . . . 0.0 111.939 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.71 135.49 38.75 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.46 1.44 . . . . 0.0 109.656 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.96 -92.62 0.49 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -142.82 159.85 41.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.637 1.575 . . . . 0.0 111.149 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -148.76 140.84 23.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.798 1.639 . . . . 0.0 109.514 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -153.5 147.59 25.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.144 0.974 . . . . 0.0 111.22 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -118.66 102.95 9.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.404 1.482 . . . . 0.0 109.047 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.39 96.47 1.89 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.352 1.061 . . . . 0.0 109.418 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.42 145.19 8.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.808 1.643 . . . . 0.0 113.234 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.51 147.26 18.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.55 1.54 . . . . 0.0 112.635 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.45 51.33 59.74 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.67 0.652 . . . . 0.0 114.104 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -149.94 170.73 18.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.531 1.132 . . . . 0.0 112.402 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.3 m -139.89 142.96 36.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.674 1.19 . . . . 0.0 109.876 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -132.89 106.87 7.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.527 1.131 . . . . 0.0 109.659 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.79 -28.82 22.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.062 1.345 . . . . 0.0 112.52 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.31 62.0 1.1 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.569 1.947 . . . . 0.0 110.75 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.55 14.04 0.86 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.73 -9.92 0.25 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.87 1.668 . . . . 0.0 115.203 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -45.5 -26.1 0.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.258 1.423 . . . . 0.0 114.606 158.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.273 2.7 tt -109.06 45.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.198 1.399 . . . . 0.0 112.724 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -49.55 -22.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.719 1.208 . . . . 0.0 113.729 165.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.24 84.57 1.55 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.975 0.797 . . . . 0.0 112.537 159.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 54' ' ' ILE . 11.6 tp -125.33 141.92 51.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.141 1.376 . . . . 0.0 110.37 164.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -145.38 -32.82 0.37 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.395 1.478 . . . . 0.0 113.418 164.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -112.83 125.88 54.83 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.85 1.26 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 41' ' ' PHE . 4.1 t80 -123.85 134.49 53.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.649 0.78 . . . . 0.0 110.109 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -126.35 126.96 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.563 1.145 . . . . 0.0 108.357 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -104.41 120.63 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.7 mt -110.67 150.65 42.05 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.204 1.002 . . . . 0.0 109.953 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 96' ' ' PHE . 86.3 Cg_endo -79.51 168.56 19.65 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.353 2.035 . . . . 0.0 112.569 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.88 32.09 1.48 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.525 1.536 . . . . 0.0 114.9 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.78 -48.19 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.707 1.603 . . . . 0.0 111.703 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 1.6 m-30 -82.99 136.75 34.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.046 0.938 . . . . 0.0 109.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -78.08 -32.67 50.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.531 -0.731 . . . . 0.0 111.69 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.512 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 14.2 p-90 -155.48 167.92 28.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.73 2.012 . . . . 0.0 109.786 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.03 164.15 28.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.569 0.699 . . . . 0.0 111.166 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.51 141.21 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 109.025 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.7 129.62 34.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.404 HG22 HD23 ' A' ' 138' ' ' LEU . 15.1 m -125.58 148.27 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.727 0.811 . . . . 0.0 109.664 170.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -148.98 158.35 44.12 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.042 0.937 . . . . 0.0 110.193 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mt -111.91 130.63 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 110.78 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.744 0.817 . . . . 0.0 109.462 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.28 127.27 32.77 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.215 -0.928 . . . . 0.0 111.576 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -112.63 17.18 19.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.693 1.597 . . . . 0.0 111.757 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 211' ' ' SER . 64.6 t -126.6 -57.44 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.489 1.915 . . . . 0.0 110.654 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -153.95 138.76 17.09 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.139 1.376 . . . . 0.0 111.378 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 p -49.7 -58.38 5.42 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.749 1.62 . . . . 0.0 115.209 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.3 m 31.22 63.22 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.011 2.524 . . . . 0.0 113.5 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.34 -98.16 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -59.38 -18.03 41.71 Favored Glycine 0 CA--C 1.541 1.662 0 O-C-N 119.699 -1.876 . . . . 0.0 113.575 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.5 m -60.81 -20.82 62.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.4 1.88 . . . . 0.0 115.027 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.81 128.42 40.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 109.785 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.63 127.56 40.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.956 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.2 ttp -126.95 152.73 46.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.017 1.727 . . . . 0.0 110.358 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.4 m -137.55 131.01 31.09 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.59 133.07 68.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 p -133.12 86.49 42.1 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 109.68 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.16 112.29 2.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.051 1.834 . . . . 0.0 108.621 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.5 t80 40.19 54.67 2.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.567 1.947 . . . . 0.0 112.99 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.38 31.75 0.92 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.6 1.56 . . . . 0.0 114.956 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.32 133.21 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.059 2.143 . . . . 0.0 108.597 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 t70 38.23 71.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.45 1.9 . . . . 0.0 113.348 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 138.97 41.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.59 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.84 140.1 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.591 0.756 . . . . 0.0 110.168 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.39 140.11 40.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.224 1.01 . . . . 0.0 110.022 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.432 ' HB3' HG21 ' A' ' 136' ' ' VAL . 7.6 p -140.85 143.03 34.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 109.22 -174.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -131.49 143.99 50.81 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.715 1.206 . . . . 0.0 109.307 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.31 90.85 0.1 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.106 0.955 . . . . 0.0 111.897 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.02 -22.02 0.99 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.162 -0.961 . . . . 0.0 113.216 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -60.75 150.99 30.71 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.492 1.146 . . . . 0.0 112.308 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.2 66.66 9.35 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.378 -0.826 . . . . 0.0 111.08 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 62.47 166.58 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.143 1.777 . . . . 0.0 112.569 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 129' ' ' CYS . 62.6 t -138.37 138.42 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.548 1.539 . . . . 0.0 109.599 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.34 122.25 28.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.348 0.659 . . . . 0.0 110.223 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 102' ' ' VAL . 3.2 mm? -97.55 110.76 56.35 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.274 1.43 . . . . 0.0 109.482 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 96.1 Cg_endo -77.72 136.68 15.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.673 2.249 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.512 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 17.0 mm -129.01 124.53 22.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 177.1 6.77 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.261 2.641 . . . . 0.0 112.075 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -65.08 141.55 58.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.786 . . . . 0.0 111.983 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.751 2.021 . . . . 0.0 109.483 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.8 m -126.24 135.32 26.99 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.741 1.216 . . . . 0.0 109.995 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.15 154.3 84.95 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.477 0.849 . . . . 0.0 112.488 -3.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.82 -27.19 67.51 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.931 1.754 . . . . 0.0 112.401 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -9.89 22.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.5 m -62.57 166.41 5.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.741 1.258 . . . . 0.0 113.315 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.69 153.24 26.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.686 1.194 . . . . 0.0 111.897 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.5 tt -119.42 131.29 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 128.224 2.61 . . . . 0.0 107.957 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.2 m -73.77 134.11 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.689 0.795 . . . . 0.0 109.788 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -135.74 131.27 35.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.288 0.635 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -96.59 147.42 23.89 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.728 -0.608 . . . . 0.0 109.974 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.99 132.46 40.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.36 1.464 . . . . 0.0 108.645 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -141.41 118.27 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.518 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.95 133.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.469 1.507 . . . . 0.0 109.943 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.84 149.77 39.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.03 1.732 . . . . 0.0 109.182 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.94 146.44 47.79 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 64.4 p -73.74 -4.01 31.92 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.062 -1.024 . . . . 0.0 113.45 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.94 155.14 43.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.401 2.281 . . . . 0.0 111.683 -177.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 151.5 28.13 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.615 1.166 . . . . 0.0 113.395 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.56 -2.15 17.2 Favored 'Cis proline' 0 C--N 1.354 0.849 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 3.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . 0.26 0.2 OUTLIER 39.41 37.76 0.31 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 115.411 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -82.47 46.65 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.128 0.971 . . . . 0.0 113.486 -164.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 40.73 74.43 0.1 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.78 2.032 . . . . 0.0 112.834 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -37.11 -51.88 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.25 1.82 . . . . 0.0 111.802 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.9 t -138.58 128.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -136.1 109.64 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.422 1.089 . . . . 0.0 108.254 171.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.76 -165.75 33.25 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.712 0.672 . . . . 0.0 112.275 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.8 m -136.78 163.95 29.42 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.094 -0.65 . . . . 0.0 110.816 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.12 150.73 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.228 1.411 . . . . 0.0 109.438 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.0 135.96 34.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.577 -0.702 . . . . 0.0 109.869 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -113.22 132.12 55.63 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.828 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -123.64 156.97 34.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.581 1.552 . . . . 0.0 109.073 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 98' ' ' TRP . 44.9 t80 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.261 0.937 . . . . 0.0 109.669 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.2 m -97.97 102.16 12.87 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 123.724 0.81 . . . . 0.0 109.074 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.37 -15.71 42.51 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.26 1.973 . . . . 0.0 113.288 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.6 m -47.8 -40.62 21.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.416 1.886 . . . . 0.0 112.767 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 33.4 p -144.81 20.46 1.64 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.867 1.267 . . . . 0.0 112.729 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.39 37.02 59.03 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.964 1.745 . . . . 0.0 115.276 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.64 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 9.3 tt0 -80.88 179.17 7.96 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.652 0.739 . . . . 0.0 112.657 177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.64 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 t -130.63 144.15 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.388 2.675 . . . . 0.0 107.713 166.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.3 m -134.79 123.16 23.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.297 2.239 . . . . 0.0 108.167 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 197' ' ' VAL . 0.3 OUTLIER -100.79 116.9 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.949 0.881 . . . . 0.0 111.312 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.56 118.1 35.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.897 1.279 . . . . 0.0 108.526 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 142.56 51.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.31 1.844 . . . . 0.0 109.04 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -167.48 160.01 12.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.602 1.561 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.48 -20.07 4.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.042 1.737 . . . . 0.0 114.029 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.25 -29.09 57.37 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.141 1.776 . . . . 0.0 114.819 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.4 p -149.61 -43.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.397 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -96.44 137.37 21.56 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.842 1.257 . . . . 0.0 110.323 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.05 -171.52 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.84 -20.4 13.07 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.721 2.009 . . . . 0.0 114.474 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -67.65 -12.32 60.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.106 1.762 . . . . 0.0 113.159 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.4 ttm -131.36 145.77 51.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.645 1.578 . . . . 0.0 108.507 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.3 p -136.81 155.88 49.23 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.988 1.315 . . . . 0.0 109.042 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' VAL . 2.6 t -116.36 125.9 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.939 -0.476 . . . . 0.0 109.82 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.4 m -117.11 130.32 56.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.462 1.105 . . . . 0.0 109.318 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -76.39 70.58 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.841 1.656 . . . . 0.0 111.093 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.22 -42.16 76.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.807 1.243 . . . . 0.0 113.553 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -147.93 177.9 8.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.885 2.074 . . . . 0.0 109.543 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -68.47 129.84 41.1 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.51 -1.369 . . . . 0.0 108.534 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 19.4 p 55.99 29.89 15.16 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.279 1.432 . . . . 0.0 114.316 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.8 m -135.28 123.87 23.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.556 1.142 . . . . 0.0 111.869 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' HG13 ' A' ' 184' ' ' VAL . 19.9 m-85 -124.84 134.89 52.56 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.978 1.311 . . . . 0.0 110.406 -173.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 14.1 mt -120.69 116.1 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -77.14 93.99 4.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.59 1.956 . . . . 0.0 109.971 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.76 121.54 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.451 1.101 . . . . 0.0 109.916 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.26 102.96 13.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.921 0.888 . . . . 0.0 109.795 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -83.7 -29.05 27.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.886 1.274 . . . . 0.0 113.343 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 108' ' ' VAL . 58.4 m -159.54 133.25 7.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.153 2.181 . . . . 0.0 110.839 173.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.6 15.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 126.481 1.913 . . . . 0.0 113.944 -163.418 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.525 0.679 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.67 137.42 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.101 0.96 . . . . 0.0 110.73 168.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.64 146.22 40.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.443 0.697 . . . . 0.0 110.331 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.01 -17.44 17.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -112.97 12.19 19.25 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.115 2.566 . . . . 0.0 113.57 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -138.75 174.03 10.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.024 1.33 . . . . 0.0 110.256 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -140.0 148.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.088 0.955 . . . . 0.0 108.434 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -132.05 143.57 50.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.45 1.1 . . . . 0.0 110.873 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.31 137.31 49.89 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.461 1.504 . . . . 0.0 108.55 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.78 150.24 46.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.139 1.776 . . . . 0.0 109.38 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -115.1 92.52 3.96 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.051 1.34 . . . . 0.0 109.831 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.76 -62.06 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.948 161.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 161.51 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 130.382 3.473 . . . . 0.0 108.663 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 36.84 58.33 1.12 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 114.786 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m 52.26 63.85 2.08 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.069 1.748 . . . . 0.0 115.426 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.5 m -123.21 -41.48 2.31 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.73 -120.6 3.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.676 1.125 . . . . 0.0 112.752 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.93 165.95 22.26 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.558 1.179 . . . . 0.0 111.423 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.0 p -136.66 157.96 45.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.3 1.44 . . . . 0.0 111.903 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.08 131.25 15.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.296 1.838 . . . . 0.0 108.291 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -132.67 120.84 22.26 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.06 1.344 . . . . 0.0 108.8 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -147.19 138.55 23.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.987 1.375 . . . . 0.0 111.266 -169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -70.41 153.52 42.89 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.189 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -63.18 161.9 12.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.554 0.742 . . . . 0.0 112.074 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.42 45.74 76.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.496 0.569 . . . . 0.0 112.847 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -138.63 158.24 44.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.624 1.97 . . . . 0.0 111.247 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -134.68 117.83 16.48 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.347 1.059 . . . . 0.0 108.551 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 139.02 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 109.617 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -144.62 101.21 3.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.402 1.081 . . . . 0.0 108.514 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.1 124.34 30.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.735 0.814 . . . . 0.0 111.067 -171.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -152.54 165.93 33.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.364 1.466 . . . . 0.0 112.334 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -153.1 110.09 3.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.19 1.396 . . . . 0.0 108.889 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 51.86 34.73 38.09 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 125.338 1.447 . . . . 0.0 115.612 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.286 0.7 OUTLIER 48.42 40.81 15.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.673 1.989 . . . . 0.0 115.506 -170.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -135.15 -49.43 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -66.58 -20.76 66.08 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 122.408 2.367 . . . . 0.0 115.427 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -52.24 -28.81 20.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.625 1.102 . . . . 0.0 112.857 166.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 -0.95 4.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.142 0.977 . . . . 0.0 113.619 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.18 -39.73 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.416 1.487 . . . . 0.0 112.721 165.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -60.23 124.3 19.86 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 123.082 1.42 . . . . 0.0 111.782 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 tpt -149.56 -35.56 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.436 1.494 . . . . 0.0 113.349 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 p -141.03 125.06 17.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.124 0.874 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.11 159.2 42.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.423 1.106 . . . . 0.0 112.32 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.56 121.5 17.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.32 112.3 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 126.479 1.911 . . . . 0.0 108.108 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -32.61 -83.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.752 2.596 . . . . 0.0 116.742 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.633 1.973 . . . . 0.0 112.694 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -121.09 37.91 4.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 110.472 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -151.01 143.81 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 128.566 2.747 . . . . 0.0 109.028 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -119.5 148.83 42.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.951 1.7 . . . . 0.0 109.167 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.09 140.91 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.258 0.551 . . . . 0.0 109.833 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -131.92 131.07 42.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.435 1.094 . . . . 0.0 108.781 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.75 126.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 129.33 41.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.93 1.292 . . . . 0.0 109.458 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -54.76 -62.31 1.74 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 113.301 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.83 173.85 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.345 1.458 . . . . 0.0 109.785 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.98 139.85 39.06 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.5 -173.87 1.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 110.988 -170.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.06 39.19 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.834 1.654 . . . . 0.0 112.004 -173.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.326 43.0 m-20 56.38 48.43 17.02 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.102 1.761 . . . . 0.0 111.053 -167.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.36 153.52 19.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 112.626 -2.079 . . . . 0.0 109.968 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.53 26.43 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.677 3.584 . . . . 0.0 115.203 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 58.66 2.92 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.704 2.002 . . . . 0.0 110.636 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.51 145.62 59.17 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.579 1.52 . . . . 0.0 110.385 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 -129.58 0.51 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.084 1.326 . . . . 0.0 113.151 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.36 158.2 31.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 111.038 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -147.91 153.29 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.848 1.659 . . . . 0.0 109.765 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.4 163.1 35.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.882 0.873 . . . . 0.0 110.784 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -123.55 105.12 9.49 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.274 1.43 . . . . 0.0 110.494 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -74.18 102.08 4.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 109.611 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.95 148.84 24.57 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.766 1.627 . . . . 0.0 113.744 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.39 140.94 38.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.742 1.617 . . . . 0.0 113.108 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 55.61 29.17 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 125.007 1.289 . . . . 0.0 114.366 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -148.62 164.01 35.55 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -134.35 129.9 36.13 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.868 1.667 . . . . 0.0 108.513 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.2 130.84 50.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.626 1.571 . . . . 0.0 107.492 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -139.85 -8.36 1.22 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -140.92 68.02 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.415 1.886 . . . . 0.0 110.819 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD13 ' H ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.43 20.7 12.41 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.255 2.222 . . . . 0.0 112.237 -177.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.24 -11.97 1.39 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.625 1.57 . . . . 0.0 114.077 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -19.75 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.401 -1.437 . . . . 0.0 114.138 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.98 34.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 126.821 2.048 . . . . 0.0 111.745 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -49.67 -28.98 6.61 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.367 -1.458 . . . . 0.0 113.418 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.54 71.71 1.04 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.046 1.308 . . . . 0.0 113.653 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.51 147.57 46.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.27 1.428 . . . . 0.0 109.481 164.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -147.91 -14.81 0.36 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 159.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -133.4 127.37 33.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.367 1.467 . . . . 0.0 109.564 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.09 124.24 36.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.814 1.246 . . . . 0.0 109.263 -166.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -117.09 115.86 26.2 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.449 1.499 . . . . 0.0 108.425 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 t -115.94 117.01 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.4 mt -128.44 151.83 77.28 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.978 0.911 . . . . 0.0 109.797 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.16 -178.85 3.48 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.072 2.515 . . . . 0.0 111.617 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.61 -23.02 71.2 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.167 -0.958 . . . . 0.0 113.855 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.25 74.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.117 0.967 . . . . 0.0 112.417 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.437 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 1.4 m-30 -91.67 149.21 21.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.89 1.276 . . . . 0.0 109.484 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.81 -31.88 4.4 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.577 -1.327 . . . . 0.0 113.181 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.73 148.43 31.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.667 1.587 . . . . 0.0 108.19 167.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -119.19 154.94 32.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.766 0.793 . . . . 0.0 110.077 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.06 150.01 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.392 1.477 . . . . 0.0 109.433 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.62 126.99 51.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.51 136.05 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.7 -0.625 . . . . 0.0 110.206 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -140.71 134.09 29.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.931 0.492 . . . . 0.0 111.387 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 115' ' ' TYR . 39.8 mt -85.38 146.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.495 1.518 . . . . 0.0 109.481 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.3 t -135.9 102.56 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.135 1.774 . . . . 0.0 109.118 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -58.16 119.94 7.73 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.054 0.942 . . . . 0.0 111.662 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -112.65 -35.6 5.46 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.016 0.926 . . . . 0.0 111.646 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -91.12 -36.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.373 1.069 . . . . 0.0 113.76 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -91.58 91.66 8.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.595 1.158 . . . . 0.0 109.924 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 65.3 p -64.33 17.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.5 m -133.94 80.95 1.89 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.394 2.678 . . . . 0.0 109.074 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.58 130.69 47.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.072 0.949 . . . . 0.0 111.811 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.87 -38.44 2.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.283 1.42 . . . . 0.0 113.537 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.4 m -71.47 -27.58 63.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.613 1.165 . . . . 0.0 112.946 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE1' HG21 ' A' ' 104' ' ' ILE . 1.7 t80 -75.85 126.97 32.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.631 1.172 . . . . 0.0 109.847 171.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -129.23 141.71 51.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.765 1.626 . . . . 0.0 109.43 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -135.85 138.77 42.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.962 0.905 . . . . 0.0 110.146 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -123.61 138.49 54.54 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.411 1.484 . . . . 0.0 107.793 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.8 145.63 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.619 0.767 . . . . 0.0 110.682 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 t -144.73 94.91 5.4 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 111.294 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.27 165.84 23.24 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.828 2.352 . . . . 0.0 112.164 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -29.67 94.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 128.092 2.557 . . . . 0.0 114.17 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 47.72 37.93 7.73 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.68 1.592 . . . . 0.0 114.867 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.0 t -93.65 155.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.946 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.64 98.85 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.335 . . . . 0.0 111.195 170.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.85 151.33 18.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.743 -0.598 . . . . 0.0 112.084 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.35 131.22 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.102 0.561 . . . . 0.0 110.219 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.23 33.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.326 0.65 . . . . 0.0 109.477 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.66 142.18 51.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.808 1.243 . . . . 0.0 108.371 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -127.5 137.66 52.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 108.2 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.48 108.99 0.54 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.468 0.707 . . . . 0.0 111.326 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.95 -25.69 4.91 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 113.791 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.75 146.27 55.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.892 1.346 . . . . 0.0 110.871 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.61 167.88 14.18 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.637 -0.664 . . . . 0.0 111.376 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -47.0 105.05 0.06 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.848 1.259 . . . . 0.0 112.78 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.01 126.29 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.506 1.122 . . . . 0.0 109.126 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.12 124.17 22.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.961 0.41 . . . . 0.0 109.949 176.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.81 96.43 49.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.557 1.943 . . . . 0.0 107.112 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 40.8 Cg_endo -74.37 143.49 31.41 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.473 2.115 . . . . 0.0 112.733 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.7 mm -122.06 133.78 24.47 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.794 1.637 . . . . 0.0 108.565 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.47 170.44 12.29 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 112.752 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -49.82 138.68 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.669 . . . . 0.0 112.716 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.17 122.71 9.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.649 0.779 . . . . 0.0 110.532 -174.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.4 t -134.6 131.66 20.38 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 110.9 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.85 152.98 83.67 Favored 'Cis proline' 0 CA--C 1.548 1.204 0 CA-C-N 119.345 0.802 . . . . 0.0 112.148 -6.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.36 -37.48 81.64 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.709 2.273 . . . . 0.0 112.089 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -7.15 8.65 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.053 1.741 . . . . 0.0 114.414 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.3 t -74.6 -179.42 4.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.136 -0.978 . . . . 0.0 112.347 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -130.5 154.52 47.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.975 1.31 . . . . 0.0 112.826 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.49 130.6 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.541 1.936 . . . . 0.0 109.854 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.23 141.29 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.96 0.904 . . . . 0.0 111.017 172.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 t -148.29 158.7 44.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.211 1.404 . . . . 0.0 110.764 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.55 136.45 53.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.31 1.044 . . . . 0.0 109.216 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.34 126.31 46.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.186 1.794 . . . . 0.0 108.367 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 p -133.46 131.15 39.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.78 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.29 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.607 1.563 . . . . 0.0 107.02 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -143.71 151.59 40.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.729 1.612 . . . . 0.0 109.336 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -85.53 142.67 29.0 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.816 -0.552 . . . . 0.0 111.524 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.9 p -85.85 7.57 23.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.912 1.685 . . . . 0.0 112.926 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.94 16.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.31 1.844 . . . . 0.0 110.733 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -51.41 139.47 27.15 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.923 1.289 . . . . 0.0 113.442 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.94 11.74 19.29 Favored 'Cis proline' 0 CA--C 1.549 1.229 0 N-CA-C 114.904 1.078 . . . . 0.0 114.904 4.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.67 15.33 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.664 1.986 . . . . 0.0 114.149 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.76 164.64 19.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.19 1.396 . . . . 0.0 112.469 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -68.98 154.59 41.8 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.812 0.815 . . . . 0.0 112.121 171.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.3 -38.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.786 1.634 . . . . 0.0 110.339 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.3 t -146.06 140.92 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -144.35 105.79 4.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.432 1.493 . . . . 0.0 108.579 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.11 -179.98 38.65 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.466 -0.771 . . . . 0.0 114.487 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.5 p -113.21 136.1 53.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.703 1.201 . . . . 0.0 112.004 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.35 150.04 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.974 2.11 . . . . 0.0 107.722 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -124.52 135.47 53.21 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.1 149.54 30.69 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.458 -0.776 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -138.26 153.68 49.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.837 2.055 . . . . 0.0 108.654 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -115.7 164.65 14.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.197 0.999 . . . . 0.0 109.719 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -136.46 105.29 9.24 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.342 1.057 . . . . 0.0 109.582 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -67.8 -14.96 43.13 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.53 2.82 . . . . 0.0 113.262 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.0 m -45.5 -46.54 13.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.49 2.316 . . . . 0.0 113.171 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 65.1 p -145.21 11.03 1.32 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.734 1.214 . . . . 0.0 113.14 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 69.29 42.71 73.99 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.199 -1.563 . . . . 0.0 112.768 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -83.52 156.67 22.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.897 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 203' ' ' THR . 0.4 OUTLIER -112.36 155.12 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.739 0.815 . . . . 0.0 110.274 165.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.6 m -143.63 114.95 7.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.696 1.199 . . . . 0.0 108.571 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.32 146.81 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.142 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.58 132.62 66.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.565 1.946 . . . . 0.0 107.56 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 138.66 32.65 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.198 1.399 . . . . 0.0 108.661 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -127.82 144.36 51.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.151 1.38 . . . . 0.0 108.539 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.49 -18.81 20.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.78 -33.6 16.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.46 1.504 . . . . 0.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.2 p -98.83 -53.05 3.39 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.77 1.228 . . . . 0.0 110.888 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -85.79 148.29 48.2 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.419 1.488 . . . . 0.0 109.997 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.08 175.17 11.24 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.386 2.058 . . . . 0.0 111.672 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 8.71 44.58 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.945 1.298 . . . . 0.0 113.147 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.97 -37.52 10.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.355 1.462 . . . . 0.0 111.707 -164.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 146.45 40.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 128.76 2.824 . . . . 0.0 106.953 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.3 p -139.91 153.17 46.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.565 0.746 . . . . 0.0 110.896 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.93 137.6 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.501 0.72 . . . . 0.0 110.27 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 33.4 m -120.72 140.76 51.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.806 1.642 . . . . 0.0 109.39 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -68.59 91.2 0.41 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.985 1.314 . . . . 0.0 110.635 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -75.27 -48.97 20.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 122.215 -0.303 . . . . 0.0 110.934 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.97 -178.59 5.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.631 1.572 . . . . 0.0 112.121 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -58.78 -34.54 71.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.138 1.375 . . . . 0.0 114.607 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 182' ' ' VAL . 50.6 p -138.0 25.16 2.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.985 1.714 . . . . 0.0 112.158 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 t -125.26 136.22 53.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.083 0.953 . . . . 0.0 111.255 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.5 133.3 52.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.178 1.391 . . . . 0.0 110.637 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.7 tt -115.97 112.35 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.154 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.94 125.62 39.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.842 2.457 . . . . 0.0 108.231 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -125.27 129.96 51.09 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.14 1.376 . . . . 0.0 111.319 -172.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.6 tt -121.87 114.9 21.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.889 0.876 . . . . 0.0 111.608 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -123.14 7.4 9.17 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.888 1.675 . . . . 0.0 113.938 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.67 -8.69 13.78 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 40.96 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 129.363 3.065 . . . . 0.0 118.67 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 -172.772 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.372 0.606 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' A' ' 47' ' ' GLY . 8.7 p -56.93 152.21 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.172 0.589 . . . . 0.0 111.565 167.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.1 142.73 57.68 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.251 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -19.39 51.04 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.28 9.12 23.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.639 1.976 . . . . 0.0 113.255 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -136.83 -178.31 5.13 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 120.485 1.493 . . . . 0.0 110.81 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -135.69 148.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.675 1.19 . . . . 0.0 110.653 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 142.52 49.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.471 1.108 . . . . 0.0 109.404 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -135.55 127.9 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.149 1.38 . . . . 0.0 108.51 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -133.54 130.78 38.93 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.506 1.122 . . . . 0.0 110.601 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.44 56.88 4.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.792 1.237 . . . . 0.0 111.274 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.43 140.24 3.62 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.922 0.772 . . . . 0.0 111.183 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -58.23 139.16 55.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.459 0.703 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 70.55 37.62 1.44 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 125.376 1.47 . . . . 0.0 113.808 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.9 m 54.14 64.12 1.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.331 1.852 . . . . 0.0 113.673 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.9 p -132.45 179.24 6.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.969 1.307 . . . . 0.0 112.755 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.97 -81.27 1.17 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.877 1.703 . . . . 0.0 114.71 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -138.53 166.73 23.55 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.053 1.741 . . . . 0.0 110.019 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -130.94 152.78 49.88 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.759 1.224 . . . . 0.0 112.758 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -160.68 162.76 32.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.373 1.469 . . . . 0.0 111.304 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -134.67 140.93 46.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.925 1.29 . . . . 0.0 110.812 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -124.87 141.19 52.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.851 1.661 . . . . 0.0 110.119 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -88.84 143.72 26.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.515 0.726 . . . . 0.0 111.444 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.26 150.68 38.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.06 1.344 . . . . 0.0 111.7 170.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.51 58.17 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.113 1.339 . . . . 0.0 113.438 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -137.77 159.09 42.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.942 1.697 . . . . 0.0 111.356 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.4 m -117.93 128.97 55.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.993 1.317 . . . . 0.0 108.86 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.89 114.85 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.747 1.219 . . . . 0.0 109.432 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.47 145.83 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.746 1.218 . . . . 0.0 111.074 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CE2' ' HE3' ' A' ' 40' ' ' LYS . 63.1 m-85 -131.89 176.25 8.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.243 1.417 . . . . 0.0 110.09 168.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.69 167.18 2.18 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.696 1.199 . . . . 0.0 111.48 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -118.07 25.46 10.32 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.827 -1.17 . . . . 0.0 112.484 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.76 11.72 69.49 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 126.099 1.809 . . . . 0.0 115.918 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.81 63.63 1.53 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -160.17 -44.39 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -122.03 -26.54 4.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.379 1.072 . . . . 0.0 112.746 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -62.15 -42.26 99.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.492 1.517 . . . . 0.0 111.813 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.46 34.93 0.14 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.029 1.731 . . . . 0.0 113.047 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -78.27 -20.28 51.93 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 118.902 -2.374 . . . . 0.0 114.596 177.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CE2' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.87 145.52 35.05 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.814 0.816 . . . . 0.0 111.706 176.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 ttt -155.7 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.1 p -134.56 132.56 39.26 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.613 1.097 . . . . 0.0 110.697 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.2 m -143.45 152.47 41.56 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 108.041 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.44 145.67 47.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.511 1.148 . . . . 0.0 112.273 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 8' ' ' VAL . 95.3 t -106.73 120.18 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.354 2.661 . . . . 0.0 108.843 -170.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 3' ' ' VAL . . . -47.66 -86.2 0.01 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -168.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 t -164.13 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.99 0.916 . . . . 0.0 111.792 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.76 32.67 5.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.846 1.258 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.55 164.07 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 110.276 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -144.43 154.12 42.63 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.742 2.017 . . . . 0.0 110.067 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.415 ' SG ' HG11 ' A' ' 8' ' ' VAL . 1.2 m -124.96 134.56 52.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.85 0.86 . . . . 0.0 110.806 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.19 118.33 31.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.89 1.276 . . . . 0.0 109.492 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.0 mm -110.1 106.49 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.294 1.038 . . . . 0.0 108.998 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.94 117.79 24.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.005 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.09 -45.46 81.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 122.205 1.003 . . . . 0.0 112.479 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 167.77 29.25 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.091 1.756 . . . . 0.0 109.923 -169.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -108.91 48.93 0.84 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.439 0.696 . . . . 0.0 110.537 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.75 160.68 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.505 1.922 . . . . 0.0 114.686 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.68 52.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.433 -1.417 . . . . 0.0 110.684 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 71.68 36.35 1.26 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.704 2.402 . . . . 0.0 111.58 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 p -67.46 155.96 89.72 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.789 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.79 32.35 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.33 3.353 . . . . 0.0 113.38 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -151.16 99.64 3.05 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 109.995 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 118.06 5.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.688 1.592 . . . . 0.0 108.965 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.89 -120.87 0.1 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.49 144.05 44.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 112.52 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -161.82 132.45 5.03 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 110.226 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -143.22 163.1 33.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.599 1.159 . . . . 0.0 110.665 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.02 107.68 9.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.364 1.466 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -84.05 95.55 8.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.815 0.846 . . . . 0.0 108.941 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.24 150.53 3.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 113.044 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -66.61 145.95 55.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.829 0.452 . . . . 0.0 112.177 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.5 64.58 3.94 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.452 1.025 . . . . 0.0 115.413 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -153.02 177.2 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.147 0.979 . . . . 0.0 112.868 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.8 m -130.7 142.43 50.42 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.182 1.393 . . . . 0.0 110.241 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.82 134.55 44.81 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.962 1.305 . . . . 0.0 109.884 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.2 -33.02 1.15 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 123.579 0.752 . . . . 0.0 112.489 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -118.06 40.34 3.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.053 1.406 . . . . 0.0 110.965 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' CE2' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -70.35 -16.35 62.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.385 1.074 . . . . 0.0 113.213 172.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -61.58 -11.47 11.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.269 1.427 . . . . 0.0 113.184 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.5 t -47.35 -36.74 9.96 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.82 -1.175 . . . . 0.0 113.127 167.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 tt -81.0 -35.17 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.84 42.22 11.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.998 2.119 . . . . 0.0 113.811 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.05 67.31 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.297 0.951 . . . . 0.0 113.022 -161.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.1 tp -131.61 115.35 15.97 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.722 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.4 m -120.9 -20.6 6.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.481 1.113 . . . . 0.0 112.891 167.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -127.52 122.37 33.15 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.078 0.951 . . . . 0.0 110.189 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.35 137.11 44.91 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.232 1.013 . . . . 0.0 109.084 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.06 136.11 55.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.95 118.55 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -131.41 146.94 64.14 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.967 0.907 . . . . 0.0 109.359 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.71 165.77 24.47 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.114 2.543 . . . . 0.0 112.308 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.73 -14.3 36.04 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 124.358 0.98 . . . . 0.0 114.828 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.06 -28.07 63.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.134 1.374 . . . . 0.0 113.946 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 7.9 m-30 -123.49 102.93 8.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.693 1.597 . . . . 0.0 109.535 -166.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.9 -27.89 26.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.43 -1.419 . . . . 0.0 113.513 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.24 145.18 24.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.489 2.315 . . . . 0.0 106.856 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.43 165.71 24.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.782 0.801 . . . . 0.0 111.054 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 151.13 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.858 1.263 . . . . 0.0 109.261 -173.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.86 125.33 44.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.63 138.2 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.978 0.894 . . . . 0.0 110.729 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.09 118.07 15.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.547 1.539 . . . . 0.0 108.54 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 149.01 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 122.894 0.478 . . . . 0.0 109.822 165.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.96 129.49 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.29 121.72 34.07 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.017 -0.427 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -26.13 6.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.764 1.626 . . . . 0.0 113.142 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.12 -35.68 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.897 0.879 . . . . 0.0 113.266 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -108.91 -179.59 3.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.085 1.354 . . . . 0.0 109.735 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.8 t -120.93 -39.54 2.71 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.504 1.122 . . . . 0.0 111.826 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.7 m -60.19 -39.73 87.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.103 0.961 . . . . 0.0 112.204 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.16 -179.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.246 1.818 . . . . 0.0 114.789 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.98 -25.68 0.8 Allowed Glycine 0 N--CA 1.478 1.476 0 O-C-N 120.071 -1.643 . . . . 0.0 115.55 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 m -53.36 -35.5 60.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.13 1.372 . . . . 0.0 111.906 163.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -90.45 131.37 36.25 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.238 1.815 . . . . 0.0 110.466 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.52 130.35 42.22 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.871 1.269 . . . . 0.0 111.229 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.444 ' HG2' HG22 ' A' ' 156' ' ' VAL . 1.4 tmm? -92.86 135.58 34.01 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.916 1.686 . . . . 0.0 110.092 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -133.91 97.4 3.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.912 1.685 . . . . 0.0 108.304 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 127' ' ' VAL . 6.2 mm -94.22 132.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -131.61 92.96 29.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.99 171.99 12.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.475 . . . . 0.0 112.328 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -35.37 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.0 2.52 . . . . 0.0 114.969 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 41.53 59.23 2.48 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.888 1.675 . . . . 0.0 114.486 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.93 157.95 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.171 1.788 . . . . 0.0 111.593 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -40.54 115.35 0.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.859 1.663 . . . . 0.0 111.85 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 136.16 51.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.419 HG11 ' HG ' ' A' ' 138' ' ' LEU . 13.1 p -115.95 151.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.668 0.787 . . . . 0.0 109.339 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.3 132.89 41.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.204 1.001 . . . . 0.0 110.383 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.3 t -133.52 119.25 19.28 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.644 1.178 . . . . 0.0 108.936 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -114.81 121.87 44.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.578 1.551 . . . . 0.0 108.301 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t0 55.54 -175.86 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.862 0.839 . . . . 0.0 113.054 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.65 30.64 1.24 Allowed Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.173 1.368 . . . . 0.0 113.587 161.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -56.56 175.55 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.998 1.399 . . . . 0.0 111.389 166.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -44.84 122.15 3.09 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.892 -1.13 . . . . 0.0 111.731 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -53.25 159.48 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.142 0.977 . . . . 0.0 112.416 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.41 135.24 54.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.766 0.793 . . . . 0.0 110.279 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -75.55 142.7 42.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -126.18 91.15 48.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 125.465 1.506 . . . . 0.0 109.345 -178.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 34.5 Cg_endo -71.05 144.18 46.55 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.196 1.931 . . . . 0.0 111.464 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 46.3 mm -128.17 135.4 27.47 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.718 1.607 . . . . 0.0 108.522 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.21 177.39 8.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.033 3.156 . . . . 0.0 112.306 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.08 141.81 57.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.395 0.678 . . . . 0.0 111.791 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.46 147.33 7.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.981 1.712 . . . . 0.0 110.314 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 98.8 m -147.48 135.33 10.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.087 0.955 . . . . 0.0 109.71 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.08 153.23 87.89 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.422 0.829 . . . . 0.0 112.722 -5.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.18 -36.58 68.31 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.182 1.921 . . . . 0.0 112.158 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.25 -16.48 60.37 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.81 128.68 36.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 110.857 170.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 162.37 25.49 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 112.723 171.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.9 151.75 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.871 1.668 . . . . 0.0 109.098 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.53 118.41 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.565 0.746 . . . . 0.0 110.821 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.4 m -130.42 150.52 51.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.4 1.08 . . . . 0.0 111.609 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -115.25 123.21 48.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.93 0.892 . . . . 0.0 108.602 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.09 113.85 26.27 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.04 1.336 . . . . 0.0 107.758 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.63 145.31 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.444 HG22 ' HG2' ' A' ' 117' ' ' MET . 11.2 t -135.36 130.7 51.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -145.07 153.88 41.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.968 1.307 . . . . 0.0 109.331 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 143.24 54.71 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.941 168.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.4 p -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.245 1.418 . . . . 0.0 113.946 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -141.6 161.06 38.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.751 2.021 . . . . 0.0 110.89 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -66.37 139.36 96.21 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 127.43 12.13 Favored 'Cis proline' 0 C--N 1.353 0.8 0 CA-C-N 120.331 1.154 . . . . 0.0 111.443 -6.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -74.22 49.91 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.713 1.605 . . . . 0.0 111.13 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.86 131.81 52.03 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.286 -1.509 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.06 90.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.174 0.589 . . . . 0.0 109.839 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.2 t -42.47 -52.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.782 2.033 . . . . 0.0 111.087 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.8 p -159.47 152.51 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.917 -0.489 . . . . 0.0 111.838 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -133.87 102.87 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.845 1.658 . . . . 0.0 108.385 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.01 -174.36 13.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.928 1.728 . . . . 0.0 111.863 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.4 m -132.88 150.34 52.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.458 1.103 . . . . 0.0 110.906 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.46 163.5 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 126.314 1.846 . . . . 0.0 108.507 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -129.49 136.38 49.81 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.927 0.491 . . . . 0.0 109.867 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.28 137.05 52.45 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.659 1.184 . . . . 0.0 107.983 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 160.13 38.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.269 1.428 . . . . 0.0 110.154 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 114.38 18.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.996 0.816 . . . . 0.0 110.253 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 m -76.46 118.2 69.8 Favored Pre-proline 0 N--CA 1.476 0.843 0 O-C-N 120.359 -1.463 . . . . 0.0 109.95 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.36 -19.36 55.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.59 2.193 . . . . 0.0 113.957 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.2 m -52.7 -50.27 63.68 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.902 2.081 . . . . 0.0 114.3 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.3 p -136.11 18.26 3.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.578 1.551 . . . . 0.0 111.803 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.76 41.14 97.75 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.095 0.855 . . . . 0.0 114.135 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -72.67 164.04 27.13 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.716 -1.461 . . . . 0.0 111.982 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 135.83 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.8 m -131.77 135.08 46.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.401 1.08 . . . . 0.0 108.298 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.443 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -102.27 135.75 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.9 0.857 . . . . 0.0 110.743 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.33 134.84 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.601 1.961 . . . . 0.0 106.721 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 133.76 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.789 1.235 . . . . 0.0 108.061 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.27 150.32 39.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.153 1.381 . . . . 0.0 108.882 -166.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -57.41 -23.42 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.74 -31.66 20.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.832 1.253 . . . . 0.0 113.6 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.2 p -96.34 -49.92 4.99 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.378 1.071 . . . . 0.0 110.199 -170.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.4 t80 -64.91 148.3 97.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 110.016 168.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 74.2 Cg_endo -75.87 -95.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.118 1.879 . . . . 0.0 111.003 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 164.39 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 128.103 2.561 . . . . 0.0 112.942 -171.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -61.21 -43.76 98.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.643 1.177 . . . . 0.0 112.515 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.7 149.31 25.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.856 1.662 . . . . 0.0 109.57 170.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -134.94 133.82 39.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.29 1.036 . . . . 0.0 110.286 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.02 130.82 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.634 0.774 . . . . 0.0 109.665 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.2 m -128.86 131.13 47.64 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.187 1.395 . . . . 0.0 108.9 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.06 94.21 1.48 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 0.0 110.342 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.59 -46.88 35.72 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.06 0.544 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -145.45 -172.6 3.92 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.475 1.91 . . . . 0.0 111.221 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -51.38 -49.41 61.59 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.708 -1.245 . . . . 0.0 113.242 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.6 p -128.24 32.51 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 110.823 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.1 t -137.37 127.96 26.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.241 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 184' ' ' VAL . 18.6 m-85 -125.07 137.09 54.21 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.011 1.324 . . . . 0.0 109.707 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.31 128.16 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.977 0.894 . . . . 0.0 109.007 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -115.69 94.51 4.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.433 1.893 . . . . 0.0 107.377 -165.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -85.79 121.4 28.39 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.775 -0.578 . . . . 0.0 110.186 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.78 101.5 11.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 111.836 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.79 10.13 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.597 1.159 . . . . 0.0 112.675 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.68 157.07 34.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.423 1.489 . . . . 0.0 112.834 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.63 -4.56 59.06 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 126.121 1.769 . . . . 0.0 112.184 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.755 0.788 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.6 126.16 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.427 166.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.25 142.73 58.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -18.86 10.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.726 1.148 . . . . 0.0 113.623 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -113.35 15.72 19.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.95 2.1 . . . . 0.0 112.753 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -139.5 166.49 24.42 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.188 -1.57 . . . . 0.0 109.725 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.15 159.78 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.383 0.611 . . . . 0.0 110.037 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.87 161.31 39.63 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.842 0.857 . . . . 0.0 111.301 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -128.11 145.85 50.88 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.337 1.455 . . . . 0.0 109.311 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.44 114.07 14.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.77 2.028 . . . . 0.0 110.618 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.38 77.01 6.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 109.189 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.59 -87.97 0.07 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.832 -0.982 . . . . 0.0 112.844 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.15 124.15 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 129.738 3.215 . . . . 0.0 109.512 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 63.78 44.05 5.18 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.541 1.136 . . . . 0.0 114.028 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m 68.02 58.09 0.48 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.383 2.273 . . . . 0.0 113.961 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -141.73 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.896 1.678 . . . . 0.0 112.002 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.28 -121.09 12.72 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.366 0.984 . . . . 0.0 111.686 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.97 166.26 15.23 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.119 0.959 . . . . 0.0 111.361 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -132.12 154.18 49.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.056 1.342 . . . . 0.0 111.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.81 141.61 22.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.509 1.524 . . . . 0.0 109.513 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -117.44 135.32 53.98 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.076 0.95 . . . . 0.0 110.042 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -131.84 139.1 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.353 1.461 . . . . 0.0 109.946 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.8 150.45 24.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.609 -0.682 . . . . 0.0 111.284 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.28 162.63 29.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.941 0.896 . . . . 0.0 111.43 170.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.54 33.31 40.51 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.636 0.636 . . . . 0.0 113.906 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -134.06 148.11 51.0 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.267 1.427 . . . . 0.0 110.625 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -105.96 132.8 51.62 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.426 1.49 . . . . 0.0 108.31 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.8 126.02 69.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.247 1.019 . . . . 0.0 109.247 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 150.16 28.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.81 1.644 . . . . 0.0 110.379 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.82 162.25 29.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.577 1.551 . . . . 0.0 110.201 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.26 127.38 8.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.451 1.9 . . . . 0.0 113.899 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.68 -6.25 30.36 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.7 -7.78 23.49 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 125.292 1.425 . . . . 0.0 115.692 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.93 24.01 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.806 1.642 . . . . 0.0 115.17 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -48.2 39.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.538 1.135 . . . . 0.0 112.674 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.32 29.12 0.06 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.263 1.825 . . . . 0.0 111.804 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -65.05 -41.84 94.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 0.0 113.773 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.458 ' HB2' ' H ' ' A' ' 86' ' ' LEU . 8.5 t0 -66.76 -94.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 108.119 158.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 29.3 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 127.238 2.215 . . . . 0.0 116.178 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.14 147.15 50.26 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 128.728 2.811 . . . . 0.0 110.058 176.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.8 tpt -151.56 -53.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.339 1.055 . . . . 0.0 111.947 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -137.11 131.15 32.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 125.322 1.449 . . . . 0.0 109.433 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.63 155.57 44.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.65 1.18 . . . . 0.0 109.583 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.9 117.2 18.93 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.137 0.975 . . . . 0.0 108.61 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.84 117.26 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.997 1.719 . . . . 0.0 108.547 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -41.02 -95.77 0.01 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 127.472 2.463 . . . . 0.0 117.519 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 t -162.19 -40.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.476 1.111 . . . . 0.0 111.908 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.61 35.84 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.656 1.582 . . . . 0.0 110.355 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.76 135.91 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.435 1.494 . . . . 0.0 109.245 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.98 153.73 25.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 109.5 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.63 142.39 47.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.199 1.0 . . . . 0.0 109.392 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.74 127.98 39.86 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.561 1.544 . . . . 0.0 107.412 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 pt -121.6 125.57 73.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.453 0.644 . . . . 0.0 109.707 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -140.05 100.03 3.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.933 1.349 . . . . 0.0 111.201 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.53 104.85 2.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.44 1.496 . . . . 0.0 111.303 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.46 154.11 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.327 1.537 . . . . 0.0 114.25 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -92.06 139.67 30.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.781 -1.199 . . . . 0.0 112.24 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.34 179.73 8.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.626 1.171 . . . . 0.0 111.597 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -136.83 44.0 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 126.022 1.729 . . . . 0.0 111.328 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 59.86 47.5 10.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.97 1.708 . . . . 0.0 112.332 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.7 p -79.36 179.78 1.69 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.719 2.008 . . . . 0.0 111.007 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 41.3 Cg_endo -70.45 12.08 0.42 Allowed 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.871 2.38 . . . . 0.0 114.397 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -145.18 65.99 12.22 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.597 1.559 . . . . 0.0 110.997 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.61 132.86 32.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.246 1.298 . . . . 0.0 109.359 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.41 164.35 11.28 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.215 171.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -57.55 109.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.385 0.674 . . . . 0.0 110.663 163.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -111.67 139.01 47.47 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.928 1.691 . . . . 0.0 109.259 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -160.77 158.75 29.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.06 0.933 . . . . 0.0 111.361 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.47 95.83 5.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.456 1.502 . . . . 0.0 109.613 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.07 108.15 1.75 Allowed 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.37 -0.831 . . . . 0.0 109.476 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.73 143.1 10.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.982 1.713 . . . . 0.0 113.209 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.39 138.11 57.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.872 0.869 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.41 73.32 0.49 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.436 1.493 . . . . 0.0 116.097 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.98 177.43 8.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.6 m -122.22 135.42 54.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.382 1.073 . . . . 0.0 109.402 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -115.26 134.82 54.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.467 1.507 . . . . 0.0 107.671 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -144.64 5.89 1.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.61 33.26 0.41 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.142 1.377 . . . . 0.0 111.595 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.59 -4.23 57.35 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.083 -1.011 . . . . 0.0 113.72 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.39 -13.13 26.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.13 0.972 . . . . 0.0 113.617 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.0 m -50.73 -32.79 20.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.901 1.681 . . . . 0.0 114.072 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -30.83 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.418 0.687 . . . . 0.0 112.254 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.6 t30 35.89 43.42 0.19 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.579 2.752 . . . . 0.0 115.456 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.42 95.12 0.12 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.884 1.23 . . . . 0.0 111.685 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.458 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 5.3 mp -140.25 155.71 46.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.833 2.053 . . . . 0.0 109.287 170.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 m -157.1 -32.68 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.388 1.075 . . . . 0.0 112.458 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -119.28 138.65 52.87 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.05 1.34 . . . . 0.0 109.822 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -130.44 129.68 43.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.13 1.372 . . . . 0.0 107.981 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -129.52 117.7 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.88 131.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.81 148.78 38.02 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.401 1.08 . . . . 0.0 109.675 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' CG ' ' CD2' ' A' ' 96' ' ' PHE . 77.8 Cg_endo -77.67 15.76 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.527 3.485 . . . . 0.0 112.907 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.18 -35.66 0.42 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.846 2.641 . . . . 0.0 116.042 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -34.21 73.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.987 1.715 . . . . 0.0 112.588 168.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.431 ' CD2' ' CG ' ' A' ' 93' ' ' PRO . 11.0 m-85 -92.54 138.2 31.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 110.325 174.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -79.35 -35.06 41.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.022 0.929 . . . . 0.0 111.74 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -158.58 170.75 21.49 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 109.756 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.65 165.15 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.042 0.937 . . . . 0.0 110.673 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.88 149.24 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.436 1.095 . . . . 0.0 109.928 -171.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -99.98 122.45 42.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.04 137.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.441 0.697 . . . . 0.0 110.456 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -138.53 155.36 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.174 1.39 . . . . 0.0 110.091 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 117' ' ' MET . 3.7 mt -124.06 135.67 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.46 121.74 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -85.04 118.72 24.78 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -102.91 -8.95 20.28 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.3 t -108.72 -57.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.952 0.901 . . . . 0.0 112.216 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.78 -33.49 76.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.024 0.53 . . . . 0.0 110.505 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.97 17.97 3.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.712 2.005 . . . . 0.0 114.381 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -103.02 -47.14 4.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 111.521 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 57.07 153.48 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.226 2.21 . . . . 0.0 116.072 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.37 58.93 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.834 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.7 p -90.43 -61.8 1.6 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.05 1.34 . . . . 0.0 112.203 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -47.23 108.39 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.254 2.222 . . . . 0.0 111.326 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.64 124.34 47.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.326 1.05 . . . . 0.0 109.209 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.483 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.5 tmm? -114.19 141.15 47.9 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.591 1.156 . . . . 0.0 109.255 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.9 m -132.03 137.38 47.8 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.344 1.458 . . . . 0.0 107.855 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 138' ' ' LEU . 14.2 pt -133.72 145.15 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 123.618 0.767 . . . . 0.0 111.123 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.0 m -135.61 95.68 14.08 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 108.916 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 75.49 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.291 3.328 . . . . 0.0 111.583 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 124' ' ' VAL . 58.9 t80 60.18 81.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.967 2.107 . . . . 0.0 112.041 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 42.93 46.28 4.6 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.911 1.684 . . . . 0.0 115.084 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 141' ' ' PRO . 11.9 t -121.92 168.6 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.322 2.249 . . . . 0.0 109.848 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -36.44 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.991 2.517 . . . . 0.0 113.7 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 145.31 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.241 1.016 . . . . 0.0 110.396 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 139.18 50.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 109.395 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.3 133.56 55.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.295 -1.32 . . . . 0.0 108.78 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.453 ' HB3' HG11 ' A' ' 136' ' ' VAL . 22.4 p -135.19 150.45 50.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.339 1.066 . . . . 0.0 110.431 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -102.61 144.08 31.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.753 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.59 27.43 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.128 2.171 . . . . 0.0 115.922 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.51 2.39 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.422 1.963 . . . . 0.0 114.089 -173.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.54 174.92 10.08 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.671 1.988 . . . . 0.0 110.11 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -56.57 158.99 4.05 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.887 -1.133 . . . . 0.0 112.468 163.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -51.96 153.66 2.51 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.72 0.808 . . . . 0.0 112.04 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 129' ' ' CYS . 29.0 m -107.16 139.09 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.435 0.636 . . . . 0.0 110.747 172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.21 108.19 11.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.787 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 119' ' ' ILE . 20.2 tp -88.22 112.29 48.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.194 1.398 . . . . 0.0 109.258 170.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 56.8 Cg_endo -78.5 152.36 26.32 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.823 1.682 . . . . 0.0 112.728 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 30.4 mm -133.8 131.77 21.25 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.428 1.491 . . . . 0.0 109.873 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.476 ' HG3' HG21 ' A' ' 124' ' ' VAL . 85.6 Cg_endo -75.94 170.96 19.05 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.281 2.654 . . . . 0.0 112.366 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.67 149.21 42.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.75 154.25 24.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.484 1.914 . . . . 0.0 109.877 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -134.78 135.93 24.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.392 1.077 . . . . 0.0 110.975 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 150.49 77.51 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.639 0.907 . . . . 0.0 111.421 -5.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.17 -32.15 74.51 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.76 1.64 . . . . 0.0 111.704 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.35 -5.91 4.08 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.706 2.002 . . . . 0.0 114.908 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 p -69.63 -178.87 1.56 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.873 -1.142 . . . . 0.0 112.276 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.87 150.49 40.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.034 0.934 . . . . 0.0 111.91 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.9 tt -107.02 138.69 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.379 1.472 . . . . 0.0 109.583 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.47 138.23 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.008 0.923 . . . . 0.0 109.617 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -141.6 131.31 24.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.999 -1.063 . . . . 0.0 110.601 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -82.9 141.52 32.14 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.545 -0.722 . . . . 0.0 109.84 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.24 111.17 13.64 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.616 1.166 . . . . 0.0 110.0 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.9 p -128.02 115.23 18.17 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.872 1.269 . . . . 0.0 110.34 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.59 121.34 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.301 1.44 . . . . 0.0 107.527 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -127.93 136.79 51.82 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.214 1.406 . . . . 0.0 108.911 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.26 130.48 35.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.234 0.54 . . . . 0.0 110.428 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -75.94 -30.81 58.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.232 1.013 . . . . 0.0 112.206 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 -179.29 4.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.839 2.055 . . . . 0.0 112.266 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.49 148.71 32.43 Favored Pre-proline 0 N--CA 1.481 1.105 0 O-C-N 121.214 -0.929 . . . . 0.0 112.651 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.3 17.15 11.71 Favored 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 119.956 1.02 . . . . 0.0 114.65 -1.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 63.61 18.69 11.27 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.204 1.802 . . . . 0.0 113.986 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -94.35 178.99 5.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.188 1.795 . . . . 0.0 112.289 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -79.37 144.31 34.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.65 -1.281 . . . . 0.0 112.328 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.48 -43.51 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.412 1.885 . . . . 0.0 110.994 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.6 t -140.39 123.55 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -135.97 97.39 3.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.43 10.35 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.667 1.127 . . . . 0.0 111.848 -168.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 m -139.13 169.63 17.44 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.291 1.036 . . . . 0.0 110.66 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.0 156.98 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 127.282 2.233 . . . . 0.0 108.461 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -120.96 139.76 52.81 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -120.23 130.79 54.68 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.286 -0.883 . . . . 0.0 109.7 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -120.56 153.37 36.84 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.294 1.437 . . . . 0.0 110.249 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -128.63 124.37 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.209 1.403 . . . . 0.0 110.132 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.8 m -95.55 113.75 62.47 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 109.823 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.16 -11.68 32.76 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.064 2.509 . . . . 0.0 112.827 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m -43.34 -48.22 6.87 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.878 2.471 . . . . 0.0 112.985 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 80.7 p -144.84 17.87 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.206 1.402 . . . . 0.0 112.395 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.0 88.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.681 -1.262 . . . . 0.0 113.542 -171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -73.77 152.07 40.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.811 0.805 . . . . 0.0 110.778 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.82 134.32 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.952 1.301 . . . . 0.0 108.351 167.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 17.8 m -134.83 109.34 8.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.034 1.734 . . . . 0.0 107.729 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 2.0 p -76.82 147.03 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.544 -0.722 . . . . 0.0 109.409 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.66 125.46 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.902 1.681 . . . . 0.0 106.893 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 135.92 44.31 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.642 1.177 . . . . 0.0 109.785 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -146.89 158.12 43.83 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.957 1.703 . . . . 0.0 109.914 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.53 -19.47 10.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.112 1.765 . . . . 0.0 113.944 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -58.09 -23.59 55.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -149.47 -46.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.029 1.332 . . . . 0.0 113.297 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -85.69 133.05 42.55 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.975 1.31 . . . . 0.0 109.392 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.01 -172.17 1.06 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 122.565 2.177 . . . . 0.0 112.676 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -107.08 -22.41 12.66 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.562 1.145 . . . . 0.0 113.526 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -55.12 -40.26 70.31 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.776 1.23 . . . . 0.0 112.566 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -105.46 144.47 32.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.939 1.695 . . . . 0.0 109.397 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.3 p -139.89 157.26 45.99 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.762 1.225 . . . . 0.0 109.536 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.3 127.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.851 0.461 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 51.5 m -119.06 131.4 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.617 1.567 . . . . 0.0 109.763 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -65.76 122.12 16.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.857 1.263 . . . . 0.0 111.066 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.36 -28.82 8.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.029 0.932 . . . . 0.0 112.057 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.73 -175.27 4.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.357 1.863 . . . . 0.0 110.914 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -56.58 -31.48 64.27 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.08 1.352 . . . . 0.0 113.764 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 61.3 p -143.4 33.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.422 . . . . 0.0 111.813 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 48.9 m -129.71 134.4 47.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.866 0.867 . . . . 0.0 111.943 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.456 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 23.8 m-85 -130.88 138.96 50.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.877 1.671 . . . . 0.0 110.801 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 34.5 mt -125.19 122.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -98.03 112.28 24.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.689 1.996 . . . . 0.0 108.348 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -103.28 124.18 48.17 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.27 116.58 32.19 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 110.945 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -120.2 20.81 11.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.541 1.937 . . . . 0.0 112.172 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.76 -168.91 3.22 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.332 1.453 . . . . 0.0 111.614 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.76 26.47 1.39 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.824 -1.173 . . . . 0.0 113.778 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 127.746 2.419 . . . . 0.0 115.01 -166.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -102.37 128.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.572 1.149 . . . . 0.0 109.654 170.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.15 138.82 57.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.919 0.888 . . . . 0.0 110.318 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.35 -13.06 4.46 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -117.19 9.38 13.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.438 2.295 . . . . 0.0 112.635 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -144.56 175.15 10.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.33 1.852 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.97 154.97 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.194 0.998 . . . . 0.0 109.452 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 149.39 42.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.88 1.272 . . . . 0.0 110.391 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.79 26.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.068 1.347 . . . . 0.0 108.942 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.33 131.83 38.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.114 1.366 . . . . 0.0 110.7 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -79.52 51.95 1.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.605 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.26 134.95 2.27 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 120.21 -1.556 . . . . 0.0 112.869 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 145.72 14.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.656 0.782 . . . . 0.0 111.102 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.48 26.22 13.99 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.3 t 67.25 71.8 0.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.824 1.649 . . . . 0.0 111.578 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -137.83 -178.14 5.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.524 1.529 . . . . 0.0 112.181 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.88 -82.89 0.5 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 126.066 1.793 . . . . 0.0 115.173 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -138.57 163.85 30.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.747 1.619 . . . . 0.0 110.345 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.2 p -135.75 145.32 46.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.217 1.007 . . . . 0.0 112.882 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -156.61 169.76 23.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.54 1.536 . . . . 0.0 111.821 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.21 153.91 48.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.307 1.443 . . . . 0.0 110.689 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.99 131.13 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.392 1.477 . . . . 0.0 109.731 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.62 128.43 33.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.864 . . . . 0.0 109.924 175.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -54.55 139.9 36.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.75 0.82 . . . . 0.0 110.979 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.72 42.79 16.31 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.48 0.562 . . . . 0.0 112.527 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -133.32 154.62 50.55 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.514 1.525 . . . . 0.0 111.291 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m -140.09 122.51 16.07 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.132 1.373 . . . . 0.0 108.393 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.97 153.81 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.024 0.916 . . . . 0.0 110.549 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.7 mtm-85 -133.74 118.84 18.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.9 1.68 . . . . 0.0 107.873 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 122.9 15.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -165.01 155.08 13.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.662 1.22 . . . . 0.0 113.338 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -142.01 18.24 2.12 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 128.426 2.691 . . . . 0.0 110.803 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.72 -88.31 0.23 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.317 2.389 . . . . 0.0 110.289 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.05 104.02 0.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.369 1.868 . . . . 0.0 110.396 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.13 -59.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 128.174 2.59 . . . . 0.0 115.28 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -80.56 -23.48 39.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 120.982 1.719 . . . . 0.0 112.568 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -67.57 -19.48 65.27 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.859 1.664 . . . . 0.0 114.084 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.03 -68.86 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.122 165.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 28.22 37.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.15 2.58 . . . . 0.0 116.194 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -136.15 127.68 28.71 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.593 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -158.17 -39.72 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 111.387 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -142.2 126.14 17.22 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.246 1.018 . . . . 0.0 110.052 164.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.8 m -133.6 155.05 50.36 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.002 0.906 . . . . 0.0 109.398 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.04 127.13 33.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.86 108.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.753 1.621 . . . . 0.0 108.95 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.38 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.472 1.037 0 C-N-CA 128.383 2.897 . . . . 0.0 117.589 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -166.86 -42.8 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.146 0.978 . . . . 0.0 112.561 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -106.94 37.63 2.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.395 1.478 . . . . 0.0 110.481 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' PRO . 4.5 m -143.61 158.59 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.358 1.863 . . . . 0.0 110.688 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -139.05 150.97 46.37 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.546 1.938 . . . . 0.0 109.909 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.62 126.53 54.3 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.176 0.59 . . . . 0.0 109.82 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -116.32 120.35 38.61 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.624 1.169 . . . . 0.0 108.145 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 HD11 ' A' ' 86' ' ' LEU . 1.3 pp -113.63 115.22 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 110.411 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -124.16 123.66 40.77 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.598 1.159 . . . . 0.0 108.796 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.21 -45.06 84.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 112.782 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 172.01 16.35 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.652 1.981 . . . . 0.0 107.66 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -60.13 -66.33 0.54 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.385 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.255 1.8 pp20? 48.72 167.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.59 54.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.349 -1.469 . . . . 0.0 112.554 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.263 44.0 m-20 53.33 45.97 27.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.349 1.859 . . . . 0.0 112.485 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -73.61 166.38 44.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.03 22.52 0.31 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.536 2.824 . . . . 0.0 113.835 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -152.23 58.63 2.66 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 126.467 1.907 . . . . 0.0 111.277 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.9 134.39 34.41 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.551 1.5 . . . . 0.0 109.552 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -101.81 0.1 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.814 0.721 . . . . 0.0 111.8 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 154.77 44.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.893 1.277 . . . . 0.0 111.881 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.61 139.26 16.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.852 1.661 . . . . 0.0 110.59 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -158.61 159.07 35.03 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.167 0.984 . . . . 0.0 111.768 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.88 90.4 3.19 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.514 1.525 . . . . 0.0 108.923 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.71 105.33 0.79 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 148.57 11.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.428 1.891 . . . . 0.0 113.8 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.57 151.78 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.47 1.108 . . . . 0.0 112.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.33 52.78 45.22 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 124.655 1.121 . . . . 0.0 114.997 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.78 175.45 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.815 0.846 . . . . 0.0 112.874 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.1 m -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.16 1.384 . . . . 0.0 109.698 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.33 121.71 19.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.84 1.256 . . . . 0.0 109.314 -175.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -117.9 15.79 14.31 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.066 1.746 . . . . 0.0 112.671 -172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -140.23 38.66 1.92 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.328 1.451 . . . . 0.0 112.741 -171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.86 -17.36 64.86 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.797 -1.189 . . . . 0.0 111.971 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -56.49 -19.19 14.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.81 1.644 . . . . 0.0 114.624 168.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.2 t -54.14 -27.27 32.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.247 -0.908 . . . . 0.0 112.285 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.0 mt -134.07 73.87 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 127.046 2.138 . . . . 0.0 108.848 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -60.94 -23.08 65.02 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.809 -1.182 . . . . 0.0 112.657 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.38 80.33 0.15 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.8 1.666 . . . . 0.0 113.232 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 54' ' ' ILE . 1.6 mp -124.59 153.03 42.8 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.9 1.68 . . . . 0.0 111.661 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -158.53 -22.12 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.471 1.509 . . . . 0.0 114.201 161.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.06 129.45 55.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.474 1.51 . . . . 0.0 108.75 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.65 121.07 31.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.93 132.38 54.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -126.37 130.17 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 pp -144.82 148.81 40.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.406 0.682 . . . . 0.0 110.152 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 96' ' ' PHE . 36.7 Cg_endo -68.52 155.06 70.33 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.898 1.732 . . . . 0.0 112.391 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.95 -24.3 64.64 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.059 0.838 . . . . 0.0 114.528 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.43 -22.88 67.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.52 1.128 . . . . 0.0 113.679 169.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 93' ' ' PRO . 11.5 m-30 -111.0 130.08 55.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.933 1.693 . . . . 0.0 108.741 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -85.75 -40.16 16.37 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.505 -1.372 . . . . 0.0 112.194 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' HD12 ' A' ' 140' ' ' ILE . 39.1 p-90 -152.23 159.28 43.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.77 2.028 . . . . 0.0 109.041 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.02 146.41 50.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.609 0.763 . . . . 0.0 110.766 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.91 135.19 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.747 1.219 . . . . 0.0 110.166 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -77.23 134.66 38.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.276 0.63 . . . . 0.0 109.885 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.55 140.4 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 109.938 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.33 157.15 45.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.06 1.744 . . . . 0.0 110.609 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 92.6 mt -118.76 139.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.959 2.104 . . . . 0.0 109.535 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.33 106.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.755 1.622 . . . . 0.0 109.601 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.69 111.83 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.415 0.686 . . . . 0.0 110.727 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.8 15.35 11.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.421 1.088 . . . . 0.0 111.466 168.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -96.28 -61.83 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.869 1.667 . . . . 0.0 111.063 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -151.63 99.08 2.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.386 1.875 . . . . 0.0 108.799 -172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.5 m -53.16 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.88 1.672 . . . . 0.0 113.052 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.1 m -146.69 -53.89 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.743 1.617 . . . . 0.0 110.779 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.2 159.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.175 2.19 . . . . 0.0 114.96 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.42 -36.1 0.44 Allowed Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.531 -1.355 . . . . 0.0 115.293 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.6 m -64.63 1.7 0.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.175 2.19 . . . . 0.0 115.033 170.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.446 ' CE2' HG21 ' A' ' 166' ' ' VAL . 17.9 t80 -134.99 122.18 21.5 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.258 2.223 . . . . 0.0 109.76 -173.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -132.18 130.34 40.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.958 1.303 . . . . 0.0 110.387 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 3.6 ttm -115.57 141.57 47.88 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.694 1.598 . . . . 0.0 110.632 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.6 m -128.27 116.41 19.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.573 1.149 . . . . 0.0 108.171 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mt -96.64 122.83 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.4 m -116.04 87.54 19.38 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.981 1.712 . . . . 0.0 109.24 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.0 163.53 37.32 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.58 2.853 . . . . 0.0 112.465 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -45.16 96.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.577 1.951 . . . . 0.0 113.259 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 37.29 47.47 0.69 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.267 1.827 . . . . 0.0 114.881 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.34 155.18 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.966 1.707 . . . . 0.0 109.535 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.75 92.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.356 1.462 . . . . 0.0 112.288 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.51 160.47 4.18 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.475 1.51 . . . . 0.0 111.523 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.49 145.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 111.391 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.85 138.86 33.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.457 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 39.8 t -135.78 124.61 24.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.339 1.455 . . . . 0.0 107.855 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -118.52 141.19 48.82 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 109.03 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.92 105.23 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.431 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.15 63.0 0.32 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.318 0.961 . . . . 0.0 113.658 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -141.59 155.89 45.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.456 1.903 . . . . 0.0 111.657 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.38 55.11 2.71 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.609 -1.307 . . . . 0.0 111.662 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 59.61 169.78 0.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.539 1.936 . . . . 0.0 112.826 -167.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.14 126.17 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.845 -1.159 . . . . 0.0 109.741 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 127.17 31.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.841 0.456 . . . . 0.0 110.047 171.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.18 95.83 47.98 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.059 1.743 . . . . 0.0 107.685 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 55.4 Cg_endo -77.98 148.13 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.903 2.402 . . . . 0.0 112.669 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.411 HD12 ' CZ3' ' A' ' 98' ' ' TRP . 87.2 mt -136.03 131.72 18.98 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.309 1.443 . . . . 0.0 109.1 -174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.47 169.85 21.34 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.922 3.748 . . . . 0.0 112.112 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -68.6 149.04 49.63 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.517 -0.739 . . . . 0.0 111.677 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.61 163.63 39.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.097 2.159 . . . . 0.0 109.573 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.3 m -131.25 131.4 23.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.942 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.97 153.63 80.41 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 119.343 0.801 . . . . 0.0 111.877 -3.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.85 -17.28 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.734 1.623 . . . . 0.0 112.886 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.49 13.53 21.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 114.415 169.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.87 152.11 46.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.744 -1.223 . . . . 0.0 112.437 174.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.79 113.63 19.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.315 0.646 . . . . 0.0 111.018 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.6 tt -85.71 120.25 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.62 0.768 . . . . 0.0 109.828 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.49 139.42 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.542 0.687 . . . . 0.0 110.703 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.1 t -143.8 150.42 38.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.44 1.096 . . . . 0.0 109.798 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -111.32 145.17 39.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.704 0.802 . . . . 0.0 109.62 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 tt -133.85 120.73 20.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.665 0.745 . . . . 0.0 109.311 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.04 124.45 26.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.309 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 116' ' ' GLU . 2.2 p -145.34 135.16 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.57 1.148 . . . . 0.0 109.698 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 162.14 35.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.226 1.41 . . . . 0.0 111.523 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -66.5 128.52 36.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.126 170.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.9 p -73.57 -6.46 46.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.892 0.877 . . . . 0.0 113.326 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -122.54 141.0 52.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.279 2.232 . . . . 0.0 108.869 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -65.59 140.84 97.66 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.696 -0.668 . . . . 0.0 111.643 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 131.67 20.94 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.415 1.184 . . . . 0.0 111.492 -4.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -73.68 41.68 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 112.499 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.91 126.7 14.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -68.63 82.15 0.28 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.391 1.077 . . . . 0.0 110.046 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 156' ' ' VAL . 14.0 m -45.91 -37.84 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.976 1.71 . . . . 0.0 113.017 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 33.7 t -147.88 136.9 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.488 1.115 . . . . 0.0 109.697 165.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -142.03 115.2 8.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.787 1.235 . . . . 0.0 108.137 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.35 -162.21 24.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.02 0.819 . . . . 0.0 113.298 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.92 153.66 51.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.625 1.17 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.92 143.58 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.168 1.787 . . . . 0.0 109.245 -175.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -115.05 115.11 26.28 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.182 -0.949 . . . . 0.0 109.328 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 152.82 26.16 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.462 -0.774 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.77 154.65 45.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 108.709 167.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -127.91 127.48 43.44 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.869 1.268 . . . . 0.0 108.727 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.3 m -86.17 106.68 10.64 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.59 -17.68 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.43 2.753 . . . . 0.0 112.514 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.3 m -55.91 -38.83 70.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.199 1.8 . . . . 0.0 113.079 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.8 p -147.75 24.59 1.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.013 1.325 . . . . 0.0 112.705 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 50.71 31.12 22.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.406 1.955 . . . . 0.0 115.851 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.59 164.5 25.76 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.182 0.991 . . . . 0.0 111.152 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.62 135.5 55.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.074 1.35 . . . . 0.0 109.008 165.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.9 m -133.49 107.17 7.87 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.481 HG11 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -83.83 151.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.4 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.91 135.44 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 125.874 1.67 . . . . 0.0 107.709 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.472 ' HD2' HG21 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 140.2 36.23 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.833 1.653 . . . . 0.0 107.425 177.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -125.29 146.14 49.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.303 1.441 . . . . 0.0 108.353 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.95 -14.42 47.07 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -17.44 61.05 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 171.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.0 p -130.38 -32.3 1.77 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.608 1.563 . . . . 0.0 113.231 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.95 146.89 76.41 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.996 1.318 . . . . 0.0 110.782 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.28 -7.72 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.586 2.857 . . . . 0.0 113.99 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.4 tttm 64.56 -24.2 0.08 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.341 2.656 . . . . 0.0 115.993 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -67.74 -18.17 64.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.43 1.092 . . . . 0.0 113.685 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.7 ttm -103.3 151.44 22.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.563 1.945 . . . . 0.0 109.418 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.0 p -131.76 159.67 37.8 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.455 1.502 . . . . 0.0 110.144 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 186' ' ' LYS . 77.8 t -121.61 130.75 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.157 0.983 . . . . 0.0 109.683 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.2 m -134.31 126.78 30.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.471 1.109 . . . . 0.0 108.697 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.42 141.4 28.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.565 1.146 . . . . 0.0 110.481 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -117.47 -36.18 3.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.564 0.746 . . . . 0.0 111.704 171.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -129.38 178.78 6.2 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.527 1.131 . . . . 0.0 111.849 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.78 -40.41 63.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.226 1.01 . . . . 0.0 112.144 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -137.01 33.8 2.61 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 111.205 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.7 t -129.18 116.99 20.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.882 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.481 ' CE2' HG11 ' A' ' 184' ' ' VAL . 2.5 t80 -100.17 136.29 40.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.365 2.266 . . . . 0.0 109.73 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.04 112.77 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.608 1.163 . . . . 0.0 109.54 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.02 120.19 22.5 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.109 1.363 . . . . 0.0 109.872 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -106.41 133.79 50.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 45.6 tp -127.47 111.54 13.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.812 -0.555 . . . . 0.0 110.966 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.58 -26.19 15.33 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.92 132.57 53.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 111.053 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.6 -48.91 79.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 127.264 2.225 . . . . 0.0 112.507 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.1 p . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.532 0.682 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' CD ' ' A' ' 9' ' ' LYS . 9.9 p -57.55 148.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.926 -0.484 . . . . 0.0 111.374 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.57 144.34 43.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.623 0.369 . . . . 0.0 110.686 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.86 -17.12 34.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.037 -1.039 . . . . 0.0 113.179 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -108.91 13.47 24.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.442 1.897 . . . . 0.0 113.275 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -137.55 170.96 15.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 46' ' ' VAL . 3.8 m -142.58 151.58 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.0 110.517 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' CD ' HG23 ' A' ' 3' ' ' VAL . 2.4 mptm? -130.51 152.11 50.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.112 0.965 . . . . 0.0 110.812 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.74 133.99 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 108.256 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -121.73 127.73 51.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.818 1.647 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.42 61.4 6.17 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.761 1.225 . . . . 0.0 110.884 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.42 142.99 3.86 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.235 0.922 . . . . 0.0 112.019 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -59.2 132.17 53.22 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.948 0.874 . . . . 0.0 109.669 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 t30 77.09 41.88 0.15 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.743 1.617 . . . . 0.0 113.199 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.343 31.1 p 49.87 58.2 5.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.921 2.488 . . . . 0.0 115.485 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 p -127.81 179.47 5.53 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.164 1.785 . . . . 0.0 113.18 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.23 -74.74 1.84 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.463 1.982 . . . . 0.0 113.957 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -139.13 170.16 16.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.655 1.582 . . . . 0.0 109.781 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -137.32 143.91 42.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.535 1.134 . . . . 0.0 111.166 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -143.4 155.46 44.41 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.552 1.541 . . . . 0.0 110.465 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -125.67 134.8 51.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.761 1.224 . . . . 0.0 109.204 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' HB2' HG23 ' A' ' 8' ' ' VAL . 17.8 m-85 -127.52 131.33 50.09 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.483 1.135 . . . . 0.0 110.521 -175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -91.91 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.716 1.207 . . . . 0.0 109.349 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 145.07 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.819 -0.55 . . . . 0.0 112.409 172.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.7 73.08 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.172 0.415 . . . . 0.0 113.837 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -127.9 126.01 40.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.297 1.439 . . . . 0.0 109.936 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m -109.19 126.56 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.25 146.1 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 110.037 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -125.95 144.37 50.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.037 1.335 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -135.38 146.23 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.43 1.492 . . . . 0.0 109.628 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.5 139.97 8.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.553 1.141 . . . . 0.0 110.193 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.11 30.36 0.06 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.135 0.974 . . . . 0.0 113.537 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.42 45.27 4.09 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 113.833 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.251 0.4 OUTLIER 54.12 55.89 7.69 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 174.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.93 -53.15 0.06 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -84.66 -17.35 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -76.19 -45.4 33.45 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 111.34 173.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.66 35.73 0.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.265 1.426 . . . . 0.0 113.15 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -16.12 62.67 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 119.651 -1.906 . . . . 0.0 114.247 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.7 134.76 56.49 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 mtp -150.01 -58.76 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 112.07 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -136.27 115.54 12.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.948 1.299 . . . . 0.0 109.905 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.08 146.95 37.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.709 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.87 128.15 43.27 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.112 1.365 . . . . 0.0 109.081 -168.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 8' ' ' VAL . 59.0 t -118.55 119.75 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.268 1.427 . . . . 0.0 110.185 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.74 0.01 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.516 1.532 . . . . 0.0 116.66 -164.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.33 -21.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 27.34 7.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.798 1.639 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.77 141.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.912 2.085 . . . . 0.0 109.416 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -116.23 153.06 32.55 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.12 128.33 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.232 0.539 . . . . 0.0 109.626 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.24 126.15 54.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.073 0.949 . . . . 0.0 108.448 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.6 pp -117.26 104.18 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 122.194 0.997 . . . . 0.0 109.516 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.82 123.05 49.34 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.611 1.164 . . . . 0.0 108.769 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.84 -57.87 10.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.161 0.982 . . . . 0.0 111.491 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 158.42 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.657 1.183 . . . . 0.0 109.383 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.42 124.38 33.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' H ' ' HB2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -159.8 172.97 16.71 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.588 1.555 . . . . 0.0 111.999 -169.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.0 pt -123.68 34.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.503 -1.373 . . . . 0.0 114.211 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.299 67.4 m-20 61.94 51.04 3.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.979 2.112 . . . . 0.0 111.689 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p -65.74 166.41 15.28 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.655 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 56.6 Cg_endo -73.37 20.38 0.36 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 123.456 2.771 . . . . 0.0 114.285 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -148.03 63.7 7.67 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.656 1.582 . . . . 0.0 111.957 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.64 140.42 62.25 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.751 1.634 . . . . 0.0 110.535 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.02 -92.81 1.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -145.62 153.92 41.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.174 1.39 . . . . 0.0 110.787 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -153.33 137.55 16.53 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.056 1.342 . . . . 0.0 108.715 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -155.83 164.67 38.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.377 1.084 . . . . 0.0 111.198 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -133.84 104.84 6.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.391 1.076 . . . . 0.0 108.355 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -68.23 115.31 7.54 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.813 0.845 . . . . 0.0 109.598 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.17 152.92 1.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.155 1.782 . . . . 0.0 112.882 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.83 -21.93 32.75 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.87 88.16 0.12 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.135 1.35 . . . . 0.0 112.282 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -161.05 171.75 18.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.674 1.19 . . . . 0.0 112.446 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.0 m -124.3 140.11 53.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.35 1.06 . . . . 0.0 109.187 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -131.09 119.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -107.58 -20.87 13.1 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.865 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -121.43 49.69 1.49 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.85 -16.72 59.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.103 -0.998 . . . . 0.0 112.626 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.19 -17.28 2.67 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.972 1.309 . . . . 0.0 114.36 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -55.15 -29.56 58.02 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.473 -1.392 . . . . 0.0 113.656 165.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 tp -78.58 -39.33 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.899 0.772 . . . . 0.0 112.195 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 33.58 43.78 0.06 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.256 1.822 . . . . 0.0 114.293 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.86 61.96 0.14 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.753 -155.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 ' HB ' ' A' ' 54' ' ' ILE . 27.2 tp -139.9 124.85 18.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.268 1.027 . . . . 0.0 110.4 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -132.05 -15.67 2.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -129.99 110.1 11.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.383 1.473 . . . . 0.0 109.443 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 120.66 43.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -168.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -116.62 112.39 21.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 109.59 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG13 HG21 ' A' ' 8' ' ' VAL . 38.5 t -95.26 131.19 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.586 1.554 . . . . 0.0 109.182 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.75 HD13 ' CE1' ' A' ' 96' ' ' PHE . 11.2 mt -132.06 136.2 27.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.415 0.686 . . . . 0.0 110.376 -161.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.2 14.91 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.561 2.841 . . . . 0.0 114.535 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.14 -35.54 0.64 Allowed Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.997 2.237 . . . . 0.0 115.023 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.33 65.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.847 1.659 . . . . 0.0 112.526 167.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.75 ' CE1' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -50.18 153.08 1.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.876 1.271 . . . . 0.0 110.757 159.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HG3' ' CZ3' ' A' ' 98' ' ' TRP . 27.6 tp60 -132.28 -33.89 1.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.327 0.651 . . . . 0.0 111.842 167.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -151.63 166.94 29.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.068 1.747 . . . . 0.0 109.673 171.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.4 166.26 23.58 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.142 0.973 . . . . 0.0 111.193 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 HG11 ' A' ' 182' ' ' VAL . 9.2 p -134.51 121.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.698 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.84 120.74 19.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -115.46 144.77 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.976 1.31 . . . . 0.0 109.414 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.35 152.11 40.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.761 1.624 . . . . 0.0 108.912 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.8 mt -123.13 124.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.512 0.725 . . . . 0.0 109.62 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -124.65 116.64 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.475 1.51 . . . . 0.0 109.631 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.31 120.36 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.161 1.784 . . . . 0.0 110.68 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.64 27.03 4.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.102 1.761 . . . . 0.0 111.405 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.85 -56.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.95 1.7 . . . . 0.0 111.37 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -119.74 128.48 53.8 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.217 1.407 . . . . 0.0 109.743 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.6 56.6 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.967 1.307 . . . . 0.0 111.702 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.9 m -132.76 -66.32 0.68 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.004 1.322 . . . . 0.0 111.349 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.67 170.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -172.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.59 -12.61 60.72 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.468 -1.395 . . . . 0.0 115.178 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 p -110.3 -25.94 9.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.573 1.549 . . . . 0.0 113.894 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.98 135.02 46.27 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 165.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -131.88 138.77 48.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.147 0.975 . . . . 0.0 109.817 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.637 ' HG3' HG22 ' A' ' 156' ' ' VAL . 2.8 ttp -121.8 137.29 54.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.683 2.393 . . . . 0.0 108.165 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.0 m -136.45 135.52 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.12 123.66 54.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -120.8 90.55 46.59 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.016 1.327 . . . . 0.0 110.416 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.22 82.07 1.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.064 3.176 . . . . 0.0 113.126 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 55.32 57.83 5.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.293 1.437 . . . . 0.0 112.129 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.83 50.09 16.43 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.377 1.471 . . . . 0.0 113.239 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.92 169.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 127.692 2.397 . . . . 0.0 109.243 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.15 79.56 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.936 2.894 . . . . 0.0 114.579 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 159.75 30.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.212 1.405 . . . . 0.0 110.504 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.39 151.18 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.438 1.095 . . . . 0.0 109.652 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.29 131.02 54.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.047 0.939 . . . . 0.0 109.593 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.536 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -137.62 150.64 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -144.92 137.99 26.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.468 1.107 . . . . 0.0 110.537 -170.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.76 100.75 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.084 2.154 . . . . 0.0 111.564 -173.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.14 43.74 0.59 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.327 0.489 . . . . 0.0 114.123 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -136.32 164.52 27.91 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.678 1.591 . . . . 0.0 111.784 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.49 165.64 18.59 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.126 -0.984 . . . . 0.0 111.565 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -54.38 132.0 43.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.222 -0.924 . . . . 0.0 111.404 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 129' ' ' CYS . 14.9 t -100.18 116.07 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.768 1.227 . . . . 0.0 110.446 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.47 100.43 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.87 1.268 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mt -83.02 112.71 40.4 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.289 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.41 134.48 15.57 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.486 2.124 . . . . 0.0 110.342 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 mm -122.89 124.29 26.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.487 1.515 . . . . 0.0 108.644 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.65 174.2 13.05 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.593 2.862 . . . . 0.0 112.564 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.11 137.84 58.22 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.585 -0.697 . . . . 0.0 111.756 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.2 pp -151.79 38.19 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.162 1.385 . . . . 0.0 112.723 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 t -40.25 138.29 1.17 Allowed Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 127.381 2.272 . . . . 0.0 114.766 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.55 158.62 90.16 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 CA-C-N 119.836 0.977 . . . . 0.0 113.137 0.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.59 -33.82 66.02 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.067 1.844 . . . . 0.0 112.877 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.28 0.79 9.01 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.106 1.362 . . . . 0.0 114.618 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 p -66.94 175.62 2.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.293 1.044 . . . . 0.0 113.268 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.61 103.76 7.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.544 1.538 . . . . 0.0 110.508 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 tt -78.61 132.08 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.845 1.258 . . . . 0.0 110.181 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.17 143.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 110.363 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.4 t -137.35 153.43 50.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.56 1.144 . . . . 0.0 109.135 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -112.17 119.82 39.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 tt -101.18 126.2 47.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.977 1.311 . . . . 0.0 109.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.46 125.14 37.86 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.635 1.574 . . . . 0.0 108.817 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 117' ' ' MET . 2.4 t -129.33 119.19 47.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.809 1.243 . . . . 0.0 109.033 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -147.91 149.08 31.58 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.644 1.178 . . . . 0.0 109.802 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -70.87 134.08 47.0 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.217 -0.302 . . . . 0.0 110.948 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.1 p -72.71 -19.23 61.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.486 1.515 . . . . 0.0 113.733 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 169.62 10.95 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.321 1.848 . . . . 0.0 111.298 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 p -53.18 146.09 22.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.252 1.021 . . . . 0.0 113.583 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.0 6.39 18.37 Favored 'Cis proline' 0 CA--C 1.545 1.056 0 N-CA-C 114.933 1.09 . . . . 0.0 114.933 4.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.93 24.47 14.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.837 1.255 . . . . 0.0 112.377 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.17 142.19 43.55 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.623 -1.298 . . . . 0.0 111.015 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -57.9 146.17 33.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.11 0.564 . . . . 0.0 111.379 168.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.38 -40.67 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.348 1.059 . . . . 0.0 111.604 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.6 t -146.67 137.92 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.584 0.754 . . . . 0.0 109.402 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -149.6 139.13 21.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.56 1.144 . . . . 0.0 110.445 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.66 -172.37 44.15 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.71 0.671 . . . . 0.0 114.238 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.7 m -115.81 132.25 56.7 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.718 0.807 . . . . 0.0 111.598 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.61 116.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.976 2.11 . . . . 0.0 108.139 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.4 138.68 31.35 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.89 -1.131 . . . . 0.0 109.143 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -112.77 146.53 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.134 0.968 . . . . 0.0 109.629 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -141.26 152.2 44.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.916 1.686 . . . . 0.0 108.209 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' ' HA2' ' A' ' 180' ' ' GLY . 31.8 t80 -121.13 150.25 41.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.788 1.235 . . . . 0.0 109.43 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 m -111.23 105.38 56.96 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 123.804 0.842 . . . . 0.0 109.458 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.44 48.69 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.855 1 C-N-CA 126.271 4.648 . . . . 0.0 113.596 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.4 t -123.04 -45.43 2.13 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.408 1.483 . . . . 0.0 110.923 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.9 p -151.09 34.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.227 1.811 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 175' ' ' TYR . . . 58.98 32.8 71.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.978 1.275 . . . . 0.0 114.878 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.48 171.3 15.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.761 1.28 . . . . 0.0 110.948 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.443 HG11 HG23 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -132.69 152.43 36.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.453 1.101 . . . . 0.0 109.794 177.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 m -138.32 140.93 39.73 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.43 1.892 . . . . 0.0 107.468 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.49 HG22 ' HD2' ' A' ' 186' ' ' LYS . 1.1 p -110.29 141.54 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 24.9 mt -133.02 120.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.49 ' HD2' HG22 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -138.96 142.31 38.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.635 1.174 . . . . 0.0 109.037 175.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 140.4 52.75 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.057 1.343 . . . . 0.0 108.309 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.48 -20.09 11.64 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.66 -16.36 64.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.282 1.433 . . . . 0.0 114.607 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 32.7 p -141.07 -42.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.697 1.599 . . . . 0.0 113.59 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.432 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 10.0 t80 -88.19 146.82 38.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.983 1.313 . . . . 0.0 110.591 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 45.9 Cg_endo -76.03 168.99 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.224 2.616 . . . . 0.0 112.656 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -94.77 10.87 33.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.482 1.513 . . . . 0.0 112.514 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -93.64 -44.51 8.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 111.986 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -100.48 144.87 28.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.366 1.466 . . . . 0.0 109.108 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -139.97 158.46 44.03 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.07 1.348 . . . . 0.0 108.978 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 72.1 t -121.01 135.56 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.3 m -127.91 126.1 40.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.16 0.984 . . . . 0.0 109.092 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -68.06 137.0 54.67 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.417 0.687 . . . . 0.0 110.401 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.69 -26.79 2.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.318 1.047 . . . . 0.0 112.945 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -161.4 172.52 16.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.139 1.776 . . . . 0.0 111.039 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' A' ' 59' ' ' GLU . 8.0 t30 -58.09 136.21 57.15 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.915 -1.116 . . . . 0.0 109.942 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.413 ' HA ' ' CG1' ' A' ' 182' ' ' VAL 0.25 2.3 p 56.31 6.51 0.26 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 31.8 m -113.67 133.4 55.34 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.989 1.316 . . . . 0.0 111.412 -169.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 4.4 m-85 -142.49 137.61 30.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.734 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 60.9 mt -122.67 118.95 56.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.31 126.85 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.205 1.402 . . . . 0.0 108.707 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -119.26 132.32 55.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.753 1.221 . . . . 0.0 109.388 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.5 tt -113.7 125.44 54.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 109.526 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -128.62 3.71 5.53 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.583 1.153 . . . . 0.0 113.864 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 m -150.5 115.63 5.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.547 1.939 . . . . 0.0 110.675 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -52.88 -35.41 57.8 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 119.618 1.099 . . . . 0.0 113.682 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.949 1.7 . . . . 0.0 113.453 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.102 0.477 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.39 139.7 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -15.94 34.32 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.464 -1.397 . . . . 0.0 113.42 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -108.48 2.09 22.03 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.09 2.156 . . . . 0.0 113.349 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -144.89 175.45 10.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.854 2.062 . . . . 0.0 110.24 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.25 158.33 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.141 -0.974 . . . . 0.0 111.124 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -149.44 143.92 26.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.356 0.662 . . . . 0.0 112.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -134.79 131.36 37.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.418 1.887 . . . . 0.0 109.362 -165.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.32 137.39 51.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.604 1.562 . . . . 0.0 110.286 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.94 45.23 0.7 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.809 1.644 . . . . 0.0 112.901 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.15 132.92 2.12 Favored Glycine 0 CA--C 1.519 0.306 0 O-C-N 120.282 -1.511 . . . . 0.0 111.527 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 148.14 7.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 110.722 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.48 25.97 13.67 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m 63.98 72.33 0.46 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.567 2.347 . . . . 0.0 114.803 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -137.18 -179.4 5.69 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.311 1.445 . . . . 0.0 112.382 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -72.76 2.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.436 1.493 . . . . 0.0 115.466 169.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.36 165.23 28.51 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.69 1.996 . . . . 0.0 108.933 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -127.02 154.16 44.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.531 1.132 . . . . 0.0 112.609 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 146.23 20.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.853 1.661 . . . . 0.0 109.897 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.27 141.71 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.356 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.44 129.37 31.03 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.766 1.226 . . . . 0.0 110.592 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.89 158.97 34.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.37 0.605 . . . . 0.0 111.518 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.0 147.3 47.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.574 -0.704 . . . . 0.0 111.622 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.6 45.55 75.99 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.653 0.644 . . . . 0.0 113.493 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.74 159.46 39.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.907 0.883 . . . . 0.0 112.117 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.3 m -136.52 132.93 35.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.937 1.295 . . . . 0.0 108.449 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.58 159.69 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.767 1.227 . . . . 0.0 110.883 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -130.2 118.94 22.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 108.303 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.398 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 m0 . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 122.181 0.991 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.47 -38.34 71.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.455 1.102 . . . . 0.0 110.673 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -39.44 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.035 2.534 . . . . 0.0 111.717 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.8 42.25 0.39 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 112.654 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 86' ' ' LEU . 2.8 p90 -148.03 155.34 41.38 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 122.542 1.163 . . . . 0.0 111.511 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -152.91 -45.45 0.1 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.229 163.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -120.45 129.43 53.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.448 1.022 . . . . 0.0 109.58 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 p -140.78 158.33 44.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.167 0.984 . . . . 0.0 112.391 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.95 134.48 47.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.966 1.306 . . . . 0.0 108.269 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.76 105.23 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.304 1.442 . . . . 0.0 108.573 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.19 152.81 6.39 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.217 1.389 . . . . 0.0 114.96 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -64.31 -2.83 2.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -135.63 29.7 3.21 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.329 1.451 . . . . 0.0 112.238 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.5 155.13 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.816 2.446 . . . . 0.0 109.996 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 70' ' ' GLU . 12.6 ttt85 -125.54 152.76 44.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.514 1.526 . . . . 0.0 109.569 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 m -116.46 149.55 39.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.267 1.032 . . . . 0.0 110.423 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.35 120.99 19.45 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.74 1.616 . . . . 0.0 107.521 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.9 pt -116.79 137.71 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 123.561 0.744 . . . . 0.0 109.973 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -137.53 116.14 12.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -43.03 -69.52 0.13 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.755 2.022 . . . . 0.0 115.051 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.81 35.96 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.906 0.882 . . . . 0.0 109.495 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.283 0.6 OUTLIER 42.21 57.71 3.21 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.092 1.757 . . . . 0.0 112.546 178.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 1.5 pp20? -63.22 131.36 48.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.466 1.506 . . . . 0.0 113.279 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -93.21 38.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.388 1.475 . . . . 0.0 111.719 -167.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.33 50.9 m-20 55.05 46.42 24.19 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 123.691 1.71 . . . . 0.0 112.166 -168.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 62' ' ' THR . 0.7 OUTLIER -68.69 171.88 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.585 2.354 . . . . 0.0 110.86 176.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.25 7.34 0.87 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.103 2.536 . . . . 0.0 114.972 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -137.98 112.03 8.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 124.978 1.311 . . . . 0.0 110.769 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.81 125.44 13.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.59 -120.83 0.08 OUTLIER Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.744 1.164 . . . . 0.0 111.423 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.152 0.981 . . . . 0.0 111.052 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -154.07 139.53 17.74 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.402 1.081 . . . . 0.0 112.583 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.68 141.83 27.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.823 0.82 . . . . 0.0 110.199 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 51' ' ' ARG . 32.4 tt0 -113.6 79.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -46.52 102.66 0.03 OUTLIER 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.947 2.099 . . . . 0.0 110.773 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.28 126.53 23.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.414 . . . . 0.0 111.558 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -55.5 109.53 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.216 1.406 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.52 55.8 1.99 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.966 0.793 . . . . 0.0 114.481 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.44 163.53 36.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.981 0.891 . . . . 0.0 113.138 174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.0 m -123.61 133.74 53.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.713 1.605 . . . . 0.0 108.985 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -119.72 102.85 8.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.079 1.751 . . . . 0.0 109.015 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -71.79 -24.33 61.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -151.69 137.73 18.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.89 1.676 . . . . 0.0 110.203 171.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.14 14.33 7.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.436 1.495 . . . . 0.0 112.537 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -53.89 -19.49 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.249 1.82 . . . . 0.0 115.256 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -48.61 -29.65 4.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 162.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.0 mt -133.0 58.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 128.963 2.905 . . . . 0.0 108.003 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -52.47 -29.98 27.6 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.149 -0.97 . . . . 0.0 112.248 163.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.42 103.55 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.662 1.125 . . . . 0.0 112.892 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -161.73 43.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -52.25 -18.54 1.58 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 120.007 -1.683 . . . . 0.0 115.4 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -113.55 141.67 46.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.018 2.127 . . . . 0.0 111.581 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -128.89 134.65 48.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.949 2.099 . . . . 0.0 109.365 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -125.72 129.29 49.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.171 1.788 . . . . 0.0 109.288 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.27 116.1 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.419 1.487 . . . . 0.0 108.203 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.6 mt -127.77 140.81 39.16 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.771 0.828 . . . . 0.0 110.808 -167.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.72 164.61 35.12 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.885 2.39 . . . . 0.0 112.812 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.1 -24.77 58.96 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 113.912 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.12 68.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.129 1.372 . . . . 0.0 114.389 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -123.23 116.28 23.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.232 1.413 . . . . 0.0 110.722 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.14 -44.23 65.99 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.197 -0.94 . . . . 0.0 112.161 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 162.6 40.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.514 1.926 . . . . 0.0 109.155 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.57 157.06 45.58 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.478 -0.764 . . . . 0.0 110.393 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -127.77 132.6 68.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.805 0.842 . . . . 0.0 109.95 -169.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.28 128.19 34.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -126.62 145.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.17 1.388 . . . . 0.0 108.27 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -149.79 157.99 43.74 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.19 134.37 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.113 1.765 . . . . 0.0 106.973 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.43 135.64 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.035 0.921 . . . . 0.0 110.745 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -79.09 122.1 25.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.982 0.913 . . . . 0.0 112.343 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -110.93 -3.12 15.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.464 1.506 . . . . 0.0 112.696 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.4 t -138.46 -48.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 126.115 1.766 . . . . 0.0 112.699 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -74.51 80.22 1.95 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.328 0.967 . . . . 0.0 112.189 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -68.53 53.34 0.08 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.471 2.308 . . . . 0.0 114.069 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.9 m -137.53 -45.01 0.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.674 1.99 . . . . 0.0 111.642 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 56.94 158.51 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.013 2.125 . . . . 0.0 115.609 -172.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.75 -38.08 0.38 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.856 2.646 . . . . 0.0 115.039 -176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.4 p -67.75 -6.6 21.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.577 2.751 . . . . 0.0 114.795 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 63.5 t80 -115.6 113.61 23.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.232 2.613 . . . . 0.0 108.686 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -120.67 121.17 37.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.128 1.371 . . . . 0.0 110.079 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 ttp -107.62 139.22 42.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.967 0.507 . . . . 0.0 111.563 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -126.4 122.62 35.86 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.467 1.507 . . . . 0.0 108.531 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -122.66 137.93 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.224 1.01 . . . . 0.0 109.051 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -140.33 100.19 7.02 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.506 1.122 . . . . 0.0 110.282 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.16 162.12 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.319 2.012 . . . . 0.0 111.458 168.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -26.08 93.61 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.288 2.635 . . . . 0.0 115.852 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 47.24 42.82 14.06 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.792 1.637 . . . . 0.0 114.664 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.54 163.89 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.874 2.07 . . . . 0.0 110.955 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.25 94.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.177 1.791 . . . . 0.0 111.658 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.66 36.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 111.199 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.6 p -123.53 131.69 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.122 0.569 . . . . 0.0 109.972 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.08 133.65 55.24 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.327 1.451 . . . . 0.0 109.165 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -139.45 146.48 40.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.464 1.105 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -104.5 127.99 52.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.211 1.404 . . . . 0.0 109.033 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -49.2 103.81 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.841 1.656 . . . . 0.0 111.893 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 135.29 -26.71 3.2 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.997 0.808 . . . . 0.0 113.732 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.39 159.14 18.86 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.156 0.978 . . . . 0.0 111.113 162.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -64.29 171.47 3.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 0.0 112.054 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -50.29 130.58 23.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.202 -0.936 . . . . 0.0 111.152 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.84 153.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 109.313 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -108.84 129.57 55.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.61 89.86 13.76 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.35 1.46 . . . . 0.0 108.671 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.75 149.24 60.23 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.079 1.853 . . . . 0.0 112.048 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.4 mt -127.52 128.27 24.0 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.495 1.918 . . . . 0.0 106.81 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.25 -175.26 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.527 2.818 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 110.86 0.38 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.315 1.046 . . . . 0.0 111.484 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 150' ' ' ILE . 4.3 tp -121.17 75.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.169 1.388 . . . . 0.0 109.743 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 m -107.45 131.63 21.57 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.317 1.047 . . . . 0.0 110.557 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.51 152.28 94.07 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.577 0.885 . . . . 0.0 112.081 -4.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.72 -40.29 74.33 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.653 2.236 . . . . 0.0 113.061 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.25 -4.22 10.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.575 1.55 . . . . 0.0 114.88 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 p -62.14 157.77 18.39 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.457 1.026 . . . . 0.0 111.11 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -105.3 110.61 23.04 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.696 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.419 ' HB ' HD11 ' A' ' 143' ' ' LEU . 8.7 tt -77.96 122.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.211 1.005 . . . . 0.0 109.049 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.46 138.87 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.431 0.692 . . . . 0.0 110.784 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -147.47 158.82 44.14 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.045 0.926 . . . . 0.0 112.439 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.94 133.86 54.37 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.521 1.129 . . . . 0.0 109.459 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.9 124.3 42.91 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.868 1.667 . . . . 0.0 107.606 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.2 t -139.54 134.6 32.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.891 0.853 . . . . 0.0 109.753 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 115' ' ' TYR . 9.2 p -134.91 130.27 52.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.845 0.831 . . . . 0.0 109.135 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -143.63 130.04 19.98 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.619 1.568 . . . . 0.0 109.327 -168.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -64.34 135.17 55.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 109.481 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.2 p -88.76 10.18 21.84 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.37 1.068 . . . . 0.0 113.004 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -141.13 145.65 36.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.711 2.404 . . . . 0.0 109.635 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.2 t -63.76 135.0 96.09 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 121.829 -0.544 . . . . 0.0 111.859 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.57 125.47 10.26 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.666 0.917 . . . . 0.0 112.454 -6.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.84 25.11 11.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.368 1.867 . . . . 0.0 113.644 -170.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.16 159.85 9.08 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.079 -1.013 . . . . 0.0 111.939 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -58.16 107.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.744 0.817 . . . . 0.0 110.857 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.441 ' HB ' HG13 ' A' ' 156' ' ' VAL . 81.1 t -60.02 -55.01 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.877 1.271 . . . . 0.0 109.334 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.69 147.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.408 1.083 . . . . 0.0 110.299 164.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -136.63 120.68 17.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.894 1.678 . . . . 0.0 107.833 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.79 -173.07 31.06 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 122.1 0.833 . . . . 0.0 112.869 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.0 m -118.02 161.91 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.638 1.209 . . . . 0.0 111.224 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.25 164.6 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.731 2.412 . . . . 0.0 106.656 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -132.21 131.89 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.11 152.51 23.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -144.71 146.5 32.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.229 1.812 . . . . 0.0 109.842 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -119.46 151.95 37.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.963 1.305 . . . . 0.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 55.8 m -137.46 112.15 9.18 Favored Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 110.427 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.33 -15.43 20.03 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.487 2.791 . . . . 0.0 112.061 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.6 m -43.79 -42.31 5.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.421 2.689 . . . . 0.0 112.36 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.8 p -145.32 27.65 1.25 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.235 1.414 . . . . 0.0 113.069 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 45.29 41.65 8.59 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 120.258 -1.526 . . . . 0.0 113.997 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -87.74 137.74 32.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.3 1.44 . . . . 0.0 109.05 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.15 140.9 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -135.15 139.14 44.38 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.809 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -112.7 135.25 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.3 123.44 69.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 126.211 1.805 . . . . 0.0 106.751 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -139.46 124.98 19.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.895 1.678 . . . . 0.0 107.207 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -128.65 152.97 47.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 109.331 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -17.98 54.41 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.95 -18.74 62.62 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.649 1.58 . . . . 0.0 114.72 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.8 p -132.51 -50.86 0.92 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 112.89 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.42 142.17 40.13 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.319 1.448 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.86 164.91 34.24 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.468 2.112 . . . . 0.0 111.623 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -93.87 8.06 42.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.821 1.248 . . . . 0.0 112.854 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.303 1.441 . . . . 0.0 113.197 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -114.83 149.69 36.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.111 1.764 . . . . 0.0 107.267 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.2 p -133.21 161.77 33.55 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.771 0.828 . . . . 0.0 108.966 165.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.0 p -129.28 125.79 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.818 0.847 . . . . 0.0 109.004 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 10.0 t -104.7 144.19 32.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.9 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -82.89 80.18 9.03 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.569 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.23 -36.56 75.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.698 1.199 . . . . 0.0 112.538 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -150.55 173.44 14.09 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.133 1.773 . . . . 0.0 111.691 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.05 128.78 28.64 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.126 -1.609 . . . . 0.0 108.983 165.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.0 m 60.34 24.4 13.89 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 119.78 14.28 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.685 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 100' ' ' VAL . 20.5 m-85 -127.81 124.56 37.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 110.953 -167.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.42 100.19 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.643 0.777 . . . . 0.0 109.774 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -76.01 125.18 28.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.866 1.267 . . . . 0.0 110.248 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -121.93 126.88 49.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.913 1.285 . . . . 0.0 111.377 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 211' ' ' SER . 1.3 tm? -92.96 109.66 21.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.233 1.013 . . . . 0.0 110.92 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -110.62 10.74 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.466 1.506 . . . . 0.0 113.914 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.578 ' H ' HD13 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -168.04 109.91 0.59 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.696 1.998 . . . . 0.0 111.544 -178.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.86 -23.61 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 119.56 -1.963 . . . . 0.0 114.409 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 126.619 1.968 . . . . 0.0 111.865 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.77 150.28 41.82 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.592 -0.692 . . . . 0.0 110.33 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -22.35 27.59 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.185 -0.947 . . . . 0.0 113.414 172.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.93 15.96 17.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.558 1.943 . . . . 0.0 113.332 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -140.63 169.3 17.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.876 1.27 . . . . 0.0 110.279 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.3 t -131.46 148.4 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.898 0.879 . . . . 0.0 109.17 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 151.42 49.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.78 0.832 . . . . 0.0 110.842 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -145.15 127.09 15.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.651 -164.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.0 140.28 42.02 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 123.766 1.746 . . . . 0.0 111.198 -169.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.86 44.79 0.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 111.384 -168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.76 159.14 26.62 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.293 1.901 . . . . 0.0 110.44 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.81 139.18 58.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 111.337 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 t30 51.21 36.83 16.86 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.86 1.264 . . . . 0.0 114.056 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.8 m 61.85 64.46 1.01 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.218 1.807 . . . . 0.0 114.57 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 p -122.38 -44.91 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -69.86 1.36 Allowed Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.973 1.26 . . . . 0.0 113.624 -169.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -133.13 169.88 16.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.452 1.501 . . . . 0.0 109.772 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -136.42 149.67 48.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.891 1.277 . . . . 0.0 112.559 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 161.76 41.82 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.316 1.846 . . . . 0.0 110.912 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -134.01 141.07 47.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.17 1.388 . . . . 0.0 110.148 -175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.61 140.6 46.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.51 . . . . 0.0 109.986 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.93 147.22 23.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.903 0.881 . . . . 0.0 110.721 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -66.62 131.86 46.9 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.444 -0.785 . . . . 0.0 110.718 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.17 54.7 3.29 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.838 -0.423 . . . . 0.0 113.402 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.12 157.84 45.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.929 . . . . 0.0 112.088 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -132.93 127.44 34.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.664 1.186 . . . . 0.0 108.033 172.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.52 142.36 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.39 1.076 . . . . 0.0 109.747 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -135.64 119.23 17.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.521 1.128 . . . . 0.0 109.052 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--N 1.322 -0.589 0 C-N-CA 126.05 1.74 . . . . 0.0 107.98 -173.211 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.4 m0 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -73.78 -53.76 9.57 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.379 1.471 . . . . 0.0 110.399 168.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.68 -12.43 61.39 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -30.7 14.82 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.623 -1.298 . . . . 0.0 112.66 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.2 157.44 3.51 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 122.924 1.345 . . . . 0.0 114.303 173.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 -38.49 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.345 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -132.84 149.21 52.29 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.092 0.949 . . . . 0.0 112.682 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.5 p -151.84 143.92 23.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.72 0.772 . . . . 0.0 110.825 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.14 118.93 34.74 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -109.36 110.98 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.17 1.388 . . . . 0.0 108.841 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.83 166.91 4.53 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 122.901 1.278 . . . . 0.0 114.125 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.97 -27.51 64.78 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.873 -1.369 . . . . 0.0 114.647 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -121.47 36.26 4.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.243 1.817 . . . . 0.0 110.786 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.88 135.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.182 2.193 . . . . 0.0 109.956 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 150.58 28.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 109.315 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.36 152.23 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.819 0.819 . . . . 0.0 110.897 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -138.76 122.51 17.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.534 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.98 128.03 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.927 0.891 . . . . 0.0 110.284 -173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.82 113.42 10.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.676 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.34 -38.65 69.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.103 1.361 . . . . 0.0 113.628 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.64 174.3 15.18 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.982 1.313 . . . . 0.0 109.47 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -63.33 -66.57 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.832 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.264 0.6 OUTLIER 50.72 169.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.961 2.504 . . . . 0.0 117.225 -174.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.528 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 pt -152.06 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 126.623 1.969 . . . . 0.0 112.064 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 67.72 36.84 3.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.885 2.074 . . . . 0.0 111.589 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 60' ' ' ILE . 3.9 p -67.95 165.55 31.18 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.712 2.005 . . . . 0.0 110.373 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.86 19.59 0.28 Allowed 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.137 2.558 . . . . 0.0 114.142 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -149.23 60.18 4.5 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.0 112.306 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.99 140.13 49.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.028 1.818 . . . . 0.0 111.992 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.87 -115.45 1.36 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.282 1.42 . . . . 0.0 112.055 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 148.73 41.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.067 1.347 . . . . 0.0 112.265 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.03 137.69 23.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.252 1.821 . . . . 0.0 109.044 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -155.59 167.96 28.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.6 1.16 . . . . 0.0 110.754 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -127.53 108.25 10.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.401 1.48 . . . . 0.0 109.773 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.99 98.62 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.053 1.341 . . . . 0.0 109.607 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 142.94 25.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.421 1.489 . . . . 0.0 113.09 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 147.25 16.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.464 1.506 . . . . 0.0 113.458 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.64 45.18 96.83 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.709 0.671 . . . . 0.0 114.294 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.16 163.97 38.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.307 1.043 . . . . 0.0 112.385 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -137.06 142.61 42.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.33 1.052 . . . . 0.0 109.094 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.4 ' HB3' HD12 ' A' ' 80' ' ' LEU . 27.2 m-80 -131.22 129.45 41.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.243 1.017 . . . . 0.0 108.289 -172.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -129.37 -16.87 3.85 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.36 59.22 1.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.146 1.779 . . . . 0.0 110.391 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.647 ' H ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.94 10.04 11.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.123 2.569 . . . . 0.0 112.258 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -16.79 4.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.977 1.311 . . . . 0.0 112.952 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.6 m -46.32 -30.24 1.99 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.328 1.851 . . . . 0.0 114.639 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.06 -29.95 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 20.91 58.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 129.737 3.215 . . . . 0.0 114.022 -168.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.56 82.29 0.08 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -163.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 tt -126.2 45.68 2.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.284 1.433 . . . . 0.0 112.159 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -67.21 -34.77 78.2 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 119.876 -1.765 . . . . 0.0 113.236 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -117.42 128.42 55.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.628 1.171 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -122.32 123.67 41.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 109.556 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 125.92 54.69 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.31 121.84 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.874 1.27 . . . . 0.0 107.859 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -125.42 150.82 68.82 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.403 1.081 . . . . 0.0 109.893 -172.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.82 168.9 21.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.598 2.199 . . . . 0.0 111.448 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.46 40.07 1.08 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.691 2.091 . . . . 0.0 114.985 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.83 -43.24 0.15 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.483 1.913 . . . . 0.0 111.504 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.6 129.95 34.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.249 1.019 . . . . 0.0 109.48 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -86.85 -36.38 18.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.439 0.696 . . . . 0.0 112.224 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -148.22 156.43 42.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.215 2.206 . . . . 0.0 108.102 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.44 131.47 34.12 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -102.99 133.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 C-N-CA 124.605 1.162 . . . . 0.0 110.754 -175.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.47 135.96 36.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.13 150.98 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.897 -0.502 . . . . 0.0 110.418 167.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -139.18 149.0 43.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.225 1.01 . . . . 0.0 111.229 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.5 mt -109.46 128.75 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.196 1.798 . . . . 0.0 108.308 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.23 111.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.492 1.517 . . . . 0.0 109.232 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -65.98 141.7 58.1 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.737 -0.602 . . . . 0.0 110.574 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.3 23.95 3.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.182 1.393 . . . . 0.0 111.628 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.07 -56.12 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.326 1.85 . . . . 0.0 112.155 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -129.31 108.75 10.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.961 1.304 . . . . 0.0 110.028 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.4 t -71.75 89.69 1.04 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 0.0 111.029 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -149.41 -39.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.8 1.24 . . . . 0.0 111.865 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 54.5 172.99 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.232 1.813 . . . . 0.0 114.432 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.68 -42.29 0.56 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.716 1.627 . . . . 0.0 115.816 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -64.49 -28.6 69.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.572 1.549 . . . . 0.0 113.901 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -88.31 115.18 25.62 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.513 1.125 . . . . 0.0 109.644 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.69 123.22 49.38 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.317 1.447 . . . . 0.0 108.898 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -113.52 130.83 56.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.824 0.849 . . . . 0.0 110.116 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.5 m -123.46 132.58 53.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.506 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.73 127.77 71.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -123.87 88.68 52.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.786 1.634 . . . . 0.0 108.417 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.47 163.98 35.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 111.944 172.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -36.36 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.626 2.37 . . . . 0.0 114.055 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 38.95 46.57 1.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.658 1.583 . . . . 0.0 114.699 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.45 156.34 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.499 1.92 . . . . 0.0 109.589 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -45.14 93.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.609 1.963 . . . . 0.0 113.03 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 155.44 24.13 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.328 1.051 . . . . 0.0 110.663 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.52 146.57 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.382 0.61 . . . . 0.0 110.222 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -122.72 134.27 54.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.781 1.232 . . . . 0.0 108.417 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.5 t -134.7 149.76 50.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 145.13 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -48.26 127.53 12.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.247 1.019 . . . . 0.0 109.617 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.34 48.9 4.62 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.78 167.32 21.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.408 1.483 . . . . 0.0 110.968 169.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -59.49 154.69 16.66 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.585 -0.697 . . . . 0.0 111.056 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -47.87 126.05 9.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 111.253 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 123.6 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.326 0.584 . . . . 0.0 110.017 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -75.79 129.86 37.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 110.365 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.9 tp -119.3 106.4 42.86 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.116 1.766 . . . . 0.0 108.104 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 142.73 39.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.669 2.246 . . . . 0.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.3 mm -134.18 127.08 18.86 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.292 1.037 . . . . 0.0 109.183 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.02 176.62 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.783 2.989 . . . . 0.0 112.777 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -80.24 144.64 32.73 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.522 -0.736 . . . . 0.0 111.434 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.44 48.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.857 1.663 . . . . 0.0 111.447 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -47.62 136.55 9.96 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 125.032 1.333 . . . . 0.0 113.785 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.1 143.72 77.14 Favored 'Cis proline' 0 CA--C 1.543 0.966 0 CA-C-N 119.963 1.023 . . . . 0.0 111.747 -1.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.03 -16.49 45.08 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.479 2.119 . . . . 0.0 113.96 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -3.09 5.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.546 1.139 . . . . 0.0 113.978 168.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 m -66.85 124.16 22.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.969 -1.082 . . . . 0.0 111.267 163.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -64.22 133.0 51.98 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.556 0.743 . . . . 0.0 111.644 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.2 tt -100.38 132.59 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.478 1.511 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.1 p -77.35 142.15 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.798 -0.564 . . . . 0.0 110.677 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.4 m -144.15 159.19 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.315 1.446 . . . . 0.0 110.409 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -123.09 141.15 52.28 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.673 0.789 . . . . 0.0 110.068 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.24 126.93 46.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.91 1.684 . . . . 0.0 108.992 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.28 112.94 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.58 126.66 71.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -131.17 139.55 49.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.066 1.747 . . . . 0.0 108.868 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.52 124.26 23.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -71.31 -15.68 62.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.794 1.237 . . . . 0.0 113.137 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.04 173.36 6.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.718 2.007 . . . . 0.0 111.366 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.6 p -52.75 147.83 14.56 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.814 1.246 . . . . 0.0 113.648 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 7.17 16.26 Favored 'Cis proline' 0 CA--C 1.546 1.092 0 N-CA-C 114.398 0.884 . . . . 0.0 114.398 0.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.04 32.76 10.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.656 1.583 . . . . 0.0 113.648 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 150.19 20.65 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.736 1.214 . . . . 0.0 111.395 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -57.73 108.64 0.59 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.821 0.848 . . . . 0.0 109.548 167.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.8 t -65.48 -56.82 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.079 0.952 . . . . 0.0 109.581 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.72 155.05 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.652 0.781 . . . . 0.0 111.984 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -142.72 77.89 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.268 1.827 . . . . 0.0 110.767 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -115.09 -178.03 18.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.17 1.367 . . . . 0.0 112.954 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.3 m -127.05 148.5 50.12 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 110.188 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.31 160.55 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.055 1.742 . . . . 0.0 109.494 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.73 137.61 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.34 145.6 43.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -140.93 158.0 44.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.859 1.264 . . . . 0.0 109.586 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -127.11 116.45 20.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.011 0.925 . . . . 0.0 110.98 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.5 m -83.33 118.47 71.69 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.92 -1.113 . . . . 0.0 109.282 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.35 -19.6 43.49 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.526 2.151 . . . . 0.0 112.547 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.3 m -45.33 -51.7 10.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.918 2.087 . . . . 0.0 112.469 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 20.8 p -143.26 34.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 0.0 112.407 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.83 42.43 94.59 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.211 -1.555 . . . . 0.0 114.1 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.97 173.91 10.18 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.105 1.362 . . . . 0.0 112.717 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 100' ' ' VAL . 17.3 m -128.62 142.01 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 111.177 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 72.7 m -137.83 108.86 6.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.65 1.18 . . . . 0.0 108.188 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.53 HG13 ' CZ ' ' A' ' 205' ' ' PHE . 2.6 m -83.81 141.25 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.826 0.822 . . . . 0.0 111.21 173.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -120.8 134.76 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.813 2.045 . . . . 0.0 107.337 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -152.58 132.92 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.27 1.428 . . . . 0.0 107.816 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -114.77 152.99 31.15 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.756 1.223 . . . . 0.0 109.664 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.66 -15.58 61.51 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.55 -31.64 13.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.544 1.537 . . . . 0.0 114.38 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.6 p -87.5 -42.28 12.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 0.0 111.326 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.465 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.2 t80 -87.3 148.61 45.08 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.729 2.011 . . . . 0.0 110.759 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 95.4 Cg_endo -76.95 178.2 7.93 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.443 2.095 . . . . 0.0 111.608 173.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.91 44.03 2.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.051 1.74 . . . . 0.0 110.87 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -144.98 -27.61 0.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.94 1.296 . . . . 0.0 113.529 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.6 ttm -137.71 139.89 40.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.22 2.208 . . . . 0.0 107.673 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.8 p -134.79 155.8 49.97 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.76 140.8 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.233 1.013 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 8.8 t -140.16 163.02 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.041 1.337 . . . . 0.0 110.49 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 118.71 26.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.218 1.407 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.8 8.29 5.28 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 112.717 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.94 16.92 2.84 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.819 1.248 . . . . 0.0 113.333 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.47 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.047 2.539 . . . . 0.0 114.368 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.7 m 80.89 21.29 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.43 1.092 . . . . 0.0 111.676 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -136.74 128.63 29.22 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.788 1.635 . . . . 0.0 111.37 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 49.1 m-85 -118.99 133.6 55.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.805 1.642 . . . . 0.0 111.335 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.65 106.25 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.642 0.777 . . . . 0.0 109.268 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -84.84 126.35 33.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.074 1.35 . . . . 0.0 110.951 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -117.91 121.32 40.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.364 1.466 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.86 98.82 11.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.816 1.246 . . . . 0.0 109.601 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -80.42 -30.1 37.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 113.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -144.96 134.88 23.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 109.353 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.1 -50.83 72.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.258 0.935 . . . . 0.0 111.783 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 125.156 1.382 . . . . 0.0 111.416 -169.514 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.16 143.29 57.96 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.807 -0.558 . . . . 0.0 109.536 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.43 -19.1 5.02 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -116.28 17.83 15.48 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.246 2.219 . . . . 0.0 113.647 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -135.34 171.63 14.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.689 1.596 . . . . 0.0 111.051 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 150.47 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.594 1.158 . . . . 0.0 108.806 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 149.77 34.47 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 112.938 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.93 130.83 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.333 1.453 . . . . 0.0 109.495 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.98 125.91 42.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.589 1.155 . . . . 0.0 110.199 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.98 55.04 3.31 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.236 1.017 . . . . 0.0 112.046 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.95 148.27 7.58 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.979 1.276 . . . . 0.0 111.039 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -59.53 133.21 55.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.431 1.092 . . . . 0.0 111.279 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 71.52 41.97 0.7 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.202 1.801 . . . . 0.0 114.021 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m 53.08 61.91 2.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.519 1.528 . . . . 0.0 113.592 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.0 p -130.56 178.48 6.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.131 1.372 . . . . 0.0 112.188 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.34 -85.26 1.04 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.343 1.449 . . . . 0.0 113.752 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.22 170.52 14.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.364 1.466 . . . . 0.0 110.777 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -139.53 148.54 42.75 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 111.304 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.75 147.56 26.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.582 1.553 . . . . 0.0 110.487 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -125.06 132.59 53.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.462 1.105 . . . . 0.0 110.399 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -129.76 133.44 47.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.908 1.337 . . . . 0.0 111.454 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.62 138.57 43.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.946 1.298 . . . . 0.0 111.473 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 148.43 51.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.278 1.031 . . . . 0.0 111.42 168.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.32 41.29 68.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.43 1.014 . . . . 0.0 112.553 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -144.14 160.76 40.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.076 1.35 . . . . 0.0 112.248 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 m -121.56 131.7 54.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.288 1.435 . . . . 0.0 108.25 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.54 141.13 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.918 0.887 . . . . 0.0 108.727 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -126.77 151.37 48.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.436 1.095 . . . . 0.0 110.982 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 125.661 1.584 . . . . 0.0 109.72 178.478 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -63.98 -24.74 67.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -70.19 0.11 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.713 168.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.303 0.3 OUTLIER 27.75 48.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 128.164 2.586 . . . . 0.0 115.761 -175.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.02 133.78 46.06 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.986 2.114 . . . . 0.0 109.337 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mmt -153.78 -45.24 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.487 1.915 . . . . 0.0 111.324 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 t -136.07 130.24 33.13 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.415 1.086 . . . . 0.0 109.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 89.6 m -140.96 145.4 35.97 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.54 121.72 36.36 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.325 1.05 . . . . 0.0 108.606 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.4 t -105.49 143.08 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.454 1.902 . . . . 0.0 106.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.92 -97.09 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.324 1.916 . . . . 0.0 117.301 -172.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 4.2 t -161.57 -42.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.634 1.173 . . . . 0.0 111.504 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.88 33.88 4.95 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.261 1.425 . . . . 0.0 110.617 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -146.69 157.12 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.524 2.33 . . . . 0.0 109.798 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -136.75 154.52 50.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.428 1.891 . . . . 0.0 110.132 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.7 t -123.55 143.26 50.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.683 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -134.04 139.09 45.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 109.405 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.1 119.75 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.009 1.324 . . . . 0.0 107.989 -167.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.72 135.51 50.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.962 0.905 . . . . 0.0 109.817 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.02 -60.7 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.246 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.5 -178.73 7.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.553 0.741 . . . . 0.0 111.957 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -65.95 129.97 41.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.923 0.889 . . . . 0.0 113.074 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -178.14 6.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.175 1.79 . . . . 0.0 110.088 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.74 44.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.227 1.411 . . . . 0.0 113.104 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 57.68 48.53 13.89 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.16 1.457 . . . . 0.0 111.855 -171.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 8.3 p -64.31 167.36 8.51 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.804 1.642 . . . . 0.0 110.791 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 53.2 Cg_endo -72.9 11.08 0.93 Allowed 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.954 2.436 . . . . 0.0 113.967 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -147.28 57.85 3.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.768 1.627 . . . . 0.0 111.973 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.86 154.06 73.95 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.408 1.405 . . . . 0.0 110.659 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.45 -105.52 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -142.85 150.91 40.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.773 1.629 . . . . 0.0 110.217 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -151.39 140.03 20.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.222 1.409 . . . . 0.0 109.254 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.33 156.73 26.75 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 110.341 172.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.13 97.95 5.66 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.851 0.861 . . . . 0.0 109.799 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.14 124.36 14.24 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.525 1.13 . . . . 0.0 109.677 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.92 163.37 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.563 1.145 . . . . 0.0 113.024 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 165.51 1.19 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.866 171.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 48' ' ' SER . . . -21.22 108.4 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.883 2.183 . . . . 0.0 118.296 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 p -167.1 177.35 6.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.375 1.07 . . . . 0.0 112.906 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 m -107.89 97.69 7.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.499 1.919 . . . . 0.0 109.45 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.877 0.871 . . . . 0.0 109.836 171.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -128.83 12.52 6.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.03 1.332 . . . . 0.0 112.493 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -153.21 38.26 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.699 -1.25 . . . . 0.0 113.106 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.9 -1.91 57.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.701 1.2 . . . . 0.0 114.036 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -12.62 1.95 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.042 1.737 . . . . 0.0 114.394 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -46.57 -32.0 3.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.022 1.329 . . . . 0.0 113.883 165.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.3 tp -70.34 -35.5 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.258 7.3 m-20 30.73 46.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.336 2.655 . . . . 0.0 115.411 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.04 107.95 0.24 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.94 0.781 . . . . 0.0 112.649 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.3 85.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.113 0.958 . . . . 0.0 113.111 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -75.59 -6.57 51.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.744 -1.223 . . . . 0.0 113.171 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -129.95 137.6 50.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.738 2.415 . . . . 0.0 111.048 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.86 128.48 38.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.114 1.366 . . . . 0.0 109.183 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.96 119.41 25.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.952 0.901 . . . . 0.0 108.825 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.39 118.17 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.92 150.28 71.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.102 0.961 . . . . 0.0 110.205 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.5 -173.49 0.99 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.674 2.249 . . . . 0.0 112.64 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.67 -26.64 24.34 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.146 1.355 . . . . 0.0 113.498 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -43.44 87.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.014 0.907 . . . . 0.0 112.287 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.55 126.07 37.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.868 1.267 . . . . 0.0 109.062 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.89 -47.39 11.11 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.307 -0.87 . . . . 0.0 110.853 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -143.06 160.0 41.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.561 1.944 . . . . 0.0 108.794 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.21 152.17 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.548 0.739 . . . . 0.0 109.817 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.4 139.7 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.781 0.832 . . . . 0.0 111.003 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.41 139.18 38.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.79 143.47 40.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 125.737 1.615 . . . . 0.0 109.725 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -148.39 133.05 17.82 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.83 1.252 . . . . 0.0 109.688 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.04 137.01 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.332 1.053 . . . . 0.0 108.432 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -140.49 95.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.92 2.088 . . . . 0.0 108.823 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -71.92 122.7 21.27 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.891 -1.131 . . . . 0.0 111.256 173.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 12.72 31.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.574 1.55 . . . . 0.0 112.891 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -127.21 -66.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.606 1.562 . . . . 0.0 110.865 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.47 128.12 37.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.757 0.823 . . . . 0.0 110.524 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -102.4 53.91 0.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.339 1.066 . . . . 0.0 110.947 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -140.32 63.54 1.47 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 123.579 1.657 . . . . 0.0 110.61 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.67 143.84 19.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 113.537 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.34 9.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.394 1.473 . . . . 0.0 114.397 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -87.19 -35.57 18.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.478 1.139 . . . . 0.0 113.707 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.41 126.47 29.71 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.071 0.948 . . . . 0.0 109.891 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -128.75 125.68 38.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.4 1.48 . . . . 0.0 108.957 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.2 ttp -114.27 134.96 54.57 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.294 1.437 . . . . 0.0 109.38 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -122.42 135.33 54.66 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.443 1.497 . . . . 0.0 108.058 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.5 pt -131.17 137.19 56.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.943 0.897 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 m -137.84 94.64 11.4 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 0.0 109.504 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.14 165.43 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.957 2.438 . . . . 0.0 111.455 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -26.17 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.907 3.283 . . . . 0.0 115.689 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 42.22 45.78 3.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.407 1.483 . . . . 0.0 114.324 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.2 t -111.19 159.82 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.055 2.142 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.55 94.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.997 2.519 . . . . 0.0 112.937 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 143.63 56.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 110.728 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.01 145.28 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.926 0.89 . . . . 0.0 110.293 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -130.29 138.01 50.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.46 1.504 . . . . 0.0 109.245 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.12 160.78 40.33 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.84 1.256 . . . . 0.0 110.423 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -120.32 154.45 34.99 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.963 0.905 . . . . 0.0 109.79 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.62 143.96 39.33 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.167 -0.333 . . . . 0.0 110.935 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.94 47.96 43.63 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.702 0.667 . . . . 0.0 114.61 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.36 162.16 24.41 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.453 1.501 . . . . 0.0 110.996 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 153.02 6.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.006 0.922 . . . . 0.0 111.941 169.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.26 118.49 3.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.307 1.043 . . . . 0.0 111.754 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.3 t -92.78 141.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 108.881 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -104.28 135.98 44.73 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.956 0.798 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tp -115.95 101.7 53.99 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.782 2.033 . . . . 0.0 108.155 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.58 147.55 40.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.562 2.175 . . . . 0.0 112.336 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -137.41 132.85 17.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.009 1.324 . . . . 0.0 109.33 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.52 174.73 11.71 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.377 3.385 . . . . 0.0 112.646 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -64.27 147.11 53.19 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.59 -0.694 . . . . 0.0 112.337 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 pp -153.97 158.84 41.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.83 2.052 . . . . 0.0 110.186 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -147.97 139.95 14.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 111.998 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.83 155.75 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 CA-C-N 119.662 0.915 . . . . 0.0 112.377 -9.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.25 -39.64 37.09 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.901 1.734 . . . . 0.0 111.761 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -72.08 8.28 1.34 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.122 1.769 . . . . 0.0 113.631 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -78.0 -178.05 5.33 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.42 -1.425 . . . . 0.0 111.554 166.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 160.39 21.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.279 1.432 . . . . 0.0 112.368 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 16.0 tt -122.56 133.11 69.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.722 1.609 . . . . 0.0 109.827 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.06 131.9 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.936 0.894 . . . . 0.0 110.666 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.2 m -146.39 166.45 26.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.136 0.97 . . . . 0.0 111.335 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -134.01 147.36 50.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.853 0.861 . . . . 0.0 111.023 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.6 tt -130.1 130.44 44.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.055 1.742 . . . . 0.0 109.164 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.51 117.33 9.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.745 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 167' ' ' VAL . 1.4 p -122.32 132.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.847 1.259 . . . . 0.0 108.753 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.24 144.92 27.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 110.195 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -77.79 126.12 30.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -68.1 -28.65 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.246 1.018 . . . . 0.0 113.346 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.53 174.08 6.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.695 1.598 . . . . 0.0 111.923 172.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 p -52.18 147.5 13.21 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.36 1.464 . . . . 0.0 113.517 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.2 12.13 19.74 Favored 'Cis proline' 0 CA--C 1.545 1.047 0 N-CA-C 114.714 1.006 . . . . 0.0 114.714 3.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.76 24.46 9.9 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.343 1.457 . . . . 0.0 113.082 170.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -88.81 135.53 33.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.897 -1.127 . . . . 0.0 111.276 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -57.64 111.1 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.732 0.813 . . . . 0.0 109.996 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.71 -57.99 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.351 1.06 . . . . 0.0 109.028 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.425 HG22 ' CG1' ' A' ' 156' ' ' VAL . 33.5 m -147.4 153.55 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.733 0.777 . . . . 0.0 111.978 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -145.75 105.92 4.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.043 1.737 . . . . 0.0 108.72 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.12 157.33 28.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 121.837 0.687 . . . . 0.0 113.003 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.2 m -74.15 150.44 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.173 0.987 . . . . 0.0 111.196 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.35 161.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.951 2.1 . . . . 0.0 108.526 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.86 132.22 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.485 0.659 . . . . 0.0 109.656 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.03 152.83 23.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -145.19 151.44 38.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.732 2.013 . . . . 0.0 108.121 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -115.39 132.95 56.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.423 1.089 . . . . 0.0 108.931 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.8 t -93.38 103.49 9.79 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.09 -17.43 45.69 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.734 2.289 . . . . 0.0 112.828 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.4 m -53.08 -42.9 66.31 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.994 2.118 . . . . 0.0 112.958 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 48.2 p -144.16 18.33 1.75 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.35 1.46 . . . . 0.0 112.483 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.46 73.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.761 1.648 . . . . 0.0 114.622 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.678 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 4.0 tt0 -73.33 -170.27 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.079 1.419 . . . . 0.0 111.585 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.678 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 1.4 p -135.41 155.18 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 128.041 2.537 . . . . 0.0 107.749 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.0 m -140.31 150.76 44.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.208 1.803 . . . . 0.0 107.996 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 205' ' ' PHE . 6.8 p -121.5 140.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 22.9 mt -123.6 129.95 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.51 140.39 33.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 108.896 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.82 34.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.509 1.123 . . . . 0.0 109.707 -168.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -28.58 67.0 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.46 -30.52 47.45 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.311 1.844 . . . . 0.0 115.039 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 p -101.21 -53.54 3.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.531 1.132 . . . . 0.0 111.632 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.525 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 17.6 t80 -85.65 148.74 49.68 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.537 1.935 . . . . 0.0 110.913 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 72.5 Cg_endo -77.1 -175.05 2.45 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.692 2.928 . . . . 0.0 111.577 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.25 30.17 6.68 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.01 1.724 . . . . 0.0 111.967 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -132.15 -38.86 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.862 1.665 . . . . 0.0 113.187 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 30.0 ttm -112.77 145.45 40.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.434 1.893 . . . . 0.0 106.804 167.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -140.43 150.05 43.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.949 0.899 . . . . 0.0 110.579 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.16 142.44 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.521 -0.737 . . . . 0.0 111.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 12.2 t -139.95 156.13 46.81 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.611 1.164 . . . . 0.0 111.232 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.64 81.79 0.84 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 111.349 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -60.59 -31.21 70.37 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.854 -1.154 . . . . 0.0 112.627 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.46 173.91 11.39 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.639 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.37 118.76 7.91 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.76 174.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.251 30.0 m 63.08 28.85 16.24 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 112.593 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 t -137.38 125.08 22.35 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.096 -1.003 . . . . 0.0 112.389 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 184' ' ' VAL . 12.3 m-85 -109.08 134.75 51.28 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 112.317 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.87 107.32 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.76 1.224 . . . . 0.0 109.72 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.91 108.43 17.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.855 1.262 . . . . 0.0 109.916 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -92.77 136.3 33.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.302 1.441 . . . . 0.0 110.185 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.56 119.96 40.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.631 0.773 . . . . 0.0 110.258 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -107.87 -6.21 16.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.899 1.68 . . . . 0.0 113.701 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -121.64 -169.91 1.95 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.767 2.027 . . . . 0.0 111.628 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -154.05 26.59 0.48 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 126.078 1.751 . . . . 0.0 113.75 -177.386 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 4' ' ' ASP 0.291 8.4 p . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 3' ' ' VAL . 4.0 t70 -75.15 147.97 40.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 119.834 -1.791 . . . . 0.0 109.916 169.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.12 -18.52 10.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.09 14.96 17.16 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.313 2.245 . . . . 0.0 113.87 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -138.74 177.79 7.63 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.107 1.321 . . . . 0.0 111.175 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.21 156.55 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.015 1.326 . . . . 0.0 111.318 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.442 ' HD2' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.32 145.44 33.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.661 1.185 . . . . 0.0 110.927 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 137.09 36.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.427 1.491 . . . . 0.0 108.421 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -132.34 124.57 29.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.515 1.126 . . . . 0.0 110.521 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -80.21 60.09 3.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.133 1.373 . . . . 0.0 111.441 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.9 131.11 1.44 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 141.23 15.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.362 1.065 . . . . 0.0 111.116 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.39 42.45 14.68 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.22 59.62 2.64 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.63 1.972 . . . . 0.0 113.302 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.8 m -133.9 -179.35 5.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.334 1.454 . . . . 0.0 111.206 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 17' ' ' THR . . . 69.22 -105.63 1.55 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.586 1.565 . . . . 0.0 113.379 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -113.53 164.54 13.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.156 0.982 . . . . 0.0 111.634 174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -130.38 145.29 51.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.551 1.14 . . . . 0.0 111.938 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 160.24 43.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.897 1.679 . . . . 0.0 110.673 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -127.99 154.99 44.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.24 1.016 . . . . 0.0 110.722 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.44 136.96 45.51 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.661 1.184 . . . . 0.0 110.935 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -92.1 147.82 22.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.53 1.132 . . . . 0.0 110.278 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.06 139.44 58.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.174 0.59 . . . . 0.0 111.64 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.69 28.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.98 0.8 . . . . 0.0 112.764 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.34 122.24 22.36 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.328 1.051 . . . . 0.0 110.763 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 m -107.37 130.28 54.81 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.978 1.311 . . . . 0.0 108.595 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' A' ' 89' ' ' PHE . 2.3 m -133.72 132.66 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.348 1.459 . . . . 0.0 109.776 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -122.79 140.05 53.33 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.801 1.241 . . . . 0.0 109.707 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.4 0 C-N-CA 124.878 1.271 . . . . 0.0 108.952 -173.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.3 m0 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 121.155 0.502 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -39.12 64.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.142 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -55.82 -62.66 1.55 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.174 0.989 . . . . 0.0 109.211 176.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.21 31.86 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.198 1.799 . . . . 0.0 113.582 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.66 128.0 40.05 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.111 2.164 . . . . 0.0 107.813 -172.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 mtp -138.45 -50.16 0.55 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 111.823 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.4 p -133.54 122.98 24.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.543 0.687 . . . . 0.0 110.697 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.6 m -144.81 154.53 42.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -138.67 149.73 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.236 1.017 . . . . 0.0 111.166 -173.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 8' ' ' VAL . 21.3 t -122.8 136.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.64 1.576 . . . . 0.0 109.019 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -87.28 0.03 OUTLIER Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.675 1.131 . . . . 0.0 114.959 -167.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.0 p -173.01 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -127.12 33.16 4.95 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.317 1.447 . . . . 0.0 111.186 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 46' ' ' VAL . 3.0 m -141.61 146.09 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.518 1.927 . . . . 0.0 108.753 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -114.29 143.75 44.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.638 1.175 . . . . 0.0 108.553 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.67 131.97 54.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 109.439 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.37 123.77 47.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.987 1.315 . . . . 0.0 108.244 -170.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.05 119.86 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 122.122 0.963 . . . . 0.0 111.822 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -132.38 118.19 19.06 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 109.976 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.52 -54.92 15.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.53 1.132 . . . . 0.0 111.356 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -130.3 122.29 27.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -164.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.02 31.54 0.44 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.9 1.28 . . . . 0.0 112.431 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.46 165.07 5.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.144 2.578 . . . . 0.0 114.335 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 mm -112.76 39.43 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.29 52.2 m-20 57.15 50.31 12.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.617 1.967 . . . . 0.0 112.837 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.9 p -73.67 176.34 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.865 2.466 . . . . 0.0 110.893 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 65.7 Cg_endo -73.16 3.95 4.18 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.9 2.4 . . . . 0.0 113.796 173.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -136.32 64.32 52.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.93 1.692 . . . . 0.0 110.502 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.89 138.33 57.18 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.302 1.335 . . . . 0.0 109.326 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.62 -121.91 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.873 0.749 . . . . 0.0 111.663 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -134.33 140.16 46.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.508 1.123 . . . . 0.0 111.052 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.72 139.76 24.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.702 1.201 . . . . 0.0 109.868 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -157.25 165.77 34.98 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.559 1.171 . . . . 0.0 111.263 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -132.7 104.46 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.307 1.443 . . . . 0.0 107.5 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 46' ' ' VAL . 6.7 mp -64.75 116.05 5.89 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.71 160.94 0.39 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.832 2.053 . . . . 0.0 114.227 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -47.28 -34.17 6.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.16 135.24 3.63 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 164.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.54 167.86 0.65 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.789 2.036 . . . . 0.0 110.824 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -123.31 105.48 9.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.802 1.241 . . . . 0.0 110.098 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -83.82 100.88 11.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -70.49 -20.69 62.84 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.6 73.85 0.98 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.96 2.43 12.63 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.69 -1.257 . . . . 0.0 114.023 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -53.0 -10.78 0.19 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.96 2.104 . . . . 0.0 115.298 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.2 m -48.95 -32.08 8.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.057 1.299 . . . . 0.0 113.994 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -87.56 -32.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.84 30.02 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.545 2.738 . . . . 0.0 115.95 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.84 109.75 0.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -160.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 178.31 55.09 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.416 2.286 . . . . 0.0 110.027 -170.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -57.99 -22.17 48.22 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 134.45 53.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.856 1.263 . . . . 0.0 110.648 173.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -138.07 135.59 35.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.555 1.542 . . . . 0.0 109.815 -174.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -141.88 142.63 33.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.717 0.77 . . . . 0.0 112.088 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.87 123.08 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.605 . . . . 0.0 109.238 -170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 96' ' ' PHE . 93.1 mt -141.03 157.64 66.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.978 0.911 . . . . 0.0 111.236 -168.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.57 160.7 43.71 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.895 2.397 . . . . 0.0 113.315 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.88 -17.08 69.07 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 121.24 -0.913 . . . . 0.0 115.022 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.09 70.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -72.84 163.71 27.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.947 1.299 . . . . 0.0 111.477 173.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -35.62 0.99 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.152 1.381 . . . . 0.0 111.54 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -154.39 160.99 41.97 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.298 1.839 . . . . 0.0 109.666 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.42 160.98 39.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.522 0.729 . . . . 0.0 110.197 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.0 145.45 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.315 1.046 . . . . 0.0 110.516 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.11 127.78 45.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.05 1.34 . . . . 0.0 108.287 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -128.58 135.38 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.818 -0.551 . . . . 0.0 110.295 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -123.81 143.35 50.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.443 1.497 . . . . 0.0 109.539 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.3 mt -111.85 131.08 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.64 103.3 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 122.564 1.173 . . . . 0.0 110.962 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.1 134.33 49.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.409 1.884 . . . . 0.0 110.751 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 -21.95 8.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.429 1.092 . . . . 0.0 113.571 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.59 -55.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 119.085 0.857 . . . . 0.0 111.026 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.04 93.4 4.48 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 109.026 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -73.42 48.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.593 1.557 . . . . 0.0 112.553 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -143.16 51.7 1.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.229 2.612 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.58 129.03 31.34 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.717 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.8 -31.83 3.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.119 1.819 . . . . 0.0 112.25 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 m -79.53 -18.0 52.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 114.066 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.66 137.35 38.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.16 1.384 . . . . 0.0 108.622 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.9 121.15 34.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.849 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 4.8 ttp -113.4 132.95 55.43 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.458 1.103 . . . . 0.0 110.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.7 m -122.1 132.42 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.383 1.473 . . . . 0.0 108.343 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.2 122.72 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.0 m -120.54 86.46 39.69 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 125.797 1.639 . . . . 0.0 109.16 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.39 157.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.609 2.872 . . . . 0.0 112.693 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -39.53 86.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.659 2.784 . . . . 0.0 114.576 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 38.87 42.53 0.65 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.02 159.4 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.755 2.022 . . . . 0.0 109.434 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.61 92.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.201 2.2 . . . . 0.0 113.047 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 149.5 49.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.61 0.764 . . . . 0.0 110.917 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.06 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.225 1.01 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.51 136.36 50.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.1 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 17.9 p -137.57 137.63 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.045 1.338 . . . . 0.0 108.606 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.54 142.13 33.14 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 166.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.59 151.37 6.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 111.043 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.01 42.85 10.38 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 120.846 -1.159 . . . . 0.0 113.155 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.01 161.64 29.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.167 1.787 . . . . 0.0 108.927 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 151.58 14.91 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.462 -0.774 . . . . 0.0 110.619 166.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -38.43 115.2 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.649 1.58 . . . . 0.0 111.784 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.02 130.64 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -81.28 123.62 28.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.417 0.687 . . . . 0.0 109.46 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.53 96.06 49.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.067 1.747 . . . . 0.0 108.534 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 146.81 41.55 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.212 1.941 . . . . 0.0 111.287 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.38 132.08 24.14 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.926 2.091 . . . . 0.0 107.633 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.93 175.83 9.87 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.144 2.562 . . . . 0.0 113.195 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -57.72 155.96 9.31 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.376 0.671 . . . . 0.0 112.534 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 pp -170.86 156.96 5.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.613 1.965 . . . . 0.0 109.86 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.8 t -137.24 138.41 25.17 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.966 0.906 . . . . 0.0 111.565 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 157.28 72.12 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 119.527 0.867 . . . . 0.0 111.97 -7.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.02 -36.39 48.97 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.577 1.518 . . . . 0.0 112.09 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -74.18 7.52 2.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.3 p -65.71 174.97 2.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.904 -1.123 . . . . 0.0 112.804 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.42 132.4 56.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.843 1.257 . . . . 0.0 110.952 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.27 116.18 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.788 1.635 . . . . 0.0 108.4 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.5 133.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 122.97 0.508 . . . . 0.0 109.949 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.1 p -131.32 160.46 34.92 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.794 1.237 . . . . 0.0 110.397 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -114.4 137.18 52.15 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.212 0.605 . . . . 0.0 109.543 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.81 138.65 49.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.955 1.702 . . . . 0.0 107.931 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.46 111.54 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.573 1.549 . . . . 0.0 108.186 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 4.7 p -120.52 130.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.963 1.305 . . . . 0.0 109.461 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -144.24 141.65 29.99 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.265 1.826 . . . . 0.0 109.349 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 137.98 52.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.493 0.317 . . . . 0.0 111.339 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -77.19 -5.26 48.53 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.613 1.165 . . . . 0.0 113.843 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 179.75 5.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.766 2.426 . . . . 0.0 110.686 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.15 150.13 22.44 Favored Pre-proline 0 N--CA 1.481 1.081 0 O-C-N 121.017 -1.052 . . . . 0.0 113.193 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.13 7.22 22.77 Favored 'Cis proline' 0 CA--C 1.545 1.029 0 CA-C-N 119.847 0.981 . . . . 0.0 114.513 -0.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.36 35.18 24.64 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 113.626 171.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -102.05 156.33 17.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 111.302 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -64.86 86.88 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.9 -1.125 . . . . 0.0 111.696 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.5 -54.38 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.763 2.025 . . . . 0.0 110.848 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 96.4 t -146.71 127.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.161 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -144.94 136.37 25.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 109.927 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.86 178.77 41.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.674 0.654 . . . . 0.0 112.255 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.2 m -109.77 149.62 29.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.005 0.907 . . . . 0.0 111.798 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.95 147.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.149 2.18 . . . . 0.0 108.215 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.36 132.54 54.34 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.405 -0.809 . . . . 0.0 109.491 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -107.73 141.23 39.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.557 1.143 . . . . 0.0 109.517 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -136.18 143.39 44.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.714 1.605 . . . . 0.0 109.573 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -115.09 115.31 26.58 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.826 0.851 . . . . 0.0 110.413 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.9 m -76.49 107.8 5.27 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.422 1.089 . . . . 0.0 109.525 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.75 -14.37 32.91 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.629 2.219 . . . . 0.0 112.908 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.2 m -53.35 -44.8 68.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 113.348 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.3 p -142.32 22.92 2.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.097 1.359 . . . . 0.0 113.016 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 53.1 39.03 57.12 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.974 1.75 . . . . 0.0 114.571 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -80.02 166.25 21.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.518 0.727 . . . . 0.0 110.815 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.76 148.83 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.4 m -129.58 145.31 51.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.055 2.142 . . . . 0.0 108.527 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.26 128.28 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.176 1.39 . . . . 0.0 109.746 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.56 120.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.733 1.613 . . . . 0.0 106.921 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.18 140.56 37.85 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.774 1.63 . . . . 0.0 107.846 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -136.67 130.54 32.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.76 -16.54 17.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.7 -14.98 63.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.536 2.335 . . . . 0.0 114.411 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.7 t -142.27 -36.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.75 1.62 . . . . 0.0 113.254 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -82.29 138.3 45.29 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.564 1.546 . . . . 0.0 110.054 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.43 178.87 6.48 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.719 2.946 . . . . 0.0 112.467 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -116.65 29.39 7.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.936 1.694 . . . . 0.0 111.842 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -114.01 -36.11 4.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.867 1.267 . . . . 0.0 112.204 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.6 ttt -121.36 142.9 49.54 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.761 2.024 . . . . 0.0 108.096 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 p -137.64 131.51 31.63 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.897 0.856 . . . . 0.0 110.909 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.77 137.17 40.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.905 0.882 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.7 t -127.89 160.06 33.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 111.268 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.79 84.29 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 111.1 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.33 -39.97 94.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.27 1.028 . . . . 0.0 112.257 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -146.0 -174.81 4.53 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.249 2.219 . . . . 0.0 111.613 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.512 HD22 HG23 ' A' ' 203' ' ' THR . 4.7 t30 -43.34 -53.27 5.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.041 2.136 . . . . 0.0 113.352 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.512 HG23 HD22 ' A' ' 202' ' ' ASN . 73.5 p -133.59 29.71 3.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.449 1.1 . . . . 0.0 112.199 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -129.83 130.09 44.85 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.581 1.152 . . . . 0.0 109.719 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -129.41 151.09 50.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.175 1.39 . . . . 0.0 110.092 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.3 tt -132.09 109.88 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.859 0.837 . . . . 0.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -83.26 101.45 11.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.08 2.152 . . . . 0.0 110.168 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -83.8 126.08 32.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.655 1.582 . . . . 0.0 109.828 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 tp -126.78 109.09 11.65 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.358 0.981 . . . . 0.0 110.925 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.39 19.81 7.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.913 1.685 . . . . 0.0 113.206 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.0 m -150.92 111.36 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.85 1.66 . . . . 0.0 111.588 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.1 -40.48 93.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.927 1.291 . . . . 0.0 113.142 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 127.337 2.255 . . . . 0.0 113.181 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 121.195 0.521 . . . . 0.0 111.484 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.6 139.38 56.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.071 0.548 . . . . 0.0 109.672 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -12.33 21.68 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.545 -1.347 . . . . 0.0 113.274 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.29 9.74 17.03 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.468 1.907 . . . . 0.0 113.353 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.61 176.66 9.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.717 1.607 . . . . 0.0 110.176 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.455 HG11 ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -134.12 128.28 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.251 1.021 . . . . 0.0 109.256 -177.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 150.4 20.39 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.819 -0.55 . . . . 0.0 110.142 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.24 127.95 16.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.988 1.315 . . . . 0.0 109.275 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -129.48 135.0 48.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.257 1.423 . . . . 0.0 110.223 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -78.34 44.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.828 2.051 . . . . 0.0 112.547 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.73 150.54 8.89 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 120.805 -1.184 . . . . 0.0 112.173 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.71 146.21 37.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.992 0.917 . . . . 0.0 111.917 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 51.42 40.92 27.74 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.9 m 59.15 64.33 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.639 1.575 . . . . 0.0 113.421 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.0 p -130.88 177.37 7.48 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.821 1.248 . . . . 0.0 111.981 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.74 -87.49 0.74 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.219 1.39 . . . . 0.0 113.59 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -135.98 165.64 25.2 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.584 1.553 . . . . 0.0 110.699 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.8 p -127.81 145.68 50.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.513 1.125 . . . . 0.0 112.032 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.31 162.48 40.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.275 1.83 . . . . 0.0 110.703 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -136.91 141.08 42.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.118 1.367 . . . . 0.0 109.193 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -120.68 138.51 53.91 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.093 1.757 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -76.79 143.07 40.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.065 1.746 . . . . 0.0 111.49 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG3' HG12 ' A' ' 50' ' ' VAL . 12.0 ttmt -64.68 145.75 55.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.14 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.95 49.7 15.9 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.111 0.386 . . . . 0.0 112.64 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.45 159.37 43.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.59 1.156 . . . . 0.0 111.221 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -140.48 118.89 12.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.022 1.329 . . . . 0.0 109.432 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 m -127.12 147.38 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.125 0.97 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -136.36 134.93 38.37 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.579 1.152 . . . . 0.0 109.441 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.401 0 C-N-CA 124.8 1.24 . . . . 0.0 108.967 -173.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.7 m0 . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -80.25 -43.68 20.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.438 1.495 . . . . 0.0 111.349 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -77.37 52.3 0.93 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.442 1.497 . . . . 0.0 112.351 166.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.72 4.44 49.61 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.288 -1.508 . . . . 0.0 114.858 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 13.0 m-85 -78.16 137.22 38.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.117 0.967 . . . . 0.0 111.754 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.48 -62.09 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.511 1.924 . . . . 0.0 111.463 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -122.39 124.57 43.98 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.906 0.882 . . . . 0.0 109.582 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.45 156.06 44.54 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.252 1.025 . . . . 0.0 110.584 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.53 127.69 49.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.274 1.03 . . . . 0.0 108.418 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.6 t -106.53 107.79 23.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.46 1.504 . . . . 0.0 109.352 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.21 162.2 3.82 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 122.568 1.094 . . . . 0.0 113.703 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -13.88 61.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.3 34.23 4.22 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.396 1.478 . . . . 0.0 111.735 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 25' ' ' LYS . 32.9 m -149.85 157.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.174 2.59 . . . . 0.0 110.296 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.5 149.22 46.62 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 110.285 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.455 ' SG ' HG11 ' A' ' 8' ' ' VAL . 3.5 m -116.09 133.97 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.521 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -122.4 117.02 25.03 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.469 1.107 . . . . 0.0 109.116 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.536 HG23 HD13 ' A' ' 86' ' ' LEU . 81.1 mt -111.37 114.35 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.351 1.461 . . . . 0.0 108.984 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.29 124.81 39.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.526 1.13 . . . . 0.0 108.025 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.7 -58.38 7.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.668 0.747 . . . . 0.0 111.615 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.89 179.92 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.971 0.909 . . . . 0.0 109.812 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -67.2 71.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.826 0.85 . . . . 0.0 111.174 164.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.19 -37.29 74.46 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.666 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.1 pt 42.28 30.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 71.45 22.58 4.15 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.707 2.003 . . . . 0.0 113.429 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 t -61.86 144.21 93.71 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.314 1.845 . . . . 0.0 111.221 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 34.99 0.33 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 124.531 3.488 . . . . 0.0 113.852 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -156.35 50.58 0.47 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.931 2.092 . . . . 0.0 111.939 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.71 135.49 38.75 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.46 1.44 . . . . 0.0 109.656 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.96 -92.62 0.49 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -142.82 159.85 41.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.637 1.575 . . . . 0.0 111.149 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -148.76 140.84 23.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.798 1.639 . . . . 0.0 109.514 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -153.5 147.59 25.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.144 0.974 . . . . 0.0 111.22 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -118.66 102.95 9.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.404 1.482 . . . . 0.0 109.047 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.39 96.47 1.89 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.352 1.061 . . . . 0.0 109.418 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.42 145.19 8.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.808 1.643 . . . . 0.0 113.234 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.51 147.26 18.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.55 1.54 . . . . 0.0 112.635 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.45 51.33 59.74 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.67 0.652 . . . . 0.0 114.104 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -149.94 170.73 18.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.531 1.132 . . . . 0.0 112.402 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.3 m -139.89 142.96 36.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.674 1.19 . . . . 0.0 109.876 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -132.89 106.87 7.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.527 1.131 . . . . 0.0 109.659 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.79 -28.82 22.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.062 1.345 . . . . 0.0 112.52 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.31 62.0 1.1 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.569 1.947 . . . . 0.0 110.75 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.55 14.04 0.86 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.73 -9.92 0.25 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.87 1.668 . . . . 0.0 115.203 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -45.5 -26.1 0.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.258 1.423 . . . . 0.0 114.606 158.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.273 2.7 tt -109.06 45.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.198 1.399 . . . . 0.0 112.724 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -49.55 -22.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.719 1.208 . . . . 0.0 113.729 165.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.24 84.57 1.55 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.975 0.797 . . . . 0.0 112.537 159.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 54' ' ' ILE . 11.6 tp -125.33 141.92 51.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.141 1.376 . . . . 0.0 110.37 164.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -145.38 -32.82 0.37 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.395 1.478 . . . . 0.0 113.418 164.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -112.83 125.88 54.83 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.85 1.26 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 41' ' ' PHE . 4.1 t80 -123.85 134.49 53.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.649 0.78 . . . . 0.0 110.109 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -126.35 126.96 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.563 1.145 . . . . 0.0 108.357 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -104.41 120.63 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.7 mt -110.67 150.65 42.05 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.204 1.002 . . . . 0.0 109.953 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 96' ' ' PHE . 86.3 Cg_endo -79.51 168.56 19.65 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.353 2.035 . . . . 0.0 112.569 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.88 32.09 1.48 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.525 1.536 . . . . 0.0 114.9 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.78 -48.19 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.707 1.603 . . . . 0.0 111.703 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 1.6 m-30 -82.99 136.75 34.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.046 0.938 . . . . 0.0 109.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -78.08 -32.67 50.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.531 -0.731 . . . . 0.0 111.69 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.512 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 14.2 p-90 -155.48 167.92 28.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.73 2.012 . . . . 0.0 109.786 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.03 164.15 28.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.569 0.699 . . . . 0.0 111.166 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.51 141.21 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 109.025 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.7 129.62 34.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.404 HG22 HD23 ' A' ' 138' ' ' LEU . 15.1 m -125.58 148.27 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.727 0.811 . . . . 0.0 109.664 170.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -148.98 158.35 44.12 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.042 0.937 . . . . 0.0 110.193 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mt -111.91 130.63 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 110.78 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.744 0.817 . . . . 0.0 109.462 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.28 127.27 32.77 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.215 -0.928 . . . . 0.0 111.576 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -112.63 17.18 19.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.693 1.597 . . . . 0.0 111.757 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 211' ' ' SER . 64.6 t -126.6 -57.44 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.489 1.915 . . . . 0.0 110.654 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -153.95 138.76 17.09 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.139 1.376 . . . . 0.0 111.378 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 p -49.7 -58.38 5.42 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.749 1.62 . . . . 0.0 115.209 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.3 m 31.22 63.22 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.011 2.524 . . . . 0.0 113.5 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.34 -98.16 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -59.38 -18.03 41.71 Favored Glycine 0 CA--C 1.541 1.662 0 O-C-N 119.699 -1.876 . . . . 0.0 113.575 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.5 m -60.81 -20.82 62.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.4 1.88 . . . . 0.0 115.027 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.81 128.42 40.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 109.785 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.63 127.56 40.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.956 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.2 ttp -126.95 152.73 46.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.017 1.727 . . . . 0.0 110.358 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.4 m -137.55 131.01 31.09 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.59 133.07 68.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 p -133.12 86.49 42.1 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 109.68 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.16 112.29 2.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.051 1.834 . . . . 0.0 108.621 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.5 t80 40.19 54.67 2.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.567 1.947 . . . . 0.0 112.99 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.38 31.75 0.92 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.6 1.56 . . . . 0.0 114.956 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.32 133.21 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.059 2.143 . . . . 0.0 108.597 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 t70 38.23 71.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.45 1.9 . . . . 0.0 113.348 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 138.97 41.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.59 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.84 140.1 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.591 0.756 . . . . 0.0 110.168 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.39 140.11 40.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.224 1.01 . . . . 0.0 110.022 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.432 ' HB3' HG21 ' A' ' 136' ' ' VAL . 7.6 p -140.85 143.03 34.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 109.22 -174.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -131.49 143.99 50.81 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.715 1.206 . . . . 0.0 109.307 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.31 90.85 0.1 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.106 0.955 . . . . 0.0 111.897 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.02 -22.02 0.99 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.162 -0.961 . . . . 0.0 113.216 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -60.75 150.99 30.71 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.492 1.146 . . . . 0.0 112.308 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.2 66.66 9.35 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.378 -0.826 . . . . 0.0 111.08 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 62.47 166.58 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.143 1.777 . . . . 0.0 112.569 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 129' ' ' CYS . 62.6 t -138.37 138.42 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.548 1.539 . . . . 0.0 109.599 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.34 122.25 28.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.348 0.659 . . . . 0.0 110.223 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 102' ' ' VAL . 3.2 mm? -97.55 110.76 56.35 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.274 1.43 . . . . 0.0 109.482 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 96.1 Cg_endo -77.72 136.68 15.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.673 2.249 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.512 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 17.0 mm -129.01 124.53 22.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 177.1 6.77 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.261 2.641 . . . . 0.0 112.075 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -65.08 141.55 58.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.786 . . . . 0.0 111.983 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.751 2.021 . . . . 0.0 109.483 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.8 m -126.24 135.32 26.99 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.741 1.216 . . . . 0.0 109.995 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.15 154.3 84.95 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.477 0.849 . . . . 0.0 112.488 -3.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.82 -27.19 67.51 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.931 1.754 . . . . 0.0 112.401 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -9.89 22.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.5 m -62.57 166.41 5.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.741 1.258 . . . . 0.0 113.315 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.69 153.24 26.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.686 1.194 . . . . 0.0 111.897 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.5 tt -119.42 131.29 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 128.224 2.61 . . . . 0.0 107.957 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.2 m -73.77 134.11 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.689 0.795 . . . . 0.0 109.788 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -135.74 131.27 35.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.288 0.635 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -96.59 147.42 23.89 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.728 -0.608 . . . . 0.0 109.974 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.99 132.46 40.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.36 1.464 . . . . 0.0 108.645 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -141.41 118.27 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.518 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.95 133.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.469 1.507 . . . . 0.0 109.943 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.84 149.77 39.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.03 1.732 . . . . 0.0 109.182 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 146.44 47.79 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 64.4 p -73.74 -4.01 31.92 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.062 -1.024 . . . . 0.0 113.45 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.94 155.14 43.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.401 2.281 . . . . 0.0 111.683 -177.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 151.5 28.13 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.615 1.166 . . . . 0.0 113.395 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.56 -2.15 17.2 Favored 'Cis proline' 0 C--N 1.354 0.849 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 3.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . 0.26 0.2 OUTLIER 39.41 37.76 0.31 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 115.411 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -82.47 46.65 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.128 0.971 . . . . 0.0 113.486 -164.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 40.73 74.43 0.1 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.78 2.032 . . . . 0.0 112.834 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -37.11 -51.88 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.25 1.82 . . . . 0.0 111.802 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.9 t -138.58 128.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -136.1 109.64 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.422 1.089 . . . . 0.0 108.254 171.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.76 -165.75 33.25 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.712 0.672 . . . . 0.0 112.275 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.8 m -136.78 163.95 29.42 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.094 -0.65 . . . . 0.0 110.816 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.12 150.73 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.228 1.411 . . . . 0.0 109.438 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.0 135.96 34.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.577 -0.702 . . . . 0.0 109.869 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -113.22 132.12 55.63 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.828 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -123.64 156.97 34.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.581 1.552 . . . . 0.0 109.073 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 98' ' ' TRP . 44.9 t80 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.261 0.937 . . . . 0.0 109.669 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.2 m -97.97 102.16 12.87 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 123.724 0.81 . . . . 0.0 109.074 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.37 -15.71 42.51 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.26 1.973 . . . . 0.0 113.288 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.6 m -47.8 -40.62 21.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.416 1.886 . . . . 0.0 112.767 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 33.4 p -144.81 20.46 1.64 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.867 1.267 . . . . 0.0 112.729 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.39 37.02 59.03 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.964 1.745 . . . . 0.0 115.276 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.64 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 9.3 tt0 -80.88 179.17 7.96 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.652 0.739 . . . . 0.0 112.657 177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.64 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 t -130.63 144.15 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.388 2.675 . . . . 0.0 107.713 166.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.3 m -134.79 123.16 23.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.297 2.239 . . . . 0.0 108.167 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 197' ' ' VAL . 0.3 OUTLIER -100.79 116.9 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.949 0.881 . . . . 0.0 111.312 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.56 118.1 35.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.897 1.279 . . . . 0.0 108.526 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 142.56 51.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.31 1.844 . . . . 0.0 109.04 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -167.48 160.01 12.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.602 1.561 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.48 -20.07 4.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.042 1.737 . . . . 0.0 114.029 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.25 -29.09 57.37 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.141 1.776 . . . . 0.0 114.819 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.4 p -149.61 -43.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.397 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -96.44 137.37 21.56 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.842 1.257 . . . . 0.0 110.323 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.05 -171.52 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.84 -20.4 13.07 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.721 2.009 . . . . 0.0 114.474 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -67.65 -12.32 60.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.106 1.762 . . . . 0.0 113.159 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.4 ttm -131.36 145.77 51.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.645 1.578 . . . . 0.0 108.507 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.3 p -136.81 155.88 49.23 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.988 1.315 . . . . 0.0 109.042 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' VAL . 2.6 t -116.36 125.9 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.939 -0.476 . . . . 0.0 109.82 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.4 m -117.11 130.32 56.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.462 1.105 . . . . 0.0 109.318 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -76.39 70.58 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.841 1.656 . . . . 0.0 111.093 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.22 -42.16 76.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.807 1.243 . . . . 0.0 113.553 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -147.93 177.9 8.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.885 2.074 . . . . 0.0 109.543 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -68.47 129.84 41.1 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.51 -1.369 . . . . 0.0 108.534 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 19.4 p 55.99 29.89 15.16 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.279 1.432 . . . . 0.0 114.316 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.8 m -135.28 123.87 23.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.556 1.142 . . . . 0.0 111.869 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' HG13 ' A' ' 184' ' ' VAL . 19.9 m-85 -124.84 134.89 52.56 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.978 1.311 . . . . 0.0 110.406 -173.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 14.1 mt -120.69 116.1 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -77.14 93.99 4.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.59 1.956 . . . . 0.0 109.971 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.76 121.54 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.451 1.101 . . . . 0.0 109.916 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.26 102.96 13.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.921 0.888 . . . . 0.0 109.795 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -83.7 -29.05 27.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.886 1.274 . . . . 0.0 113.343 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 108' ' ' VAL . 58.4 m -159.54 133.25 7.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.153 2.181 . . . . 0.0 110.839 173.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.6 15.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 126.481 1.913 . . . . 0.0 113.944 -163.418 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.64 146.22 40.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.443 0.697 . . . . 0.0 110.331 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.01 -17.44 17.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -112.97 12.19 19.25 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.115 2.566 . . . . 0.0 113.57 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -138.75 174.03 10.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.024 1.33 . . . . 0.0 110.256 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -140.0 148.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.088 0.955 . . . . 0.0 108.434 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -132.05 143.57 50.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.45 1.1 . . . . 0.0 110.873 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.31 137.31 49.89 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.461 1.504 . . . . 0.0 108.55 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.78 150.24 46.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.139 1.776 . . . . 0.0 109.38 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -115.1 92.52 3.96 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.051 1.34 . . . . 0.0 109.831 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.76 -62.06 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.948 161.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 161.51 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 130.382 3.473 . . . . 0.0 108.663 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 36.84 58.33 1.12 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 114.786 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m 52.26 63.85 2.08 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.069 1.748 . . . . 0.0 115.426 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.5 m -123.21 -41.48 2.31 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.73 -120.6 3.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.676 1.125 . . . . 0.0 112.752 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.93 165.95 22.26 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.558 1.179 . . . . 0.0 111.423 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.0 p -136.66 157.96 45.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.3 1.44 . . . . 0.0 111.903 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.08 131.25 15.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.296 1.838 . . . . 0.0 108.291 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -132.67 120.84 22.26 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.06 1.344 . . . . 0.0 108.8 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -147.19 138.55 23.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.987 1.375 . . . . 0.0 111.266 -169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -70.41 153.52 42.89 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.189 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -63.18 161.9 12.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.554 0.742 . . . . 0.0 112.074 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.42 45.74 76.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.496 0.569 . . . . 0.0 112.847 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -138.63 158.24 44.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.624 1.97 . . . . 0.0 111.247 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -134.68 117.83 16.48 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.347 1.059 . . . . 0.0 108.551 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 139.02 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 109.617 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -144.62 101.21 3.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.402 1.081 . . . . 0.0 108.514 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.468 0.466 0 C-N-CA 123.735 0.814 . . . . 0.0 111.067 -171.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.3 m0 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -52.24 -28.81 20.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.625 1.102 . . . . 0.0 112.857 166.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 -0.95 4.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.142 0.977 . . . . 0.0 113.619 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.18 -39.73 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.416 1.487 . . . . 0.0 112.721 165.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -60.23 124.3 19.86 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 123.082 1.42 . . . . 0.0 111.782 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 tpt -149.56 -35.56 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.436 1.494 . . . . 0.0 113.349 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 p -141.03 125.06 17.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.124 0.874 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.11 159.2 42.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.423 1.106 . . . . 0.0 112.32 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.56 121.5 17.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.32 112.3 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 126.479 1.911 . . . . 0.0 108.108 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -32.61 -83.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.752 2.596 . . . . 0.0 116.742 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.633 1.973 . . . . 0.0 112.694 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -121.09 37.91 4.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 110.472 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -151.01 143.81 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 128.566 2.747 . . . . 0.0 109.028 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -119.5 148.83 42.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.951 1.7 . . . . 0.0 109.167 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.09 140.91 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.258 0.551 . . . . 0.0 109.833 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -131.92 131.07 42.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.435 1.094 . . . . 0.0 108.781 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.75 126.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 129.33 41.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.93 1.292 . . . . 0.0 109.458 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -54.76 -62.31 1.74 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 113.301 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.83 173.85 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.345 1.458 . . . . 0.0 109.785 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.98 139.85 39.06 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.5 -173.87 1.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 110.988 -170.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.06 39.19 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.834 1.654 . . . . 0.0 112.004 -173.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.326 43.0 m-20 56.38 48.43 17.02 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.102 1.761 . . . . 0.0 111.053 -167.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.36 153.52 19.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 112.626 -2.079 . . . . 0.0 109.968 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.53 26.43 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.677 3.584 . . . . 0.0 115.203 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 58.66 2.92 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.704 2.002 . . . . 0.0 110.636 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.51 145.62 59.17 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.579 1.52 . . . . 0.0 110.385 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 -129.58 0.51 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.084 1.326 . . . . 0.0 113.151 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.36 158.2 31.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 111.038 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -147.91 153.29 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.848 1.659 . . . . 0.0 109.765 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.4 163.1 35.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.882 0.873 . . . . 0.0 110.784 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -123.55 105.12 9.49 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.274 1.43 . . . . 0.0 110.494 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -74.18 102.08 4.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 109.611 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.95 148.84 24.57 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.766 1.627 . . . . 0.0 113.744 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.39 140.94 38.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.742 1.617 . . . . 0.0 113.108 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 55.61 29.17 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 125.007 1.289 . . . . 0.0 114.366 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -148.62 164.01 35.55 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -134.35 129.9 36.13 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.868 1.667 . . . . 0.0 108.513 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.2 130.84 50.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.626 1.571 . . . . 0.0 107.492 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -139.85 -8.36 1.22 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -140.92 68.02 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.415 1.886 . . . . 0.0 110.819 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' H ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.43 20.7 12.41 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.255 2.222 . . . . 0.0 112.237 -177.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.24 -11.97 1.39 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.625 1.57 . . . . 0.0 114.077 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -19.75 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.401 -1.437 . . . . 0.0 114.138 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.98 34.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 126.821 2.048 . . . . 0.0 111.745 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -49.67 -28.98 6.61 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.367 -1.458 . . . . 0.0 113.418 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.54 71.71 1.04 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.046 1.308 . . . . 0.0 113.653 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.51 147.57 46.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.27 1.428 . . . . 0.0 109.481 164.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -147.91 -14.81 0.36 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 159.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -133.4 127.37 33.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.367 1.467 . . . . 0.0 109.564 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.09 124.24 36.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.814 1.246 . . . . 0.0 109.263 -166.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -117.09 115.86 26.2 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.449 1.499 . . . . 0.0 108.425 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 t -115.94 117.01 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.4 mt -128.44 151.83 77.28 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.978 0.911 . . . . 0.0 109.797 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.16 -178.85 3.48 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.072 2.515 . . . . 0.0 111.617 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.61 -23.02 71.2 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.167 -0.958 . . . . 0.0 113.855 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.25 74.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.117 0.967 . . . . 0.0 112.417 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.437 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 1.4 m-30 -91.67 149.21 21.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.89 1.276 . . . . 0.0 109.484 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.81 -31.88 4.4 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.577 -1.327 . . . . 0.0 113.181 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.73 148.43 31.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.667 1.587 . . . . 0.0 108.19 167.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -119.19 154.94 32.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.766 0.793 . . . . 0.0 110.077 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.06 150.01 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.392 1.477 . . . . 0.0 109.433 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.62 126.99 51.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.51 136.05 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.7 -0.625 . . . . 0.0 110.206 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -140.71 134.09 29.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.931 0.492 . . . . 0.0 111.387 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 115' ' ' TYR . 39.8 mt -85.38 146.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.495 1.518 . . . . 0.0 109.481 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.3 t -135.9 102.56 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.135 1.774 . . . . 0.0 109.118 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -58.16 119.94 7.73 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.054 0.942 . . . . 0.0 111.662 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -112.65 -35.6 5.46 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.016 0.926 . . . . 0.0 111.646 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -91.12 -36.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.373 1.069 . . . . 0.0 113.76 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -91.58 91.66 8.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.595 1.158 . . . . 0.0 109.924 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 65.3 p -64.33 17.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.5 m -133.94 80.95 1.89 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.394 2.678 . . . . 0.0 109.074 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.58 130.69 47.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.072 0.949 . . . . 0.0 111.811 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.87 -38.44 2.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.283 1.42 . . . . 0.0 113.537 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.4 m -71.47 -27.58 63.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.613 1.165 . . . . 0.0 112.946 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE1' HG21 ' A' ' 104' ' ' ILE . 1.7 t80 -75.85 126.97 32.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.631 1.172 . . . . 0.0 109.847 171.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -129.23 141.71 51.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.765 1.626 . . . . 0.0 109.43 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -135.85 138.77 42.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.962 0.905 . . . . 0.0 110.146 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -123.61 138.49 54.54 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.411 1.484 . . . . 0.0 107.793 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.8 145.63 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.619 0.767 . . . . 0.0 110.682 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 t -144.73 94.91 5.4 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 111.294 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.27 165.84 23.24 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.828 2.352 . . . . 0.0 112.164 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -29.67 94.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 128.092 2.557 . . . . 0.0 114.17 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 47.72 37.93 7.73 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.68 1.592 . . . . 0.0 114.867 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.0 t -93.65 155.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.946 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.64 98.85 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.335 . . . . 0.0 111.195 170.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.85 151.33 18.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.743 -0.598 . . . . 0.0 112.084 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.35 131.22 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.102 0.561 . . . . 0.0 110.219 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.23 33.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.326 0.65 . . . . 0.0 109.477 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.66 142.18 51.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.808 1.243 . . . . 0.0 108.371 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -127.5 137.66 52.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 108.2 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.48 108.99 0.54 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.468 0.707 . . . . 0.0 111.326 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.95 -25.69 4.91 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 113.791 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.75 146.27 55.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.892 1.346 . . . . 0.0 110.871 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.61 167.88 14.18 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.637 -0.664 . . . . 0.0 111.376 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -47.0 105.05 0.06 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.848 1.259 . . . . 0.0 112.78 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.01 126.29 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.506 1.122 . . . . 0.0 109.126 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.12 124.17 22.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.961 0.41 . . . . 0.0 109.949 176.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.81 96.43 49.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.557 1.943 . . . . 0.0 107.112 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 40.8 Cg_endo -74.37 143.49 31.41 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.473 2.115 . . . . 0.0 112.733 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.7 mm -122.06 133.78 24.47 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.794 1.637 . . . . 0.0 108.565 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.47 170.44 12.29 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 112.752 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -49.82 138.68 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.669 . . . . 0.0 112.716 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.17 122.71 9.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.649 0.779 . . . . 0.0 110.532 -174.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.4 t -134.6 131.66 20.38 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 110.9 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.85 152.98 83.67 Favored 'Cis proline' 0 CA--C 1.548 1.204 0 CA-C-N 119.345 0.802 . . . . 0.0 112.148 -6.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.36 -37.48 81.64 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.709 2.273 . . . . 0.0 112.089 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -7.15 8.65 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.053 1.741 . . . . 0.0 114.414 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.3 t -74.6 -179.42 4.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.136 -0.978 . . . . 0.0 112.347 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -130.5 154.52 47.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.975 1.31 . . . . 0.0 112.826 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.49 130.6 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.541 1.936 . . . . 0.0 109.854 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.23 141.29 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.96 0.904 . . . . 0.0 111.017 172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 t -148.29 158.7 44.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.211 1.404 . . . . 0.0 110.764 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.55 136.45 53.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.31 1.044 . . . . 0.0 109.216 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.34 126.31 46.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.186 1.794 . . . . 0.0 108.367 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 p -133.46 131.15 39.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.78 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.29 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.607 1.563 . . . . 0.0 107.02 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -143.71 151.59 40.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.729 1.612 . . . . 0.0 109.336 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -85.53 142.67 29.0 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.816 -0.552 . . . . 0.0 111.524 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.9 p -85.85 7.57 23.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.912 1.685 . . . . 0.0 112.926 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.94 16.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.31 1.844 . . . . 0.0 110.733 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -51.41 139.47 27.15 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.923 1.289 . . . . 0.0 113.442 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.94 11.74 19.29 Favored 'Cis proline' 0 CA--C 1.549 1.229 0 N-CA-C 114.904 1.078 . . . . 0.0 114.904 4.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.67 15.33 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.664 1.986 . . . . 0.0 114.149 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.76 164.64 19.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.19 1.396 . . . . 0.0 112.469 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -68.98 154.59 41.8 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.812 0.815 . . . . 0.0 112.121 171.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.3 -38.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.786 1.634 . . . . 0.0 110.339 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.3 t -146.06 140.92 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -144.35 105.79 4.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.432 1.493 . . . . 0.0 108.579 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.11 -179.98 38.65 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.466 -0.771 . . . . 0.0 114.487 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.5 p -113.21 136.1 53.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.703 1.201 . . . . 0.0 112.004 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.35 150.04 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.974 2.11 . . . . 0.0 107.722 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -124.52 135.47 53.21 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.1 149.54 30.69 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.458 -0.776 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -138.26 153.68 49.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.837 2.055 . . . . 0.0 108.654 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -115.7 164.65 14.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.197 0.999 . . . . 0.0 109.719 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -136.46 105.29 9.24 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.342 1.057 . . . . 0.0 109.582 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -67.8 -14.96 43.13 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.53 2.82 . . . . 0.0 113.262 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.0 m -45.5 -46.54 13.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.49 2.316 . . . . 0.0 113.171 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 65.1 p -145.21 11.03 1.32 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.734 1.214 . . . . 0.0 113.14 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 69.29 42.71 73.99 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.199 -1.563 . . . . 0.0 112.768 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -83.52 156.67 22.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.897 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 203' ' ' THR . 0.4 OUTLIER -112.36 155.12 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.739 0.815 . . . . 0.0 110.274 165.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.6 m -143.63 114.95 7.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.696 1.199 . . . . 0.0 108.571 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.32 146.81 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.142 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.58 132.62 66.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.565 1.946 . . . . 0.0 107.56 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 138.66 32.65 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.198 1.399 . . . . 0.0 108.661 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -127.82 144.36 51.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.151 1.38 . . . . 0.0 108.539 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.49 -18.81 20.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.78 -33.6 16.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.46 1.504 . . . . 0.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.2 p -98.83 -53.05 3.39 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.77 1.228 . . . . 0.0 110.888 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -85.79 148.29 48.2 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.419 1.488 . . . . 0.0 109.997 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.08 175.17 11.24 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.386 2.058 . . . . 0.0 111.672 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 8.71 44.58 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.945 1.298 . . . . 0.0 113.147 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.97 -37.52 10.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.355 1.462 . . . . 0.0 111.707 -164.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 146.45 40.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 128.76 2.824 . . . . 0.0 106.953 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.3 p -139.91 153.17 46.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.565 0.746 . . . . 0.0 110.896 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.93 137.6 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.501 0.72 . . . . 0.0 110.27 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 33.4 m -120.72 140.76 51.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.806 1.642 . . . . 0.0 109.39 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -68.59 91.2 0.41 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.985 1.314 . . . . 0.0 110.635 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -75.27 -48.97 20.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 122.215 -0.303 . . . . 0.0 110.934 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.97 -178.59 5.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.631 1.572 . . . . 0.0 112.121 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -58.78 -34.54 71.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.138 1.375 . . . . 0.0 114.607 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 182' ' ' VAL . 50.6 p -138.0 25.16 2.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.985 1.714 . . . . 0.0 112.158 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 t -125.26 136.22 53.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.083 0.953 . . . . 0.0 111.255 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.5 133.3 52.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.178 1.391 . . . . 0.0 110.637 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.7 tt -115.97 112.35 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.154 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.94 125.62 39.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.842 2.457 . . . . 0.0 108.231 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -125.27 129.96 51.09 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.14 1.376 . . . . 0.0 111.319 -172.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.6 tt -121.87 114.9 21.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.889 0.876 . . . . 0.0 111.608 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -123.14 7.4 9.17 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.888 1.675 . . . . 0.0 113.938 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.67 -8.69 13.78 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 40.96 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 129.363 3.065 . . . . 0.0 118.67 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 -172.772 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' A' ' 47' ' ' GLY . 8.7 p . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.014 0.435 . . . . 0.0 111.565 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.1 142.73 57.68 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.251 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -19.39 51.04 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.28 9.12 23.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.639 1.976 . . . . 0.0 113.255 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -136.83 -178.31 5.13 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 120.485 1.493 . . . . 0.0 110.81 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -135.69 148.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.675 1.19 . . . . 0.0 110.653 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 142.52 49.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.471 1.108 . . . . 0.0 109.404 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -135.55 127.9 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.149 1.38 . . . . 0.0 108.51 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -133.54 130.78 38.93 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.506 1.122 . . . . 0.0 110.601 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.44 56.88 4.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.792 1.237 . . . . 0.0 111.274 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.43 140.24 3.62 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.922 0.772 . . . . 0.0 111.183 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -58.23 139.16 55.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.459 0.703 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 70.55 37.62 1.44 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 125.376 1.47 . . . . 0.0 113.808 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.9 m 54.14 64.12 1.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.331 1.852 . . . . 0.0 113.673 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.9 p -132.45 179.24 6.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.969 1.307 . . . . 0.0 112.755 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.97 -81.27 1.17 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.877 1.703 . . . . 0.0 114.71 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -138.53 166.73 23.55 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.053 1.741 . . . . 0.0 110.019 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -130.94 152.78 49.88 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.759 1.224 . . . . 0.0 112.758 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -160.68 162.76 32.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.373 1.469 . . . . 0.0 111.304 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -134.67 140.93 46.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.925 1.29 . . . . 0.0 110.812 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -124.87 141.19 52.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.851 1.661 . . . . 0.0 110.119 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -88.84 143.72 26.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.515 0.726 . . . . 0.0 111.444 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.26 150.68 38.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.06 1.344 . . . . 0.0 111.7 170.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.51 58.17 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.113 1.339 . . . . 0.0 113.438 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -137.77 159.09 42.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.942 1.697 . . . . 0.0 111.356 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.4 m -117.93 128.97 55.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.993 1.317 . . . . 0.0 108.86 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.89 114.85 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.747 1.219 . . . . 0.0 109.432 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.47 145.83 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.746 1.218 . . . . 0.0 111.074 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CE2' ' HE3' ' A' ' 40' ' ' LYS . 63.1 m-85 . . . . . 0 C--N 1.327 -0.39 0 C-N-CA 125.243 1.417 . . . . 0.0 110.09 168.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.5 m0 . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 2.6 p30 -62.15 -42.26 99.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.492 1.517 . . . . 0.0 111.813 166.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.46 34.93 0.14 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.029 1.731 . . . . 0.0 113.047 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -78.27 -20.28 51.93 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 118.902 -2.374 . . . . 0.0 114.596 177.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CE2' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.87 145.52 35.05 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.814 0.816 . . . . 0.0 111.706 176.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 ttt -155.7 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.1 p -134.56 132.56 39.26 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.613 1.097 . . . . 0.0 110.697 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.2 m -143.45 152.47 41.56 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 108.041 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.44 145.67 47.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.511 1.148 . . . . 0.0 112.273 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 8' ' ' VAL . 95.3 t -106.73 120.18 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.354 2.661 . . . . 0.0 108.843 -170.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 3' ' ' VAL . . . -47.66 -86.2 0.01 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -168.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 t -164.13 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.99 0.916 . . . . 0.0 111.792 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.76 32.67 5.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.846 1.258 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.55 164.07 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 110.276 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -144.43 154.12 42.63 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.742 2.017 . . . . 0.0 110.067 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.415 ' SG ' HG11 ' A' ' 8' ' ' VAL . 1.2 m -124.96 134.56 52.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.85 0.86 . . . . 0.0 110.806 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.19 118.33 31.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.89 1.276 . . . . 0.0 109.492 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.0 mm -110.1 106.49 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.294 1.038 . . . . 0.0 108.998 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.94 117.79 24.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.005 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.09 -45.46 81.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 122.205 1.003 . . . . 0.0 112.479 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 167.77 29.25 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.091 1.756 . . . . 0.0 109.923 -169.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -108.91 48.93 0.84 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.439 0.696 . . . . 0.0 110.537 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.75 160.68 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.505 1.922 . . . . 0.0 114.686 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.68 52.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.433 -1.417 . . . . 0.0 110.684 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 71.68 36.35 1.26 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.704 2.402 . . . . 0.0 111.58 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 p -67.46 155.96 89.72 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.789 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.79 32.35 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.33 3.353 . . . . 0.0 113.38 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -151.16 99.64 3.05 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 109.995 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 118.06 5.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.688 1.592 . . . . 0.0 108.965 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.89 -120.87 0.1 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.49 144.05 44.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 112.52 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -161.82 132.45 5.03 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 110.226 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -143.22 163.1 33.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.599 1.159 . . . . 0.0 110.665 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.02 107.68 9.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.364 1.466 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -84.05 95.55 8.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.815 0.846 . . . . 0.0 108.941 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.24 150.53 3.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 113.044 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -66.61 145.95 55.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.829 0.452 . . . . 0.0 112.177 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.5 64.58 3.94 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.452 1.025 . . . . 0.0 115.413 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -153.02 177.2 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.147 0.979 . . . . 0.0 112.868 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.8 m -130.7 142.43 50.42 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.182 1.393 . . . . 0.0 110.241 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.82 134.55 44.81 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.962 1.305 . . . . 0.0 109.884 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.2 -33.02 1.15 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 123.579 0.752 . . . . 0.0 112.489 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -118.06 40.34 3.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.053 1.406 . . . . 0.0 110.965 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' CE2' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -70.35 -16.35 62.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.385 1.074 . . . . 0.0 113.213 172.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -61.58 -11.47 11.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.269 1.427 . . . . 0.0 113.184 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.5 t -47.35 -36.74 9.96 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.82 -1.175 . . . . 0.0 113.127 167.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 tt -81.0 -35.17 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.84 42.22 11.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.998 2.119 . . . . 0.0 113.811 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.05 67.31 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.297 0.951 . . . . 0.0 113.022 -161.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.1 tp -131.61 115.35 15.97 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.722 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.4 m -120.9 -20.6 6.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.481 1.113 . . . . 0.0 112.891 167.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -127.52 122.37 33.15 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.078 0.951 . . . . 0.0 110.189 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.35 137.11 44.91 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.232 1.013 . . . . 0.0 109.084 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.06 136.11 55.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.95 118.55 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -131.41 146.94 64.14 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.967 0.907 . . . . 0.0 109.359 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.71 165.77 24.47 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.114 2.543 . . . . 0.0 112.308 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.73 -14.3 36.04 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 124.358 0.98 . . . . 0.0 114.828 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.06 -28.07 63.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.134 1.374 . . . . 0.0 113.946 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 7.9 m-30 -123.49 102.93 8.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.693 1.597 . . . . 0.0 109.535 -166.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.9 -27.89 26.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.43 -1.419 . . . . 0.0 113.513 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.24 145.18 24.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.489 2.315 . . . . 0.0 106.856 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.43 165.71 24.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.782 0.801 . . . . 0.0 111.054 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 151.13 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.858 1.263 . . . . 0.0 109.261 -173.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.86 125.33 44.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.63 138.2 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.978 0.894 . . . . 0.0 110.729 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.09 118.07 15.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.547 1.539 . . . . 0.0 108.54 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 149.01 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 122.894 0.478 . . . . 0.0 109.822 165.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.96 129.49 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.29 121.72 34.07 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.017 -0.427 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -26.13 6.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.764 1.626 . . . . 0.0 113.142 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.12 -35.68 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.897 0.879 . . . . 0.0 113.266 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -108.91 -179.59 3.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.085 1.354 . . . . 0.0 109.735 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.8 t -120.93 -39.54 2.71 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.504 1.122 . . . . 0.0 111.826 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.7 m -60.19 -39.73 87.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.103 0.961 . . . . 0.0 112.204 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.16 -179.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.246 1.818 . . . . 0.0 114.789 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.98 -25.68 0.8 Allowed Glycine 0 N--CA 1.478 1.476 0 O-C-N 120.071 -1.643 . . . . 0.0 115.55 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 m -53.36 -35.5 60.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.13 1.372 . . . . 0.0 111.906 163.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -90.45 131.37 36.25 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.238 1.815 . . . . 0.0 110.466 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.52 130.35 42.22 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.871 1.269 . . . . 0.0 111.229 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.444 ' HG2' HG22 ' A' ' 156' ' ' VAL . 1.4 tmm? -92.86 135.58 34.01 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.916 1.686 . . . . 0.0 110.092 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -133.91 97.4 3.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.912 1.685 . . . . 0.0 108.304 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 127' ' ' VAL . 6.2 mm -94.22 132.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -131.61 92.96 29.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.99 171.99 12.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.475 . . . . 0.0 112.328 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -35.37 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.0 2.52 . . . . 0.0 114.969 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 41.53 59.23 2.48 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.888 1.675 . . . . 0.0 114.486 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.93 157.95 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.171 1.788 . . . . 0.0 111.593 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -40.54 115.35 0.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.859 1.663 . . . . 0.0 111.85 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 136.16 51.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.419 HG11 ' HG ' ' A' ' 138' ' ' LEU . 13.1 p -115.95 151.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.668 0.787 . . . . 0.0 109.339 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.3 132.89 41.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.204 1.001 . . . . 0.0 110.383 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.3 t -133.52 119.25 19.28 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.644 1.178 . . . . 0.0 108.936 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -114.81 121.87 44.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.578 1.551 . . . . 0.0 108.301 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t0 55.54 -175.86 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.862 0.839 . . . . 0.0 113.054 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.65 30.64 1.24 Allowed Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.173 1.368 . . . . 0.0 113.587 161.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -56.56 175.55 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.998 1.399 . . . . 0.0 111.389 166.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -44.84 122.15 3.09 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.892 -1.13 . . . . 0.0 111.731 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -53.25 159.48 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.142 0.977 . . . . 0.0 112.416 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.41 135.24 54.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.766 0.793 . . . . 0.0 110.279 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -75.55 142.7 42.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -126.18 91.15 48.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 125.465 1.506 . . . . 0.0 109.345 -178.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 34.5 Cg_endo -71.05 144.18 46.55 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.196 1.931 . . . . 0.0 111.464 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 46.3 mm -128.17 135.4 27.47 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.718 1.607 . . . . 0.0 108.522 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.21 177.39 8.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.033 3.156 . . . . 0.0 112.306 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.08 141.81 57.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.395 0.678 . . . . 0.0 111.791 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.46 147.33 7.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.981 1.712 . . . . 0.0 110.314 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 98.8 m -147.48 135.33 10.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.087 0.955 . . . . 0.0 109.71 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.08 153.23 87.89 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.422 0.829 . . . . 0.0 112.722 -5.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.18 -36.58 68.31 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.182 1.921 . . . . 0.0 112.158 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.25 -16.48 60.37 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.81 128.68 36.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 110.857 170.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 162.37 25.49 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 112.723 171.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.9 151.75 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.871 1.668 . . . . 0.0 109.098 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.53 118.41 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.565 0.746 . . . . 0.0 110.821 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.4 m -130.42 150.52 51.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.4 1.08 . . . . 0.0 111.609 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.25 123.21 48.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.93 0.892 . . . . 0.0 108.602 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.09 113.85 26.27 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.04 1.336 . . . . 0.0 107.758 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.63 145.31 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.444 HG22 ' HG2' ' A' ' 117' ' ' MET . 11.2 t -135.36 130.7 51.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -145.07 153.88 41.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.968 1.307 . . . . 0.0 109.331 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 143.24 54.71 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.941 168.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.4 p -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.245 1.418 . . . . 0.0 113.946 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -141.6 161.06 38.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.751 2.021 . . . . 0.0 110.89 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -66.37 139.36 96.21 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 127.43 12.13 Favored 'Cis proline' 0 C--N 1.353 0.8 0 CA-C-N 120.331 1.154 . . . . 0.0 111.443 -6.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -74.22 49.91 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.713 1.605 . . . . 0.0 111.13 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.86 131.81 52.03 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.286 -1.509 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.06 90.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.174 0.589 . . . . 0.0 109.839 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.2 t -42.47 -52.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.782 2.033 . . . . 0.0 111.087 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.8 p -159.47 152.51 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.917 -0.489 . . . . 0.0 111.838 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.87 102.87 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.845 1.658 . . . . 0.0 108.385 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.01 -174.36 13.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.928 1.728 . . . . 0.0 111.863 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.4 m -132.88 150.34 52.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.458 1.103 . . . . 0.0 110.906 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.46 163.5 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 126.314 1.846 . . . . 0.0 108.507 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -129.49 136.38 49.81 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.927 0.491 . . . . 0.0 109.867 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.28 137.05 52.45 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.659 1.184 . . . . 0.0 107.983 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 160.13 38.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.269 1.428 . . . . 0.0 110.154 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 114.38 18.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.996 0.816 . . . . 0.0 110.253 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 m -76.46 118.2 69.8 Favored Pre-proline 0 N--CA 1.476 0.843 0 O-C-N 120.359 -1.463 . . . . 0.0 109.95 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.36 -19.36 55.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.59 2.193 . . . . 0.0 113.957 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.2 m -52.7 -50.27 63.68 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.902 2.081 . . . . 0.0 114.3 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.3 p -136.11 18.26 3.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.578 1.551 . . . . 0.0 111.803 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.76 41.14 97.75 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.095 0.855 . . . . 0.0 114.135 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -72.67 164.04 27.13 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.716 -1.461 . . . . 0.0 111.982 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 135.83 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.8 m -131.77 135.08 46.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.401 1.08 . . . . 0.0 108.298 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.443 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -102.27 135.75 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.9 0.857 . . . . 0.0 110.743 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.33 134.84 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.601 1.961 . . . . 0.0 106.721 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 133.76 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.789 1.235 . . . . 0.0 108.061 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.27 150.32 39.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.153 1.381 . . . . 0.0 108.882 -166.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -57.41 -23.42 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.74 -31.66 20.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.832 1.253 . . . . 0.0 113.6 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.2 p -96.34 -49.92 4.99 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.378 1.071 . . . . 0.0 110.199 -170.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.4 t80 -64.91 148.3 97.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 110.016 168.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 74.2 Cg_endo -75.87 -95.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.118 1.879 . . . . 0.0 111.003 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 164.39 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 128.103 2.561 . . . . 0.0 112.942 -171.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -61.21 -43.76 98.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.643 1.177 . . . . 0.0 112.515 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.7 149.31 25.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.856 1.662 . . . . 0.0 109.57 170.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -134.94 133.82 39.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.29 1.036 . . . . 0.0 110.286 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.02 130.82 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.634 0.774 . . . . 0.0 109.665 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.2 m -128.86 131.13 47.64 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.187 1.395 . . . . 0.0 108.9 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.06 94.21 1.48 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 0.0 110.342 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.59 -46.88 35.72 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.06 0.544 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -145.45 -172.6 3.92 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.475 1.91 . . . . 0.0 111.221 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -51.38 -49.41 61.59 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.708 -1.245 . . . . 0.0 113.242 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.6 p -128.24 32.51 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 110.823 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.1 t -137.37 127.96 26.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.241 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 184' ' ' VAL . 18.6 m-85 -125.07 137.09 54.21 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.011 1.324 . . . . 0.0 109.707 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.31 128.16 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.977 0.894 . . . . 0.0 109.007 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -115.69 94.51 4.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.433 1.893 . . . . 0.0 107.377 -165.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -85.79 121.4 28.39 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.775 -0.578 . . . . 0.0 110.186 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.78 101.5 11.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 111.836 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.79 10.13 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.597 1.159 . . . . 0.0 112.675 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.68 157.07 34.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.423 1.489 . . . . 0.0 112.834 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.63 -4.56 59.06 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 126.121 1.769 . . . . 0.0 112.184 -170.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.469 0.475 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.25 142.73 58.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -18.86 10.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.726 1.148 . . . . 0.0 113.623 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -113.35 15.72 19.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.95 2.1 . . . . 0.0 112.753 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -139.5 166.49 24.42 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.188 -1.57 . . . . 0.0 109.725 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.15 159.78 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.383 0.611 . . . . 0.0 110.037 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.87 161.31 39.63 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.842 0.857 . . . . 0.0 111.301 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -128.11 145.85 50.88 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.337 1.455 . . . . 0.0 109.311 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.44 114.07 14.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.77 2.028 . . . . 0.0 110.618 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.38 77.01 6.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 109.189 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.59 -87.97 0.07 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.832 -0.982 . . . . 0.0 112.844 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.15 124.15 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 129.738 3.215 . . . . 0.0 109.512 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 63.78 44.05 5.18 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.541 1.136 . . . . 0.0 114.028 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m 68.02 58.09 0.48 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.383 2.273 . . . . 0.0 113.961 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -141.73 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.896 1.678 . . . . 0.0 112.002 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.28 -121.09 12.72 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.366 0.984 . . . . 0.0 111.686 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.97 166.26 15.23 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.119 0.959 . . . . 0.0 111.361 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -132.12 154.18 49.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.056 1.342 . . . . 0.0 111.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.81 141.61 22.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.509 1.524 . . . . 0.0 109.513 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -117.44 135.32 53.98 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.076 0.95 . . . . 0.0 110.042 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -131.84 139.1 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.353 1.461 . . . . 0.0 109.946 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.8 150.45 24.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.609 -0.682 . . . . 0.0 111.284 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.28 162.63 29.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.941 0.896 . . . . 0.0 111.43 170.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.54 33.31 40.51 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.636 0.636 . . . . 0.0 113.906 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -134.06 148.11 51.0 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.267 1.427 . . . . 0.0 110.625 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -105.96 132.8 51.62 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.426 1.49 . . . . 0.0 108.31 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.8 126.02 69.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.247 1.019 . . . . 0.0 109.247 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 150.16 28.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.81 1.644 . . . . 0.0 110.379 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 125.577 1.551 . . . . 0.0 110.201 171.695 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.35 0.595 . . . . 0.0 111.804 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -65.05 -41.84 94.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 0.0 113.773 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.458 ' HB2' ' H ' ' A' ' 86' ' ' LEU . 8.5 t0 -66.76 -94.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 108.119 158.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 29.3 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 127.238 2.215 . . . . 0.0 116.178 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.14 147.15 50.26 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 128.728 2.811 . . . . 0.0 110.058 176.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.8 tpt -151.56 -53.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.339 1.055 . . . . 0.0 111.947 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -137.11 131.15 32.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 125.322 1.449 . . . . 0.0 109.433 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.63 155.57 44.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.65 1.18 . . . . 0.0 109.583 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.9 117.2 18.93 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.137 0.975 . . . . 0.0 108.61 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.84 117.26 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.997 1.719 . . . . 0.0 108.547 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -41.02 -95.77 0.01 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 127.472 2.463 . . . . 0.0 117.519 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 t -162.19 -40.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.476 1.111 . . . . 0.0 111.908 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.61 35.84 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.656 1.582 . . . . 0.0 110.355 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.76 135.91 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.435 1.494 . . . . 0.0 109.245 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.98 153.73 25.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 109.5 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.63 142.39 47.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.199 1.0 . . . . 0.0 109.392 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.74 127.98 39.86 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.561 1.544 . . . . 0.0 107.412 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 pt -121.6 125.57 73.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.453 0.644 . . . . 0.0 109.707 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -140.05 100.03 3.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.933 1.349 . . . . 0.0 111.201 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.53 104.85 2.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.44 1.496 . . . . 0.0 111.303 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.46 154.11 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.327 1.537 . . . . 0.0 114.25 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -92.06 139.67 30.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.781 -1.199 . . . . 0.0 112.24 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.34 179.73 8.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.626 1.171 . . . . 0.0 111.597 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -136.83 44.0 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 126.022 1.729 . . . . 0.0 111.328 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 59.86 47.5 10.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.97 1.708 . . . . 0.0 112.332 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.7 p -79.36 179.78 1.69 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.719 2.008 . . . . 0.0 111.007 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 41.3 Cg_endo -70.45 12.08 0.42 Allowed 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.871 2.38 . . . . 0.0 114.397 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -145.18 65.99 12.22 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.597 1.559 . . . . 0.0 110.997 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.61 132.86 32.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.246 1.298 . . . . 0.0 109.359 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.41 164.35 11.28 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.215 171.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -57.55 109.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.385 0.674 . . . . 0.0 110.663 163.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -111.67 139.01 47.47 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.928 1.691 . . . . 0.0 109.259 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -160.77 158.75 29.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.06 0.933 . . . . 0.0 111.361 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.47 95.83 5.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.456 1.502 . . . . 0.0 109.613 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.07 108.15 1.75 Allowed 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.37 -0.831 . . . . 0.0 109.476 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.73 143.1 10.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.982 1.713 . . . . 0.0 113.209 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.39 138.11 57.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.872 0.869 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.41 73.32 0.49 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.436 1.493 . . . . 0.0 116.097 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.98 177.43 8.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.6 m -122.22 135.42 54.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.382 1.073 . . . . 0.0 109.402 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -115.26 134.82 54.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.467 1.507 . . . . 0.0 107.671 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -144.64 5.89 1.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.61 33.26 0.41 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.142 1.377 . . . . 0.0 111.595 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.59 -4.23 57.35 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.083 -1.011 . . . . 0.0 113.72 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.39 -13.13 26.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.13 0.972 . . . . 0.0 113.617 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.0 m -50.73 -32.79 20.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.901 1.681 . . . . 0.0 114.072 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -30.83 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.418 0.687 . . . . 0.0 112.254 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.6 t30 35.89 43.42 0.19 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.579 2.752 . . . . 0.0 115.456 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.42 95.12 0.12 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.884 1.23 . . . . 0.0 111.685 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.458 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 5.3 mp -140.25 155.71 46.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.833 2.053 . . . . 0.0 109.287 170.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 m -157.1 -32.68 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.388 1.075 . . . . 0.0 112.458 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -119.28 138.65 52.87 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.05 1.34 . . . . 0.0 109.822 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -130.44 129.68 43.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.13 1.372 . . . . 0.0 107.981 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -129.52 117.7 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.88 131.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.81 148.78 38.02 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.401 1.08 . . . . 0.0 109.675 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' CG ' ' CD2' ' A' ' 96' ' ' PHE . 77.8 Cg_endo -77.67 15.76 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.527 3.485 . . . . 0.0 112.907 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.18 -35.66 0.42 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.846 2.641 . . . . 0.0 116.042 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -34.21 73.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.987 1.715 . . . . 0.0 112.588 168.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.431 ' CD2' ' CG ' ' A' ' 93' ' ' PRO . 11.0 m-85 -92.54 138.2 31.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 110.325 174.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -79.35 -35.06 41.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.022 0.929 . . . . 0.0 111.74 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -158.58 170.75 21.49 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 109.756 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.65 165.15 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.042 0.937 . . . . 0.0 110.673 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.88 149.24 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.436 1.095 . . . . 0.0 109.928 -171.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -99.98 122.45 42.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.04 137.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.441 0.697 . . . . 0.0 110.456 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -138.53 155.36 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.174 1.39 . . . . 0.0 110.091 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 117' ' ' MET . 3.7 mt -124.06 135.67 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.46 121.74 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -85.04 118.72 24.78 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -102.91 -8.95 20.28 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.3 t -108.72 -57.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.952 0.901 . . . . 0.0 112.216 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.78 -33.49 76.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.024 0.53 . . . . 0.0 110.505 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.97 17.97 3.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.712 2.005 . . . . 0.0 114.381 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -103.02 -47.14 4.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 111.521 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 57.07 153.48 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.226 2.21 . . . . 0.0 116.072 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.37 58.93 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.834 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.7 p -90.43 -61.8 1.6 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.05 1.34 . . . . 0.0 112.203 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -47.23 108.39 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.254 2.222 . . . . 0.0 111.326 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.64 124.34 47.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.326 1.05 . . . . 0.0 109.209 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.483 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.5 tmm? -114.19 141.15 47.9 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.591 1.156 . . . . 0.0 109.255 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.9 m -132.03 137.38 47.8 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.344 1.458 . . . . 0.0 107.855 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 138' ' ' LEU . 14.2 pt -133.72 145.15 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 123.618 0.767 . . . . 0.0 111.123 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.0 m -135.61 95.68 14.08 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 108.916 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 75.49 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.291 3.328 . . . . 0.0 111.583 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 124' ' ' VAL . 58.9 t80 60.18 81.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.967 2.107 . . . . 0.0 112.041 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 42.93 46.28 4.6 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.911 1.684 . . . . 0.0 115.084 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 141' ' ' PRO . 11.9 t -121.92 168.6 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.322 2.249 . . . . 0.0 109.848 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -36.44 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.991 2.517 . . . . 0.0 113.7 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 145.31 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.241 1.016 . . . . 0.0 110.396 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 139.18 50.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 109.395 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.3 133.56 55.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.295 -1.32 . . . . 0.0 108.78 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.453 ' HB3' HG11 ' A' ' 136' ' ' VAL . 22.4 p -135.19 150.45 50.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.339 1.066 . . . . 0.0 110.431 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -102.61 144.08 31.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.753 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.59 27.43 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.128 2.171 . . . . 0.0 115.922 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.51 2.39 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.422 1.963 . . . . 0.0 114.089 -173.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.54 174.92 10.08 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.671 1.988 . . . . 0.0 110.11 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -56.57 158.99 4.05 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.887 -1.133 . . . . 0.0 112.468 163.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -51.96 153.66 2.51 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.72 0.808 . . . . 0.0 112.04 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 129' ' ' CYS . 29.0 m -107.16 139.09 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.435 0.636 . . . . 0.0 110.747 172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.21 108.19 11.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.787 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 119' ' ' ILE . 20.2 tp -88.22 112.29 48.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.194 1.398 . . . . 0.0 109.258 170.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 56.8 Cg_endo -78.5 152.36 26.32 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.823 1.682 . . . . 0.0 112.728 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 30.4 mm -133.8 131.77 21.25 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.428 1.491 . . . . 0.0 109.873 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.476 ' HG3' HG21 ' A' ' 124' ' ' VAL . 85.6 Cg_endo -75.94 170.96 19.05 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.281 2.654 . . . . 0.0 112.366 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.67 149.21 42.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.75 154.25 24.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.484 1.914 . . . . 0.0 109.877 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -134.78 135.93 24.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.392 1.077 . . . . 0.0 110.975 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 150.49 77.51 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.639 0.907 . . . . 0.0 111.421 -5.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.17 -32.15 74.51 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.76 1.64 . . . . 0.0 111.704 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.35 -5.91 4.08 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.706 2.002 . . . . 0.0 114.908 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 p -69.63 -178.87 1.56 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.873 -1.142 . . . . 0.0 112.276 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.87 150.49 40.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.034 0.934 . . . . 0.0 111.91 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.9 tt -107.02 138.69 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.379 1.472 . . . . 0.0 109.583 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.47 138.23 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.008 0.923 . . . . 0.0 109.617 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -141.6 131.31 24.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.999 -1.063 . . . . 0.0 110.601 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -82.9 141.52 32.14 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.545 -0.722 . . . . 0.0 109.84 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.24 111.17 13.64 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.616 1.166 . . . . 0.0 110.0 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.9 p -128.02 115.23 18.17 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.872 1.269 . . . . 0.0 110.34 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.59 121.34 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.301 1.44 . . . . 0.0 107.527 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -127.93 136.79 51.82 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.214 1.406 . . . . 0.0 108.911 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.26 130.48 35.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.234 0.54 . . . . 0.0 110.428 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -75.94 -30.81 58.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.232 1.013 . . . . 0.0 112.206 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.51 -179.29 4.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.839 2.055 . . . . 0.0 112.266 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.49 148.71 32.43 Favored Pre-proline 0 N--CA 1.481 1.105 0 O-C-N 121.214 -0.929 . . . . 0.0 112.651 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.3 17.15 11.71 Favored 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 119.956 1.02 . . . . 0.0 114.65 -1.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 63.61 18.69 11.27 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.204 1.802 . . . . 0.0 113.986 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -94.35 178.99 5.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.188 1.795 . . . . 0.0 112.289 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -79.37 144.31 34.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.65 -1.281 . . . . 0.0 112.328 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.48 -43.51 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.412 1.885 . . . . 0.0 110.994 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.6 t -140.39 123.55 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -135.97 97.39 3.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.43 10.35 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.667 1.127 . . . . 0.0 111.848 -168.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 m -139.13 169.63 17.44 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.291 1.036 . . . . 0.0 110.66 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.0 156.98 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 127.282 2.233 . . . . 0.0 108.461 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -120.96 139.76 52.81 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -120.23 130.79 54.68 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.286 -0.883 . . . . 0.0 109.7 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -120.56 153.37 36.84 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.294 1.437 . . . . 0.0 110.249 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -128.63 124.37 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.209 1.403 . . . . 0.0 110.132 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.8 m -95.55 113.75 62.47 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 109.823 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.16 -11.68 32.76 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.064 2.509 . . . . 0.0 112.827 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m -43.34 -48.22 6.87 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.878 2.471 . . . . 0.0 112.985 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 80.7 p -144.84 17.87 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.206 1.402 . . . . 0.0 112.395 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.0 88.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.681 -1.262 . . . . 0.0 113.542 -171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -73.77 152.07 40.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.811 0.805 . . . . 0.0 110.778 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.82 134.32 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.952 1.301 . . . . 0.0 108.351 167.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 17.8 m -134.83 109.34 8.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.034 1.734 . . . . 0.0 107.729 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 2.0 p -76.82 147.03 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.544 -0.722 . . . . 0.0 109.409 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.66 125.46 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.902 1.681 . . . . 0.0 106.893 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 135.92 44.31 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.642 1.177 . . . . 0.0 109.785 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -146.89 158.12 43.83 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.957 1.703 . . . . 0.0 109.914 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.53 -19.47 10.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.112 1.765 . . . . 0.0 113.944 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -58.09 -23.59 55.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -149.47 -46.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.029 1.332 . . . . 0.0 113.297 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -85.69 133.05 42.55 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.975 1.31 . . . . 0.0 109.392 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.01 -172.17 1.06 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 122.565 2.177 . . . . 0.0 112.676 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -107.08 -22.41 12.66 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.562 1.145 . . . . 0.0 113.526 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -55.12 -40.26 70.31 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.776 1.23 . . . . 0.0 112.566 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -105.46 144.47 32.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.939 1.695 . . . . 0.0 109.397 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.3 p -139.89 157.26 45.99 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.762 1.225 . . . . 0.0 109.536 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.3 127.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.851 0.461 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 51.5 m -119.06 131.4 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.617 1.567 . . . . 0.0 109.763 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -65.76 122.12 16.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.857 1.263 . . . . 0.0 111.066 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.36 -28.82 8.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.029 0.932 . . . . 0.0 112.057 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.73 -175.27 4.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.357 1.863 . . . . 0.0 110.914 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.58 -31.48 64.27 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.08 1.352 . . . . 0.0 113.764 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 61.3 p -143.4 33.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.422 . . . . 0.0 111.813 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 48.9 m -129.71 134.4 47.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.866 0.867 . . . . 0.0 111.943 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.456 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 23.8 m-85 -130.88 138.96 50.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.877 1.671 . . . . 0.0 110.801 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 34.5 mt -125.19 122.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -98.03 112.28 24.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.689 1.996 . . . . 0.0 108.348 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -103.28 124.18 48.17 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.27 116.58 32.19 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 110.945 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -120.2 20.81 11.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.541 1.937 . . . . 0.0 112.172 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.76 -168.91 3.22 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.332 1.453 . . . . 0.0 111.614 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.76 26.47 1.39 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.824 -1.173 . . . . 0.0 113.778 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 127.746 2.419 . . . . 0.0 115.01 -166.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.238 0.542 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.15 138.82 57.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.919 0.888 . . . . 0.0 110.318 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.35 -13.06 4.46 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -117.19 9.38 13.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.438 2.295 . . . . 0.0 112.635 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -144.56 175.15 10.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.33 1.852 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.97 154.97 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.194 0.998 . . . . 0.0 109.452 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 149.39 42.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.88 1.272 . . . . 0.0 110.391 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.79 26.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.068 1.347 . . . . 0.0 108.942 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.33 131.83 38.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.114 1.366 . . . . 0.0 110.7 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -79.52 51.95 1.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.605 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.26 134.95 2.27 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 120.21 -1.556 . . . . 0.0 112.869 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 145.72 14.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.656 0.782 . . . . 0.0 111.102 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.48 26.22 13.99 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.3 t 67.25 71.8 0.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.824 1.649 . . . . 0.0 111.578 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -137.83 -178.14 5.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.524 1.529 . . . . 0.0 112.181 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.88 -82.89 0.5 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 126.066 1.793 . . . . 0.0 115.173 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -138.57 163.85 30.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.747 1.619 . . . . 0.0 110.345 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.2 p -135.75 145.32 46.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.217 1.007 . . . . 0.0 112.882 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -156.61 169.76 23.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.54 1.536 . . . . 0.0 111.821 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.21 153.91 48.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.307 1.443 . . . . 0.0 110.689 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.99 131.13 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.392 1.477 . . . . 0.0 109.731 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.62 128.43 33.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.864 . . . . 0.0 109.924 175.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -54.55 139.9 36.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.75 0.82 . . . . 0.0 110.979 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.72 42.79 16.31 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.48 0.562 . . . . 0.0 112.527 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -133.32 154.62 50.55 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.514 1.525 . . . . 0.0 111.291 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m -140.09 122.51 16.07 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.132 1.373 . . . . 0.0 108.393 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.97 153.81 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.024 0.916 . . . . 0.0 110.549 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.7 mtm-85 -133.74 118.84 18.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.9 1.68 . . . . 0.0 107.873 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.7 m0 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -67.57 -19.48 65.27 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.859 1.664 . . . . 0.0 114.084 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.03 -68.86 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.122 165.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 28.22 37.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.15 2.58 . . . . 0.0 116.194 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -136.15 127.68 28.71 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.593 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -158.17 -39.72 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 111.387 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -142.2 126.14 17.22 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.246 1.018 . . . . 0.0 110.052 164.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.8 m -133.6 155.05 50.36 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.002 0.906 . . . . 0.0 109.398 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.04 127.13 33.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.86 108.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.753 1.621 . . . . 0.0 108.95 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.38 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.472 1.037 0 C-N-CA 128.383 2.897 . . . . 0.0 117.589 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -166.86 -42.8 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.146 0.978 . . . . 0.0 112.561 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -106.94 37.63 2.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.395 1.478 . . . . 0.0 110.481 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' PRO . 4.5 m -143.61 158.59 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.358 1.863 . . . . 0.0 110.688 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -139.05 150.97 46.37 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.546 1.938 . . . . 0.0 109.909 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.62 126.53 54.3 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.176 0.59 . . . . 0.0 109.82 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -116.32 120.35 38.61 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.624 1.169 . . . . 0.0 108.145 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 HD11 ' A' ' 86' ' ' LEU . 1.3 pp -113.63 115.22 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 110.411 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -124.16 123.66 40.77 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.598 1.159 . . . . 0.0 108.796 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.21 -45.06 84.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 112.782 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 172.01 16.35 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.652 1.981 . . . . 0.0 107.66 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -60.13 -66.33 0.54 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.385 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.255 1.8 pp20? 48.72 167.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.59 54.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.349 -1.469 . . . . 0.0 112.554 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.263 44.0 m-20 53.33 45.97 27.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.349 1.859 . . . . 0.0 112.485 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -73.61 166.38 44.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.03 22.52 0.31 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.536 2.824 . . . . 0.0 113.835 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -152.23 58.63 2.66 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 126.467 1.907 . . . . 0.0 111.277 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.9 134.39 34.41 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.551 1.5 . . . . 0.0 109.552 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -101.81 0.1 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.814 0.721 . . . . 0.0 111.8 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 154.77 44.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.893 1.277 . . . . 0.0 111.881 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.61 139.26 16.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.852 1.661 . . . . 0.0 110.59 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -158.61 159.07 35.03 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.167 0.984 . . . . 0.0 111.768 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.88 90.4 3.19 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.514 1.525 . . . . 0.0 108.923 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.71 105.33 0.79 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 148.57 11.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.428 1.891 . . . . 0.0 113.8 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.57 151.78 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.47 1.108 . . . . 0.0 112.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.33 52.78 45.22 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 124.655 1.121 . . . . 0.0 114.997 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.78 175.45 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.815 0.846 . . . . 0.0 112.874 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.1 m -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.16 1.384 . . . . 0.0 109.698 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.33 121.71 19.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.84 1.256 . . . . 0.0 109.314 -175.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -117.9 15.79 14.31 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.066 1.746 . . . . 0.0 112.671 -172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -140.23 38.66 1.92 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.328 1.451 . . . . 0.0 112.741 -171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.86 -17.36 64.86 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.797 -1.189 . . . . 0.0 111.971 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -56.49 -19.19 14.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.81 1.644 . . . . 0.0 114.624 168.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.2 t -54.14 -27.27 32.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.247 -0.908 . . . . 0.0 112.285 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.0 mt -134.07 73.87 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 127.046 2.138 . . . . 0.0 108.848 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -60.94 -23.08 65.02 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.809 -1.182 . . . . 0.0 112.657 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.38 80.33 0.15 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.8 1.666 . . . . 0.0 113.232 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 54' ' ' ILE . 1.6 mp -124.59 153.03 42.8 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.9 1.68 . . . . 0.0 111.661 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -158.53 -22.12 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.471 1.509 . . . . 0.0 114.201 161.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.06 129.45 55.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.474 1.51 . . . . 0.0 108.75 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.65 121.07 31.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.93 132.38 54.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -126.37 130.17 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 pp -144.82 148.81 40.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.406 0.682 . . . . 0.0 110.152 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 96' ' ' PHE . 36.7 Cg_endo -68.52 155.06 70.33 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.898 1.732 . . . . 0.0 112.391 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.95 -24.3 64.64 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.059 0.838 . . . . 0.0 114.528 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.43 -22.88 67.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.52 1.128 . . . . 0.0 113.679 169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 93' ' ' PRO . 11.5 m-30 -111.0 130.08 55.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.933 1.693 . . . . 0.0 108.741 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -85.75 -40.16 16.37 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.505 -1.372 . . . . 0.0 112.194 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' HD12 ' A' ' 140' ' ' ILE . 39.1 p-90 -152.23 159.28 43.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.77 2.028 . . . . 0.0 109.041 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.02 146.41 50.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.609 0.763 . . . . 0.0 110.766 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.91 135.19 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.747 1.219 . . . . 0.0 110.166 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -77.23 134.66 38.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.276 0.63 . . . . 0.0 109.885 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.55 140.4 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 109.938 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.33 157.15 45.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.06 1.744 . . . . 0.0 110.609 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 92.6 mt -118.76 139.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.959 2.104 . . . . 0.0 109.535 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.33 106.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.755 1.622 . . . . 0.0 109.601 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.69 111.83 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.415 0.686 . . . . 0.0 110.727 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.8 15.35 11.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.421 1.088 . . . . 0.0 111.466 168.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -96.28 -61.83 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.869 1.667 . . . . 0.0 111.063 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -151.63 99.08 2.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.386 1.875 . . . . 0.0 108.799 -172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.5 m -53.16 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.88 1.672 . . . . 0.0 113.052 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.1 m -146.69 -53.89 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.743 1.617 . . . . 0.0 110.779 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.2 159.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.175 2.19 . . . . 0.0 114.96 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.42 -36.1 0.44 Allowed Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.531 -1.355 . . . . 0.0 115.293 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.6 m -64.63 1.7 0.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.175 2.19 . . . . 0.0 115.033 170.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.446 ' CE2' HG21 ' A' ' 166' ' ' VAL . 17.9 t80 -134.99 122.18 21.5 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.258 2.223 . . . . 0.0 109.76 -173.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -132.18 130.34 40.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.958 1.303 . . . . 0.0 110.387 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 3.6 ttm -115.57 141.57 47.88 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.694 1.598 . . . . 0.0 110.632 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.6 m -128.27 116.41 19.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.573 1.149 . . . . 0.0 108.171 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mt -96.64 122.83 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.4 m -116.04 87.54 19.38 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.981 1.712 . . . . 0.0 109.24 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.0 163.53 37.32 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.58 2.853 . . . . 0.0 112.465 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -45.16 96.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.577 1.951 . . . . 0.0 113.259 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 37.29 47.47 0.69 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.267 1.827 . . . . 0.0 114.881 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.34 155.18 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.966 1.707 . . . . 0.0 109.535 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.75 92.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.356 1.462 . . . . 0.0 112.288 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.51 160.47 4.18 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.475 1.51 . . . . 0.0 111.523 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.49 145.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 111.391 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.85 138.86 33.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.457 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 39.8 t -135.78 124.61 24.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.339 1.455 . . . . 0.0 107.855 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -118.52 141.19 48.82 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 109.03 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.92 105.23 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.431 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.15 63.0 0.32 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.318 0.961 . . . . 0.0 113.658 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -141.59 155.89 45.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.456 1.903 . . . . 0.0 111.657 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.38 55.11 2.71 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.609 -1.307 . . . . 0.0 111.662 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 59.61 169.78 0.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.539 1.936 . . . . 0.0 112.826 -167.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.14 126.17 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.845 -1.159 . . . . 0.0 109.741 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 127.17 31.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.841 0.456 . . . . 0.0 110.047 171.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.18 95.83 47.98 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.059 1.743 . . . . 0.0 107.685 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 55.4 Cg_endo -77.98 148.13 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.903 2.402 . . . . 0.0 112.669 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.411 HD12 ' CZ3' ' A' ' 98' ' ' TRP . 87.2 mt -136.03 131.72 18.98 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.309 1.443 . . . . 0.0 109.1 -174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.47 169.85 21.34 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.922 3.748 . . . . 0.0 112.112 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -68.6 149.04 49.63 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.517 -0.739 . . . . 0.0 111.677 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.61 163.63 39.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.097 2.159 . . . . 0.0 109.573 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.3 m -131.25 131.4 23.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.942 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.97 153.63 80.41 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 119.343 0.801 . . . . 0.0 111.877 -3.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.85 -17.28 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.734 1.623 . . . . 0.0 112.886 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.49 13.53 21.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 114.415 169.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.87 152.11 46.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.744 -1.223 . . . . 0.0 112.437 174.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.79 113.63 19.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.315 0.646 . . . . 0.0 111.018 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.6 tt -85.71 120.25 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.62 0.768 . . . . 0.0 109.828 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.49 139.42 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.542 0.687 . . . . 0.0 110.703 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.1 t -143.8 150.42 38.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.44 1.096 . . . . 0.0 109.798 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -111.32 145.17 39.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.704 0.802 . . . . 0.0 109.62 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 tt -133.85 120.73 20.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.665 0.745 . . . . 0.0 109.311 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.04 124.45 26.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.309 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 116' ' ' GLU . 2.2 p -145.34 135.16 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.57 1.148 . . . . 0.0 109.698 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 162.14 35.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.226 1.41 . . . . 0.0 111.523 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -66.5 128.52 36.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.126 170.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.9 p -73.57 -6.46 46.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.892 0.877 . . . . 0.0 113.326 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -122.54 141.0 52.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.279 2.232 . . . . 0.0 108.869 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -65.59 140.84 97.66 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.696 -0.668 . . . . 0.0 111.643 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 131.67 20.94 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.415 1.184 . . . . 0.0 111.492 -4.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -73.68 41.68 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 112.499 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.91 126.7 14.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -68.63 82.15 0.28 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.391 1.077 . . . . 0.0 110.046 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 156' ' ' VAL . 14.0 m -45.91 -37.84 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.976 1.71 . . . . 0.0 113.017 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 33.7 t -147.88 136.9 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.488 1.115 . . . . 0.0 109.697 165.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -142.03 115.2 8.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.787 1.235 . . . . 0.0 108.137 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.35 -162.21 24.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.02 0.819 . . . . 0.0 113.298 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.92 153.66 51.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.625 1.17 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.92 143.58 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.168 1.787 . . . . 0.0 109.245 -175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -115.05 115.11 26.28 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.182 -0.949 . . . . 0.0 109.328 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 152.82 26.16 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.462 -0.774 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.77 154.65 45.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 108.709 167.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -127.91 127.48 43.44 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.869 1.268 . . . . 0.0 108.727 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.3 m -86.17 106.68 10.64 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.59 -17.68 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.43 2.753 . . . . 0.0 112.514 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.3 m -55.91 -38.83 70.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.199 1.8 . . . . 0.0 113.079 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.8 p -147.75 24.59 1.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.013 1.325 . . . . 0.0 112.705 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 50.71 31.12 22.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.406 1.955 . . . . 0.0 115.851 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.59 164.5 25.76 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.182 0.991 . . . . 0.0 111.152 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.62 135.5 55.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.074 1.35 . . . . 0.0 109.008 165.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.9 m -133.49 107.17 7.87 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.481 HG11 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -83.83 151.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.4 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.91 135.44 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 125.874 1.67 . . . . 0.0 107.709 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.472 ' HD2' HG21 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 140.2 36.23 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.833 1.653 . . . . 0.0 107.425 177.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -125.29 146.14 49.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.303 1.441 . . . . 0.0 108.353 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.95 -14.42 47.07 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -17.44 61.05 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 171.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.0 p -130.38 -32.3 1.77 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.608 1.563 . . . . 0.0 113.231 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.95 146.89 76.41 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.996 1.318 . . . . 0.0 110.782 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.28 -7.72 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.586 2.857 . . . . 0.0 113.99 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.4 tttm 64.56 -24.2 0.08 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.341 2.656 . . . . 0.0 115.993 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -67.74 -18.17 64.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.43 1.092 . . . . 0.0 113.685 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.7 ttm -103.3 151.44 22.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.563 1.945 . . . . 0.0 109.418 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.0 p -131.76 159.67 37.8 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.455 1.502 . . . . 0.0 110.144 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 186' ' ' LYS . 77.8 t -121.61 130.75 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.157 0.983 . . . . 0.0 109.683 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.2 m -134.31 126.78 30.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.471 1.109 . . . . 0.0 108.697 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.42 141.4 28.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.565 1.146 . . . . 0.0 110.481 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -117.47 -36.18 3.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.564 0.746 . . . . 0.0 111.704 171.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -129.38 178.78 6.2 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.527 1.131 . . . . 0.0 111.849 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.78 -40.41 63.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.226 1.01 . . . . 0.0 112.144 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -137.01 33.8 2.61 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 111.205 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.7 t -129.18 116.99 20.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.882 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.481 ' CE2' HG11 ' A' ' 184' ' ' VAL . 2.5 t80 -100.17 136.29 40.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.365 2.266 . . . . 0.0 109.73 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.04 112.77 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.608 1.163 . . . . 0.0 109.54 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.02 120.19 22.5 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.109 1.363 . . . . 0.0 109.872 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -106.41 133.79 50.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 45.6 tp -127.47 111.54 13.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.812 -0.555 . . . . 0.0 110.966 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.58 -26.19 15.33 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.92 132.57 53.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 111.053 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.6 -48.91 79.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 127.264 2.225 . . . . 0.0 112.507 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' CD ' ' A' ' 9' ' ' LYS . 9.9 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.075 0.464 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.57 144.34 43.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.623 0.369 . . . . 0.0 110.686 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.86 -17.12 34.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.037 -1.039 . . . . 0.0 113.179 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -108.91 13.47 24.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.442 1.897 . . . . 0.0 113.275 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -137.55 170.96 15.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 46' ' ' VAL . 3.8 m -142.58 151.58 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.0 110.517 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' CD ' HG23 ' A' ' 3' ' ' VAL . 2.4 mptm? -130.51 152.11 50.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.112 0.965 . . . . 0.0 110.812 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.74 133.99 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 108.256 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -121.73 127.73 51.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.818 1.647 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.42 61.4 6.17 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.761 1.225 . . . . 0.0 110.884 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.42 142.99 3.86 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.235 0.922 . . . . 0.0 112.019 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -59.2 132.17 53.22 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.948 0.874 . . . . 0.0 109.669 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 t30 77.09 41.88 0.15 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.743 1.617 . . . . 0.0 113.199 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.343 31.1 p 49.87 58.2 5.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.921 2.488 . . . . 0.0 115.485 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 p -127.81 179.47 5.53 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.164 1.785 . . . . 0.0 113.18 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.23 -74.74 1.84 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.463 1.982 . . . . 0.0 113.957 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -139.13 170.16 16.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.655 1.582 . . . . 0.0 109.781 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -137.32 143.91 42.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.535 1.134 . . . . 0.0 111.166 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -143.4 155.46 44.41 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.552 1.541 . . . . 0.0 110.465 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -125.67 134.8 51.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.761 1.224 . . . . 0.0 109.204 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' HB2' HG23 ' A' ' 8' ' ' VAL . 17.8 m-85 -127.52 131.33 50.09 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.483 1.135 . . . . 0.0 110.521 -175.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -91.91 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.716 1.207 . . . . 0.0 109.349 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 145.07 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.819 -0.55 . . . . 0.0 112.409 172.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.7 73.08 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.172 0.415 . . . . 0.0 113.837 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -127.9 126.01 40.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.297 1.439 . . . . 0.0 109.936 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m -109.19 126.56 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.25 146.1 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 110.037 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -125.95 144.37 50.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.037 1.335 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 125.43 1.492 . . . . 0.0 109.628 173.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.2 m0 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -76.19 -45.4 33.45 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 111.34 173.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.66 35.73 0.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.265 1.426 . . . . 0.0 113.15 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -16.12 62.67 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 119.651 -1.906 . . . . 0.0 114.247 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.7 134.76 56.49 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 mtp -150.01 -58.76 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 112.07 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -136.27 115.54 12.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.948 1.299 . . . . 0.0 109.905 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.08 146.95 37.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.709 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.87 128.15 43.27 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.112 1.365 . . . . 0.0 109.081 -168.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 8' ' ' VAL . 59.0 t -118.55 119.75 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.268 1.427 . . . . 0.0 110.185 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.74 0.01 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.516 1.532 . . . . 0.0 116.66 -164.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.33 -21.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 27.34 7.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.798 1.639 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.77 141.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.912 2.085 . . . . 0.0 109.416 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -116.23 153.06 32.55 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.12 128.33 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.232 0.539 . . . . 0.0 109.626 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.24 126.15 54.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.073 0.949 . . . . 0.0 108.448 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.6 pp -117.26 104.18 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 122.194 0.997 . . . . 0.0 109.516 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.82 123.05 49.34 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.611 1.164 . . . . 0.0 108.769 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.84 -57.87 10.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.161 0.982 . . . . 0.0 111.491 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 158.42 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.657 1.183 . . . . 0.0 109.383 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.42 124.38 33.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' H ' ' HB2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -159.8 172.97 16.71 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.588 1.555 . . . . 0.0 111.999 -169.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.0 pt -123.68 34.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.503 -1.373 . . . . 0.0 114.211 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.299 67.4 m-20 61.94 51.04 3.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.979 2.112 . . . . 0.0 111.689 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p -65.74 166.41 15.28 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.655 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 56.6 Cg_endo -73.37 20.38 0.36 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 123.456 2.771 . . . . 0.0 114.285 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -148.03 63.7 7.67 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.656 1.582 . . . . 0.0 111.957 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.64 140.42 62.25 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.751 1.634 . . . . 0.0 110.535 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.02 -92.81 1.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -145.62 153.92 41.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.174 1.39 . . . . 0.0 110.787 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -153.33 137.55 16.53 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.056 1.342 . . . . 0.0 108.715 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -155.83 164.67 38.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.377 1.084 . . . . 0.0 111.198 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -133.84 104.84 6.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.391 1.076 . . . . 0.0 108.355 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -68.23 115.31 7.54 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.813 0.845 . . . . 0.0 109.598 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.17 152.92 1.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.155 1.782 . . . . 0.0 112.882 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.83 -21.93 32.75 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.87 88.16 0.12 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.135 1.35 . . . . 0.0 112.282 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -161.05 171.75 18.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.674 1.19 . . . . 0.0 112.446 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.0 m -124.3 140.11 53.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.35 1.06 . . . . 0.0 109.187 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -131.09 119.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -107.58 -20.87 13.1 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.865 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -121.43 49.69 1.49 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.85 -16.72 59.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.103 -0.998 . . . . 0.0 112.626 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.19 -17.28 2.67 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.972 1.309 . . . . 0.0 114.36 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -55.15 -29.56 58.02 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.473 -1.392 . . . . 0.0 113.656 165.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 tp -78.58 -39.33 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.899 0.772 . . . . 0.0 112.195 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 33.58 43.78 0.06 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.256 1.822 . . . . 0.0 114.293 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.86 61.96 0.14 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.753 -155.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 ' HB ' ' A' ' 54' ' ' ILE . 27.2 tp -139.9 124.85 18.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.268 1.027 . . . . 0.0 110.4 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -132.05 -15.67 2.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -129.99 110.1 11.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.383 1.473 . . . . 0.0 109.443 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 120.66 43.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -168.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -116.62 112.39 21.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 109.59 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG13 HG21 ' A' ' 8' ' ' VAL . 38.5 t -95.26 131.19 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.586 1.554 . . . . 0.0 109.182 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.75 HD13 ' CE1' ' A' ' 96' ' ' PHE . 11.2 mt -132.06 136.2 27.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.415 0.686 . . . . 0.0 110.376 -161.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.2 14.91 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.561 2.841 . . . . 0.0 114.535 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.14 -35.54 0.64 Allowed Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.997 2.237 . . . . 0.0 115.023 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.33 65.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.847 1.659 . . . . 0.0 112.526 167.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.75 ' CE1' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -50.18 153.08 1.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.876 1.271 . . . . 0.0 110.757 159.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HG3' ' CZ3' ' A' ' 98' ' ' TRP . 27.6 tp60 -132.28 -33.89 1.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.327 0.651 . . . . 0.0 111.842 167.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -151.63 166.94 29.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.068 1.747 . . . . 0.0 109.673 171.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.4 166.26 23.58 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.142 0.973 . . . . 0.0 111.193 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 HG11 ' A' ' 182' ' ' VAL . 9.2 p -134.51 121.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.698 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.84 120.74 19.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -115.46 144.77 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.976 1.31 . . . . 0.0 109.414 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.35 152.11 40.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.761 1.624 . . . . 0.0 108.912 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.8 mt -123.13 124.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.512 0.725 . . . . 0.0 109.62 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -124.65 116.64 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.475 1.51 . . . . 0.0 109.631 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -83.31 120.36 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.161 1.784 . . . . 0.0 110.68 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.64 27.03 4.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.102 1.761 . . . . 0.0 111.405 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.85 -56.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.95 1.7 . . . . 0.0 111.37 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -119.74 128.48 53.8 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.217 1.407 . . . . 0.0 109.743 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.6 56.6 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.967 1.307 . . . . 0.0 111.702 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.9 m -132.76 -66.32 0.68 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.004 1.322 . . . . 0.0 111.349 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.67 170.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -172.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.59 -12.61 60.72 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.468 -1.395 . . . . 0.0 115.178 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 p -110.3 -25.94 9.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.573 1.549 . . . . 0.0 113.894 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.98 135.02 46.27 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 165.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -131.88 138.77 48.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.147 0.975 . . . . 0.0 109.817 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.637 ' HG3' HG22 ' A' ' 156' ' ' VAL . 2.8 ttp -121.8 137.29 54.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.683 2.393 . . . . 0.0 108.165 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.0 m -136.45 135.52 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.12 123.66 54.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -120.8 90.55 46.59 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.016 1.327 . . . . 0.0 110.416 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.22 82.07 1.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.064 3.176 . . . . 0.0 113.126 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 55.32 57.83 5.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.293 1.437 . . . . 0.0 112.129 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.83 50.09 16.43 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.377 1.471 . . . . 0.0 113.239 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.92 169.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 127.692 2.397 . . . . 0.0 109.243 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.15 79.56 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.936 2.894 . . . . 0.0 114.579 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 159.75 30.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.212 1.405 . . . . 0.0 110.504 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.39 151.18 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.438 1.095 . . . . 0.0 109.652 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.29 131.02 54.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.047 0.939 . . . . 0.0 109.593 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.536 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -137.62 150.64 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -144.92 137.99 26.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.468 1.107 . . . . 0.0 110.537 -170.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.76 100.75 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.084 2.154 . . . . 0.0 111.564 -173.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.14 43.74 0.59 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.327 0.489 . . . . 0.0 114.123 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -136.32 164.52 27.91 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.678 1.591 . . . . 0.0 111.784 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.49 165.64 18.59 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.126 -0.984 . . . . 0.0 111.565 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -54.38 132.0 43.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.222 -0.924 . . . . 0.0 111.404 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 129' ' ' CYS . 14.9 t -100.18 116.07 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.768 1.227 . . . . 0.0 110.446 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.47 100.43 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.87 1.268 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mt -83.02 112.71 40.4 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.289 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.41 134.48 15.57 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.486 2.124 . . . . 0.0 110.342 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 mm -122.89 124.29 26.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.487 1.515 . . . . 0.0 108.644 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.65 174.2 13.05 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.593 2.862 . . . . 0.0 112.564 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.11 137.84 58.22 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.585 -0.697 . . . . 0.0 111.756 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.2 pp -151.79 38.19 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.162 1.385 . . . . 0.0 112.723 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 t -40.25 138.29 1.17 Allowed Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 127.381 2.272 . . . . 0.0 114.766 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.55 158.62 90.16 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 CA-C-N 119.836 0.977 . . . . 0.0 113.137 0.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.59 -33.82 66.02 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.067 1.844 . . . . 0.0 112.877 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.28 0.79 9.01 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.106 1.362 . . . . 0.0 114.618 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 p -66.94 175.62 2.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.293 1.044 . . . . 0.0 113.268 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.61 103.76 7.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.544 1.538 . . . . 0.0 110.508 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 tt -78.61 132.08 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.845 1.258 . . . . 0.0 110.181 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.17 143.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 110.363 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.4 t -137.35 153.43 50.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.56 1.144 . . . . 0.0 109.135 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -112.17 119.82 39.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 tt -101.18 126.2 47.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.977 1.311 . . . . 0.0 109.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.46 125.14 37.86 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.635 1.574 . . . . 0.0 108.817 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 117' ' ' MET . 2.4 t -129.33 119.19 47.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.809 1.243 . . . . 0.0 109.033 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -147.91 149.08 31.58 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.644 1.178 . . . . 0.0 109.802 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -70.87 134.08 47.0 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.217 -0.302 . . . . 0.0 110.948 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.1 p -72.71 -19.23 61.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.486 1.515 . . . . 0.0 113.733 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 169.62 10.95 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.321 1.848 . . . . 0.0 111.298 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 p -53.18 146.09 22.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.252 1.021 . . . . 0.0 113.583 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.0 6.39 18.37 Favored 'Cis proline' 0 CA--C 1.545 1.056 0 N-CA-C 114.933 1.09 . . . . 0.0 114.933 4.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.93 24.47 14.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.837 1.255 . . . . 0.0 112.377 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.17 142.19 43.55 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.623 -1.298 . . . . 0.0 111.015 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -57.9 146.17 33.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.11 0.564 . . . . 0.0 111.379 168.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.38 -40.67 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.348 1.059 . . . . 0.0 111.604 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.6 t -146.67 137.92 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.584 0.754 . . . . 0.0 109.402 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -149.6 139.13 21.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.56 1.144 . . . . 0.0 110.445 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.66 -172.37 44.15 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.71 0.671 . . . . 0.0 114.238 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.7 m -115.81 132.25 56.7 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.718 0.807 . . . . 0.0 111.598 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.61 116.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.976 2.11 . . . . 0.0 108.139 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.4 138.68 31.35 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.89 -1.131 . . . . 0.0 109.143 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -112.77 146.53 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.134 0.968 . . . . 0.0 109.629 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -141.26 152.2 44.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.916 1.686 . . . . 0.0 108.209 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' ' HA2' ' A' ' 180' ' ' GLY . 31.8 t80 -121.13 150.25 41.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.788 1.235 . . . . 0.0 109.43 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 m -111.23 105.38 56.96 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 123.804 0.842 . . . . 0.0 109.458 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.44 48.69 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.855 1 C-N-CA 126.271 4.648 . . . . 0.0 113.596 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.4 t -123.04 -45.43 2.13 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.408 1.483 . . . . 0.0 110.923 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.9 p -151.09 34.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.227 1.811 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 175' ' ' TYR . . . 58.98 32.8 71.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.978 1.275 . . . . 0.0 114.878 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.48 171.3 15.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.761 1.28 . . . . 0.0 110.948 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.443 HG11 HG23 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -132.69 152.43 36.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.453 1.101 . . . . 0.0 109.794 177.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 m -138.32 140.93 39.73 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.43 1.892 . . . . 0.0 107.468 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.49 HG22 ' HD2' ' A' ' 186' ' ' LYS . 1.1 p -110.29 141.54 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 24.9 mt -133.02 120.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.49 ' HD2' HG22 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -138.96 142.31 38.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.635 1.174 . . . . 0.0 109.037 175.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 140.4 52.75 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.057 1.343 . . . . 0.0 108.309 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.48 -20.09 11.64 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.66 -16.36 64.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.282 1.433 . . . . 0.0 114.607 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 32.7 p -141.07 -42.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.697 1.599 . . . . 0.0 113.59 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.432 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 10.0 t80 -88.19 146.82 38.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.983 1.313 . . . . 0.0 110.591 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 45.9 Cg_endo -76.03 168.99 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.224 2.616 . . . . 0.0 112.656 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -94.77 10.87 33.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.482 1.513 . . . . 0.0 112.514 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -93.64 -44.51 8.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 111.986 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -100.48 144.87 28.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.366 1.466 . . . . 0.0 109.108 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -139.97 158.46 44.03 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.07 1.348 . . . . 0.0 108.978 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 72.1 t -121.01 135.56 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.3 m -127.91 126.1 40.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.16 0.984 . . . . 0.0 109.092 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -68.06 137.0 54.67 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.417 0.687 . . . . 0.0 110.401 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.69 -26.79 2.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.318 1.047 . . . . 0.0 112.945 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -161.4 172.52 16.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.139 1.776 . . . . 0.0 111.039 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' A' ' 59' ' ' GLU . 8.0 t30 -58.09 136.21 57.15 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.915 -1.116 . . . . 0.0 109.942 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.413 ' HA ' ' CG1' ' A' ' 182' ' ' VAL 0.25 2.3 p 56.31 6.51 0.26 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 31.8 m -113.67 133.4 55.34 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.989 1.316 . . . . 0.0 111.412 -169.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 4.4 m-85 -142.49 137.61 30.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.734 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 60.9 mt -122.67 118.95 56.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.31 126.85 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.205 1.402 . . . . 0.0 108.707 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -119.26 132.32 55.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.753 1.221 . . . . 0.0 109.388 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.5 tt -113.7 125.44 54.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 109.526 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -128.62 3.71 5.53 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.583 1.153 . . . . 0.0 113.864 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 m -150.5 115.63 5.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.547 1.939 . . . . 0.0 110.675 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -52.88 -35.41 57.8 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 119.618 1.099 . . . . 0.0 113.682 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.949 1.7 . . . . 0.0 113.453 -168.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.612 0.72 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.17 138.26 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.392 166.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.39 139.7 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -15.94 34.32 Favored 'General case' 0 CA--C 1.55 0.95 0 O-C-N 120.464 -1.397 . . . . 0.0 113.42 172.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -108.48 2.09 22.03 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.09 2.156 . . . . 0.0 113.349 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -144.89 175.45 10.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 126.854 2.062 . . . . 0.0 110.24 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 m -134.25 158.33 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 121.141 -0.974 . . . . 0.0 111.124 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -149.44 143.92 26.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.356 0.662 . . . . 0.0 112.604 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -134.79 131.36 37.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.418 1.887 . . . . 0.0 109.362 -165.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.32 137.39 51.92 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.604 1.562 . . . . 0.0 110.286 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.94 45.23 0.7 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.809 1.644 . . . . 0.0 112.901 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.15 132.92 2.12 Favored Glycine 0 CA--C 1.519 0.306 0 O-C-N 120.282 -1.511 . . . . 0.0 111.527 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 148.14 7.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.978 0.911 . . . . 0.0 110.722 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.48 25.97 13.67 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m 63.98 72.33 0.46 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.567 2.347 . . . . 0.0 114.803 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -137.18 -179.4 5.69 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.311 1.445 . . . . 0.0 112.382 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.21 -72.76 2.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.436 1.493 . . . . 0.0 115.466 169.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.36 165.23 28.51 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.69 1.996 . . . . 0.0 108.933 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.8 p -127.02 154.16 44.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.531 1.132 . . . . 0.0 112.609 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.04 146.23 20.22 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.853 1.661 . . . . 0.0 109.897 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.27 141.71 45.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.81 1.244 . . . . 0.0 110.356 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -136.44 129.37 31.03 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.766 1.226 . . . . 0.0 110.592 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -72.89 158.97 34.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.37 0.605 . . . . 0.0 111.518 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -62.0 147.3 47.54 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.574 -0.704 . . . . 0.0 111.622 170.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.6 45.55 75.99 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.653 0.644 . . . . 0.0 113.493 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.74 159.46 39.63 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.907 0.883 . . . . 0.0 112.117 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.3 m -136.52 132.93 35.93 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.937 1.295 . . . . 0.0 108.449 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.58 159.69 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.767 1.227 . . . . 0.0 110.883 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -130.2 118.94 22.15 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 108.303 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -118.57 92.03 3.71 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.05 153.41 25.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.714 1.206 . . . . 0.0 112.013 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -144.44 54.75 1.27 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.021 1.728 . . . . 0.0 109.789 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.43 40.53 39.55 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 124.212 0.911 . . . . 0.0 114.688 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.328 0.2 OUTLIER 63.39 86.31 0.12 Allowed 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 177.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -174.92 -79.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.097 2.559 . . . . 0.0 111.388 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -101.78 30.82 4.14 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 126.327 1.851 . . . . 0.0 112.212 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.47 -38.34 71.26 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.455 1.102 . . . . 0.0 110.673 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -39.44 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.035 2.534 . . . . 0.0 111.717 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 37.8 42.25 0.39 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 112.654 -175.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 86' ' ' LEU . 2.8 p90 -148.03 155.34 41.38 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 122.542 1.163 . . . . 0.0 111.511 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -152.91 -45.45 0.1 Allowed 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.229 163.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -120.45 129.43 53.87 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.448 1.022 . . . . 0.0 109.58 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 14.6 p -140.78 158.33 44.13 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.167 0.984 . . . . 0.0 112.391 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.95 134.48 47.49 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.966 1.306 . . . . 0.0 108.269 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -129.76 105.23 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.304 1.442 . . . . 0.0 108.573 -171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.19 152.81 6.39 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.217 1.389 . . . . 0.0 114.96 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -64.31 -2.83 2.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -135.63 29.7 3.21 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.329 1.451 . . . . 0.0 112.238 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -148.5 155.13 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 127.816 2.446 . . . . 0.0 109.996 172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 70' ' ' GLU . 12.6 ttt85 -125.54 152.76 44.61 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.514 1.526 . . . . 0.0 109.569 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 m -116.46 149.55 39.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 122.267 1.032 . . . . 0.0 110.423 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -135.35 120.99 19.45 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.74 1.616 . . . . 0.0 107.521 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.9 pt -116.79 137.71 49.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 123.561 0.744 . . . . 0.0 109.973 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.41 ' CZ3' ' HG3' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -137.53 116.14 12.11 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 -175.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -43.03 -69.52 0.13 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.755 2.022 . . . . 0.0 115.051 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.81 35.96 1.28 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 123.906 0.882 . . . . 0.0 109.495 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . 0.283 0.6 OUTLIER 42.21 57.71 3.21 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.092 1.757 . . . . 0.0 112.546 178.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' CZ3' ' A' ' 55' ' ' TRP . 1.5 pp20? -63.22 131.36 48.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.466 1.506 . . . . 0.0 113.279 -175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -93.21 38.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.388 1.475 . . . . 0.0 111.719 -167.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.33 50.9 m-20 55.05 46.42 24.19 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 123.691 1.71 . . . . 0.0 112.166 -168.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 62' ' ' THR . 0.7 OUTLIER -68.69 171.88 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 127.585 2.354 . . . . 0.0 110.86 176.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.25 7.34 0.87 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 123.103 2.536 . . . . 0.0 114.972 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.4 t -137.98 112.03 8.79 Favored Pre-proline 0 N--CA 1.473 0.681 0 C-N-CA 124.978 1.311 . . . . 0.0 110.769 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.81 125.44 13.2 Favored 'Trans proline' 0 C--N 1.35 0.641 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.59 -120.83 0.08 OUTLIER Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.744 1.164 . . . . 0.0 111.423 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.97 132.12 20.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.152 0.981 . . . . 0.0 111.052 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -154.07 139.53 17.74 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.402 1.081 . . . . 0.0 112.583 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -146.68 141.83 27.23 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.823 0.82 . . . . 0.0 110.199 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 51' ' ' ARG . 32.4 tt0 -113.6 79.92 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -46.52 102.66 0.03 OUTLIER 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.947 2.099 . . . . 0.0 110.773 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.28 126.53 23.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.234 1.414 . . . . 0.0 111.558 -172.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -55.5 109.53 0.57 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.216 1.406 . . . . 0.0 110.64 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.52 55.8 1.99 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.966 0.793 . . . . 0.0 114.481 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.44 163.53 36.88 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.981 0.891 . . . . 0.0 113.138 174.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.0 m -123.61 133.74 53.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.713 1.605 . . . . 0.0 108.985 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -119.72 102.85 8.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.079 1.751 . . . . 0.0 109.015 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -71.79 -24.33 61.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -151.69 137.73 18.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.89 1.676 . . . . 0.0 110.203 171.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.14 14.33 7.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.436 1.495 . . . . 0.0 112.537 172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 m -53.89 -19.49 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.249 1.82 . . . . 0.0 115.256 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.3 m -48.61 -29.65 4.53 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 162.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.0 mt -133.0 58.16 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 128.963 2.905 . . . . 0.0 108.003 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -52.47 -29.98 27.6 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.149 -0.97 . . . . 0.0 112.248 163.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.42 103.55 1.35 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.662 1.125 . . . . 0.0 112.892 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 41' ' ' PHE . 0.2 OUTLIER -161.73 43.05 0.15 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -52.25 -18.54 1.58 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 120.007 -1.683 . . . . 0.0 115.4 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -113.55 141.67 46.88 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.018 2.127 . . . . 0.0 111.581 164.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -128.89 134.65 48.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.949 2.099 . . . . 0.0 109.365 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -125.72 129.29 49.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.171 1.788 . . . . 0.0 109.288 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.27 116.1 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.419 1.487 . . . . 0.0 108.203 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.6 mt -127.77 140.81 39.16 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.771 0.828 . . . . 0.0 110.808 -167.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.72 164.61 35.12 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.885 2.39 . . . . 0.0 112.812 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.1 -24.77 58.96 Favored Glycine 0 CA--C 1.539 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 113.912 171.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.15 -27.12 68.5 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.129 1.372 . . . . 0.0 114.389 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -123.23 116.28 23.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.232 1.413 . . . . 0.0 110.722 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.14 -44.23 65.99 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.197 -0.94 . . . . 0.0 112.161 -174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.39 162.6 40.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.514 1.926 . . . . 0.0 109.155 176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.57 157.06 45.58 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.478 -0.764 . . . . 0.0 110.393 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -127.77 132.6 68.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 123.805 0.842 . . . . 0.0 109.95 -169.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.28 128.19 34.86 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -126.62 145.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 125.17 1.388 . . . . 0.0 108.27 175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -149.79 157.99 43.74 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.23 -0.919 . . . . 0.0 110.059 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.0 mt -119.19 134.37 63.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 126.113 1.765 . . . . 0.0 106.973 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.3 m -136.43 135.64 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 122.035 0.921 . . . . 0.0 110.745 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -79.09 122.1 25.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.982 0.913 . . . . 0.0 112.343 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -110.93 -3.12 15.74 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.464 1.506 . . . . 0.0 112.696 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.4 t -138.46 -48.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 126.115 1.766 . . . . 0.0 112.699 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -74.51 80.22 1.95 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.328 0.967 . . . . 0.0 112.189 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 t -68.53 53.34 0.08 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 127.471 2.308 . . . . 0.0 114.069 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.9 m -137.53 -45.01 0.54 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.674 1.99 . . . . 0.0 111.642 -174.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 56.94 158.51 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 127.013 2.125 . . . . 0.0 115.609 -172.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.75 -38.08 0.38 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 127.856 2.646 . . . . 0.0 115.039 -176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 54.4 p -67.75 -6.6 21.82 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.577 2.751 . . . . 0.0 114.795 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.52 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 63.5 t80 -115.6 113.61 23.82 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 128.232 2.613 . . . . 0.0 108.686 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -120.67 121.17 37.71 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.128 1.371 . . . . 0.0 110.079 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 15.7 ttp -107.62 139.22 42.5 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.967 0.507 . . . . 0.0 111.563 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -126.4 122.62 35.86 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.467 1.507 . . . . 0.0 108.531 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -122.66 137.93 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.224 1.01 . . . . 0.0 109.051 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -140.33 100.19 7.02 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.506 1.122 . . . . 0.0 110.282 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.16 162.12 42.62 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.319 2.012 . . . . 0.0 111.458 168.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -26.08 93.61 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.288 2.635 . . . . 0.0 115.852 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 47.24 42.82 14.06 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 125.792 1.637 . . . . 0.0 114.664 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.54 163.89 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.874 2.07 . . . . 0.0 110.955 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.25 94.53 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.177 1.791 . . . . 0.0 111.658 167.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 136.66 36.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.215 1.006 . . . . 0.0 111.199 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.6 p -123.53 131.69 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.122 0.569 . . . . 0.0 109.972 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.08 133.65 55.24 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.327 1.451 . . . . 0.0 109.165 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.6 t -139.45 146.48 40.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.464 1.105 . . . . 0.0 109.39 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -104.5 127.99 52.34 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.211 1.404 . . . . 0.0 109.033 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -49.2 103.81 0.05 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.841 1.656 . . . . 0.0 111.893 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 135.29 -26.71 3.2 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.997 0.808 . . . . 0.0 113.732 -174.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.39 159.14 18.86 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.156 0.978 . . . . 0.0 111.113 162.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -64.29 171.47 3.06 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.826 0.85 . . . . 0.0 112.054 174.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -50.29 130.58 23.3 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.202 -0.936 . . . . 0.0 111.152 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -84.84 153.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.89 0.876 . . . . 0.0 109.313 172.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -108.84 129.57 55.4 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.61 89.86 13.76 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.35 1.46 . . . . 0.0 108.671 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -70.75 149.24 60.23 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.079 1.853 . . . . 0.0 112.048 174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 70.4 mt -127.52 128.27 24.0 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 126.495 1.918 . . . . 0.0 106.81 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.25 -175.26 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.527 2.818 . . . . 0.0 111.98 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 110.86 0.38 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.315 1.046 . . . . 0.0 111.484 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 150' ' ' ILE . 4.3 tp -121.17 75.49 1.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.169 1.388 . . . . 0.0 109.743 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.3 m -107.45 131.63 21.57 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.317 1.047 . . . . 0.0 110.557 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -70.51 152.28 94.07 Favored 'Cis proline' 0 CA--C 1.546 1.089 0 CA-C-N 119.577 0.885 . . . . 0.0 112.081 -4.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.72 -40.29 74.33 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.653 2.236 . . . . 0.0 113.061 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -67.25 -4.22 10.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.575 1.55 . . . . 0.0 114.88 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.0 p -62.14 157.77 18.39 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.457 1.026 . . . . 0.0 111.11 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -105.3 110.61 23.04 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.295 -0.878 . . . . 0.0 109.696 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.419 ' HB ' HD11 ' A' ' 143' ' ' LEU . 8.7 tt -77.96 122.31 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.211 1.005 . . . . 0.0 109.049 175.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.0 m -67.46 138.87 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.431 0.692 . . . . 0.0 110.784 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -147.47 158.82 44.14 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 122.045 0.926 . . . . 0.0 112.439 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.94 133.86 54.37 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.521 1.129 . . . . 0.0 109.459 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.9 124.3 42.91 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.868 1.667 . . . . 0.0 107.606 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 10.2 t -139.54 134.6 32.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.891 0.853 . . . . 0.0 109.753 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 115' ' ' TYR . 9.2 p -134.91 130.27 52.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-O 121.845 0.831 . . . . 0.0 109.135 -175.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -143.63 130.04 19.98 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.619 1.568 . . . . 0.0 109.327 -168.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -64.34 135.17 55.92 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.149 0.98 . . . . 0.0 109.481 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.2 p -88.76 10.18 21.84 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.37 1.068 . . . . 0.0 113.004 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -141.13 145.65 36.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.711 2.404 . . . . 0.0 109.635 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.2 t -63.76 135.0 96.09 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 121.829 -0.544 . . . . 0.0 111.859 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.57 125.47 10.26 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.666 0.917 . . . . 0.0 112.454 -6.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.84 25.11 11.94 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.368 1.867 . . . . 0.0 113.644 -170.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.16 159.85 9.08 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 121.079 -1.013 . . . . 0.0 111.939 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -58.16 107.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.744 0.817 . . . . 0.0 110.857 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.441 ' HB ' HG13 ' A' ' 156' ' ' VAL . 81.1 t -60.02 -55.01 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.877 1.271 . . . . 0.0 109.334 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.0 m -147.69 147.09 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.408 1.083 . . . . 0.0 110.299 164.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -136.63 120.68 17.69 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.894 1.678 . . . . 0.0 107.833 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.79 -173.07 31.06 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-O 122.1 0.833 . . . . 0.0 112.869 -174.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 49.0 m -118.02 161.91 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.638 1.209 . . . . 0.0 111.224 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.25 164.6 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.731 2.412 . . . . 0.0 106.656 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -132.21 131.89 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.11 152.51 23.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -144.71 146.5 32.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.229 1.812 . . . . 0.0 109.842 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -119.46 151.95 37.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.963 1.305 . . . . 0.0 110.378 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 55.8 m -137.46 112.15 9.18 Favored Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 124.99 1.316 . . . . 0.0 110.427 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.33 -15.43 20.03 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.487 2.791 . . . . 0.0 112.061 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.6 m -43.79 -42.31 5.49 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.421 2.689 . . . . 0.0 112.36 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.8 p -145.32 27.65 1.25 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.235 1.414 . . . . 0.0 113.069 173.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 45.29 41.65 8.59 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 120.258 -1.526 . . . . 0.0 113.997 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -87.74 137.74 32.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.3 1.44 . . . . 0.0 109.05 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.15 140.9 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 163.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -135.15 139.14 44.38 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.318 1.847 . . . . 0.0 107.809 -177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -112.7 135.25 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.123 0.969 . . . . 0.0 110.397 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.3 123.44 69.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 126.211 1.805 . . . . 0.0 106.751 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -139.46 124.98 19.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.895 1.678 . . . . 0.0 107.207 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -128.65 152.97 47.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.114 1.366 . . . . 0.0 109.331 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.94 -17.98 54.41 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -70.95 -18.74 62.62 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.649 1.58 . . . . 0.0 114.72 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.8 p -132.51 -50.86 0.92 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.42 1.488 . . . . 0.0 112.89 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -84.42 142.17 40.13 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.319 1.448 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.86 164.91 34.24 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 122.468 2.112 . . . . 0.0 111.623 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -93.87 8.06 42.63 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.821 1.248 . . . . 0.0 112.854 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 -106.17 -26.27 11.65 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.303 1.441 . . . . 0.0 113.197 -169.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -114.83 149.69 36.67 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.111 1.764 . . . . 0.0 107.267 167.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.2 p -133.21 161.77 33.55 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.771 0.828 . . . . 0.0 108.966 165.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 8.0 p -129.28 125.79 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.818 0.847 . . . . 0.0 109.004 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 10.0 t -104.7 144.19 32.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.9 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -82.89 80.18 9.03 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.569 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -59.23 -36.56 75.66 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.698 1.199 . . . . 0.0 112.538 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -150.55 173.44 14.09 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 126.133 1.773 . . . . 0.0 111.691 170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -53.05 128.78 28.64 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.126 -1.609 . . . . 0.0 108.983 165.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.0 m 60.34 24.4 13.89 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 119.78 14.28 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.685 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 100' ' ' VAL . 20.5 m-85 -127.81 124.56 37.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 110.953 -167.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.5 mm -120.42 100.19 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.643 0.777 . . . . 0.0 109.774 -171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -76.01 125.18 28.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.866 1.267 . . . . 0.0 110.248 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -121.93 126.88 49.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.913 1.285 . . . . 0.0 111.377 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.578 HD13 ' H ' ' A' ' 211' ' ' SER . 1.3 tm? -92.96 109.66 21.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.233 1.013 . . . . 0.0 110.92 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -110.62 10.74 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.466 1.506 . . . . 0.0 113.914 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.578 ' H ' HD13 ' A' ' 209' ' ' LEU . 0.5 OUTLIER -168.04 109.91 0.59 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.696 1.998 . . . . 0.0 111.544 -178.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.86 -23.61 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 119.56 -1.963 . . . . 0.0 114.409 -174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 126.619 1.968 . . . . 0.0 111.865 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.54 124.73 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.173 -0.954 . . . . 0.0 109.443 165.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.77 150.28 41.82 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.592 -0.692 . . . . 0.0 110.33 173.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -22.35 27.59 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 121.185 -0.947 . . . . 0.0 113.414 172.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.93 15.96 17.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.558 1.943 . . . . 0.0 113.332 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -140.63 169.3 17.9 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.876 1.27 . . . . 0.0 110.279 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.3 t -131.46 148.4 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.898 0.879 . . . . 0.0 109.17 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.3 151.42 49.97 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.78 0.832 . . . . 0.0 110.842 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -145.15 127.09 15.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.651 -164.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -137.0 140.28 42.02 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 123.766 1.746 . . . . 0.0 111.198 -169.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -101.86 44.79 0.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.563 1.145 . . . . 0.0 111.384 -168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.76 159.14 26.62 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.293 1.901 . . . . 0.0 110.44 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.81 139.18 58.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 111.337 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 t30 51.21 36.83 16.86 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.86 1.264 . . . . 0.0 114.056 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.8 m 61.85 64.46 1.01 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.218 1.807 . . . . 0.0 114.57 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 p -122.38 -44.91 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 -169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.99 -69.86 1.36 Allowed Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.973 1.26 . . . . 0.0 113.624 -169.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -133.13 169.88 16.22 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.452 1.501 . . . . 0.0 109.772 172.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -136.42 149.67 48.38 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.891 1.277 . . . . 0.0 112.559 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -153.76 161.76 41.82 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.316 1.846 . . . . 0.0 110.912 -175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -134.01 141.07 47.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.17 1.388 . . . . 0.0 110.148 -175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -134.61 140.6 46.2 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.476 1.51 . . . . 0.0 109.986 -170.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -94.93 147.22 23.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.903 0.881 . . . . 0.0 110.721 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.6 ptmt -66.62 131.86 46.9 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.444 -0.785 . . . . 0.0 110.718 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.17 54.7 3.29 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.838 -0.423 . . . . 0.0 113.402 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.12 157.84 45.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.024 0.929 . . . . 0.0 112.088 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -132.93 127.44 34.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.664 1.186 . . . . 0.0 108.033 172.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 m -134.52 142.36 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.39 1.076 . . . . 0.0 109.747 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -135.64 119.23 17.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.521 1.128 . . . . 0.0 109.052 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -137.63 131.62 31.8 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.05 1.74 . . . . 0.0 107.98 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -154.76 145.75 22.64 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 110.893 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.09 26.39 0.17 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.863 0.865 . . . . 0.0 113.209 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.26 54.23 2.76 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 123.854 0.74 . . . . 0.0 114.109 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 47.57 64.56 1.56 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 126.423 1.889 . . . . 0.0 115.466 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -36.4 0.09 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -176.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -106.86 -28.82 9.87 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.898 1.226 . . . . 0.0 113.463 174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -73.78 -53.76 9.57 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.379 1.471 . . . . 0.0 110.399 168.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.68 -12.43 61.39 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -30.7 14.82 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 120.623 -1.298 . . . . 0.0 112.66 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.2 157.44 3.51 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 122.924 1.345 . . . . 0.0 114.303 173.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 -38.49 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.345 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 98.5 p -132.84 149.21 52.29 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 122.092 0.949 . . . . 0.0 112.682 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.5 p -151.84 143.92 23.88 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.72 0.772 . . . . 0.0 110.825 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.14 118.93 34.74 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.844 1.257 . . . . 0.0 107.979 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.3 t -109.36 110.98 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.17 1.388 . . . . 0.0 108.841 -175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.83 166.91 4.53 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-O 122.901 1.278 . . . . 0.0 114.125 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.97 -27.51 64.78 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.873 -1.369 . . . . 0.0 114.647 -172.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -121.47 36.26 4.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.243 1.817 . . . . 0.0 110.786 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.88 135.61 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.182 2.193 . . . . 0.0 109.956 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 150.58 28.51 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 109.315 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 m -121.36 152.23 39.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.819 0.819 . . . . 0.0 110.897 170.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -138.76 122.51 17.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.234 1.014 . . . . 0.0 108.534 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.98 128.03 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.927 0.891 . . . . 0.0 110.284 -173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.82 113.42 10.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.676 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -55.34 -38.65 69.04 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.103 1.361 . . . . 0.0 113.628 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.64 174.3 15.18 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.982 1.313 . . . . 0.0 109.47 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -63.33 -66.57 0.52 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 118.457 -0.782 . . . . 0.0 110.832 175.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.264 0.6 OUTLIER 50.72 169.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 127.961 2.504 . . . . 0.0 117.225 -174.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.528 ' H ' HG23 ' A' ' 62' ' ' THR . 36.2 pt -152.06 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 126.623 1.969 . . . . 0.0 112.064 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 67.72 36.84 3.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.885 2.074 . . . . 0.0 111.589 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 60' ' ' ILE . 3.9 p -67.95 165.55 31.18 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 126.712 2.005 . . . . 0.0 110.373 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.86 19.59 0.28 Allowed 'Trans proline' 0 CA--C 1.553 1.434 0 C-N-CA 123.137 2.558 . . . . 0.0 114.142 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.7 t -149.23 60.18 4.5 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.633 1.573 . . . . 0.0 112.306 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.99 140.13 49.16 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.028 1.818 . . . . 0.0 111.992 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.87 -115.45 1.36 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.282 1.42 . . . . 0.0 112.055 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 148.73 41.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.067 1.347 . . . . 0.0 112.265 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.03 137.69 23.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.252 1.821 . . . . 0.0 109.044 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -155.59 167.96 28.71 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.6 1.16 . . . . 0.0 110.754 172.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -127.53 108.25 10.63 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.401 1.48 . . . . 0.0 109.773 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.99 98.62 0.78 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.053 1.341 . . . . 0.0 109.607 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.38 142.94 25.15 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.421 1.489 . . . . 0.0 113.09 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -55.11 147.25 16.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.464 1.506 . . . . 0.0 113.458 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.64 45.18 96.83 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.709 0.671 . . . . 0.0 114.294 173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.16 163.97 38.28 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.307 1.043 . . . . 0.0 112.385 -172.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.7 m -137.06 142.61 42.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.33 1.052 . . . . 0.0 109.094 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.4 ' HB3' HD12 ' A' ' 80' ' ' LEU . 27.2 m-80 -131.22 129.45 41.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.243 1.017 . . . . 0.0 108.289 -172.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -129.37 -16.87 3.85 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -174.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.36 59.22 1.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.146 1.779 . . . . 0.0 110.391 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.647 ' H ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.94 10.04 11.42 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.123 2.569 . . . . 0.0 112.258 -178.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -16.79 4.54 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.977 1.311 . . . . 0.0 112.952 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.6 m -46.32 -30.24 1.99 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.328 1.851 . . . . 0.0 114.639 167.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.7 tp -69.06 -29.95 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 20.91 58.51 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 129.737 3.215 . . . . 0.0 114.022 -168.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.56 82.29 0.08 OUTLIER Glycine 0 CA--C 1.53 1.015 0 N-CA-C 115.971 1.148 . . . . 0.0 115.971 -163.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 tt -126.2 45.68 2.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.284 1.433 . . . . 0.0 112.159 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.1 m -67.21 -34.77 78.2 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 119.876 -1.765 . . . . 0.0 113.236 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -117.42 128.42 55.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.628 1.171 . . . . 0.0 109.239 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -122.32 123.67 41.94 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.432 1.093 . . . . 0.0 109.556 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.64 125.92 54.69 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -116.31 121.84 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 C-N-CA 124.874 1.27 . . . . 0.0 107.859 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -125.42 150.82 68.82 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.403 1.081 . . . . 0.0 109.893 -172.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.82 168.9 21.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.598 2.199 . . . . 0.0 111.448 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.46 40.07 1.08 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.691 2.091 . . . . 0.0 114.985 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.83 -43.24 0.15 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.483 1.913 . . . . 0.0 111.504 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.6 129.95 34.93 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.249 1.019 . . . . 0.0 109.48 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -86.85 -36.38 18.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.439 0.696 . . . . 0.0 112.224 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -148.22 156.43 42.56 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.215 2.206 . . . . 0.0 108.102 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.44 131.47 34.12 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.54 -0.725 . . . . 0.0 109.941 175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -102.99 133.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.648 0 C-N-CA 124.605 1.162 . . . . 0.0 110.754 -175.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -79.47 135.96 36.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 167.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.13 150.98 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.897 -0.502 . . . . 0.0 110.418 167.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -139.18 149.0 43.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.225 1.01 . . . . 0.0 111.229 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.5 mt -109.46 128.75 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 126.196 1.798 . . . . 0.0 108.308 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.23 111.18 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.492 1.517 . . . . 0.0 109.232 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -65.98 141.7 58.1 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.737 -0.602 . . . . 0.0 110.574 169.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.3 23.95 3.49 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.182 1.393 . . . . 0.0 111.628 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.07 -56.12 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 126.326 1.85 . . . . 0.0 112.155 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -129.31 108.75 10.55 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.961 1.304 . . . . 0.0 110.028 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.4 t -71.75 89.69 1.04 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.636 1.174 . . . . 0.0 111.029 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 13.7 t -149.41 -39.61 0.15 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.8 1.24 . . . . 0.0 111.865 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 54.5 172.99 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.232 1.813 . . . . 0.0 114.432 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.68 -42.29 0.56 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.716 1.627 . . . . 0.0 115.816 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -64.49 -28.6 69.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.572 1.549 . . . . 0.0 113.901 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -88.31 115.18 25.62 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.513 1.125 . . . . 0.0 109.644 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.69 123.22 49.38 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.317 1.447 . . . . 0.0 108.898 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -113.52 130.83 56.26 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.824 0.849 . . . . 0.0 110.116 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.5 m -123.46 132.58 53.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.506 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.73 127.77 71.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -123.87 88.68 52.14 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.786 1.634 . . . . 0.0 108.417 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.47 163.98 35.99 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.949 2.433 . . . . 0.0 111.944 172.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -36.36 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.626 2.37 . . . . 0.0 114.055 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 38.95 46.57 1.11 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.658 1.583 . . . . 0.0 114.699 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.4 t -124.45 156.34 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.499 1.92 . . . . 0.0 109.589 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -45.14 93.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.609 1.963 . . . . 0.0 113.03 175.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 155.44 24.13 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.328 1.051 . . . . 0.0 110.663 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.52 146.57 29.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.382 0.61 . . . . 0.0 110.222 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -122.72 134.27 54.46 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.781 1.232 . . . . 0.0 108.417 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 45.5 t -134.7 149.76 50.53 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 175.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.88 145.13 32.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -48.26 127.53 12.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.247 1.019 . . . . 0.0 109.617 175.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.34 48.9 4.62 Favored Glycine 0 CA--C 1.54 1.636 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.78 167.32 21.08 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.408 1.483 . . . . 0.0 110.968 169.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -59.49 154.69 16.66 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.585 -0.697 . . . . 0.0 111.056 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -47.87 126.05 9.83 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.045 0.938 . . . . 0.0 111.253 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.46 123.6 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.326 0.584 . . . . 0.0 110.017 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -75.79 129.86 37.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.457 0.703 . . . . 0.0 110.365 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.9 tp -119.3 106.4 42.86 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 126.116 1.766 . . . . 0.0 108.104 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.9 142.73 39.53 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.669 2.246 . . . . 0.0 111.235 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.3 mm -134.18 127.08 18.86 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.292 1.037 . . . . 0.0 109.183 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.02 176.62 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.783 2.989 . . . . 0.0 112.777 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -80.24 144.64 32.73 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.522 -0.736 . . . . 0.0 111.434 171.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.44 48.54 0.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.857 1.663 . . . . 0.0 111.447 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.9 t -47.62 136.55 9.96 Favored Pre-proline 0 N--CA 1.482 1.146 0 C-N-CA 125.032 1.333 . . . . 0.0 113.785 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.1 143.72 77.14 Favored 'Cis proline' 0 CA--C 1.543 0.966 0 CA-C-N 119.963 1.023 . . . . 0.0 111.747 -1.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.03 -16.49 45.08 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.479 2.119 . . . . 0.0 113.96 -173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -3.09 5.63 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.546 1.139 . . . . 0.0 113.978 168.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.1 m -66.85 124.16 22.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.969 -1.082 . . . . 0.0 111.267 163.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -64.22 133.0 51.98 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.556 0.743 . . . . 0.0 111.644 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.2 tt -100.38 132.59 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.478 1.511 . . . . 0.0 108.514 169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.1 p -77.35 142.15 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.798 -0.564 . . . . 0.0 110.677 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.4 m -144.15 159.19 43.07 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.315 1.446 . . . . 0.0 110.409 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -123.09 141.15 52.28 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.673 0.789 . . . . 0.0 110.068 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.3 tt -124.24 126.93 46.92 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.91 1.684 . . . . 0.0 108.992 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.28 112.94 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.58 126.66 71.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -131.17 139.55 49.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.066 1.747 . . . . 0.0 108.868 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -70.52 124.26 23.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.2 p -71.31 -15.68 62.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.794 1.237 . . . . 0.0 113.137 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.04 173.36 6.7 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.718 2.007 . . . . 0.0 111.366 175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.6 p -52.75 147.83 14.56 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 124.814 1.246 . . . . 0.0 113.648 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.58 7.17 16.26 Favored 'Cis proline' 0 CA--C 1.546 1.092 0 N-CA-C 114.398 0.884 . . . . 0.0 114.398 0.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.04 32.76 10.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.656 1.583 . . . . 0.0 113.648 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.37 150.19 20.65 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.736 1.214 . . . . 0.0 111.395 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -57.73 108.64 0.59 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.821 0.848 . . . . 0.0 109.548 167.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.8 t -65.48 -56.82 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 124.079 0.952 . . . . 0.0 109.581 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.8 m -147.72 155.05 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.652 0.781 . . . . 0.0 111.984 165.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -142.72 77.89 1.59 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.268 1.827 . . . . 0.0 110.767 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -115.09 -178.03 18.74 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.17 1.367 . . . . 0.0 112.954 -176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.3 m -127.05 148.5 50.12 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 110.188 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.31 160.55 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.055 1.742 . . . . 0.0 109.494 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.73 137.61 52.51 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.34 145.6 43.08 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -140.93 158.0 44.57 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.859 1.264 . . . . 0.0 109.586 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -127.11 116.45 20.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.011 0.925 . . . . 0.0 110.98 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.5 m -83.33 118.47 71.69 Favored Pre-proline 0 N--CA 1.474 0.764 0 O-C-N 120.92 -1.113 . . . . 0.0 109.282 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.35 -19.6 43.49 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.526 2.151 . . . . 0.0 112.547 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.3 m -45.33 -51.7 10.75 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.918 2.087 . . . . 0.0 112.469 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 20.8 p -143.26 34.69 1.33 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.552 1.141 . . . . 0.0 112.407 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.83 42.43 94.59 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 120.211 -1.555 . . . . 0.0 114.1 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -84.97 173.91 10.18 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.105 1.362 . . . . 0.0 112.717 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 100' ' ' VAL . 17.3 m -128.62 142.01 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 111.177 168.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 72.7 m -137.83 108.86 6.75 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.65 1.18 . . . . 0.0 108.188 -178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.53 HG13 ' CZ ' ' A' ' 205' ' ' PHE . 2.6 m -83.81 141.25 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.826 0.822 . . . . 0.0 111.21 173.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -120.8 134.76 63.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.813 2.045 . . . . 0.0 107.337 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -152.58 132.92 13.66 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.27 1.428 . . . . 0.0 107.816 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 11.8 mttp -114.77 152.99 31.15 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.756 1.223 . . . . 0.0 109.664 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.66 -15.58 61.51 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -95.55 -31.64 13.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.544 1.537 . . . . 0.0 114.38 171.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 63.6 p -87.5 -42.28 12.89 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 0.0 111.326 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.465 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.2 t80 -87.3 148.61 45.08 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.729 2.011 . . . . 0.0 110.759 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.465 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 95.4 Cg_endo -76.95 178.2 7.93 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.443 2.095 . . . . 0.0 111.608 173.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -119.91 44.03 2.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.051 1.74 . . . . 0.0 110.87 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -144.98 -27.61 0.48 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.94 1.296 . . . . 0.0 113.529 -170.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.6 ttm -137.71 139.89 40.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 127.22 2.208 . . . . 0.0 107.673 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 72.8 p -134.79 155.8 49.97 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.724 0.81 . . . . 0.0 111.336 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.76 140.8 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.233 1.013 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 8.8 t -140.16 163.02 33.84 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.041 1.337 . . . . 0.0 110.49 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.52 118.71 26.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.218 1.407 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -129.8 8.29 5.28 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.692 0.797 . . . . 0.0 112.717 -176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.94 16.92 2.84 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.819 1.248 . . . . 0.0 113.333 -172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.4 t30 47.47 102.92 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 128.047 2.539 . . . . 0.0 114.368 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.7 m 80.89 21.29 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.43 1.092 . . . . 0.0 111.676 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 9.6 t -136.74 128.63 29.22 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.788 1.635 . . . . 0.0 111.37 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.53 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 49.1 m-85 -118.99 133.6 55.72 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.805 1.642 . . . . 0.0 111.335 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.65 106.25 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.642 0.777 . . . . 0.0 109.268 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -84.84 126.35 33.39 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.074 1.35 . . . . 0.0 110.951 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -117.91 121.32 40.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.364 1.466 . . . . 0.0 110.354 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.86 98.82 11.69 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.816 1.246 . . . . 0.0 109.601 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -80.42 -30.1 37.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.528 1.131 . . . . 0.0 113.771 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -144.96 134.88 23.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.577 1.551 . . . . 0.0 109.353 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -58.1 -50.83 72.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.258 0.935 . . . . 0.0 111.783 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 125.156 1.382 . . . . 0.0 111.416 -169.514 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p -71.26 126.7 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 O-C-N 120.554 -1.341 . . . . 0.0 109.413 164.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -65.16 143.29 57.96 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.807 -0.558 . . . . 0.0 109.536 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.43 -19.1 5.02 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -116.28 17.83 15.48 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.246 2.219 . . . . 0.0 113.647 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -135.34 171.63 14.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.689 1.596 . . . . 0.0 111.051 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 150.47 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.594 1.158 . . . . 0.0 108.806 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.31 149.77 34.47 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 112.938 174.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -127.93 130.83 49.09 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.333 1.453 . . . . 0.0 109.495 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.98 125.91 42.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.589 1.155 . . . . 0.0 110.199 -173.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -84.98 55.04 3.31 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.236 1.017 . . . . 0.0 112.046 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.95 148.27 7.58 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.979 1.276 . . . . 0.0 111.039 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -59.53 133.21 55.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.431 1.092 . . . . 0.0 111.279 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 71.52 41.97 0.7 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.202 1.801 . . . . 0.0 114.021 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.1 m 53.08 61.91 2.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.519 1.528 . . . . 0.0 113.592 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.0 p -130.56 178.48 6.58 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.131 1.372 . . . . 0.0 112.188 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.34 -85.26 1.04 Allowed Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.343 1.449 . . . . 0.0 113.752 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -131.22 170.52 14.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.364 1.466 . . . . 0.0 110.777 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -139.53 148.54 42.75 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.62 1.168 . . . . 0.0 111.304 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.75 147.56 26.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.582 1.553 . . . . 0.0 110.487 -176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -125.06 132.59 53.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.462 1.105 . . . . 0.0 110.399 -174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -129.76 133.44 47.01 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 122.908 1.337 . . . . 0.0 111.454 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.62 138.57 43.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.946 1.298 . . . . 0.0 111.473 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.42 148.43 51.73 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.278 1.031 . . . . 0.0 111.42 168.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.32 41.29 68.48 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.43 1.014 . . . . 0.0 112.553 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -144.14 160.76 40.38 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.076 1.35 . . . . 0.0 112.248 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.2 m -121.56 131.7 54.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.288 1.435 . . . . 0.0 108.25 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.54 141.13 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.918 0.887 . . . . 0.0 108.727 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -126.77 151.37 48.32 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.436 1.095 . . . . 0.0 110.982 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -124.97 171.26 10.36 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.661 1.584 . . . . 0.0 109.72 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -50.9 107.86 0.2 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.495 1.518 . . . . 0.0 112.464 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -61.96 -16.29 50.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.21 1.004 . . . . 0.0 113.693 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.36 -9.45 49.54 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 126.134 1.825 . . . . 0.0 115.453 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.253 0.1 OUTLIER 67.46 88.5 0.11 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 169.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -140.95 -54.32 0.49 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.931 -1.031 . . . . 0.0 113.673 -171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.66 18.86 0.71 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.214 177.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -63.98 -24.74 67.84 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -70.19 0.11 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.713 168.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.303 0.3 OUTLIER 27.75 48.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 128.164 2.586 . . . . 0.0 115.761 -175.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -131.02 133.78 46.06 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.986 2.114 . . . . 0.0 109.337 -172.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.0 mmt -153.78 -45.24 0.09 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.487 1.915 . . . . 0.0 111.324 174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.6 t -136.07 130.24 33.13 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.415 1.086 . . . . 0.0 109.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 89.6 m -140.96 145.4 35.97 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.88 0.872 . . . . 0.0 109.855 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.54 121.72 36.36 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.325 1.05 . . . . 0.0 108.606 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.4 t -105.49 143.08 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 126.454 1.902 . . . . 0.0 106.303 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.92 -97.09 0.01 OUTLIER Glycine 0 CA--C 1.536 1.405 0 C-N-CA 126.324 1.916 . . . . 0.0 117.301 -172.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 4.2 t -161.57 -42.12 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.634 1.173 . . . . 0.0 111.504 177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -113.88 33.88 4.95 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.261 1.425 . . . . 0.0 110.617 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.1 m -146.69 157.12 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 127.524 2.33 . . . . 0.0 109.798 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -136.75 154.52 50.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.428 1.891 . . . . 0.0 110.132 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.7 t -123.55 143.26 50.31 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.659 0.742 . . . . 0.0 110.683 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -134.04 139.09 45.77 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.965 0.888 . . . . 0.0 109.405 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.1 119.75 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.009 1.324 . . . . 0.0 107.989 -167.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -127.72 135.51 50.25 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.962 0.905 . . . . 0.0 109.817 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -66.02 -60.7 2.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.246 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.5 -178.73 7.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.553 0.741 . . . . 0.0 111.957 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -65.95 129.97 41.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.923 0.889 . . . . 0.0 113.074 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -178.14 6.04 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.175 1.79 . . . . 0.0 110.088 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.74 44.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.227 1.411 . . . . 0.0 113.104 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 57.68 48.53 13.89 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.16 1.457 . . . . 0.0 111.855 -171.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 8.3 p -64.31 167.36 8.51 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.804 1.642 . . . . 0.0 110.791 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 53.2 Cg_endo -72.9 11.08 0.93 Allowed 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 122.954 2.436 . . . . 0.0 113.967 172.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.3 t -147.28 57.85 3.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 125.768 1.627 . . . . 0.0 111.973 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.86 154.06 73.95 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.408 1.405 . . . . 0.0 110.659 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.45 -105.52 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -142.85 150.91 40.51 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.773 1.629 . . . . 0.0 110.217 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -151.39 140.03 20.7 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.222 1.409 . . . . 0.0 109.254 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.33 156.73 26.75 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.628 0.771 . . . . 0.0 110.341 172.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -123.13 97.95 5.66 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.851 0.861 . . . . 0.0 109.799 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.14 124.36 14.24 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.525 1.13 . . . . 0.0 109.677 171.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.92 163.37 0.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.563 1.145 . . . . 0.0 113.024 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.81 165.51 1.19 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.866 171.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 48' ' ' SER . . . -21.22 108.4 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.883 2.183 . . . . 0.0 118.296 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.8 p -167.1 177.35 6.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.375 1.07 . . . . 0.0 112.906 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 70.3 m -107.89 97.69 7.37 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.499 1.919 . . . . 0.0 109.45 175.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.84 127.38 35.63 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.877 0.871 . . . . 0.0 109.836 171.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -128.83 12.52 6.26 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.03 1.332 . . . . 0.0 112.493 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -153.21 38.26 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 O-C-N 120.699 -1.25 . . . . 0.0 113.106 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.9 -1.91 57.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.701 1.2 . . . . 0.0 114.036 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -12.62 1.95 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.042 1.737 . . . . 0.0 114.394 175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -46.57 -32.0 3.15 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.022 1.329 . . . . 0.0 113.883 165.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.3 tp -70.34 -35.5 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.258 7.3 m-20 30.73 46.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 128.336 2.655 . . . . 0.0 115.411 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 159.04 107.95 0.24 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 123.94 0.781 . . . . 0.0 112.649 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.3 85.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.113 0.958 . . . . 0.0 113.111 172.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -75.59 -6.57 51.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.744 -1.223 . . . . 0.0 113.171 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -129.95 137.6 50.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.738 2.415 . . . . 0.0 111.048 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -131.86 128.48 38.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.114 1.366 . . . . 0.0 109.183 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.96 119.41 25.46 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.952 0.901 . . . . 0.0 108.825 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.39 118.17 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.4 mt -126.92 150.28 71.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.102 0.961 . . . . 0.0 110.205 -171.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.5 -173.49 0.99 Allowed 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.674 2.249 . . . . 0.0 112.64 174.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -89.67 -26.64 24.34 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.146 1.355 . . . . 0.0 113.498 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -43.44 87.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.014 0.907 . . . . 0.0 112.287 172.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.55 126.07 37.47 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.868 1.267 . . . . 0.0 109.062 176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.89 -47.39 11.11 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.307 -0.87 . . . . 0.0 110.853 -172.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -143.06 160.0 41.21 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.561 1.944 . . . . 0.0 108.794 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.21 152.17 45.77 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.548 0.739 . . . . 0.0 109.817 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.4 139.7 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.781 0.832 . . . . 0.0 111.003 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -78.41 139.18 38.77 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.79 143.47 40.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 125.737 1.615 . . . . 0.0 109.725 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -148.39 133.05 17.82 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.83 1.252 . . . . 0.0 109.688 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.04 137.01 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.332 1.053 . . . . 0.0 108.432 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -140.49 95.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 126.92 2.088 . . . . 0.0 108.823 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -71.92 122.7 21.27 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.891 -1.131 . . . . 0.0 111.256 173.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 12.72 31.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.574 1.55 . . . . 0.0 112.891 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.5 t -127.21 -66.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.606 1.562 . . . . 0.0 110.865 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -91.47 128.12 37.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.757 0.823 . . . . 0.0 110.524 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -102.4 53.91 0.79 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.339 1.066 . . . . 0.0 110.947 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.2 t -140.32 63.54 1.47 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 123.579 1.657 . . . . 0.0 110.61 -172.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.67 143.84 19.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 113.537 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 109.39 -29.34 9.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.394 1.473 . . . . 0.0 114.397 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.8 p -87.19 -35.57 18.5 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.478 1.139 . . . . 0.0 113.707 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -68.41 126.47 29.71 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.071 0.948 . . . . 0.0 109.891 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -128.75 125.68 38.39 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.4 1.48 . . . . 0.0 108.957 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 64.2 ttp -114.27 134.96 54.57 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.294 1.437 . . . . 0.0 109.38 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.3 m -122.42 135.33 54.66 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.443 1.497 . . . . 0.0 108.058 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 28.5 pt -131.17 137.19 56.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.943 0.897 . . . . 0.0 110.443 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 m -137.84 94.64 11.4 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 124.687 1.195 . . . . 0.0 109.504 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.14 165.43 32.63 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.957 2.438 . . . . 0.0 111.455 169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -26.17 84.43 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.907 3.283 . . . . 0.0 115.689 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 42.22 45.78 3.66 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.407 1.483 . . . . 0.0 114.324 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.2 t -111.19 159.82 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.055 2.142 . . . . 0.0 110.297 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -43.55 94.81 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.997 2.519 . . . . 0.0 112.937 175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.98 143.63 56.24 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.439 0.696 . . . . 0.0 110.728 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.01 145.28 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.926 0.89 . . . . 0.0 110.293 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -130.29 138.01 50.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.46 1.504 . . . . 0.0 109.245 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.12 160.78 40.33 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.84 1.256 . . . . 0.0 110.423 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -120.32 154.45 34.99 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.963 0.905 . . . . 0.0 109.79 -174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -57.62 143.96 39.33 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.167 -0.333 . . . . 0.0 110.935 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.94 47.96 43.63 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.702 0.667 . . . . 0.0 114.61 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.36 162.16 24.41 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.453 1.501 . . . . 0.0 110.996 171.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 153.02 6.85 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.006 0.922 . . . . 0.0 111.941 169.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -50.26 118.49 3.01 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.307 1.043 . . . . 0.0 111.754 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.3 t -92.78 141.26 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.06 1.344 . . . . 0.0 108.881 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -104.28 135.98 44.73 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.956 0.798 . . . . 0.0 110.848 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.1 tp -115.95 101.7 53.99 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.782 2.033 . . . . 0.0 108.155 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.58 147.55 40.81 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.562 2.175 . . . . 0.0 112.336 174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 53.0 mt -137.41 132.85 17.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 125.009 1.324 . . . . 0.0 109.33 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.52 174.73 11.71 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.377 3.385 . . . . 0.0 112.646 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -64.27 147.11 53.19 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.59 -0.694 . . . . 0.0 112.337 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.8 pp -153.97 158.84 41.25 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.83 2.052 . . . . 0.0 110.186 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.0 t -147.97 139.95 14.21 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 111.998 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.83 155.75 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.906 0 CA-C-N 119.662 0.915 . . . . 0.0 112.377 -9.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.25 -39.64 37.09 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 121.901 1.734 . . . . 0.0 111.761 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -72.08 8.28 1.34 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.122 1.769 . . . . 0.0 113.631 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -78.0 -178.05 5.33 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.42 -1.425 . . . . 0.0 111.554 166.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.59 160.39 21.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.279 1.432 . . . . 0.0 112.368 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 16.0 tt -122.56 133.11 69.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.722 1.609 . . . . 0.0 109.827 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.06 131.9 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.936 0.894 . . . . 0.0 110.666 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.2 m -146.39 166.45 26.31 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.136 0.97 . . . . 0.0 111.335 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -134.01 147.36 50.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.853 0.861 . . . . 0.0 111.023 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.6 tt -130.1 130.44 44.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.055 1.742 . . . . 0.0 109.164 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.51 117.33 9.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.745 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 167' ' ' VAL . 1.4 p -122.32 132.73 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.847 1.259 . . . . 0.0 108.753 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.24 144.92 27.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.548 1.539 . . . . 0.0 110.195 -171.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -77.79 126.12 30.37 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 122.802 0.441 . . . . 0.0 111.076 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -68.1 -28.65 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.246 1.018 . . . . 0.0 113.346 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.53 174.08 6.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.695 1.598 . . . . 0.0 111.923 172.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 p -52.18 147.5 13.21 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.36 1.464 . . . . 0.0 113.517 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.2 12.13 19.74 Favored 'Cis proline' 0 CA--C 1.545 1.047 0 N-CA-C 114.714 1.006 . . . . 0.0 114.714 3.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.76 24.46 9.9 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.343 1.457 . . . . 0.0 113.082 170.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -88.81 135.53 33.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.897 -1.127 . . . . 0.0 111.276 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -57.64 111.1 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.732 0.813 . . . . 0.0 109.996 170.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.71 -57.99 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.351 1.06 . . . . 0.0 109.028 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.425 HG22 ' CG1' ' A' ' 156' ' ' VAL . 33.5 m -147.4 153.55 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.733 0.777 . . . . 0.0 111.978 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -145.75 105.92 4.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.043 1.737 . . . . 0.0 108.72 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -161.12 157.33 28.88 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 121.837 0.687 . . . . 0.0 113.003 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 53.2 m -74.15 150.44 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.173 0.987 . . . . 0.0 111.196 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.35 161.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.951 2.1 . . . . 0.0 108.526 176.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.86 132.22 41.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.485 0.659 . . . . 0.0 109.656 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -107.03 152.83 23.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -145.19 151.44 38.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.732 2.013 . . . . 0.0 108.121 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -115.39 132.95 56.46 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.423 1.089 . . . . 0.0 108.931 174.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.8 t -93.38 103.49 9.79 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.09 -17.43 45.69 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.734 2.289 . . . . 0.0 112.828 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 12.4 m -53.08 -42.9 66.31 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.994 2.118 . . . . 0.0 112.958 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 48.2 p -144.16 18.33 1.75 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.35 1.46 . . . . 0.0 112.483 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.46 73.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.761 1.648 . . . . 0.0 114.622 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.678 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 4.0 tt0 -73.33 -170.27 0.77 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 123.079 1.419 . . . . 0.0 111.585 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.678 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 1.4 p -135.41 155.18 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 128.041 2.537 . . . . 0.0 107.749 174.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 53.0 m -140.31 150.76 44.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.208 1.803 . . . . 0.0 107.996 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.47 ' HB ' ' CZ ' ' A' ' 205' ' ' PHE . 6.8 p -121.5 140.97 43.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 22.9 mt -123.6 129.95 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.51 140.39 33.47 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.061 1.744 . . . . 0.0 108.896 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 144.82 34.67 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.509 1.123 . . . . 0.0 109.707 -168.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -28.58 67.0 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -170.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -78.46 -30.52 47.45 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.311 1.844 . . . . 0.0 115.039 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.7 p -101.21 -53.54 3.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.531 1.132 . . . . 0.0 111.632 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.525 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 17.6 t80 -85.65 148.74 49.68 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.537 1.935 . . . . 0.0 110.913 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 72.5 Cg_endo -77.1 -175.05 2.45 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.692 2.928 . . . . 0.0 111.577 173.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.25 30.17 6.68 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.01 1.724 . . . . 0.0 111.967 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -132.15 -38.86 1.07 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.862 1.665 . . . . 0.0 113.187 -163.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 30.0 ttm -112.77 145.45 40.55 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.434 1.893 . . . . 0.0 106.804 167.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 65.7 p -140.43 150.05 43.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.949 0.899 . . . . 0.0 110.579 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 4.8 p -134.16 142.44 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 O-C-N 121.521 -0.737 . . . . 0.0 111.352 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 12.2 t -139.95 156.13 46.81 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.611 1.164 . . . . 0.0 111.232 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.64 81.79 0.84 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.852 1.261 . . . . 0.0 111.349 173.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -60.59 -31.21 70.37 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.854 -1.154 . . . . 0.0 112.627 176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.46 173.91 11.39 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.248 1.819 . . . . 0.0 110.639 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.37 118.76 7.91 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.76 174.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.251 30.0 m 63.08 28.85 16.24 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.432 0.693 . . . . 0.0 112.593 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.5 t -137.38 125.08 22.35 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.096 -1.003 . . . . 0.0 112.389 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.47 ' CZ ' ' HB ' ' A' ' 184' ' ' VAL . 12.3 m-85 -109.08 134.75 51.28 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 112.317 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.2 tp -115.87 107.32 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.76 1.224 . . . . 0.0 109.72 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -84.91 108.43 17.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.855 1.262 . . . . 0.0 109.916 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -92.77 136.3 33.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.302 1.441 . . . . 0.0 110.185 176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.56 119.96 40.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.631 0.773 . . . . 0.0 110.258 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -107.87 -6.21 16.81 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.899 1.68 . . . . 0.0 113.701 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.3 t -121.64 -169.91 1.95 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.767 2.027 . . . . 0.0 111.628 176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -154.05 26.59 0.48 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 23.9 mmtm . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 126.078 1.751 . . . . 0.0 113.75 -177.386 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 119.858 -0.115 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 4' ' ' ASP 0.291 8.4 p 47.65 -176.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 127.158 2.183 . . . . 0.0 113.881 -171.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 3' ' ' VAL . 4.0 t70 -75.15 147.97 40.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 119.834 -1.791 . . . . 0.0 109.916 169.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.12 -18.52 10.11 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -115.09 14.96 17.16 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.313 2.245 . . . . 0.0 113.87 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -138.74 177.79 7.63 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 120.107 1.321 . . . . 0.0 111.175 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -142.21 156.55 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.015 1.326 . . . . 0.0 111.318 179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' HD2' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -142.32 145.44 33.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.661 1.185 . . . . 0.0 110.927 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 137.09 36.56 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.427 1.491 . . . . 0.0 108.421 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -132.34 124.57 29.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.515 1.126 . . . . 0.0 110.521 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -80.21 60.09 3.58 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.133 1.373 . . . . 0.0 111.441 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.9 131.11 1.44 Allowed Glycine 0 N--CA 1.459 0.167 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.33 141.23 15.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.362 1.065 . . . . 0.0 111.116 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.7 t30 60.39 42.45 14.68 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.22 59.62 2.64 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.63 1.972 . . . . 0.0 113.302 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.8 m -133.9 -179.35 5.49 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.334 1.454 . . . . 0.0 111.206 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 17' ' ' THR . . . 69.22 -105.63 1.55 Allowed Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.586 1.565 . . . . 0.0 113.379 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -113.53 164.54 13.51 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.156 0.982 . . . . 0.0 111.634 174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.1 p -130.38 145.29 51.78 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.551 1.14 . . . . 0.0 111.938 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.16 160.24 43.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.897 1.679 . . . . 0.0 110.673 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -127.99 154.99 44.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.24 1.016 . . . . 0.0 110.722 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -133.44 136.96 45.51 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.661 1.184 . . . . 0.0 110.935 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -92.1 147.82 22.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.53 1.132 . . . . 0.0 110.278 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -63.06 139.44 58.77 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.174 0.59 . . . . 0.0 111.64 174.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.69 28.53 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.98 0.8 . . . . 0.0 112.764 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.34 122.24 22.36 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.328 1.051 . . . . 0.0 110.763 -175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.6 m -107.37 130.28 54.81 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.978 1.311 . . . . 0.0 108.595 175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG23 ' CD2' ' A' ' 89' ' ' PHE . 2.3 m -133.72 132.66 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.348 1.459 . . . . 0.0 109.776 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -122.79 140.05 53.33 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.801 1.241 . . . . 0.0 109.707 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -139.16 133.75 31.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.878 1.271 . . . . 0.0 108.952 -173.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -163.54 56.86 0.18 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.9 -1.125 . . . . 0.0 111.826 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -71.24 54.41 0.2 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.83 1.652 . . . . 0.0 113.67 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.82 47.65 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 125.377 1.465 . . . . 0.0 114.535 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.284 1.3 t70 49.83 74.11 0.22 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 127.249 2.219 . . . . 0.0 116.386 -178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -160.48 -42.32 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -171.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -124.72 18.11 8.7 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 111.69 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -39.12 64.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.142 -175.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.426 ' HA ' ' CD1' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -55.82 -62.66 1.55 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.174 0.989 . . . . 0.0 109.211 176.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 40.21 31.86 0.11 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.198 1.799 . . . . 0.0 113.582 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.66 128.0 40.05 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 127.111 2.164 . . . . 0.0 107.813 -172.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 mtp -138.45 -50.16 0.55 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.354 0.662 . . . . 0.0 111.823 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.4 p -133.54 122.98 24.36 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 121.543 0.687 . . . . 0.0 110.697 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.6 m -144.81 154.53 42.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -138.67 149.73 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.236 1.017 . . . . 0.0 111.166 -173.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' HA ' HG12 ' A' ' 8' ' ' VAL . 21.3 t -122.8 136.61 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.64 1.576 . . . . 0.0 109.019 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.28 -87.28 0.03 OUTLIER Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.675 1.131 . . . . 0.0 114.959 -167.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.0 p -173.01 -19.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -127.12 33.16 4.95 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.317 1.447 . . . . 0.0 111.186 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 46' ' ' VAL . 3.0 m -141.61 146.09 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.518 1.927 . . . . 0.0 108.753 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -114.29 143.75 44.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.638 1.175 . . . . 0.0 108.553 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -111.67 131.97 54.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.55 0.69 . . . . 0.0 109.439 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.37 123.77 47.29 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.987 1.315 . . . . 0.0 108.244 -170.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.05 119.86 42.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 122.122 0.963 . . . . 0.0 111.822 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -132.38 118.19 19.06 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.882 1.273 . . . . 0.0 109.976 -173.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -67.52 -54.92 15.96 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.53 1.132 . . . . 0.0 111.356 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -130.3 122.29 27.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -164.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -83.02 31.54 0.44 Allowed 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.9 1.28 . . . . 0.0 112.431 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -61.46 165.07 5.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.144 2.578 . . . . 0.0 114.335 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 mm -112.76 39.43 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 C-N-CA 125.063 1.345 . . . . 0.0 111.851 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.29 52.2 m-20 57.15 50.31 12.05 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.617 1.967 . . . . 0.0 112.837 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.9 p -73.67 176.34 2.83 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 127.865 2.466 . . . . 0.0 110.893 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 65.7 Cg_endo -73.16 3.95 4.18 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.9 2.4 . . . . 0.0 113.796 173.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -136.32 64.32 52.6 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 125.93 1.692 . . . . 0.0 110.502 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.89 138.33 57.18 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.302 1.335 . . . . 0.0 109.326 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.62 -121.91 0.23 Allowed Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.873 0.749 . . . . 0.0 111.663 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -134.33 140.16 46.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.508 1.123 . . . . 0.0 111.052 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -147.72 139.76 24.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.702 1.201 . . . . 0.0 109.868 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -157.25 165.77 34.98 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.559 1.171 . . . . 0.0 111.263 175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -132.7 104.46 6.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.307 1.443 . . . . 0.0 107.5 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.411 ' HB3' HG21 ' A' ' 46' ' ' VAL . 6.7 mp -64.75 116.05 5.89 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.71 160.94 0.39 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.832 2.053 . . . . 0.0 114.227 -175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -47.28 -34.17 6.38 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.16 135.24 3.63 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 164.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 177.54 167.86 0.65 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.789 2.036 . . . . 0.0 110.824 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.5 m -123.31 105.48 9.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.802 1.241 . . . . 0.0 110.098 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -83.82 100.88 11.23 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 174.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -70.49 -20.69 62.84 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.6 73.85 0.98 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.28 1.832 . . . . 0.0 110.949 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.96 2.43 12.63 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.69 -1.257 . . . . 0.0 114.023 173.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -53.0 -10.78 0.19 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.96 2.104 . . . . 0.0 115.298 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.2 m -48.95 -32.08 8.46 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 120.057 1.299 . . . . 0.0 113.994 163.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.8 tp -87.56 -32.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 37.84 30.02 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.545 2.738 . . . . 0.0 115.95 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -170.84 109.75 0.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -160.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 178.31 55.09 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.416 2.286 . . . . 0.0 110.027 -170.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.9 m -57.99 -22.17 48.22 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 134.45 53.69 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.856 1.263 . . . . 0.0 110.648 173.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -138.07 135.59 35.99 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.555 1.542 . . . . 0.0 109.815 -174.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -141.88 142.63 33.09 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.717 0.77 . . . . 0.0 112.088 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.87 123.08 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.605 . . . . 0.0 109.238 -170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 96' ' ' PHE . 93.1 mt -141.03 157.64 66.62 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.978 0.911 . . . . 0.0 111.236 -168.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.57 160.7 43.71 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.895 2.397 . . . . 0.0 113.315 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.88 -17.08 69.07 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 121.24 -0.913 . . . . 0.0 115.022 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.74 -29.09 70.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.163 0.985 . . . . 0.0 112.99 167.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.581 ' CE2' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -72.84 163.71 27.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.947 1.299 . . . . 0.0 111.477 173.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -35.62 0.99 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.152 1.381 . . . . 0.0 111.54 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 34.4 p-90 -154.39 160.99 41.97 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.298 1.839 . . . . 0.0 109.666 174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.42 160.98 39.57 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.522 0.729 . . . . 0.0 110.197 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.0 145.45 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.315 1.046 . . . . 0.0 110.516 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -99.11 127.78 45.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.05 1.34 . . . . 0.0 108.287 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.9 m -128.58 135.38 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 121.818 -0.551 . . . . 0.0 110.295 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -123.81 143.35 50.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.443 1.497 . . . . 0.0 109.539 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 18.3 mt -111.85 131.08 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.64 103.3 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 122.564 1.173 . . . . 0.0 110.962 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.1 134.33 49.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.409 1.884 . . . . 0.0 110.751 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 -21.95 8.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.429 1.092 . . . . 0.0 113.571 171.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.7 t -80.59 -55.8 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 119.085 0.857 . . . . 0.0 111.026 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.04 93.4 4.48 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.61 1.164 . . . . 0.0 109.026 -173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.5 t -73.42 48.72 0.26 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.593 1.557 . . . . 0.0 112.553 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 14.1 t -143.16 51.7 1.38 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.229 2.612 . . . . 0.0 109.29 -174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.58 129.03 31.34 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.717 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.8 -31.83 3.44 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.119 1.819 . . . . 0.0 112.25 -173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 m -79.53 -18.0 52.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 114.066 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.66 137.35 38.27 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.16 1.384 . . . . 0.0 108.622 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -123.9 121.15 34.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.849 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 4.8 ttp -113.4 132.95 55.43 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.458 1.103 . . . . 0.0 110.37 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.7 m -122.1 132.42 54.48 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.383 1.473 . . . . 0.0 108.343 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.2 122.72 70.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.0 m -120.54 86.46 39.69 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 125.797 1.639 . . . . 0.0 109.16 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.39 157.07 62.46 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.609 2.872 . . . . 0.0 112.693 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -39.53 86.63 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 128.659 2.784 . . . . 0.0 114.576 -174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 38.87 42.53 0.65 Allowed 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.02 159.4 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.755 2.022 . . . . 0.0 109.434 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -44.61 92.31 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.201 2.2 . . . . 0.0 113.047 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.96 149.5 49.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.61 0.764 . . . . 0.0 110.917 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.67 147.06 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.225 1.01 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.51 136.36 50.68 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.1 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 17.9 p -137.57 137.63 38.75 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.045 1.338 . . . . 0.0 108.606 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.54 142.13 33.14 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 166.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -53.59 151.37 6.01 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 111.043 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.01 42.85 10.38 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 120.846 -1.159 . . . . 0.0 113.155 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.01 161.64 29.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.167 1.787 . . . . 0.0 108.927 171.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 151.58 14.91 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.462 -0.774 . . . . 0.0 110.619 166.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -38.43 115.2 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.649 1.58 . . . . 0.0 111.784 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.02 130.64 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -81.28 123.62 28.65 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.417 0.687 . . . . 0.0 109.46 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.53 96.06 49.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 126.067 1.747 . . . . 0.0 108.534 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.16 146.81 41.55 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.212 1.941 . . . . 0.0 111.287 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.38 132.08 24.14 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.926 2.091 . . . . 0.0 107.633 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.93 175.83 9.87 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.144 2.562 . . . . 0.0 113.195 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -57.72 155.96 9.31 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.376 0.671 . . . . 0.0 112.534 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 pp -170.86 156.96 5.24 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.613 1.965 . . . . 0.0 109.86 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.8 t -137.24 138.41 25.17 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 123.966 0.906 . . . . 0.0 111.565 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.22 157.28 72.12 Favored 'Cis proline' 0 CA--C 1.543 0.972 0 CA-C-N 119.527 0.867 . . . . 0.0 111.97 -7.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -64.02 -36.39 48.97 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.577 1.518 . . . . 0.0 112.09 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -74.18 7.52 2.7 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 12.3 p -65.71 174.97 2.06 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.904 -1.123 . . . . 0.0 112.804 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.42 132.4 56.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.843 1.257 . . . . 0.0 110.952 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 17.5 tt -108.27 116.18 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.788 1.635 . . . . 0.0 108.4 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 p -74.5 133.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 122.97 0.508 . . . . 0.0 109.949 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.1 p -131.32 160.46 34.92 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.794 1.237 . . . . 0.0 110.397 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -114.4 137.18 52.15 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.212 0.605 . . . . 0.0 109.543 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.81 138.65 49.33 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.955 1.702 . . . . 0.0 107.931 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.46 111.54 6.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.573 1.549 . . . . 0.0 108.186 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 4.7 p -120.52 130.98 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.963 1.305 . . . . 0.0 109.461 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -144.24 141.65 29.99 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.265 1.826 . . . . 0.0 109.349 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 137.98 52.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.493 0.317 . . . . 0.0 111.339 174.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 70.9 p -77.19 -5.26 48.53 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.613 1.165 . . . . 0.0 113.843 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.2 179.75 5.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.766 2.426 . . . . 0.0 110.686 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.15 150.13 22.44 Favored Pre-proline 0 N--CA 1.481 1.081 0 O-C-N 121.017 -1.052 . . . . 0.0 113.193 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.13 7.22 22.77 Favored 'Cis proline' 0 CA--C 1.545 1.029 0 CA-C-N 119.847 0.981 . . . . 0.0 114.513 -0.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.36 35.18 24.64 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.352 1.461 . . . . 0.0 113.626 171.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -102.05 156.33 17.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.408 1.483 . . . . 0.0 111.302 -174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -64.86 86.88 0.05 Allowed 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.9 -1.125 . . . . 0.0 111.696 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 57.2 t -52.5 -54.38 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.763 2.025 . . . . 0.0 110.848 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 96.4 t -146.71 127.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 109.161 174.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -144.94 136.37 25.24 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.823 1.249 . . . . 0.0 109.927 174.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.86 178.77 41.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.674 0.654 . . . . 0.0 112.255 -173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.2 m -109.77 149.62 29.53 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.005 0.907 . . . . 0.0 111.798 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.2 p -138.95 147.21 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 127.149 2.18 . . . . 0.0 108.215 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.36 132.54 54.34 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.405 -0.809 . . . . 0.0 109.491 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -107.73 141.23 39.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.557 1.143 . . . . 0.0 109.517 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -136.18 143.39 44.39 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.714 1.605 . . . . 0.0 109.573 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -115.09 115.31 26.58 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.826 0.851 . . . . 0.0 110.413 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 5.9 m -76.49 107.8 5.27 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.422 1.089 . . . . 0.0 109.525 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.75 -14.37 32.91 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.629 2.219 . . . . 0.0 112.908 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 5.2 m -53.35 -44.8 68.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.439 2.296 . . . . 0.0 113.348 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.3 p -142.32 22.92 2.02 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.097 1.359 . . . . 0.0 113.016 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 53.1 39.03 57.12 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.974 1.75 . . . . 0.0 114.571 -170.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -80.02 166.25 21.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.518 0.727 . . . . 0.0 110.815 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.76 148.83 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.4 m -129.58 145.31 51.49 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 127.055 2.142 . . . . 0.0 108.527 -178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.26 128.28 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.176 1.39 . . . . 0.0 109.746 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.6 mt -119.56 120.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 125.733 1.613 . . . . 0.0 106.921 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.18 140.56 37.85 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.774 1.63 . . . . 0.0 107.846 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -136.67 130.54 32.32 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -58.76 -16.54 17.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -172.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.7 -14.98 63.4 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.536 2.335 . . . . 0.0 114.411 171.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.7 t -142.27 -36.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.75 1.62 . . . . 0.0 113.254 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -82.29 138.3 45.29 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.564 1.546 . . . . 0.0 110.054 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -74.43 178.87 6.48 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.719 2.946 . . . . 0.0 112.467 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -116.65 29.39 7.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.936 1.694 . . . . 0.0 111.842 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -114.01 -36.11 4.87 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.867 1.267 . . . . 0.0 112.204 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.6 ttt -121.36 142.9 49.54 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.761 2.024 . . . . 0.0 108.096 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 39.3 p -137.64 131.51 31.63 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.897 0.856 . . . . 0.0 110.909 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.77 137.17 40.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 123.905 0.882 . . . . 0.0 110.499 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.7 t -127.89 160.06 33.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.718 1.207 . . . . 0.0 111.268 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.79 84.29 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 111.1 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.33 -39.97 94.97 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.27 1.028 . . . . 0.0 112.257 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -146.0 -174.81 4.53 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.249 2.219 . . . . 0.0 111.613 174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.512 HD22 HG23 ' A' ' 203' ' ' THR . 4.7 t30 -43.34 -53.27 5.39 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 127.041 2.136 . . . . 0.0 113.352 172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.512 HG23 HD22 ' A' ' 202' ' ' ASN . 73.5 p -133.59 29.71 3.86 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.449 1.1 . . . . 0.0 112.199 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.8 t -129.83 130.09 44.85 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.581 1.152 . . . . 0.0 109.719 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -129.41 151.09 50.42 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.175 1.39 . . . . 0.0 110.092 -174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.3 tt -132.09 109.88 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.859 0.837 . . . . 0.0 110.779 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -83.26 101.45 11.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.08 2.152 . . . . 0.0 110.168 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -83.8 126.08 32.58 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.655 1.582 . . . . 0.0 109.828 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 17.5 tp -126.78 109.09 11.65 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.358 0.981 . . . . 0.0 110.925 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.39 19.81 7.43 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.913 1.685 . . . . 0.0 113.206 -172.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.0 m -150.92 111.36 4.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.85 1.66 . . . . 0.0 111.588 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -61.1 -40.48 93.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.927 1.291 . . . . 0.0 113.142 -176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 127.337 2.255 . . . . 0.0 113.181 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 121.836 0.827 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p -71.9 141.03 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.676 0.79 . . . . 0.0 111.484 169.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -67.6 139.38 56.86 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.071 0.548 . . . . 0.0 109.672 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.51 -12.33 21.68 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.545 -1.347 . . . . 0.0 113.274 173.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -114.29 9.74 17.03 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.468 1.907 . . . . 0.0 113.353 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.61 176.66 9.45 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.717 1.607 . . . . 0.0 110.176 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.455 HG11 ' SG ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -134.12 128.28 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.251 1.021 . . . . 0.0 109.256 -177.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.95 150.4 20.39 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.819 -0.55 . . . . 0.0 110.142 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -145.24 127.95 16.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.988 1.315 . . . . 0.0 109.275 -174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -129.48 135.0 48.09 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.257 1.423 . . . . 0.0 110.223 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -78.34 44.31 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.828 2.051 . . . . 0.0 112.547 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.73 150.54 8.89 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 120.805 -1.184 . . . . 0.0 112.173 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.71 146.21 37.4 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.992 0.917 . . . . 0.0 111.917 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 51.42 40.92 27.74 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 93.9 m 59.15 64.33 1.41 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.639 1.575 . . . . 0.0 113.421 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.0 p -130.88 177.37 7.48 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.821 1.248 . . . . 0.0 111.981 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.74 -87.49 0.74 Allowed Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.219 1.39 . . . . 0.0 113.59 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -135.98 165.64 25.2 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.584 1.553 . . . . 0.0 110.699 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.8 p -127.81 145.68 50.85 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.513 1.125 . . . . 0.0 112.032 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.31 162.48 40.84 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.275 1.83 . . . . 0.0 110.703 -174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -136.91 141.08 42.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.118 1.367 . . . . 0.0 109.193 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -120.68 138.51 53.91 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.093 1.757 . . . . 0.0 108.831 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -76.79 143.07 40.08 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.065 1.746 . . . . 0.0 111.49 171.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG3' HG12 ' A' ' 50' ' ' VAL . 12.0 ttmt -64.68 145.75 55.74 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.14 168.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.95 49.7 15.9 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 123.111 0.386 . . . . 0.0 112.64 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.45 159.37 43.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.59 1.156 . . . . 0.0 111.221 -170.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -140.48 118.89 12.16 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.022 1.329 . . . . 0.0 109.432 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.4 m -127.12 147.38 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.125 0.97 . . . . 0.0 110.822 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -136.36 134.93 38.37 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.579 1.152 . . . . 0.0 109.441 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.15 134.6 21.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.8 1.24 . . . . 0.0 108.967 -173.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -146.84 138.65 24.48 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.341 1.057 . . . . 0.0 110.314 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -172.5 60.13 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.642 1.577 . . . . 0.0 112.27 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 53.49 39.42 59.93 Favored Glycine 0 CA--C 1.542 1.722 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 51.86 74.43 0.26 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.57 -42.88 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -98.33 -18.08 18.53 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 120.303 1.411 . . . . 0.0 114.803 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -80.25 -43.68 20.97 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.438 1.495 . . . . 0.0 111.349 178.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -77.37 52.3 0.93 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.442 1.497 . . . . 0.0 112.351 166.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.72 4.44 49.61 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 120.288 -1.508 . . . . 0.0 114.858 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 89' ' ' PHE . 13.0 m-85 -78.16 137.22 38.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.117 0.967 . . . . 0.0 111.754 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -143.48 -62.09 0.4 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.511 1.924 . . . . 0.0 111.463 175.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -122.39 124.57 43.98 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.906 0.882 . . . . 0.0 109.582 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.45 156.06 44.54 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 122.252 1.025 . . . . 0.0 110.584 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.53 127.69 49.84 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.274 1.03 . . . . 0.0 108.418 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.6 t -106.53 107.79 23.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.46 1.504 . . . . 0.0 109.352 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.21 162.2 3.82 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 122.568 1.094 . . . . 0.0 113.703 175.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -71.66 -13.88 61.88 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.3 34.23 4.22 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.396 1.478 . . . . 0.0 111.735 -177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 25' ' ' LYS . 32.9 m -149.85 157.57 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 128.174 2.59 . . . . 0.0 110.296 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -137.5 149.22 46.62 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.284 1.434 . . . . 0.0 110.285 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.455 ' SG ' HG11 ' A' ' 8' ' ' VAL . 3.5 m -116.09 133.97 55.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.256 0.551 . . . . 0.0 110.521 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -122.4 117.02 25.03 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.469 1.107 . . . . 0.0 109.116 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.536 HG23 HD13 ' A' ' 86' ' ' LEU . 81.1 mt -111.37 114.35 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.351 1.461 . . . . 0.0 108.984 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.29 124.81 39.66 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.526 1.13 . . . . 0.0 108.025 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -53.7 -58.38 7.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.668 0.747 . . . . 0.0 111.615 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.89 179.92 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.971 0.909 . . . . 0.0 109.812 -173.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -67.2 71.04 0.1 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.826 0.85 . . . . 0.0 111.174 164.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.19 -37.29 74.46 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.17 -0.919 . . . . 0.0 112.666 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.1 pt 42.28 30.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 116.121 1.897 . . . . 0.0 116.121 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 71.45 22.58 4.15 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 126.707 2.003 . . . . 0.0 113.429 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.5 t -61.86 144.21 93.71 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.314 1.845 . . . . 0.0 111.221 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 34.99 0.33 Allowed 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 124.531 3.488 . . . . 0.0 113.852 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.5 t -156.35 50.58 0.47 Allowed Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 126.931 2.092 . . . . 0.0 111.939 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.71 135.49 38.75 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.46 1.44 . . . . 0.0 109.656 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.96 -92.62 0.49 Allowed Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -142.82 159.85 41.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.637 1.575 . . . . 0.0 111.149 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -148.76 140.84 23.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.798 1.639 . . . . 0.0 109.514 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -153.5 147.59 25.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 122.144 0.974 . . . . 0.0 111.22 177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -118.66 102.95 9.24 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.404 1.482 . . . . 0.0 109.047 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mp -72.39 96.47 1.89 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.352 1.061 . . . . 0.0 109.418 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.42 145.19 8.9 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.808 1.643 . . . . 0.0 113.234 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -55.51 147.26 18.16 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.55 1.54 . . . . 0.0 112.635 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.45 51.33 59.74 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.67 0.652 . . . . 0.0 114.104 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.4 t -149.94 170.73 18.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.531 1.132 . . . . 0.0 112.402 -173.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.3 m -139.89 142.96 36.48 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.674 1.19 . . . . 0.0 109.876 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -132.89 106.87 7.96 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.527 1.131 . . . . 0.0 109.659 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.79 -28.82 22.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.062 1.345 . . . . 0.0 112.52 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.31 62.0 1.1 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.569 1.947 . . . . 0.0 110.75 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.55 14.04 0.86 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 175.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.73 -9.92 0.25 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.87 1.668 . . . . 0.0 115.203 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.9 m -45.5 -26.1 0.53 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.258 1.423 . . . . 0.0 114.606 158.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.273 2.7 tt -109.06 45.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.198 1.399 . . . . 0.0 112.724 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -49.55 -22.72 1.34 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.719 1.208 . . . . 0.0 113.729 165.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -83.24 84.57 1.55 Allowed Glycine 0 CA--C 1.538 1.495 0 C-N-CA 123.975 0.797 . . . . 0.0 112.537 159.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 54' ' ' ILE . 11.6 tp -125.33 141.92 51.79 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.141 1.376 . . . . 0.0 110.37 164.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.6 m -145.38 -32.82 0.37 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.395 1.478 . . . . 0.0 113.418 164.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -112.83 125.88 54.83 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.85 1.26 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CE2' ' CE2' ' A' ' 41' ' ' PHE . 4.1 t80 -123.85 134.49 53.58 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.649 0.78 . . . . 0.0 110.109 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -126.35 126.96 44.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.563 1.145 . . . . 0.0 108.357 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.4 t -104.41 120.63 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.7 mt -110.67 150.65 42.05 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.204 1.002 . . . . 0.0 109.953 -176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG3' ' CE2' ' A' ' 96' ' ' PHE . 86.3 Cg_endo -79.51 168.56 19.65 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.353 2.035 . . . . 0.0 112.569 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.88 32.09 1.48 Allowed Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.525 1.536 . . . . 0.0 114.9 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.78 -48.19 0.5 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.707 1.603 . . . . 0.0 111.703 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 1.6 m-30 -82.99 136.75 34.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.046 0.938 . . . . 0.0 109.201 177.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -78.08 -32.67 50.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.531 -0.731 . . . . 0.0 111.69 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.512 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 14.2 p-90 -155.48 167.92 28.81 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.73 2.012 . . . . 0.0 109.786 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.03 164.15 28.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.569 0.699 . . . . 0.0 111.166 170.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.51 141.21 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.991 1.317 . . . . 0.0 109.025 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.7 129.62 34.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 171.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.404 HG22 HD23 ' A' ' 138' ' ' LEU . 15.1 m -125.58 148.27 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.727 0.811 . . . . 0.0 109.664 170.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -148.98 158.35 44.12 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.042 0.937 . . . . 0.0 110.193 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.1 mt -111.91 130.63 65.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.74 110.78 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.744 0.817 . . . . 0.0 109.462 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.28 127.27 32.77 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.215 -0.928 . . . . 0.0 111.576 175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -112.63 17.18 19.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.693 1.597 . . . . 0.0 111.757 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.521 HG21 ' HA ' ' A' ' 211' ' ' SER . 64.6 t -126.6 -57.44 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 126.489 1.915 . . . . 0.0 110.654 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -153.95 138.76 17.09 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.139 1.376 . . . . 0.0 111.378 -173.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 p -49.7 -58.38 5.42 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.749 1.62 . . . . 0.0 115.209 -168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.3 m 31.22 63.22 0.22 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 128.011 2.524 . . . . 0.0 113.5 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.34 -98.16 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -166.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -59.38 -18.03 41.71 Favored Glycine 0 CA--C 1.541 1.662 0 O-C-N 119.699 -1.876 . . . . 0.0 113.575 171.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.5 m -60.81 -20.82 62.35 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.4 1.88 . . . . 0.0 115.027 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.81 128.42 40.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.674 1.189 . . . . 0.0 109.785 170.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.63 127.56 40.86 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.956 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.2 ttp -126.95 152.73 46.77 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.017 1.727 . . . . 0.0 110.358 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 99.4 m -137.55 131.01 31.09 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.59 133.07 68.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 47.2 p -133.12 86.49 42.1 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 109.68 -172.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.16 112.29 2.71 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.051 1.834 . . . . 0.0 108.621 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.5 t80 40.19 54.67 2.77 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.567 1.947 . . . . 0.0 112.99 -176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 45.38 31.75 0.92 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.6 1.56 . . . . 0.0 114.956 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.32 133.21 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 127.059 2.143 . . . . 0.0 108.597 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.3 t70 38.23 71.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.45 1.9 . . . . 0.0 113.348 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.85 138.97 41.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.59 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.84 140.1 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.591 0.756 . . . . 0.0 110.168 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.39 140.11 40.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.224 1.01 . . . . 0.0 110.022 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.432 ' HB3' HG21 ' A' ' 136' ' ' VAL . 7.6 p -140.85 143.03 34.53 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.257 1.823 . . . . 0.0 109.22 -174.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -131.49 143.99 50.81 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.715 1.206 . . . . 0.0 109.307 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.31 90.85 0.1 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 122.106 0.955 . . . . 0.0 111.897 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 151.02 -22.02 0.99 Allowed Glycine 0 CA--C 1.527 0.83 0 O-C-N 121.162 -0.961 . . . . 0.0 113.216 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -60.75 150.99 30.71 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 118.492 1.146 . . . . 0.0 112.308 167.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.2 66.66 9.35 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.378 -0.826 . . . . 0.0 111.08 -177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 62.47 166.58 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.143 1.777 . . . . 0.0 112.569 -169.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 129' ' ' CYS . 62.6 t -138.37 138.42 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.548 1.539 . . . . 0.0 109.599 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.34 122.25 28.22 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.348 0.659 . . . . 0.0 110.223 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 102' ' ' VAL . 3.2 mm? -97.55 110.76 56.35 Favored Pre-proline 0 C--O 1.233 0.213 0 C-N-CA 125.274 1.43 . . . . 0.0 109.482 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 96.1 Cg_endo -77.72 136.68 15.46 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.673 2.249 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.512 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 17.0 mm -129.01 124.53 22.44 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 177.1 6.77 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.261 2.641 . . . . 0.0 112.075 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.0 ttpp -65.08 141.55 58.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.443 -0.786 . . . . 0.0 111.983 170.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.751 2.021 . . . . 0.0 109.483 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.8 m -126.24 135.32 26.99 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 124.741 1.216 . . . . 0.0 109.995 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.15 154.3 84.95 Favored 'Cis proline' 0 CA--C 1.54 0.782 0 CA-C-N 119.477 0.849 . . . . 0.0 112.488 -3.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -63.82 -27.19 67.51 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.931 1.754 . . . . 0.0 112.401 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -9.89 22.21 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 171.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 46.5 m -62.57 166.41 5.32 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.741 1.258 . . . . 0.0 113.315 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.69 153.24 26.72 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.686 1.194 . . . . 0.0 111.897 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 20.5 tt -119.42 131.29 72.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 128.224 2.61 . . . . 0.0 107.957 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.2 m -73.77 134.11 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.689 0.795 . . . . 0.0 109.788 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.3 m -135.74 131.27 35.34 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.288 0.635 . . . . 0.0 110.117 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 39.4 t60 -96.59 147.42 23.89 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.728 -0.608 . . . . 0.0 109.974 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tt -133.99 132.46 40.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.36 1.464 . . . . 0.0 108.645 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -141.41 118.27 11.12 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.518 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.95 133.43 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.469 1.507 . . . . 0.0 109.943 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.84 149.77 39.02 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.03 1.732 . . . . 0.0 109.182 -174.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -71.94 146.44 47.79 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 64.4 p -73.74 -4.01 31.92 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.062 -1.024 . . . . 0.0 113.45 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.94 155.14 43.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.401 2.281 . . . . 0.0 111.683 -177.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.38 151.5 28.13 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 124.615 1.166 . . . . 0.0 113.395 -174.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.56 -2.15 17.2 Favored 'Cis proline' 0 C--N 1.354 0.849 0 N-CA-C 115.29 1.227 . . . . 0.0 115.29 3.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . 0.26 0.2 OUTLIER 39.41 37.76 0.31 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 115.411 176.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -82.47 46.65 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.128 0.971 . . . . 0.0 113.486 -164.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 40.73 74.43 0.1 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.78 2.032 . . . . 0.0 112.834 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -37.11 -51.88 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.25 1.82 . . . . 0.0 111.802 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.9 t -138.58 128.9 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -136.1 109.64 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.422 1.089 . . . . 0.0 108.254 171.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -177.76 -165.75 33.25 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.712 0.672 . . . . 0.0 112.275 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 8.8 m -136.78 163.95 29.42 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.094 -0.65 . . . . 0.0 110.816 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.12 150.73 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.228 1.411 . . . . 0.0 109.438 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -94.0 135.96 34.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.577 -0.702 . . . . 0.0 109.869 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -113.22 132.12 55.63 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 125.357 1.463 . . . . 0.0 107.828 173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -123.64 156.97 34.84 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.581 1.552 . . . . 0.0 109.073 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.434 ' HB2' ' CZ2' ' A' ' 98' ' ' TRP . 44.9 t80 -120.0 133.11 55.64 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.261 0.937 . . . . 0.0 109.669 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.2 m -97.97 102.16 12.87 Favored Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 123.724 0.81 . . . . 0.0 109.074 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.37 -15.71 42.51 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.26 1.973 . . . . 0.0 113.288 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 16.6 m -47.8 -40.62 21.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.416 1.886 . . . . 0.0 112.767 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 33.4 p -144.81 20.46 1.64 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.867 1.267 . . . . 0.0 112.729 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 54.39 37.02 59.03 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.964 1.745 . . . . 0.0 115.276 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.64 ' HG2' ' H ' ' A' ' 182' ' ' VAL . 9.3 tt0 -80.88 179.17 7.96 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.652 0.739 . . . . 0.0 112.657 177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.64 ' H ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 t -130.63 144.15 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 128.388 2.675 . . . . 0.0 107.713 166.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.3 m -134.79 123.16 23.14 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.297 2.239 . . . . 0.0 108.167 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 197' ' ' VAL . 0.3 OUTLIER -100.79 116.9 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 121.949 0.881 . . . . 0.0 111.312 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.56 118.1 35.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 124.897 1.279 . . . . 0.0 108.526 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 142.56 51.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.31 1.844 . . . . 0.0 109.04 175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -167.48 160.01 12.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.602 1.561 . . . . 0.0 110.094 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.48 -20.07 4.38 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.042 1.737 . . . . 0.0 114.029 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -55.25 -29.09 57.37 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.141 1.776 . . . . 0.0 114.819 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.4 p -149.61 -43.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.232 1.413 . . . . 0.0 113.397 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -96.44 137.37 21.56 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.842 1.257 . . . . 0.0 110.323 178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.05 -171.52 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.601 2.201 . . . . 0.0 112.81 177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.84 -20.4 13.07 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.721 2.009 . . . . 0.0 114.474 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -67.65 -12.32 60.18 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.106 1.762 . . . . 0.0 113.159 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.4 ttm -131.36 145.77 51.98 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.645 1.578 . . . . 0.0 108.507 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 75.3 p -136.81 155.88 49.23 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.988 1.315 . . . . 0.0 109.042 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 184' ' ' VAL . 2.6 t -116.36 125.9 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 O-C-N 121.939 -0.476 . . . . 0.0 109.82 -177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.4 m -117.11 130.32 56.55 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.462 1.105 . . . . 0.0 109.318 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -76.39 70.58 2.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.841 1.656 . . . . 0.0 111.093 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.22 -42.16 76.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.807 1.243 . . . . 0.0 113.553 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -147.93 177.9 8.96 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.885 2.074 . . . . 0.0 109.543 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -68.47 129.84 41.1 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.51 -1.369 . . . . 0.0 108.534 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . 0.25 19.4 p 55.99 29.89 15.16 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.279 1.432 . . . . 0.0 114.316 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.8 m -135.28 123.87 23.6 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.556 1.142 . . . . 0.0 111.869 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' HG13 ' A' ' 184' ' ' VAL . 19.9 m-85 -124.84 134.89 52.56 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.978 1.311 . . . . 0.0 110.406 -173.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 14.1 mt -120.69 116.1 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -77.14 93.99 4.0 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.59 1.956 . . . . 0.0 109.971 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -73.76 121.54 20.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.451 1.101 . . . . 0.0 109.916 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.26 102.96 13.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.921 0.888 . . . . 0.0 109.795 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -83.7 -29.05 27.86 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.886 1.274 . . . . 0.0 113.343 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.521 ' HA ' HG21 ' A' ' 108' ' ' VAL . 58.4 m -159.54 133.25 7.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 127.153 2.181 . . . . 0.0 110.839 173.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.6 15.01 0.15 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 126.481 1.913 . . . . 0.0 113.944 -163.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.525 0.679 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.67 137.42 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.101 0.96 . . . . 0.0 110.73 168.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -75.64 146.22 40.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.443 0.697 . . . . 0.0 110.331 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.01 -17.44 17.46 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -112.97 12.19 19.25 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.115 2.566 . . . . 0.0 113.57 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -138.75 174.03 10.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.024 1.33 . . . . 0.0 110.256 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -140.0 148.39 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.088 0.955 . . . . 0.0 108.434 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -132.05 143.57 50.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.45 1.1 . . . . 0.0 110.873 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.31 137.31 49.89 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.461 1.504 . . . . 0.0 108.55 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.78 150.24 46.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 126.139 1.776 . . . . 0.0 109.38 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -115.1 92.52 3.96 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.051 1.34 . . . . 0.0 109.831 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.76 -62.06 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.948 161.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 161.51 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 130.382 3.473 . . . . 0.0 108.663 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t30 36.84 58.33 1.12 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 114.786 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m 52.26 63.85 2.08 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.069 1.748 . . . . 0.0 115.426 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 78.5 m -123.21 -41.48 2.31 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.73 -120.6 3.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.676 1.125 . . . . 0.0 112.752 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.93 165.95 22.26 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.558 1.179 . . . . 0.0 111.423 174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.0 p -136.66 157.96 45.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.3 1.44 . . . . 0.0 111.903 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.08 131.25 15.44 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.296 1.838 . . . . 0.0 108.291 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -132.67 120.84 22.26 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.06 1.344 . . . . 0.0 108.8 -171.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -147.19 138.55 23.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.987 1.375 . . . . 0.0 111.266 -169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -70.41 153.52 42.89 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.189 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -63.18 161.9 12.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.554 0.742 . . . . 0.0 112.074 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.42 45.74 76.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.496 0.569 . . . . 0.0 112.847 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -138.63 158.24 44.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.624 1.97 . . . . 0.0 111.247 -174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.3 m -134.68 117.83 16.48 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.347 1.059 . . . . 0.0 108.551 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.6 139.02 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.456 . . . . 0.0 109.617 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -144.62 101.21 3.64 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.402 1.081 . . . . 0.0 108.514 -165.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -131.1 124.34 30.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.735 0.814 . . . . 0.0 111.067 -171.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -152.54 165.93 33.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.364 1.466 . . . . 0.0 112.334 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -153.1 110.09 3.47 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.19 1.396 . . . . 0.0 108.889 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 51.86 34.73 38.09 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 125.338 1.447 . . . . 0.0 115.612 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.286 0.7 OUTLIER 48.42 40.81 15.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.673 1.989 . . . . 0.0 115.506 -170.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -135.15 -49.43 0.74 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -66.58 -20.76 66.08 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 122.408 2.367 . . . . 0.0 115.427 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -52.24 -28.81 20.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.625 1.102 . . . . 0.0 112.857 166.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -67.44 -0.95 4.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.142 0.977 . . . . 0.0 113.619 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.18 -39.73 3.01 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.416 1.487 . . . . 0.0 112.721 165.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -60.23 124.3 19.86 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 123.082 1.42 . . . . 0.0 111.782 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.1 tpt -149.56 -35.56 0.17 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.436 1.494 . . . . 0.0 113.349 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 p -141.03 125.06 17.19 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.124 0.874 . . . . 0.0 111.491 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.1 p -140.11 159.2 42.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.423 1.106 . . . . 0.0 112.32 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.56 121.5 17.71 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.32 112.3 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 126.479 1.911 . . . . 0.0 108.108 -176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -32.61 -83.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 127.752 2.596 . . . . 0.0 116.742 -172.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.633 1.973 . . . . 0.0 112.694 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -121.09 37.91 4.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.929 1.292 . . . . 0.0 110.472 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.6 m -151.01 143.81 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 128.566 2.747 . . . . 0.0 109.028 -175.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -119.5 148.83 42.81 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.951 1.7 . . . . 0.0 109.167 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.09 140.91 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.258 0.551 . . . . 0.0 109.833 177.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -131.92 131.07 42.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.435 1.094 . . . . 0.0 108.781 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.75 126.62 74.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 129.33 41.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.93 1.292 . . . . 0.0 109.458 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -54.76 -62.31 1.74 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.912 0.863 . . . . 0.0 113.301 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.83 173.85 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.345 1.458 . . . . 0.0 109.785 -175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -104.98 139.85 39.06 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.892 -0.505 . . . . 0.0 110.575 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.5 -173.87 1.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 110.988 -170.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.06 39.19 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.834 1.654 . . . . 0.0 112.004 -173.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.326 43.0 m-20 56.38 48.43 17.02 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.102 1.761 . . . . 0.0 111.053 -167.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.36 153.52 19.52 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 112.626 -2.079 . . . . 0.0 109.968 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.53 26.43 0.28 Allowed 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.677 3.584 . . . . 0.0 115.203 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -151.21 58.66 2.92 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 126.704 2.002 . . . . 0.0 110.636 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.51 145.62 59.17 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 121.579 1.52 . . . . 0.0 110.385 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.1 -129.58 0.51 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.084 1.326 . . . . 0.0 113.151 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.36 158.2 31.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.119 1.368 . . . . 0.0 111.038 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -147.91 153.29 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.848 1.659 . . . . 0.0 109.765 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -159.4 163.1 35.77 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.882 0.873 . . . . 0.0 110.784 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -123.55 105.12 9.49 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.274 1.43 . . . . 0.0 110.494 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.2 mt -74.18 102.08 4.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.747 1.219 . . . . 0.0 109.611 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.95 148.84 24.57 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.766 1.627 . . . . 0.0 113.744 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -55.39 140.94 38.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.742 1.617 . . . . 0.0 113.108 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 55.61 29.17 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 125.007 1.289 . . . . 0.0 114.366 174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -148.62 164.01 35.55 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -134.35 129.9 36.13 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.868 1.667 . . . . 0.0 108.513 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.2 130.84 50.44 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.626 1.571 . . . . 0.0 107.492 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -139.85 -8.36 1.22 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -140.92 68.02 1.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.415 1.886 . . . . 0.0 110.819 174.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' H ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -119.43 20.7 12.41 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.255 2.222 . . . . 0.0 112.237 -177.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -56.24 -11.97 1.39 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.625 1.57 . . . . 0.0 114.077 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.23 -19.75 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 O-C-N 120.401 -1.437 . . . . 0.0 114.138 165.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.98 34.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 126.821 2.048 . . . . 0.0 111.745 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -49.67 -28.98 6.61 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 120.367 -1.458 . . . . 0.0 113.418 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.54 71.71 1.04 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.046 1.308 . . . . 0.0 113.653 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.51 147.57 46.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.27 1.428 . . . . 0.0 109.481 164.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.6 m -147.91 -14.81 0.36 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 159.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -133.4 127.37 33.26 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.367 1.467 . . . . 0.0 109.564 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.09 124.24 36.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.814 1.246 . . . . 0.0 109.263 -166.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -117.09 115.86 26.2 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.449 1.499 . . . . 0.0 108.425 -174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 t -115.94 117.01 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -168.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.4 mt -128.44 151.83 77.28 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.978 0.911 . . . . 0.0 109.797 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.16 -178.85 3.48 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.072 2.515 . . . . 0.0 111.617 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.61 -23.02 71.2 Favored Glycine 0 CA--C 1.536 1.402 0 O-C-N 121.167 -0.958 . . . . 0.0 113.855 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.25 74.28 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.117 0.967 . . . . 0.0 112.417 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.437 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 1.4 m-30 -91.67 149.21 21.75 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.89 1.276 . . . . 0.0 109.484 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.81 -31.88 4.4 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.577 -1.327 . . . . 0.0 113.181 -176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.73 148.43 31.98 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.667 1.587 . . . . 0.0 108.19 167.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -119.19 154.94 32.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.766 0.793 . . . . 0.0 110.077 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.06 150.01 26.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 125.392 1.477 . . . . 0.0 109.433 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.62 126.99 51.11 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.51 136.05 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.7 -0.625 . . . . 0.0 110.206 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -140.71 134.09 29.81 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.931 0.492 . . . . 0.0 111.387 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 115' ' ' TYR . 39.8 mt -85.38 146.24 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.495 1.518 . . . . 0.0 109.481 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.3 t -135.9 102.56 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 126.135 1.774 . . . . 0.0 109.118 175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -58.16 119.94 7.73 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.054 0.942 . . . . 0.0 111.662 164.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.9 mmtt -112.65 -35.6 5.46 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.016 0.926 . . . . 0.0 111.646 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.5 p -91.12 -36.15 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.373 1.069 . . . . 0.0 113.76 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -91.58 91.66 8.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.595 1.158 . . . . 0.0 109.924 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 65.3 p -64.33 17.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 94.5 m -133.94 80.95 1.89 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.394 2.678 . . . . 0.0 109.074 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.58 130.69 47.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.072 0.949 . . . . 0.0 111.811 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.87 -38.44 2.1 Favored Glycine 0 N--CA 1.475 1.291 0 C-N-CA 125.283 1.42 . . . . 0.0 113.537 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.4 m -71.47 -27.58 63.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.613 1.165 . . . . 0.0 112.946 172.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE1' HG21 ' A' ' 104' ' ' ILE . 1.7 t80 -75.85 126.97 32.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.631 1.172 . . . . 0.0 109.847 171.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -129.23 141.71 51.06 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.765 1.626 . . . . 0.0 109.43 171.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -135.85 138.77 42.84 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.962 0.905 . . . . 0.0 110.146 170.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.8 m -123.61 138.49 54.54 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.411 1.484 . . . . 0.0 107.793 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.8 145.63 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.619 0.767 . . . . 0.0 110.682 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 t -144.73 94.91 5.4 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 111.294 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.27 165.84 23.24 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.828 2.352 . . . . 0.0 112.164 168.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -29.67 94.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 128.092 2.557 . . . . 0.0 114.17 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 47.72 37.93 7.73 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 125.68 1.592 . . . . 0.0 114.867 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 76.0 t -93.65 155.69 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.644 1.578 . . . . 0.0 110.946 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.64 98.85 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.039 1.335 . . . . 0.0 111.195 170.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.85 151.33 18.2 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 121.743 -0.598 . . . . 0.0 112.084 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.35 131.22 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.102 0.561 . . . . 0.0 110.219 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 136.23 33.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.326 0.65 . . . . 0.0 109.477 171.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.1 t -124.66 142.18 51.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.808 1.243 . . . . 0.0 108.371 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -127.5 137.66 52.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 108.2 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.48 108.99 0.54 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.468 0.707 . . . . 0.0 111.326 -173.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 127.95 -25.69 4.91 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 113.791 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.75 146.27 55.03 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.892 1.346 . . . . 0.0 110.871 168.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.61 167.88 14.18 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.637 -0.664 . . . . 0.0 111.376 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -47.0 105.05 0.06 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.848 1.259 . . . . 0.0 112.78 -177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.01 126.29 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 124.506 1.122 . . . . 0.0 109.126 -172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.12 124.17 22.7 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.961 0.41 . . . . 0.0 109.949 176.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.81 96.43 49.5 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.557 1.943 . . . . 0.0 107.112 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 40.8 Cg_endo -74.37 143.49 31.41 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.473 2.115 . . . . 0.0 112.733 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 25.7 mm -122.06 133.78 24.47 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.794 1.637 . . . . 0.0 108.565 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.47 170.44 12.29 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 112.752 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -49.82 138.68 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.374 0.669 . . . . 0.0 112.716 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.17 122.71 9.78 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.649 0.779 . . . . 0.0 110.532 -174.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 10.4 t -134.6 131.66 20.38 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.994 0.918 . . . . 0.0 110.9 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.85 152.98 83.67 Favored 'Cis proline' 0 CA--C 1.548 1.204 0 CA-C-N 119.345 0.802 . . . . 0.0 112.148 -6.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.36 -37.48 81.64 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.709 2.273 . . . . 0.0 112.089 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.35 -7.15 8.65 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.053 1.741 . . . . 0.0 114.414 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.3 t -74.6 -179.42 4.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.136 -0.978 . . . . 0.0 112.347 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -130.5 154.52 47.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.975 1.31 . . . . 0.0 112.826 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.6 tt -121.49 130.6 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.541 1.936 . . . . 0.0 109.854 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.23 141.29 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.96 0.904 . . . . 0.0 111.017 172.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 34.7 t -148.29 158.7 44.25 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.211 1.404 . . . . 0.0 110.764 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.55 136.45 53.84 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.31 1.044 . . . . 0.0 109.216 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.34 126.31 46.62 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.186 1.794 . . . . 0.0 108.367 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.7 p -133.46 131.15 39.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.78 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.29 127.08 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.607 1.563 . . . . 0.0 107.02 176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -143.71 151.59 40.23 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.729 1.612 . . . . 0.0 109.336 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -85.53 142.67 29.0 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.816 -0.552 . . . . 0.0 111.524 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.9 p -85.85 7.57 23.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.912 1.685 . . . . 0.0 112.926 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.65 170.94 16.43 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.31 1.844 . . . . 0.0 110.733 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -51.41 139.47 27.15 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 124.923 1.289 . . . . 0.0 113.442 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.94 11.74 19.29 Favored 'Cis proline' 0 CA--C 1.549 1.229 0 N-CA-C 114.904 1.078 . . . . 0.0 114.904 4.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 62.67 15.33 7.96 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.664 1.986 . . . . 0.0 114.149 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -83.76 164.64 19.45 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.19 1.396 . . . . 0.0 112.469 -172.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -68.98 154.59 41.8 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.812 0.815 . . . . 0.0 112.121 171.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.3 -38.27 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.786 1.634 . . . . 0.0 110.339 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.3 t -146.06 140.92 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.946 1.298 . . . . 0.0 109.602 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -144.35 105.79 4.26 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.432 1.493 . . . . 0.0 108.579 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.11 -179.98 38.65 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.466 -0.771 . . . . 0.0 114.487 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 1.5 p -113.21 136.1 53.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.703 1.201 . . . . 0.0 112.004 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.35 150.04 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.974 2.11 . . . . 0.0 107.722 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -124.52 135.47 53.21 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -111.1 149.54 30.69 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.458 -0.776 . . . . 0.0 109.333 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -138.26 153.68 49.08 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.837 2.055 . . . . 0.0 108.654 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -115.7 164.65 14.04 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.197 0.999 . . . . 0.0 109.719 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -136.46 105.29 9.24 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.342 1.057 . . . . 0.0 109.582 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -67.8 -14.96 43.13 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.53 2.82 . . . . 0.0 113.262 -174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.0 m -45.5 -46.54 13.88 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.49 2.316 . . . . 0.0 113.171 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 65.1 p -145.21 11.03 1.32 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.734 1.214 . . . . 0.0 113.14 174.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 69.29 42.71 73.99 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 120.199 -1.563 . . . . 0.0 112.768 -169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -83.52 156.67 22.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.197 0.999 . . . . 0.0 108.897 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 203' ' ' THR . 0.4 OUTLIER -112.36 155.12 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.739 0.815 . . . . 0.0 110.274 165.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 96.6 m -143.63 114.95 7.98 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.696 1.199 . . . . 0.0 108.571 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.4 p -82.32 146.81 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.205 -0.934 . . . . 0.0 109.142 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.58 132.62 66.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 126.565 1.946 . . . . 0.0 107.56 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 138.66 32.65 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.198 1.399 . . . . 0.0 108.661 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -127.82 144.36 51.09 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.151 1.38 . . . . 0.0 108.539 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.49 -18.81 20.7 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.78 -33.6 16.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.46 1.504 . . . . 0.0 113.5 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.2 p -98.83 -53.05 3.39 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.77 1.228 . . . . 0.0 110.888 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -85.79 148.29 48.2 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.419 1.488 . . . . 0.0 109.997 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.08 175.17 11.24 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.386 2.058 . . . . 0.0 111.672 173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.59 8.71 44.58 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.945 1.298 . . . . 0.0 113.147 173.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.97 -37.52 10.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.355 1.462 . . . . 0.0 111.707 -164.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 146.45 40.41 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 128.76 2.824 . . . . 0.0 106.953 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 70.3 p -139.91 153.17 46.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.565 0.746 . . . . 0.0 110.896 177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.93 137.6 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.501 0.72 . . . . 0.0 110.27 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 33.4 m -120.72 140.76 51.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.806 1.642 . . . . 0.0 109.39 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -68.59 91.2 0.41 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.985 1.314 . . . . 0.0 110.635 171.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -75.27 -48.97 20.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 122.215 -0.303 . . . . 0.0 110.934 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -138.97 -178.59 5.4 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 125.631 1.572 . . . . 0.0 112.121 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -58.78 -34.54 71.56 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.138 1.375 . . . . 0.0 114.607 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 182' ' ' VAL . 50.6 p -138.0 25.16 2.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.985 1.714 . . . . 0.0 112.158 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 t -125.26 136.22 53.31 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.083 0.953 . . . . 0.0 111.255 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -125.5 133.3 52.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.178 1.391 . . . . 0.0 110.637 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 1.7 tt -115.97 112.35 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.154 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.94 125.62 39.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.842 2.457 . . . . 0.0 108.231 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -125.27 129.96 51.09 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.14 1.376 . . . . 0.0 111.319 -172.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.6 tt -121.87 114.9 21.68 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.889 0.876 . . . . 0.0 111.608 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -123.14 7.4 9.17 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.888 1.675 . . . . 0.0 113.938 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.67 -8.69 13.78 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -172.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 40.96 16.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 129.363 3.065 . . . . 0.0 118.67 -173.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt . . . . . 0 N--CA 1.477 0.896 0 C-N-CA 125.228 1.411 . . . . 0.0 113.28 -172.772 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.372 0.606 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' HA2' ' A' ' 47' ' ' GLY . 8.7 p -56.93 152.21 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.172 0.589 . . . . 0.0 111.565 167.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.1 142.73 57.68 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.484 -0.76 . . . . 0.0 111.251 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -19.39 51.04 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -110.28 9.12 23.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.639 1.976 . . . . 0.0 113.255 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mmmm -136.83 -178.31 5.13 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 120.485 1.493 . . . . 0.0 110.81 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -135.69 148.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.675 1.19 . . . . 0.0 110.653 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.22 142.52 49.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.471 1.108 . . . . 0.0 109.404 -177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -135.55 127.9 30.3 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.149 1.38 . . . . 0.0 108.51 -166.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -133.54 130.78 38.93 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.506 1.122 . . . . 0.0 110.601 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -87.44 56.88 4.14 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.792 1.237 . . . . 0.0 111.274 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.43 140.24 3.62 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 123.922 0.772 . . . . 0.0 111.183 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -58.23 139.16 55.55 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.459 0.703 . . . . 0.0 109.943 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.8 t30 70.55 37.62 1.44 Allowed 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 125.376 1.47 . . . . 0.0 113.808 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.9 m 54.14 64.12 1.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.331 1.852 . . . . 0.0 113.673 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 67.9 p -132.45 179.24 6.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.969 1.307 . . . . 0.0 112.755 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 76.97 -81.27 1.17 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.877 1.703 . . . . 0.0 114.71 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -138.53 166.73 23.55 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.053 1.741 . . . . 0.0 110.019 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -130.94 152.78 49.88 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.759 1.224 . . . . 0.0 112.758 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -160.68 162.76 32.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.373 1.469 . . . . 0.0 111.304 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -134.67 140.93 46.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.925 1.29 . . . . 0.0 110.812 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -124.87 141.19 52.28 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.851 1.661 . . . . 0.0 110.119 -174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -88.84 143.72 26.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.515 0.726 . . . . 0.0 111.444 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.26 150.68 38.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.06 1.344 . . . . 0.0 111.7 170.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.53 30.51 58.17 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.113 1.339 . . . . 0.0 113.438 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -137.77 159.09 42.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.942 1.697 . . . . 0.0 111.356 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.4 m -117.93 128.97 55.33 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.993 1.317 . . . . 0.0 108.86 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 t -122.89 114.85 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.747 1.219 . . . . 0.0 109.432 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.47 145.83 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.746 1.218 . . . . 0.0 111.074 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CE2' ' HE3' ' A' ' 40' ' ' LYS . 63.1 m-85 -131.89 176.25 8.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.243 1.417 . . . . 0.0 110.09 168.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.69 167.18 2.18 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.696 1.199 . . . . 0.0 111.48 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -118.07 25.46 10.32 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 120.827 -1.17 . . . . 0.0 112.484 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -89.76 11.72 69.49 Favored Glycine 0 CA--C 1.542 1.77 0 C-N-CA 126.099 1.809 . . . . 0.0 115.918 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.81 63.63 1.53 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -160.17 -44.39 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -122.03 -26.54 4.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.379 1.072 . . . . 0.0 112.746 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 2.6 p30 -62.15 -42.26 99.08 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.492 1.517 . . . . 0.0 111.813 166.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.46 34.93 0.14 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.029 1.731 . . . . 0.0 113.047 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -78.27 -20.28 51.93 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 118.902 -2.374 . . . . 0.0 114.596 177.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CE2' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -57.87 145.52 35.05 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.814 0.816 . . . . 0.0 111.706 176.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.5 ttt -155.7 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.076 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.1 p -134.56 132.56 39.26 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.613 1.097 . . . . 0.0 110.697 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 61.2 m -143.45 152.47 41.56 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 108.041 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.44 145.67 47.46 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 122.511 1.148 . . . . 0.0 112.273 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' HG12 ' A' ' 8' ' ' VAL . 95.3 t -106.73 120.18 57.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 128.354 2.661 . . . . 0.0 108.843 -170.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 3' ' ' VAL . . . -47.66 -86.2 0.01 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -168.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.1 t -164.13 -40.48 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.99 0.916 . . . . 0.0 111.792 173.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -112.76 32.67 5.49 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.846 1.258 . . . . 0.0 111.082 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.55 164.07 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.399 1.88 . . . . 0.0 110.276 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -144.43 154.12 42.63 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.742 2.017 . . . . 0.0 110.067 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.415 ' SG ' HG11 ' A' ' 8' ' ' VAL . 1.2 m -124.96 134.56 52.58 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.85 0.86 . . . . 0.0 110.806 -174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -119.19 118.33 31.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.89 1.276 . . . . 0.0 109.492 -168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.0 mm -110.1 106.49 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.294 1.038 . . . . 0.0 108.998 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.94 117.79 24.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.005 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -66.09 -45.46 81.13 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 122.205 1.003 . . . . 0.0 112.479 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.23 167.77 29.25 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.091 1.756 . . . . 0.0 109.923 -169.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -108.91 48.93 0.84 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.439 0.696 . . . . 0.0 110.537 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -51.75 160.68 0.63 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.505 1.922 . . . . 0.0 114.686 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.68 52.08 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 O-C-N 120.433 -1.417 . . . . 0.0 110.684 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 71.68 36.35 1.26 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 127.704 2.402 . . . . 0.0 111.58 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 p -67.46 155.96 89.72 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.789 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.79 32.35 0.33 Allowed 'Trans proline' 0 CA--C 1.551 1.351 0 C-N-CA 124.33 3.353 . . . . 0.0 113.38 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.0 t -151.16 99.64 3.05 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 126.228 1.811 . . . . 0.0 109.995 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.17 118.06 5.47 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.688 1.592 . . . . 0.0 108.965 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.89 -120.87 0.1 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 167.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.49 144.05 44.14 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.732 0.813 . . . . 0.0 112.52 -172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -161.82 132.45 5.03 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 110.226 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -143.22 163.1 33.88 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.599 1.159 . . . . 0.0 110.665 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.02 107.68 9.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.364 1.466 . . . . 0.0 109.235 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mp -84.05 95.55 8.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.815 0.846 . . . . 0.0 108.941 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.24 150.53 3.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.495 1.518 . . . . 0.0 113.044 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -66.61 145.95 55.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.829 0.452 . . . . 0.0 112.177 -174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.5 64.58 3.94 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.452 1.025 . . . . 0.0 115.413 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.1 t -153.02 177.2 11.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.147 0.979 . . . . 0.0 112.868 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.8 m -130.7 142.43 50.42 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.182 1.393 . . . . 0.0 110.241 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -132.82 134.55 44.81 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.962 1.305 . . . . 0.0 109.884 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -133.2 -33.02 1.15 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 123.579 0.752 . . . . 0.0 112.489 -177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -118.06 40.34 3.17 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 123.053 1.406 . . . . 0.0 110.965 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD13 ' CE2' ' A' ' 41' ' ' PHE . 0.5 OUTLIER -70.35 -16.35 62.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.385 1.074 . . . . 0.0 113.213 172.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 m -61.58 -11.47 11.41 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.269 1.427 . . . . 0.0 113.184 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.5 t -47.35 -36.74 9.96 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.82 -1.175 . . . . 0.0 113.127 167.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 tt -81.0 -35.17 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.84 42.22 11.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.998 2.119 . . . . 0.0 113.811 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.05 67.31 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.297 0.951 . . . . 0.0 113.022 -161.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 28.1 tp -131.61 115.35 15.97 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.63 1.572 . . . . 0.0 109.722 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.4 m -120.9 -20.6 6.86 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.481 1.113 . . . . 0.0 112.891 167.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -127.52 122.37 33.15 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.078 0.951 . . . . 0.0 110.189 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.35 137.11 44.91 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.232 1.013 . . . . 0.0 109.084 172.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -121.06 136.11 55.05 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.95 118.55 55.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.631 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.7 mt -131.41 146.94 64.14 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.967 0.907 . . . . 0.0 109.359 -169.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.71 165.77 24.47 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 123.114 2.543 . . . . 0.0 112.308 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -60.73 -14.3 36.04 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 124.358 0.98 . . . . 0.0 114.828 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.06 -28.07 63.09 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.134 1.374 . . . . 0.0 113.946 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.435 ' CG ' ' HB2' ' A' ' 139' ' ' PRO . 7.9 m-30 -123.49 102.93 8.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.693 1.597 . . . . 0.0 109.535 -166.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -84.9 -27.89 26.32 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.43 -1.419 . . . . 0.0 113.513 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.24 145.18 24.45 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.489 2.315 . . . . 0.0 106.856 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -133.43 165.71 24.22 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.782 0.801 . . . . 0.0 111.054 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 151.13 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.858 1.263 . . . . 0.0 109.261 -173.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -98.86 125.33 44.23 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.63 138.2 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 121.978 0.894 . . . . 0.0 110.729 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.09 118.07 15.31 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.547 1.539 . . . . 0.0 108.54 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 149.01 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 122.894 0.478 . . . . 0.0 109.822 165.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.96 129.49 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.29 121.72 34.07 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.017 -0.427 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -26.13 6.58 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.764 1.626 . . . . 0.0 113.142 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.12 -35.68 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.897 0.879 . . . . 0.0 113.266 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -108.91 -179.59 3.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.085 1.354 . . . . 0.0 109.735 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.8 t -120.93 -39.54 2.71 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.504 1.122 . . . . 0.0 111.826 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.7 m -60.19 -39.73 87.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.103 0.961 . . . . 0.0 112.204 171.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.16 -179.54 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.246 1.818 . . . . 0.0 114.789 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.98 -25.68 0.8 Allowed Glycine 0 N--CA 1.478 1.476 0 O-C-N 120.071 -1.643 . . . . 0.0 115.55 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.2 m -53.36 -35.5 60.35 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.13 1.372 . . . . 0.0 111.906 163.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -90.45 131.37 36.25 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.238 1.815 . . . . 0.0 110.466 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.52 130.35 42.22 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.871 1.269 . . . . 0.0 111.229 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.444 ' HG2' HG22 ' A' ' 156' ' ' VAL . 1.4 tmm? -92.86 135.58 34.01 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.916 1.686 . . . . 0.0 110.092 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 m -133.91 97.4 3.88 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.912 1.685 . . . . 0.0 108.304 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 127' ' ' VAL . 6.2 mm -94.22 132.44 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.1 m -131.61 92.96 29.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -68.99 171.99 12.66 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.013 2.475 . . . . 0.0 112.328 171.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -35.37 90.25 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.0 2.52 . . . . 0.0 114.969 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 41.53 59.23 2.48 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.888 1.675 . . . . 0.0 114.486 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -117.93 157.95 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.171 1.788 . . . . 0.0 111.593 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -40.54 115.35 0.56 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.859 1.663 . . . . 0.0 111.85 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.75 136.16 51.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.419 HG11 ' HG ' ' A' ' 138' ' ' LEU . 13.1 p -115.95 151.75 17.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.668 0.787 . . . . 0.0 109.339 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.3 132.89 41.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.204 1.001 . . . . 0.0 110.383 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.3 t -133.52 119.25 19.28 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.644 1.178 . . . . 0.0 108.936 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -114.81 121.87 44.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.578 1.551 . . . . 0.0 108.301 -171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 t0 55.54 -175.86 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.862 0.839 . . . . 0.0 113.054 -170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -75.65 30.64 1.24 Allowed Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.173 1.368 . . . . 0.0 113.587 161.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -56.56 175.55 0.11 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.998 1.399 . . . . 0.0 111.389 166.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -44.84 122.15 3.09 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.892 -1.13 . . . . 0.0 111.731 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -53.25 159.48 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.142 0.977 . . . . 0.0 112.416 -174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.41 135.24 54.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.766 0.793 . . . . 0.0 110.279 -176.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -75.55 142.7 42.72 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.557 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' HG ' HG11 ' A' ' 127' ' ' VAL . 0.6 OUTLIER -126.18 91.15 48.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 125.465 1.506 . . . . 0.0 109.345 -178.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 34.5 Cg_endo -71.05 144.18 46.55 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.196 1.931 . . . . 0.0 111.464 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 46.3 mm -128.17 135.4 27.47 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.718 1.607 . . . . 0.0 108.522 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.21 177.39 8.68 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 124.033 3.156 . . . . 0.0 112.306 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.08 141.81 57.13 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.395 0.678 . . . . 0.0 111.791 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.46 147.33 7.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.981 1.712 . . . . 0.0 110.314 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 98.8 m -147.48 135.33 10.7 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.087 0.955 . . . . 0.0 109.71 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.08 153.23 87.89 Favored 'Cis proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.422 0.829 . . . . 0.0 112.722 -5.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.18 -36.58 68.31 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.182 1.921 . . . . 0.0 112.158 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.25 -16.48 60.37 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.81 128.68 36.87 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 110.857 170.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 162.37 25.49 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 112.723 171.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.9 151.75 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.871 1.668 . . . . 0.0 109.098 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.53 118.41 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 123.565 0.746 . . . . 0.0 110.821 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.4 m -130.42 150.52 51.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.4 1.08 . . . . 0.0 111.609 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -115.25 123.21 48.25 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.93 0.892 . . . . 0.0 108.602 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.09 113.85 26.27 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.04 1.336 . . . . 0.0 107.758 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.63 145.31 42.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.444 HG22 ' HG2' ' A' ' 117' ' ' MET . 11.2 t -135.36 130.7 51.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -145.07 153.88 41.91 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.968 1.307 . . . . 0.0 109.331 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.77 143.24 54.71 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.941 168.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.4 p -74.7 -11.52 60.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.245 1.418 . . . . 0.0 113.946 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -141.6 161.06 38.86 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.751 2.021 . . . . 0.0 110.89 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.1 t -66.37 139.36 96.21 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.17 127.43 12.13 Favored 'Cis proline' 0 C--N 1.353 0.8 0 CA-C-N 120.331 1.154 . . . . 0.0 111.443 -6.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -74.22 49.91 0.37 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.713 1.605 . . . . 0.0 111.13 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.86 131.81 52.03 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.286 -1.509 . . . . 0.0 110.659 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -70.06 90.93 0.67 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.174 0.589 . . . . 0.0 109.839 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.2 t -42.47 -52.9 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.782 2.033 . . . . 0.0 111.087 171.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.8 p -159.47 152.51 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.917 -0.489 . . . . 0.0 111.838 171.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.87 102.87 5.6 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.845 1.658 . . . . 0.0 108.385 173.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -133.01 -174.36 13.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.928 1.728 . . . . 0.0 111.863 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.4 m -132.88 150.34 52.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.458 1.103 . . . . 0.0 110.906 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 1.9 m -144.46 163.5 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 126.314 1.846 . . . . 0.0 108.507 -175.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -129.49 136.38 49.81 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.927 0.491 . . . . 0.0 109.867 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.28 137.05 52.45 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.659 1.184 . . . . 0.0 107.983 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.55 160.13 38.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.269 1.428 . . . . 0.0 110.154 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -125.58 114.38 18.66 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.996 0.816 . . . . 0.0 110.253 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.2 m -76.46 118.2 69.8 Favored Pre-proline 0 N--CA 1.476 0.843 0 O-C-N 120.359 -1.463 . . . . 0.0 109.95 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.36 -19.36 55.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.59 2.193 . . . . 0.0 113.957 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.2 m -52.7 -50.27 63.68 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.902 2.081 . . . . 0.0 114.3 -174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.3 p -136.11 18.26 3.21 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.578 1.551 . . . . 0.0 111.803 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.76 41.14 97.75 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.095 0.855 . . . . 0.0 114.135 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -72.67 164.04 27.13 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.716 -1.461 . . . . 0.0 111.982 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 135.83 60.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 157.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.8 m -131.77 135.08 46.51 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.401 1.08 . . . . 0.0 108.298 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.443 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -102.27 135.75 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.9 0.857 . . . . 0.0 110.743 179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.7 mp -115.33 134.84 57.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.601 1.961 . . . . 0.0 106.721 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 133.76 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.789 1.235 . . . . 0.0 108.061 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.27 150.32 39.66 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.153 1.381 . . . . 0.0 108.882 -166.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -57.41 -23.42 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -86.74 -31.66 20.83 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.832 1.253 . . . . 0.0 113.6 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.2 p -96.34 -49.92 4.99 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.378 1.071 . . . . 0.0 110.199 -170.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 3.4 t80 -64.91 148.3 97.66 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 110.016 168.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 74.2 Cg_endo -75.87 -95.23 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.118 1.879 . . . . 0.0 111.003 172.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 164.39 -33.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 128.103 2.561 . . . . 0.0 112.942 -171.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -61.21 -43.76 98.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.643 1.177 . . . . 0.0 112.515 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 35.9 tpp -85.7 149.31 25.39 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.856 1.662 . . . . 0.0 109.57 170.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.8 p -134.94 133.82 39.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.29 1.036 . . . . 0.0 110.286 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.02 130.82 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.634 0.774 . . . . 0.0 109.665 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 24.2 m -128.86 131.13 47.64 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.187 1.395 . . . . 0.0 108.9 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -72.06 94.21 1.48 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 0.0 110.342 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.59 -46.88 35.72 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.06 0.544 . . . . 0.0 111.38 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -145.45 -172.6 3.92 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.475 1.91 . . . . 0.0 111.221 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -51.38 -49.41 61.59 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.708 -1.245 . . . . 0.0 113.242 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 74.6 p -128.24 32.51 4.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 110.823 -173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.1 t -137.37 127.96 26.84 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.889 1.276 . . . . 0.0 110.241 -178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.443 ' CE2' HG13 ' A' ' 184' ' ' VAL . 18.6 m-85 -125.07 137.09 54.21 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.011 1.324 . . . . 0.0 109.707 -174.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.31 128.16 75.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.977 0.894 . . . . 0.0 109.007 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -115.69 94.51 4.72 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.433 1.893 . . . . 0.0 107.377 -165.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -85.79 121.4 28.39 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.775 -0.578 . . . . 0.0 110.186 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.78 101.5 11.33 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.206 1.403 . . . . 0.0 111.836 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.79 10.13 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.597 1.159 . . . . 0.0 112.675 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.68 157.07 34.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.423 1.489 . . . . 0.0 112.834 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.63 -4.56 59.06 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -177.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.963 0 C-N-CA 126.121 1.769 . . . . 0.0 112.184 -170.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.6 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.755 0.788 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.6 126.16 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.124 -0.985 . . . . 0.0 109.427 166.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -65.25 142.73 58.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.1 -18.86 10.97 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.726 1.148 . . . . 0.0 113.623 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -113.35 15.72 19.14 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.95 2.1 . . . . 0.0 112.753 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -139.5 166.49 24.42 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.188 -1.57 . . . . 0.0 109.725 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.15 159.78 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.383 0.611 . . . . 0.0 110.037 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.87 161.31 39.63 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.842 0.857 . . . . 0.0 111.301 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -128.11 145.85 50.88 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.337 1.455 . . . . 0.0 109.311 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -131.44 114.07 14.49 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.77 2.028 . . . . 0.0 110.618 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -90.38 77.01 6.64 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.902 1.281 . . . . 0.0 109.189 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.59 -87.97 0.07 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.832 -0.982 . . . . 0.0 112.844 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 171.15 124.15 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 129.738 3.215 . . . . 0.0 109.512 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 39.1 t30 63.78 44.05 5.18 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.541 1.136 . . . . 0.0 114.028 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m 68.02 58.09 0.48 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.383 2.273 . . . . 0.0 113.961 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.7 p -141.73 -178.1 5.5 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.896 1.678 . . . . 0.0 112.002 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.28 -121.09 12.72 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.366 0.984 . . . . 0.0 111.686 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.97 166.26 15.23 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.119 0.959 . . . . 0.0 111.361 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.3 p -132.12 154.18 49.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.056 1.342 . . . . 0.0 111.721 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.81 141.61 22.81 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.509 1.524 . . . . 0.0 109.513 -174.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -117.44 135.32 53.98 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.076 0.95 . . . . 0.0 110.042 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -131.84 139.1 48.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.353 1.461 . . . . 0.0 109.946 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.8 150.45 24.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.609 -0.682 . . . . 0.0 111.284 173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.28 162.63 29.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.941 0.896 . . . . 0.0 111.43 170.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 52.54 33.31 40.51 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.636 0.636 . . . . 0.0 113.906 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -134.06 148.11 51.0 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.267 1.427 . . . . 0.0 110.625 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 98.7 m -105.96 132.8 51.62 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.426 1.49 . . . . 0.0 108.31 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.0 t -125.8 126.02 69.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 124.247 1.019 . . . . 0.0 109.247 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 150.16 28.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.81 1.644 . . . . 0.0 110.379 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -130.82 162.25 29.99 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.577 1.551 . . . . 0.0 110.201 171.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.26 127.38 8.79 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.451 1.9 . . . . 0.0 113.899 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.68 -6.25 30.36 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 173.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.7 -7.78 23.49 Favored Glycine 0 CA--C 1.54 1.652 0 C-N-CA 125.292 1.425 . . . . 0.0 115.692 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.93 24.01 14.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.806 1.642 . . . . 0.0 115.17 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -48.2 39.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.538 1.135 . . . . 0.0 112.674 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.32 29.12 0.06 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.263 1.825 . . . . 0.0 111.804 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -65.05 -41.84 94.8 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.328 1.051 . . . . 0.0 113.773 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.458 ' HB2' ' H ' ' A' ' 86' ' ' LEU . 8.5 t0 -66.76 -94.84 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 108.119 158.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 29.3 26.44 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 127.238 2.215 . . . . 0.0 116.178 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.14 147.15 50.26 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 128.728 2.811 . . . . 0.0 110.058 176.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.8 tpt -151.56 -53.64 0.13 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.339 1.055 . . . . 0.0 111.947 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -137.11 131.15 32.25 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 125.322 1.449 . . . . 0.0 109.433 -174.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.8 m -143.63 155.57 44.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.65 1.18 . . . . 0.0 109.583 -171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mt -130.9 117.2 18.93 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.137 0.975 . . . . 0.0 108.61 -174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.9 t -113.84 117.26 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.997 1.719 . . . . 0.0 108.547 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -41.02 -95.77 0.01 OUTLIER Glycine 0 CA--C 1.532 1.141 0 C-N-CA 127.472 2.463 . . . . 0.0 117.519 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 t -162.19 -40.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.476 1.111 . . . . 0.0 111.908 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -112.61 35.84 3.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.656 1.582 . . . . 0.0 110.355 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.76 135.91 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.435 1.494 . . . . 0.0 109.245 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.98 153.73 25.15 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.637 0.775 . . . . 0.0 109.5 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.4 m -117.63 142.39 47.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 122.199 1.0 . . . . 0.0 109.392 171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -130.74 127.98 39.86 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.561 1.544 . . . . 0.0 107.412 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.3 pt -121.6 125.57 73.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.453 0.644 . . . . 0.0 109.707 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -140.05 100.03 3.82 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.933 1.349 . . . . 0.0 111.201 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.53 104.85 2.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.44 1.496 . . . . 0.0 111.303 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.46 154.11 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 123.327 1.537 . . . . 0.0 114.25 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -92.06 139.67 30.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.781 -1.199 . . . . 0.0 112.24 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.34 179.73 8.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.626 1.171 . . . . 0.0 111.597 -176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -136.83 44.0 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 126.022 1.729 . . . . 0.0 111.328 -177.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 59.86 47.5 10.03 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.97 1.708 . . . . 0.0 112.332 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 2.7 p -79.36 179.78 1.69 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.719 2.008 . . . . 0.0 111.007 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 41.3 Cg_endo -70.45 12.08 0.42 Allowed 'Trans proline' 0 CA--C 1.549 1.238 0 C-N-CA 122.871 2.38 . . . . 0.0 114.397 173.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -145.18 65.99 12.22 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.597 1.559 . . . . 0.0 110.997 174.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.61 132.86 32.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 121.246 1.298 . . . . 0.0 109.359 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.41 164.35 11.28 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.103 -0.499 . . . . 0.0 113.215 171.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -57.55 109.63 0.73 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.385 0.674 . . . . 0.0 110.663 163.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -111.67 139.01 47.47 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.928 1.691 . . . . 0.0 109.259 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -160.77 158.75 29.07 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 122.06 0.933 . . . . 0.0 111.361 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.47 95.83 5.13 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.456 1.502 . . . . 0.0 109.613 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.07 108.15 1.75 Allowed 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.37 -0.831 . . . . 0.0 109.476 174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.73 143.1 10.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.982 1.713 . . . . 0.0 113.209 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -66.39 138.11 57.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.872 0.869 . . . . 0.0 111.737 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.41 73.32 0.49 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.436 1.493 . . . . 0.0 116.097 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.98 177.43 8.51 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.6 m -122.22 135.42 54.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.382 1.073 . . . . 0.0 109.402 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -115.26 134.82 54.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.467 1.507 . . . . 0.0 107.671 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -144.64 5.89 1.22 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.61 33.26 0.41 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.142 1.377 . . . . 0.0 111.595 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.59 -4.23 57.35 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.083 -1.011 . . . . 0.0 113.72 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.39 -13.13 26.07 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.13 0.972 . . . . 0.0 113.617 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.0 m -50.73 -32.79 20.63 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.901 1.681 . . . . 0.0 114.072 173.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -30.83 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.418 0.687 . . . . 0.0 112.254 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.6 t30 35.89 43.42 0.19 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.579 2.752 . . . . 0.0 115.456 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.42 95.12 0.12 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.884 1.23 . . . . 0.0 111.685 -169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.458 ' H ' ' HB2' ' A' ' 39' ' ' ASP . 5.3 mp -140.25 155.71 46.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.833 2.053 . . . . 0.0 109.287 170.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.6 m -157.1 -32.68 0.08 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.388 1.075 . . . . 0.0 112.458 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -119.28 138.65 52.87 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.05 1.34 . . . . 0.0 109.822 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -130.44 129.68 43.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.13 1.372 . . . . 0.0 107.981 -171.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -129.52 117.7 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.88 131.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 92.5 mt -107.81 148.78 38.02 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.401 1.08 . . . . 0.0 109.675 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' CG ' ' CD2' ' A' ' 96' ' ' PHE . 77.8 Cg_endo -77.67 15.76 1.21 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.527 3.485 . . . . 0.0 112.907 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 70.18 -35.66 0.42 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.846 2.641 . . . . 0.0 116.042 175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -34.21 73.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.987 1.715 . . . . 0.0 112.588 168.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.431 ' CD2' ' CG ' ' A' ' 93' ' ' PRO . 11.0 m-85 -92.54 138.2 31.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.752 1.221 . . . . 0.0 110.325 174.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -79.35 -35.06 41.54 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.022 0.929 . . . . 0.0 111.74 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -158.58 170.75 21.49 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.976 2.11 . . . . 0.0 109.756 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.65 165.15 28.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.042 0.937 . . . . 0.0 110.673 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.88 149.24 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.436 1.095 . . . . 0.0 109.928 -171.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -99.98 122.45 42.91 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.04 137.8 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.441 0.697 . . . . 0.0 110.456 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.8 tttp -138.53 155.36 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.174 1.39 . . . . 0.0 110.091 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 117' ' ' MET . 3.7 mt -124.06 135.67 62.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.46 121.74 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -85.04 118.72 24.78 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.245 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -102.91 -8.95 20.28 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.3 t -108.72 -57.84 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.952 0.901 . . . . 0.0 112.216 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.78 -33.49 76.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.024 0.53 . . . . 0.0 110.505 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 56.97 17.97 3.66 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.712 2.005 . . . . 0.0 114.381 179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 91.7 m -103.02 -47.14 4.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 111.521 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 57.07 153.48 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 127.226 2.21 . . . . 0.0 116.072 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.73 -13.37 58.93 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.834 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.7 p -90.43 -61.8 1.6 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.05 1.34 . . . . 0.0 112.203 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -47.23 108.39 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.254 2.222 . . . . 0.0 111.326 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.64 124.34 47.13 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 124.326 1.05 . . . . 0.0 109.209 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.483 ' HB3' HD11 ' A' ' 104' ' ' ILE . 3.5 tmm? -114.19 141.15 47.9 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.591 1.156 . . . . 0.0 109.255 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.9 m -132.03 137.38 47.8 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.344 1.458 . . . . 0.0 107.855 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.55 HD12 HD22 ' A' ' 138' ' ' LEU . 14.2 pt -133.72 145.15 33.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 123.618 0.767 . . . . 0.0 111.123 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 57.0 m -135.61 95.68 14.08 Favored Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 108.916 -169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.18 75.49 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.291 3.328 . . . . 0.0 111.583 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 124' ' ' VAL . 58.9 t80 60.18 81.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.967 2.107 . . . . 0.0 112.041 -176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 42.93 46.28 4.6 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.911 1.684 . . . . 0.0 115.084 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 141' ' ' PRO . 11.9 t -121.92 168.6 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 127.322 2.249 . . . . 0.0 109.848 -175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -36.44 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.991 2.517 . . . . 0.0 113.7 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 145.31 30.57 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.241 1.016 . . . . 0.0 110.396 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 139.18 50.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.093 0.957 . . . . 0.0 109.395 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.3 133.56 55.06 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.295 -1.32 . . . . 0.0 108.78 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.453 ' HB3' HG11 ' A' ' 136' ' ' VAL . 22.4 p -135.19 150.45 50.13 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.339 1.066 . . . . 0.0 110.431 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -102.61 144.08 31.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.753 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.59 27.43 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.128 2.171 . . . . 0.0 115.922 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.9 25.51 2.39 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.422 1.963 . . . . 0.0 114.089 -173.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.54 174.92 10.08 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.671 1.988 . . . . 0.0 110.11 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -56.57 158.99 4.05 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.887 -1.133 . . . . 0.0 112.468 163.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -51.96 153.66 2.51 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.72 0.808 . . . . 0.0 112.04 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 129' ' ' CYS . 29.0 m -107.16 139.09 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.435 0.636 . . . . 0.0 110.747 172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.21 108.19 11.34 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.787 175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.55 HD22 HD12 ' A' ' 119' ' ' ILE . 20.2 tp -88.22 112.29 48.6 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.194 1.398 . . . . 0.0 109.258 170.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.423 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 56.8 Cg_endo -78.5 152.36 26.32 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.823 1.682 . . . . 0.0 112.728 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 30.4 mm -133.8 131.77 21.25 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.428 1.491 . . . . 0.0 109.873 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.476 ' HG3' HG21 ' A' ' 124' ' ' VAL . 85.6 Cg_endo -75.94 170.96 19.05 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.281 2.654 . . . . 0.0 112.366 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.67 149.21 42.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.75 154.25 24.02 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.484 1.914 . . . . 0.0 109.877 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -134.78 135.93 24.3 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.392 1.077 . . . . 0.0 110.975 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 150.49 77.51 Favored 'Cis proline' 0 CA--C 1.542 0.893 0 CA-C-N 119.639 0.907 . . . . 0.0 111.421 -5.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.17 -32.15 74.51 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 121.76 1.64 . . . . 0.0 111.704 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.35 -5.91 4.08 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.706 2.002 . . . . 0.0 114.908 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 6.4 p -69.63 -178.87 1.56 Allowed 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.873 -1.142 . . . . 0.0 112.276 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.87 150.49 40.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.034 0.934 . . . . 0.0 111.91 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.9 tt -107.02 138.69 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 125.379 1.472 . . . . 0.0 109.583 174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.47 138.23 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.008 0.923 . . . . 0.0 109.617 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -141.6 131.31 24.17 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.999 -1.063 . . . . 0.0 110.601 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -82.9 141.52 32.14 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.545 -0.722 . . . . 0.0 109.84 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.24 111.17 13.64 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.616 1.166 . . . . 0.0 110.0 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.9 p -128.02 115.23 18.17 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.872 1.269 . . . . 0.0 110.34 -176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.4 t -117.59 121.34 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.301 1.44 . . . . 0.0 107.527 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -127.93 136.79 51.82 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.214 1.406 . . . . 0.0 108.911 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.26 130.48 35.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.234 0.54 . . . . 0.0 110.428 175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.9 p -75.94 -30.81 58.82 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.232 1.013 . . . . 0.0 112.206 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.51 -179.29 4.56 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.839 2.055 . . . . 0.0 112.266 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.49 148.71 32.43 Favored Pre-proline 0 N--CA 1.481 1.105 0 O-C-N 121.214 -0.929 . . . . 0.0 112.651 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.3 17.15 11.71 Favored 'Cis proline' 0 CA--C 1.548 1.206 0 CA-C-N 119.956 1.02 . . . . 0.0 114.65 -1.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 63.61 18.69 11.27 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.204 1.802 . . . . 0.0 113.986 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -94.35 178.99 5.44 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.188 1.795 . . . . 0.0 112.289 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -79.37 144.31 34.28 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.65 -1.281 . . . . 0.0 112.328 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.48 -43.51 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.412 1.885 . . . . 0.0 110.994 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.6 t -140.39 123.55 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -135.97 97.39 3.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.64 -157.43 10.35 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 124.667 1.127 . . . . 0.0 111.848 -168.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 9.3 m -139.13 169.63 17.44 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.291 1.036 . . . . 0.0 110.66 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.0 156.98 15.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 127.282 2.233 . . . . 0.0 108.461 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -120.96 139.76 52.81 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.381 -0.824 . . . . 0.0 109.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -120.23 130.79 54.68 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.286 -0.883 . . . . 0.0 109.7 -178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -120.56 153.37 36.84 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.294 1.437 . . . . 0.0 110.249 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -128.63 124.37 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.209 1.403 . . . . 0.0 110.132 177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.8 m -95.55 113.75 62.47 Favored Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 123.738 0.815 . . . . 0.0 109.823 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.16 -11.68 32.76 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.064 2.509 . . . . 0.0 112.827 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.2 m -43.34 -48.22 6.87 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.878 2.471 . . . . 0.0 112.985 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 80.7 p -144.84 17.87 1.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.206 1.402 . . . . 0.0 112.395 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 64.57 34.0 88.75 Favored Glycine 0 CA--C 1.535 1.295 0 O-C-N 120.681 -1.262 . . . . 0.0 113.542 -171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -73.77 152.07 40.45 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.811 0.805 . . . . 0.0 110.778 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 33.2 t -117.82 134.32 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 124.952 1.301 . . . . 0.0 108.351 167.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 17.8 m -134.83 109.34 8.47 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.034 1.734 . . . . 0.0 107.729 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.456 ' HB ' ' CE2' ' A' ' 205' ' ' PHE . 2.0 p -76.82 147.03 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 121.544 -0.722 . . . . 0.0 109.409 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 63.9 mt -123.66 125.46 71.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.902 1.681 . . . . 0.0 106.893 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 135.92 44.31 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.642 1.177 . . . . 0.0 109.785 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -146.89 158.12 43.83 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.957 1.703 . . . . 0.0 109.914 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.53 -19.47 10.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.112 1.765 . . . . 0.0 113.944 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -58.09 -23.59 55.36 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.2 p -149.47 -46.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.029 1.332 . . . . 0.0 113.297 -174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -85.69 133.05 42.55 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.975 1.31 . . . . 0.0 109.392 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.01 -172.17 1.06 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 122.565 2.177 . . . . 0.0 112.676 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -107.08 -22.41 12.66 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.562 1.145 . . . . 0.0 113.526 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -55.12 -40.26 70.31 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.776 1.23 . . . . 0.0 112.566 172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.6 ttt -105.46 144.47 32.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.939 1.695 . . . . 0.0 109.397 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.3 p -139.89 157.26 45.99 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.762 1.225 . . . . 0.0 109.536 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.3 127.61 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.851 0.461 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 51.5 m -119.06 131.4 55.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.617 1.567 . . . . 0.0 109.763 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -65.76 122.12 16.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.857 1.263 . . . . 0.0 111.066 173.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -109.36 -28.82 8.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.029 0.932 . . . . 0.0 112.057 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.73 -175.27 4.87 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.357 1.863 . . . . 0.0 110.914 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -56.58 -31.48 64.27 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.08 1.352 . . . . 0.0 113.764 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 61.3 p -143.4 33.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.254 1.422 . . . . 0.0 111.813 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 48.9 m -129.71 134.4 47.61 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.866 0.867 . . . . 0.0 111.943 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.456 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 23.8 m-85 -130.88 138.96 50.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.877 1.671 . . . . 0.0 110.801 -176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 34.5 mt -125.19 122.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -98.03 112.28 24.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.689 1.996 . . . . 0.0 108.348 -174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 44.7 m-20 -103.28 124.18 48.17 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.27 116.58 32.19 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 110.945 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -120.2 20.81 11.95 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.541 1.937 . . . . 0.0 112.172 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.76 -168.91 3.22 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.332 1.453 . . . . 0.0 111.614 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.76 26.47 1.39 Allowed 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.824 -1.173 . . . . 0.0 113.778 178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 C-N-CA 127.746 2.419 . . . . 0.0 115.01 -166.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -102.37 128.0 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.572 1.149 . . . . 0.0 109.654 170.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -60.15 138.82 57.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.919 0.888 . . . . 0.0 110.318 176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.35 -13.06 4.46 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 177.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -117.19 9.38 13.5 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.438 2.295 . . . . 0.0 112.635 -176.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -144.56 175.15 10.35 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 126.33 1.852 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.4 t -123.97 154.97 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.194 0.998 . . . . 0.0 109.452 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.52 149.39 42.48 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.88 1.272 . . . . 0.0 110.391 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.79 26.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.068 1.347 . . . . 0.0 108.942 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -134.33 131.83 38.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.114 1.366 . . . . 0.0 110.7 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -79.52 51.95 1.32 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.698 1.599 . . . . 0.0 111.605 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.26 134.95 2.27 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 120.21 -1.556 . . . . 0.0 112.869 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 145.72 14.33 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.656 0.782 . . . . 0.0 111.102 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 t30 58.48 26.22 13.99 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.3 t 67.25 71.8 0.35 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.824 1.649 . . . . 0.0 111.578 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.0 p -137.83 -178.14 5.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.524 1.529 . . . . 0.0 112.181 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.88 -82.89 0.5 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 126.066 1.793 . . . . 0.0 115.173 176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -138.57 163.85 30.98 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.747 1.619 . . . . 0.0 110.345 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.2 p -135.75 145.32 46.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.217 1.007 . . . . 0.0 112.882 -175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -156.61 169.76 23.94 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.54 1.536 . . . . 0.0 111.821 -174.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.21 153.91 48.96 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.307 1.443 . . . . 0.0 110.689 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.99 131.13 42.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.392 1.477 . . . . 0.0 109.731 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -78.62 128.43 33.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.859 0.864 . . . . 0.0 109.924 175.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -54.55 139.9 36.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.75 0.82 . . . . 0.0 110.979 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.72 42.79 16.31 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.48 0.562 . . . . 0.0 112.527 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -133.32 154.62 50.55 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.514 1.525 . . . . 0.0 111.291 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 59.4 m -140.09 122.51 16.07 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.132 1.373 . . . . 0.0 108.393 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.97 153.81 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.024 0.916 . . . . 0.0 110.549 178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.7 mtm-85 -133.74 118.84 18.55 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.9 1.68 . . . . 0.0 107.873 -174.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.96 122.9 15.46 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -165.01 155.08 13.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.662 1.22 . . . . 0.0 113.338 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -142.01 18.24 2.12 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 128.426 2.691 . . . . 0.0 110.803 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.72 -88.31 0.23 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 127.317 2.389 . . . . 0.0 110.289 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.05 104.02 0.3 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.369 1.868 . . . . 0.0 110.396 176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 164.13 -59.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 128.174 2.59 . . . . 0.0 115.28 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -80.56 -23.48 39.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 120.982 1.719 . . . . 0.0 112.568 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 38' ' ' ASN . 0.4 OUTLIER -67.57 -19.48 65.27 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.859 1.664 . . . . 0.0 114.084 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.03 -68.86 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.122 165.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 28.22 37.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 128.15 2.58 . . . . 0.0 116.194 -175.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -136.15 127.68 28.71 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.008 1.323 . . . . 0.0 107.593 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 ttt -158.17 -39.72 0.06 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.918 0.887 . . . . 0.0 111.387 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 t -142.2 126.14 17.22 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.246 1.018 . . . . 0.0 110.052 164.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.8 m -133.6 155.05 50.36 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.002 0.906 . . . . 0.0 109.398 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 mp -133.04 127.13 33.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.86 108.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.753 1.621 . . . . 0.0 108.95 -168.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.38 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.472 1.037 0 C-N-CA 128.383 2.897 . . . . 0.0 117.589 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -166.86 -42.8 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.146 0.978 . . . . 0.0 112.561 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -106.94 37.63 2.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.395 1.478 . . . . 0.0 110.481 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 93' ' ' PRO . 4.5 m -143.61 158.59 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.358 1.863 . . . . 0.0 110.688 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -139.05 150.97 46.37 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.546 1.938 . . . . 0.0 109.909 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.62 126.53 54.3 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.176 0.59 . . . . 0.0 109.82 174.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -116.32 120.35 38.61 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.624 1.169 . . . . 0.0 108.145 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 HD11 ' A' ' 86' ' ' LEU . 1.3 pp -113.63 115.22 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.024 0.93 . . . . 0.0 110.411 -175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -124.16 123.66 40.77 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.598 1.159 . . . . 0.0 108.796 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -57.21 -45.06 84.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 112.782 -175.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.91 172.01 16.35 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 126.652 1.981 . . . . 0.0 107.66 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -60.13 -66.33 0.54 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.385 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.255 1.8 pp20? 48.72 167.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.0 mt -143.59 54.42 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.349 -1.469 . . . . 0.0 112.554 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.263 44.0 m-20 53.33 45.97 27.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.349 1.859 . . . . 0.0 112.485 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 p -73.61 166.38 44.66 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 112.537 -2.119 . . . . 0.0 110.445 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.03 22.52 0.31 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.536 2.824 . . . . 0.0 113.835 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.9 t -152.23 58.63 2.66 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 126.467 1.907 . . . . 0.0 111.277 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.9 134.39 34.41 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.551 1.5 . . . . 0.0 109.552 176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.92 -101.81 0.1 OUTLIER Glycine 0 CA--C 1.529 0.913 0 C-N-CA 123.814 0.721 . . . . 0.0 111.8 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.82 154.77 44.51 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.893 1.277 . . . . 0.0 111.881 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -154.61 139.26 16.98 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.852 1.661 . . . . 0.0 110.59 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -158.61 159.07 35.03 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 122.167 0.984 . . . . 0.0 111.768 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -125.88 90.4 3.19 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.514 1.525 . . . . 0.0 108.923 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.71 105.33 0.79 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.35 148.57 11.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.428 1.891 . . . . 0.0 113.8 -174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.57 151.78 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.47 1.108 . . . . 0.0 112.775 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.33 52.78 45.22 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 124.655 1.121 . . . . 0.0 114.997 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.78 175.45 13.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.815 0.846 . . . . 0.0 112.874 -175.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.1 m -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.16 1.384 . . . . 0.0 109.698 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.33 121.71 19.34 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.84 1.256 . . . . 0.0 109.314 -175.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -117.9 15.79 14.31 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.066 1.746 . . . . 0.0 112.671 -172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -140.23 38.66 1.92 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.328 1.451 . . . . 0.0 112.741 -171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.86 -17.36 64.86 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.797 -1.189 . . . . 0.0 111.971 -178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.8 m -56.49 -19.19 14.24 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.81 1.644 . . . . 0.0 114.624 168.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.2 t -54.14 -27.27 32.34 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.247 -0.908 . . . . 0.0 112.285 166.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.0 mt -134.07 73.87 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 127.046 2.138 . . . . 0.0 108.848 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -60.94 -23.08 65.02 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 120.809 -1.182 . . . . 0.0 112.657 168.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.38 80.33 0.15 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.8 1.666 . . . . 0.0 113.232 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.432 HD11 HD13 ' A' ' 54' ' ' ILE . 1.6 mp -124.59 153.03 42.8 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.9 1.68 . . . . 0.0 111.661 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -158.53 -22.12 0.08 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 125.471 1.509 . . . . 0.0 114.201 161.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.06 129.45 55.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.474 1.51 . . . . 0.0 108.75 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.65 121.07 31.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.93 132.38 54.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -126.37 130.17 71.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 pp -144.82 148.81 40.68 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 123.406 0.682 . . . . 0.0 110.152 -171.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 96' ' ' PHE . 36.7 Cg_endo -68.52 155.06 70.33 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.898 1.732 . . . . 0.0 112.391 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -61.95 -24.3 64.64 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.059 0.838 . . . . 0.0 114.528 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.43 -22.88 67.14 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.52 1.128 . . . . 0.0 113.679 169.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.452 ' CD2' ' HG2' ' A' ' 93' ' ' PRO . 11.5 m-30 -111.0 130.08 55.7 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.933 1.693 . . . . 0.0 108.741 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 -85.75 -40.16 16.37 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.505 -1.372 . . . . 0.0 112.194 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' HD12 ' A' ' 140' ' ' ILE . 39.1 p-90 -152.23 159.28 43.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.77 2.028 . . . . 0.0 109.041 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.02 146.41 50.35 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.609 0.763 . . . . 0.0 110.766 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.91 135.19 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 124.747 1.219 . . . . 0.0 110.166 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -77.23 134.66 38.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.276 0.63 . . . . 0.0 109.885 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.55 140.4 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.803 1.241 . . . . 0.0 109.938 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -140.33 157.15 45.99 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.06 1.744 . . . . 0.0 110.609 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 92.6 mt -118.76 139.46 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 126.959 2.104 . . . . 0.0 109.535 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -130.33 106.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.755 1.622 . . . . 0.0 109.601 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.69 111.83 3.88 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.415 0.686 . . . . 0.0 110.727 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.8 15.35 11.77 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.421 1.088 . . . . 0.0 111.466 168.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.8 t -96.28 -61.83 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.869 1.667 . . . . 0.0 111.063 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -151.63 99.08 2.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.386 1.875 . . . . 0.0 108.799 -172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.5 m -53.16 97.89 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.88 1.672 . . . . 0.0 113.052 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 20.1 m -146.69 -53.89 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.743 1.617 . . . . 0.0 110.779 -174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.2 159.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 127.175 2.19 . . . . 0.0 114.96 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.42 -36.1 0.44 Allowed Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.531 -1.355 . . . . 0.0 115.293 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.6 m -64.63 1.7 0.79 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.175 2.19 . . . . 0.0 115.033 170.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.446 ' CE2' HG21 ' A' ' 166' ' ' VAL . 17.9 t80 -134.99 122.18 21.5 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.258 2.223 . . . . 0.0 109.76 -173.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -132.18 130.34 40.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.958 1.303 . . . . 0.0 110.387 179.447 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.405 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 3.6 ttm -115.57 141.57 47.88 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.694 1.598 . . . . 0.0 110.632 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 46.6 m -128.27 116.41 19.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 124.573 1.149 . . . . 0.0 108.171 173.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mt -96.64 122.83 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.4 m -116.04 87.54 19.38 Favored Pre-proline 0 C--O 1.237 0.429 0 C-N-CA 125.981 1.712 . . . . 0.0 109.24 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.0 163.53 37.32 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.58 2.853 . . . . 0.0 112.465 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -45.16 96.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.577 1.951 . . . . 0.0 113.259 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 37.29 47.47 0.69 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.267 1.827 . . . . 0.0 114.881 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.34 155.18 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.966 1.707 . . . . 0.0 109.535 -177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.75 92.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.356 1.462 . . . . 0.0 112.288 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.51 160.47 4.18 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.475 1.51 . . . . 0.0 111.523 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.1 p -138.49 145.15 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.588 0.709 . . . . 0.0 111.391 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.85 138.86 33.75 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.457 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 39.8 t -135.78 124.61 24.0 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.339 1.455 . . . . 0.0 107.855 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -118.52 141.19 48.82 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.958 1.303 . . . . 0.0 109.03 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -56.92 105.23 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.957 0.903 . . . . 0.0 111.431 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.15 63.0 0.32 Allowed Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.318 0.961 . . . . 0.0 113.658 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -141.59 155.89 45.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.456 1.903 . . . . 0.0 111.657 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -91.38 55.11 2.71 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.609 -1.307 . . . . 0.0 111.662 176.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 59.61 169.78 0.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.539 1.936 . . . . 0.0 112.826 -167.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.14 126.17 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 120.845 -1.159 . . . . 0.0 109.741 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 127.17 31.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.841 0.456 . . . . 0.0 110.047 171.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.18 95.83 47.98 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.059 1.743 . . . . 0.0 107.685 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 55.4 Cg_endo -77.98 148.13 24.61 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.903 2.402 . . . . 0.0 112.669 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.411 HD12 ' CZ3' ' A' ' 98' ' ' TRP . 87.2 mt -136.03 131.72 18.98 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.309 1.443 . . . . 0.0 109.1 -174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.47 169.85 21.34 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 124.922 3.748 . . . . 0.0 112.112 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -68.6 149.04 49.63 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.517 -0.739 . . . . 0.0 111.677 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pp -154.61 163.63 39.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.097 2.159 . . . . 0.0 109.573 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 87.3 m -131.25 131.4 23.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.942 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.97 153.63 80.41 Favored 'Cis proline' 0 CA--C 1.544 1.013 0 CA-C-N 119.343 0.801 . . . . 0.0 111.877 -3.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -66.85 -17.28 51.78 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.734 1.623 . . . . 0.0 112.886 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.49 13.53 21.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.362 1.465 . . . . 0.0 114.415 169.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.87 152.11 46.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.744 -1.223 . . . . 0.0 112.437 174.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -80.79 113.63 19.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.315 0.646 . . . . 0.0 111.018 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 18.6 tt -85.71 120.25 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.62 0.768 . . . . 0.0 109.828 172.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -65.49 139.42 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.542 0.687 . . . . 0.0 110.703 172.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.1 t -143.8 150.42 38.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.44 1.096 . . . . 0.0 109.798 174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -111.32 145.17 39.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.704 0.802 . . . . 0.0 109.62 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 tt -133.85 120.73 20.8 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.665 0.745 . . . . 0.0 109.311 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.04 124.45 26.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.309 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 116' ' ' GLU . 2.2 p -145.34 135.16 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.57 1.148 . . . . 0.0 109.698 -174.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 162.14 35.81 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.226 1.41 . . . . 0.0 111.523 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -66.5 128.52 36.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.126 170.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 34.9 p -73.57 -6.46 46.7 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.892 0.877 . . . . 0.0 113.326 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -122.54 141.0 52.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.279 2.232 . . . . 0.0 108.869 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.1 t -65.59 140.84 97.66 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.696 -0.668 . . . . 0.0 111.643 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.54 131.67 20.94 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.415 1.184 . . . . 0.0 111.492 -4.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -73.68 41.68 0.12 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 112.499 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.91 126.7 14.74 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.92 1.288 . . . . 0.0 110.214 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -68.63 82.15 0.28 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.391 1.077 . . . . 0.0 110.046 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 156' ' ' VAL . 14.0 m -45.91 -37.84 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.976 1.71 . . . . 0.0 113.017 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 33.7 t -147.88 136.9 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.488 1.115 . . . . 0.0 109.697 165.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -142.03 115.2 8.82 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.787 1.235 . . . . 0.0 108.137 171.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.35 -162.21 24.94 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.02 0.819 . . . . 0.0 113.298 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.92 153.66 51.98 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.625 1.17 . . . . 0.0 111.065 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.92 143.58 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.168 1.787 . . . . 0.0 109.245 -175.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -115.05 115.11 26.28 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.182 -0.949 . . . . 0.0 109.328 -173.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -82.28 152.82 26.16 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.462 -0.774 . . . . 0.0 110.316 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.77 154.65 45.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.863 1.265 . . . . 0.0 108.709 167.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -127.91 127.48 43.44 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.869 1.268 . . . . 0.0 108.727 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.3 m -86.17 106.68 10.64 Favored Pre-proline 0 N--CA 1.467 0.418 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.59 -17.68 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.43 2.753 . . . . 0.0 112.514 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.3 m -55.91 -38.83 70.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.199 1.8 . . . . 0.0 113.079 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.8 p -147.75 24.59 1.08 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.013 1.325 . . . . 0.0 112.705 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 50.71 31.12 22.5 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.406 1.955 . . . . 0.0 115.851 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -71.59 164.5 25.76 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.182 0.991 . . . . 0.0 111.152 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.62 135.5 55.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.074 1.35 . . . . 0.0 109.008 165.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.9 m -133.49 107.17 7.87 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.481 HG11 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -83.83 151.48 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 121.475 -0.766 . . . . 0.0 110.4 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.91 135.44 62.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 125.874 1.67 . . . . 0.0 107.709 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.472 ' HD2' HG21 ' A' ' 197' ' ' VAL . 0.0 OUTLIER -139.98 140.2 36.23 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.833 1.653 . . . . 0.0 107.425 177.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -125.29 146.14 49.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.303 1.441 . . . . 0.0 108.353 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -62.95 -14.42 47.07 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -17.44 61.05 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 171.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 18.0 p -130.38 -32.3 1.77 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.608 1.563 . . . . 0.0 113.231 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -76.95 146.89 76.41 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.996 1.318 . . . . 0.0 110.782 173.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.28 -7.72 11.87 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.586 2.857 . . . . 0.0 113.99 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.4 tttm 64.56 -24.2 0.08 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 128.341 2.656 . . . . 0.0 115.993 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -67.74 -18.17 64.8 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.43 1.092 . . . . 0.0 113.685 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.7 ttm -103.3 151.44 22.7 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.563 1.945 . . . . 0.0 109.418 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.0 p -131.76 159.67 37.8 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.455 1.502 . . . . 0.0 110.144 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.472 HG21 ' HD2' ' A' ' 186' ' ' LYS . 77.8 t -121.61 130.75 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.157 0.983 . . . . 0.0 109.683 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.2 m -134.31 126.78 30.41 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.471 1.109 . . . . 0.0 108.697 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -89.42 141.4 28.59 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.565 1.146 . . . . 0.0 110.481 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -117.47 -36.18 3.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.564 0.746 . . . . 0.0 111.704 171.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -129.38 178.78 6.2 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.527 1.131 . . . . 0.0 111.849 -175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.78 -40.41 63.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.226 1.01 . . . . 0.0 112.144 171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 50.8 p -137.01 33.8 2.61 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 111.205 -169.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.7 t -129.18 116.99 20.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.882 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.481 ' CE2' HG11 ' A' ' 184' ' ' VAL . 2.5 t80 -100.17 136.29 40.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.365 2.266 . . . . 0.0 109.73 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.04 112.77 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.608 1.163 . . . . 0.0 109.54 172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.02 120.19 22.5 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.109 1.363 . . . . 0.0 109.872 170.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -106.41 133.79 50.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.6 1.16 . . . . 0.0 108.907 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 45.6 tp -127.47 111.54 13.93 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.812 -0.555 . . . . 0.0 110.966 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -96.58 -26.19 15.33 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.92 132.57 53.28 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.175 0.99 . . . . 0.0 111.053 -176.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.6 -48.91 79.67 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 127.264 2.225 . . . . 0.0 112.507 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.1 p . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.532 0.682 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' CD ' ' A' ' 9' ' ' LYS . 9.9 p -57.55 148.12 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.926 -0.484 . . . . 0.0 111.374 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -58.57 144.34 43.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.623 0.369 . . . . 0.0 110.686 174.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.86 -17.12 34.25 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 121.037 -1.039 . . . . 0.0 113.179 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -108.91 13.47 24.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.442 1.897 . . . . 0.0 113.275 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -137.55 170.96 15.18 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.235 1.414 . . . . 0.0 110.306 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 46' ' ' VAL . 3.8 m -142.58 151.58 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.0 110.517 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' CD ' HG23 ' A' ' 3' ' ' VAL . 2.4 mptm? -130.51 152.11 50.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.112 0.965 . . . . 0.0 110.812 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.74 133.99 40.52 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.899 1.68 . . . . 0.0 108.256 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -121.73 127.73 51.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.818 1.647 . . . . 0.0 109.693 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.42 61.4 6.17 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.761 1.225 . . . . 0.0 110.884 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.42 142.99 3.86 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.235 0.922 . . . . 0.0 112.019 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -59.2 132.17 53.22 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.948 0.874 . . . . 0.0 109.669 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 t30 77.09 41.88 0.15 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.743 1.617 . . . . 0.0 113.199 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.343 31.1 p 49.87 58.2 5.71 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.921 2.488 . . . . 0.0 115.485 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 p -127.81 179.47 5.53 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.164 1.785 . . . . 0.0 113.18 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.23 -74.74 1.84 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.463 1.982 . . . . 0.0 113.957 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -139.13 170.16 16.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.655 1.582 . . . . 0.0 109.781 174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -137.32 143.91 42.32 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.535 1.134 . . . . 0.0 111.166 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -143.4 155.46 44.41 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.552 1.541 . . . . 0.0 110.465 -175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -125.67 134.8 51.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.761 1.224 . . . . 0.0 109.204 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' HB2' HG23 ' A' ' 8' ' ' VAL . 17.8 m-85 -127.52 131.33 50.09 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 122.483 1.135 . . . . 0.0 110.521 -175.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -91.91 144.41 25.5 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.716 1.207 . . . . 0.0 109.349 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 145.07 11.03 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.819 -0.55 . . . . 0.0 112.409 172.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.7 73.08 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.172 0.415 . . . . 0.0 113.837 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -127.9 126.01 40.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.297 1.439 . . . . 0.0 109.936 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.0 m -109.19 126.56 53.4 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 170.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.25 146.1 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 125.01 1.324 . . . . 0.0 110.037 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -125.95 144.37 50.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.037 1.335 . . . . 0.0 109.463 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -135.38 146.23 48.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.43 1.492 . . . . 0.0 109.628 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -162.5 139.97 8.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.553 1.141 . . . . 0.0 110.193 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -165.11 30.36 0.06 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.135 0.974 . . . . 0.0 113.537 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.42 45.27 4.09 Favored Glycine 0 CA--C 1.538 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 113.833 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.251 0.4 OUTLIER 54.12 55.89 7.69 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 174.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.93 -53.15 0.06 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -84.66 -17.35 38.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 0.5 OUTLIER -76.19 -45.4 33.45 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 111.34 173.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.66 35.73 0.07 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.265 1.426 . . . . 0.0 113.15 172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -16.12 62.67 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 119.651 -1.906 . . . . 0.0 114.247 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.7 134.76 56.49 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.858 1.263 . . . . 0.0 110.951 177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.7 mtp -150.01 -58.76 0.19 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.502 1.521 . . . . 0.0 112.07 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -136.27 115.54 12.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.948 1.299 . . . . 0.0 109.905 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 37.9 m -141.08 146.95 37.8 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.709 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.87 128.15 43.27 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.112 1.365 . . . . 0.0 109.081 -168.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 8' ' ' VAL . 59.0 t -118.55 119.75 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.268 1.427 . . . . 0.0 110.185 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.56 -86.74 0.01 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.516 1.532 . . . . 0.0 116.66 -164.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.33 -21.42 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 175.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -122.95 27.34 7.72 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.798 1.639 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.77 141.86 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.912 2.085 . . . . 0.0 109.416 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 32.7 ttm-85 -116.23 153.06 32.55 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -129.12 128.33 43.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.232 0.539 . . . . 0.0 109.626 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -112.24 126.15 54.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.073 0.949 . . . . 0.0 108.448 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.586 ' HB ' HD13 ' A' ' 86' ' ' LEU . 1.6 pp -117.26 104.18 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 122.194 0.997 . . . . 0.0 109.516 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.82 123.05 49.34 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.611 1.164 . . . . 0.0 108.769 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -57.84 -57.87 10.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.161 0.982 . . . . 0.0 111.491 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.45 158.42 43.97 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.657 1.183 . . . . 0.0 109.383 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.42 124.38 33.36 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' H ' ' HB2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -159.8 172.97 16.71 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.588 1.555 . . . . 0.0 111.999 -169.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.0 pt -123.68 34.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 120.503 -1.373 . . . . 0.0 114.211 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.299 67.4 m-20 61.94 51.04 3.88 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.979 2.112 . . . . 0.0 111.689 -170.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 3.7 p -65.74 166.41 15.28 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.655 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 56.6 Cg_endo -73.37 20.38 0.36 Allowed 'Trans proline' 0 CA--C 1.552 1.398 0 C-N-CA 123.456 2.771 . . . . 0.0 114.285 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -148.03 63.7 7.67 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.656 1.582 . . . . 0.0 111.957 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.64 140.42 62.25 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 121.751 1.634 . . . . 0.0 110.535 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.02 -92.81 1.11 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -174.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -145.62 153.92 41.57 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.174 1.39 . . . . 0.0 110.787 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -153.33 137.55 16.53 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.056 1.342 . . . . 0.0 108.715 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -155.83 164.67 38.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.377 1.084 . . . . 0.0 111.198 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -133.84 104.84 6.48 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.391 1.076 . . . . 0.0 108.355 -175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.5 mt -68.23 115.31 7.54 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.813 0.845 . . . . 0.0 109.598 175.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.17 152.92 1.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.155 1.782 . . . . 0.0 112.882 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.83 -21.93 32.75 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -172.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.87 88.16 0.12 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.135 1.35 . . . . 0.0 112.282 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.8 p -161.05 171.75 18.06 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.674 1.19 . . . . 0.0 112.446 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 97.0 m -124.3 140.11 53.27 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.35 1.06 . . . . 0.0 109.187 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -131.09 119.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -107.58 -20.87 13.1 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.865 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -121.43 49.69 1.49 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.85 -16.72 59.67 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.103 -0.998 . . . . 0.0 112.626 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.19 -17.28 2.67 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.972 1.309 . . . . 0.0 114.36 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -55.15 -29.56 58.02 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.473 -1.392 . . . . 0.0 113.656 165.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.2 tp -78.58 -39.33 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.899 0.772 . . . . 0.0 112.195 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 33.58 43.78 0.06 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.256 1.822 . . . . 0.0 114.293 -171.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.86 61.96 0.14 Allowed Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.753 -155.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD13 ' HB ' ' A' ' 54' ' ' ILE . 27.2 tp -139.9 124.85 18.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.268 1.027 . . . . 0.0 110.4 174.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.7 m -132.05 -15.67 2.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -129.99 110.1 11.39 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.383 1.473 . . . . 0.0 109.443 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.7 120.66 43.17 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -168.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -116.62 112.39 21.22 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 109.59 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG13 HG21 ' A' ' 8' ' ' VAL . 38.5 t -95.26 131.19 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.586 1.554 . . . . 0.0 109.182 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.75 HD13 ' CE1' ' A' ' 96' ' ' PHE . 11.2 mt -132.06 136.2 27.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.415 0.686 . . . . 0.0 110.376 -161.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.2 14.91 0.43 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.561 2.841 . . . . 0.0 114.535 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.14 -35.54 0.64 Allowed Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.997 2.237 . . . . 0.0 115.023 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.03 -26.33 65.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.847 1.659 . . . . 0.0 112.526 167.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.75 ' CE1' HD13 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -50.18 153.08 1.54 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.876 1.271 . . . . 0.0 110.757 159.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' HG3' ' CZ3' ' A' ' 98' ' ' TRP . 27.6 tp60 -132.28 -33.89 1.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.327 0.651 . . . . 0.0 111.842 167.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.411 ' CZ3' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -151.63 166.94 29.67 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.068 1.747 . . . . 0.0 109.673 171.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.4 166.26 23.58 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 122.142 0.973 . . . . 0.0 111.193 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 HG23 HG11 ' A' ' 182' ' ' VAL . 9.2 p -134.51 121.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.698 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.84 120.74 19.85 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -115.46 144.77 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.976 1.31 . . . . 0.0 109.414 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.35 152.11 40.26 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.761 1.624 . . . . 0.0 108.912 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.8 mt -123.13 124.69 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 123.512 0.725 . . . . 0.0 109.62 -173.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.5 t -124.65 116.64 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 125.475 1.51 . . . . 0.0 109.631 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -83.31 120.36 25.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.161 1.784 . . . . 0.0 110.68 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -131.64 27.03 4.7 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.102 1.761 . . . . 0.0 111.405 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.85 -56.92 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 125.95 1.7 . . . . 0.0 111.37 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -119.74 128.48 53.8 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.217 1.407 . . . . 0.0 109.743 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.6 56.6 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.967 1.307 . . . . 0.0 111.702 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 52.9 m -132.76 -66.32 0.68 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.004 1.322 . . . . 0.0 111.349 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.67 170.17 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -172.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.59 -12.61 60.72 Favored Glycine 0 CA--C 1.537 1.465 0 O-C-N 120.468 -1.395 . . . . 0.0 115.178 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.1 p -110.3 -25.94 9.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.573 1.549 . . . . 0.0 113.894 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -71.98 135.02 46.27 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 165.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -131.88 138.77 48.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 122.147 0.975 . . . . 0.0 109.817 172.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.637 ' HG3' HG22 ' A' ' 156' ' ' VAL . 2.8 ttp -121.8 137.29 54.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.683 2.393 . . . . 0.0 108.165 -173.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.0 m -136.45 135.52 38.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.12 123.66 54.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.0 m -120.8 90.55 46.59 Favored Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 125.016 1.327 . . . . 0.0 110.416 -168.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.22 82.07 1.64 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.064 3.176 . . . . 0.0 113.126 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 55.32 57.83 5.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.293 1.437 . . . . 0.0 112.129 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.83 50.09 16.43 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.377 1.471 . . . . 0.0 113.239 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.92 169.73 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 127.692 2.397 . . . . 0.0 109.243 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.15 79.56 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.936 2.894 . . . . 0.0 114.579 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 159.75 30.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.212 1.405 . . . . 0.0 110.504 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.0 p -134.39 151.18 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.438 1.095 . . . . 0.0 109.652 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.29 131.02 54.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.047 0.939 . . . . 0.0 109.593 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.536 ' HB3' HG21 ' A' ' 136' ' ' VAL . 0.9 OUTLIER -137.62 150.64 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -144.92 137.99 26.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.468 1.107 . . . . 0.0 110.537 -170.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -46.76 100.75 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.084 2.154 . . . . 0.0 111.564 -173.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.14 43.74 0.59 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.327 0.489 . . . . 0.0 114.123 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -136.32 164.52 27.91 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.678 1.591 . . . . 0.0 111.784 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.49 165.64 18.59 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.126 -0.984 . . . . 0.0 111.565 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -54.38 132.0 43.25 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.222 -0.924 . . . . 0.0 111.404 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 129' ' ' CYS . 14.9 t -100.18 116.07 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.768 1.227 . . . . 0.0 110.446 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.47 100.43 11.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.87 1.268 . . . . 0.0 109.533 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.4 mt -83.02 112.71 40.4 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.289 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.41 134.48 15.57 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.486 2.124 . . . . 0.0 110.342 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 mm -122.89 124.29 26.63 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.487 1.515 . . . . 0.0 108.644 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.65 174.2 13.05 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.593 2.862 . . . . 0.0 112.564 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.11 137.84 58.22 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.585 -0.697 . . . . 0.0 111.756 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.2 pp -151.79 38.19 0.59 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.162 1.385 . . . . 0.0 112.723 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.6 t -40.25 138.29 1.17 Allowed Pre-proline 0 N--CA 1.478 0.975 0 C-N-CA 127.381 2.272 . . . . 0.0 114.766 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.55 158.62 90.16 Favored 'Cis proline' 0 CA--C 1.541 0.859 0 CA-C-N 119.836 0.977 . . . . 0.0 113.137 0.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.59 -33.82 66.02 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.067 1.844 . . . . 0.0 112.877 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -72.28 0.79 9.01 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.106 1.362 . . . . 0.0 114.618 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 10.1 p -66.94 175.62 2.42 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.293 1.044 . . . . 0.0 113.268 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -128.61 103.76 7.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.544 1.538 . . . . 0.0 110.508 -176.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 tt -78.61 132.08 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.845 1.258 . . . . 0.0 110.181 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.17 143.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.455 0.645 . . . . 0.0 110.363 170.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.4 t -137.35 153.43 50.23 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.56 1.144 . . . . 0.0 109.135 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -112.17 119.82 39.68 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.8 tt -101.18 126.2 47.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.977 1.311 . . . . 0.0 109.561 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.46 125.14 37.86 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.635 1.574 . . . . 0.0 108.817 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.637 HG22 ' HG3' ' A' ' 117' ' ' MET . 2.4 t -129.33 119.19 47.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.809 1.243 . . . . 0.0 109.033 -175.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -147.91 149.08 31.58 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.644 1.178 . . . . 0.0 109.802 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -70.87 134.08 47.0 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.217 -0.302 . . . . 0.0 110.948 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.1 p -72.71 -19.23 61.44 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.486 1.515 . . . . 0.0 113.733 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 169.62 10.95 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.321 1.848 . . . . 0.0 111.298 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.8 p -53.18 146.09 22.54 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.252 1.021 . . . . 0.0 113.583 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.0 6.39 18.37 Favored 'Cis proline' 0 CA--C 1.545 1.056 0 N-CA-C 114.933 1.09 . . . . 0.0 114.933 4.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.93 24.47 14.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.837 1.255 . . . . 0.0 112.377 176.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.17 142.19 43.55 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.623 -1.298 . . . . 0.0 111.015 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -57.9 146.17 33.0 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.11 0.564 . . . . 0.0 111.379 168.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.38 -40.67 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.348 1.059 . . . . 0.0 111.604 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 90.6 t -146.67 137.92 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.584 0.754 . . . . 0.0 109.402 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -149.6 139.13 21.59 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.56 1.144 . . . . 0.0 110.445 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 170.66 -172.37 44.15 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.71 0.671 . . . . 0.0 114.238 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 5.7 m -115.81 132.25 56.7 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.718 0.807 . . . . 0.0 111.598 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.61 116.54 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.976 2.11 . . . . 0.0 108.139 -176.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.4 138.68 31.35 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 120.89 -1.131 . . . . 0.0 109.143 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -112.77 146.53 38.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 122.134 0.968 . . . . 0.0 109.629 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -141.26 152.2 44.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.916 1.686 . . . . 0.0 108.209 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . 0.416 ' CE2' ' HA2' ' A' ' 180' ' ' GLY . 31.8 t80 -121.13 150.25 41.54 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.788 1.235 . . . . 0.0 109.43 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 m -111.23 105.38 56.96 Favored Pre-proline 0 C--O 1.244 0.804 0 C-N-CA 123.804 0.842 . . . . 0.0 109.458 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.44 48.69 1.6 Allowed 'Trans proline' 0 CA--C 1.541 0.855 1 C-N-CA 126.271 4.648 . . . . 0.0 113.596 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.4 t -123.04 -45.43 2.13 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.408 1.483 . . . . 0.0 110.923 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.9 p -151.09 34.12 0.59 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.227 1.811 . . . . 0.0 110.656 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 175' ' ' TYR . . . 58.98 32.8 71.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.978 1.275 . . . . 0.0 114.878 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.48 171.3 15.35 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.761 1.28 . . . . 0.0 110.948 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.443 HG11 HG23 ' A' ' 100' ' ' VAL . 0.4 OUTLIER -132.69 152.43 36.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.453 1.101 . . . . 0.0 109.794 177.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.7 m -138.32 140.93 39.73 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.43 1.892 . . . . 0.0 107.468 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.49 HG22 ' HD2' ' A' ' 186' ' ' LYS . 1.1 p -110.29 141.54 25.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 24.9 mt -133.02 120.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.49 ' HD2' HG22 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -138.96 142.31 38.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 124.635 1.174 . . . . 0.0 109.037 175.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 140.4 52.75 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.057 1.343 . . . . 0.0 108.309 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.48 -20.09 11.64 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.66 -16.36 64.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.282 1.433 . . . . 0.0 114.607 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 32.7 p -141.07 -42.31 0.38 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.697 1.599 . . . . 0.0 113.59 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.432 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 10.0 t80 -88.19 146.82 38.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.983 1.313 . . . . 0.0 110.591 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 45.9 Cg_endo -76.03 168.99 23.01 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.224 2.616 . . . . 0.0 112.656 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -94.77 10.87 33.46 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.482 1.513 . . . . 0.0 112.514 175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -93.64 -44.51 8.15 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 111.986 -170.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -100.48 144.87 28.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.366 1.466 . . . . 0.0 109.108 167.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.2 p -139.97 158.46 44.03 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.07 1.348 . . . . 0.0 108.978 171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 72.1 t -121.01 135.56 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.3 m -127.91 126.1 40.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.16 0.984 . . . . 0.0 109.092 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -68.06 137.0 54.67 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.417 0.687 . . . . 0.0 110.401 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.69 -26.79 2.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.318 1.047 . . . . 0.0 112.945 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -161.4 172.52 16.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.139 1.776 . . . . 0.0 111.039 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.452 ' HB2' ' H ' ' A' ' 59' ' ' GLU . 8.0 t30 -58.09 136.21 57.15 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.915 -1.116 . . . . 0.0 109.942 174.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.413 ' HA ' ' CG1' ' A' ' 182' ' ' VAL 0.25 2.3 p 56.31 6.51 0.26 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -178.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 31.8 m -113.67 133.4 55.34 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.989 1.316 . . . . 0.0 111.412 -169.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 184' ' ' VAL . 4.4 m-85 -142.49 137.61 30.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.9 -1.5 . . . . 0.0 110.734 -177.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 60.9 mt -122.67 118.95 56.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -87.31 126.85 35.1 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.205 1.402 . . . . 0.0 108.707 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -119.26 132.32 55.9 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.753 1.221 . . . . 0.0 109.388 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.5 tt -113.7 125.44 54.13 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 109.526 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -128.62 3.71 5.53 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.583 1.153 . . . . 0.0 113.864 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 28.6 m -150.5 115.63 5.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.547 1.939 . . . . 0.0 110.675 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -52.88 -35.41 57.8 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 119.618 1.099 . . . . 0.0 113.682 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.949 1.7 . . . . 0.0 113.453 -168.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_